Citrus Sinensis ID: 004247
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 766 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.402 | 0.404 | 0.440 | 5e-72 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.429 | 0.464 | 0.430 | 5e-72 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.378 | 0.389 | 0.452 | 7e-72 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.396 | 0.466 | 0.445 | 4e-71 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.373 | 0.397 | 0.448 | 3e-70 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.366 | 0.391 | 0.442 | 2e-69 | |
| Q8RXC8 | 460 | Receptor-like cytosolic s | no | no | 0.399 | 0.665 | 0.44 | 3e-69 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.399 | 0.426 | 0.439 | 3e-69 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.374 | 0.404 | 0.440 | 6e-69 | |
| Q5XF57 | 579 | Probable receptor-like se | no | no | 0.377 | 0.499 | 0.441 | 7e-69 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 273 bits (697), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 142/322 (44%), Positives = 205/322 (63%), Gaps = 14/322 (4%)
Query: 401 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKE 459
+ + LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 460 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 519
F E++ I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGT--PGLDWATR 528
Query: 520 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
K+A G A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT
Sbjct: 529 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT- 587
Query: 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639
T V GTFGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647
Query: 640 ILSSG----KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--G 693
+LS+ + T L DP LG NY +M RM+ A+ CIR RP+MS +++
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLA 707
Query: 694 DADVTKWARLQ----VNASEES 711
+ D+T RL +N++++S
Sbjct: 708 EEDLTNGMRLGESEIINSAQQS 729
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 149/346 (43%), Positives = 211/346 (60%), Gaps = 17/346 (4%)
Query: 407 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 465
LF+Y++L+ AT+ F ENL+G+GG VYKG LPDG+ +AVK LK +EF E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 466 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 525
++ +HH++++S++G C + LL+YD++S L +LHG K + W+ R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
A L YLH R+IHRD+KSSNILL D+F+ ++SDFGLA+ A ++HIT T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P++S
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAI 599
Query: 646 VTQ----LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA--DVTK 699
T+ L DP LG NY +M RM+ A+ C+R RP+M +++ A D+T
Sbjct: 600 ETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTN 659
Query: 700 WARLQVNASEESEMLDD-ESCPRSNLQSHLNLALLDVEDDSFSMSS 744
RL ESE+ + + L + + D FS SS
Sbjct: 660 GMRLG-----ESEVFNSAQQSAEIRLFRRMAFGSQNYSTDFFSHSS 700
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 138/305 (45%), Positives = 201/305 (65%), Gaps = 15/305 (4%)
Query: 403 ATCRL----FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVI 457
ATC L F +L AT F A+ ++G+GG +VY+G + DG E+AVK+L + +++
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 458 KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 517
+EF+ E+E+++ LHH+N++ L+G C E L+Y+ + GS+E +LH D W
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLD-----WD 442
Query: 518 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
R K+A+G A L YLH S RVIHRD K+SN+LL DDF P++SDFGLA+ A+ S HI
Sbjct: 443 ARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 502
Query: 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGR+P+ P G+E+LV WA
Sbjct: 503 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWA 561
Query: 638 KPILSSGK-VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV---LKLLRG 693
+P+L++ + + QL+DPAL Y++D M ++ + +C+ ++ RP M V LKL+
Sbjct: 562 RPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN 621
Query: 694 DADVT 698
DAD T
Sbjct: 622 DADET 626
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 140/314 (44%), Positives = 204/314 (64%), Gaps = 10/314 (3%)
Query: 390 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKI 449
LP GL +S + F Y++L AT+ F NL+G+GG V+KG LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 450 LKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK 508
LK S +EF E+EII+ +HH++++SL+G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-- 367
Query: 509 KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568
K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DFGLAK
Sbjct: 368 KGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628
AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+P+ ++
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVY 486
Query: 629 GQESLVMWAKPILS----SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 684
+SLV WA+P+L+ G L D +GN YD ++M RMV + C+R R RP+M
Sbjct: 487 VDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRM 546
Query: 685 SLVLKLLRGDADVT 698
S +++ L G+ ++
Sbjct: 547 SQIVRALEGNVSLS 560
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 132/294 (44%), Positives = 197/294 (67%), Gaps = 8/294 (2%)
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 466
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 467 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 526
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 642
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIE 595
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696
+G +++L+D L Y ++ RM+ + C+R RP+M V++ L D D
Sbjct: 596 TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 649
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 128/289 (44%), Positives = 192/289 (66%), Gaps = 8/289 (2%)
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 466
F Y++L T F ++G+GG VYKG L +GK +A+K LK S + +EF E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 467 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 526
I+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+ WS R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T+ SHI+ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 642
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P L
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
G +++++DP L N+Y ++ +M+ + C+R RP+M V++ L
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 143/325 (44%), Positives = 197/325 (60%), Gaps = 19/325 (5%)
Query: 397 LHEKYSATCRLFNYQ--DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK--- 451
LH+ Y L N+ D+ AT NF EN+IG+GG + VY+G LP+GK +AVK L
Sbjct: 118 LHDIYDFQSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGT 177
Query: 452 PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 511
P E EF+ E+ II + H N +G C E + LV+ GSL LHG K
Sbjct: 178 PDEQT-AEFLSELGIIAHVDHPNTAKFIGCCIE-GGMHLVFRLSPLGSLGSLLHGPSK-- 233
Query: 512 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571
WS RY VA+G A+ L YLH G +R+IHRD+K+ NILL++DF+PQ+ DFGLAKW
Sbjct: 234 YKLTWSRRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLP 293
Query: 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631
+H + GTFGY APEYFM+G V++K DV+AFGV+LLEL+TG + + Q+
Sbjct: 294 KQLTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQ 349
Query: 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
SLV+WAKP+L + +L+DP+LG+ Y+ +++ R+ + LCI + RP+MS V++LL
Sbjct: 350 SLVLWAKPLLERKAIKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELL 409
Query: 692 RGDADVTKWAR------LQVNASEE 710
G DV R +Q SEE
Sbjct: 410 LGHEDVVMTPREAKIKMMQRTYSEE 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 138/314 (43%), Positives = 199/314 (63%), Gaps = 8/314 (2%)
Query: 386 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 445
D + LP GL FNY++L AT+ F NL+G+GG V+KG L +GKE+
Sbjct: 320 DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEV 379
Query: 446 AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 504
AVK LK S +EF E+ II+ +HH+++++L+G+C D LLVY+F+ +LE +L
Sbjct: 380 AVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHL 439
Query: 505 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564
HG K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DF
Sbjct: 440 HG--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497
Query: 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624
GLAK AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+PI
Sbjct: 498 GLAKIASDTNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV 556
Query: 625 DHPKGQESLVMWAKPILSS----GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 680
++ SLV WA+P+L+ G ++D L N YD ++M RMV + C+R
Sbjct: 557 NNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPR 616
Query: 681 RPQMSLVLKLLRGD 694
RP+M V ++L G+
Sbjct: 617 RPRMDQVARVLEGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 130/295 (44%), Positives = 195/295 (66%), Gaps = 8/295 (2%)
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 466
F Y++L T F N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 467 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 526
I+ +HH++++SL+G+C D+ LL+Y+++ +LE +LHG K W+ R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGS 458
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
A+ L YLH ++IHRD+KS+NILL D+FE Q++DFGLAK ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 642
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV 697
+G ++L+D L +Y +++ RM+ + C+R RP+M V++ L + D+
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDM 632
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 133/301 (44%), Positives = 194/301 (64%), Gaps = 12/301 (3%)
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 464
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 465 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 524
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644
TFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ Q+ +++WAKP + +G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN----PTQKHILLWAKPAMETG 487
Query: 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTKWAR 702
++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K R
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWR 547
Query: 703 L 703
+
Sbjct: 548 M 548
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 766 | ||||||
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.981 | 0.992 | 0.739 | 0.0 | |
| 224066793 | 738 | predicted protein [Populus trichocarpa] | 0.945 | 0.981 | 0.726 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.899 | 0.988 | 0.705 | 0.0 | |
| 356547275 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.951 | 0.990 | 0.670 | 0.0 | |
| 449523137 | 756 | PREDICTED: uncharacterized LOC101203034 | 0.954 | 0.966 | 0.685 | 0.0 | |
| 449463428 | 756 | PREDICTED: uncharacterized protein LOC10 | 0.954 | 0.966 | 0.685 | 0.0 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.945 | 0.974 | 0.657 | 0.0 | |
| 302141759 | 732 | unnamed protein product [Vitis vinifera] | 0.919 | 0.961 | 0.689 | 0.0 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.946 | 0.966 | 0.657 | 0.0 | |
| 42563282 | 794 | adenine nucleotide alpha hydrolases-doma | 0.960 | 0.926 | 0.622 | 0.0 |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1130 bits (2922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/772 (73%), Positives = 646/772 (83%), Gaps = 20/772 (2%)
Query: 1 MKMVQQEGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD 60
MKM+Q SG RTV+VGVKLD+ SRELLTWA+VKVAQPGDTVIALHVL NN IVD
Sbjct: 1 MKMIQHAEKKGGSGC-RTVMVGVKLDSESRELLTWAMVKVAQPGDTVIALHVLGNNEIVD 59
Query: 61 RDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIV 120
R+GKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRG+SIRKILVREA+SYSAT IV
Sbjct: 60 REGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGSSIRKILVREAKSYSATNIIV 119
Query: 121 GTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS----TAGTEDHRRN 176
G A+ HHTIRS TS+AKYCAKKLSKDC VLAV+NGKVVFQKEG + + G+ED +R
Sbjct: 120 GAARTHHTIRSPTSVAKYCAKKLSKDCLVLAVHNGKVVFQKEGSTAKTGDSHGSEDDQRK 179
Query: 177 SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLG-GSVMNLEQALVKARSDCSG 235
+++ HRSIS+SK NSKV+++ G I P +G G+ QALVKAR + G
Sbjct: 180 GFVNIFHRSISLSK-----NSKVISESG--INEAPKYVVGEGNEQTFHQALVKARPNSLG 232
Query: 236 SAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQ 295
S K+NC++CG V N D SC+QS E+S D G ++SLA+VPV VE S+S L+ Q
Sbjct: 233 SIMKQNCTVCGAVGNSLDESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSSSFRSLIAQ 292
Query: 296 LPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQ-PSYLANSDVKQITYDP 354
+PE +PGWPLLRRAI P +A DRSSLR+ISVVQWA+RLP+RQ S ++N D KQ
Sbjct: 293 VPELKPGWPLLRRAILPGGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLDHKQ----N 348
Query: 355 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 414
G+ + +L+G+SGAIV VG + ++ P S DH++ +LP ELEG HEKYSATCRLF YQ+LL
Sbjct: 349 GEGQP-SLDGESGAIVAVGTDALTIPPSPDHNA-KLPIELEGFHEKYSATCRLFQYQELL 406
Query: 415 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN 474
SATSNFLAE L+GKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFVLEIEIITTL+HKN
Sbjct: 407 SATSNFLAEYLVGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEIITTLNHKN 466
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
IISLLGFCFE N LLLVYDFLSRGSLEENLHGN+KDP AF W ERYKVA+GVAEAL YLH
Sbjct: 467 IISLLGFCFEYNKLLLVYDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGVAEALNYLH 526
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
+G+AQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI CTDVAGTFGYLAPEYF
Sbjct: 527 TGTAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYLAPEYF 586
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
MYGKVN+KIDVYAFGVVLLELL+GRKPISND PKGQESLVMWAKPIL GK QLLDP+L
Sbjct: 587 MYGKVNEKIDVYAFGVVLLELLSGRKPISNDLPKGQESLVMWAKPILDDGKFCQLLDPSL 646
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEML 714
G++YD DQMERMVLA+ LC++R PRARPQMSLVLKLL GDA+VTKWARLQVN EES+ML
Sbjct: 647 GDDYDQDQMERMVLAATLCVKRSPRARPQMSLVLKLLHGDAEVTKWARLQVNKVEESDML 706
Query: 715 DDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
DDE+CPRSN+QSHLNLA LDVEDDS S+SSIEQ+VSLEDYL GR SRSSSFD
Sbjct: 707 DDETCPRSNIQSHLNLAFLDVEDDSLSISSIEQTVSLEDYLQGRCSRSSSFD 758
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066793|ref|XP_002302218.1| predicted protein [Populus trichocarpa] gi|222843944|gb|EEE81491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1041 bits (2691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/741 (72%), Positives = 619/741 (83%), Gaps = 17/741 (2%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD+ SRELLTWALVKVAQPGDTVIALHVL +N IVDR+GKSSLLSLVKAFDSV
Sbjct: 8 TVIVGVKLDSMSRELLTWALVKVAQPGDTVIALHVLGSNEIVDREGKSSLLSLVKAFDSV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+S RKILVRE +SY+ATK IVG AKNH +I S+TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSTRKILVREVKSYAATKVIVGAAKNHPSIWSSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGTEDHRRNSLLDVIHRSISMSKITGQKNS 197
YCAKKL KDCSVLAVNNGKVVFQ+E P+T+GT+DH + SLL V+HR+IS K + + N
Sbjct: 128 YCAKKLPKDCSVLAVNNGKVVFQRERSPNTSGTKDHSK-SLLSVVHRTISSEKKSRELNE 186
Query: 198 KVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCS 257
+ +G S + D + LE+AL+KARS+ S K NCS+CG D S +
Sbjct: 187 S--SANGGSKDDQDSDQI------LEKALMKARSNSLESIMKENCSVCGSATIFADDSSN 238
Query: 258 QSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAP 317
+S E S SD G D+SLA+VPV +E ++S++ L+RQ+PE +PGWPLL RA+ PD++
Sbjct: 239 ESAEASSSDNGGDDKSLALVPVPRLEEPTSSVSTLIRQVPELKPGWPLLCRAVLPDKKES 298
Query: 318 DRSSLRKISVVQW-ALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEI 376
+ S +R++ VVQW L L T NSD KQ D G+++ NL+G+SGAIV VG E
Sbjct: 299 NISLVRQVCVVQWEQLSLST------VNSDHKQDGSDKGEDK-FNLDGESGAIVAVGMET 351
Query: 377 VSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK 436
++P + H+S PKELEGLHEKYSATCRLF YQ+LLSATSNFLAENLIGKGGSSQVYK
Sbjct: 352 ATAPHTPHHNSRSPPKELEGLHEKYSATCRLFQYQELLSATSNFLAENLIGKGGSSQVYK 411
Query: 437 GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496
GCL DGKELAVKILKPSEDV+KEFVLEIEIITTLHHKNIISLLGFCFED NLLLVYDFL
Sbjct: 412 GCLSDGKELAVKILKPSEDVLKEFVLEIEIITTLHHKNIISLLGFCFEDKNLLLVYDFLP 471
Query: 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556
RGSLE+NL+GNKKDP FGW+ERYKVA+GVAEAL+YLHS SAQ VIHRDVKSSNILLSDD
Sbjct: 472 RGSLEDNLYGNKKDPLTFGWNERYKVALGVAEALDYLHSCSAQPVIHRDVKSSNILLSDD 531
Query: 557 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616
FEPQLSDFGLAKWA TSSSHI CTDVAGTFGYLAPEYFMYGKVN KIDVYAFGVVLLELL
Sbjct: 532 FEPQLSDFGLAKWAPTSSSHIICTDVAGTFGYLAPEYFMYGKVNKKIDVYAFGVVLLELL 591
Query: 617 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 676
+G+KPISND PKGQESLVMWAKPIL+ GKV+QLLD +LG++YD DQMERMVLA+ LC++R
Sbjct: 592 SGKKPISNDLPKGQESLVMWAKPILNGGKVSQLLDSSLGDSYDLDQMERMVLAANLCVKR 651
Query: 677 DPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVE 736
PRARPQMSLV+KLL+GDA+ TKWARLQVNA+EES++LDDE+CPRSNL SHLNLALLDVE
Sbjct: 652 APRARPQMSLVVKLLQGDAEATKWARLQVNAAEESDVLDDEACPRSNLLSHLNLALLDVE 711
Query: 737 DDSFSMSSIEQSVSLEDYLLG 757
DD S+SSIE S+SLEDYL G
Sbjct: 712 DDLLSLSSIEHSISLEDYLAG 732
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/750 (70%), Positives = 601/750 (80%), Gaps = 61/750 (8%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD SRELLTWALVKVAQPGDTVIALH+L NN IVDR+GKSSLLSLVKAFD+V
Sbjct: 8 TVIVGVKLDPASRELLTWALVKVAQPGDTVIALHILDNNEIVDREGKSSLLSLVKAFDNV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+SIR+ILVREA+SY+ATK IVG +NH +I +TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSIRRILVREAKSYTATKVIVGATRNHLSIWPSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGTEDHRRNSLLDVIHRSISMSKITGQKNS 197
YCAKKL KDCSVLA NNGKVVFQ+E P+ G + S S++ I
Sbjct: 128 YCAKKLPKDCSVLAFNNGKVVFQRERTPNNTG-------------NFSCSLASIM----- 169
Query: 198 KVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCS 257
+ +CS +CG V D SC+
Sbjct: 170 --------------------------------KENCS---------VCGSVMKPADDSCN 188
Query: 258 QSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAP 317
QS E S D D+SLA+VPV VE ++S++ L+ Q+PE +PGWPLLR ++ P+R+
Sbjct: 189 QSAEASCGDRDGDDKSLALVPVPRVEEPTSSVSTLIGQVPELKPGWPLLRSSVLPNRKTS 248
Query: 318 DRSSLRKISVVQWALRLPTRQPSY-LANSDVKQITYDPGDNESINLNGDSGAIVPVGNEI 376
+RS +R+ISVVQWA+RLP+RQ S NSD KQ D G+ E +NL+G+SGAIV VG E
Sbjct: 249 NRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQDVSDKGE-EQLNLDGESGAIVAVGMET 307
Query: 377 VSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK 436
++PLS DH+S LPKELEGLHEKYSATCRLF Q+LLSATSNFLAENLIGKGGSSQVYK
Sbjct: 308 ATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQCQELLSATSNFLAENLIGKGGSSQVYK 367
Query: 437 GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496
GCLPDGKELAVKILKPSEDV+KEFV EIEIITTL HKNIISLLGFCFE NLLLVYDFLS
Sbjct: 368 GCLPDGKELAVKILKPSEDVLKEFVQEIEIITTLSHKNIISLLGFCFEGKNLLLVYDFLS 427
Query: 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556
RGSLEENLHGNKKDP AFGW+ERYKVA+G+AEAL+YLHS SAQ VIHRDVKSSNILLSDD
Sbjct: 428 RGSLEENLHGNKKDPRAFGWNERYKVALGIAEALDYLHSCSAQPVIHRDVKSSNILLSDD 487
Query: 557 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616
FEPQLSDFGLAKWA TSSSHI C DVAGTFGYLAPEYFMYGKVN+KIDVYAFGVVLLELL
Sbjct: 488 FEPQLSDFGLAKWAPTSSSHIICNDVAGTFGYLAPEYFMYGKVNNKIDVYAFGVVLLELL 547
Query: 617 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 676
+G+KPISND PKGQESLVMWAKPIL+ GKV+QLLDP LG++ D DQMERMVLA+ LC+RR
Sbjct: 548 SGKKPISNDLPKGQESLVMWAKPILNGGKVSQLLDPILGDSCDRDQMERMVLAATLCVRR 607
Query: 677 DPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVE 736
PRARPQMSLV+KLL+GDA+VT+WARLQVNA EES++LDDE+CPRSNLQSHLNLALLDVE
Sbjct: 608 APRARPQMSLVVKLLQGDAEVTRWARLQVNAVEESDVLDDEACPRSNLQSHLNLALLDVE 667
Query: 737 DDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
+DS S SS+EQS+SL+DYL GRWSRSSS D
Sbjct: 668 NDSLSSSSLEQSISLQDYLQGRWSRSSSLD 697
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547275|ref|XP_003542041.1| PREDICTED: uncharacterized protein LOC100797280 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1015 bits (2624), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/773 (67%), Positives = 600/773 (77%), Gaps = 44/773 (5%)
Query: 1 MKMVQ--QEGDVISSGAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
MKM+ G SGAG RTVVVG+K+D+HS ELLTWAL KVAQPGD V+ALHVL N+
Sbjct: 1 MKMLPPPTAGGASHSGAGDRTVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDE 60
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IV+R+GKSSL SLVKAFDS+LAVYEGFCNLKQVDLK KICRG+S+R+ILVREA +YSAT
Sbjct: 61 IVNREGKSSLFSLVKAFDSILAVYEGFCNLKQVDLKFKICRGSSVRRILVREANAYSATH 120
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPST----AGTEDH 173
IVG+++ H IR S+A+YCAKKL KDC VLAV+NGK+VF++EG P+T G +
Sbjct: 121 IIVGSSQGLHIIRPCISVARYCAKKLPKDCWVLAVDNGKIVFKREGSPATRAELKGLDQD 180
Query: 174 RRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDC 233
+ LL IHR+IS K SKV+ DDG+ I K G+ + +L KA D
Sbjct: 181 HKTRLLGSIHRTIS-------KGSKVLDDDGTGIHEKGC----GNGEYSDHSLAKAFLDS 229
Query: 234 SGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLV 293
K+ CSIC SEEES D + LAIVPVQ +AAS
Sbjct: 230 KEFVEKKRCSICA------------SEEESCGDASDENNPLAIVPVQTNDAAS------- 270
Query: 294 RQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYD 353
+PGWPLLR+ I D++ ++S LR+ISVVQWA++LP+R SY A+ D K D
Sbjct: 271 ------KPGWPLLRKTIASDKKCSEKSLLRQISVVQWAMQLPSRDLSYAAHQDHKANNCD 324
Query: 354 PGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 413
++ + L+ SGA+VPV EI ++ S + +S +PKELEGLHEKYS+TCRLF YQ+L
Sbjct: 325 QNKDQFLALDSKSGALVPVDAEIGTAS-SPERNSRSIPKELEGLHEKYSSTCRLFEYQEL 383
Query: 414 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 473
+ ATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKILKPS+DV+KEFVLEIEIITTL+HK
Sbjct: 384 VLATSNFLPENLIGKGGSSQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHK 443
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
NIISLLGFCFED NLLLVYDFLSRGSLEENLHGNKK+P FGW+ERYKVAMGVAEALEYL
Sbjct: 444 NIISLLGFCFEDGNLLLVYDFLSRGSLEENLHGNKKNPLVFGWTERYKVAMGVAEALEYL 503
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H+ Q VIHRDVKSSN+LLS+DFEPQLSDFGLAKWASTSSSHI CTDVAGTFGY+APEY
Sbjct: 504 HNNEGQSVIHRDVKSSNVLLSEDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYMAPEY 563
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
FMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV Q+LDP+
Sbjct: 564 FMYGKVNDKIDVYAFGVVLLELLSGRKPISGDYPKGQESLVMWASPILNSGKVLQMLDPS 623
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEM 713
LG NYD+++MERMVLA+ LCIRR PRARP MSL+ KLL GD DV KWARL+ NA E EM
Sbjct: 624 LGENYDHEEMERMVLAATLCIRRAPRARPLMSLISKLLGGDPDVIKWARLEANALEAPEM 683
Query: 714 LDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
LD E+CP SNLQSHLNLALLDVEDDS SM S+EQ+VSLEDYL GRWSRSSSFD
Sbjct: 684 LDGEACPPSNLQSHLNLALLDVEDDSLSMCSVEQNVSLEDYLRGRWSRSSSFD 736
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523137|ref|XP_004168581.1| PREDICTED: uncharacterized LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1014 bits (2621), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/761 (68%), Positives = 614/761 (80%), Gaps = 30/761 (3%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAG----TEDHRRNSLLDVIHRSISMSK 190
+AKYCAKKL KD VLAV+NGKV+F++EGCP G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 191 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 249
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 250 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 307
+ + QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SFVE----QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 308 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 365
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 366 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 425
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 605
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDV 595
Query: 606 YAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMER 665
YA+GVVLLEL++GRKPIS ++PKGQESLVMWA+PIL GKV++LLDP LG NY+ D+MER
Sbjct: 596 YAYGVVLLELISGRKPISTEYPKGQESLVMWARPILIDGKVSRLLDPTLGGNYNQDEMER 655
Query: 666 MVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQ 725
+VLA+ LCIRR PRARP MSLVLKLL+GDADVTKWAR Q+NA +S LDDE CPRS++Q
Sbjct: 656 VVLAASLCIRRAPRARPPMSLVLKLLQGDADVTKWARQQINALGDSNTLDDEVCPRSDIQ 715
Query: 726 SHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
SHLNLALLDV+DDS S+SSIE S+SLEDYL GRWSRSSSFD
Sbjct: 716 SHLNLALLDVDDDSLSLSSIEHSISLEDYLQGRWSRSSSFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463428|ref|XP_004149436.1| PREDICTED: uncharacterized protein LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1013 bits (2619), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/761 (68%), Positives = 613/761 (80%), Gaps = 30/761 (3%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAG----TEDHRRNSLLDVIHRSISMSK 190
+AKYCAKKL KD VLAV+NGKV+F++EGCP G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 191 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 249
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 250 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 307
+ + QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SFVE----QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 308 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 365
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 366 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 425
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 605
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDV 595
Query: 606 YAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMER 665
YA+GVVLLEL++GRKPIS +PKGQESLVMWA+PIL GKV++LLDP LG NY+ D+MER
Sbjct: 596 YAYGVVLLELISGRKPISTKYPKGQESLVMWARPILIDGKVSRLLDPTLGGNYNQDEMER 655
Query: 666 MVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQ 725
+VLA+ LCIRR PRARP MSLVLKLL+GDADVTKWAR Q+NA +S LDDE CPRS++Q
Sbjct: 656 VVLAASLCIRRAPRARPPMSLVLKLLQGDADVTKWARQQINALGDSNTLDDEVCPRSDIQ 715
Query: 726 SHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
SHLNLALLDV+DDS S+SSIE S+SLEDYL GRWSRSSSFD
Sbjct: 716 SHLNLALLDVDDDSLSLSSIEHSISLEDYLQGRWSRSSSFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 982 bits (2538), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/762 (65%), Positives = 589/762 (77%), Gaps = 38/762 (4%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTV+VGVK+D+ S+ELLTWALVKVA PGDTV+ALHVL NN V+ DGKSSLLSLVKAF
Sbjct: 10 GGRTVLVGVKMDSPSKELLTWALVKVAHPGDTVVALHVLGNNETVNGDGKSSLLSLVKAF 69
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLA Y+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 70 DSVLAAYKGFCNLKQVDLKLKICRGSSVKKTLVREANGYSATHVVVGTTHGLHKIRSSTV 129
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTA----GTEDHRRNSLLDVIHRSISMSK 190
+AK+CAKKLSKDC VLAVNNGKVVF+++ P + G + H RN LL IH ++
Sbjct: 130 VAKHCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVAELQGVDRHNRNGLLGSIHWTLG--- 186
Query: 191 ITGQKNSKVVTDDGSSI-----TSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSIC 245
KN KV++DD S + + P+ D +L K + + +CSIC
Sbjct: 187 ----KNRKVLSDDSSGMDADEKKTGPISD---------HSLAKFFLESKETVRNPSCSIC 233
Query: 246 GPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPL 305
G LPD S QS E D G + SLA+VPVQ AA T E +PGWPL
Sbjct: 234 GTTLALPDPSFYQSAEGVSGDEGR-ENSLAMVPVQPTVAAKT----------ELKPGWPL 282
Query: 306 LRRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNG 364
L I DR++ RS +ISVVQWA+RLP+R SY + D K D G ++ L+
Sbjct: 283 LDGRILSDRQSAGRSLFHLQISVVQWAMRLPSRNLSYAVDRDEKSKICDQGQDQPAALDS 342
Query: 365 DSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAEN 424
+SGA+V V E+ ++ S +++S +PKELEGLHEKYS+TCRLF YQ+L+SATSNFL EN
Sbjct: 343 ESGALVLVDAELGTAS-SPENNSGNIPKELEGLHEKYSSTCRLFEYQELVSATSNFLHEN 401
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 484
LIGKGGSSQVY+GCLPDGKELAVKIL PS+DV+ EF+LEIEIITTLHHKNIISLLGFCFE
Sbjct: 402 LIGKGGSSQVYRGCLPDGKELAVKILNPSDDVLSEFLLEIEIITTLHHKNIISLLGFCFE 461
Query: 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 544
+ LLLVYDFLSRGSLEENLHGNKK+ FGWSERYKVA+GVAEAL+YLHS Q VIHR
Sbjct: 462 NGKLLLVYDFLSRGSLEENLHGNKKNSLVFGWSERYKVAVGVAEALDYLHSKDDQPVIHR 521
Query: 545 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 604
DVKSSN+LLS++FEPQLSDFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKID
Sbjct: 522 DVKSSNVLLSENFEPQLSDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 581
Query: 605 VYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQME 664
VYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV QLLDP+LG+NYD+++ME
Sbjct: 582 VYAFGVVLLELLSGRKPISRDYPKGQESLVMWASPILNSGKVLQLLDPSLGDNYDHEEME 641
Query: 665 RMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNL 724
++VLA+ LCI+R PRARPQM+L+ KLL+GDA+ KWARLQVNA + EMLDDE+CP SNL
Sbjct: 642 KIVLAATLCIKRAPRARPQMNLISKLLQGDAEAIKWARLQVNALDPPEMLDDEACPPSNL 701
Query: 725 QSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
QSH+NLALLDVEDD SM S+EQ ++LEDYL GRWSR+SSFD
Sbjct: 702 QSHINLALLDVEDDLLSMCSVEQGLTLEDYLRGRWSRASSFD 743
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302141759|emb|CBI18962.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2536), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/747 (68%), Positives = 590/747 (78%), Gaps = 43/747 (5%)
Query: 24 KLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEG 83
KLD+ SRELLTWALVKVAQPGD VIALHVL +N + S +V +F AVYEG
Sbjct: 25 KLDSQSRELLTWALVKVAQPGDRVIALHVLGHNEMGVCRNCGSRWEIVASF----AVYEG 80
Query: 84 FCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKL 143
FCNLKQVDLKLKICRG+SI KILVRE +SY A+K IVGTA+NHH IRS+ ++AKYCAKKL
Sbjct: 81 FCNLKQVDLKLKICRGSSIGKILVREVKSYVASKVIVGTARNHHAIRSSAAVAKYCAKKL 140
Query: 144 SKDCSVLAVNNGKVVFQKEGCPSTA----GTEDHRRNSLLDVIHRSISMSKITGQKNSKV 199
KDCSVLAVNNGKVVFQ+E T E+HRRN LL I +S+ SK + N
Sbjct: 141 PKDCSVLAVNNGKVVFQREASMRTTVDSQEKEEHRRNGLLGGIQQSV--SKKSKALNHGK 198
Query: 200 VTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQS 259
V ++ S+I C SA + L SCSQS
Sbjct: 199 VNEEPSTI-------------------------CDPSACQS--------LELGLNSCSQS 225
Query: 260 EEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDR 319
E S D D+SLAIVPVQ +EA+S+SI++L+R+LPE RPGWPLLRRAI PDR+ +
Sbjct: 226 IEGSSGDSHHEDDSLAIVPVQKLEASSSSISLLIRELPELRPGWPLLRRAILPDRQTSTK 285
Query: 320 SSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSS 379
SS+R+ISVVQWA+RLP+R A+ D + + D ++ S NL+G+SGAIVPVG S+
Sbjct: 286 SSVRQISVVQWAMRLPSRNFPSAASLDNIESSCDGDEDLSTNLDGESGAIVPVGTVNASA 345
Query: 380 PLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL 439
P S ST+L KELEGLHEKYSATCRLF +Q+L SATSNF+ ENLIGKGGSS+VY+GCL
Sbjct: 346 PPSPSRSSTKLAKELEGLHEKYSATCRLFKFQELFSATSNFMPENLIGKGGSSRVYRGCL 405
Query: 440 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 499
DGKELAVKILK S+D++KEF+LEIEII+TLHHKNIISLLGFCFE+NNLLLVYDFLSRGS
Sbjct: 406 SDGKELAVKILKQSDDILKEFLLEIEIISTLHHKNIISLLGFCFENNNLLLVYDFLSRGS 465
Query: 500 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559
LEENL+GNKKD AFGWSERYKVA+GVAEAL+YLH GSAQ VIH DVKSSNILL+DDFEP
Sbjct: 466 LEENLYGNKKDLFAFGWSERYKVAVGVAEALDYLHCGSAQAVIHGDVKSSNILLADDFEP 525
Query: 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
QLSDFGLAKWASTSSSHITC+DVAGTFGY+APEYFMYGKVN+KIDVYAFGVVLLELL+GR
Sbjct: 526 QLSDFGLAKWASTSSSHITCSDVAGTFGYMAPEYFMYGKVNEKIDVYAFGVVLLELLSGR 585
Query: 620 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 679
KPIS+D+PKGQESLVMWAKPIL GKV++LLDP+LG+NYD QMERMV A+ILCIRR PR
Sbjct: 586 KPISSDYPKGQESLVMWAKPILYGGKVSELLDPSLGSNYDSSQMERMVWAAILCIRRAPR 645
Query: 680 ARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDS 739
ARPQMSLVLKLL+GDA+ TKWARLQVNA E S+ DDE+ P SNLQSHLNLALLDVE+DS
Sbjct: 646 ARPQMSLVLKLLQGDAEATKWARLQVNACEGSDTPDDEAFPHSNLQSHLNLALLDVEEDS 705
Query: 740 FSMSSIEQSVSLEDYLLGRWSRSSSFD 766
SMSSIEQSVSLEDYL GRWSRSSSFD
Sbjct: 706 LSMSSIEQSVSLEDYLQGRWSRSSSFD 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/761 (65%), Positives = 590/761 (77%), Gaps = 36/761 (4%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTVVVGVK+D+ +ELLTWALVKVA P DTV+ALHVL ++ V+ GKSSLLSLVKAF
Sbjct: 17 GGRTVVVGVKMDSPCKELLTWALVKVAHPRDTVVALHVLGSHETVNGVGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLAVY+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 77 DSVLAVYKGFCNLKQVDLKLKICRGSSVKKSLVREANGYSATHIVVGTTHGLHKIRSSTV 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTA----GTEDHRRNSLLDVIHRSISMSK 190
+AKYCAKKLSKDC VLAVNNGKVVF+++ P + G + H RN L+ I ++
Sbjct: 137 VAKYCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVTELQGIDRHNRNGLIGSIQWTLG--- 193
Query: 191 ITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRN 250
K++KV++DD S + + + G V + +L K + + +CSICG
Sbjct: 194 ----KSTKVLSDDNSGMEAD--EKKTGQVS--DHSLAKLFLESKETVRNPSCSICGTTLA 245
Query: 251 LPDGSCSQSEEESPSDGGAGDE----SLAIVPVQNVEAASTSITMLVRQLPESRPGWPLL 306
LPD SC QS +DG +GD+ SLAIVPVQ AA T E +PGWPLL
Sbjct: 246 LPDSSCYQS-----ADGVSGDDGRENSLAIVPVQPSVAAIT----------EMKPGWPLL 290
Query: 307 RRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 365
R I DR++ DR + +ISVVQWA+RLP+R SY + + K D G ++ L+ +
Sbjct: 291 HRGILLDRQSADRLLMHPQISVVQWAMRLPSRNLSYAVDCNEKPNICDQGQDQHAALDSE 350
Query: 366 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 425
SGA+VPV E+ ++ L +H+S +PKELEGLHEKYS+TCRLF YQ+L+ ATSNFL NL
Sbjct: 351 SGALVPVDAELGTASL-PEHNSGNIPKELEGLHEKYSSTCRLFEYQELVLATSNFLPGNL 409
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
IGKGGSSQVY+GCLPDGKELAVKILKPS++V+ EF+LEIEIITTLHHKNIISLLGFCFE+
Sbjct: 410 IGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFLLEIEIITTLHHKNIISLLGFCFEN 469
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
LLLVYDFLSRGSLEENLHGNKK FGWSERYKVA+G+AEAL+YLHS Q VIHRD
Sbjct: 470 GKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYKVAVGIAEALDYLHSKDDQPVIHRD 529
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 605
VKSSN+LLS+DFEPQL DFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 530 VKSSNVLLSEDFEPQLCDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 589
Query: 606 YAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMER 665
YAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV QLLDP+LG NYD+ +ME+
Sbjct: 590 YAFGVVLLELLSGRKPISPDYPKGQESLVMWATPILNSGKVLQLLDPSLGENYDHGEMEK 649
Query: 666 MVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQ 725
MVLA+ LCI+R PRARPQMSL+ KLL+GDA+ K ARLQVNA + EMLDDE+CP SNLQ
Sbjct: 650 MVLAATLCIKRAPRARPQMSLISKLLQGDAEAIKRARLQVNALDAPEMLDDEACPPSNLQ 709
Query: 726 SHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
SH+NLALLDVEDDS SM S+EQ ++LEDYL GRWSR+SSFD
Sbjct: 710 SHINLALLDVEDDSLSMCSVEQGLTLEDYLRGRWSRASSFD 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42563282|ref|NP_177852.2| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] gi|332197836|gb|AEE35957.1| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/795 (62%), Positives = 593/795 (74%), Gaps = 59/795 (7%)
Query: 2 KMVQQEGDVISS----GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS GRT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTA--------- 168
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 169 --------GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVM 220
G ED RR +LL+V+ RS++++K T KVV+ SK ++
Sbjct: 208 TVIGFGYIGKEDVRRITLLNVLQRSVTLNKTT-----KVVSHSEEDSNSKEEEEDQACGQ 262
Query: 221 NLEQALVKARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESL 274
NL Q L AR + NCS+CG P G S S+ + D ++++
Sbjct: 263 NLRQVLAAARLE--------NCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAM 314
Query: 275 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 334
IVPV E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+L
Sbjct: 315 EIVPVNGSEDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKL 371
Query: 335 PTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKEL 394
P R D KQ+ YD ++ LN A+VP G +++ D+ +LP+EL
Sbjct: 372 PPR--------DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEEL 419
Query: 395 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 454
EGL+E++S+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +E
Sbjct: 420 EGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTE 479
Query: 455 DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 514
DV+ +FV EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF
Sbjct: 480 DVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAF 539
Query: 515 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574
WSERYKVA+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S+
Sbjct: 540 CWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASIST 599
Query: 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634
+HI C+DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS+ PKGQESLV
Sbjct: 600 THIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLV 659
Query: 635 MWAKPILSSGKVTQLLDPAL--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
MWAKPIL GK +QLLDP+L NN + DQM+RM LA+ LCIRR P+ARP+MS+VLKLL+
Sbjct: 660 MWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLK 719
Query: 693 GDADVTKWARLQVN-ASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSL 751
GD D +WA QVN +SEESEML DE C RSNLQSHLNLALLDVEDDS SM SIEQ VS+
Sbjct: 720 GDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLNLALLDVEDDSISMGSIEQGVSV 779
Query: 752 EDYLLGRWSRSSSFD 766
EDYL GR SRSSSFD
Sbjct: 780 EDYLKGRTSRSSSFD 794
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 766 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.977 | 0.943 | 0.613 | 6.7e-239 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.966 | 0.978 | 0.573 | 3.4e-219 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.768 | 0.835 | 0.518 | 6.9e-150 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.438 | 0.544 | 0.556 | 8.5e-119 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.396 | 0.525 | 0.432 | 9.5e-80 | |
| TAIR|locus:2156050 | 552 | AT5G37790 [Arabidopsis thalian | 0.563 | 0.782 | 0.399 | 2.2e-76 | |
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.373 | 0.379 | 0.446 | 2.9e-72 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.381 | 0.436 | 0.447 | 9.7e-72 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.438 | 0.857 | 0.433 | 2.3e-71 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.493 | 0.526 | 0.387 | 4.7e-70 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2303 (815.8 bits), Expect = 6.7e-239, P = 6.7e-239
Identities = 480/782 (61%), Positives = 579/782 (74%)
Query: 2 KMVQQEGDVISS---GAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS G G RT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGTEDHRRN 176
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 177 SLLD---VIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDC 233
+++ + + + V + + + S +D +QA +
Sbjct: 208 TVIGFGYIGKEDVRRITLLNVLQRSVTLNKTTKVVSHSEEDSNSKEEEEDQACGQNLRQV 267
Query: 234 SGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESLAIVPVQNVEAAST 287
+A NCS+CG P G S S+ + D ++++ IVPV E +
Sbjct: 268 LAAARLENCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAMEIVPVNGSEDSGG 327
Query: 288 SITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDV 347
S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+LP R D
Sbjct: 328 SVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKLPPR--------DT 376
Query: 348 KQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRL 407
KQ+ YD ++ LN A+VP G +++ D+ +LP+ELEGL+E++S+TCR
Sbjct: 377 KQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEELEGLYERFSSTCRF 432
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 467
F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +EDV+ +FV EIEII
Sbjct: 433 FKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTEDVLNDFVAEIEII 492
Query: 468 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 527
TTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF WSERYKVA+GVA
Sbjct: 493 TTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKVAVGVA 552
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
EAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S++HI C+DVAGTFG
Sbjct: 553 EALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDVAGTFG 612
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647
YLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS+ PKGQESLVMWAKPIL GK +
Sbjct: 613 YLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLVMWAKPILDDGKYS 672
Query: 648 QLLDPAL--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQV 705
QLLDP+L NN + DQM+RM LA+ LCIRR P+ARP+MS+VLKLL+GD D +WA QV
Sbjct: 673 QLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLKGDEDTLEWAMQQV 732
Query: 706 NAS-EESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSS 764
N+S EESEML DE C RSNLQSHLNLALLDVEDDS SM SIEQ VS+EDYL GR SRSSS
Sbjct: 733 NSSSEESEMLKDEQCQRSNLQSHLNLALLDVEDDSISMGSIEQGVSVEDYLKGRTSRSSS 792
Query: 765 FD 766
FD
Sbjct: 793 FD 794
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2117 (750.3 bits), Expect = 3.4e-219, P = 3.4e-219
Identities = 444/774 (57%), Positives = 569/774 (73%)
Query: 7 EGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS 66
E V++ G G TV+VGVK D S ELL WALVKVA+PGDTVIALHVL N IVDR SS
Sbjct: 3 ENGVVTGG-GHTVMVGVKFDESSNELLDWALVKVAEPGDTVIALHVLGNE-IVDRADNSS 60
Query: 67 LLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH 126
L+S+VK FDSVL VYEGFC LKQ++LKLK+ RG+S RKILV+EA+ SA+K +VG ++
Sbjct: 61 LVSIVKNFDSVLEVYEGFCKLKQLELKLKLSRGSSTRKILVKEAKMCSASKVVVGISRRF 120
Query: 127 HTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS----TAGTEDHRRNSLLDVI 182
HTI S+ S+AKY A+K++KDC VLAV+NGKV+FQK+G S + G D RRN+L
Sbjct: 121 HTIHSSVSVAKYLARKVAKDCWVLAVDNGKVMFQKDGSSSIIHHSKGKSDARRNTL---- 176
Query: 183 HRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNC 242
S +T +KN+KVV S + + ++ + +L ++LV A C G NC
Sbjct: 177 -SSFFQMPVTLRKNTKVVNH--SEVEEEEAEEDHSNGQSLRRSLVYA---CLG-----NC 225
Query: 243 SICGPVRNLPD-GSCSQSEE-ESPSDGGAG-DESLAIVPVQNVEAASTSITMLVRQLPES 299
S+ + +LP G+ S+S D A +++A+VP + E + ITMLV++LPE
Sbjct: 226 SV-RDMNSLPTPGNLSRSSSCNGDQDDNADLHKAMALVPAKFPEDLTPFITMLVKELPEF 284
Query: 300 RPGWPLLRRAIFPD--RRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDN 357
RPGWPLL R D AP SS RKI VVQW L+LP R S + +SD KQI +D ++
Sbjct: 285 RPGWPLLCRVASSDVLASAPRSSSFRKIPVVQWVLKLPARTNSVVGSSDTKQIGFDSSES 344
Query: 358 ES----INLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 413
E + N + AIVP + IV L DH S P+ +EGL + S +C+ F Y++L
Sbjct: 345 EENDKLSSSNVERQAIVPDESMIVKCSL--DHSSGRFPENVEGLQARISTSCQFFTYKEL 402
Query: 414 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 473
+S TSNF A+N IGKGGSS+V++G LP+G+E+AVKILK +E V+K+FV EI+IITTLHHK
Sbjct: 403 VSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKDFVAEIDIITTLHHK 462
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
N+ISLLG+CFE+NNLLLVY++LSRGSLEENLHGNKKD AF W+ERYKVA+G+AEAL+YL
Sbjct: 463 NVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAVGIAEALDYL 522
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H+ + Q VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS S++ I C+DVAGTFGYLAPEY
Sbjct: 523 HNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVAGTFGYLAPEY 582
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
FMYGK+N+KIDVYA+GVVLLELL+GRKP++++ PK Q+SLVMWAKPIL + +QLLD +
Sbjct: 583 FMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKPILDDKEYSQLLDSS 642
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQV-NASEESE 712
L ++ + DQME+M LA+ LCIR +P+ RP M +VL+LL+GD ++ KWA+LQV N E+S
Sbjct: 643 LQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGDVEMLKWAKLQVSNPLEDSM 702
Query: 713 MLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 766
+L DE RSNLQSHLNLA LD+EDDS SM S+EQ +S+E+YL GR SRSSSF+
Sbjct: 703 LLKDEKLRRSNLQSHLNLAFLDMEDDSLSMGSMEQGISVEEYLKGRTSRSSSFN 756
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1463 (520.1 bits), Expect = 6.9e-150, P = 6.9e-150
Identities = 323/623 (51%), Positives = 423/623 (67%)
Query: 156 KVVFQK-EGCPSTAGTEDHRRNSLLDVIHRSISMSKITGQ---KNSKVVTDDGSSITSKP 211
KV+ Q+ + C +T+ R I S S++K + K+ V I +
Sbjct: 103 KVLVQEVKSCGATSLIVGSSRKH--HTIRSSASLAKYCARNLAKDVSVFAVKSGKIMFRR 160
Query: 212 VDDLGGS---VMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGS-CSQSEE-ESPSD 266
V + G+ MN+ +LV D + AAK S P R + S+S +SP
Sbjct: 161 VPNTNGADGPQMNIP-SLVCGSPDIAIEAAKIGNSF-SPARTSSRWTRTSRSSSLQSPDS 218
Query: 267 GGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKIS 326
G D LA+VPVQ E S S+ ES PGW LR +R++ + S +K +
Sbjct: 219 LGV-DNLLALVPVQTNETDSGSL--------ESGPGWHFLRGLYGNNRKSWTKVSAKK-A 268
Query: 327 VVQWALRLPTRQPSYLANSDVKQITYDPGDNE--SINLNGDSGAIVPVGNEIVSSPLSTD 384
V+QW RL R + D K+ D G +E S +++G+ +I G+E++ SPLS
Sbjct: 269 VLQWVSRLRGRHSETVIYLDRKRS--DSGCDEDCSSSIDGEDVSISRFGSELMQSPLSPF 326
Query: 385 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKE 444
S +P+ELEGLHEKYS+TCRLF Y+++LS TSNF +ENL+G+GG+S VY+G LPDG+E
Sbjct: 327 IGSNNIPEELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGRE 386
Query: 445 LAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 504
LAVKILKP DV+KEF+LEIE+IT++HHKNI+SL GFCFE+NNL+LVYD+L RGSLEENL
Sbjct: 387 LAVKILKPCLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENL 446
Query: 505 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564
HGN+KD FGW ERYKVA+GVAEAL+YLH+ VIHRDVKSSN+LL+DDFEPQLSDF
Sbjct: 447 HGNRKDAKKFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDF 506
Query: 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624
G A AS++S H+ D+AGTFGYLAPEYFM+GKV DKIDVYAFGVVLLEL++GRKPI
Sbjct: 507 GFASLASSTSQHVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICV 566
Query: 625 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 684
D KGQESLV+WA PIL SGK QLLDP+L N+ D +E+++LA+ LCI+R P RPQ+
Sbjct: 567 DQSKGQESLVLWANPILDSGKFAQLLDPSLENDNSNDLIEKLLLAATLCIKRTPHDRPQI 626
Query: 685 SLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSS 744
LVLK+L+G+ + T+W + QV ASE D S +N++SH+NLALLD+EDD+ S SS
Sbjct: 627 GLVLKILQGEEEATEWGKQQVRASE------DVSAYLTNIESHINLALLDLEDDAASDSS 680
Query: 745 IE-QSVSLEDYLLGRWSRSSSFD 766
E S+S+E+YL GRWSR++SF+
Sbjct: 681 PEASSISVEEYLKGRWSRTASFN 703
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 8.5e-119, Sum P(2) = 8.5e-119
Identities = 192/345 (55%), Positives = 250/345 (72%)
Query: 406 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEI 464
R F+Y L +ATS+F ENLIGKGG ++VYKG L DGK +AVKILKPS ++ +KEFV E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 465 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 524
I+++L H NI L+G C N+L+ VY+ S+GSLEE L G W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGKH----VLRWEERLKIAI 378
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
G+ EAL+YLH+ + VIHRDVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644
TFGYLAPEYFMYGKV+DK+DVYAFGVVLLEL++GR IS+D P+GQESLVMWAKP++ G
Sbjct: 439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKG 498
Query: 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQ 704
+LLDP + +D DQ +MVLA+ C+ R RP + +LKLLRG+ DV+KW +++
Sbjct: 499 NAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGEDDVSKWVKIE 558
Query: 705 VNASEESEMLDDESCPRSNLQSHLNLALLDVED-DSFSMSSIEQS 748
++ + DDE P SN + HL+LA++DVED DS S SS+E+S
Sbjct: 559 ---EDDEDGFDDEVYPNSNTELHLSLAMVDVEDNDSVSNSSLERS 600
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 9.5e-80, Sum P(2) = 9.5e-80
Identities = 138/319 (43%), Positives = 202/319 (63%)
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 464
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 465 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 524
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644
TFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ P Q+ +++WAKP + +G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN---PT-QKHILLWAKPAMETG 487
Query: 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG--DADVTKWAR 702
++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K R
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWR 547
Query: 703 L---QVNASEESEMLDDES 718
+ N +++ DD S
Sbjct: 548 MPKDMTNDDDDNNEWDDYS 566
|
|
| TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
Identities = 185/463 (39%), Positives = 260/463 (56%)
Query: 298 ESRPGWPLLRRAIFPDRRAPD----RSSLRKISVVQWAL-RLPTRQPSYLANSDVKQITY 352
E+ W L A P+ PD SS R Q L ++ +PS A+S + ++
Sbjct: 93 ENNKAWLLAETA--PENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSV 150
Query: 353 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 412
G + +N ++G GN +TD + LE + T F+Y +
Sbjct: 151 SGGSTTVLMVNLENGVKETTGN-------ATDDLRWTRARSLEKSISPVANTLVRFSYGE 203
Query: 413 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKE-LAVKIL-KPSEDVIKEFVLEIEIITTL 470
+++AT NF ++G+G S V++G + + LA+K L K ++ K F E+ I ++L
Sbjct: 204 IVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSL 263
Query: 471 HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFG--WSERYKVAM 524
H NI+ LLGFC + + L LVY ++S GSLE LH KK AAFG WS RYKVA+
Sbjct: 264 HSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVAL 323
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
G+A+A+ YLH+G+ Q V+HRD+K SNILLS P+L DFGLA W + S C V G
Sbjct: 324 GIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKG 383
Query: 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644
TFGYLAPEYF +GK++DK DVYAFGVVLLEL+TGRKPI GQE+LV+WAKP+L G
Sbjct: 384 TFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRG 443
Query: 645 --KVTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV---T 698
+ +LLDP L + QMERM+ A+ C+ + RP M ++ +L+G+ V T
Sbjct: 444 IEAIVELLDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPET 503
Query: 699 KWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDV---EDD 738
+R N S + +S ++ HL+LA+L V EDD
Sbjct: 504 HSSRKTTNISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDD 546
|
|
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.9e-72, Sum P(2) = 2.9e-72
Identities = 130/291 (44%), Positives = 187/291 (64%)
Query: 406 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEI 464
RLF Y +L AT F N + +GG V++G LP+G+ +AVK K S EF E+
Sbjct: 397 RLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEV 456
Query: 465 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 524
E+++ H+N++ L+GFC ED+ LLVY+++ GSL+ +L+G +K+ W R K+A+
Sbjct: 457 EVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQKE--TLEWPARQKIAV 514
Query: 525 GVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
G A L YLH ++HRD++ +NIL++ D EP + DFGLA+W + T V
Sbjct: 515 GAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARWQPDGEMGVD-TRVI 573
Query: 584 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643
GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK I PKGQ+ L WA+P+L
Sbjct: 574 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQQCLTEWARPLLEE 633
Query: 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
+ +L+DP LGN + ++ M+ A+ LCIRRDP RP+MS VL++L GD
Sbjct: 634 YAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPRMSQVLRILEGD 684
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 9.7e-72, Sum P(2) = 9.7e-72
Identities = 133/297 (44%), Positives = 188/297 (63%)
Query: 400 KYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIK 458
K+ R F Y +L +AT F + + +GG V+ G LPDG+ +AVK K S +
Sbjct: 370 KFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIASTQGDR 429
Query: 459 EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE 518
EF E+E+++ H+N++ L+G C ED LLVY+++ GSL +L+G ++P GWS
Sbjct: 430 EFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGREP--LGWSA 487
Query: 519 RYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
R K+A+G A L YLH ++HRD++ +NILL+ DFEP + DFGLA+W +
Sbjct: 488 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGDKGV 547
Query: 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637
T V GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK + PKGQ+ L WA
Sbjct: 548 E-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCLTEWA 606
Query: 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
+P+L + +LLDP L N Y ++ M L + LCIRRDP +RP+MS VL++L GD
Sbjct: 607 RPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDPNSRPRMSQVLRMLEGD 663
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
Identities = 154/355 (43%), Positives = 222/355 (62%)
Query: 378 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 437
SSPL+ ST+ + + + + F++Q++ AT+ F +ENL+G+GG ++VYKG
Sbjct: 28 SSPLAAS--STKCVEGFQETDQFQRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKG 85
Query: 438 CL-PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492
L +G+E+AVK + + E KEF++EI I + H N++SLLG C DN L LV+
Sbjct: 86 ILGKNGEEIAVKRITRGGRDDERREKEFLMEIGTIGHVSHPNVLSLLGCCI-DNGLYLVF 144
Query: 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 552
F SRGSL LH + P W RYK+A+G A+ L YLH G +R+IHRD+KSSN+L
Sbjct: 145 IFSSRGSLASLLHDLNQAPLE--WETRYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVL 202
Query: 553 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 612
L+ DFEPQ+SDFGLAKW + SH + + GTFG+LAPEY+ +G V++K DV+AFGV L
Sbjct: 203 LNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFL 262
Query: 613 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 672
LEL++G+KP+ H +SL WAK I+ G++ +L+DP +G +D Q+ R+ A+ L
Sbjct: 263 LELISGKKPVDASH----QSLHSWAKLIIKDGEIEKLVDPRIGEEFDLQQLHRIAFAASL 318
Query: 673 CIRRDPRARPQMSLVLKLLRG-DADVTKWARLQVNASEES----EMLDDESCPRS 722
CIR RP M VL++L+G D + KW + +E E L+D C S
Sbjct: 319 CIRSSSLCRPSMIEVLEVLQGEDIEKEKWKMEEEEEVKEEFWGYEDLEDCECDSS 373
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 4.7e-70, Sum P(2) = 4.7e-70
Identities = 152/392 (38%), Positives = 233/392 (59%)
Query: 337 RQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLST-DHDSTELPKELE 395
R+ +S + Y P N S+N G GN S+ S+ D +S PK
Sbjct: 284 RRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGR 343
Query: 396 GLHEK-YSATCRL-FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP- 452
G + T ++ F Y++L T F ++G+GG VYKG L +GK +A+K LK
Sbjct: 344 GTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSV 403
Query: 453 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 512
S + +EF E+EII+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+
Sbjct: 404 SAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLP 461
Query: 513 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572
WS R ++A+G A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T
Sbjct: 462 VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT 521
Query: 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 632
+ SHI+ T V GTFGYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ES
Sbjct: 522 AQSHIS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEES 580
Query: 633 LVMWAKPIL----SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
LV WA+P L G +++++DP L N+Y ++ +M+ + C+R RP+M V+
Sbjct: 581 LVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVV 640
Query: 689 KLL--RGD-ADVTKWARLQVNASEESEMLDDE 717
+ L R D +D+T ++ + +S +E
Sbjct: 641 RALDTRDDLSDLTNGVKVGQSRVYDSGQYSNE 672
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_II0708 | hypothetical protein (739 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 766 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 7e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 6e-51
Identities = 87/268 (32%), Positives = 127/268 (47%), Gaps = 36/268 (13%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---EIEIITTLHHKNIISLLGF 481
+G G VYK GK +AVKILK + K+ EI I+ L H NI+ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+ ++L LV ++ G L + L E K+A+ + LEYLHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFMYG 597
IHRD+K NILL ++ +++DFGLAK SSS T GT Y+APE YG
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYG 177
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL---VMWAKPILSSGKVTQLLDPAL 654
K+DV++ GV+L ELLTG+ P S ++ Q L ++ K + + A
Sbjct: 178 P---KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARP 682
D +++ C+ +DP RP
Sbjct: 235 ------DLIKK-------CLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 6e-48
Identities = 72/195 (36%), Positives = 114/195 (58%), Gaps = 13/195 (6%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G+GG VY GK++A+KI+K S +++E + EIEI+ L+H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
++N+L LV ++ GSL++ L N+ E ++ + + E LEYLHS +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 543 HRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 600
HRD+K NILL SD+ + +L+DFGL+K +S + GT Y+APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 601 DKIDVYAFGVVLLEL 615
+K D+++ GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 6e-47
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLG 480
+G+G +VY GK +A+K++K + + + EI+I+ L H NI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHSGS 537
+++ L LV ++ G L + L + A F + + ALEYLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-------ILSALEYLHS-- 115
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ ++HRD+K NILL +D +L+DFGLA+ T GT Y+APE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDH 626
+D+++ GV+L ELLTG+ P D
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 426 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +VYKG L DGKE+ AVK LK SE I+EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
LG C E+ L++V +++ G L + L K P S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 599 VNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
K DV++FGV+L E+ T G +P +SN L G L P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------VLEYLKKGYR--LPKPPN 228
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
Y M + C DP RP S ++++L
Sbjct: 229 CPPELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IGKGG +VYK GKE+A+K++K KE ++ EI+I+ H NI+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 541
+ + L +V +F S GSL++ L + +E V + + LEYLHS +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
IHRD+K++NILL+ D E +L DFGL+ S + + T + GT ++APE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDY 176
Query: 602 KIDVYAFGVVLLELLTGRKPISNDHP 627
K D+++ G+ +EL G+ P S P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 39/278 (14%)
Query: 426 IGKGGSSQVYKGCL----PDGKEL-AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +VYKG L K AVK LK SE I+EF+ E I+ L H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
LG C E+ L +V +++ G L L N+ S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 598 KVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
K K DV++FGV+L E+ T G +P +SN+ L +G L P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLEYLKNGYR--LPQPP 226
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
YD M + C DP RP S ++++L
Sbjct: 227 NCPPELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 424 NLIGKGGSSQVYKGCLPD-GKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLL 479
L+G+G VY D G+ +AVK + SE+ ++ EI I+++L H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 480 GFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE----RYKVAMGVAEALEYL 533
G E N L + +++S GSL L K P E +Y + E L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKY-TRQ-ILEGLAYL 117
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
HS ++HRD+K +NIL+ D +L+DFG AK + V GT ++APE
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---L 650
+ D+++ G ++E+ TG+ P S G ++ I SSG+ ++ L
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSE---LGNPMAALYK--IGSSGEPPEIPEHL 229
Query: 651 DPALGNNYDYDQMERMVLASILCIRRDPRARP 682
D + + C+RRDP+ RP
Sbjct: 230 SEEA-----KDFLRK-------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 424 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
+G+G +VYKG L DGK AVK LK SE+ K+F+ E ++ L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 478 LLGFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
LLG C E+ L LV +++ G L + + + + A+ +A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
L S ++ +HRD+ + N L+ +D ++SDFGL++ + T ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQ 648
G K DV++FGV+L E+ T G P +SN+ V+ L G +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VL---EYLRKGY--R 225
Query: 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
L P + Y+ M C + DP RP S +++ L
Sbjct: 226 LPKPEYCPDELYELMLS-------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 38/216 (17%)
Query: 426 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +VYKG L +G E AVK LK SE+ +EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
LG C + L +V +++ G L + L + + + ++A+ +A+ +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES--- 120
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---------- 588
+ +HRD+ + N L++++ ++SDFGL++ D+ Y
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR------------DIYEDDYYRKRGGGKLPI 168
Query: 589 --LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+APE GK K DV++FGV+L E+ T G +P
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 27/286 (9%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHK 473
++ +G+G +VY D K +A+K+L ++ F+ EI+I+ +L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
NI+ L F ++ +L LV +++ GSLE+ L SE + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 534 HSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH----ITCTDVAGTFGY 588
HS + +IHRD+K NILL D +L DFGLAK S + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 589 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645
+APE + + D+++ G+ L ELLTG P + S + I+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL---KIILELP 231
Query: 646 VTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 689
L P + ++ + +L + +DP+ R S L
Sbjct: 232 TPSLASP---LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 484
IGKG V G G+++AVK LK + F+ E ++TTL H N++ LLG +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 544
N L +V +++++GSL + L + A +++ A+ V E +EYL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 545 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDK 602
D+ + N+L+S+D ++SDFGLAK AS +G + APE K + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTK 179
Query: 603 IDVYAFGVVLLELLT-GRKP 621
DV++FG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 25/276 (9%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN 474
+ IGKG +VY DGK +K + SE ++ + E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
II E L +V ++ G L + + KK+ F + + + AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
S ++++HRD+K NI L+ + +L DFG++K S++ V GT YL+PE
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPYYLSPELC 175
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
N K D+++ G VL EL T + P ++ L + K+ + P +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL---------KILKGQYPPI 223
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690
+ Y + + +V + +++DP RP ++ +L+
Sbjct: 224 PSQYSSE-LRNLVSS---LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 484
IG+G S +VYK GKE+A+K ++ + + + EI I+ H NI+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 485 DNNLL-LVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+ L +V +++ GSL + + N A+ V V + LEYLHS Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
VIHRD+KS NILLS D +L+DFG A A + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHP 627
K+D+++ G++ +E+ G P + P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 419 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 474
N+ +LIG+G VYKG L G +A+K + E+ +K + EI+++ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I+ +G ++L ++ ++ GSL + + F S V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
Q VIHRD+K++NIL + D +L+DFG+A + V GT ++APE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKP-------------ISNDHP 627
+ D+++ G ++ELLTG P + +DHP
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 424 NLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNII 476
+G+G +V G+++AVK L S E +F EIEI+ TL H+NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 477 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
G C + +L L+ ++L GSL + L ++ + + + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPE 592
S QR IHRD+ + NIL+ + ++SDFGLAK + + + F Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651
K + DV++FGV L EL T G + P E L M VT+LL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPP-AEFLRMIG-IAQGQMIVTRLLE 237
Query: 652 ----------PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLKLLR 692
P + YD M+ C +P+ RP + L+L + R
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 37/278 (13%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
IG G ++ VY CLP+ +++A+K + K V E E++ ++ +H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 482 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAM--GVAEALEYLHSGSA 538
+ L LV +LS GSL + + + G E + V + LEYLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAGTFGYLAPEYFMY 596
IHRD+K+ NILL +D +++DFG++ + + GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 597 GK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655
+ K D+++FG+ +EL TG P S P + L++ L + P+L
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLML----TLQNDP------PSLE 228
Query: 656 NNYDYDQ----MERMVLASILCIRRDPRARPQMSLVLK 689
DY + +M+ LC+++DP RP +LK
Sbjct: 229 TGADYKKYSKSFRKMI---SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 426 IGKGGSSQVYKG-----CLPDGKEL-AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 477
+G+G +V+ G + KEL AVK LK S D K+F E E++T H+NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENL--HG--------NKKDPAAFGWSERYKVAMGVA 527
G C E + ++V++++ G L + L HG S+ ++A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD---VAG 584
+ YL ++Q +HRD+ + N L+ D ++ DFG+ S + TD V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182
Query: 585 T----FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++ PE MY K + DV++FGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 424 NLIGKGGSSQVYKGC-LPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 479
N IG G +VY L G+ +AVK ++ IKE E++++ L H N++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
G + + ++ S G+LEE L + Y + + E L YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHS---H 118
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPEYFMYG 597
++HRD+K +NI L + +L DFG A +T++ +AGT Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 598 KVNDK---IDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPA 653
K D+++ G V+LE+ TG++P S D+ E +M+ + +G + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFH---VGAGHKPPIPDSL 231
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ D ++R C+ DP+ RP S +L+
Sbjct: 232 QLSPEGKDFLDR-------CLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 420 FLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 476
F IGKG +VYK + +A+K+ L+ +ED I++ EI+ ++ I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
G + + L ++ ++ GS + L K D + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLHE- 116
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ IHRD+K++NILLS++ + +L+DFG++ + ST S T GT ++APE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTPFWMAPEVIK 171
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
++K D+++ G+ +EL G P+S+ HP
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 426 IGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIIS 477
+GKG +V K GK A+K+LK + + ++ V E I++ ++H I+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 478 LLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYL 533
L + F+ L LV ++ G L +L + + Y AE ALEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY-----AAEIVLALEYL 109
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
HS +I+RD+K NILL D +L+DFGLAK S+ S GT YLAPE
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEV 164
Query: 594 FM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
+ YGK +D ++ GV+L E+LTG+ P
Sbjct: 165 LLGKGYGKA---VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKE----FVL-EIEIITTL- 470
+F +IG+G S V KE A+KIL + +IKE +V E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 471 HHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVA 527
H II L + F+D NL V ++ G L + +G+ + R+ A +
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAE-IL 112
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA---- 583
ALEYLHS + +IHRD+K NILL D +++DFG AK +SS + A
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 584 --------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
GT Y++PE D++A G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 420 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL 478
F +G+G VYK G+ +A+K++ P E+ ++E + EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
G F++ +L +V ++ GS+ + + K E + + LEYLHS
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ IHRD+K+ NILL+++ + +L+DFG++ + T + T V GT ++APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQEI 174
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
N+K D+++ G+ +E+ G+ P S+ HP
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEII 467
NF E IGKG S VYK CL DG+ +A+K + K +D +KE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 468 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 527
L H N+I L E+N L +V + G L + KK +K + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGT 585
ALE++HS +R++HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGT 169
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645
Y++PE N K D+++ G +L E+ + P D + +L K K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------K 219
Query: 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
+ + P L ++ Y + R +++ CI DP RP +S VL
Sbjct: 220 IEKCDYPPLPADH-YSEELRDLVS--RCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNI 475
F E +G G +V++G + +A+KILK S+D++K +F E++ + L HK++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
ISL C + ++ + + +GSL L + + +A VAE + YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-----WASTSSSHITCTDVAGTFGYLA 590
Q IHRD+ + NIL+ +D +++DFGLA+ +S I + + A
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTA 172
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT 617
PE +G + K DV++FG++L E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 35/284 (12%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 468
+NF E IG+G S+VY+ CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 469 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
L+H N+I L EDN L +V + G L + + KK +K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 586
A+E++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646
Y++PE N K D+++ G +L E+ + P D + +L + K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQ------KI 220
Query: 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690
Q P L + Y + R +++ +CI DP RP + V ++
Sbjct: 221 EQCDYPPLPTEH-YSEKLRELVS--MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-25
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 30/296 (10%)
Query: 402 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF 460
S + D+LS+ EN+I +G YKG + +G + VK + +
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 461 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 520
+ ++ L H NI+ L+G C + L+++++ +L E L W R
Sbjct: 734 IADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 521 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580
K+A+G+A+AL +LH + V+ ++ I++ EP L S + CT
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---------LSLPGLLCT 834
Query: 581 DVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638
D Y+APE + +K D+Y FG++L+ELLTG+ P ++ S+V WA+
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHGSIVEWAR 893
Query: 639 PILSSGKVTQLLDPALGNNYDYDQ---MERMVLASILCIRRDPRARPQMSLVLKLL 691
S + +DP++ + +Q +E M LA + C DP ARP + VLK L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA-LHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 51/274 (18%)
Query: 426 IGKGGSSQVYKGCL-PDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G+G S VYK P GK A+K + E+ K+ + E++ + + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 540
+++ + +V +++ GSL + L KK E +A + + L+YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-----AGTFGYLAPEYF- 594
+IHRD+K SN+L++ E +++DFG+ S + T GT Y++PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 595 --MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLVMWAKPILSSGKVTQ 648
Y D+++ G+ LLE G+ P +++ P L + + +
Sbjct: 174 GESYSY---AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682
+ + C+++DP+ RP
Sbjct: 231 -------------EFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 46/272 (16%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+G G S V K L P GK +AVK L+ +E + K+ + E++I+ + I+ G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW-SERY--KVAMGVAEALEYLHSGSA 538
+ + ++ + +++ GSL++ L G ER K+A+ V + L YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
++IHRDVK SNIL++ + +L DFG++ S + T V GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGND 175
Query: 599 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD------- 651
+ K D+++ G+ L+EL TGR P + + +LL
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFP--------------YPPENDPPDGIFELLQYIVNEPP 221
Query: 652 PALGN-NYDYDQMERMVLASILCIRRDPRARP 682
P L + + D LC+ +DPR RP
Sbjct: 222 PRLPSGKFSPD----FQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 426 IGKGGSSQVYKGC--LPDGKEL--AVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL 479
+G G V KG + GKE+ AVK LK KEF+ E ++ L H I+ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
G C + L+LV + G L + L ++ P S+ ++A VA + YL S +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLES---K 114
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYG 597
+HRD+ + N+LL + + ++SDFG+++ S + T AG + + APE YG
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYG 173
Query: 598 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
K + K DV+++GV L E + G KP KG E + M L SG+ +L P
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGE--MKGAEVIAM-----LESGE--RLPRPEECP 224
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
Y M C + P RP S + R D
Sbjct: 225 QEIYSIMLS-------CWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 35/286 (12%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 468
+NF E IG+G S+VY+ CL DG +A+K + K D IKE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 469 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
L+H N+I EDN L +V + G L + KK +K + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 586
ALE++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646
Y++PE N K D+++ G +L E+ + P D + +L K K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KI 220
Query: 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
Q P L +++ +++ ++V +CI DP RP ++ V + +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 39/276 (14%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
+G G +VYK + A KI++ SE+ +++F++EI+I++ H NI+ L F
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 484 EDNNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+N L ++ +F G+L E G + + V + EAL +LHS
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHS---H 122
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+VIHRD+K+ NILL+ D + +L+DFG+ AK ST T GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACET 179
Query: 599 VND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
D K D+++ G+ L+EL P +P V+ IL S T L P+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----MRVLLK--ILKSEPPT-LDQPS 232
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
++ D ++ C+ +DP RP + +LK
Sbjct: 233 KWSSSFNDFLKS-------CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 71/270 (26%), Positives = 131/270 (48%), Gaps = 30/270 (11%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
IG G V+ G + +++A+K ++ ++F+ E +++ L H ++ L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ + LV++F+ G L + L + F + + V E + YL S + VIHRD
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWA---STSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
+ + N L+ ++ ++SDFG+ ++ +SS T V + +PE F + K + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSK 181
Query: 603 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661
DV++FGV++ E+ + G+ P N + +V +++G +L P L + Y+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN---RSNSEVV----ETINAG--FRLYKPRLASQSVYE 232
Query: 662 QMERMVLASILCIRRDPRARPQMSLVLKLL 691
M+ C + P RP SL+L L
Sbjct: 233 LMQH-------CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 420 FLAENLIGKGGSSQVYKGCL--PDGKE----LAVKILKPSE--DVIKEFVLEIEIITTLH 471
FL E +G+G +VYKG L P+ + +A+K LK + V +EF E E+++ L
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYK-------- 521
H NI+ LLG C ++ +++++L+ G L E L + D A E K
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 522 --VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
+A+ +A +EYL S+ +HRD+ + N L+ + ++SDFGL++ ++ +
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ ++ PE +YGK + D+++FGVVL E+ + G +P
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 68/182 (37%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 442 GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYDFLSR 497
G+++AVK LKP + I + EIEI+ L+H+NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557
GSL+E L NK ++ K A+ + + ++YL GS Q V HRD+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEH 146
Query: 558 EPQLSDFGLAKWASTSSSHITCTD--VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 615
+ ++ DFGL K T + T D + F Y APE + K DV++FGV L EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 616 LT 617
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHHK 473
+F +IGKG +V D K++ A+K + + ++ + E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 474 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEA 529
+++L + F+D N+ LV D L G L +L K + F E + A
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-------IVLA 112
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
LEYLHS + +IHRD+K NILL + ++DF +A + + T +GT GY+
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYM 166
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
APE + +D ++ GV E L G++P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 70/205 (34%), Positives = 115/205 (56%), Gaps = 20/205 (9%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-FVLEIEIITTLHHKNIISLLGFCFE 484
IG+G V +G G+++AVK +K DV + F+ E ++T LHHKN++ LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 544
N L +V + +S+G+L L + A + + ++ VAE +EYL S ++++HR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 545 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 604
D+ + NIL+S+D ++SDFGLA+ + + V T APE + K + K D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 605 VYAFGVVLLELLT-GRKPISNDHPK 628
V+++GV+L E+ + GR P +PK
Sbjct: 180 VWSYGVLLWEVFSYGRAP----YPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 50/290 (17%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHH---KNIIS 477
LIG+G VY+G +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMGVAEALEYLHS 535
G + L ++ ++ GS+ + E+Y + V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIHK 119
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF 594
VIHRD+K++NIL+++ +L DFG+ A SS T GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAPEVI 173
Query: 595 MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
GK D K D+++ G+ + E+ TG P S+ L+ +KP P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------PR 221
Query: 654 L-GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWAR 702
L N Y E + C+ +P+ R +LK +KW +
Sbjct: 222 LEDNGYSKLLREFVA----ACLDEEPKERLSAEELLK--------SKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISLL 479
IG+G QVYK G+ +A+K ++ + KE + EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 480 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
++ +V++++ G L+ K F S+ + E L+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVK----FTESQIKCYMKQLLEGLQYLH 117
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
S ++HRD+K SNIL+++D +L+DFGLA+ T + T+ T Y PE
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELL 173
Query: 595 M----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
+ YG ++D+++ G +L EL G KPI
Sbjct: 174 LGATRYGP---EVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 37/275 (13%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNIIS 477
L+G G VY+G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
LG E++NL + + + GSL + L +G+ +P ++ + + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ +HRD+K +NIL+ + +L+DFG+AK S G+ ++APE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIA 174
Query: 596 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
G D+++ G +LE+ TG+ P S ++ I S ++ P +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFK--IGRSKEL-----PPI 223
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
++ D+ + +L C++RDP RP + +L+
Sbjct: 224 PDHLS-DEAKDFIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 446 AVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 503
AVK LK D++ +F+ E I+ +L H+N+I L G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 504 LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563
L + Y A+ +A + YL S +R IHRD+ + NILL+ D + ++ D
Sbjct: 86 LRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGD 140
Query: 564 FGLAKWASTSSSHITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
FGL + + H + F + APE + DV+ FGV L E+ T G +P
Sbjct: 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 4e-22
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 421 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 478
L E GK ++ Y C K L AVK LK S++ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---------PAAFGWSERYKVAMGVAEA 529
G C E + L++V++++ G L + L + D PA S+ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+ YL S Q +HRD+ + N L+ ++ ++ DFG+++ ++ + ++
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE MY K + DV++ GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 482
+IG+G +VYK G+ +A+KI+ ED +E E I+ +H NI + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 483 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDPAAFGWSERYKVAMGVAEAL 530
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYL 589
YLH +VIHRD+K NILL+ + E +L DFG+ A+ ST T GT ++
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 590 APEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 627
APE + D + DV++ G+ +EL G+ P+ + HP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IGKG +VYKG KE+ A+KI L+ +ED I++ EI +++ I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
+ L ++ ++L GS + L P + + + + L+YLHS +R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
HRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 603 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 662
D+++ G+ +EL G P S+ HP L+ P P L Y
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLEGQYS-KP 228
Query: 663 MERMVLASILCIRRDPRARPQMSLVLK 689
+ V A C+ +DPR RP +LK
Sbjct: 229 FKEFVEA---CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G G +V++G + +AVK LKP K+F+ E +I+ L H +I L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ +V + + GSL E L G A + +A VA + YL AQ IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 603
+ + N+L+ ++ +++DFGLA+ I F + APE +Y + + K
Sbjct: 129 LAARNVLVGENNICKVADFGLAR---VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 604 DVYAFGVVLLELLT-GRKP 621
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKN 474
+F N IGKG V+K D + A+K + K + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--YKVAMGVAEALEY 532
II + L +V ++ G L + L + P E ++ + + L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL----PEDQVWRFFIQILLGLAH 116
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LHS ++++HRD+KS N+ L ++ D G+AK S ++ + GT YL+PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
N+K DV+A GVVL E TG+ P ++ Q +L++ K+ + + P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL---------KIIRGVFP 219
Query: 653 ALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 690
+ Y LA ++ C+ +D R RP +L+
Sbjct: 220 PVSQMYSQQ------LAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++ LLG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 486 N-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 544
L +V +++++GSL + L + + G K ++ V EA+EYL + + +HR
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 545 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDKI 603
D+ + N+L+S+D ++SDFGL K AS++ D + APE K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 180
Query: 604 DVYAFGVVLLELLT-GRKP 621
DV++FG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 479
++G+G V K C G+ +A+K K SED +K+ L E++++ L H+NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
L LV++++ R LE + P + +A+ Y HS
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 595
+IHRD+K NIL+S+ +L DFG A+ A + TD T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 596 YGKVNDKIDVYAFGVVLLELLTGR 619
YGK +DV+A G ++ ELL G
Sbjct: 179 YGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 29/267 (10%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
+D L ++ ++L GS + L +P ++ + + + L+YLHS ++ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
HRD+K++N+LLS+ E +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 603 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 662
D+++ G+ +EL G P S HP L+ P P L NY
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNYS-KP 228
Query: 663 MERMVLASILCIRRDPRARPQMSLVLK 689
++ V A C+ ++P RP +LK
Sbjct: 229 LKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF 483
IG G VYK + G+ +A+K++K D + EI ++ H NI++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL---EYLHSGSAQR 540
+ L +V ++ GSL++ + G ++A E L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF---MY 596
IHRD+K +NILL++D + +L+DFG+ A+ +T + + GT ++APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMAPEVAAVERK 178
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
G + K D++A G+ +EL + P+ + HP
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVK--ILKPS-----EDVIKEFVLEIEIITTLHHKNII 476
++GKG VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 534
LG C +DN + + +F+ GS+ L N+ P +Y ++ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH 119
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHIT-CTDVAGTFGYLA 590
+ V+HRD+K +N++L + +L DFG A+ W +H + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK--VTQ 648
PE K D+++ G + E+ TG+ P+++ + A + + + + +
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLMPR 229
Query: 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
L D D+ C+ RD RP L+LLR D
Sbjct: 230 LPDSFSAAAIDFVTS---------CLTRDQHERPS---ALQLLRHD 263
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 476
++ ++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYL 533
LLG C + ++ +F++ G+L + L + + +A ++ A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL 120
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT---FGYLA 590
+ IHRD+ + N L+ ++ +++DFGL++ + T T AG + A
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 173
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT 617
PE Y K + K DV+AFGV+L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 35/278 (12%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 475
+ + +G+G V K L + + A+K + P+ D+ K+ + E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 476 ISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ G + +++ + ++ GSL+ KK G K+A V + L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----YL 589
HS +++IHRD+K SNILL+ + +L DFG++ S +AGTF Y+
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTFTGTSFYM 170
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-----LSSG 644
APE + DV++ G+ LLE+ R P P+G+ L PI + +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG----PIELLSYIVNM 223
Query: 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682
+L D GN + + + + C+ +DP RP
Sbjct: 224 PNPELKD-EPGNGIKWSEEFKDFIKQ--CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 425 LIGKGGSSQVYKGC---LPD--GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISL 478
+GKG V L D G+ +AVK L+ S + +++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 479 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
G C+ NL LV ++L GSL + L ++ + A + + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL--- 124
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYF 594
++R +HRD+ + NIL+ + ++ DFGL K + + + F Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 595 MYGKVNDKIDVYAFGVVLLELLT 617
K + DV++FGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 27/232 (11%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
EI I++ L H NII+ +DN LL+ ++ + G+L + + ++ F E +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVL 104
Query: 523 AM--GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580
+ A+ Y+H ++HRD+K+ NI L+ +L DFG++K + S
Sbjct: 105 WYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AE 159
Query: 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640
V GT Y++PE K N K D++A G VL ELLT ++ +P
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LN 208
Query: 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
L V P + Y ++ S +++DP RP VL
Sbjct: 209 LVVKIVQGNYTPVVSV---YSSELISLVHS--LLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 60/290 (20%)
Query: 420 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNII 476
FL E +G G V+ G ++A+K+++ SED +F+ E +++ L H N++
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLV 62
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L G C + + +V ++++ G L L K G + V EA+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA----STSSSHITCTDVAGT---FGYL 589
IHRD+ + N L+ +D ++SDFGLA++ TSS GT +
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKFPVKWA 168
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT- 647
PE F Y + + K DV++FGV++ E+ + G+ P S+ +V
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER----------------FSNSEVVE 212
Query: 648 ------QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
+L P L Y M C P RP +L L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 34/286 (11%)
Query: 421 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 478
L E GK ++ Y K L AVK LK P+ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------------AAFGWSERYKVAMGV 526
G C + + L++V++++ G L + L + D G S+ +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
A + YL S Q +HRD+ + N L+ + ++ DFG+++ ++ +
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 645
++ PE MY K + DV++FGV+L E+ T G++P + V+ ++ G+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI---ECITQGR 242
Query: 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
V L P + YD M + C +R+P+ R + + K+L
Sbjct: 243 V--LERPRVCPKEVYDIM-------LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLGF 481
IG+G VYK G+ +A+K +K + I + L EI+++ L+H NII LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYLHSGSA 538
+L LV++F+ + +L+ KD G E + + + + L + HS
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQ-LLQGLAFCHS--- 116
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF---- 594
++HRD+K N+L++ + +L+DFGLA+ S S T T Y APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGR 619
Y +D+++ G + ELL+ R
Sbjct: 175 GYST---PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IG+G S VY + G+E+A+K + + KE ++ EI ++ H NI++ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 138
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 603
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 604 DVYAFGVVLLELLTGRKPISNDHP 627
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 426 IGKGGSSQVYKGC-LPDGK----ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL 478
+G G VYKG +P+G+ +A+K+L+ KE + E ++ ++ H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHS 535
LG C + L+ + G L + + +K + + W + +A+ + YL
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 596 YGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ K DV+++GV + EL+T G KP
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L C E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ +V +++S+GSL + L + + +A +AE + YL S + IHRD
Sbjct: 74 EPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 603
+ + NIL+ ++ +++DFGLA+ F + APE YG+ K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 604 DVYAFGVVLLELLT-GRKP 621
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 419 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-----DVIKEFVL-EIEIITTLH 471
+ +G+G + VYK G+ +A+K +K E D I L EI+++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EAL 530
H NII LL +N+ LV++F+ LE+ + KD + K M + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI----KDKSIVLTPADIKSYMLMTLRGL 115
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
EYLHS ++HRD+K +N+L++ D +L+DFGLA+ + + +T V T Y A
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 591 PEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
PE YG +D+++ G + ELL R P
Sbjct: 171 PELLFGARHYGV---GVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 425 LIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 479
L+G+G V K C G+ +A+K SED V K + EI ++ L H+N+++L+
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
L LV++F+ L++ +K P S K + +E+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---- 595
+IHRD+K NIL+S +L DFG A+ + ++ TD T Y APE +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 596 YGKVNDKIDVYAFGVVLLELLTGR----------------KPISNDHPKGQESLVMWAKP 639
YG+ +D++A G ++ E+LTG K + N P+ QE + P
Sbjct: 178 YGR---AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE--IFQKNP 232
Query: 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASI-LCIRRDPRARPQMSLVLK 689
+ + ++ ++ + + ++ +VL C+R DP RP S +L
Sbjct: 233 LFAGMRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
IGKG VYKG L E+AVK + P + K F+ E EI+ H NI+ L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
C + + +V + + GSL L K + ++++ A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAK----WASTSSSHITCTDVAGTFGYLAPEYFMYG 597
IHRD+ + N L+ ++ ++SDFG+++ T S + + T APE YG
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 598 KVNDKIDVYAFGVVLLELLT-GRKPISN 624
+ + DV+++G++L E + G P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVK-------ILKPSEDVIKEFV----LEIEIITTLHH 472
LIGKG +VY + G+ +AVK I + K+ V EIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
NI+ LGF + L + +++ GS+ L + F V E L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LHS + ++HRD+K+ N+L+ D ++SDFG++K + + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 593 YF-MYGK-VNDKIDVYAFGVVLLELLTGRKPISND 625
Y + + K+D+++ G V+LE+ GR+P S++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 442 GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 497
G+ +AVK LK + + EI I+ TL+H+NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557
GSL + L +K ++ A + E + YLHS Q IHRD+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 558 EPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 615
++ DFGLAK + + + F Y A E K + DV++FGV L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 616 LTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651
LT PK E ++ + ++ ++ +LL+
Sbjct: 204 LTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 26/188 (13%)
Query: 444 ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500
++A+K++K SED EF+ E +++ L H+ ++ L G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560
L + K S+ ++ V E + YL S ++ IHRD+ + N L+ D +
Sbjct: 87 LNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 561 LSDFGLAKWA----STSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLE 614
+SDFGL+++ TSS V F + PE +Y K + K DV+AFGV++ E
Sbjct: 141 VSDFGLSRYVLDDEYTSS-------VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 615 LLT-GRKP 621
+ + G+ P
Sbjct: 194 VYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNII 476
L+G+G +VY C + G+ELAVK + ++ + EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 477 SLLGFCFEDNNLLLVY-DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
G C D+ L ++ +++ GS+++ L K A + K + E +EYLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPEYF 594
++HRD+K +NIL +L DFG +K T S T V GT +++PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 595 M---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
YG+ K DV++ G ++E+LT + P +
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHKNIISLLGF 481
+G+G VYK G+ +A+K ++ E+ I L EI ++ L H NI+ LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHG--NKKDPAAFGWSERY-KVAMG-VAEALEYLHSGS 537
+ L LV+++ + +L +K+ S K M + L Y HS
Sbjct: 67 IHTERKLYLVFEYC-----DMDLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 595
R++HRD+K NIL++ D +L+DFGLA+ A T T T Y APE +
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLR-TYTHEVVTLWYRAPEILLGS 173
Query: 596 --YGKVNDKIDVYAFGVVLLELLTGR 619
Y +D+++ G + E++TG+
Sbjct: 174 KHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
E +IG G +V +G L P KE+ A+K LK S+ +F+ E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L G + ++++ +++ GSL++ L N F + + G+A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYL--- 122
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------YLA 590
S +HRD+ + NIL++ + ++SDFGL++ S + T T G + A
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTA 176
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE Y K DV++FG+V+ E+++ G +P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 73/265 (27%), Positives = 110/265 (41%), Gaps = 26/265 (9%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKNIISLLGF 481
IGKG V K DGK L K + KE V E+ I+ L H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 482 CFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA- 538
+ +N L +V ++ G L + + KK+ +++ + AL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 539 -QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
V+HRD+K +NI L + +L DFGLAK SS GT Y++PE +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM 185
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
++K D+++ G ++ EL P + Q L K GK ++ P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKIK----EGKFRRI--P----- 231
Query: 658 YDYDQMERMVLASILCIRRDPRARP 682
Y Y V+ S + DP RP
Sbjct: 232 YRYSSELNEVIKS--MLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IG+G S V+ + G+E+A+K + + KE ++ EI ++ L + NI++ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
+ L +V ++L+ GSL + + D A V +ALE+LH A +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 603
RD+KS N+LL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 604 DVYAFGVVLLELLTGRKPISNDHP 627
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 28/253 (11%)
Query: 441 DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497
DGK+ +K I K S +E E+ +++ + H NI+ E+ NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557
G L + + N + F + + + AL+++H ++++HRD+KS NI L+ D
Sbjct: 84 GDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 138
Query: 558 EPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616
+L DFG+A+ ST TC GT YL+PE N+K D++A G VL E+
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 617 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 676
T + + K +LV+ K+ + P + ++Y YD R +++ + +R
Sbjct: 196 TLKHAFEAGNMK---NLVL---------KIIRGSYPPVSSHYSYDL--RNLVSQLF--KR 239
Query: 677 DPRARPQMSLVLK 689
+PR RP ++ +L+
Sbjct: 240 NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 426 IGKGGSSQVY----KGCLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVA 527
G C E LL+V++++ G L L + D P + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
+ YL S +HRD+ + N L+ ++ DFG+ S I TD G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRVGG 182
Query: 588 -------YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++ PE +Y K + D+++FGVVL E+ T G++P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 20/210 (9%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
+ +IG G +V++G L P KE +A+K LKP +E ++F+ E I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLH 534
L G + +++ +++ G+L++ L + + +++ V M G+A ++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL- 123
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG--YLAPE 592
S +HRD+ + NIL++ + E ++SDFGL++ T T G + APE
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
Y K DV++FG+V+ E+++ G +P
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+ +V +++S+GSL + L G + P + + M E + Y
Sbjct: 74 P-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--------- 123
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
+HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 602 KIDVYAFGVVLLELLT-GRKP 621
K DV++FG++L EL T GR P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 7e-19
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 139
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 603
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 604 DVYAFGVVLLELLTGRKPISNDHP 627
D+++ G++ +E++ G P N++P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 425 LIGKGGSSQVYKG------CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNI 475
+G+G QV K + +AVK+LK E + + V E+E++ + HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK--------------------KDPAAFG 515
I+LLG C ++ L +V ++ + G+L + L + KD +F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 516 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575
+ VA +E+L S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 139 YQ--------VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
+ T+ ++APE + DV++FGV+L E+ T
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IGKG +V+KG +++ A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQ 539
+ L ++ ++L GS + L D +++A + E L+YLHS +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD--------EFQIATMLKEILKGLDYLHS---E 120
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
+ IHRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 659
+ K D+++ G+ +EL G P S+ HP L+ P +G+ ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK----------- 227
Query: 660 YDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ + A C+ +DP RP +LK
Sbjct: 228 --PFKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
L+GKG +V+KG L D +AVK K P E IK F+ E I+ H NI+ L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
C + + +V + + G L K + + K A+ A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHITCTDVAGTFGYLAPEYFMYGK 598
IHRD+ + N L+ ++ ++SDFG+++ SSS + + T APE YG+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 599 VNDKIDVYAFGVVLLELLT 617
+ + DV+++G++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 398 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 452
HE++ A +L + D +F+ IG+G + V C+ GK++AVK +
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIV---CIATEKHTGKQVAVKKMDL 57
Query: 453 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 511
+ +E + E+ I+ HH+N++ + + L +V +FL G+L + + + +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 117
Query: 512 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571
V + V AL YLH+ Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 118 EQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQ 167
Query: 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
S + GT ++APE ++D+++ G++++E++ G P N+ P
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 397 LHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSED 455
L+ + + + L T + IGKG +VYK DG AVKIL P D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 456 VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-----LLLVYDFLSRGSLEENLHG--- 506
V +E E I+ +L +H N++ G ++ + L LV + + GS+ E + G
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 507 --NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564
+ D A + + G L++LH+ R+IHRDVK +NILL+ + +L DF
Sbjct: 121 CGQRLDEAMISY-----ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGR 619
G++ A +S+ + GT ++APE + D + DV++ G+ +EL G
Sbjct: 173 GVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 620 KPISNDHP 627
P+ + HP
Sbjct: 231 PPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G+G +V+ G ++A+K LKP + + F+ E +I+ L H ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ +V +F+ +GSL + L + D + +A +A+ + Y+ IHRD
Sbjct: 74 P-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 605
++++NIL+ D+ +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 606 YAFGVVLLELLT-GRKP 621
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 424 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKPSEDV--IKEFVLEIEIITTLHHKNIIS 477
+IGKG VY G L DG+++ AVK L D+ +++F+ E I+ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 478 LLGFCFEDNNL-LLVYDFLSRGSLEENLHGNKKDPA-----AFGWSERYKVAMGVAEALE 531
LLG C L+V ++ G L + +P FG + VA+ +E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGME 112
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------WASTSSSHITCTDVAGT 585
YL S ++ +HRD+ + N +L + F +++DFGLA+ + S + V
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-- 167
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
++A E K K DV++FGV+L EL+T
Sbjct: 168 --WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IG+G S VY + G+E+A+K + + KE ++ EI ++ + NI++ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
+ L +V ++L+ GSL + + D V +AL++LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHS---NQVIH 138
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 603
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 604 DVYAFGVVLLELLTGRKPISNDHP 627
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 426 IGKGGSSQVYK------GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 479
+G G +VYK G L K + K SE+ ++++++EIEI+ T +H I+ LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 480 GFCFEDNNLLLVYDFLSRGSLEE---NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
G + D L ++ +F G+++ L +P + + + EAL+YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVICRQMLEALQYLHS- 128
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
++IHRD+K+ N+LL+ D + +L+DFG++ A + GT ++APE M
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 597 GKVND-----KIDVYAFGVVLLEL 615
+ D K D+++ G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
E +IG G +V +G L P +E +A+K LK +E ++F+ E I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L G + ++++ +F+ G+L+ L N F + + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG---TFGYLAPEY 593
S +HRD+ + NIL++ + ++SDFGL+++ +S T T G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 594 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
Y K DV+++G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ +V +++S+GSL + L + A +A VA + Y+ IHRD
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 605
++S+NIL+ D +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 606 YAFGVVLLELLT-GRKP 621
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 419 NFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN 474
+F +GKG VYK L D + A+K + KE V EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
IIS + N L +V ++ G L + + KK E +++ + + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
Q+++HRD+KS+NILL + ++ D G++K ++ T + GT Y+APE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVW 173
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
+ K D+++ G +L E+ T P + + L KV + P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEA---RSMQDL---------RYKVQRGKYPPI 221
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
Y D ++ + + ++ P+ RP +L
Sbjct: 222 PPIYSQD-LQNFIRS---MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 421 LAENLIGKGGSSQVYKGCLPDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 478
L E GK +Y + + +A+K LK + EF E ++ LHH NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD-----PAAFGWSERYKVAMG 525
LG ++ + +++++L++G L E L H G D ++ + +A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+A +EYL S+ +H+D+ + NIL+ + ++SD GL++ ++ +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++ PE MYGK + D+++FGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 35/268 (13%)
Query: 445 LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 502
+AVKIL+P +++ +F+ E++I++ L NII LLG C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 503 NL----------HGNKKDPAA-----FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 547
L +GN P A +S VA+ +A ++YL S+ +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 548 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 607
+ N L+ ++ +++DFG+++ + ++A E + GK DV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 608 FGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPIL-SSGKVTQLLDPALGNNYDYDQM 663
FGV L E+L + + P G+ E ++ A G+ L P Y+ M
Sbjct: 226 FGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 664 ERMVLASILCIRRDPRARPQMSLVLKLL 691
+ C RD R RP S + L
Sbjct: 282 LQ-------CWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 427 GKGGSSQVYKGCLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 484
G GGS K +P G +A K+ + V K+ + E++I+ I+S G
Sbjct: 16 GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 485 DNNLLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
+NN+ + +F+ GSL+ G G K+A+ V E L YL++ R++H
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMH 127
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 603
RD+K SNIL++ + +L DFG++ S I T V GT Y++PE GK K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFV-GTSTYMSPERIQGGKYTVKS 183
Query: 604 DVYAFGVVLLELLTGRKPI--SNDHPKGQES----------LVMWAKPILSSGKVTQLLD 651
DV++ G+ ++EL G+ P SN GQ+ +V P L S +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED-- 241
Query: 652 PALGNNYDYDQMERMVLASILCIRRDP--RARPQ-----MSLVLKLLRGDADVTKWA 701
+ V A C+ +DP R PQ + L + D+ WA
Sbjct: 242 -----------LRDFVDA---CLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAWA 284
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 24/194 (12%)
Query: 442 GKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496
GK A+KIL ++K E VL E I+ ++ H +++L G +D+NL LV +++
Sbjct: 26 GKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84
Query: 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556
G L +L + + P + Y A V ALEYLHS +++RD+K N+LL D
Sbjct: 85 GGELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSD 137
Query: 557 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLL 613
+++DFG AK T T + GT YLAPE + YGK +D +A G+++
Sbjct: 138 GYIKITDFGFAKRVKGR----TYT-LCGTPEYLAPEIILSKGYGK---AVDWWALGILIY 189
Query: 614 ELLTGRKPISNDHP 627
E+L G P +D+P
Sbjct: 190 EMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 426 IGKGGSSQVY---KGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISL 478
I KG +V+ K G A+K++K + ++ + + + E +I++ ++ L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 479 LGFCFE-DNNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+ F+ NL LV ++L G SL EN+ +D A +E + ALEYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-------IVLALEYLH 110
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT------CTDVAGTFGY 588
S +IHRD+K NIL+ + +L+DFGL+K + GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 589 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
+APE + + K +D ++ G +L E L G P + P
Sbjct: 168 IAPEVILGQGHSK---TVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 42/288 (14%)
Query: 419 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTL 470
+L +G G S Y+ + G +AVK + E+V++ EI ++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 471 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 530
+H +II +LG ED++ L ++++ GS+ L AF + + L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116
Query: 531 EYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTD-----VAG 584
YLH ++IHRDVK +N+L+ S +++DFG A+ ++ T + G
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGA---AARLAAKGTGAGEFQGQLLG 170
Query: 585 TFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641
T ++APE YG+ DV++ G V++E+ T + P + + +L+
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
++ + + L P L R V + C+ P RP +LK
Sbjct: 228 TAPSIPEHLSPGL----------RDVT--LRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 58/218 (26%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G G +V+ G + ++AVK LKP ++ F+ E ++ TL H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+ ++ +++++GSL + L ++ P +S + +AE + Y+ +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNY 124
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVN 600
IHRD++++N+L+S+ +++DFGLA+ + T + A + APE +G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 601 DKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 637
K DV++FG++L E++T G+ P +P S VM A
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 420 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 479
F+ E +G G V+ G ++A+K + ++F+ E +++ L H ++ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
G C + L +V +F+ G L L+ ++ + V E +EYL S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
IHRD+ + N L+S ++SDFG+ ++ + + + + PE F + K
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 600 NDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658
+ K DV++FGV++ E+ T G+ P E + M +S G +L P L +
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEM-----ISRGF--RLYRPKLASMT 229
Query: 659 DYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
Y+ M C P RP + +L+ +
Sbjct: 230 VYEVMYS-------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 32/222 (14%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 482
++G G QVYKG + G+ A+K++ +ED +E LEI ++ HH+NI + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 483 FE------DNNLLLVYDFLSRGS---LEENLHGN--KKDPAAFGWSERYKVAMGVAEALE 531
+ D+ L LV +F GS L +N GN K+D A+ + + L
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICREILRGLA 135
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLA 590
+LH A +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++A
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMA 189
Query: 591 PEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 627
PE + D + D+++ G+ +E+ G P+ + HP
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHK 473
+ F N IG+G VY+ G+ +A+K ++ D I L EI ++ L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 474 NIISLLGFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
NI+ L +++ LV ++ + SL +N+ P F S+ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRG 120
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
L+YLH +IHRD+K SN+LL+D +++DFGLA+ + +T V T Y
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 590 APEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 622
APE + ID++A G +L ELL KP+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 30/295 (10%)
Query: 398 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED 455
HE++ A ++ + D + NF+ IG+G + V + GK +AVK + +
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ 58
Query: 456 VIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 514
+E + E+ I+ H+N++ + + L +V +FL G+L + + + +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 515 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574
V + V +AL LH AQ VIHRD+KS +ILL+ D +LSDFG A S
Sbjct: 119 A-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK 168
Query: 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634
+ GT ++APE ++D+++ G++++E++ G P N+
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------- 219
Query: 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
P+ + + L P L N + + L +L RDP R + +LK
Sbjct: 220 ---PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV--RDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 426 IGKGGSSQVYK----GCLPDGKEL--AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 477
IG+G +V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSER 519
LLG C + L++++++ G L E L +P +E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 520 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ ++ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ A ++ PE Y + + DV+A+GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 424 NLIGKGGSSQVYKGC----LPDGKE---LAVKILK--PSEDVIKEFVLEIEIITTLHHKN 474
N +G G +VY+G L G +AVK L+ ++ KEF+ E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALE 531
I+ LLG C + ++ + + G L L + + P E + + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 532 YLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
YL IHRD+ + N L+S+ D ++ DFGLA+ S + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++APE + GK + DV++FGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 18/189 (9%)
Query: 444 ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500
++AVK+LK +E + + + E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 501 EENLHGNKKDPAAFGWS------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 548
E L + + ++ + A VA +EYL S ++ IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 168
Query: 549 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 608
N+L+++D +++DFGLA+ + T+ ++APE + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 609 GVVLLELLT 617
GV+L E+ T
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 423 ENLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 476
E++IG+G QV + + DG ++ A+K+LK SE+ ++F E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 524
+LLG C L + ++ G+L + L ++ DPA + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
VA ++YL S ++ IHRD+ + N+L+ ++ +++DFGL++ V
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 585 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
T G ++A E Y K DV++FGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 426 IGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 480
IG+G + V C+ G+++AVK + + +E + E+ I+ H NI+ +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 481 FCFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+ L +V +FL G+L + + H + V + V +AL +LH+ Q
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLAVLKALSFLHA---Q 134
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
VIHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHP 627
++D+++ G++++E++ G P N+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 445 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501
+AVK+LK ++ + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 502 ENLHGNKKDPAAFGWS--------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVK 547
E L + P +S + A VA +EYL S Q+ IHRD+
Sbjct: 107 EYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161
Query: 548 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 607
+ N+L+++D +++DFGLA+ + T+ ++APE + DV++
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 608 FGVVLLELLT 617
FGV+L E+ T
Sbjct: 222 FGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 426 IGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLG 480
IG+G V+K C G+ +A+K SED VIK+ L EI ++ L H N+++L+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 481 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L LV+++ LE+N G + K+ +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 595
IHRDVK NIL++ + +L DFG A+ + TD T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGD 175
Query: 596 --YGKVNDKIDVYAFGVVLLELLTG 618
YG +DV+A G V ELLTG
Sbjct: 176 TQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
+G G +VYK + LA I SE+ ++++++EI+I+ + H NI+ LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
+NNL ++ +F + G+++ + ++ + V EAL YLH ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-- 601
RD+K+ NIL + D + +L+DFG++ A + + GT ++APE M D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 602 ---KIDVYAFGVVLLEL 615
K DV++ G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 424 NLIGKGGSSQVYKGCL----PDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNI 475
+G G +VY+G D EL V + SE +F++E I++ +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEY 532
+ L+G FE ++ + ++ G L+ L N+ + P++ + A VA+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGY 588
L IHRD+ + N LL+ P ++DFG+A+ +S + +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 635
+ PE F+ G K DV++FGV+L E+ + G P QE +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 445 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501
+AVK+LK ++ + + + E+E++ + HKNII+LLG C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 502 ENLH------------GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 549
E L K + + A VA +EYL S +R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 550 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFG 609
N+L+++D +++DFGLA+ + ++ ++APE + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 610 VVLLELLT 617
+++ E+ T
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 50/272 (18%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G G VYK L + LAVK+ L + ++ K+ + E+EI+ II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
F +N + + +F+ GSL+ ++ + G ++A+ V + L YL S +++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
HRDVK SN+L++ + +L DFG+ ST + GT Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 603 IDVYAFGVVLLELLTGRKPISNDHPKGQ------------ESLVMWAKPILSSGKVTQLL 650
DV++ G+ +EL GR P +P+ Q + +V P+L G+ +
Sbjct: 174 SDVWSLGISFMELALGRFP----YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS--- 226
Query: 651 DPALGNNYDYDQMERMVLASILCIRRDPRARP 682
E+ V C+R+ P+ RP
Sbjct: 227 -------------EKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 426 IGKGGSSQVYKGCLPDGK---ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 480
+G G V KG K ++A+K+LK + V E + E EI+ L + I+ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 539
C E L+LV + S G L + L G K + E ++V+MG ++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG---K 114
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 594
+HRD+ + N+LL + ++SDFGL+K S+ A + G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECI 170
Query: 595 MYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ K + + DV+++G+ + E + G+KP
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 426 IGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IG+G +V+ G L D +AVK + + D+ +F+ E I+ H NI+ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
+ + +V + + G L + + E ++ A +EYL S + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
HRD+ + N L+++ ++SDFG+++ T + APE YG+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 603 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661
DV++FG++L E + G P +N + + + +L P L + Y
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---------QGVRLPCPELCPDAVYR 227
Query: 662 QMERMVLASILCIRRDPRARPQMSLVLKLL 691
MER C DP RP S V + L
Sbjct: 228 LMER-------CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 482
L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+NI + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 483 FE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
+ D+ L LV +F GS+ + + K + W + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++APE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIA 184
Query: 596 YGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 627
+ D K D+++ G+ +E+ G P+ + HP
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 57/192 (29%), Positives = 102/192 (53%), Gaps = 26/192 (13%)
Query: 445 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501
+AVK+LK +E + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 502 ENLHGNKKDPAAFGW----------------SERYKVAMGVAEALEYLHSGSAQRVIHRD 545
E L + + + S Y+VA G +EYL S Q+ IHRD
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG----MEYLAS---QKCIHRD 162
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 605
+ + N+L++++ +++DFGLA+ + + T+ ++APE + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 606 YAFGVVLLELLT 617
++FGV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 426 IGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNIISLL 479
+GKGG +V C GK A K L ++ + E +I+ + + I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
+ FE ++L LV ++ G L+ H F + A + LE+LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+R+++RD+K N+LL D ++SD GLA AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 599 VNDKIDVYAFGVVLLELLTGRKP 621
+ +D +A G L E++ GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 445 LAVKILKPSEDVIKEFVL------------EIEIITTLHHKNIISLLGFCFEDNNLLLVY 492
+A + P E V+ +FV+ E+ + H I+ D+ LLL+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 552
++ S G L + + K+ F E + + AL+ +HS ++++HRD+KS+NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIF 201
Query: 553 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 612
L +L DFG +K S S S + GT YLAPE + + + K D+++ GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 613 LELLTGRKPISNDHPKGQESLVMWAK----PILSSGKVTQLLDPALGNN 657
ELLT +P + V++ K P S + LLDP L N
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 58/293 (19%)
Query: 426 IGKGGSSQVYKGCLPD------GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
+G+G VY+G +A+K + S EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 478 LLGFCFEDNNLLLVYDFLSRGSL--------EENLHGNKKDPAAFGWSERYKVAMGVAEA 529
LLG L+V + +++G L E + P + ++A +A+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP--TLQKFIQMAAEIADG 131
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-- 587
+ YL A++ +HRD+ + N ++++D ++ DFG+ + I TD G
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 588 -----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAK 638
++APE G K DV++FGVVL E+ T +P +SN+ V+ K
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VL--K 232
Query: 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
++ G + P + + M C + +P+ RP ++ L
Sbjct: 233 FVIDGGHLDL---PENCPDKLLELMRM-------CWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 424 NLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNIIS 477
++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA-------AFGWSER--YKVAMG 525
LLG C L L ++ G+L + L ++ DPA A S + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKT 169
Query: 586 FG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
G ++A E Y DV+++GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 37/279 (13%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 483
IGKG +V+K +G + AVKIL P D+ +E E I+ L H N++ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 484 EDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK---VAMGVAEALEYLHS 535
+ + L LV + + GS+ + + G K ER + +A + EAL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQH 139
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF- 594
+ IHRDVK +NILL+ + +L DFG++ A +S+ + GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 595 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650
+ + + DV++ G+ +EL G P+++ HP M A + L
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALFKIPRNPPPTLH 250
Query: 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
P L +N D + + C+ +D RP +S +L+
Sbjct: 251 QPELWSNEFNDFIRK-------CLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 423 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 476
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 524
+LLG C L L ++ G+L + L ++ DPA + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKK 180
Query: 585 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 638
T G ++A E Y DV+++GV+L E+++ G P G ++ K
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYEK 235
Query: 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
L G +L P ++ YD M + C R P RP + +L
Sbjct: 236 --LPQG--YRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 21/236 (8%)
Query: 448 KILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 506
K + + I + V E+ II L H NI+ E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 507 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566
K+ F + + + + AL YLH +R++HRD+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626
AK S T V GT Y PE +K DV+AFG +L ++ T + P +
Sbjct: 161 AKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---Y 214
Query: 627 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682
SL V + +P Y + V+ S C+ D ARP
Sbjct: 215 STNMLSLATKI--------VEAVYEPL--PEGMYSEDVTDVITS--CLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 425 LIGKGGSSQVYKGCLPDGK----ELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 478
IG+G VY+G + +AVK K S V ++F+ E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
+G +N + +V + G L L NK + + + ++ AL YL S
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES--- 125
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+R +HRD+ + N+L+S +L DFGL+++ S+ + ++APE + +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184
Query: 599 VNDKIDVYAFGVVLLELLT-GRKP 621
DV+ FGV + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 398 HEKYSATCRLFNYQ-DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 452
HE++ A R+ Q D S N++ IG+G + V C+ G+++AVK++
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIV---CIAREKHSGRQVAVKMMDL 56
Query: 453 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 511
+ +E + E+ I+ H+N++ + L ++ +FL G+L + + + +
Sbjct: 57 RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNE 116
Query: 512 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571
V V +AL YLHS Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 117 EQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQ 166
Query: 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
S + GT ++APE ++D+++ G++++E++ G P +D P
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 39/283 (13%)
Query: 420 FLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL----KPSEDVIKEFVLEIEIITTLHHKN 474
F+ + IG G VY E+ AVK + K + + ++ + E++ + L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I G +++ LV ++ GS + L +KK E + G + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLH 138
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
S +IHRD+K+ NILL++ + +L+DFG A +S ++S + GT ++APE
Sbjct: 139 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 595 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651
+ G+ + K+DV++ G+ +EL + P+ N M A L + Q
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALY--HIAQNDS 237
Query: 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
P L +N D V C+++ P+ RP +LLR D
Sbjct: 238 PTLQSNEWTDSFRGFV---DYCLQKIPQERPAS---AELLRHD 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 426 IGKGGSSQVYKG---CLPDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 479
+G G V KG K +AVKILK + + E + E ++ L + I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
G C E + +LV + G L + L NK ++V+MG ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN-- 115
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 594
+HRD+ + N+LL ++SDFGL+K ++ A T G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 595 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
Y K + K DV++FGV++ E + G+KP KG E M + SG+ ++ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM-----IESGE--RMECPQ 221
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
YD M+ LC RP ++V LR
Sbjct: 222 RCPPEMYDLMK-------LCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
NFL ++GKG +V EL A+KILK +DVI + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVI---IQDDDVECTMVEKRVLA 55
Query: 478 LLG---F------CFED-NNLLLVYDFLSRGSLEENLH--GNKKDP-AAFGWSERYKVAM 524
L G F CF+ + L V ++++ G L ++ G K+P A F +E
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------ 109
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
+A L +LHS + +I+RD+K N++L + +++DFG+ K + T T G
Sbjct: 110 -IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT-FCG 163
Query: 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
T Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 28/262 (10%)
Query: 445 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500
+AVK+L+ DV K +F+ EI+I++ L + NII LLG C D+ L ++ +++ G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 501 EENL----------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 550
+ L H N + + + +A+ +A ++YL S +HRD+ + N
Sbjct: 105 NQFLSQREIESTFTHAN--NIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 551 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGV 610
L+ + + +++DFG+++ + + ++A E + GK DV+AFGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 611 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLAS 670
L E+ T K ++ + + + G+ L L + + M R
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR----- 274
Query: 671 ILCIRRDPRARPQMSLVLKLLR 692
C RD + RP + + LR
Sbjct: 275 --CWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 424 NLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLG 480
N IG G VYK P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 538
+ + ++ +F+ GSLE E++ VA + + YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHR--- 186
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ ++HRD+K SN+L++ +++DFG+++ A T C GT Y++PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPE----- 238
Query: 598 KVNDKI----------DVYAFGVVLLELLTGRKP 621
++N + D+++ GV +LE GR P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLG 480
IG G QVYK G +AVK ++ + ++ K +++++++ H I+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 481 FCFEDNNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 530
+ D+++ + + +S +G + E++ G K+ + + +AL
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------------KMTVAIVKAL 127
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
YL VIHRDVK SNILL +L DFG++ S + T AG Y+A
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182
Query: 591 PEYFMYGKVNDKI----DVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646
PE N K DV++ G+ L+EL TG+ P N + + +L+ K+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---------VLT--KI 231
Query: 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
Q P+L N + + LC+ +D R RP+ +L+
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFV--DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 480
IG G VY + + +A+K + K S + ++ + E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
++ LV ++ GS + L +KK E + G + L YLHS
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 597
IHRD+K+ NILL++ +L+DFG A S ++S + GT ++APE + G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISN 624
+ + K+DV++ G+ +EL + P+ N
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 418 SNFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITT 469
S+F +G G +V +KG G+ A+K LK E + ++ E I+
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 470 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGV 526
L H I++++ ++N + + +F+ G L +L + P A F +E +
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------L 127
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
A EYLHS + +I+RD+K N+LL + +++DFG AK + C GT
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTP 179
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
YLAPE +D + GV+L E + G P +D P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 28/254 (11%)
Query: 444 ELAVKILKPSEDVIKEFVL--EIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500
++AVK+LKP+ + L E++I++ L +H+NI++LLG C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 501 EENLHGNKKDPAAFG--WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 558
L ++ S Y+VA G + +L S + IHRD+ + N+LL+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKG----MAFLASKNC---IHRDLAARNVLLTHGKI 179
Query: 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT- 617
++ DFGLA+ S+++ + ++APE + DV+++G++L E+ +
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 618 GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRD 677
G P +P G + K I ++ Q P YD M+ C D
Sbjct: 240 GSNP----YP-GMPVDSKFYKLIKEGYRMAQ---PEHAPAEIYDIMKT-------CWDAD 284
Query: 678 PRARPQMSLVLKLL 691
P RP +++L+
Sbjct: 285 PLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 442 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 496
GK A+KILK ++D + + E ++ H + SL + F+ + L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVN 78
Query: 497 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553
G L +L + +D F +E + AL+YLHSG ++++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG---KIVYRDLKLENLML 128
Query: 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 613
D +++DFGL K T ++ T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 614 ELLTGRKPISN-DHPKGQESLVM 635
E++ GR P N DH K E ++M
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 480
IG G VYK + G+ A+K++K P ED V+++ EI ++ H NI++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
+ L + +F GSL++ H S+ V+ + L YLHS
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 597
+HRD+K +NILL+D+ +L+DFG++ A +++ GT ++APE G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
N D++A G+ +EL + P+ + HP +L + K S+ + +L D +N
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTK---SNFQPPKLKDKMKWSN 239
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ +M L ++P+ RP +L+
Sbjct: 240 -SFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 425 LIGKGGSSQVYKGC-LPDGKEL----AVKILK----PSEDVIKEFVLEIEIITTLHHKNI 475
++G G VYKG +P+G+ + A+KIL P +V EF+ E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+ LLG C + LV + G L + +H +K + G + +A+ + YL
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE 127
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+R++HRD+ + N+L+ +++DFGLA+ ++A E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 596 YGKVNDKIDVYAFGVVLLELLT-GRKP 621
Y K + DV+++GV + EL+T G KP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 483 FEDNNLLLVYDFLSRGSLEENL---HGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSA 538
++ + ++ +F+++GSL + L G+K+ P +S + +AE + ++
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ--- 120
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+ IHRD++++NIL+S +++DFGLA+ + + + APE +G
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 599 VNDKIDVYAFGVVLLELLT-GRKP 621
K DV++FG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 23/249 (9%)
Query: 445 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500
+AVK+L+ ED K +F+ EI+I++ L NII LL C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 501 EENL-------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553
+ L K D +S +A +A ++YL S+ +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 613
++ +++DFG+++ + + +++ E + GK DV+AFGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 614 ELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILC 673
E+LT K ++ + + G+ L PAL + Y M + C
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSC 276
Query: 674 IRRDPRARP 682
RR+ + RP
Sbjct: 277 WRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLG 480
+G+GG QV+ D E+ A+K +K S + ++ + E +I+TT + ++ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 481 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS- 535
+ F+D L L +++ G +L NL +D A F Y M EA++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-----YMAEM--FEAVDALHEL 120
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
G IHRD+K N L+ +L+DFGL+K + ++ V G+ Y+APE
Sbjct: 121 G----YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN----SVVGSPDYMAPEVLR 171
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
+ +D ++ G +L E L G P S P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 425 LIGKGGSSQVY----KGCLPDGKEL--AVKIL--KPSEDVIKEFVLEIEIITTLHHKNII 476
+G+G +V+ KG +G E VK L E++ EF E+++ L HKN++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-----DPAAFGWSERYKVAMGVAEALE 531
LLG C E ++ ++ G L++ L K P ++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
+L S R +HRD+ + N L+S E ++S L+K S + + +LAP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLT 617
E + K DV++FGV++ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 425 LIGKGGSSQVYKGC-LPDGKEL----AVKIL--KPSEDVIKEFVLEIEIITTLHHKNIIS 477
L+G G V+KG +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--DPAAF-GWSERYKVAMGVAEALEYLH 534
LLG C +L LV GSL +++ ++ DP W + +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
R++HR++ + NILL D Q++DFG+A ++ ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 595 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 627
++G+ + DV+++GV + E+++ G +P + P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 478
++GKG +V L EL AVK+LK +DVI + + ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVI---LQDDDVECTMTEKRVLALAGKHP 56
Query: 479 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEAL 530
L CF+ + L V ++++ G L ++ + + A F Y A + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----Y--AAEIVLGL 109
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
++LH + +I+RD+K N+LL + +++DFG+ K +T + GT Y+A
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIA 164
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
PE Y +D +A GV+L E+L G+ P D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 33/271 (12%)
Query: 425 LIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIISL 478
++G+G V+ C D K + +K + P E + K+ L E +++ L H NII
Sbjct: 7 VVGRGAFGIVHL-CRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
ED L++V ++ G+L E + K+ + + + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 539 QRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ ++HRD+K+ NILL ++ DFG++K S+ S T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGK 176
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
N K D++A G VL EL + ++ + +LV+ K+ + +
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVL---------KIMSGTFAPISDR 224
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVL 688
Y D R ++ S+L DP RPQ+S ++
Sbjct: 225 YSPDL--RQLILSML--NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 425 LIGKGGSSQVYKGCLPDGKE-LAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISL 478
+G G +V+ + A+K++ +VI+ + V E ++ + H II L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
+ L ++ +++ G L L + + F S A + ALEYLHS
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS--- 119
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+ +++RD+K NILL + +L+DFG AK T T + GT YLAPE
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT-LCGTPEYLAPEVIQSKG 174
Query: 599 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
N +D +A G+++ E+L G P +D+P G
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 442 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 496
G+ A+KIL+ ++D + V E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYAN 78
Query: 497 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553
G L +L + ++ A F +E + ALEYLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFTEERARFYGAE-------IVSALEYLHS---RDVVYRDIKLENLML 128
Query: 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 613
D +++DFGL K + + T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 614 ELLTGRKPISN-DHPKGQESLVM 635
E++ GR P N DH + E ++M
Sbjct: 187 EMMCGRLPFYNQDHERLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 37/240 (15%)
Query: 425 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLG--- 480
++GKG +V+ L + A+K LK +DV+ +++ ++ T+ K ++SL
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVV---LMDDDVECTMVEKRVLSLAWEHP 56
Query: 481 -----FC-FE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+C F+ NL V ++L+ G L ++ K F A + L++L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
HS + +++RD+K NILL D +++DFG+ K + TCT GT Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCT-FCGTPDYIAPEI 167
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKP------------ISNDHPKGQESLVMWAKPIL 641
+ K N +D ++FGV+L E+L G+ P I D+P L AK IL
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISL 478
IG+G QVYK D EL V + K D KE + EI+I+ L+H+NI++L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 479 ----------LGFCFEDNNLLLVYDFLSR---GSLEENL-HGNKKDPAAFGWSERYKVAM 524
L F + LV++++ G LE L H ++ +F K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MKQLL 126
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
E L Y H + +HRD+K SNILL++ + +L+DFGLA+ ++ S V
Sbjct: 127 ---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 585 TFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPI 622
T Y PE YG IDV++ G +L EL T +KPI
Sbjct: 180 TLWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 426 IGKGGSSQVYKGCL-PDGKELAVKILKPSEDV---IKEFV-LEIEIITTLHHKNIISLLG 480
+G GG +V + + A+K +K V +E + E EI+ +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 481 FCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
F+D +L+ ++ L RG +E ++ R+ +A V A
Sbjct: 61 -TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------------YTARFYIAC-VVLA 105
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
EYLH+ + +I+RD+K N+LL + +L DFG AK S T T GT Y+
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYV 159
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
APE + + +D ++ G++L ELLTGR P D
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 485
+G G +V+ G ++A+K LK + F+ E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAEALEYLHSGSAQRVIH 543
+ ++ +++ GSL + L K P + + M +AE + ++ + IH
Sbjct: 74 P-IYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDK 602
RD++++NIL+S+ +++DFGLA+ + T + A + APE YG K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 603 IDVYAFGVVLLELLT-GRKP 621
DV++FG++L E++T GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVK---ILKPSED-------VIKEFVLEIEIITTLHHK 473
LIG G VY G G+ +AVK + S ++ EI ++ L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALE 531
NI+ LG + ++L + +++ GS+ N +G ++ + + + + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT----DVAGTFG 587
YLH+ + +IHRD+K +NIL+ + ++SDFG++K +S + G+
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624
++APE K D+++ G +++E+LTG+ P +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 416 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDVI--KEFVLEIEII 467
+T F+ E +G+ +VYKG L + +A+K LK + +EF E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 468 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD--------- 510
+ L H NI+ LLG ++ L +++ + S L E L H G+ D
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 511 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570
PA F + +A +E+L S+ V+H+D+ + N+L+ D ++SD GL +
Sbjct: 123 PADF-----VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ + + +++PE MYGK + D++++GVVL E+ + G +P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 474
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD--PAAFGWSERYKVAMGVAEALEY 532
I+ LL +N L LV++FL + L++ + + P S +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
HS RV+HRD+K N+L++ + +L+DFGLA+ T T T Y APE
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 170
Query: 593 YFMYGKV-NDKIDVYAFGVVLLELLTGR 619
+ K + +D+++ G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL----AVKILKPSEDVIKE-----FVLEIEIITTLHHKNI 475
++GKGG +V++ G + A+K+LK + V + E I+ + H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 476 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALE 531
+ L+ + F+ L L+ ++LS G L +L +D A F SE ++ ALE
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
+LH Q +I+RD+K NILL +L+DFGL K S +T T GT Y+AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHT-FCGTIEYMAP 169
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628
E M +D ++ G ++ ++LTG P + ++ K
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 426 IGKGGSSQVY--------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
IG+G ++Y + C+ +L +K E KE +L + + H NI++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMKHPNIVT 63
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
E+ L +V ++ G L + + N++ F + + ++ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119
Query: 538 AQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFM 595
++++HRD+KS NI LS + +L DFG+A+ + S TC GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQ 175
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655
N+K D+++ G VL EL T + P ++ LV+ K+ Q +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVL---------KICQGYFAPIS 223
Query: 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
N+ D R +++ + + PR RP ++ +LK
Sbjct: 224 PNFSRDL--RSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 440 PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495
P G +A K++ KP+ + + + E++++ + I+ G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555
GSL++ L K+ P KV++ V L YL +++HRDVK SNIL++
Sbjct: 86 DGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 556 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 615
E +L DFG++ S ++ GT Y++PE + + D+++ G+ L+EL
Sbjct: 140 RGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 616 LTGRKPISNDHPKGQESLVMWAKPILSSG 644
GR PI P +E ++ +P++
Sbjct: 196 AIGRYPIPP--PDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 442 GKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFLS 496
G A+K+LK S+ + + E I+ ++ L + F+ + L LV ++L+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80
Query: 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSD 555
G + W+++Y V +E LH QR +IHRD+K N+L+
Sbjct: 81 GGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLH----QRGIIHRDIKPENLLIDQ 132
Query: 556 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 615
+L+DFGL++ + GT YLAPE + + D ++ G V+ E
Sbjct: 133 TGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 616 LTGRKPISNDHPK 628
L G P + P
Sbjct: 187 LFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 35/239 (14%)
Query: 454 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 513
+D+IKE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 514 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573
E V G + L YLHS +IHRDVK+ NILLS+ +L DFG A + +
Sbjct: 115 V---EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 574 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 630
+ + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 169 NXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 216
Query: 631 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
M A L + Q PAL + + + V + C+++ P+ RP ++LK
Sbjct: 217 ----MNAMSALY--HIAQNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 65/269 (24%)
Query: 426 IGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEF----VLEIEIITTLHHKNIISL 478
IG+G +VYK DGKE A+K K ++ EI ++ L H+N++SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 479 LGFCFEDNN--LLLVYDFLSRGSLEENL---------HGNKKDPAAFGWSERYKVAMGVA 527
+ E + + L++D+ E +L P + S +++ GV
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLA-KWASTSSSHITCTDV 582
YLHS V+HRD+K +NIL+ + + + D GLA + + V
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 583 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638
T Y APE + Y K ID++A G + ELLT PI KG+E+
Sbjct: 176 VVTIWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTLE-PIF----KGREA------ 221
Query: 639 PILSSGKVTQLLDPALGNNYDYDQMERMV 667
N + DQ+ER+
Sbjct: 222 ------------KIKKSNPFQRDQLERIF 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 521 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580
K+A+ + +ALEYLHS VIHRDVK SN+L++ + + +L DFG++ + S + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 581 DVAGTFGYLAPEYF---MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW 636
AG Y+APE + K D K DV++ G+ ++EL TGR P + W
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------W 210
Query: 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKL 690
P +V + P L + + V C++++ + RP Q
Sbjct: 211 KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQHPFFELH 267
Query: 691 LRGDADVTKWARL 703
L + DV + L
Sbjct: 268 LSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 46/249 (18%)
Query: 419 NFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKP--------------SEDVIKEF 460
NF ++G G +V+ G GK A+K+LK +E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 461 VLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 519
V + TLH + F+ D L L+ D+++ G L +L+ + F SE
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESE- 106
Query: 520 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576
V + +AE AL++LH +I+RD+K NILL + L+DFGL+K
Sbjct: 107 --VRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 577 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634
GT Y+APE G + +D ++ GV+ ELLTG P + D + +S +
Sbjct: 162 RA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 635 MWAKPILSS 643
++ IL S
Sbjct: 221 --SRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 480
+G G VYK L G+ AVKI+K P +D +I++ EI ++ H NI++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE---YLHSGS 537
L + ++ GSL++ H G ++A E L+ YLHS
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY- 596
+HRD+K +NILL+D+ + +L+DFG+A A +++ GT ++APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 597 --GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
G N D++A G+ +EL + P+ + HP
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 418 SNFLAENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLH 471
S E +IG G +V G L P +E+ A+K LK +E ++F+ E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
H NII L G + +++V +++ GSL+ L +K F + + G+A ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLA 590
YL S +HRD+ + NIL++ + ++SDFGL++ + T + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE Y K DV+++G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 67/227 (29%), Positives = 116/227 (51%), Gaps = 28/227 (12%)
Query: 425 LIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFV---LEIEIITTLHHKNIIS 477
++G+G +V+ K PD +L A+K+LK + +++ V +E +I+ ++H I+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 478 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYL 533
L + F+ + L L+ DFL G L L ++ F +E +A AL++L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHITCTDVAGTFGYLAP 591
HS +I+RD+K NILL ++ +L+DFGL+K + ++ C GT Y+AP
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAP 167
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638
E D ++FGV++ E+LTG P K ++++ AK
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 451 KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 510
K S + ++ + E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKP 121
Query: 511 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570
E + G + L YLHS +IHRD+K+ NILL++ + +L+DFG A A
Sbjct: 122 LQEV---EIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 571 STSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
S ++S + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 176 SPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--- 226
Query: 628 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 687
M A L + Q P L +N D V + C+++ P+ RP +
Sbjct: 227 -------MNAMSALY--HIAQNESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEEL 274
Query: 688 LK 689
LK
Sbjct: 275 LK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 425 LIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIIS 477
++G+G V +G L DG +L AVK +K + I+EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 478 LLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEA 529
L+G CFE ++L +++ F+ G L L ++ P K + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS----SHITCTDVAGT 585
+EYL S + IHRD+ + N +L +D ++DFGL+K + I V
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++A E K DV+AFGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
NFL ++GKG +V EL A+KILK +DV+ + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVV---IQDDDVECTMVEKRVLA 55
Query: 478 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMG 525
L G CF+ + L V ++++ G L + G K+P A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+A L +LHS + +I+RD+K N++L + +++DFG+ K +T GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
Y+APE Y +D +AFGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 481
IG+G VYKG G+ +A+K I SE+ V + EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 482 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
+++ L L+++FLS L+ ++L + A S Y++ G+ + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS--- 119
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG- 597
+RV+HRD+K N+L+ + +L+DFGLA+ T V T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPI 622
+ + +D+++ G + E+ T +KP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 426 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--------- 475
IGKG QVY+ D + A+K+L KE V + E+ T+ +NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 476 --ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
I L F F+ D++L LV D++S G L +L + ++ +A V ALE+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVL-ALEH 111
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LH +++RD+K NILL L DFGL+K A+ + + T T GT YLAPE
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT-FCGTTEYLAPE 166
Query: 593 YFM----YGKVNDKIDVYAFGVVLLELLTGRKP 621
+ Y K +D ++ GV++ E+ G P
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 419 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILK----PSEDVIKEFVLEIEIIT 468
N + +G+G +V K +AVK+LK SE +++ + E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 469 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYK------ 521
++H ++I L G C +D LLL+ ++ GSL L ++K P+ G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 522 -----VAMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568
+ MG ++ ++YL + +++HRD+ + N+L+++ + ++SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
S++ + ++A E + DV++FGV+L E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 70/235 (29%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 414 LSATSNFLAE-------NLI-GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE 465
LS FL LI GK G V K P K KI+K K F IE
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKA-----KNFN-AIE 58
Query: 466 I-ITTL--HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
+ L + N I L +L+ D++ G L + L K +E K+
Sbjct: 59 PMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKI 114
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCT 580
+ EAL LH +IH D+K N+L D + + L D+GL K T S +
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY---- 166
Query: 581 DVAGTFGYLAPEYFMYGKVNDKI---------DVYAFGVVLLELLTGRKPISNDH 626
D GT Y +PE KI D +A GV+ ELLTG+ P D
Sbjct: 167 D--GTLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 76/298 (25%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 420 FLAENL-----IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLH 471
F AE+L IG+G V K G +AVK ++ + D K +++++++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 472 H-KNIISLLG---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 515
I+ G C E D VY+ L + + E + G
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------- 110
Query: 516 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575
K+A+ +AL YL ++IHRDVK SNILL + +L DFG++ S
Sbjct: 111 -----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-- 161
Query: 576 HITCTDVAGTFGYLAPEY---FMYGKVNDKIDVYAFGVVLLELLTGRKPISN-DHPKGQE 631
I T AG Y+APE + + DV++ G+ L E+ TG+ P + Q
Sbjct: 162 -IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ V+ P P L N+ + + V LC+ +D RP+ +L+
Sbjct: 221 TQVVKGDP------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNIISLL 479
IGKG +V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHS 535
+ F+ + L V D+++ G L +L + P A F +E +A AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+I+RD+K NILL L+DFGL K S T + GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLR 169
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPI-SNDH 626
+ +D + G VL E+L G P S D
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 425 LIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLL 479
++GKG +V L G+ AVK+LK +D ++ + E I++ + ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 535
CF+ + L V +F++ G L ++ +++ A F +E + AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHD 114
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ +I+RD+K N+LL + +L+DFG+ K + T + GT Y+APE
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQ 169
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKP 621
+D +A GV+L E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 417 TSNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKP----SEDVIKEFVLEIEIITTLH 471
NFL ++GKG +V EL A+KILK +D ++ ++E ++
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 472 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAE 528
++ L CF+ + L V ++++ G L ++ G K+P A + A ++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
L +LH + +I+RD+K N++L + +++DFG+ K +T GT Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
+APE Y +D +A+GV+L E+L G+ P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 35/239 (14%)
Query: 454 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK----K 509
ED KE VL + + H NI++ D +L +V ++ G L + + +
Sbjct: 43 EDSRKEAVL----LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 510 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569
+ W ++ +GV +++H +RV+HRD+KS NI L+ + + +L DFG A+
Sbjct: 99 EDTILQWF--VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
++ ++ CT V GT Y+ PE + N+K D+++ G +L EL T + P +
Sbjct: 150 LTSPGAY-ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--- 204
Query: 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
W IL KV Q L ++Y Y+ R ++ + +R+PR+RP + +L
Sbjct: 205 ------WKNLIL---KVCQGSYKPLPSHYSYEL--RSLIKQMF--KRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 49/206 (23%)
Query: 442 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLLV 491
G+++A+K I +D+I K + EI+++ L H+NII LL F D + +V
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND--VYIV 82
Query: 492 YDFL---------SRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 541
+ + S L + + + + + L+YLHS + V
Sbjct: 83 TELMETDLHKVIKSPQPLTD---------------DHIQYFLYQILRGLKYLHSAN---V 124
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDVAGTFGYLAPEYFM----Y 596
IHRD+K SNIL++ + + ++ DFGLA+ T+ T Y APE + Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKPI 622
K ID+++ G + ELLT RKP+
Sbjct: 185 TK---AIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 47/133 (35%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 549
LV D+ + G L + + K F E + + V A+ ++HS + +IHRD+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 550 NILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 608
NILL + +L DFG +K +A+T S + T GT Y+APE + + K D+++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 609 GVVLLELLTGRKP 621
GV+L ELLT ++P
Sbjct: 232 GVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 424 NLIGKGGSSQVYKGC-LPDGKELAVK-ILKP-SEDVIKEFVL-EIEI---ITTLHHKNII 476
IG+G VYK L G+ +A+K + P SE+ I L EI + + + H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 477 SLLGFC-----FEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMG-VAEA 529
LL C + L LV++ + +++L K P E K M +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+++LHS R++HRD+K NIL++ D + +++DFGLA+ S + T V T Y
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYR 173
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
APE + +D+++ G + EL R+P+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLG-- 480
++GKG +V L E A+K LK K+ VLE + + T+ + +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 481 ------FC-FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
FC F+ +L V ++L+ G L ++ + + F + A + L++
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQF 111
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LH + +I+RD+K N+LL D +++DFG+ K + GT Y+APE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPE 166
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
K N+ +D ++FGV+L E+L G+ P +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 426 IGKGGSSQVY------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 479
+GKGG +V G L K+L K LK + V E I+ +H + I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 480 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
+ F+ +L LV ++ G L +++ ++ F + LE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+R+I+RD+K N+LL +D ++SD GLA AGT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 599 VNDKIDVYAFGVVLLELLTGRKP 621
+ +D +A GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 35/165 (21%)
Query: 471 HHKNIISLLGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDPAAFGWSERYK 521
H NI+ LL +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHIT 578
+ + +AL+Y+HSG VIHRD+K SNILL+ D +L+DFGLA+ S + +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 579 CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 619
TD T Y APE + Y K +D+++ G +L E+L G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILK---PSEDVIKE---FVLEIEIITTLHHKNII 476
L+G+G +VY C + G+ELA K ++ S + KE EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 477 SLLGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
G C D L + +++ GS+++ L K A S K + E + YL
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFGYLAPE 592
HS ++HRD+K +NIL +L DFG +K T S V GT +++PE
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
K DV++ G ++E+LT + P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKILK---PS-EDVIKEFVLEIEIITTL-HHKNIISLL 479
+G G VY + EL A+K +K S E+ + + E++ + L H NI+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYL 533
E++ L V++++ E NL+ KD +SE Y++ G L ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHI 115
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC----TDVAGTFGYL 589
H HRD+K N+L+S +++DFGLA+ I TD T Y
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYR 165
Query: 590 APEYFMY-GKVNDKIDVYAFGVVLLELLTGR 619
APE + + +D++A G ++ EL T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 426 IGKGGSSQVYK-GCLPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 481
IG+G V+K G+ +A+K L+ E I L EI+ + H ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+ +LV +++ L E L +++ P + Y + + + Y+H A +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVKSY--MRMLLKGVAYMH---ANGI 120
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KV 599
+HRD+K +N+L+S D +++DFGLA+ S + VA T Y APE +YG K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE-LLYGARKY 178
Query: 600 NDKIDVYAFGVVLLELLTGR 619
+ +D++A G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 55/250 (22%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE-----FVLEIEIITTLH 471
+F +IG+G +V+ D ++ A+K+L+ S D+IK E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS-DMIKRNQIAHVRAERDILADAD 59
Query: 472 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-- 528
I+ L + F+D +L LV +++ G L L +KD + Y +AE
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELV 111
Query: 529 -ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 568
AL+ +H IHRD+K NIL+ D +L+DFGL K
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 569 --------WASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT 617
+ GT Y+APE YG + D ++ GV+L E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL---ECDWWSLGVILYEMLY 225
Query: 618 GRKPISNDHP 627
G P +D
Sbjct: 226 GFPPFYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 442 GKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 496
GK A+KILK + K+ V E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 497 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553
G L +L + +D A F +E + AL YLHS V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLHS---CDVVYRDLKLENLML 128
Query: 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGV 610
D +++DFGL K + + T GT YLAPE YG+ +D + GV
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGV 183
Query: 611 VLLELLTGRKPISN-DHPKGQESLVM 635
V+ E++ GR P N DH K E ++M
Sbjct: 184 VMYEMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 442 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 496
G+ A+KILK ++D + + E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYAN 78
Query: 497 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553
G L +L + +D A F +E + AL+YLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALDYLHS--EKNVVYRDLKLENLML 129
Query: 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 613
D +++DFGL K + T GT YLAPE +D + GVV+
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 614 ELLTGRKPISN-DHPKGQESLVM 635
E++ GR P N DH K E ++M
Sbjct: 188 EMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTL 470
+N+ L+G+G +VY D G+ELAVK ++ S + KE EI+++ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 471 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
H+ I+ G + + L + + + GS+++ L K A + K + E
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-SHITCTDVAGTFG 587
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+++PE K D+++ G ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 478
++GKG +V L E+ A+K+LK +DVI + + ++ T+ K I++L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVI---LQDDDVDCTMTEKRILALAAKHP 56
Query: 479 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
L CF+ + L V ++++ G L + ++K F A V AL +L
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFL 112
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H VI+RD+K NILL + +L+DFG+ K + +T T GT Y+APE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEI 167
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626
+ +D +A GV++ E++ G+ P D+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 442 GKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLL------GFCFEDNNLLLVY 492
GK++A+K + + DV K + E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 552
D L L +H ++ Y++ G L+Y+HS + VIHRD+K SN+L
Sbjct: 88 D-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDLKPSNLL 139
Query: 553 LSDDFEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPE-YFMYGKVNDKIDVYAFG 609
+++D E ++ DFG+A+ S+S + T+ T Y APE + ID+++ G
Sbjct: 140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
Query: 610 VVLLELLTGRKPI-SNDHPKGQESLVM 635
+ E+L GR+ + + Q L++
Sbjct: 200 CIFAEML-GRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 481
IG+G VYK G+ +A+K I +ED V + EI ++ L+H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+N L LV++FL L+ + + + + + Y HS RV
Sbjct: 67 VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRV 120
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN 600
+HRD+K N+L+ + +L+DFGLA+ T V T Y APE + + +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYS 178
Query: 601 DKIDVYAFGVVLLELLTGRKPI 622
+D+++ G + E++ R+P+
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+ E L YLH AQR+IHRDVK+ NI ++D + + D G A++ + + + +AGT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGT 219
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631
APE K N K D+++ G+VL E+L I D P E
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 442 GKELAVKILKPSEDVIKEFV-----LEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 495
GK A+K+LK + V K E +++ + + L + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555
+ G L +L ++ F E + + ALE+LH +I+RD+K NILL
Sbjct: 88 NGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDS 140
Query: 556 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDK-IDVYAFGVVLL 613
+ L+DFGL+K GT Y+AP+ G +DK +D ++ GV++
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 614 ELLTGRKPISNDHPKGQES 632
ELLTG P + D K ++
Sbjct: 200 ELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 476
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 477 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ + F + L + D ++ G L +L HG F E A + LE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHM 113
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 594 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESL 633
G D D ++ G +L +LL G P K + +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLH 471
N+ L+G+G +VY D G+ELAVK + S++ KE EI+++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 472 HKNIISLLGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
H I+ G C D L + +++ GS+++ L K A + + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFG 587
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+++PE K DV++ ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV--LEIEIITTL-HHKNIISLLGF 481
IG+G S+V K GK A+K +K +++ EI+ + L H NI+ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 482 CFE--DNNLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAM-GVAEALEYLHS 535
F+ L LV++ + + NL+ +K P +R K M + ++L+++H
Sbjct: 67 LFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH- 117
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ HRD+K NIL+ DD +L+DFG + S T+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171
Query: 596 Y-GKVNDKIDVYAFGVVLLELLT 617
G K+D++A G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 426 IGKGGSSQVYK-GCLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 480
+G G V+K P G +A K++ KP+ + + + E++++ + I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 70
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
+ D + + + + GSL++ L + P KV++ V + L YL +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE--KHK 124
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
++HRDVK SNIL++ E +L DFG++ S ++ GT Y++PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYS 180
Query: 601 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640
+ D+++ G+ L+E+ GR PI P +E +M+ P+
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPV 218
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 419 NFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDVIKEFVLE----------- 463
LA ++G+G +V YK G+ A+K LK K ++
Sbjct: 2 RCLA--VLGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEK 50
Query: 464 --IEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 520
E + H +++L CF+ ++++ V ++ + G L ++H + +SE
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPR 102
Query: 521 KV--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSS 575
V A V L+YLH ++++RD+K N+LL + +++DFGL K +S
Sbjct: 103 AVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
C GT +LAPE +D + GV++ E+L G P D
Sbjct: 160 TF-C----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 53/237 (22%)
Query: 425 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNII 476
L+GKG +V+ KG GK A+K+L E + +K + E EI+ TL H +
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLH---GN--KKDPAAFGWSERYKVAMGVAEALE 531
+L + L LV D+ G L L G ++ A F +E V ALE
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------VLLALE 117
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA---------------STSSSH 576
YLH +++RD+K NILL + LSDF L+K + SS +
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 577 ITCTDVA------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
++ GT Y+APE +D + G++L E+L G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEIITTLHHKNIISL 478
IG+G +V+K + +A+K +L +E KE F + EI+I+ L H+N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 479 LGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEA 529
+ C N LV++F E +L G + F SE KV +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS-SSHITC-TDVAGTFG 587
L Y+H +++HRD+K++NIL++ D +L+DFGLA+ S S +S T+ T
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 588 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 189 YRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 476
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 477 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ + F + L + D ++ G L +L HG F +E A + LE++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHM 113
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 594 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPILSSGKVTQL 649
G D D ++ G +L +LL G P K + + + + L +L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 650 LDPALG 655
G
Sbjct: 227 RSLLEG 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
++GKG VY L +A+K + + S V + EI + + L H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
E+ + + + GSL L +K P + E L+YLH ++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 542 IHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYLAPEYF----- 594
+HRD+K N+L++ ++SDFG +K + + CT+ GT Y+APE
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPR 186
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKP 621
YG D+++ G ++E+ TG+ P
Sbjct: 187 GYGA---PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
L+Y+HS +IHRD+K SNI +++D E ++ DFGLA+ T T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 589 LAPE-YFMYGKVNDKIDVYAFGVVLLELLTGR 619
APE + N +D+++ G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G+G + VYKG E+ A+K L E + EI ++ L H+NI+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 483 FEDNNLLLVYDFLSRGSLEE--NLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+N L+LV++++ L++ + HG + S Y++ G+A + H
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHE---N 119
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGTFGYLAPEYFM 595
RV+HRD+K N+L++ E +L+DFGLA+ +T S+ + T Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWYRAPDVLL 173
Query: 596 YGKV-NDKIDVYAFGVVLLELLTGR 619
+ + ID+++ G ++ E++TGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 44/280 (15%)
Query: 419 NFLAENLIGKGGSSQVY---KGCLPD-GKELAVKILKPSEDVIKEFVLE-----IEIITT 469
NF ++G G +V+ K D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 470 LHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMG 525
+ + L + F+ + L L+ D++S G + +L+ +D F E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE------- 113
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+ ALE+LH +++RD+K NILL + L+DFGL+K + T + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGT 169
Query: 586 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641
Y+APE +GK +D ++ G+++ ELLTG P + + + +S V ++ IL
Sbjct: 170 IEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL 224
Query: 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR 681
K +G + +L +L +DP+ R
Sbjct: 225 ---KCDPPFPSFIG------PEAQDLLHKLLR--KDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 425 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI------KEFVLEIEII-TTLHHKNII 476
+IGKG +V DGK AVK+L+ + ++ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 477 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
L + F+ L V DF++ G L +L + P R+ A +A AL YLHS
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHS 114
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+++RD+K NILL L+DFGL K S T T GT YLAPE
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIR 169
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKP 621
++ +D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 44/227 (19%)
Query: 418 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 472
+ + IG+G V P G ++A+K + P E F EI+I+ H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 473 KNIISLLGF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER-------- 519
+NII +L FE N++ +V + + E +L+ K ++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQY 110
Query: 520 --YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH- 576
Y++ G L+Y+HS + V+HRD+K SN+LL+ + + ++ DFGLA+ A H
Sbjct: 111 FLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 577 ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 622
T+ T Y APE + K K ID+++ G +L E+L+ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 26/191 (13%)
Query: 450 LKPSEDVIKEFVLEIEIITTLHHKN---IISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 506
+KP+ + + + E+++ LH N I+ G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 92
Query: 507 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564
+ P E K+++ V L YL +++HRDVK SNIL++ E +L DF
Sbjct: 93 AGRIP------ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 565 GLAKWA--STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
G++ S ++S + GT Y++PE + D+++ G+ L+E+ GR PI
Sbjct: 145 GVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
Query: 623 SNDHPKGQESL 633
K E++
Sbjct: 199 PPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 442 GKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL--GFCFEDNNLLLVYDFL 495
G E+A+K+L+ E F E + L+H NI++LL G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS- 554
+L E L + PA E ++ + V +AL H Q ++HRD+K NI++S
Sbjct: 62 PGRTLREVLAADGALPAG----ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 555 DDFEP--QLSDFGLAKWAS----TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYA 607
P ++ DFG+ + +T T+V GT Y APE V D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 608 FGVVLLELLTGR 619
+G++ LE LTG+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 426 IGKGGSSQVY----KGCLPDGKE--LAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 477
+G+G VY KG + D E +A+K + + + + EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------AAFGWSERYKVAMGVAEALE 531
LLG + L++ + ++RG L+ L + + A + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 587
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 588 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
+++PE G DV++FGVVL E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 420 FLAENLIGKGGSSQVYKGCLPDGK-----ELAVKILK--PSEDVIKEFVLEIEIITTLHH 472
+L+ +G +++ G L D K E+ VK +K SE + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 473 KNIISLLGFCFEDNNLLLV-YDFLSRGSLEENL----HGNKKDPAAFGWSERYKVAMG-- 525
+NI+ +L C ED V Y +++ G+L+ L G +P A S + V M
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQ 125
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+A + YLH + VIH+D+ + N ++ ++ + +++D L++ H +
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
++A E + + + DV++FGV+L EL+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 31/215 (14%)
Query: 425 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 478
++GKG +V L G+ AVK LK +DV+ +++ ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVV---LIDDDVECTMVEKRVLALAWENP 56
Query: 479 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---AL 530
L F+ +L V +FL+ G L ++ +D F + Y+ AE L
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRF---DLYRATFYAAEIVCGL 109
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
++LHS + +I+RD+K N++L D +++DFG+ K + + GT Y+A
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
PE K +D ++FGV+L E+L G+ P D
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF--VLEIEIITTLHHKNIISLLGFC 482
+G+G + VYKG +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
L LV++++ + K P + L Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYIL 125
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVND 601
HRD+K N+L+SD E +L+DFGLA+ A + SH +V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 602 KIDVYAFGVVLLELLTG 618
+D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFC 482
+GKG VYK P G +A+K ++ D K + ++E++I+ I+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
F + + + +++ GSL++ L+ ++ V + L++L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
HRDVK +N+L++ + + +L DFG++ AS + ++I C Y+APE G N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------YMAPERIKSGGPN 179
Query: 601 DKI------DVYAFGVVLLELLTGRKPI---SNDHPKGQESLVMWAKPILSSGKVTQLLD 651
DV++ G+ +LE+ GR P + + Q S ++ P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------ 227
Query: 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL------KLLRGDADVTKWA 701
P L + Y D + + C+ + P RP + +L K D D+ +W
Sbjct: 228 PTLPSGYSDDAQDFVA----KCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 49/206 (23%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
E ++G G ++ +GCL P +EL A+ L+ S+ + F+ E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L G N +++V +++S G+L+ L +K + + G+A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
S +H+ + + +L++ D ++S F + + + + T + + + APE Y
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQY 182
Query: 597 GKVNDKIDVYAFGVVLLELLT-GRKP 621
+ DV++FG+V+ E+++ G +P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLG 480
++G+G V K + KE+ A+K K SE + +KE L E++++ TL +NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 481 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L LV++++ + LE E +G + KV + + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
++HRD+K N+L+S + +L DFG A+ S S+ T+ T Y +PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 598 KVNDKIDVYAFGVVLLELLTGR 619
+D+++ G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 418 SNFLAENLIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTL 470
+ F ++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 471 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 530
+ ++ LLG C + + L+ + G L + + +K + G + +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
YL +R++HRD+ + N+L+ +++DFGLAK ++A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
E ++ + DV+++GV + EL+T G KP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLE---IEIITTLHH-----KNI 475
+IG+G ++V L + + A+K++K KE V + I+ + T H N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK------KELVNDDEDIDWVQTEKHVFETASNH 55
Query: 476 ISLLGF--CFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEA 529
L+G CF+ ++ L V +F+S G L ++ +K P A F +E ++ A
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLA 108
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
L +LH +I+RD+K N+LL + +L+D+G+ K T + GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYI 163
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI----SNDHP 627
APE +D +A GV++ E++ GR P +D+P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 425 LIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 477
++G G VYKG +PDG+ + A+K+L+ S KE + E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
LLG C + + LV + G L + + NK G + + +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
R++HRD+ + N+L+ +++DFGLA+ + ++A E ++
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 598 KVNDKIDVYAFGVVLLELLT-GRKP 621
+ + DV+++GV + EL+T G KP
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 446 AVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 503
AVK+L+P ++F+ E++I++ L NI LLG C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 504 LHGNKKDPAAFGWSERYK-------VAMGV--AEALEYLHSGSAQRVIHRDVKSSNILLS 554
L K G + K + M A + YL S +HRD+ + N L+
Sbjct: 110 LQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGT----FGYLAPEYFMYGKVNDKIDVYAFGV 610
++ +++DFG+++ +S + V G ++A E + GK K DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 611 VLLELLT 617
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 482 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
CF+ + L LV ++++ G L ++ +K P R+ A + AL +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RFYAAE-ICIALNFLHE---RG 116
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
+I+RD+K N+LL D +L+D+G+ K T + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYG 174
Query: 601 DKIDVYAFGVVLLELLTGRKP--ISNDHP--KGQESL--VMWAKPI 640
+D +A GV++ E++ GR P I D+P ++ L V+ KPI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 22/192 (11%)
Query: 442 GKELAVK-ILKP-SEDVI-KEFVLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSR 497
G+ +A+K I+KP S V+ K E++++ L H+NIISL F ++ V + L
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557
L L + F Y++ G L+Y+HS V+HRD+K SNIL++++
Sbjct: 95 -DLHRLLTSRPLEKQ-FIQYFLYQILRG----LKYVHSAG---VVHRDLKPSNILINENC 145
Query: 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL 616
+ ++ DFGLA+ + T T Y APE + + K + ++D+++ G + E+L
Sbjct: 146 DLKICDFGLAR---IQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 617 TGRKPI--SNDH 626
G KP+ DH
Sbjct: 201 EG-KPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 76/307 (24%), Positives = 121/307 (39%), Gaps = 61/307 (19%)
Query: 425 LIGK----GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-LEIEIITT--LHHKNIIS 477
LIGK + K P +AVK + ++ L+ EIIT+ L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 478 LLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 533
+ F D+ L +V ++ GS E+ L + + G E + + V AL+Y+
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF-ILKDVLNALDYI 117
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----Y 588
HS + IHR VK+S+ILLS D + LS + +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 589 LAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645
L+PE + G N+K D+Y+ G+ EL G P + M + + G
Sbjct: 175 LSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKV--RGT 226
Query: 646 VTQLLD---------------PALGNNYDYDQMERMVLASI---------LCIRRDPRAR 681
V LLD + + + D ++ + LC++RDP +R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 682 PQMSLVL 688
P S +L
Sbjct: 287 PSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 42/201 (20%)
Query: 442 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGFC-------FEDNNLLLV 491
+++A+K I ++ I K + EI+++ L H+N+I++ F D + +V
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIV 87
Query: 492 YDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRD 545
Y+ + + +LH + S+ Y++ G L+Y+HS + V+HRD
Sbjct: 88 YELM-----DTDLHQIIRSSQTL--SDDHCQYFLYQLLRG----LKYIHSAN---VLHRD 133
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVND 601
+K SN+LL+ + + ++ DFGLA+ +TS T+ T Y APE + Y
Sbjct: 134 LKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA-- 189
Query: 602 KIDVYAFGVVLLELLTGRKPI 622
IDV++ G + ELL GRKP+
Sbjct: 190 -IDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 482 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
CF+ ++ L V ++++ G L ++ +K P R+ A ++ AL YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAE-ISLALNYLHE---RG 116
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
+I+RD+K N+LL + +L+D+G+ K T + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 174
Query: 601 DKIDVYAFGVVLLELLTGRKPI----SNDHP 627
+D +A GV++ E++ GR P S+D+P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 426 IGKGGSSQVYKG--CLPDGKELAVKI-LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G+G + VYKG L D +I L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 483 FEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
+ +L LV+++L + L++ L GN + + V + + + L L+ ++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--------MHNVKLFLFQLLRGLNYCHRRK 124
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKV 599
V+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDY 182
Query: 600 NDKIDVYAFGVVLLELLTGR 619
+ +ID++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 44/272 (16%)
Query: 426 IGKGGSSQVYKGCL---PD------GKELAV--KILKPSEDVIKEFVLEIEIITTLHHKN 474
+G+G + +YKG L D G+E++V K+L F +++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
++ L G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE 118
Query: 535 SGSAQRVIHRDVKSSNILL---SDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFG 587
++++H +V NIL+ + LSD G+ + +
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169
Query: 588 YLAPEYFMYGKVNDKI--DVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK----PI 640
++APE G+ + I D ++FG LLE+ + G +P+S E + P+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQDQHRLPM 227
Query: 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASIL 672
++ L++ + YD +R +IL
Sbjct: 228 PDCAELANLIN----QCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
E +I+ ++H ++L G +++ L LV +F+ G L NK+ P G ++
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582
+ EYL S +++RD+K N+LL D +++DFG AK T ++ C
Sbjct: 141 VL----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLC--- 189
Query: 583 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
GT Y+APE + D + G+ + E+L G P + P
Sbjct: 190 -GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 442 GKELAVKIL-KPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-----CFEDNNLLLVYD 493
G +AVK L +P + +I K E+ ++ + H+N+I LL E+ N + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 494 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 551
L L + K D F + + L+Y+HS +IHRD+K SN+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSAD---IIHRDLKPSNL 151
Query: 552 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGV 610
+++D E ++ DFGLA+ T T Y APE + + N +D+++ G
Sbjct: 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 611 VLLELLTGR 619
++ ELLTGR
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVL----EIEIITTLHH 472
+F + +IG+G +V D G A+K L+ SE + KE V E +I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 473 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
++ L + F+D N L L+ ++L G + L KKD + Y +AE +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFY-----IAETIL 112
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL----------------AKWASTSSS 575
+ S IHRD+K N+LL +LSDFGL + ++
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 576 HITCT--------------------DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 615
GT Y+APE F+ N + D ++ GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 616 LTGRKPISNDHP 627
L G P +D+P
Sbjct: 233 LVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 426 IGKGGSSQV------YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 479
+GKGG +V G + K+L K LK K +LE EI+ ++ I++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE-KMALLEKEILEKVNSPFIVNL- 58
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
+ FE +L LV ++ G L+ H + + + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+++RD+K N+LL D +LSD GLA T T AGT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEP 170
Query: 599 VNDKIDVYAFGVVLLELLTGRKPISNDHPK 628
+ +D +A G + E++ GR P + K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 419 NFLAENLIGKG--GSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 472
+F ++L+G+G G QV + G A+K++K S + +E V E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 473 KNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
I L + F+D NL LV ++ G L +L +D ++ Y +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY-----LAELVL 113
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
+HS +HRD+K N+L+ +L+DFG A T++ + GT Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAP 172
Query: 592 EYF---------MYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
E YG + D ++ GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-STSSSHITCTDVAGTFG 587
AL+Y+H+ + V HRD+K NIL + D + ++ DFGLA+ A + + + I TD T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 588 YLAPEY--FMYGKVNDKIDVYAFGVVLLELLTGR 619
Y APE + K ID+++ G + E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 476 ISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I L + F+D+ L +V +++ G L NL N P W+ Y V AL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFY--TAEVVLALDAIH 159
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEY 593
S IHRDVK N+LL +L+DFG K + C GT Y++PE
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR--CDTAVGTPDYISPEV 214
Query: 594 FM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G+G + V+KG + L A+K L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 541
D +L LV+++L +++L D K+ + + L Y H ++V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 600
+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 601 DKIDVYAFGVVLLELLTGR 619
+ID++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 44/124 (35%), Positives = 62/124 (50%), Gaps = 25/124 (20%)
Query: 524 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 575
M AE ALEYLH+ ++HRD+K N+L++ +L+DFGL+K S +
Sbjct: 105 MYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 576 -HITC-------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISN 624
HI V GT Y+APE + YGK +D +A G++L E L G P
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPFFG 218
Query: 625 DHPK 628
D P+
Sbjct: 219 DTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 11/99 (11%)
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS----SSHITCTDVAG 584
L+Y+HS + V+HRD+K N+L++ D E ++ DFGLA+ S + + + T+
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171
Query: 585 TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 622
T Y APE + + IDV++ G +L ELL GRKP+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 521
E +I+ ++ + ++SL + +E + L LV ++ G L+ H A F
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVF 106
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 581
A + LE LH +R+++RD+K NILL D ++SD GLA T
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKG 160
Query: 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628
GT GY+APE + D +A G +L E++ G+ P K
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 443 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDFLSRGSL 500
K ++ + LK E + V+E+ ++ L HKNI+ + N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 501 EENLHGNKKDPAAFGWSERY---KVAMGVAEALEYLHS----GSAQRVIHRDVKSSNILL 553
N+ K FG E + + + AL Y H+ + +RV+HRD+K NI L
Sbjct: 102 SRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 554 SDDFE-----------------PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
S ++ DFGL+K S +C GT Y +PE ++
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLH 215
Query: 597 --GKVNDKIDVYAFGVVLLELLTGRKP 621
+DK D++A G ++ EL +G+ P
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 426 IGKGGSSQVYKGCLPD-GKELA---VKILKPSEDVIKEFVLEIEIITTLH---HKNIISL 478
IG G VYK P G +A V++ + + V E+ ++ L H NI+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 479 LGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 532
+ C + + LV++ + + L L K P +E K M L++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LH A ++HRD+K NIL++ + +L+DFGLA+ S + T V T Y APE
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPE 177
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
+ +D+++ G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 481
+G+G VYK DGK+ LK E + EI ++ L H N+I+L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 482 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
D + L++D+ NKK P S + + + + YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK-PMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 537 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 591
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 592 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 622
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 426 IGKGGSSQVYKGCLPDGKELA----VKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
IG+G V+K + E+ V++ E V + EI ++ L HKNI+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 482 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
D L LV+++ + L+ ++ +G DP S +++ G+A + HS
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNG-DIDPEIVK-SFMFQLLKGLA----FCHS--- 117
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
V+HRD+K N+L++ + E +L+DFGLA+ + V T Y P+ K
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 599 VND-KIDVYAFGVVLLELLTGRKPI 622
+ ID+++ G + EL +P+
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHV-LANNAIVDRDGKSSLLSLVKA--- 73
+V V V D S+ L WAL +A G T++ +HV +I GK + S K
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEED 60
Query: 74 --FDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS 131
+L Y FC+ K V + + + K +V + TK ++G + ++H
Sbjct: 61 KEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMK 120
Query: 132 T--TSLAKYCAKKLSKDCSVLAVNNG 155
+ +A K+ C+V V+ G
Sbjct: 121 FKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 426 IGKGGSSQVYKGCLPDGKELA---VKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 480
IG G +V G G A VK L+ S ++ F+ E++ L+H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 539
C E LLV +F G L+ L N+ A + ++A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY------ 593
IH D+ N L+ D ++ D+GLA +IT A +LAPE
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 594 -FMYGKVNDKIDVYAFGVVLLELLT-GRKPISN 624
+ K ++++ GV + EL T +P +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 424 NLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKE----------FVL--EIEII 467
+G+G +V K GK +A+K +K E DV K+ F E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 468 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMG 525
+ H+NI+ L+ E + + LV D ++ L++ + + +E + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQVKCILLQ 127
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG- 584
+ L LH +HRD+ +NI ++ +++DFGLA+ T +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 585 -----------TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 622
T Y APE M K + +D+++ G + ELLTG KP+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 426 IGKGGSSQVYKG--CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+G+G + VYKG L G+ +A+K L+ E + E ++ L H NI++L
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 482 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPA---AFGWSERYKVAMGVAEALEYLHSG 536
L LV+++L L++ + G F +++ G L Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCHQ- 121
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
+RV+HRD+K N+L+S+ E +L+DFGLA+ A + S +V T Y P+ +
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLL- 176
Query: 597 GKVN--DKIDVYAFGVVLLELLTGR 619
G +D++ G + E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 441 DGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL-GFCFEDNNLLLVYDFLS 496
DGK+ +K L S K E ++++ L H NI++ + ED L +V F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556
G L L K ++ + + +A AL+YLH + ++HRD+K+ N+ L+
Sbjct: 84 GGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRT 138
Query: 557 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616
++ D G+A+ + + + GT Y++PE F N K DV+A G + E+
Sbjct: 139 NIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 617 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 676
T + + K SLV + GK+ + P DY ++A++L +
Sbjct: 197 TLKHAFN---AKDMNSLVYR----IIEGKLPPM--PK-----DYSPELGELIATMLS--K 240
Query: 677 DPRARPQMSLVLK 689
P RP + +L+
Sbjct: 241 RPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 426 IGKGGSSQVYKGC-LPDGKELA----VKILKPSEDVIKEFVLEIEII---TTLHHKNIIS 477
IG+G +V+K L +G V++ E + + E+ ++ T H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 478 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 531
L C + L LV++ + + L L K P +E K M + L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
+LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V T Y AP
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 178
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
E + +D+++ G + E+ RKP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 425 LIGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNII 476
+IGKG +V + DG AVK+L+ + K+ I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 477 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 533
L + F+ L V D+++ G L +L + +P A R+ A VA A+ YL
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAE-VASAIGYL 112
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
HS +I+RD+K NILL L+DFGL K T + GT YLAPE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEV 167
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ +D + G VL E+L G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/291 (21%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 426 IGKGGSSQVYKGCLPD------GKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 477
+G+G VY+G D +AVK + S + + EF+ E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA------AFGWSERYKVAMGVAEALE 531
LLG + L+V + ++ G L+ L + + E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 587
YL +A++ +HRD+ + N +++ DF ++ DFG+ + I TD G
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 588 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 643
++APE G D+++FGVVL E+ + +P LS+
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG----------------LSN 227
Query: 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
+V + + + + ER+ +C + +P+ RP ++ LL+ D
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 461 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 520
+ E+ ++ L H NI++L + L LV+++L + +L +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNV 105
Query: 521 KVAM-GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
K+ M + L Y H ++++HRD+K N+L+++ E +L+DFGLA+ S + T
Sbjct: 106 KIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160
Query: 580 TDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 619
++ T Y P+ + + + ID++ G +L E+ TGR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 481
+G+G VYK DGK+ LK E + EI ++ L H N+ISL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 482 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
D + L++D+ NKK P + + + + YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 537 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 591
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 592 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 622
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 71/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 392 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKG--GSSQVYKGCLPDGKELAVKI 449
K ++ +Y T + +DL ++ +IG+G G Q+ + K A+K+
Sbjct: 19 KNIDNFLNRYKDT--INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKL 75
Query: 450 LKPSEDVIKE---FVLEIEIITTLHHKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLH 505
L E + + F E I + + L + F+D+ L +V +++ G L NL
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 506 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565
N P W+ Y V AL+ +HS IHRDVK N+LL +L+DFG
Sbjct: 135 SNYDVPEK--WARFYTAE--VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 566 LAKWASTSSSHITCTDVAGTFGYLAPEYF-------MYGKVNDKIDVYAFGVVLLELLTG 618
+ C GT Y++PE YG+ + D ++ GV L E+L G
Sbjct: 188 TCM-KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
Query: 619 RKPISNDHPKGQESLVMWAKPILS 642
P D G S +M K L+
Sbjct: 244 DTPFYADSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 443 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 502
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 503 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562
L K ++ + + + + Y+H +R++HRD+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIG 147
Query: 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 615
DFG+++ S T GT Y++PE + + K D+++ G +L E+
Sbjct: 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKI--LKPSEDVIKEFVLEIEIITTLHH 472
A +++L +G+G + VYKG +G+ +A+K+ +K E V + E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
NI+ L L V++++ L + + + P + L Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
+H Q ++HRD+K N+L+S E +L+DFGLA+ S S + V T Y P+
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 593 YFMYG-KVNDKIDVYAFGVVLLELLTGR 619
+ + +D++ G + +E+L G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 425 LIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVI------KEFVLEIEIITTLHHKNIIS 477
LIGKGG +VY P + +A+K K ED+ K F+ E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKVAMG 525
+ C + + + ++ +L+ L K AF S +K+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-LSIFHKICAT 125
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW---------------- 569
+ EY+HS + V+HRD+K NILL E + D+G A +
Sbjct: 126 I----EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
SS + GT Y+APE + ++ D+YA GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDN--NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWS 517
EI I+ L H NI+++ N + +V +++ E +L K P F S
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQP--FLQS 106
Query: 518 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
E + + + + +LH ++HRD+K+SN+LL++ ++ DFGLA+ +
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 578 TCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPI 622
T V T Y APE + K + ID+++ G + ELLT +KP+
Sbjct: 164 TQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 425 LIGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNII 476
++GKG V + L +++AVK+LK S D I+EF+ E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 477 SLLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAE 528
L+G +++ F+ G L L ++ ++P + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
+EYL S++ IHRD+ + N +L+++ ++DFGL+K + + +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
LA E DV+AFGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 426 IGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNI--------I 476
IGKG +V + D + + A+K ++ + V + E+ TL + + I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55
Query: 477 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEY 532
L F F+ L LV F++ G L +L G + + AE ALE
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALEN 108
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLA 590
LH + VI+RD+K NILL L DFGL K ++ C GT YLA
Sbjct: 109 LHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPEYLA 161
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
PE + +D + GV+L E+LTG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 49/146 (33%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 479 LGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHS 535
L F F+ + L V D+++ G L +L + +P A R+ A +A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAE-IASALGYLHS 114
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+++RD+K NILL L+DFGL K + T + GT YLAPE
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLH 169
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKP 621
+ +D + G VL E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 415 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEII 467
S ++ +G+G +VYK + G+ +A+K IL +E K+ F + EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 468 TTLHHKNIISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
L H N++ L+ E VY ++ +L G ++P K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP-------SVKL 112
Query: 523 AMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA------- 567
+ E + YLH ++HRD+K++NIL+ + +++DFGLA
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 568 ---KWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRK 620
K + T++ T Y PE + Y +D++ G V E+ T R+
Sbjct: 170 PNPKGGGGGGTR-KYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFT-RR 224
Query: 621 PI 622
PI
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 47/256 (18%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFV----LEIEIITTLHHK 473
+F + +IG+G +V D G A+KIL+ ++ + KE V E +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 474 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
++ + + F+D NL L+ +FL G + L KKD ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLA 113
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTD--- 581
+ S IHRD+K N+LL +LSDFGL K A + +H +D
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 582 ----------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 620 KPISNDHPKGQESLVM 635
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 458 KEFVLEIEIITTLHHKNIISLLGFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKD 510
+E VL + ++HKNII LL F E ++ LV + + +L + + +
Sbjct: 64 RELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD- 116
Query: 511 PAAFGWSER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFG
Sbjct: 117 ------HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
Query: 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
LA+ A TS T T Y APE + + +D+++ G ++ E++ G
Sbjct: 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEI----EIITTLHHK 473
+F + +IG+G +V D G A+KIL+ ++ + KE V I +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 474 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
++ + + F+D NL L+ +FL G + L KKD + ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLA 113
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTDVA- 583
+ + IHRD+K N+LL +LSDFGL K A + +H +D +
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 584 ------------------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 620 KPISNDHPKGQESLVM 635
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 426 IGKGGSSQVYKGCLPD-----------GKELAV--KILKPSE-DVIKEFVLEIEIITTLH 471
+G+G +Q+Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
HK+I+ L G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 532 YLHSGSAQRVIHRDVKSSNILLS-----DDFEP--QLSDFGLAKWASTSSSHITCTDVAG 584
YL + ++H +V + NILL+ + P +LSD G+ T S C +
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI---PITVLSRQECVE--- 170
Query: 585 TFGYLAPEYFMYGKV-NDKIDVYAFGVVLLEL-LTGRKPISN 624
++APE K + D ++FG L E+ G P+ +
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 54/165 (32%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 481 FC-FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
FC F+D+ L +V +++ G L NL N P W++ Y V AL+ +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEK--WAKFYTAE--VVLALDAIHS--- 160
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYF--- 594
+IHRDVK N+LL +L+DFG K T C GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR--CDTAVGTPDYISPEVLKSQ 218
Query: 595 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 70/239 (29%)
Query: 443 KELAVKILK----PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-LLLVYDFLS 496
+ +AVK+LK SE K + E++I+ + HH N+++LLG C + L+++ ++
Sbjct: 38 RTVAVKMLKEGATASEY--KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 497 RGSLEENLHGNK--------------------------------KDPAAFGW-------- 516
G+L L + + A+ G+
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 517 -------SERYKV----------AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559
E YK + VA +E+L S ++ IHRD+ + NILLS++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVV 212
Query: 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLT 617
++ DFGLA+ ++ D ++APE ++ KV + DV++FGV+L E+ +
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 79/352 (22%), Positives = 144/352 (40%), Gaps = 46/352 (13%)
Query: 426 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNII------- 476
+G G + V+ D K +AVK + ++ +K + EI+II L H NI+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 477 -------SLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGV 526
+G E N++ +V +++ LE+ + Y++ G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM-----YQLLRG- 126
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH---ITCTDV 582
L+Y+HS + V+HRD+K +N+ ++ +D ++ DFGLA+ SH ++ V
Sbjct: 127 ---LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 583 AGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641
T Y +P + ID++A G + E+LTG+ + H Q L++ + P++
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 701
+LL+ + R L +L +P A + + ++L +
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLP-GVNPEA---LDFLEQILTFN----PMD 290
Query: 702 RLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLED 753
RL + + SCP S + D DD M+ I + D
Sbjct: 291 RLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNWD 342
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 29/167 (17%)
Query: 463 EIEIITTLHHKNIISLLGF------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW 516
E+ ++ ++HKNIISLL E ++ LV + + +L + +H
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD------- 121
Query: 517 SER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+
Sbjct: 122 HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 171
Query: 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 618
T+ ++ T T Y APE + + +D+++ G ++ EL+ G
Sbjct: 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 442 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498
G ++A+K L +P SE K E+ ++ + H+N+I LL D +L +DF
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 558
G + + + L+Y+H+ +IHRD+K N+ +++D E
Sbjct: 100 PFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156
Query: 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLT 617
++ DFGLA+ + T T Y APE + + +D+++ G ++ E+LT
Sbjct: 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
Query: 618 GRKPI--SNDH-PKGQESLVMWAKPILSSGKVTQLLDPALGNNY--DYDQMERMVLASIL 672
G KP+ +DH + E + + P S + Q L NY + + S+L
Sbjct: 212 G-KPLFKGHDHLDQLMEIMKVTGTP---SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267
Query: 673 CIRRDPRARPQMSLVL-KLLRGDAD 696
P A P VL K+L DA+
Sbjct: 268 -----PNANPLAVNVLEKMLVLDAE 287
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 521
E +I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNP---GFDEERA 104
Query: 522 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-- 577
V A + LE LH +R+++RD+K NILL D ++SD GLA I
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA-------VEIPE 154
Query: 578 --TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
T GT GY+APE + D + G ++ E++ G+ P
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 441 DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLL 490
DGK +A+K + K E++++ H N++S L FE+ + +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE--IYV 81
Query: 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRVIHRDVKSS 549
V + + + +LH P S+ KV + + L+YLHS ++HRD+K
Sbjct: 82 VTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPG 132
Query: 550 NILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYA 607
N+L++ + ++ DFGLA S H+T V T Y APE M + +D+++
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWS 190
Query: 608 FGVVLLELLTGR 619
G + ELL R
Sbjct: 191 VGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
L+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ A T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182
Query: 590 APEYFM-YGKVNDKIDVYAFGVVLLELLTGR 619
APE + + N +D+++ G ++ ELL G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 521
E +I+ ++ + +++L + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFEEERA 104
Query: 522 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
+ A + LE LH + ++RD+K NILL D ++SD GLA S
Sbjct: 105 LFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I 158
Query: 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
GT GY+APE + D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 426 IGKGGSSQVYKGCLPDGKE-LAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
IG+G VYK E +A+K ++ E V + EI ++ + H NI+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHS 535
+ L LV+++ L+ +L + F + R Y++ G+A Y HS
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 536 GSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
RV+HRD+K N+L+ +L+DFGLA+ T V T Y APE
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEIL 175
Query: 595 MYGK-VNDKIDVYAFGVVLLELLTGRKPI 622
+ + + +D+++ G + E++ +KP+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 521
E I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E+
Sbjct: 50 EKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFDEQRA 104
Query: 522 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
+ A + LE L +R+++RD+K NILL D ++SD GLA T
Sbjct: 105 IFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158
Query: 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
GT GY+APE K D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHH 472
S F+ IG G +V D L A+K L+ ++ +++ E +I+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 473 KNIISLLGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
+ ++ L + F+D +NL V D++ G SL L ++D A F +E +
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE-------LTC 112
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA--------------------- 567
A+E +H IHRD+K NIL+ D +L+DFGL
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 568 ------KWASTSSS------------HITCT--DVAGTFGYLAPEYFMYGKVNDKIDVYA 607
+W+ H C + GT Y+APE + D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 608 FGVVLLELLTGRKPISNDHPKG-QESLVMWAK 638
GV+L E+L G+ P D P Q ++ W
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 467 ITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 525
ITTLH + F+D N L LV D+ G L L +D + Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+AE + +HS +HRD+K N+LL + +L+DFG + + + GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 586 FGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 621
Y++PE GK + D ++ GV + E+L G P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 426 IGKGGSSQVYKGCLPDGK---ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 479
+G+G V +G L ++AVK +K + +++F+ E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 480 GFCFEDN------NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALE 531
G C + + +++ F+ G L L ++ P K +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
YL S++ IHRD+ + N +L+++ ++DFGL+K + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
E K DV++FGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 426 IGKGGSSQVYKGCLPDG---KELAVKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 480
IG G +V G + G ++ VK L+ S V ++ F+ E + +L H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLH 534
C E LLV +F G L+ L +K DP ++A +A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL-----QRMACEIALGLLHLH 117
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
+ IH D+ N LL+ D ++ D+GL+ ++T + ++APE
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 595 --MYGK--VNDKI---DVYAFGVVLLELLT-GRKP 621
++G V D+ +V++ GV + EL G +P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 442 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 497
G+++A+K L +P SE K E+ ++ + H+N+I LL + DF L
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLS 554
++ +L P SE KV V + L+Y+HS +IHRD+K N+ ++
Sbjct: 100 PYMQTDLQKIMGHP----LSED-KVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLL 613
+D E ++ DFGLA+ A T T Y APE + + N +D+++ G ++
Sbjct: 152 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 614 ELLTGR 619
E+LTG+
Sbjct: 207 EMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDPAAFGWS 517
EI+I+ T+ H+ II+L+ + + +V D + + ++ P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT--------YVDRSGPLPL--E 185
Query: 518 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
+ + + EAL YLH + +IHRDVK+ NI L + L DFG A
Sbjct: 186 QAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
C +GT +PE K D+++ G+VL E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA+ +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++ D
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++APE + DV++FGV+L E+ + G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 644
++APE + DV++FGV+L E+ + G P +P Q + + L G
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YPGVQINEEFCQR--LKDG 293
Query: 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
T++ P ++ R++LA C + DP+ RP S ++++L
Sbjct: 294 --TRMRAP----ENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 461 VLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 519
E I+ ++H +II L G F + L++ + + L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAIC----DI 184
Query: 520 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
+ V A++YLH R+IHRD+K+ NI ++ + L DFG A+ I
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDINA 237
Query: 580 TDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
AGT APE +D+++ G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 463 EIEIITTLHHKNIISLLGFCFEDNNLLLVYD-FLSRGSLEENLHG---NKKDPAAFGWSE 518
E+ ++ ++HKNIISLL +L D +L ++ NL + D +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 124
Query: 519 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578
Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 125 LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 174
Query: 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616
T T Y APE + + +D+++ G ++ E++
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 426 IGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISL 478
I +G +VY K + K AVK++K ++ + K V E + + I+ L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGW-SERYKVAMGVAEALEYLHS 535
NN+ LV ++L G ++ LH G + A + SE VA AL+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE-------VALALDYLHR 122
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568
+IHRD+K N+L+S++ +L+DFGL+K
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA+ +++L +++ IHRDV + N+LL+D ++ DFGLA+ S+++ +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++APE + DV+++G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 9/137 (6%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
++V V S L WA + G ++ LHV+ + L +A +
Sbjct: 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARA---L 57
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST--TSL 135
L V ++ + G IL A+ A ++G+ +R S+
Sbjct: 58 LEALREALAEAGVKVETVVLEGDPAEAIL-EAAEELGADLIVMGSRG-RSGLRRLLLGSV 115
Query: 136 AKYCAKKLSKDCSVLAV 152
A+ + C VL V
Sbjct: 116 AERVLRHAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
+++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 191
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
APE + + +D+++ G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 427 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFCFE 484
GK S++Y + VK LK + + EF+ + + L H NI+ LG C E
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66
Query: 485 DNNLLLVYDFLSRGSL------EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
LLV+++ G L E+ N + ++A +A + ++H
Sbjct: 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMHK--- 117
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+H D+ N L+ D ++ D+G+ T D +LAPE + G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE--LVGE 175
Query: 599 VNDKI---------DVYAFGVVLLELL-TGRKPISN 624
+ + +V+A GV L EL +P S+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
N++ L + ++++ LV G L ++ P +R+ M VA L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE--ECVKRWAAEMVVA--LDAL 101
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H + ++ RD+ +NILL D QL+ F +W+ S C A Y APE
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS---CDGEAVENMYCAPEV 153
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
+ + D ++ G +L ELLTG K + HP G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 38/169 (22%)
Query: 467 ITTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 525
IT LH + F+D NNL LV D+ G L L + F +R M
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLL-------SKFE--DRLPEDMA 104
Query: 526 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG----LAKWASTSSSHIT 578
+AE + + S +HRD+K N+LL + +L+DFG L + S+
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN--- 161
Query: 579 CTDVA-GTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 621
VA GT Y++PE G+ + D ++ GV + E+L G P
Sbjct: 162 ---VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKPSEDVIKE----FVLEIEIITTLHHK 473
+F +IG+G +V L + K A+KIL E + + F E +++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSL-------EENLHGNKKDPAAFGWSERYKVAMGV 526
I +L ++NNL LV D+ G L E+ L +D A F +E +A+
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMARFYLAEMV-IAIDS 117
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
L Y +HRD+K NIL+ + +L+DFG + + + GT
Sbjct: 118 VHQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167
Query: 587 GYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKP 621
Y++PE GK + D ++ GV + E+L G P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 480
LI + + +YKG + KE+ ++ K + +I EI+ + + NI+ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 481 FCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
F + + L L+ ++ +RG L E L K + + +A+ + L L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF-- 594
+ + ++++ S + L++++++ ++ GL K S+ +V Y + +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK----NV-NFMVYFSYKMLND 194
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISN 624
++ + K D+Y+ GVVL E+ TG+ P N
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 581
VA + A++Y+H + +IHRD+K+ N+L++ + L DFG A +A S S
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 614
+AGT APE +D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 60/271 (22%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHH 472
S F+ +G G +V C D L A+K L+ + + + E +I+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 473 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
+ ++ L + F+D +NL V D++ G + L + P R+ +A + A+E
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAE-LTLAIE 115
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHI------ 577
+H IHRD+K NIL+ D +L+DFGL +W S SHI
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 578 -----------TCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVY 606
C D + GT Y+APE + D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 607 AFGVVLLELLTGRKPISNDHP-KGQESLVMW 636
+ GV+L E+L G+ P P + Q ++ W
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 60/208 (28%)
Query: 479 LGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
L + F+D +NL V D++ G SL + +D A F +E + A+E +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-------LTCAVESVH 118
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTS------------------ 573
IHRD+K NIL+ D +L+DFGL +W S
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 574 ----SSHITCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFG 609
++ C D + GT Y+APE + D ++ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 610 VVLLELLTGRKPISNDHP-KGQESLVMW 636
V+L E+L G+ P P + Q ++ W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S+++ +
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++APE + DV+++G++L E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA +E+L S + +HRD+ + N+L+ + ++ DFGLA+ S++I+
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
++APE DV++FG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 4/138 (2%)
Query: 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDS 76
+ ++V V S L WAL + G +I LHV+ + +
Sbjct: 3 KRILVAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEE 62
Query: 77 VLAVYEGFCNLKQVDLKLK-ICRGTSIRKILVREAQSYSATKFIVGT-AKNHHTIRSTTS 134
+ + ++ + RG + ++ A+ A ++G+ ++ S
Sbjct: 63 EAEAEALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRGRSGLRRLLLGS 122
Query: 135 LAKYCAKKLSKDCSVLAV 152
+A+ + C VL V
Sbjct: 123 VAEKVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 423 ENLIGKGGSSQVYKGC---LPDGKEL-----AVKILKPSEDVIKEFVLE-IEIITTLHHK 473
E+L G+G ++++KG + D EL +K+L S E E +++ L HK
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+++ G C + ++V +++ GSL+ L KK+ S + +VA +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 534 HSGSAQRVIHRDVKSSNILL 553
+ + H +V + N+LL
Sbjct: 117 ED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 453 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 512
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + D
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-- 96
Query: 513 AFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570
G SE + GV +AL+Y+H +HR VK+S+IL+S D + LS GL
Sbjct: 97 --GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNL 149
Query: 571 STSSS-------HITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKP 621
S + H +L+PE + K D+Y+ G+ EL G P
Sbjct: 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 622 ISNDHPKGQ 630
D P Q
Sbjct: 210 F-KDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKN-IISLLG 480
IG+G +VYK GK +A+K L+ E+ I L EI ++ L I+ LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 481 FCFEDNN-----LLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEAL 530
+ L LV+++L L++ + N + PA S Y++ GVA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+ H V+HRD+K N+L+ +++D GL + S T V T Y
Sbjct: 125 -HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 590 APEYFMYGK-VNDKIDVYAFGVVLLELLTG 618
APE + + +D+++ G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS--LLGFC 482
L+ G +++VY D +KI E E+ I+ L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWA 570
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 69/265 (26%)
Query: 419 NFLAENLIGKGGSSQV---YKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLH 471
+F +IGKG +V K GK A+K L SE D + E +++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 472 HKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVA 527
++SL + F+D L L+ +FL G L L K D +SE R+ +A V
Sbjct: 60 SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDT----FSEDVTRFYMAECVL 112
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 568
A+E +H IHRD+K NIL+ +LSDFGL+
Sbjct: 113 -AIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 569 ----------------WASTSSSHITCT----------DVAGTFGYLAPEYFMYGKVNDK 602
+ SS T GT Y+APE F+ +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 603 IDVYAFGVVLLELLTGRKPISNDHP 627
D ++ G ++ E L G P +++
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 22/204 (10%)
Query: 440 PDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496
P G + V+I +E+ +K E+ + H NI++ + L ++ F++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 497 RGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554
GS L K G SE + G L YLH IHR++K+S+IL+S
Sbjct: 83 YGSANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 555 DDFEPQLSDFG-LAKWASTSSSHITCTDV----AGTFGYLAPEYF---MYGKVNDKIDVY 606
D LS L D +L+PE +YG N K D+Y
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIY 194
Query: 607 AFGVVLLELLTGRKPISNDHPKGQ 630
+ G+ EL TGR P D + Q
Sbjct: 195 SVGITACELATGRVPFQ-DMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
VA +E+L S + +HRD+ + N+LL+ ++ DFGLA+ S++++
Sbjct: 246 VARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 586 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
++APE DV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 440 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLV--YDFLS 496
P + L K +K + EI + L+H+NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 497 RGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 550
+L+ D AF W +R + + A+EY+H +++IHRD+K N
Sbjct: 248 ------DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 551 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--GTFGYLAPEYFMYGKVNDKIDVYAF 608
I L+ D + L DFG A D GT +PE + D+++
Sbjct: 298 IFLNCDGKIVLGDFGT---AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 609 GVVLLELLT 617
G++LL++L+
Sbjct: 355 GLILLDMLS 363
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 766 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.62 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.56 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.29 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 97.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.65 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.5 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.19 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.08 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.55 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-56 Score=488.65 Aligned_cols=288 Identities=49% Similarity=0.879 Sum_probs=260.1
Q ss_pred cccccCHHHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhH-HHHHHHHHHHHHhcCCCceeEEeeEE
Q 004247 404 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFC 482 (766)
Q Consensus 404 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~ 482 (766)
..+.|++.++..+|++|...++||+||||.||+|.+.+|+.||||++...... .++|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56889999999999999999999999999999999999999999998875543 66799999999999999999999999
Q ss_pred eecC-ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 483 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 483 ~~~~-~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
.+.+ +.+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||..+..+||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 499999999999999999976543 7899999999999999999999988779999999999999999999999
Q ss_pred ecccccccccC-CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~-~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+|+.... ....... ..||.+|+||||+..+..+.|+|||||||+|+||+||+.|++...+.....++.|..+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999977665 2222211 17999999999999999999999999999999999999999876666777799999999
Q ss_pred cccCccccccCcccC-CCCCh-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 641 LSSGKVTQLLDPALG-NNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 641 ~~~g~~~~lld~~l~-~~~~~-~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
+..+++.+++|+.+. ..+.. +++.+++.+|++|++.+|.+||+|.+|+++|+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999999997 55554 78999999999999999999999999999995443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=382.39 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=205.1
Q ss_pred ccceeeeccCceEEEEEEeC-CCCEEEEEEcc--CChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-eEEEEeecC
Q 004247 421 LAENLIGKGGSSQVYKGCLP-DGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 496 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~lV~E~~~ 496 (766)
...+.||+|..|+||++.++ +++.+|+|++. .+....+++.+|++|++..+|||||.+||.|...+. ..|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 45688999999999999975 78889999994 456778999999999999999999999999999985 999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|++++...+ .+++...-+|+.++++||.|||+ .++||||||||+|||++..|++||||||.++.+.+.
T Consensus 162 gGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999997653 58899999999999999999995 288999999999999999999999999999987765
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc--cchhhHHHhhccccccCccccccCccc
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.+.+++||..|||||.+++..|+.++||||||++++|+.+|+.||....+ .....+..+. . .+ .-|.+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v-~~-----ppP~l 302 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---V-DE-----PPPRL 302 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---h-cC-----CCCCC
Confidence 34558999999999999999999999999999999999999999976422 1222222211 0 00 11233
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... ....+..++..||++||.+||++.+++++
T Consensus 303 P~~~---fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEGE---FSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred Cccc---CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2221 22334455567999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=392.56 Aligned_cols=252 Identities=33% Similarity=0.521 Sum_probs=204.8
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-ceEEEEeecCC
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLSR 497 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~g 497 (766)
..+.||.|+||+||+|.+.....||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999544449999998643 23679999999999999999999999999887 79999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc-eEeecccCCCeeeCCCC-CeeEecccccccccCCCC
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~~~ 575 (766)
|+|.++++.. ....+++..++.|+.+||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999874 23579999999999999999999999 66 99999999999999998 99999999998776543
Q ss_pred CceecccccccCCCCchhhc--cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 576 HITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+......+... +. .|.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~------~~-----Rp~ 266 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG------GL-----RPP 266 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------CC-----CCC
Confidence 1222368999999999999 568999999999999999999999999887662222211111 00 111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
+ +......+..++..||..||..||++.+++..|+...
T Consensus 267 ~----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 267 I----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred C----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1 1113344555666799999999999999999987543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=385.11 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh--------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++++.. .......+|++||++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34678899999999999999985 589999999997532 122345699999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---CCeeEecc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDF 564 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DF 564 (766)
.||||||+.||+|.+.+-.++ .+.+..-..++.|++.|+.|||+ +||+||||||+||||..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999997665 46777778899999999999999 999999999999999766 78999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCccc-hhhHHHhhccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPI 640 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~lv~~~~~~ 640 (766)
|+|+..+... ...++||||.|.|||++..+. +..++|+|||||+||-+|+|.+||....... ....+
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------ 394 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------ 394 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence 9999887433 334589999999999998664 3448899999999999999999998654332 11111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..|++.. -|. ....-.++...++.++|..||++||++.|+|++
T Consensus 395 -~~G~y~f--~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 -LKGRYAF--GPL----QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -hcCcccc--cCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1222111 011 112233455667788999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=393.38 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=208.4
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..|...++||+|||+.||.+.. ..|..||+|++.+ .....+...+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588889999999999999997 7899999999976 4566788999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|+|.+++|..+++.. ..+++.+++.++.||+.||.|||+ ++|||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999744 369999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
..... .++||||.|+|||++.....+..+||||+|||||-||.|++||+...-++...-+......+ |
T Consensus 171 ~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~----------P 238 (592)
T KOG0575|consen 171 DGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM----------P 238 (592)
T ss_pred ccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc----------c
Confidence 53322 24899999999999999999999999999999999999999998765443332222111111 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .-..+. ..++..+|+.||.+|||+++||.+
T Consensus 239 ~----~ls~~A---~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 S----HLSAEA---KDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c----ccCHHH---HHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 111222 334456899999999999999973
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.65 Aligned_cols=203 Identities=30% Similarity=0.536 Sum_probs=182.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..+|.+.+.||+|+||+||+|.+. ++..||||.+... ....+.+..||.||+.++|||||.|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888888999999999999974 6899999998654 466778899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC------CCeeEecccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------FEPQLSDFGL 566 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~------~~vkL~DFGl 566 (766)
|||.||+|.++|+..+ .+++..++.++.||+.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998775 58999999999999999999999 899999999999999865 4589999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
|+.+....- ..+.+|+|-|||||+++.++|+.|+|+||+|++||+|++|+.||....+.+
T Consensus 162 AR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 999875432 334899999999999999999999999999999999999999998766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=371.36 Aligned_cols=241 Identities=29% Similarity=0.415 Sum_probs=200.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.++||+|+||.||.++.+ +++.||+|++++.. ...+...+|..||..++||+||+++-.|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457899999999999999999864 68899999998743 4567788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
+||+.||.|..+|++.+ .|++..++.++.+|+.||.|||+ ++||||||||+|||||.+|+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998665 58999999999999999999999 999999999999999999999999999999554
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... ..+++||+.|||||++....|+..+|+||||+++|||++|.+||...+.......+...+.
T Consensus 177 ~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------ 242 (357)
T KOG0598|consen 177 KDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------ 242 (357)
T ss_pred cCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------
Confidence 43222 2348999999999999999999999999999999999999999988765443333322110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP 682 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP 682 (766)
.....+-.... ..+....|.+||++|-
T Consensus 243 -~~~p~~ls~~a---rdll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEEA---RDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHHH---HHHHHHHhccCHHHhc
Confidence 00111112222 3344568899999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=360.71 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=212.0
Q ss_pred cCcccceeeeccCceEEEEEE-eCCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEee-EEeecCc-eEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG-FCFEDNN-LLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~~~-~~lV 491 (766)
.+|.+.+.||+|.||+||++. ..+|..+|.|.++- +......+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458889999999999999997 56999999999874 3456778999999999999999999999 5555555 8999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
|||+.+|+|...++..+.....+++..+++++.|++.||.++|..-.+ -|+||||||.||+|+.+|.+||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999998888888999999999999999999999984422 3899999999999999999999999999998
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
...... ....+|||.||+||.++...|+.|+||||+||++|||+.-+.||.+++-. .+ ...+..|+...+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L----~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SL----CKKIEQGDYPPLP 249 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HH----HHHHHcCCCCCCc
Confidence 875443 33479999999999999999999999999999999999999999886321 11 1123333333222
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
| ......+..++..|+..||+.||+...++..+.
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1 233445566677899999999999655555443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=376.95 Aligned_cols=252 Identities=28% Similarity=0.461 Sum_probs=208.0
Q ss_pred ccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 421 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
...+.||+|-||.||.|.++....||+|.++......+.|.+|+.+|++|+|+|||+++++|..+..++||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 34678999999999999997777999999998777778999999999999999999999999998899999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.++|+... ...+...+.+.++.|||+|++||++ +++|||||.+.|||++++..+||+|||||+...++... ...
T Consensus 289 l~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~~ 362 (468)
T KOG0197|consen 289 LDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-ASE 362 (468)
T ss_pred HHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee-ecC
Confidence 99998722 2568889999999999999999999 99999999999999999999999999999954443322 222
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCC
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 659 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~ 659 (766)
...-..-|.|||.+..++++.|||||||||+||||+| |+.||......+....+. .|. .+..|..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~Gy--Rlp~P~~----- 428 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RGY--RLPRPEG----- 428 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------ccC--cCCCCCC-----
Confidence 2233557999999999999999999999999999999 999998765544333322 221 1222222
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 660 YDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 660 ~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
....+..++..||+.+|++|||+..+...|+..
T Consensus 429 --CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 429 --CPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 223455577789999999999999888877643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=349.04 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=209.1
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.|.....+|+|+||+||+++.+ +|+.||||++..++ ...+-.++||++|++|+|+|+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4677789999999999999875 69999999997654 3456678999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
++. ++.+-|.... ..++.....+|+.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+....
T Consensus 83 ~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 987 4444454443 468889999999999999999999 889999999999999999999999999999887532
Q ss_pred CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc--------cccc-cC
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--------PILS-SG 644 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~--------~~~~-~g 644 (766)
..+++.+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|.+.+..++..+++... .++. ++
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 33456889999999999986 689999999999999999999999999888777766554321 1111 11
Q ss_pred ccccccCcccCC-----CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGN-----NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~-----~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+..+-=|.... .-......-++.++..||+.||.+|++.++++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111 1111222345667778999999999999998864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.48 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=207.0
Q ss_pred hcCcccceeeeccCceEEEEEE-eCCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.+.|.+.++||.|..++||+|. .+.+..||||++..++ ...+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568889999999999999997 4678999999998643 446889999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
||.+|++.+++...-. ..+.+..+..|+.++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+-.+-..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986544 458999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCC-cee-cccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc-ccccCcccc
Q 004247 574 SSH-ITC-TDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP-ILSSGKVTQ 648 (766)
Q Consensus 574 ~~~-~~~-~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~-~~~~g~~~~ 648 (766)
... ... .+++||+.|||||+++. ..|+.|+||||||++.+||.+|+.||....+.....+.....+ .+. ..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~----t~ 255 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL----TS 255 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc----cc
Confidence 221 112 45799999999999664 3799999999999999999999999988766432222111111 000 11
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.++..-... .-..+..++..||++||.+|||++++++
T Consensus 256 ~~~~d~~k~----~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKK----FSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhh----hcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111 1123444556799999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=364.61 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=206.4
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 489 (766)
..++|...+.||+|+|++||+|.. ..++.||||++.+. +...+-+..|-++|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788999999999999999986 47899999999753 23445677899999999 8999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+|+||+++|+|.++|++.+ .|++.-.+.++.+|+.||+|||+ +|||||||||+|||||.++++||+|||-|+.
T Consensus 151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999998875 58999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCC-----------ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004247 570 ASTSSSH-----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 570 ~~~~~~~-----------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 638 (766)
+...... ..+..++||..|.+||++..+..+..+|||+|||+||+||.|.+||.+.+.--.-..++-.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l- 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL- 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-
Confidence 8653222 1124489999999999999999999999999999999999999999876543222222211
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+-.+...++ +....++.+.|..||.+|++..+|-++
T Consensus 303 ------------~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ------------DYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------cccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 111112222 233334456789999999999888775
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=360.76 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=202.4
Q ss_pred hcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec-C
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~ 486 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999974 23568999999753 24456789999999999 899999999998764 4
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCC--------------------------------------------------------
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 510 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~-------------------------------------------------------- 510 (766)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 589999999999999998753210
Q ss_pred --CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCC
Q 004247 511 --PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588 (766)
Q Consensus 511 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y 588 (766)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1357888999999999999999999 89999999999999999999999999999865443322222234567899
Q ss_pred CCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHH
Q 004247 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 667 (766)
Q Consensus 589 ~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~ 667 (766)
+|||++....++.++|||||||+||||++ |..||........... .+..+... .... .....+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~------~~~~~~~~-----~~~~----~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ------RLKDGTRM-----RAPE----NATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH------HHhcCCCC-----CCCC----CCCHHHH
Confidence 99999998899999999999999999997 9999976443221111 01111110 0011 1123455
Q ss_pred HHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 668 LASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 668 ~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.++..||+.||.+||++.++++.|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 67778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.32 Aligned_cols=200 Identities=30% Similarity=0.444 Sum_probs=182.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|...+.||.|+||.|.+++.+ +|..||+|++.+.. ...+...+|..+|+.+.||+++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999875 68889999998754 34567788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++||.|..+|++.+ .|++..++.++.||+.||+|||+ ++|++|||||+|||||.+|++||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999998765 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
. + -+.||||.|+|||+++...|+.++|+|||||++|||+.|.+||...++..
T Consensus 197 r----T-~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 197 R----T-WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred c----E-EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 3 2 23799999999999999999999999999999999999999998877643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.05 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred HHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 414 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 414 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
....++|.++++||+|+||.||+|..+ +|..+|+|+++++. ..++....|-+||....+|+||+|+-.|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 446789999999999999999999854 79999999999864 4567788899999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||||||++||++..+|.... .|++..++.++.+++.|+.-||+ .|+|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999997664 69999999999999999999999 999999999999999999999999999985
Q ss_pred cccCC-----------------------CC-----Cce-----------------ecccccccCCCCchhhccCCCCCch
Q 004247 569 WASTS-----------------------SS-----HIT-----------------CTDVAGTFGYLAPEYFMYGKVNDKI 603 (766)
Q Consensus 569 ~~~~~-----------------------~~-----~~~-----------------~~~~~GT~~Y~APE~l~~~~~s~ks 603 (766)
-+... .. ... ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 32210 00 000 0125799999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCccchh-hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004247 604 DVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682 (766)
Q Consensus 604 DVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP 682 (766)
|+||||||+||||.|.+||..+.+.... .++.|...+..... ....++. ..++.+|+. ||++|-
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-----------~~~s~eA---~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-----------VDLSDEA---KDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-----------CcccHHH---HHHHHHHhc-CHHHhc
Confidence 9999999999999999999998887644 45566543322111 0011233 334455555 999998
Q ss_pred C
Q 004247 683 Q 683 (766)
Q Consensus 683 s 683 (766)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 7
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=344.74 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=203.0
Q ss_pred cCcccceeeeccCceEEEEEEeCC-----------------CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 478 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l 478 (766)
++|.+.+.||+|+||.||++.+.+ +..||||++... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568889999999999999997532 346999999763 3456789999999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCCHhHhhhcCCC---------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEe
Q 004247 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543 (766)
Q Consensus 479 ~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 543 (766)
+++|.+.+..++||||+++|+|.+++..... ....++|..++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999998864321 11357889999999999999999999 88999
Q ss_pred ecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCC
Q 004247 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKP 621 (766)
Q Consensus 544 rDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~P 621 (766)
|||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986644333222233456889999999998999999999999999999997 5677
Q ss_pred CCCCCccchhhHHHhhccccccCcc-ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 622 ISNDHPKGQESLVMWAKPILSSGKV-TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 622 f~~~~~~~~~~lv~~~~~~~~~g~~-~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
|....... ...+....+..... ..... .......+..++..||+.+|.+|||+.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543222 11111111111100 00000 1111234566778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.09 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=210.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHH--HHHHHHHHhcC-CCceeEEeeEEeecC-ceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEF--VLEIEIITTLH-HKNIISLLGFCFEDN-NLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~--~~Ei~iL~~l~-HpnIv~l~~~~~~~~-~~~lV 491 (766)
-++|.+.+.||.|.||.||+|.. .+|..||||.++..-...+++ ++|+.-|++|+ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45788899999999999999985 478899999998654334443 57999999999 999999999999887 99999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
||||+. +|+++++... ..|++..++.|+.||++||+|+|+ +|+.|||+||+|||+..+..+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999966 9999998663 589999999999999999999999 999999999999999989999999999999776
Q ss_pred CCCCCceecccccccCCCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc-----ccC-
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL-----SSG- 644 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~-----~~g- 644 (766)
.... ++..+-|.+|+|||++. .+-|+.+.|+|++|||++|+.+-++.|.+.+..++...+.-...-. ..|
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 6544 34578999999999875 6689999999999999999999999999887766655443221110 110
Q ss_pred ccccccCcccCC-------CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~-------~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
++...++=.+.. ..-.......+.++..|+..||.+|||+.+.|++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111100000 0011244556677778999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.06 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=200.8
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 489 (766)
..++|.+.++||+|.||+|+++..+ +++.||||++++. .+.++..+.|.+|+.... ||++++|+.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4568999999999999999999975 6788999999974 467788899999998886 999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+.||++..+.+. ..|++..+..|+.+|+.||.|||+ ++|||||||.+|||||.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999995444432 358999999999999999999999 9999999999999999999999999999996
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... ...+++|||.|||||++....|+..+|+|||||+|||||.|..||.+++..+.-.-+...
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------ 583 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------ 583 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence 553222 334689999999999999999999999999999999999999999987654332222111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 684 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~ 684 (766)
|+. ++.......+.++...|+++|++|--+
T Consensus 584 -~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 122223344455567899999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=354.13 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=207.2
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV 491 (766)
+.|..++.||+|+||.||+|.. .+|+.||+|.++.+ +....-..+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3567778999999999999985 58999999998754 34566778999999999999999999998876 689999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
+|||+. +|..++.... ..|+..++..++.||+.||+|+|. ++|+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 9998887543 479999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc---
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT--- 647 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~--- 647 (766)
...... .+..+-|++|.|||++.+. .|+.++|+||.||||.||++|++.|.+.....|...+.....-.....+.
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 654432 4567889999999998855 79999999999999999999999999988777666553222111111111
Q ss_pred ----cccCc------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 648 ----QLLDP------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 648 ----~lld~------~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
..+.+ .+...+ .......+.++-.+|..||.+|.|+.++|+
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 111100 001122334445577889999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.59 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=204.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC-----h-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-----E-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 486 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~-----~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 486 (766)
...+.|.+.+.||+|+||.|++|.. .+|..||||++... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999975 47899999987653 1 24556778999999999 999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEeccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 565 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFG 565 (766)
.+++||||+.||+|.+++...+ .+.+.++..++.|++.|++|+|+ ++|+||||||+||||+.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998733 58889999999999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCC-CC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+....... +..
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i~~ 237 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------IRK 237 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------Hhc
Confidence 998774 1122334579999999999999877 86 789999999999999999999987443222211 111
Q ss_pred C--ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 644 G--KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 644 g--~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+ .+...++ ...+..++..||..+|.+|+++.+|++
T Consensus 238 ~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 1112111 234455667899999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.55 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=198.2
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~lV~E 493 (766)
.+|...+.||+|+||.||++... +|...|||...... ...+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999875 48999999987542 22567899999999999999999999855544 5899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccccccC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 572 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~ 572 (766)
|+++|+|.+++...+. .+++..+..++.||++||.|||+ ++||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987653 58999999999999999999998 99999999999999999 79999999999987764
Q ss_pred CC-CCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 573 SS-SHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 573 ~~-~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
.. .......+.||+.|||||++..+... .++|||||||+++||+||..||... ...... ...+...+..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~---~~~ig~~~~~---- 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEA---LLLIGREDSL---- 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHH---HHHHhccCCC----
Confidence 11 11122347899999999999965433 5999999999999999999999763 111111 1111111111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
|.+... .......+...|+.++|.+|||+.++|++.-
T Consensus 242 -P~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 -PEIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -CCCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 122111 1122333446799999999999999998643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.51 Aligned_cols=263 Identities=26% Similarity=0.361 Sum_probs=213.6
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.+|...+.||+|.||.||+|++ .+|+.||||.++..+ .......+||..|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999985 589999999998643 235678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
||+. +|+..|+... ..++...+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999997654 478899999999999999999999 88999999999999999999999999999988775
Q ss_pred CCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc---cccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK---VTQL 649 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~---~~~l 649 (766)
....+. .+-|..|.|||.+.+. .|+..+|+||.||++.||+-|.+-|.+++.-+|...+-.+........ +..+
T Consensus 155 ~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 544432 3789999999988754 799999999999999999999998988887777666543322221111 1111
Q ss_pred cC---------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld---------~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
-| +.+. ..........+.++..++..||.+|.++.++|++
T Consensus 233 pdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111 1223334445677778999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=340.86 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=199.7
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|...+.||+|+||.||++.. .+|+.||||++.... .....+.+|+.++..++|+||++++++|.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 477889999999999999986 578999999986432 233467889999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|..++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988864332 358899999999999999999999 89999999999999999999999999999875432
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||...........+. .. ...+.
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~~-~~~~~-------- 221 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RR-VKEDQ-------- 221 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--HH-hhccc--------
Confidence 21 223579999999999999999999999999999999999999998654322111111 00 00000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
..+.......+..++..||+.||.+||+ +++++++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011111234455667899999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.42 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=206.1
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
-.+++.+...||+|.||+||+|.+.. .||||+++. ..+..+.|.+|+..|++-+|.||+-+.|||..... .||.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 34456678899999999999999843 499999985 34678899999999999999999999999988766 9999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
-+|+|-+|+.+||-.. ..|.....+.|+.||++|+.|||. ++|||||||..||||.+++.|||+||||+..-..
T Consensus 467 qwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred hhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999998655 479999999999999999999999 9999999999999999999999999999965433
Q ss_pred CCCCceecccccccCCCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
-..........|...|||||+++.+ .|+..+||||||+|+|||+||..||...... + +.|+ -|.-.-.
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-q---Iifm-----VGrG~l~ 611 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-Q---IIFM-----VGRGYLM 611 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-h---eEEE-----ecccccC
Confidence 3222333345688899999999743 6899999999999999999999999843322 1 1121 1221111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
.|..... .+..+.|..++..||.+++++||.+.+||..|+....
T Consensus 612 pd~s~~~---s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKIR---SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhhh---ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2222211 2223345555667999999999999999997765443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.47 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=205.6
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhH-HHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.|.....||+|+.|.||.|.. .+++.||||++....+. .+-+.+|+.+|+..+|+|||++++.|..++.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 355567899999999999975 57889999999876644 4567899999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
||+|.+.+... .+++.++..|+.+++.||+|||. ++|||||||.+||||+.+|.+||+|||++..+.....
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999999754 38999999999999999999999 9999999999999999999999999999987766544
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....+|||.|||||++....|++|+||||||++.+||+-|.+||-.+++.....++.- +|. |.+..
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------ng~------P~lk~ 491 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------NGT------PKLKN 491 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------cCC------CCcCC
Confidence 33457999999999999999999999999999999999999999987766544433321 111 11111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+-.+..+||+.|+.+||++.|+|++
T Consensus 492 --~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 --PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11111223334467999999999999999984
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.21 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=196.0
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEEee
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDF 494 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 494 (766)
...||+|++|.||+|.. +|+.||||.++... ...+.|.+|+.+|.+++||||++++++|.+ ...+++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997542 235778899999999999999999999977 3568999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++|+|.+++.... .++|.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999997543 588999999999999999999972 368899999999999999999999999998654422
Q ss_pred CCceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
. ...||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+. ..+. . +
T Consensus 178 ~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~------~~~~-~----~ 241 (283)
T PHA02988 178 F-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII------NKNN-S----L 241 (283)
T ss_pred c-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcCC-C----C
Confidence 1 2468999999999975 689999999999999999999999998654332211110 0000 0 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+ +......+..++..||+.||.+|||+.++++.|+.
T Consensus 242 ~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 242 KL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11 11112345566678999999999999999998863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=340.09 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||++... +++.||||+++.. ....+.+.+|+.++..++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 6788999998753 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|++++.|..+.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554322 358899999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh-ccc--------cccC
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPI--------LSSG 644 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~-~~~--------~~~g 644 (766)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+. ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 221 122357999999999999889999999999999999999999999875433221111111 000 0000
Q ss_pred ccccccCcccCCCCC------hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYD------YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~------~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+....... ......+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 010110011100000 0012346667788999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=355.06 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=202.4
Q ss_pred cCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4578889999999999999963 246689999997543 3456788999999999 899999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC-----------------------------------------------------------
Q 004247 489 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 509 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~----------------------------------------------------------- 509 (766)
++||||+++|+|.++++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999865321
Q ss_pred ------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 510 ------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 510 ------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
....++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01257899999999999999999999 899999999999999999999999999998665433222
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......++..|+|||++....++.++|||||||++|||++ |..||....... ....+. ..+.. ...+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~--~~~~---- 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEGYR--MLSP---- 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhCcc--CCCC----
Confidence 2222345678999999999999999999999999999998 899997543221 111111 11100 0001
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.... ..+..++..||+.||.+||++.+|++.|+.
T Consensus 340 ~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112 245566678999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=348.60 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=203.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999875 58899999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 57899999999999999999999 8999999999999999999999999999986544
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhh-HHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~~~~lld 651 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +..|... +.. ....+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~---~~~~~ 224 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQR---PVYDD 224 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-ccC---CCCCc
Confidence 1223579999999999998899999999999999999999999998765433222 1122111 100 00000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+. ......+..++..||..+|.+||++.+++++
T Consensus 225 ~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 1112234455667999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.09 Aligned_cols=255 Identities=22% Similarity=0.426 Sum_probs=207.6
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35788999999999999999998888899999988766667889999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.++++.... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999975432 458899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||....... ...+...... . +..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~---~-----~~~- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYR---M-----PRM- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCC---C-----CCC-
Confidence 1122346778999999998899999999999999999998 999997644322 1111111000 0 100
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. ....+..++..||..+|++||++.++++.|+.
T Consensus 227 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 EN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 11345567788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.82 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=203.9
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||.||++..+++..+|+|.+.........+.+|+.+++.++||||++++++|...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45888899999999999999988888999999886655567889999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.++++... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999987543 258899999999999999999999 89999999999999999999999999999865432211
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......++..|+|||++....++.++||||||+++|||++ |+.||........ +..... +. ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~----~~--~~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISR----GF--RLYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHC----CC--CCCCCC---
Confidence 1112345678999999998899999999999999999999 9999976543221 111111 10 001111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.. ...+..++..||+.+|.+||++.++++.|
T Consensus 225 -~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -LA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CC---CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 23456777889999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=348.85 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=207.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.|...+.||+|.||.||+|.+. .++.||||++... ++..+++.+|+.+|.+++++||.++|+.|..+..++++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3556688999999999999864 6889999999864 467789999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
.||++.+.|.... .+.+..+..|+.+++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997543 34777778899999999999999 8999999999999999999999999999987766544
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.. .+++|||.|||||+++...|+.|+||||||++.+||++|.+|+...++.....++- .-.-|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp------------k~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP------------KSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc------------CCCCCccc
Confidence 33 46899999999999998899999999999999999999999999887743332221 11223343
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+. ..+.+++..||.+||+.||++.++|++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3222 223444556999999999999999974
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.94 Aligned_cols=264 Identities=21% Similarity=0.325 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||.|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999864 68899999987432 3345678999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 9999886543 357889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc---------ccC
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---------SSG 644 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---------~~g 644 (766)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 1223568999999999875 468999999999999999999999998765443322221111000 000
Q ss_pred ccccccCcccCCCC----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+...+.+...... ..........++..||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111111110000 00111234566778999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.34 Aligned_cols=239 Identities=31% Similarity=0.498 Sum_probs=200.0
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHhH
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 502 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ 502 (766)
.+-||.|+.|.||+|.+ .++.||||.++.- -..+|..|++|+||||+.+.|+|.....+|||||||+.|-|+.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 45689999999999999 6688999987632 2357889999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceeccc
Q 004247 503 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582 (766)
Q Consensus 503 ~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 582 (766)
.|+... .+.-.....|..+||.|+.|||. +.|||||||.-||||+.+..+||+|||-++......+. ..+
T Consensus 202 VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk---MSF 271 (904)
T KOG4721|consen 202 VLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK---MSF 271 (904)
T ss_pred HHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh---hhh
Confidence 997654 57778888999999999999999 88999999999999999999999999999987765333 348
Q ss_pred ccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHH
Q 004247 583 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 662 (766)
Q Consensus 583 ~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~ 662 (766)
+||..|||||++.....++|+|||||||||||||||..||.+-+. ..+.|.-. .+...+ ..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG----sNsL~L-------pvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG----SNSLHL-------PVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc----CCcccc-------cCcccC
Confidence 999999999999999999999999999999999999999975332 22333210 111122 223344
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 663 MERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 663 ~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+-+.+++.+||+..|.+||++.+++.+|.-
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 5567777788999999999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.93 Aligned_cols=246 Identities=30% Similarity=0.411 Sum_probs=204.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+. +...+.+.+|++|++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999875 6788999998653 4566788999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+.| +|..+|...+ .++++.++.|+.+++.||.|||+ ++|+|||+||.||||+.++.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999997654 58999999999999999999999 99999999999999999999999999999988764
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... -+.+.|||-|||||.+.++.|+..+|.|||||+||||++|++||.... ...++. .+.. ||.
T Consensus 154 t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~---~I~~--------d~v 217 (808)
T KOG0597|consen 154 TSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVK---SILK--------DPV 217 (808)
T ss_pred cee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHH---HHhc--------CCC
Confidence 433 345789999999999999999999999999999999999999996532 222221 1111 111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .+......+..+..-.|.+||..|-+..+++.+
T Consensus 218 ~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C---CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 111222334444455789999999999998864
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=333.74 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=205.5
Q ss_pred cCcccceeeeccCceEEEEEEeCC------CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
++|.+.+.||+|+||.||+|.... ...||+|.++.. ......|.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998642 257999998753 345567899999999999999999999999988999
Q ss_pred EEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 490 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999975421 11457889999999999999999999 8999999999999999999
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 636 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 636 (766)
.++|+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||.+.........+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR- 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986544332222233467889999999998999999999999999999998 999997654432221111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.... ........+..++..||+.+|.+||++.+|+++|+.
T Consensus 241 ------~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 ------SRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 111222455666778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.23 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 68999999986532 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997543 58899999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. +..
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~~------ 215 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-------GKL------ 215 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCc------
Confidence 21 125799999999999988899999999999999999999999976543322211111 110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+||+ +.+++++
T Consensus 216 ~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111 123445667899999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=329.31 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=207.1
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...+++.||||.++......+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45788999999999999999998788899999998765556789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ...+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||+++........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999997543 2468999999999999999999999 89999999999999999999999999999877533211
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......++..|+|||++....++.++||||||+++|||++ |+.||...........+ .. ....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~---~~~~--------- 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---DQ---GYRM--------- 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc---CCCC---------
Confidence 1111223457999999998899999999999999999999 99999765432111111 00 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.........+..++.+|++.+|.+||++.++++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011122456667788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=369.20 Aligned_cols=258 Identities=26% Similarity=0.480 Sum_probs=211.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
+.+-...+.||+|+||.||+|... +...||||.++... +...+|.+|++++..|+|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566788999999999999842 45679999998643 4688999999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC----------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC
Q 004247 489 LLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 558 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 558 (766)
+||+|||..|+|.++|..... .+.+++..+.+.|+.|||.|+.||-+ +.+|||||-++|.|+.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 999999999999999975432 13448899999999999999999998 88999999999999999999
Q ss_pred eeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004247 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 559 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 637 (766)
+||+||||++..-....+....+..-...|||||.+++++|+.+||||||||+|||+++ |+.||.+....+....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~---- 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC---- 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH----
Confidence 99999999986544433332222334678999999999999999999999999999999 9999987654433222
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+..|++-+ -+......+..+++.||+.+|.+||++++|-..|+.
T Consensus 718 ---i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 718 ---IRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred ---HHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 23333311 122334567778889999999999999999998863
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.86 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=202.0
Q ss_pred cCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
++|.+.+.||+|+||.||+|.. .++..||||+++.. ......+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3688899999999999999874 23457999999753 34456788999999999 899999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC-----------------------------------------------------------
Q 004247 489 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 509 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~----------------------------------------------------------- 509 (766)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864311
Q ss_pred -------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceeccc
Q 004247 510 -------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582 (766)
Q Consensus 510 -------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 582 (766)
....+++..++.|+.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247889999999999999999999 89999999999999999999999999999866543322222233
Q ss_pred ccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChH
Q 004247 583 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661 (766)
Q Consensus 583 ~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~ 661 (766)
.+++.|+|||++..+.++.++|||||||++|||++ |+.||............. ..+ ..+.... ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~------~~~-----~~~~~~~-~~-- 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV------KRG-----YQMSRPD-FA-- 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH------Hcc-----cCccCCC-CC--
Confidence 45678999999998899999999999999999997 999997654322111110 000 0000001 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 662 QMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 662 ~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+..++..||+.+|.+||++.+|++.|+.
T Consensus 341 -~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 -PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1345556678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=330.76 Aligned_cols=254 Identities=19% Similarity=0.367 Sum_probs=202.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.++ .+..||+|.++.. ......|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 4568999999864 2445678999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999987654
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... ......++..|+|||++..+.++.++|||||||++|||++ |..||........ +... ..+..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~~--- 226 (266)
T cd05064 158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV----EDGFR--- 226 (266)
T ss_pred cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCCC---
Confidence 322111 1112345678999999999999999999999999999875 9999976543221 1111 11110
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... .......+..++..||+.+|.+||++.++++.|..
T Consensus 227 --~~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --LPA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001 11122345566778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=340.80 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=176.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||++... +|..+|+|++... ....+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999875 6888999998753 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997543 478999999999999999999971 36999999999999999999999999999765432
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 23579999999999998899999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.84 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=194.9
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 424 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
++||+|+||.||++.. .+|+.||||+++.. ......+.+|+.++..++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 47899999999753 234567888999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 9999987543 58899999999999999999999 8999999999999999999999999999975432221 1
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
.....||+.|+|||++....++.++|||||||++|||++|+.||...........+. .+. ..+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~------~~~p~~~ 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEE------IRFPRTL 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-------cCC------CCCCCCC
Confidence 223679999999999998899999999999999999999999997643322111111 000 0111111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
...+..++..||+.||.+|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 ----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22344566789999999999 79998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.74 Aligned_cols=244 Identities=26% Similarity=0.364 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++..++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999875 68899999987532 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997543 57889999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.. ....||+.|+|||++....++.++|||||||++|||++|+.||....+......+ ..+.+
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-------~~~~~------ 232 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-------LAGRL------ 232 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH-------hcCCc------
Confidence 22 1257999999999999889999999999999999999999999765432211111 11110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+||+ +.+++.+
T Consensus 233 ~~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFPNWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0011111 23445667899999999997 6777765
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=357.95 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=201.4
Q ss_pred cccceeeeccCceEEEEEEeC-C-CCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~-g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
|.+.+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.+|..++||||++++++|...+.++|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 888999999999999999854 3 6778888775443 444567889999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.++|.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886543333568899999999999999999999 89999999999999999999999999999876543332
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......+||++|+|||++....++.++|||||||++|||++|+.||...........+.. +.... +..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~-----~~~ 293 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-------GKYDP-----FPC 293 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCCC-----CCc
Confidence 223346799999999999989999999999999999999999999976443221111111 11110 001
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
. ....+..++..||+.+|.+||++.+++.
T Consensus 294 ~----~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 P----VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred c----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 1123555667899999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=345.79 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=197.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||++... +++.||||+++.. ......+.+|+.++..++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 6889999999753 234467788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997543 58899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCC---------------------------------ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCC
Q 004247 573 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619 (766)
Q Consensus 573 ~~~~---------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~ 619 (766)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999899999999999999999999999
Q ss_pred CCCCCCCccchhhHH-HhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 620 KPISNDHPKGQESLV-MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 620 ~Pf~~~~~~~~~~lv-~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.||....+......+ .|.... .+.+.. . ..+....++.. +.|...++..||++.+|+++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~--~-~s~~~~~li~~-l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETL--------IFPPEV--P-ISEKAKDLILR-FCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcc--------cCCCcC--C-CCHHHHHHHHH-HcCChhhcCCCCCHHHHhCC
Confidence 999876543322211 111110 011100 1 12333343332 23555556678999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.19 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=205.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|++++..++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999763 34789999997643 3567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC----------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC
Q 004247 489 LLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 558 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 558 (766)
++||||+++++|.+++..... ....+++..+..++.+++.||.|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975431 22457899999999999999999999 89999999999999999999
Q ss_pred eeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004247 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 559 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 637 (766)
+||+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||....... .+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence 99999999976543322111222456788999999999999999999999999999998 999997544322 11111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
. .+..... .......+..++..||+.+|.+||++.+|++.|+
T Consensus 238 ~----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1111111 1111234556677899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.11 Aligned_cols=258 Identities=21% Similarity=0.394 Sum_probs=203.1
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.+++|.+.+.||+|+||.||+|... .+..||||++.... ....++.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677999999999999999998753 35679999986432 345678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998753321 2346788999999999999999999 89999999999999999999999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999976544322222122356788999999998899999999999999999999 788987654322111111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.+..... .. .....+..++..||+.+|.+||++.++++.|+
T Consensus 236 --~~~~~~~-----~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGGLLDK-----PD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCCcCCC-----CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111010 01 11234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.75 Aligned_cols=254 Identities=23% Similarity=0.413 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCC----EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.+|+..+.||+|+||.||+|.+. +|. .||||+++.. ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999853 333 4899998753 34567899999999999999999999999764 5789
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997643 358899999999999999999999 89999999999999999999999999999977
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.............++..|+|||++....++.++|||||||++|||++ |+.||.+........... .+. .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~--~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE--RL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CCC--CC
Confidence 65443333223345778999999999999999999999999999998 999997653322111111 110 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+ . .....+..++..||..+|.+||++.+++..|...
T Consensus 231 ~~~---~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 PQP---P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCC---C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 0 1112455677789999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.16 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=204.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.+|.+.+.||+|+||.||+|... .++.||+|++.........+.+|++++..++||||++++++|..++.+++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45888899999999999999864 58899999998766667789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999975432 458999999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||...........+. .+ ..+..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~-----~~~~~- 226 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KG-----YRMER- 226 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CC-----CCCCC-
Confidence 1 112334678999999998999999999999999999998 999997644322111110 00 00111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.......+..++..||+.+|.+||++.++++.|+.
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11112335556678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=333.12 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=195.7
Q ss_pred cCcccceeeeccCceEEEEEEeC--CCCEEEEEEccCC---hhHHHHHHHHHHHHHhc---CCCceeEEeeEEee-----
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE----- 484 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~----- 484 (766)
.+|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 4688999998643 22334566788777766 69999999999852
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
...+++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 599999875432 358899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+..........
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9998665432 1223579999999999998899999999999999999999999998765433222221111000000
Q ss_pred cccc-------ccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQ-------LLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~-------lld~~l~~---~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. .+.+.... ....+....+..++..||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1000 00000000 0000112234567788999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=340.83 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=196.1
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----CceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~ 489 (766)
+|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999864 6899999998742 23445788999999999999999999998643 2479
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68999886543 58999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCC-CceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc-------
Q 004247 570 ASTSSS-HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP------- 639 (766)
Q Consensus 570 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~------- 639 (766)
...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 122234679999999999875 6789999999999999999999999976543222111100000
Q ss_pred -ccccCccccccCc---ccCCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 -ILSSGKVTQLLDP---ALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 -~~~~g~~~~lld~---~l~~~~---~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+........+.. .....+ .......+..++..||+.+|.+||++.+++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000 000000 00011234566778999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.62 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=204.7
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 486 (766)
..++|.+.+.||+|+||+||+|.. .+|+.||||++... ......+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 356899999999999999999985 47899999998643 345667889999999999999999988775432
Q ss_pred ---ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 487 ---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 487 ---~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence 3689999999999999997654444578999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
||+++...............||+.|+|||++....++.++|||||||+||||++|+.||...........+ . .
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~------~-~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT------L-A 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------h-c
Confidence 99998765433322233467999999999999989999999999999999999999999765432211111 0 1
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+... + +... ....+..++..||+.+|.+||++.+++++
T Consensus 260 ~~~~----~-~~~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYD----P-LPPS----ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC----C-CCCC----CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 1 1111 12345556678999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.33 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=205.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.+. +...||||+++.. ......|.+|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999874 2457999998754 3445688999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.............+++.|+|||++.+..++.++||||||+++|+|++ |..||....... +..... .+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~--- 226 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVE----DGYR--- 226 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCC---
Confidence 53322222222345678999999998899999999999999999998 999996543221 111111 0000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+ ........+..++..||+.+|++||++.+|+++|..
T Consensus 227 -~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 -LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 011122345677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.89 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=203.2
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
.+|.+.+.||+|+||.||+|...++..+|||.++........+.+|+.++..++||||++++++|...+..++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45788899999999999999887777899999886555557899999999999999999999999988899999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... ..+++..++.++.+|+.||.|||+ .+++|+||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999997543 258999999999999999999999 89999999999999999999999999999865443211
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......++..|+|||++..+.++.++|||||||++|+|++ |..||...........+. .+... ..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~-----~~-- 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-------QGLRL-----YR-- 222 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-------cCCCC-----CC--
Confidence 1112345678999999998899999999999999999999 999997544322111111 11000 00
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.......+..++..||+.+|.+||++.++++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011245566777899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.98 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=172.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 568999999999999999999875 78899999987532 233467889999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+. ++|.+++.... ..+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 58888876543 357889999999999999999999 89999999999999999999999999999754332
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 21 1223568999999999875 458899999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.60 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=201.8
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
+|.+.+.||+|+||.||+|..+++..+|+|++.........+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 57788999999999999999877788999998765544567889999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999997543 268999999999999999999999 889999999999999999999999999998654322211
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
.....++..|+|||++....++.++||||||+++|+|++ |+.||........... .. .+ .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~----~~-----~~~~~--- 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---VS----AG-----YRLYR--- 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---HH----cC-----CcCCC---
Confidence 111234567999999998899999999999999999999 8999975443221111 10 00 00001
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.......+..++..||..+|++||++.++++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111233566677889999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=340.31 Aligned_cols=241 Identities=26% Similarity=0.373 Sum_probs=194.4
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
++||+|+||.||++... +|+.||+|+++.. ......+.+|+.++..++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 234567788999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 9998886543 58899999999999999999999 8999999999999999999999999999875432211 1
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+... . ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------~------~~~p~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------E------IRFPRTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------C------CCCCCCC
Confidence 22357999999999999899999999999999999999999999765433221111100 0 0011111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
+ ..+..++..||+.||.+|| ++.+++++
T Consensus 219 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 2344556679999999998 88888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.03 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|++++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 68999999997532 44567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 358899999999999999999999 8999999999999999999999999999986654
Q ss_pred CC---------------------------CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 004247 573 SS---------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 573 ~~---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 625 (766)
.. .........||+.|+|||++....++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 001122357999999999999999999999999999999999999999876
Q ss_pred CccchhhHH-HhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHH
Q 004247 626 HPKGQESLV-MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKL 690 (766)
Q Consensus 626 ~~~~~~~lv-~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-~~eVL~~ 690 (766)
........+ .|.... .+ +.. .. ....+..++..|+. +|.+||+ +.+++++
T Consensus 234 ~~~~~~~~i~~~~~~~----~~-----p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKESL----RF-----PPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCcc----cC-----CCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 532221111 111100 00 000 00 11233445566887 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.47 Aligned_cols=259 Identities=26% Similarity=0.465 Sum_probs=205.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
..+|.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|++++.+++||||++++++|...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457889999999999999999742 3456899998754 345678999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCC---------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 490 LVYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
+||||+++++|.+++.... .....+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999987543 122358999999999999999999999 8999999999999999999999
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcc
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
|+|||+++...............+++.|+|||++....++.++|||||||++|+|++ |..||...........+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 999999986644332222223456788999999998899999999999999999998 99999765432211111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+.... .....+ ..+..++..||+.+|.+||++.+|++.|+..
T Consensus 236 --~~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 236 --TQGRVLQ-----RPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred --HcCCcCC-----CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111111 111112 2456677889999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.85 Aligned_cols=241 Identities=26% Similarity=0.365 Sum_probs=195.1
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
++||+|+||.||++... +|+.||||++... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6899999999753 244567889999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 9999886543 58899999999999999999999 8999999999999999999999999999875433221 1
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
.....||+.|+|||++....++.++|||||||++|+|++|+.||...........+.. +. ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-------~~------~~~p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------ED------IKFPRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-------CC------ccCCCCC
Confidence 2236799999999999988999999999999999999999999976543221111110 00 0111111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
...+..++..||+.||.+|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12344556689999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.27 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=202.6
Q ss_pred cCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|++.+.||+|+||.||+|.. .++..+++|.++.. ......+.+|+++++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 35678999999753 2445678899999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 491 VYDFLSRGSLEENLHGNKK-------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
||||+++++|.+++..... ....+++.....++.+++.||.|||+ ++|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853321 12357889999999999999999999 8999999999999999999
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 636 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 636 (766)
.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||....+......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986644322222223456788999999998899999999999999999999 999997643322111111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.... .... ....+..++..||+.+|.+||++.+|+++|.+
T Consensus 241 ------~~~~~~-----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 ------KRQLLP-----CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111000 0111 12345556678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.72 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=197.1
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|...+.||+|+||+||+|.. .+++.||||++... ......+.+|++++..++||||++++++|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999986 46889999999753 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997543 47888999999999999999999 89999999999999999999999999997643210
Q ss_pred CC---------------------------------------------CceecccccccCCCCchhhccCCCCCchhhHHH
Q 004247 574 SS---------------------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 608 (766)
Q Consensus 574 ~~---------------------------------------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSl 608 (766)
.. .......+||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccchh-hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 004247 609 GVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 687 (766)
Q Consensus 609 GvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eV 687 (766)
||++|||++|+.||....+.... .++.|..... +. + ...+. .+...++.- +.|+..+|..||++.++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~----~--~~~~s-~~~~dli~~-ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLH----IP----P--QVKLS-PEAVDLITK-LCCSAEERLGRNGADDI 302 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC----CC----C--CCCCC-HHHHHHHHH-HccCcccccCCCCHHHH
Confidence 99999999999999765543221 1222211110 00 0 00112 222332222 24777888889999999
Q ss_pred HHH
Q 004247 688 LKL 690 (766)
Q Consensus 688 L~~ 690 (766)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.73 Aligned_cols=249 Identities=35% Similarity=0.562 Sum_probs=192.8
Q ss_pred cceeeeccCceEEEEEEeC-----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 422 AENLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~-----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+.+.||.|.||.||+|.+. .+..|+||+++.. ....+.|.+|++++++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999875 3567999999753 34578999999999999999999999999988889999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++|+|.++|..... ..+++..++.|+.||+.||.|||+ ++++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999987622 468999999999999999999999 889999999999999999999999999998763332
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.........+...|+|||.+....++.++||||||+++|||++ |+.||...........+. .+....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-------~~~~~~----- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-------QGQRLP----- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-------TTEETT-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccce-----
Confidence 2222223457788999999999999999999999999999999 789987653322111111 111100
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.+......+..++..||..+|.+||++.++++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111123355566789999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.89 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=207.7
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChh-HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..+|.+.+.||.|+||.||+|...+++.+++|++..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456888999999999999999988899999999986553 5678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999976432 468999999999999999999999 8899999999999999999999999999986644322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. ....++..|+|||++..+.++.++||||||+++|+|++ |+.||........... ... +. ..
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~----~~-----~~-- 223 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---ITA----GY-----RM-- 223 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HHh----CC-----cC--
Confidence 11 12346778999999998899999999999999999998 8999976542221111 110 00 00
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.........+..++..||+.+|.+|||+.++++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0011122445677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.19 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=202.2
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEee-cCc
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-DNN 487 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~-~~~ 487 (766)
++|.+.+.||+|+||.||+|... +++.||+|+++.. ....+.+.+|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999632 3578999998753 23456788999999999 89999999998865 457
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC---------------------------------------------------------
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 510 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~--------------------------------------------------------- 510 (766)
++++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998643210
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCC
Q 004247 511 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590 (766)
Q Consensus 511 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 590 (766)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1268999999999999999999999 8999999999999999999999999999987654333332233456788999
Q ss_pred chhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHH
Q 004247 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLA 669 (766)
Q Consensus 591 PE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~ 669 (766)
||++.+..++.++|||||||+||||++ |..||........ +.. .+..+... .. +......+..+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~~-----~~----~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTRM-----RA----PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCCC-----CC----CccCCHHHHHH
Confidence 999999999999999999999999998 9999976433221 100 01111100 00 11122346677
Q ss_pred HHhhcccCCCCCCCHHHHHHHhhC
Q 004247 670 SILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 670 ~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+..||+.+|++||++.+|+++|..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 788999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.35 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=196.0
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
+.||+|+||.||+|... +++.+|+|.+... .+....+.+|+++++.++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999874 7899999987643 35567899999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997543 358899999999999999999999 899999999999999999999999999997654322111111
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCC
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 659 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~ 659 (766)
...++..|+|||++..+.++.++||||||+++|||++ |..||...........+.. +. .. ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------~~-----~~----~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------GV-----RL----PCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CC-----CC----CCc
Confidence 1233567999999998999999999999999999998 8899865443221111110 00 00 001
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 660 YDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 660 ~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
......+..++..||+.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111234556777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.15 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=198.9
Q ss_pred cCcccceeeeccCceEEEEEEeCC--CCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.+.||+|+||.||+|.... +..||+|++... ......+.+|+.++..++||||++++++|.+.+.+++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468899999999999999997543 368999998643 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999997553 58899999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+. .+..
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-------~~~~----- 245 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-------EGII----- 245 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCC-----
Confidence 321 23579999999999998889999999999999999999999998654422111111 1110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.+....+ ..+..++..||+.+|.+|+ ++.+++++
T Consensus 246 -~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0011111 2234566789999999995 89998875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.41 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=191.7
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||+|+||.||++... +++.||+|+++.. ......+.+|+.++.+++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 6889999998742 34456788999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 99997543 58899999999999999999999 8999999999999999999999999999985433222 123
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... +. ..+....+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~------~~~-~~------~~~~~~~~- 217 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK------ILQ-EP------LRFPDGFD- 217 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH------HHc-CC------CCCCCcCC-
Confidence 36799999999999988999999999999999999999999976543221111 111 00 00111111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 004247 661 DQMERMVLASILCIRRDPRARPQ---MSLVLKL 690 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs---~~eVL~~ 690 (766)
..+..++..||+.||.+||+ +.+++.+
T Consensus 218 ---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 ---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 23445567799999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.46 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=197.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..++||||++++++|.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999874 6899999999753 234566788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997543 58999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCc------------------------------------eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHH
Q 004247 573 SSSHI------------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616 (766)
Q Consensus 573 ~~~~~------------------------------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLl 616 (766)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100 001246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCccchhh-HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 004247 617 TGRKPISNDHPKGQES-LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ---MSLVLKL 690 (766)
Q Consensus 617 tG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs---~~eVL~~ 690 (766)
+|+.||....+..... +..|..... + +. .....+.+.. ++..|+. +|.+|++ +.+++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~-------~--~~--~~~~s~~~~~---li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETLQ-------F--PD--EVPLSPEAKD---LIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccC-------C--CC--CCCCCHHHHH---HHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999998765432211 111211100 0 00 0011223333 3345665 8999998 9988875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=341.42 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999864 78999999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997653 368999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhc------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...........+... ...
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~ 227 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF------QRF 227 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC------CCc
Confidence 3322 222357999999999987 456889999999999999999999999765433221111110 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+. .. ......+..++..||+ +|.+||++.+++++
T Consensus 228 ~~~~-----~~--~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKFP-----ED--PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCCC-----CC--CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 00 0111223344456887 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=347.24 Aligned_cols=259 Identities=23% Similarity=0.388 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||+|... .+..||||+++.. ....+.+.+|+++|..+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999752 2347999999753 234567999999999996 9999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCC----------------------------------------------------------
Q 004247 488 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 509 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~---------------------------------------------------------- 509 (766)
.+|||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865321
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC
Q 004247 510 ----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555 (766)
Q Consensus 510 ----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 555 (766)
....+++..+..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247888999999999999999999 89999999999999999
Q ss_pred CCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHH
Q 004247 556 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 634 (766)
Q Consensus 556 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv 634 (766)
++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 99999999999986654333222233457889999999998899999999999999999997 999997543221111
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 635 ~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. +..+. .... .......+..++..||+.+|++||++.+|.++|+.
T Consensus 351 ~~----~~~~~-----~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 351 NK----IKSGY-----RMAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HH----HhcCC-----CCCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 00 11110 0000 11112345667788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=322.03 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=202.9
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||.||+|..+++..+|+|.+.........+.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 468888999999999999999888889999999876555567999999999999999999999885 4568999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.++++.... ..+++..++.++.+++.||.|||+ ++|+||||||+||++++++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999975432 358899999999999999999999 889999999999999999999999999998664432211
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....++..|+|||++....++.++||||||+++|+|++ |..||......... .+.. .+. ...
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~~-----~~~--- 223 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQVE----RGY-----RMP--- 223 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH----cCC-----CCC---
Confidence 112345678999999988899999999999999999999 89999764432211 1111 000 000
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+....+..++..|+..+|.+|||+.++++.|+.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 -CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122345667788999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.74 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=202.5
Q ss_pred CcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
+|.+.+.||+|+||.||+|... ....+++|.+.... .....+.+|+.++..++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999752 23578999887543 345688999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCC
Q 004247 491 VYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 550 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 550 (766)
||||+.+|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999864321 12357899999999999999999998 899999999999
Q ss_pred eeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccc
Q 004247 551 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 629 (766)
Q Consensus 551 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~ 629 (766)
||+++++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986544332222222356778999999988889999999999999999999 999997654322
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+..+..... .... .......+..++..||+.+|.+||++.++++.|+.
T Consensus 238 ---~~~~~~~~~---------~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 238 ---LFNLLKTGY---------RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ---HHHHHhCCC---------CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 111111100 0001 11122356667788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=323.07 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=204.5
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...++..||+|+++......+.+.+|+.++..++||||+++++++.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 35689999999999999999988777789999998755555788999999999999999999998754 56899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++..... ..+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999975422 357899999999999999999999 89999999999999999999999999999866543221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....++..|+|||++..+.++.++||||||+++|||++ |..||...........+. .+. ...
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~~-----~~~-- 223 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGY-----RMP-- 223 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cCC-----CCC--
Confidence 1 122356778999999998899999999999999999999 888997654332211111 000 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+....+..++..|++.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011223456677888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=327.82 Aligned_cols=258 Identities=24% Similarity=0.445 Sum_probs=206.0
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.+|.+.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999742 45678999987544 445678999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC
Q 004247 491 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 558 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 558 (766)
||||+++++|.+++..... ....+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975431 12358999999999999999999999 89999999999999999999
Q ss_pred eeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004247 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 559 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 637 (766)
++|+|||++................|+..|+|||++....++.++|||||||++|||++ |+.||........ +..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-
Confidence 99999999976544332222233567889999999998899999999999999999999 9999876543221 111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+..+...... ......+..++.+||+.+|.+||++.+|++.|...
T Consensus 238 ---~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 238 ---ITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ---HhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111110 01123455677789999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.42 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=196.4
Q ss_pred CcccceeeeccCceEEEEEEe----CCCCEEEEEEccCC-----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 419 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
+|.+.+.||+|+||.||++.. .+++.||+|++... ....+.+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999875 36889999998642 23345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999997543 58899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
......... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...........+. .....
T Consensus 154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~----- 225 (332)
T cd05614 154 EFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK----- 225 (332)
T ss_pred cccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc-----
Confidence 654332221 1236799999999999864 47889999999999999999999997543322111111 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.++.+....+ ..+..++..||+.||.+|| ++.+++++
T Consensus 226 --~~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --CDPPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111111111 2234456679999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.20 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=206.1
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 486 (766)
..++|.+.+.||+|+||.||++... ....+|+|.+... ......+.+|++++..+ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3457888999999999999999863 2367999998753 34456788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 487 NLLLVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
.+++||||+++|+|..+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 9999999999999999997532 223468999999999999999999998 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 633 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 633 (766)
.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654332222222345678999999998899999999999999999998 9999975443221111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. .+.. ..........+..++..||+.+|.+|||+.++++.|...
T Consensus 247 ~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 LK-------EGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH-------cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 10 1100 011112234566677889999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.87 Aligned_cols=257 Identities=21% Similarity=0.390 Sum_probs=205.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457889999999999999999864 24689999987543 4456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 489 LLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
++||||+++|+|.+++...... ...+.|..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 1347899999999999999999998 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcccc
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|||+++...............+|..|+|||.+..+.++.++|||||||++|||++ |..||...........+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999986544332222223457889999999998899999999999999999998 999997654322211111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.+..... ... ....+..++..||+.+|.+|||+.++++.|+
T Consensus 236 -~~~~~~~-----~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLDL-----PEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCCC-----CCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 111 1345566778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.18 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=206.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChh---HHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV 491 (766)
++|...+.|++|.||.||+|.++ +++.||+|.++.+.+ .--.-++||.+|.+++|||||.+..+..- -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45788899999999999999974 688899999986542 23356799999999999999999988753 3569999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
||||+. +|..++...+ ++|...+...+..|+++||.|||. +.|+||||||+|+|+++.|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999977 9999998765 579999999999999999999999 889999999999999999999999999999887
Q ss_pred CCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..... .+..+-|.+|.|||.+.+. .|+..+|+||+|||+.||+++++.|.+.....+...+...........+..+.
T Consensus 229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 76433 3457889999999998855 69999999999999999999999999887666655443222111111111111
Q ss_pred C--------------cccCCCCChH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 D--------------PALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d--------------~~l~~~~~~~-~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ..+...|... ..+.-+.+....|..||.+|-|+.+.|++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1 1111111111 11333444556888999999999999975
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.36 Aligned_cols=201 Identities=25% Similarity=0.429 Sum_probs=176.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||++... ++..+|+|++... ......+.+|++++..++||||++++++|..++.+++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 6888999988753 3455778999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997543 478899999999999999999961 46999999999999999999999999999765432
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred cc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 21 235799999999999988899999999999999999999999976443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=320.81 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=206.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +++.||||.++. .......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 789999998753 2344567899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.........+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886543333467889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.... .....|++.|+|||++.+..++.++|+||||+++|||++|+.||....... ..+.... ..+.. +
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~----~~~~~-----~ 226 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI----EQCDY-----P 226 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH----hcCCC-----C
Confidence 3221 123468899999999998889999999999999999999999996543221 1111111 11110 1
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+. .......+..++..||+.+|.+||++.+|++.|+..
T Consensus 227 ~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 110 111224456667789999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=320.87 Aligned_cols=254 Identities=23% Similarity=0.403 Sum_probs=205.1
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|..++++.||+|.+.........+.+|+.+++.++|+||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 3578899999999999999999889999999999876656678999999999999999999999874 467899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999875432 468899999999999999999999 89999999999999999999999999999876532221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......++..|+|||++..+.++.++||||||+++|||++ |+.||........ ..... .+. .....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~-----~~~~~ 225 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNLE----RGY-----RMPRP 225 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHH----cCC-----CCCCC
Confidence 1122356788999999998899999999999999999999 9999976543221 11111 000 00011
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. ....+..++..||+.+|++||+++++++.|+.
T Consensus 226 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DN----CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC----CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 11346667778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.65 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=202.2
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567999999999999999999874 3567899988743 3345678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---CeeE
Q 004247 488 LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQL 561 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL 561 (766)
.++||||+++++|.+++..... ....++|..+..++.+|+.||.|||+ ++++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 22358999999999999999999999 8899999999999998654 5999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |+.||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~----- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT----- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999987643222111112234568999999998999999999999999999997 999997654332211111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
..... .........+..++..||+.+|++||++.+|+++|.
T Consensus 236 -~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 001111234556667899999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.36 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=206.8
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.+|.+.+.||+|.||.|-+|.. ..|+.||||.++++ ++..-.+.+||+||+.|+||||+.++.+|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577778899999999999985 68999999999864 456667889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||..+|.|++++.+.+ .+++.+++.++.||..|+.|+|+ ++++|||||.+|||||.++++||+||||+.++..
T Consensus 133 EYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999998765 58999999999999999999999 8999999999999999999999999999988766
Q ss_pred CCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
...- .++||+|-|.+||++.+..|. +.+|-|||||+||.|+.|..||++.+.+. ++. .+..|.+.+--
T Consensus 206 ~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr----QIs~GaYrEP~- 274 (668)
T KOG0611|consen 206 KKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR----QISRGAYREPE- 274 (668)
T ss_pred ccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH----HhhcccccCCC-
Confidence 5432 348999999999999988875 78999999999999999999998754322 221 12233222211
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
......-++.+||..||++|-|+.+|..+.
T Consensus 275 ----------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 ----------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111223355789999999999999998876
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.06 Aligned_cols=264 Identities=20% Similarity=0.272 Sum_probs=194.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--------Cc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------NN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------~~ 487 (766)
..+|.+.+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||++++++|... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 467999999999999999999864 688999998865432 234799999999999999999987532 24
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGL 566 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGl 566 (766)
+++||||+++ +|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 6799999975 7877775433333568999999999999999999999 8999999999999998664 699999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc--
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 643 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 643 (766)
++........ ....||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.........+.........
T Consensus 218 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 218 AKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred chhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9866543222 235789999999998754 6999999999999999999999999876543322211111000000
Q ss_pred -----Ccccc-----ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 -----GKVTQ-----LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 -----g~~~~-----lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.. .....+...++......+..++..||+.||.+|||+.+++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000000000111112345667788999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.94 Aligned_cols=253 Identities=23% Similarity=0.421 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCC----EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|.+.+.||+|+||.||+|... ++. .+++|.+... .....++..|+.++..+.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45788899999999999999863 444 4788887643 234567888999999999999999999985 456789
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 358999999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.............|+..|+|||++..+.++.++|||||||++|||++ |+.||.+..+.....++ ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCcC--
Confidence 54333333334567889999999998999999999999999999998 99999765443222221 111100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+.. . ...+..++..||..+|.+||++.++++.|..
T Consensus 231 ~~~~~----~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQPQI----C---TIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCC----C---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111 1 1234556678999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.85 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.+|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34777889999999999999853 35789999997543 34567889999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 490 LVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
+++||+.+++|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 112357889999999999999999999 8999999999999999999
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 636 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 636 (766)
.+||+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR- 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999886644332222233456789999999998899999999999999999998 888987654322111111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.... . ..+....+..++..||+.+|.+||++.+|+..|+.
T Consensus 241 ------~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 ------NRQVLP-----C----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------cCCcCC-----C----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111110 0 11122335566778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.43 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=193.4
Q ss_pred eeeeccCceEEEEEEe----CCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 424 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+.||+|+||.||++.. .+++.||||+++... .....+.+|+.+++.++||||++++++|..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 367899999987532 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++|+|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999997543 47888899999999999999999 899999999999999999999999999987543322
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....||+.|+|||++....++.++|||||||+||||++|+.||...........+. .+.. .+
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~-------~~~~------~~ 219 (323)
T cd05584 155 TV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-------KGKL------NL 219 (323)
T ss_pred Cc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC------CC
Confidence 21 223579999999999998889999999999999999999999997654322111111 1110 01
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.... ...+..++..||+.+|.+|| ++.+++++
T Consensus 220 ~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 12345566789999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.59 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=190.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+|...+.||+|+||.||+|... +|+.||||++... ......+.+|+++++.++|+||++++++|...+.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456688999999999999864 6899999998643 345678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.... ...+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986532 24567788899999999999999 8999999999999999999999999999987643321
Q ss_pred CceecccccccCCCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+..... .+.
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~----- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQ----- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccC-----
Confidence 1223579999999998743 234568999999999999999999997433222221111100 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. .......+..++..||+.||.+||++.+++++
T Consensus 293 ~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001 11112345566678999999999999999975
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.36 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=202.9
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||.||+|....+..+|+|.+.......+.+.+|+.+++.++|+|++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 458889999999999999999877778999998876555678899999999999999999999885 4568999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.++++.... ..+++..+..++.+++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999975432 357899999999999999999999 88999999999999999999999999999866433211
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......++..|+|||++..+.++.++||||||+++|||++ |+.||......... .+..... . +..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~---~------~~~-- 224 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVERGY---R------MPC-- 224 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCC---C------CCC--
Confidence 1122346788999999998899999999999999999999 99999765432211 1111000 0 000
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.......+..++..||+.+|.+||++.+|++.|+.
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 --PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122345566678999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=326.58 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=201.1
Q ss_pred cccceeeeccCceEEEEEEe-----CCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEE
Q 004247 420 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 490 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l 490 (766)
|...+.||+|+||+||++.. .++..||+|+++... .....+.+|+++++.++||||++++++|... ..+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988652 367889999997543 3567888999999999999999999998753 45899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999653 48999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
........ .....++..|+|||++..+.++.++||||||+++|||++|..||....... .....+.........+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 54322111 112345677999999998899999999999999999999999986543211 1111111111111111122
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
++..............+..++..||+.+|.+||++.+|++.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222111111222234566677789999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=313.02 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=206.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|-||.||.|+.+ ++-.||+|++.++. ....++.+|++|-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356889999999999999999864 67789999997653 4456888999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
+||..+|+|+..|+.... ..+++.....++.|+|.||.|+|. .+||||||||+|+|++..+.+||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985443 458888899999999999999999 889999999999999999999999999987655
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.. ...+.+||..|++||+..+..++.++|+|++|++.||+|.|.+||..........-+... ++.+
T Consensus 176 ~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------~~~~ 241 (281)
T KOG0580|consen 176 SN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------DLKF 241 (281)
T ss_pred CC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------cccC
Confidence 22 223479999999999999999999999999999999999999999876532221111111 1112
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
| ..-......++..|+..+|.+|.+..+|+.+
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2 1112234456678999999999999999876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.50 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=192.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCC-ceeEEeeEEeecCceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~ 492 (766)
+|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|++++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999865 5789999999753 24456788899999999765 6888999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987543 57899999999999999999999 8999999999999999999999999999874322
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ... .
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-------~~~------~ 218 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-------EHN------V 218 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCC------C
Confidence 211 1223579999999999998899999999999999999999999997654322211111 000 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 684 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~ 684 (766)
.+.... ...+..++..||+.+|.+||+.
T Consensus 219 ~~~~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 011111 2234556678999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=335.50 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=193.3
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHH---HhcCCCceeEEeeEEeecCceEEE
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEII---TTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|++++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 6899999999753 23345666776665 466799999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|...++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888542 58999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------ 218 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------ 218 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 2221 12346799999999999988999999999999999999999999976543322111111100
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
...... ...+..++..||+.||.+|| ++.+++++
T Consensus 219 -~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 -RYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011111 12345566789999999999 56676664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.53 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=194.5
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||+|+||+||++... +|+.||||++.... ...+.+..|+++++.++|+||+++.++|...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 78899999987532 2345678899999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
..++.........+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98886543334568999999999999999999999 89999999999999999999999999999766543222 22
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...... +. . .+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~-~~--------~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILN-DS--------V--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhcc-cC--------C--CCcc
Confidence 357999999999999999999999999999999999999999764332111111 011110 00 0 0111
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 661 DQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.....+..++..||+.||.+|| ++.+++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1123345566779999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.70 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=197.4
Q ss_pred cccceeeeccCceEEEEEEeCC-CC--EEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------Cc
Q 004247 420 FLAENLIGKGGSSQVYKGCLPD-GK--ELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 487 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~-g~--~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~ 487 (766)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.. ....+.+.+|+.+++.++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998754 32 5899998753 45567889999999999999999999987542 24
Q ss_pred eEEEEeecCCCCHhHhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
.++||||+++|+|.+++.... ..+..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 223458999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccC
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
+++...............+++.|+|||++....++.++||||||+++|||++ |+.||........... +..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-------LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHcC
Confidence 9987654322111122346778999999998899999999999999999999 8899976433211111 1111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.... ........+..++..||+.+|++||++.++++.|+.
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1100 011122345667788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=326.91 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=199.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
+|.+.++||+|+||.||++... +++.||||++.... .....+.+|+.+++.++||||++++++|..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 68999999987532 223567889999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865432 358999999999999999999999 89999999999999999999999999999875433
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. .....||+.|+|||++....++.++|||||||++|||++|+.||...........+.. . +..+.
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--~-~~~~~-------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--R-VKEDQ-------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--H-hhhcc--------
Confidence 22 1234789999999999988999999999999999999999999986543221111110 0 00000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
..+.......+..++..||+.||.+|| ++.+++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001111223445667789999999999 88888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.40 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=208.2
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +|+.||+|.++.. ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999976 7999999988632 234678899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.........+++..++.++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987544444568999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......... +.. . +..+......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK---K-IEKCDYPPLP-- 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-HHh---h-hhcCCCCCCC--
Confidence 3221 12246899999999999888999999999999999999999999654321111 111 0 1111111110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.......+..++..||..+|.+||++.+|++.|+..
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 111223455667789999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.68 Aligned_cols=203 Identities=27% Similarity=0.374 Sum_probs=174.8
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|++++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999986 47899999998653 234567888999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997543 57889999999999999999999 8999999999999999999999999999963321
Q ss_pred CCCC---------------------------------------------ceecccccccCCCCchhhccCCCCCchhhHH
Q 004247 573 SSSH---------------------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 607 (766)
Q Consensus 573 ~~~~---------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwS 607 (766)
.... ......+||+.|+|||++....++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCc
Q 004247 608 FGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 608 lGvvL~eLltG~~Pf~~~~~ 627 (766)
|||+||||++|+.||.....
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH
Confidence 99999999999999976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=324.73 Aligned_cols=270 Identities=26% Similarity=0.349 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~ 489 (766)
.+|.+.+.||+|+||.||++.. .++..||||.+.... ...+.+.+|++++..++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 357899999987543 456788999999999999999999998754 34689
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcee-cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
.......... ....++..|+|||++.++.++.++|||||||++|||++|..|+......-...+-...........+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 6543322111 112344569999999988999999999999999999998877643211000000000000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+...............+..++..||..+|++|||+.+|++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111000001111223456677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.19 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=205.3
Q ss_pred hcCcccceeeeccCceEEEEEEeCC-----------------CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIIS 477 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~ 477 (766)
..+|.+.+.||+|+||.||++...+ +..||+|++... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999987542 245899998754 345678999999999999999999
Q ss_pred EeeEEeecCceEEEEeecCCCCHhHhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCC
Q 004247 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 550 (766)
Q Consensus 478 l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 550 (766)
++++|..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999976542 11258999999999999999999999 899999999999
Q ss_pred eeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCcc
Q 004247 551 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPK 628 (766)
Q Consensus 551 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~ 628 (766)
|+++.++.++|+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986544332222233457889999999998899999999999999999998 67788654321
Q ss_pred chhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 629 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 629 ~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
. .................+. ........+..++..||+.+|.+||++.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1121111111111111110 01111245677788899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.21 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=203.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~lV~ 492 (766)
.|...+++|.|.||.||+|... +++.||||....+... -.+|+.||+.+.|||||+|+-+|.... .+.|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4667799999999999999864 5789999998765542 236999999999999999999987532 456899
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEeccccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWAS 571 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~~ 571 (766)
|||+. +|.+.++........++...+.-+..||++||.|||. .+|+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 9999998654444567778888899999999999999 999999999999999976 899999999999988
Q ss_pred CCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC------
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 644 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 644 (766)
.+..... ...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+++...+..++..........
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7766644 4679999999988754 79999999999999999999999999988776665553322111111
Q ss_pred -ccccccCcccCCC-----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 -KVTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 -~~~~lld~~l~~~-----~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..+...|.+... +....-...+.++..+|+.+|.+|.++.+++.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111222111 111122344556678999999999999999874
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.42 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=206.7
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|..++++.+|||.+.......+++.+|+.+++.++|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46799999999999999999998888899999998766666789999999999999999999999998889999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999976432 358999999999999999999999 88999999999999999999999999999866532111
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......++..|+|||.+.++.++.++||||||+++|+|++ |+.||......... ........ ...
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~~~~~---------~~~- 225 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQVERGYR---------MPR- 225 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC---------CCC-
Confidence 1112235678999999998889999999999999999999 99999764432211 11110000 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+......+..++..||+.+|.+||++.++++.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00112345667778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=333.06 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=192.7
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999865 5789999998753 23345677788888877 5899999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999986543 48899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
... ......||+.|+|||++..+.++.++|||||||++|||++|+.||...........+.. +..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------~~~------ 218 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNV------ 218 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC------
Confidence 221 22346799999999999999999999999999999999999999986543322211110 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 684 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~ 684 (766)
.+... ....+..++..||+.+|.+|++.
T Consensus 219 ~~p~~----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKS----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCc----CCHHHHHHHHHHcccCHHhcCCC
Confidence 01111 12344556678999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.82 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=199.8
Q ss_pred cccceeeeccCceEEEEEEeCC----CCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004247 420 FLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 487 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 487 (766)
|.+.+.||+|+||.||+|.... +..||||+++.. ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998753 2445688999999999999999999999876554
Q ss_pred -eEEEEeecCCCCHhHhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 488 -LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 488 -~~lV~E~~~ggsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
.++||||+++|+|..++.... .....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 223468999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||....... +..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence 99986654332222222345778999999988889999999999999999999 889996543321 111111 1
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+.... . .......+..++..||+.||.+||++.+|++.|+.
T Consensus 231 ~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRLK-----Q----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCC-----C----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11000 1 11122355666778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.58 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=204.0
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+-|.+.+.||+|+.|.|-+|.+ .+|+.+|||++.+. ......+.+||-||+.+.|||+++||+++....++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3478899999999999999986 58999999999754 234567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++||.|+++|...+ ++++.++.+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|-+-..
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999997664 58999999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
+.-- .+-||.|.|.|||++++..|+ .++||||.|||||.||||+.||++++.......+. .|.+.-
T Consensus 165 gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~-------~G~f~M--- 231 (786)
T KOG0588|consen 165 GKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ-------RGVFEM--- 231 (786)
T ss_pred Cccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH-------cCcccC---
Confidence 3322 236899999999999999886 69999999999999999999999765443322222 121110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .+-..+.+. ++..|+..||.+|-|+.+|+++
T Consensus 232 ---P-s~Is~eaQd---LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ---P-SNISSEAQD---LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---C-CcCCHHHHH---HHHHHhccCccccccHHHHhhC
Confidence 0 112233343 3456999999999999999996
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.10 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=194.3
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 424 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
++||+|+||.||++.. .+|+.||+|+++.. ......+.+|++++..++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 47899999999753 234567788999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|..++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 9999886543 58899999999999999999995 158999999999999999999999999998754322221
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
.....||+.|+|||++.++.++.++|||||||+||||++|+.||...........+.... ..+...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------CCCCCCC
Confidence 223579999999999998999999999999999999999999997654322222211100 0011111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
. ..+..++..||+.||.+|+ ++.+++++
T Consensus 220 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 S----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 2344556679999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=342.71 Aligned_cols=194 Identities=22% Similarity=0.321 Sum_probs=168.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||.||++... +++.||||.... ..+.+|+++++.++||||++++++|......++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 357999999999999999999864 688999997542 35678999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
. ++|..++.... .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 68988886543 57899999999999999999999 8999999999999999999999999999975433221
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 624 (766)
. ......||+.|+|||++....++.++|||||||+||||++|+.||..
T Consensus 238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1 12235799999999999988999999999999999999999988754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.48 Aligned_cols=252 Identities=30% Similarity=0.457 Sum_probs=201.4
Q ss_pred CcccceeeeccCceEEEEEEeCC--C--CE-EEEEEccC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPD--G--KE-LAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~--g--~~-vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
+-.+.+.||+|+||.||+|.+.. + .. ||||..+. .....++|++|.+++++++|||||++||++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34456899999999999998642 2 23 89999984 3567889999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+|||+|.||+|.++|+..+. .++..++..++.+.|.||+|||+ +++|||||-.+|+|++.++.+||+|||+++.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999987653 68999999999999999999999 8999999999999999999999999999876
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
......... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+. ..+....
T Consensus 312 ~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~~~r~~ 383 (474)
T KOG0194|consen 312 GSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KNGYRMP 383 (474)
T ss_pred Ccceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hcCccCC
Confidence 542111110 1124578999999999999999999999999999999 899998765443222221 1111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.....+..+. .++..||..+|++||+|.++.+.|+.
T Consensus 384 ------~~~~~p~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 384 ------IPSKTPKELA---KVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred ------CCCCCHHHHH---HHHHHhccCChhhccCHHHHHHHHHH
Confidence 0112333333 34457999999999999999998864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.68 Aligned_cols=203 Identities=26% Similarity=0.353 Sum_probs=174.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+++|..++||||+++++.|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 68999999987532 23466889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997643 57888899999999999999999 8999999999999999999999999999753210
Q ss_pred CC-----------------------------------------CCceecccccccCCCCchhhccCCCCCchhhHHHHHH
Q 004247 573 SS-----------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 611 (766)
Q Consensus 573 ~~-----------------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvv 611 (766)
.. .........||+.|+|||++....++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113579999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCc
Q 004247 612 LLELLTGRKPISNDHP 627 (766)
Q Consensus 612 L~eLltG~~Pf~~~~~ 627 (766)
||||++|+.||....+
T Consensus 234 lyell~G~~Pf~~~~~ 249 (376)
T cd05598 234 LYEMLVGQPPFLADTP 249 (376)
T ss_pred eeehhhCCCCCCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=342.42 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=174.3
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|...+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++++++||||++++++|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999986 468899999987532 345678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997543 47888999999999999999999 89999999999999999999999999997532110
Q ss_pred C---------------------------------------------CCceecccccccCCCCchhhccCCCCCchhhHHH
Q 004247 574 S---------------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 608 (766)
Q Consensus 574 ~---------------------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSl 608 (766)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000112579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCc
Q 004247 609 GVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 609 GvvL~eLltG~~Pf~~~~~ 627 (766)
||+||||++|+.||....+
T Consensus 235 Gvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH
Confidence 9999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.05 Aligned_cols=254 Identities=23% Similarity=0.274 Sum_probs=199.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
...++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++.++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999874 68899999986432 33455788999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998643 36788888999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
...... .......||+.|+|||++... .++.++|||||||+||||++|+.||...........+..... .
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~ 265 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-----S 265 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----c
Confidence 643322 122346799999999998643 478999999999999999999999987554322111111000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~--RPs~~eVL~~ 690 (766)
+ ...... .....+..++..||+.+|.+ ||++.+++++
T Consensus 266 ---~---~~~~~~--~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 ---L---TFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---C---CCCCcC--CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000100 11123344556799989987 9999999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=326.57 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEeCC---------------CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD---------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLG 480 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~---------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 480 (766)
++|.+.+.||+|+||.||++.... ...||||.++.. ......|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 234899998753 345567999999999999999999999
Q ss_pred EEeecCceEEEEeecCCCCHhHhhhcCCC--------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCee
Q 004247 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 552 (766)
Q Consensus 481 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NIL 552 (766)
++...+..++||||+++++|.+++..... ....+++..++.++.+++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11246889999999999999999999 89999999999999
Q ss_pred eCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCccch
Q 004247 553 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQ 630 (766)
Q Consensus 553 L~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~ 630 (766)
++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543322222222345778999999998999999999999999999998 6677765433221
Q ss_pred hhHHHhhcccccc-CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 631 ESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 631 ~~lv~~~~~~~~~-g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
... ....... +....... .......+..++..||+.+|.+||++.+|++.|+
T Consensus 242 ~~~---~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IEN---TGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHH---HHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 1111110 00000000 0011235677788999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=341.29 Aligned_cols=207 Identities=25% Similarity=0.335 Sum_probs=178.1
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004247 412 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 486 (766)
Q Consensus 412 el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 486 (766)
.+....++|.+.+.||+|+||.||++... +++.+|+|++... ......+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 44445678999999999999999999875 6889999998642 233456788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998643 37888999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
+........ .......||+.|+|||++... .++.++|||||||+||||++|+.||.....
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 987643221 222346799999999999753 378899999999999999999999986554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.57 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=206.2
Q ss_pred HhcCcccceeeeccCceEEEEEEeCC-----CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 487 (766)
..++|.+.++||+|+||.||+|...+ +..|++|+++.. ......+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45689999999999999999998755 688999998753 3456778899999999999999999998876 467
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC----CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
.+++++|+++++|.+++...... ...+++..++.++.+++.||.|||+ ++++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 1468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 642 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 642 (766)
||+++.+.............++..|+|||++....++.++|||||||++|||++ |+.||....+.. +..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc---
Confidence 999986644333222223456788999999998889999999999999999999 999997654322 2111111
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 643 ~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+. ........ ...+..++..||+.+|++||++.++++.|..
T Consensus 235 -~~-----~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 235 -GY-----RLAQPINC----PDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred -CC-----CCCCCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 10 00000111 1245567788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.30 Aligned_cols=256 Identities=28% Similarity=0.357 Sum_probs=200.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---------------hHHHHHHHHHHHHHhcCCCceeEE
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------------DVIKEFVLEIEIITTLHHKNIISL 478 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---------------~~~~~~~~Ei~iL~~l~HpnIv~l 478 (766)
...++|.+.+.||+|.||.|-+|.. .+++.||||++.+.+ ...+...+||.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4467899999999999999999986 478999999996521 123578899999999999999999
Q ss_pred eeEEee--cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC
Q 004247 479 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556 (766)
Q Consensus 479 ~~~~~~--~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 556 (766)
+++..+ .+.+|||+|||..|.+...=- ....+++.++++|+..++.||+|||. ++||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 999865 468999999999988764321 11238999999999999999999999 999999999999999999
Q ss_pred CCeeEecccccccccCCCCC---ceecccccccCCCCchhhccCC----CCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 557 FEPQLSDFGLAKWASTSSSH---ITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 557 ~~vkL~DFGla~~~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
|++||+|||.+.....+... ......+|||.|+|||....+. -+.+.||||+||+||-|+.|+.||.++....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866433111 1112268999999999988743 3568999999999999999999997654322
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
... .+++..|.-....+.-+.+-.++..+|.+||+.|-+..+|..+..
T Consensus 327 l~~---------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 LFD---------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHH---------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 111 222222222222234455566677899999999999999987754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.66 Aligned_cols=269 Identities=17% Similarity=0.220 Sum_probs=198.4
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCC------CceeEEeeEE
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISLLGFC 482 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~ 482 (766)
.+++...+++|.+.+.||+|+||+||+|.+. .++.||||+++........+..|+.++..++| +++++++++|
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3444456789999999999999999999864 67889999997655555566778888887765 4589999988
Q ss_pred eec-CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC----
Q 004247 483 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---- 557 (766)
Q Consensus 483 ~~~-~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---- 557 (766)
... .++++|||++ +++|.+++.... .+++..+..|+.||+.||.|||+. .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 764 5789999988 778998886543 589999999999999999999961 4899999999999998765
Q ss_pred ------------CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 004247 558 ------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 558 ------------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 625 (766)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999988643221 22368999999999999999999999999999999999999999876
Q ss_pred CccchhhHHHhhccccc------------------cCccccccCcc-----cCCCC--ChHHHHHHHHHHHhhcccCCCC
Q 004247 626 HPKGQESLVMWAKPILS------------------SGKVTQLLDPA-----LGNNY--DYDQMERMVLASILCIRRDPRA 680 (766)
Q Consensus 626 ~~~~~~~lv~~~~~~~~------------------~g~~~~lld~~-----l~~~~--~~~~~~~~~~~~~~Cl~~dP~~ 680 (766)
.......++......+. .+.+....++. ..... .......+..++..||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 54333222211100000 00000000100 00000 0001234557778899999999
Q ss_pred CCCHHHHHHH
Q 004247 681 RPQMSLVLKL 690 (766)
Q Consensus 681 RPs~~eVL~~ 690 (766)
|||+.++|++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999974
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.29 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=206.0
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++.. .+++.+|||.+... .....++.+|+.+++.++||||++++++|..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999985 48899999987642 234568889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.........+++..++.++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987543334568999999999999999999999 8999999999999999999999999999886654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.... .....|+..|+|||++....++.++||||||+++|+|++|..||......... . .... . ....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~---~~~~-~-----~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-L---CKKI-E-----QCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-H---hhhh-h-----cCCCC
Confidence 3221 12356899999999999888999999999999999999999999754322111 1 1100 0 11111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+... .....+..++..||+.+|.+||||.+|++.++.
T Consensus 227 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLPSD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCcc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11111 122345556678999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.38 Aligned_cols=246 Identities=26% Similarity=0.432 Sum_probs=197.7
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
++||+|+||.||+|...++..+|+|+++.. ......+.+|++++..++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998753 344557889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecc
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 581 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~ 581 (766)
+++.... ..+.+..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCC
Confidence 9986543 357899999999999999999999 899999999999999999999999999997544322111 111
Q ss_pred cccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 582 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
..+++.|+|||++..+.++.++||||||+++|+|++ |..||...........+ . .+. ... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~----~~~-----~~~----~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---E----KGY-----RMS----CPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---H----cCC-----CCC----CCC
Confidence 245678999999998999999999999999999999 99999765332211111 1 010 000 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 661 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.....+..++..||..+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12245666778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=364.53 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=209.3
Q ss_pred cCcccceeeeccCceEEEEEEeC--CCC----EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP--DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~--~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.+-...+.||+|+||.||.|... +|. .||||.++.. .+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34566789999999999999864 343 4899999864 577889999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 490 LVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
|++|||++|+|..+|++.+. .+..++....+.++.+||+|+.||++ +++|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987632 24578899999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
|+.+...........-.-...|||||.++.+.++.|+|||||||+|||++| |..||...+....... + ...|+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--~----~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--V----LEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH--H----HhCCc
Confidence 994444333222111122357999999999999999999999999999999 9999987655433221 2 22221
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+- .+......+.+++..||+.+|++||++..+++.+...
T Consensus 923 ---L~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 923 ---LD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ---cC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 1233445666788899999999999999999976543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.06 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC--------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 485 (766)
.++|.+.+.||+|+||.||++... ++..+|+|+++.. .....++.+|++++..+ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356899999999999999999742 2357999999854 34456788999999999 799999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
+..++||||+++|+|.+++..... ....++|..++.++.|++.||+|||+ ++++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 999999999999999999976432 11358899999999999999999998 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999976543221111111234578999999998889999999999999999998 889986543321111
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+. .+.... ........+..++..||+.+|.+||++.+|++.|...
T Consensus 254 ~~~-------~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 254 LLK-------EGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHH-------cCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 111000 0111123444566789999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.77 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=203.3
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|+||.||+|... +++.|++|.+... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999864 6899999998642 35567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++..... ..+++..++.++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999976422 468899999999999999999998 899999999999999999999999999998665432
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....|++.|+|||++..+.++.++||||||+++|+|++|+.||...... ....... .+.... +
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~-----~ 221 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKII----RGVFPP-----V 221 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCCCCC-----C
Confidence 22 12356899999999999999999999999999999999999999765421 1111110 111111 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122345667778999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.54 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=193.2
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|... +++.||||+++.. ......+..|.+++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999875 5789999998753 23456678899999876 799999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 99999887543 58899999999999999999999 8999999999999999999999999999875433222
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++....++.++|||||||++|||++|+.||...........+. . +. . .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~------~-~~---~---~~p~~ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL------H-DD---V---LYPVW 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CC---C---CCCCC
Confidence 1234679999999999998899999999999999999999999998665332211111 0 10 0 00011
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCC-------CHHHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARP-------QMSLVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RP-------s~~eVL~~ 690 (766)
.+ ..+..++..||+.+|.+|| ++.+++++
T Consensus 219 ~~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LS----KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11 2344556779999999999 78888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.36 Aligned_cols=251 Identities=27% Similarity=0.515 Sum_probs=203.5
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
.+|.+.+.||+|+||.||++.+.++..+|+|++.........|.+|++++++++|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46788899999999999999887788999999986554556789999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999987543 357899999999999999999999 88999999999999999999999999998765432211
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......++.+|+|||++..+.++.++||||||+++|||++ |+.||....... ..... ..+ .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~--~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI----NAG--FRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----hCC--CCCCCCCC--
Confidence 1112345678999999998899999999999999999998 999997644322 11111 001 01111111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
....+..++..||+.+|.+||++.++++.|
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124566778899999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=334.39 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=192.5
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||++... +++.||||+++.. ......+..|+.++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 6889999999753 23456688899999998 699999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 99999886543 58999999999999999999999 8999999999999999999999999999875322111
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc--hhhHHHhhccccccCccccccCcccC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+....+..+.. .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 2233679999999999999899999999999999999999999996422111 00000111111111110 011
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCC------HHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs------~~eVL~~ 690 (766)
... ...+..++..||+.||.+||+ +.+++++
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 223455667899999999997 6777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.48 Aligned_cols=240 Identities=24% Similarity=0.383 Sum_probs=190.6
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999753 23445677788888764 899999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 99999997542 57899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-------------PCYPRW 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------CCCCcc
Confidence 1223579999999999998899999999999999999999999997654322211111110 111111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 689 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~-eVL~ 689 (766)
.. ..+..++..||+.+|.+||++. ++++
T Consensus 219 ~~----~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LT----REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CC----HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11 2344556789999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=333.12 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=192.1
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|..+ +++.||||+++.. ......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 6889999998753 23456778899998877 699999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 99999887543 58899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++....++.++|||||||++|||++|+.||...........+. .+.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~~~------~~~~~ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEV------VYPTW 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCC------CCCCC
Confidence 1223579999999999998899999999999999999999999997654322211111 1110 00011
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~------~eVL~~ 690 (766)
. ...+..++..||+.||.+||++ .+++++
T Consensus 219 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 219 L----SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1 1234456678999999999998 556543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.60 Aligned_cols=256 Identities=23% Similarity=0.417 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.+|...+.||+|+||.||++... ++..+|+|.+... ......+.+|++++..++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 4567899988754 3556789999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 491 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875431 11358899999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 638 (766)
||+|||++................+++.|+|||++....++.++|||||||++|||++ |..||...........+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999976543322222222346788999999998899999999999999999998 999996544322211111000
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
+ . ...... ...+..++..||+.+|.+||++.+|++.|+
T Consensus 242 ~---------~---~~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 E---------L---ERPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c---------C---CCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 0 000111 123456667899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.14 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=208.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-eEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~lV~ 492 (766)
++|...+.||+|+||.++...++ +++.|++|.+... ........+|+.++++++|||||.+++.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999988764 6789999998753 3455578899999999999999999999999988 99999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
+|++||+|.+.|...+ ...|+++.+..++.|++.|+.|||+ ..|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 3679999999999999999999998 8899999999999999999999999999998877
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.... ...+.||+.|+.||++.+..|+.|+|||||||++|||++-+++|...+.......+.. ..++|
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-----------~~~~P 225 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-----------GLYSP 225 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-----------ccCCC
Confidence 6522 2347899999999999999999999999999999999999999987665432222211 11122
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. +......+..++..||+.+|..||++.++|.+
T Consensus 226 l-----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 L-----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 11222233344567999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=328.93 Aligned_cols=264 Identities=19% Similarity=0.332 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999865 67889999987432 3345678899999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888876543 357889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc---
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL--- 650 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll--- 650 (766)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+..+.
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 21 123468999999998864 468999999999999999999999998765443322222111100000000000
Q ss_pred ---C---cccCCC----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 ---D---PALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 ---d---~~l~~~----~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+ +..... ........+..++..||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0 000000 000011234456678999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.54 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEe--------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 485 (766)
.++|.+.+.||+|+||.||+|.. .++..||+|.+... ......+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688889999999999999963 13457999998753 34567889999999999 899999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
...++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999975432 12357889999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999987654333222223456788999999998889999999999999999998 888886543322111
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+ ..+.... ........+..++..||+.+|.+||++.+|++.|+..
T Consensus 251 ~~-------~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 251 LL-------KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HH-------HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 11 1110000 0111223455566789999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=331.81 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=190.4
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|... +|+.||||+++.. ......+..|..++..+ +||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 6889999999753 23445667788888765 899999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 99999987542 57899999999999999999999 8999999999999999999999999999874322111
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. + .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------~------~~~~~~~ 218 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------D------TPHYPRW 218 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------C------CCCCCCC
Confidence 22346799999999999999999999999999999999999999976543221111110 0 0111111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH-HHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMS-LVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~-eVL~~ 690 (766)
.. ..+..++..||+.||.+||++. +++++
T Consensus 219 ~~----~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 219 IT----KESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CC----HHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11 2344556679999999999974 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.84 Aligned_cols=260 Identities=22% Similarity=0.395 Sum_probs=203.1
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.+++|.+.+.||+|+||.||+|... .+..||+|.++... .....+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999743 24579999987543 334568889999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
.++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 1345678889999999999999999 89999999999999999999999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||....... .... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~---~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF---V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---H
Confidence 99999986544322222222345778999999998899999999999999999999 788986543322 1111 0
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. +.... . .......+..++..||+.+|.+||++.++++.|+..
T Consensus 235 ~~-~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MD-GGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred Hc-CCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 11000 0 111124566677789999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.01 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=202.3
Q ss_pred eeeeccCceEEEEEEeCC----CCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||+|+||.||+|.... +..|++|+++.... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998753 78899999986543 367899999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCC-----CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 498 GSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 498 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
++|.+++...... ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865221 2568999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||........ ..... .+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEYLR----KGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCCC-----
Confidence 432222334568899999999998899999999999999999999 6999976533211 11111 0100
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
... .......+..++..||+.+|.+||++.+++++|+
T Consensus 226 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 1111234556677899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.44 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=189.1
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|... +++.||||+++.. ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 6789999999753 23345566777777654 899999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 99999987543 58889999999999999999999 8999999999999999999999999999986533221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... +.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-------------PHFPRW 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------CCCCCC
Confidence 2233679999999999998899999999999999999999999998654322111111000 111111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 689 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~-eVL~ 689 (766)
. ...+..++..||+.+|.+||++. ++++
T Consensus 219 ~----~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 I----SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 12334555689999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.62 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=203.0
Q ss_pred cCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
++|.+.+.||+|+||.||++.. ..+..+|||+++.. ....+.+.+|+.+++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688999999999999999974 13457999998754 34456789999999999 799999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++|+|.++++.... ..+++..+..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 348999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
...............++..|+|||++..+.++.++|||||||++|||++ |..||........ ...... .+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCC--
Confidence 6654332222222456788999999998899999999999999999998 9999976543221 111111 110
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.... .....+..++..||..+|++||++.++++.|..
T Consensus 262 ---~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---RMAQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---cCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000000 112345567778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.69 Aligned_cols=263 Identities=22% Similarity=0.368 Sum_probs=201.5
Q ss_pred cCcccceeeeccCceEEEEEEeC-----------------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 478 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l 478 (766)
++|.+.+.||+|+||.||++... ++..+|+|+++.. ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 2346899999753 3456789999999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCCHhHhhhcCCCC-------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCe
Q 004247 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 551 (766)
Q Consensus 479 ~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 551 (766)
++++...+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ ++|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998764321 1347888999999999999999999 8999999999999
Q ss_pred eeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCccc
Q 004247 552 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 629 (766)
Q Consensus 552 LL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~ 629 (766)
|++.++.++|+|||+++.+.............+++.|+|||+...+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986544322222222345678999999988899999999999999999998 778886543322
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
... .......... .....+. .......+..++..||+.||.+||++.+|++.|+
T Consensus 242 ~~~---~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIE---NTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111 1111110000 0000000 0111245566778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.05 Aligned_cols=255 Identities=25% Similarity=0.470 Sum_probs=202.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CC---CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
+++|...+.||+|+||.||+|... ++ ..+|+|.++.. ....+.+.+|++++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999874 33 36899998754 3446778999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCcee-cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 571 STSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
......... .....++.|+|||++..+.++.++|||||||++|||++ |+.||...........+ . .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~---~~~~~-- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---N---DGFRL-- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---h---cCCCC--
Confidence 543222111 11223567999999998899999999999999999998 99999765432211111 0 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+. ..+....+..++..||+.+|.+||++.+|++.|..
T Consensus 230 ---~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 ---PA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 11112345677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.46 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=206.3
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEe--
Q 004247 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF-- 483 (766)
Q Consensus 408 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~-- 483 (766)
+.++.+..+.++|.+.+.||+|+||.||++... +++.+|+|++.........+.+|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 444566667889999999999999999999864 688999999876555556788999999999 6999999999884
Q ss_pred ---ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 484 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 484 ---~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
.++.+++||||+++++|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 3456899999999999999886433333468899999999999999999999 8999999999999999999999
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 635 (766)
|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.... ..
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK 240 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence 999999986643221 1223469999999999853 45788999999999999999999999765432211 11
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
. ..+....+.++. . ....+..++..||+.+|.+||++.++++++
T Consensus 241 ~-----~~~~~~~~~~~~----~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 I-----PRNPPPTLHQPE----L---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c-----cccCCCcccCCC----C---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 001101111111 0 112355667789999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.79 Aligned_cols=254 Identities=22% Similarity=0.412 Sum_probs=200.2
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCC----EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++|.+.+.||+|+||+||+|.+ .+|. .||+|+++.. ......+.+|+.++..++||||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45788899999999999999985 3454 4899998743 3456788899999999999999999999975 4578
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
++|||+++|+|.++++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
..............+++.|+|||.+....++.++|||||||++|||++ |..||.......... +.. .+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~----~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---LLE----KGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHH----CCCcCC
Confidence 754333222222345778999999998899999999999999999998 999997543322111 111 111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. .......+..++..||+.||.+||++.++++.|..
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 232 Q---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred C---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 01112345566778999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=333.40 Aligned_cols=248 Identities=20% Similarity=0.333 Sum_probs=191.4
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||++... +++.||+|+++.. ......+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 6789999999753 23456678899988877 799999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 99998886543 58899999999999999999999 8999999999999999999999999999975432221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc--hhhHHHhhccccccCccccccCcccC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+..+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC-
Confidence 1223679999999999999999999999999999999999999996321111 00000011000111110 01
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCC------HHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs------~~eVL~~ 690 (766)
+......+..++..||+.||.+||+ +.+++++
T Consensus 225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 ---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111233455667899999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.70 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=200.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec------C
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED------N 486 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~------~ 486 (766)
.+++.|.+.+.||+|+||.||+|... +++.||+|++.........+.+|+.++..+ +|+||++++++|... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35677888999999999999999864 688999999976655567788999999998 699999999998753 4
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+++||||+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 58999999999999999976432 358899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
+......... .....|++.|+|||++. ...++.++|||||||++|||++|+.||....+....... +.
T Consensus 158 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-~~---- 230 (272)
T cd06637 158 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-PR---- 230 (272)
T ss_pred ceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-hc----
Confidence 9865433221 22357999999999986 346888999999999999999999999754432221111 00
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... +.+... .....+..++..||..+|.+||++.+++++
T Consensus 231 --~~~-----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 --NPA-----PRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --CCC-----CCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 111111 111235566678999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.94 Aligned_cols=257 Identities=25% Similarity=0.469 Sum_probs=203.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||++..+ ++..||+|++... ......+.+|+.+++.++||||++++++|..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 4678999998754 24457799999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCC
Q 004247 489 LLVYDFLSRGSLEENLHGNKK------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 550 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 550 (766)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 999999999999999974321 12357888999999999999999999 899999999999
Q ss_pred eeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccc
Q 004247 551 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 629 (766)
Q Consensus 551 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~ 629 (766)
||++.++.++|+|||++................++..|+|||++..+.++.++|||||||++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322111222345678999999998899999999999999999998 888986543322
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
..... ..+..... .......+..++.+||+.+|.+||++.++++.|+
T Consensus 241 ---~~~~~----~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 ---VIYYV----RDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ---HHHHH----hcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111 11111100 0111234666778899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=339.39 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=198.7
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 489 (766)
+|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 47899999998643 234567889999999999999999999998766 789
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5888877543 358999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc---------
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP--------- 639 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~--------- 639 (766)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...++..+...+.....
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 5443222 12234689999999998864 479999999999999999999999987654433222211100
Q ss_pred --------ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 --------ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 --------~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.............. .........+..++..||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 0011112345567778999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.69 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=198.5
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCC--EEEEEEccC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.++||+|+||.||+|... ++. .+++|.++. .....+.+.+|+.++.++ +||||+++++++...+.+++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999874 333 478888874 234567889999999999 799999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 492 YDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
|||+++++|.++++.... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975431 12358899999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 638 (766)
||+|||++......... .....+..|+|||++....++.++|||||||++|||++ |..||........... .
T Consensus 159 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~---~- 231 (297)
T cd05089 159 KIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK---L- 231 (297)
T ss_pred EECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H-
Confidence 99999998643221111 11223567999999998889999999999999999998 9999976543221111 0
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+ +.+..... ....+..++..||+.+|.+||++.++++.|..
T Consensus 232 ---~~~-----~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 232 ---PQG-----YRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred ---hcC-----CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 00001111 11345566778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.94 Aligned_cols=254 Identities=22% Similarity=0.411 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.+.|.+.+.||+|+||.||++...++..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 35788999999999999999998788889999998766666789999999999999999999999887 78899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999976432 457899999999999999999998 88999999999999999999999999999765443221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......++..|+|||++..+.++.++|+|||||++|+|++ |+.||......... .+.. .+.... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~~~~~-----~- 224 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE----RGYRMP-----R- 224 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHh----CCCCCC-----C-
Confidence 1112346678999999998889999999999999999999 99999765432211 1111 110000 0
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.......+..++.+||+.+|++||++.++++.|..
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345566678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.46 Aligned_cols=250 Identities=30% Similarity=0.465 Sum_probs=204.4
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||.|+||.||+|.. .|+.||||.++......+++.+|+.++..++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35788899999999999999987 57899999998766567889999999999999999999999998899999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999975432 358999999999999999999999 8999999999999999999999999999987633221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
...++..|+|||++..+.++.++||||||+++|+|++ |+.||....... +...... +.. ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~-----~~~- 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEK----GYR-----MEA- 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhc----CCC-----CCC-
Confidence 1245678999999998899999999999999999998 999997553322 1111111 000 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.......+..++..||..+|.+||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112345566778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.42 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=201.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CC---CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.+|.+.+.||+|+||.||+|... ++ ..||||+++.. ......|..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788999999999999999864 33 36999998753 45567899999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 358999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecc-cc--cccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 572 TSSSHITCTD-VA--GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 572 ~~~~~~~~~~-~~--GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
.......... .. ++..|+|||++..+.++.++|||||||++|||++ |..||....... ...+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~---~~~ 231 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDY---RLP 231 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCC---cCC
Confidence 4332211111 11 2457999999999999999999999999999987 999997654322 111111100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. ..+....+..++..||+.+|.+||++.+|+..|+.
T Consensus 232 ------~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 ------P----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------C----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 01112334566678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.53 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=192.0
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||+|+||.||++..+ +|+.||+|.+.... .....+..|++++..++||||+++++++..+..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986422 2234566799999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 988865432 358899999999999999999999 8999999999999999999999999999986654322 22
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...||+.|+|||++..+.++.++|||||||++|||++|+.||...........+ ...... +.+.. ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~-~~~~~-----~~~~~-- 222 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLE-DEVKF-----EHQNF-- 222 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhc-ccccc-----ccccC--
Confidence 357999999999999889999999999999999999999999754332111111 111110 11000 00111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 661 DQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
...+..++..||+.||.+||++.++++.+
T Consensus 223 --~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 --TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12345566779999999999997766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.60 Aligned_cols=252 Identities=32% Similarity=0.481 Sum_probs=199.2
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHH---HHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
|++.+.||+|+||+||++... +++.||+|++....... ....+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999976 46689999998765332 23456999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++... ..+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.++|+|||++..... .
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred cccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--c
Confidence 999999999833 358999999999999999999999 8999999999999999999999999999976422 1
Q ss_pred CceecccccccCCCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
........+|..|+|||++. ...++.++||||||+++|+|++|..||.................. .......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 224 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------PLPSSSQ 224 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------HHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------ccccccc
Confidence 22333467899999999998 788999999999999999999999999865222222211111000 0000000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........+..++..||+.+|.+||++.+++++
T Consensus 225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111556667778999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=323.03 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||.||++... ++..+|+|.++.. .....++.+|++++.+++||||++++++|..++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999864 6788999998753 34556788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... .+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997542 57899999999999999999996 1479999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc---------
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK--------- 645 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~--------- 645 (766)
. ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......................
T Consensus 155 ~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1 235789999999999888899999999999999999999999975443221111110000000000
Q ss_pred --------cccccCcccC---CCCC-hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 --------VTQLLDPALG---NNYD-YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 --------~~~lld~~l~---~~~~-~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..++.+.... ...+ ......+..++.+||..+|.+||++.+|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 0000 0012235667788999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.43 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=204.8
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChh---HHHHHHHHHHHHHhcCCCc-eeEEeeEEeecC------c
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKN-IISLLGFCFEDN------N 487 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~------~ 487 (766)
.|...+.||+|+||+||+|.. .+|+.||+|.++...+ ......+|+.+|+.|+|+| |+.|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567799999999999986 4789999999986533 4567789999999999999 999999999877 7
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
++|||||++. +|.+++.........++...+..++.||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 9999999966 9999998665322356668899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+...-... ..+..++|..|.|||++.+. .|+...||||+||++.||++++..|.++....+...+-..........+
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 96553322 24456899999999999876 7999999999999999999999999887764443333211111111011
Q ss_pred ccc---cC--cccCCCC---C-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQL---LD--PALGNNY---D-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~l---ld--~~l~~~~---~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... .+ +...... + .........++..||+.+|.+|.|+...+.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 110 01 0000000 0 0111356667788999999999999999986
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.52 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|++++++++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999986 468999999986431 234578899999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987543 47889999999999999999999 89999999999999999999999999999765
Q ss_pred cCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~---~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIAT---QPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhc---cCC----
Confidence 43221111 12356889999999999888999999999999999999999999754332111 11100 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.+... ....+..++..||..+|.+||++.+++++
T Consensus 225 -~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPSH----VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCcc----CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111111 12234556678999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.79 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=191.3
Q ss_pred eeeeccCceEEEEEEeCC---CCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 424 NLIGKGGSSQVYKGCLPD---GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~---g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
+.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 4578999987543 34457889999999999999999999999989999999999999
Q ss_pred CHhHhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 499 SLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 499 sL~~~L~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
+|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 22346778888999999999999999 899999999999999999999999999997554332222
Q ss_pred eecccccccCCCCchhhccC-------CCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 578 TCTDVAGTFGYLAPEYFMYG-------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~-------~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
......|+..|+|||++... .++.++||||||+++|||++ |+.||........... .+ .+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~------~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TV------REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hh------hcccCCC
Confidence 22235678899999998632 35789999999999999996 9999975433221111 00 0111122
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.++.+... ..+ .+..++..|+ .+|++|||+.+|+..|+
T Consensus 231 ~~~~~~~~-~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP-LSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC-CCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 112 2334455688 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.75 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=201.4
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEe
Q 004247 409 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCF 483 (766)
Q Consensus 409 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 483 (766)
.+.++....++|.+.+.||+|+||.||++... +++.+|+|++... ......+.+|+.++..++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556667789999999999999999999875 6889999998642 233456788999999999999999999999
Q ss_pred ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 484 ~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
.++.+++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999998643 37788889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
||+++....... .......||+.|+|||++... .++.++|||||||+||||++|+.||...+.......+.
T Consensus 186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---- 260 (371)
T cd05622 186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---- 260 (371)
T ss_pred CCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH----
Confidence 999987643322 122346799999999998753 37899999999999999999999998655432222111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHHhh
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKLLR 692 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~--RPs~~eVL~~L~ 692 (766)
.......+.+ . ......+..++..||...+.+ ||++.+++++.-
T Consensus 261 --~~~~~~~~~~-----~--~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 --NHKNSLTFPD-----D--NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred --cCCCcccCCC-----c--CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1000000100 0 011122334445688744433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.67 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=193.4
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||++... +++.||||+++.. ......+.+|++++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999999753 23456678899999888 699999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 99999887543 58999999999999999999999 8999999999999999999999999999875322221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .+. ......
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-------~~~------~~~~~~ 218 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-------EDE------VRYPRW 218 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCC------CCCCCc
Confidence 1223579999999999999999999999999999999999999997654322111111 000 001111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~-----~eVL~~ 690 (766)
. ...+..++..||+.||.+||++ .+++++
T Consensus 219 ~----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 L----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 2334556678999999999999 877764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.18 Aligned_cols=237 Identities=26% Similarity=0.370 Sum_probs=190.3
Q ss_pred eeeeccCceEEEEEEe----CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 424 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|++++.+++||||++++++|...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999997532 234567789999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 99999998654 258999999999999999999999 89999999999999999999999999999865443221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....||+.|+|||++....++.++|||||||++|||++|+.||...........+. .+.. .+..
T Consensus 155 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~-------~~~~------~~p~ 219 (318)
T cd05582 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL-------KAKL------GMPQ 219 (318)
T ss_pred --eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH-------cCCC------CCCC
Confidence 223679999999999998889999999999999999999999997654322111111 0000 0001
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSL 686 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~e 686 (766)
.. ...+..++..||+.||.+||++.+
T Consensus 220 ~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 123445567899999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.77 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=194.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhc---CCCceeEEeeEEee-----cC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE-----DN 486 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~-----~~ 486 (766)
+|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+.+++.+ +||||++++++|.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999865 68899999987431 2234556777777665 69999999999864 24
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 89888875432 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.-.........+
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 987654322 12356899999999999889999999999999999999999999765443222111100000000000
Q ss_pred cc-------ccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQ-------LLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~-------lld~~l~~---~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. .+.+.... ....+....+..++..||+.||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000000 0001122345567778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.49 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=198.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|...+.||+|+||+||+|... +++.||+|++.... .....+.+|++++..++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999864 78899999987532 234557889999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999988865432 358999999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+. ... ..+. . .
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~-~~~~--~----~ 223 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRV-LETE--E----V 223 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhh-hccc--c----c
Confidence 22 123579999999999998899999999999999999999999997654322211111 111 1100 0 0
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
....+ ...+..++..||+.+|.+||+ +.+++++
T Consensus 224 ~~~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11111 123455667799999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.33 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=199.5
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999986 478899999987543 34567888999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.++++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999986542 57899999999999999999999 8999999999999999999999999999986643221
Q ss_pred CceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 576 HITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
. .....|++.|+|||.+. ...++.++|||||||++|||++|+.||....+..... .+.. ..+ ..+
T Consensus 162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~-----~~~---~~~ 229 (267)
T cd06646 162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK-----SNF---QPP 229 (267)
T ss_pred c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec-----CCC---CCC
Confidence 1 12356899999999884 3457889999999999999999999996543321111 0000 000 001
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.... .......+..++..||+.+|++||++++++++|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 011123455667789999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=314.67 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=202.2
Q ss_pred cCcccceeeeccCceEEEEEEeC-C---CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.+|.+.+.||+|+||.||+|... + +..+|+|.++.. ....+.+.+|+.++..++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999863 2 337999998753 34567889999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997543 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 572 TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 572 ~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
....... .....++..|+|||++.++.++.++||||||+++|||++ |..||........ ..+.. .+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----~~~--~- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----EGY--R- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh----CCC--c-
Confidence 4332211 111234568999999998899999999999999999887 9999976543221 11111 110 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... .......+..++..|++.+|.+||+|.++++.|..
T Consensus 228 --~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 --LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 000 01112345567778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=312.21 Aligned_cols=248 Identities=29% Similarity=0.456 Sum_probs=196.2
Q ss_pred eeeeccCceEEEEEEeC--C--CCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP--D--GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~--~--g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||+|+||.||+|... + +..+|+|.+..... ..+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999752 2 36899999986543 5678999999999999999999999875 5578999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... .+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997543 58899999999999999999998 889999999999999999999999999998765433221
Q ss_pred ee-cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 578 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 578 ~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.. ....++..|+|||.+....++.++||||||+++|+|++ |..||....... +..+... +.. ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~~--~~----- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GER--LP----- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CCc--CC-----
Confidence 11 11224568999999998899999999999999999998 999997654322 2211111 100 00
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
........+..++..||..+|.+||++.++++.|+...
T Consensus 219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01111234556778899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=313.33 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=193.9
Q ss_pred eeeccCceEEEEEEe---CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 425 LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~---~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
.||+|+||.||+|.+ .++..+|+|+++.. ....+++.+|+.++..+.||||+++++++. .+.+++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 36788999998753 245678899999999999999999999985 45789999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||.|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996542 58899999999999999999999 8999999999999999999999999999987654432211
Q ss_pred e-cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 579 C-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 579 ~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
. ....++..|+|||.+..+.++.++|||||||++|||++ |+.||...........+ ..+.... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~~~~~~-----~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ESGERME-----CPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCCCC-----CCC
Confidence 1 12234678999999988889999999999999999998 99999765432211111 1111101 111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. ...+..++..||+.||.+||++.+|.+.|+.
T Consensus 222 ~~----~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 RC----PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC----CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11 1334556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=312.76 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=198.4
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEe-ecCceEEEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 496 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 496 (766)
.+|.+.+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|+.+++.++|+|++++++++. .++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688899999999999999977 57889999987543 3567899999999999999999999765 4567899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..+..++.+++.||.|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 9999999975432 358899999999999999999999 8999999999999999999999999999875543221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
...++..|+|||++....++.++|||||||++|+|++ |+.||....... +..+. ..+.- +...
T Consensus 158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~-----~~~~ 221 (256)
T cd05082 158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYK-----MDAP 221 (256)
T ss_pred ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCC-----CCCC
Confidence 2345678999999998899999999999999999998 999997543221 11111 11100 0111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. .....+..++..||+.+|.+||++.++++.|+.
T Consensus 222 ~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 D----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1 112344556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=320.70 Aligned_cols=265 Identities=29% Similarity=0.423 Sum_probs=208.9
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee
Q 004247 407 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE 484 (766)
Q Consensus 407 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 484 (766)
.+++.++..++++|.+.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++.++ +|||+++++++|..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 355667777889999999999999999999987 4688999999976655567788899999999 79999999999875
Q ss_pred c-----CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 485 D-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 485 ~-----~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
. +.+++||||+++++|.++++........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 35899999999999999887543333568999999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 634 (766)
||+|||++......... .....|+..|+|||++..+ .++.++|||||||++|||++|+.||....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 99999999865432211 1234689999999998644 368899999999999999999999976543211 11
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 635 ~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. +....+.++ ......+..++..||+.+|++||++.+++++
T Consensus 244 ~~~~-----~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPR-----NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhc-----CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 100111111 1122346667788999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.02 Aligned_cols=267 Identities=23% Similarity=0.333 Sum_probs=209.3
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-----cC
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-----DN 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-----~~ 486 (766)
....|...+.||+|+||.|+.+.. .+|+.||||.+.. .....++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 455666678999999999999986 4789999998873 34567889999999999999999999999865 35
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+|+|+|+| +.+|...++... .++......++.||++||.|+|+ .+|+||||||+|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 689999999 559999997553 48889999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
|+...........+..+.|.+|.|||++.. ..|+...||||.||+|.||++|++.|.+.+...+..++....+......
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998865433334466789999999998764 5799999999999999999999999999888777777655433322211
Q ss_pred cccccCcc-------cC--CCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLDPA-------LG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~-------l~--~~~~~-----~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..+-... +. ...+. ......+.+.-+||..||.+|+|+++.|++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111100 00 00010 111123344456999999999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.00 Aligned_cols=252 Identities=25% Similarity=0.290 Sum_probs=202.9
Q ss_pred cCcccceeeeccCceEEEEEEeCC-CCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+.|.+.+.||.|.-|+||++.+.+ +..+|+|++.+.. +...+...|-+||+.+.||.++.||..|..+...||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356778899999999999999864 5889999998643 45567788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|||+||+|..+++++.. ..|++..++.++.+++.||+|||. .|||+|||||+||||.++|++.|+||.|+..+..
T Consensus 157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999987654 579999999999999999999999 9999999999999999999999999999754321
Q ss_pred C---------------------------------CC---------------------CceecccccccCCCCchhhccCC
Q 004247 573 S---------------------------------SS---------------------HITCTDVAGTFGYLAPEYFMYGK 598 (766)
Q Consensus 573 ~---------------------------------~~---------------------~~~~~~~~GT~~Y~APE~l~~~~ 598 (766)
. .. ......++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 00 00112367999999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCC
Q 004247 599 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDP 678 (766)
Q Consensus 599 ~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP 678 (766)
.+.++|+|+|||+|||||.|..||.+.+......-+......+. . .......+..++...|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp-------------~--~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP-------------E--EPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC-------------C--CCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999999998776543322221111110 0 11222344455667899999
Q ss_pred CCCCC----HHHHHH
Q 004247 679 RARPQ----MSLVLK 689 (766)
Q Consensus 679 ~~RPs----~~eVL~ 689 (766)
.+|-- +.||-+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99999 677655
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.92 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=196.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+.++..++|+||++++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999864 6899999998742 234456888999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997532 358899999999999999999999 8999999999999999999999999999876544
Q ss_pred CCCCceecccccccCCCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
.... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||...........+. ......
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~ 227 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKEHF 227 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH------cCCCcc
Confidence 3221 1122469999999999873 457889999999999999999999997654322211111 100000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ .+. ... ..+....++.. ++|...++..||++.+++++
T Consensus 228 ~~-~~~-~~~-~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QF-PPD-VTD-VSEEAKDLIRR-LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-CCc-cCC-CCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence 00 000 011 22334444333 34666666679999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=323.31 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=201.2
Q ss_pred cCcccceeeeccCceEEEEEEeC--------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 486 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 486 (766)
++|.+.+.||+|+||.||++... ....+|+|+++.. ......+.+|+.++..+ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888999999999999999742 3457899998753 34466788999999999 6999999999999989
Q ss_pred ceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
.+++||||+++|+|.+++..... ....++|..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999975421 12458999999999999999999999 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 633 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 633 (766)
.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|+|++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986644322211111234567999999998899999999999999999999 8999976543221111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+ ..+.... ........+..++..||+.+|.+||++.++++.|..
T Consensus 249 ~-------~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 249 L-------REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred H-------HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1 1111000 011112244456678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=336.32 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=201.6
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 488 (766)
++|.+.+.||+|+||.||+|.+. .++.||||+++.. ......+.+|+++|..+. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45777899999999999999853 3468999999854 233457889999999997 99999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC-----------------------------------------------------------
Q 004247 489 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 509 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~----------------------------------------------------------- 509 (766)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 510 -----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 510 -----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
....+++..+..|+.||+.||.|||+ .+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11246788889999999999999998 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 633 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 633 (766)
.++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999986543322222223457889999999998889999999999999999998 8999865432221111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. +..+. .+.. .......+..++..||..+|.+||++.+|++.|+.
T Consensus 354 ~------~~~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 354 A------IKRGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred H------HHcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0 00110 0000 11112345566678999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.15 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=199.6
Q ss_pred cCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec-Cc
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NN 487 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~~ 487 (766)
++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688999999999999999963 35788999999753 34456788999999999 689999999988654 56
Q ss_pred eEEEEeecCCCCHhHhhhcCCC----------------------------------------------------------
Q 004247 488 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 509 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~---------------------------------------------------------- 509 (766)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999865321
Q ss_pred -----CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceeccccc
Q 004247 510 -----DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584 (766)
Q Consensus 510 -----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 584 (766)
....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01246888899999999999999999 8999999999999999999999999999986543322222222346
Q ss_pred ccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHH
Q 004247 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQM 663 (766)
Q Consensus 585 T~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~ 663 (766)
++.|+|||++....++.++||||||+++|+|++ |..||............ +..+.... ..... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~~~~~-----~~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------LKEGTRMR-----APDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH------HhccCCCC-----CCCCC----C
Confidence 778999999998899999999999999999997 99999754332111110 11111000 00111 1
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 664 ERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 664 ~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+..++..||+.+|.+||++.+|+++|+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 245666788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.56 Aligned_cols=264 Identities=20% Similarity=0.329 Sum_probs=199.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||.|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999865 68899999986432 3345678899999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
++ ++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 58998886543 357899999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC--
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-- 651 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld-- 651 (766)
.. .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+...........+..+++
T Consensus 159 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 KT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred Cc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11 1234678999999998754 578899999999999999999999987654332221111111000111111110
Q ss_pred -------cccCCC----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 -------PALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 -------~~l~~~----~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..... ........+..++..||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000112234566788999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.63 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=177.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|...+.||+|+||.||++... +++.||||+++.. ......+.+|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999864 6899999999743 234567888999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997543 58899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCC---------------------------------ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCC
Q 004247 573 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619 (766)
Q Consensus 573 ~~~~---------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~ 619 (766)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0011357999999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 004247 620 KPISNDHPK 628 (766)
Q Consensus 620 ~Pf~~~~~~ 628 (766)
.||....+.
T Consensus 234 ~Pf~~~~~~ 242 (360)
T cd05627 234 PPFCSETPQ 242 (360)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=330.62 Aligned_cols=198 Identities=27% Similarity=0.364 Sum_probs=169.9
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 486 (766)
..++|.+.+.||+|+||.||++... +|+.||||++... ......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 6899999998643 345567889999999999999999999986543
Q ss_pred -ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 487 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 487 -~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
.+++||||+.+ +|.+.++. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999975 67666642 37788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 169 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 169 LARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9976543221 223578999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.34 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC------Ch---hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP------SE---DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 486 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~------~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 486 (766)
+.|...++||.|..++|.++++ .+|+++|+|++.. ++ ...+.-.+|+.||+++ .||+|+.+.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4577788999999999999876 4788999999853 11 3345567899999999 5999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+++|+|.|+.|.|.++|... ..+++.+.+.|+.|+++|+.|||. ++||||||||+|||++++-++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999654 469999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhc------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+..+..+.. -.+.||||+|+|||.+. ...|+..+|+|++||+||.||.|.+||......-...+++..+..
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 998776543 23589999999999885 236888999999999999999999999654322222223322222
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+..+.. .......++.+||+.||.+|-|+.|+|.+
T Consensus 247 F~speWad-------------is~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 247 FRSPEWAD-------------ISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cCCcchhh-------------ccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 22211111 12234456678999999999999999874
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.06 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=195.7
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.++||+|+||.||+|.. .+++.||+|++... ......+.+|++++.+++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 47889999998653 34456789999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999997542 36788889999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh-hHHHhhccccccCccccccCcc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.....||..|+|||++....++.++||||||+++|+|++|+.||......... ....+... .... ..+.
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~-----~~~~ 219 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDE-----DPPV 219 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-Hhcc-----CCCC
Confidence 12357999999999999889999999999999999999999999653321110 00000000 0000 0011
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+... .....+..++..||+.+|.+||++.+++++
T Consensus 220 ~~~~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVG---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111 111234556678999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=328.89 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=191.6
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||++... +++.||||+++.. ....+.+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999999753 23456788899999888 699999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 99999886543 58999999999999999999999 8999999999999999999999999999975332211
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.............+....+.... ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~ 225 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRF 225 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCC
Confidence 12336799999999999989999999999999999999999999964322111111111110010000 001111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~------~eVL~~ 690 (766)
.+ ..+..++..||+.||.+||++ .+++++
T Consensus 226 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 226 LS----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11 234456678999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.10 Aligned_cols=192 Identities=25% Similarity=0.394 Sum_probs=165.8
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||++++++|...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999875 5678999986543 235699999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 95 58888886543 368999999999999999999999 899999999999999999999999999997543322
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCC
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf 622 (766)
. .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 12357999999999999899999999999999999999965554
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.34 Aligned_cols=245 Identities=26% Similarity=0.418 Sum_probs=193.1
Q ss_pred eeccCceEEEEEEeC---CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||+|+||.||+|.+. .+..||+|++.... ...+.+.+|+.++++++||||++++++|. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 45679999997543 34567999999999999999999999985 4578999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce-e
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-C 579 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~-~ 579 (766)
.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........... .
T Consensus 82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99987543 368999999999999999999999 8999999999999999999999999999986544332211 1
Q ss_pred cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 580 ~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
....+++.|+|||++....++.++|||||||++|||++ |..||...........+. .+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------QGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCCC---------CC
Confidence 11234678999999998889999999999999999996 999997654332221111 11100 01
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 659 DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+......+..++..||..+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11122344456678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.75 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=188.7
Q ss_pred eeeccCceEEEEEEeCC---CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCC
Q 004247 425 LIGKGGSSQVYKGCLPD---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 499 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 499 (766)
.||+|+||.||+|...+ ...+++|.+... ......+.+|+.+++.++||||++++++|.....+++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887643 3445678899999999999999999999999999999999999999
Q ss_pred HhHhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 500 LEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 500 L~~~L~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
|.+++...... ...+.+.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765421 2345678889999999999999999 8999999999999999999999999999875433222222
Q ss_pred ecccccccCCCCchhhcc-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 579 CTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+....... ... ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV------VRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hhc-cCccCC
Confidence 222456788999999753 356789999999999999999 78888654332111100 011 111122
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
++.+...+. ..+..+...|+ .||.+||++.+|+++|.
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222222 23333445677 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.85 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=197.7
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
+.||+|+||.||++...+++.||+|++.... .....+.+|+++++++.|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999999998779999999987543 35678999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecc
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 581 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~ 581 (766)
+++.... ..+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9997543 257889999999999999999999 8899999999999999999999999999986543221111111
Q ss_pred cccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 582 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
..++..|+|||++.++.++.++|||||||++|||++ |..||...........+.. +. ... ...
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------~~--~~~-------~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------GY--RMP-------APQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-------CC--CCC-------CCc
Confidence 234677999999998899999999999999999999 8899876543222111110 00 000 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 661 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.....+..++..||+.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11234556777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.71 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=198.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|+..++||+|+||.||++... +++.||||.+.... .....+.+|+.++..++|+||+++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999864 68899999986532 234567789999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998865432 358899999999999999999999 89999999999999999999999999999765433
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. .... .. ..
T Consensus 156 ~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~--~~----~~ 223 (285)
T cd05630 156 QTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKE--VQ----EE 223 (285)
T ss_pred ccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhh--hh----hh
Confidence 221 234799999999999988999999999999999999999999976433221111110 0000 00 00
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
....+. ..+..++..||+.||.+||+ +.+++++
T Consensus 224 ~~~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111111 23445567799999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=327.22 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=191.6
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+|...++||+|+||.||+|... +|+.||||+++.. ....+.+..|+.++..+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999864 6899999998753 234456788999998886 577888999999989999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999986543 58999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||...........+.. +..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~------ 218 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNV------ 218 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC------
Confidence 221 12235799999999999988999999999999999999999999986543221111110 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 684 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~ 684 (766)
...... ...+..++..||+.+|.+|++.
T Consensus 219 ~~p~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 001111 1234556678999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=310.77 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=203.4
Q ss_pred cCcccceeeeccCceEEEEEEeCC-CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
++|.+.+.||.|+||.||+|...+ ++.+++|.+..... .+.+.+|+++++.++||||+++++++......+++|||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 578889999999999999999764 88999999986544 6789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999986543 368999999999999999999999 88999999999999999999999999999876543321
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||....+...... ... .. .+.+.
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~~-----~~-----~~~~~- 220 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IPN-----KP-----PPTLS- 220 (256)
T ss_pred --cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hcc-----CC-----CCCCC-
Confidence 2234689999999999988999999999999999999999999976443221111 000 00 00010
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........+..++..||+.+|.+||++.+|+++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 011112345556678999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.30 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=201.1
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccC--ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+|.+.+.||+|+||.||++... +++.+|+|.++. .....+.+.+|+.+++.++|+||+++++++...+.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999864 688999999864 2345678889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998865332 357899999999999999999999 8999999999999999999999999999976644322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....|++.|+|||++....++.++|+||||+++|+|++|+.||...........+ ..+....+ .
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~-----~ 221 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-------CQGSYKPL-----P 221 (255)
T ss_pred c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH-------hcCCCCCC-----C
Confidence 1 22357899999999999888999999999999999999999999765432211111 11111111 1
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... ...+..++..||+.+|.+||++.+++..
T Consensus 222 ~~~----~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHY----SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccc----CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 1234556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=334.85 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=172.6
Q ss_pred cCcccceeeeccCceEEEEEEeC---CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.+|.+.+.||+|+||.||++... .++.||||.+.... .+.+|+++|+.++||||++++++|......++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 46899999999999999999753 46789999987542 346799999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+. ++|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 168 ~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 95 5888888433 368999999999999999999999 899999999999999999999999999998665543
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
.........||+.|+|||++....++.++|||||||+||||++|+.||.+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 33333346799999999999988999999999999999999999999976544
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=322.44 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=198.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCC--EEEEEEccC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.+. ++. .+++|.++. .......+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457889999999999999999864 454 457777764 234567889999999999 89999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC
Q 004247 491 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 558 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 558 (766)
||||+++++|.++++.... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975431 12357899999999999999999999 89999999999999999999
Q ss_pred eeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004247 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 559 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 637 (766)
+||+|||++........ .....++..|+|||++....++.++|||||||++|||+| |..||........ ....
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL 236 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHHH
Confidence 99999999864321111 111234678999999988889999999999999999998 9999975443211 1111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. .+. ....... ....+..++..||+.+|++||++.++++.|..
T Consensus 237 ~----~~~-----~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 P----QGY-----RLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred h----cCC-----cCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 000 0000001 11235567778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=330.59 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=206.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l 490 (766)
...|.+.+.||+|.||.||++..+ +|+.+|+|++.+.. .....+.+|+.||+++. |||||.+++.|.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 446778899999999999999976 49999999997643 24568899999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC----CCeeEecccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGL 566 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGl 566 (766)
|||++.||.|.+.|... .+++..+..++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 28999999999999999999999 999999999999999543 4799999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+...... .....++||+.|+|||++....|+..+||||+||++|.|++|..||.+.........+.. +++
T Consensus 186 a~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------~~~ 255 (382)
T KOG0032|consen 186 AKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------GDF 255 (382)
T ss_pred ceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------CCC
Confidence 9988762 233458999999999999999999999999999999999999999988765444332222 221
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+-++ .-.........++..|+..||.+|+|+.++|++
T Consensus 256 -~f~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 111112233345567999999999999999985
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.24 Aligned_cols=236 Identities=28% Similarity=0.350 Sum_probs=186.4
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||+||+|... +|+.||||++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 78999999987532 23345555655 46789999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 99999987543 58899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .+. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-------NKP------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH-------cCC------CCCCCC
Confidence 2234679999999999999899999999999999999999999997654322111111 000 001111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMS 685 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~ 685 (766)
. ...+..++..||+.||.+||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 22344566779999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.55 Aligned_cols=270 Identities=26% Similarity=0.366 Sum_probs=203.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-----CCCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEee--cCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-----~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 488 (766)
..|.+.+.||+|+||.||++... +++.+|||+++.... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999853 468899999986554 47789999999999999999999999977 5678
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997653 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcee-cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........... ....++..|+|||++....++.++||||||+++|||++|+.|+............. .........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL 236 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence 77633222111 12345667999999998899999999999999999999999986532211000000 00000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+...............+..++.+||+.+|.+||++.+|+++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111000000111124566777899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=311.50 Aligned_cols=238 Identities=25% Similarity=0.419 Sum_probs=191.1
Q ss_pred eeeeccCceEEEEEEeCCCC-----------EEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 424 NLIGKGGSSQVYKGCLPDGK-----------ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~-----------~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+.||+|+||.||+|.+.+.. .+++|++.........|.+|+.+++.++||||++++++|.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999975432 57888887655447889999999999999999999999988 7789999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-------CeeEeccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-------EPQLSDFG 565 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-------~vkL~DFG 565 (766)
||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999976532 58899999999999999999998 8999999999999999887 79999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccC--CCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 642 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 642 (766)
++...... ....++..|+|||++... .++.++|||||||++|+|++ |..||.............+.
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~----- 222 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ----- 222 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-----
Confidence 99865431 123577889999999876 78999999999999999999 57788665432221111100
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 643 ~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
. .+ .......+..++..||..+|.+||++.+|++.|.
T Consensus 223 --~--~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 --H--RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --C--CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0001145666778899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=318.95 Aligned_cols=260 Identities=29% Similarity=0.423 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 488 (766)
..|.+.+.||+|+||.||++.. .++..||+|.++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3477889999999999999973 35788999998754 34556899999999999999999999999775 568
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++++|.+++.... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999999986543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCcc---------chhhHHHhhc
Q 004247 569 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK---------GQESLVMWAK 638 (766)
Q Consensus 569 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------~~~~lv~~~~ 638 (766)
.......... .....|+..|+|||++.+..++.++|||||||++|||++++.|+...... .......+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-V 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-H
Confidence 7654332211 12345777899999998888999999999999999999988765321110 00000000 0
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+..+.. ..........+..++..||+.+|.+||++.++++.|+.
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 RVLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 00001100 00111223456778888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=330.87 Aligned_cols=263 Identities=22% Similarity=0.259 Sum_probs=197.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED----- 485 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 485 (766)
...++|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 6889999998753 34456788999999999999999999998643
Q ss_pred -CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 486 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 486 -~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999965 67776642 37888999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc------
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK------ 638 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~------ 638 (766)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 164 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99986544322 223579999999999998899999999999999999999999997654322111110000
Q ss_pred ----------cccc-cCccccccCccc------C--CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 ----------PILS-SGKVTQLLDPAL------G--NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 ----------~~~~-~g~~~~lld~~l------~--~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... ......+..+.. . ..........+..++..||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 000000000000 0 00011112345667788999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=312.77 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=199.5
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCC-------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
+|...+.||+|+||.||+|...+|+.+|||.++.. ......+.+|+++++.++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888999999988642 12345688999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999996543 47899999999999999999998 889999999999999999999999999998653
Q ss_pred CCCCC----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 572 TSSSH----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 572 ~~~~~----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
..... .......|+..|+|||++....++.++|||||||++|+|++|+.||...........+. .. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~---~~~-- 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG--AH---RGL-- 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh--hc---cCC--
Confidence 21111 11123568999999999998889999999999999999999999997543322111110 00 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.+.+... ....+..++..||+.+|.+||++.++++
T Consensus 227 ---~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111 2234456667899999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.07 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=193.6
Q ss_pred eeeeccCceEEEEEEeC-CCC--EEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|.+. ++. .+++|.++.. ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 343 4688988742 34567889999999999 799999999999999999999999999
Q ss_pred CCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 498 GSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 498 gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
|+|.+++..... ....+++..+..++.+++.||+|||+ ++++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 12357899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccC
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
++........ ......+..|+|||++....++.++|||||||++|||++ |..||........... .. .+
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~----~~ 227 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LP----QG 227 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH---Hh----CC
Confidence 9863221111 111234667999999998899999999999999999997 9999965433221111 10 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. ... .......+..++..||+.+|.+||++.++++.|...
T Consensus 228 ~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC-----CCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 000 111123456677889999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.16 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=196.4
Q ss_pred eeeeccCceEEEEEEeCC-------CCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 424 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~-------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+.||+|+||.||+|...+ +..+|||.+.... .....+.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999886543 4567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-----CeeEecccc
Q 004247 495 LSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-----EPQLSDFGL 566 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-----~vkL~DFGl 566 (766)
+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 22457899999999999999999998 8899999999999999877 899999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
++...............++..|+|||++..+.++.++|||||||++|||++ |+.||....... ..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence 986544322222222356788999999999999999999999999999998 999997543221 11111 0110
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.. . ........+..++..||..+|.+||++.+|++.|+
T Consensus 231 ~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL-----Q----KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc-----C----CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 0 01111234566778899999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.08 Aligned_cols=240 Identities=27% Similarity=0.325 Sum_probs=185.7
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhc---CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
||+|+||+||+|... +|+.||||++.... .....+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 68999999986432 2334556677777766 699999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 99999987543 58899999999999999999999 8999999999999999999999999999875433222
Q ss_pred eecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......||+.|+|||++... .++.++|||||||+||+|++|+.||...........+. .+.. .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~------~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA-------FGKV------RFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH-------cCCC------CCCC
Confidence 12346799999999998754 48999999999999999999999997654322111111 1110 0111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCC----CHHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARP----QMSLVLKL 690 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RP----s~~eVL~~ 690 (766)
.... ..+..++..||+.||.+|| ++.+++++
T Consensus 219 ~~~~---~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVLS---DEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccCC---HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1111 2334456779999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.11 Aligned_cols=236 Identities=28% Similarity=0.364 Sum_probs=185.7
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|... +|+.||+|++.... .....+..|.. +++.++||||++++++|...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 68899999987532 23345555654 67889999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|...+.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 99998886542 57888899999999999999999 8999999999999999999999999999875422221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++....++.++|||||||++|||++|+.||...+.......+. ..+ + .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~--------------~--~ 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL-HKP--------------L--Q 214 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh-cCC--------------C--C
Confidence 1233679999999999998899999999999999999999999997654321111110 000 0 0
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMS 685 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~ 685 (766)
.+......+..++..||+.+|.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111123455666789999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.51 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=214.1
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
....+.+.||+|-||.|.++....+..||||.++... ...++|.+||++|.+|+||||+.|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456788999999999999999788999999999754 45689999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.+++...... .+.-.....|+.||+.||+||.+ .++|||||.+.|+|++.++++||+|||+++-+-....
T Consensus 618 EnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999876432 13445556799999999999999 8899999999999999999999999999996665555
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCccchhhHHHhhccccccCc-cccccCc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQESLVMWAKPILSSGK-VTQLLDP 652 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~~~lv~~~~~~~~~g~-~~~lld~ 652 (766)
+......+-...|||||.+..++++.++|||+||++|||+++ ...||.... .+.++.....++..+. -.-+..|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcceeccCC
Confidence 544444556789999999999999999999999999999976 788997543 3334444444443332 2222233
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
..+ ...+.++++.||+++-.+||+++++..+|..+.
T Consensus 770 ~~c-------p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 770 PAC-------PQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CcC-------cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 332 245567788999999999999999999887543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=340.42 Aligned_cols=195 Identities=24% Similarity=0.317 Sum_probs=169.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..+|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|+++|++++|+||+++++++..++..++|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999875 578899996432 34678999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
. ++|..++.... ..++|..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 68988886543 368999999999999999999999 8999999999999999999999999999987654332
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 623 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 623 (766)
........||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 222234679999999999999999999999999999999999887653
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=311.07 Aligned_cols=248 Identities=28% Similarity=0.464 Sum_probs=197.5
Q ss_pred eeeeccCceEEEEEEeCC--C--CEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLPD--G--KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~--g--~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||+|+||.||+|.+.+ + ..||||.+.... ...+.+.+|+.++++++||||+++++++.. ..+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 368999998643 456789999999999999999999999988 889999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.+++..... ..++|..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976542 468999999999999999999999 899999999999999999999999999998775533221
Q ss_pred ee-cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 578 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 578 ~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.. ....++..|+|||++....++.++|||||||++|||++ |+.||...........+. . .+. .+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--~----~~~--~~~~---- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--K----EGE--RLER---- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--h----cCC--cCCC----
Confidence 11 12467889999999998899999999999999999999 999996543322111111 0 000 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.......+..++..||+.+|.+||++.++++.|.
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111234556677899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.44 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=203.1
Q ss_pred cCcccceeeeccCceEEEEEEeC--------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 486 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 486 (766)
.+|.+.+.||+|+||.||++... .+..||+|+++.. ....+.+.+|+.++.++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35888999999999999999742 1236899998753 34567899999999999 7999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
..+++|||+++|+|.+++..... ....++|..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999975421 12358899999999999999999999 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 633 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 633 (766)
.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986654322222222345678999999998899999999999999999998 8899976543221111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
+. .+.... ........+..++..||+.+|.+||++.++++.|....
T Consensus 249 ~~-------~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 249 LK-------EGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HH-------cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 10 110000 01111234556778899999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=329.55 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=197.5
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 485 (766)
..++|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999864 6889999998753 34456788999999999999999999987543
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 77777742 37788999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc-------
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK------- 638 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~------- 638 (766)
+++....... .....||+.|+|||++.+..++.++|||||||+||+|++|+.||...+.......+....
T Consensus 172 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986544322 123578999999999999999999999999999999999999997655432221111000
Q ss_pred ---------------cccccCccccccCcccC---CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 ---------------PILSSGKVTQLLDPALG---NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 ---------------~~~~~g~~~~lld~~l~---~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+....-....++...+. ..........+..++..||+.||.+|||+.++|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000000 00000112345567788999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.58 Aligned_cols=237 Identities=28% Similarity=0.347 Sum_probs=186.7
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++||+|+||.||+|... +|+.||||++... ......+..|.. +++.++||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 7899999998753 233445666665 46779999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99999886543 58899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. . +.+ . +...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~------~-~~~--~----~~~~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL------H-KPL--V----LRPG 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH------c-CCc--c----CCCC
Confidence 1234679999999999999999999999999999999999999997654322111111 0 000 0 1111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSL 686 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~e 686 (766)
. ...+..++..|++.+|.+||++.+
T Consensus 219 ~----~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 A----SLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred C----CHHHHHHHHHHhccCHHhcCCCCC
Confidence 1 123445567799999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.03 Aligned_cols=205 Identities=30% Similarity=0.441 Sum_probs=182.9
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-C-----CceeEEeeEEeecCceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-----KNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~~~~~~lV 491 (766)
+|.++++||+|.||.|.+|.+ ++++.||||+++.......+...|+.||..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 789999999999999999986 46999999999999999999999999999997 4 3899999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC--CCeeEeccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKW 569 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--~~vkL~DFGla~~ 569 (766)
+|.+.. +|+++|+.++- ..|+...++.++.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.+.+
T Consensus 267 fELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999955 99999987765 358899999999999999999999 999999999999999643 4799999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 634 (766)
...... ..+.+..|.|||++.+..|+.+.|+||||||+.||++|.+.|.+++..++...+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 654322 356789999999999999999999999999999999999999988876665444
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=327.51 Aligned_cols=240 Identities=26% Similarity=0.324 Sum_probs=186.7
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||+|+||.||+|... +++.||+|++.... .....+..|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 67889999987532 22334445544 56788999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999997543 47788888999999999999999 8999999999999999999999999999975432221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. . +.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~------~~~------~~~~~ 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-N------KPL------QLKPN 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH-h------CCc------CCCCC
Confidence 1234679999999999999899999999999999999999999997654322111110 0 000 00111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
. ...+..++..||+.+|.+||++.+.+.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 I----TNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1 123445556799999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=344.86 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=205.0
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCC-CEEEEEEccC-ChhHHHHHHHHHHHHHhcC-CCceeEEeeE-Eee---c---
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKP-SEDVIKEFVLEIEIITTLH-HKNIISLLGF-CFE---D--- 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g-~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~-~~~---~--- 485 (766)
...++.++++|.+|||+.||+|.+..+ ..||+|++-. ++...+.+.+||++|++|. |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345678899999999999999998665 9999998753 5677889999999999997 9999999993 321 1
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
-+++|.||||.||.|-+++..... ..|++.++++|+.++++|+.+||... .+|||||||-+||||+.+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 257899999999999999986554 34999999999999999999999844 679999999999999999999999999
Q ss_pred ccccccCCCC-Ccee------cccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004247 566 LAKWASTSSS-HITC------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635 (766)
Q Consensus 566 la~~~~~~~~-~~~~------~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 635 (766)
.|.-...... .... -...-|+.|+|||++. +...++|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 9863322221 1000 0123699999999885 457899999999999999999999999764221
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCCch
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVT 698 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~~~ 698 (766)
.+++....-.....+..++..++..||+.||.+||++-+|++.+......+
T Consensus 265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 111111111112345667777888899999999999999998776544433
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=357.13 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=197.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 488 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 488 (766)
...++|.+.+.||+|+||+||++... ++..+|+|++... ......|..|+.+|..|+|||||+++++|... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999875 5778899998742 34567889999999999999999999998653 568
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC----CCceEeecccCCCeeeCCC--------
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----AQRVIHRDVKSSNILLSDD-------- 556 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~IiHrDLKp~NILL~~~-------- 556 (766)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999764333346899999999999999999999832 1459999999999999642
Q ss_pred ---------CCeeEecccccccccCCCCCceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 004247 557 ---------FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 557 ---------~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 625 (766)
+.+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3489999999986644322 123579999999999864 45889999999999999999999999754
Q ss_pred CccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 626 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 626 ~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
..... ++.-. ..+ +.+..... ...+..++..||+.+|.+||++.++|.
T Consensus 247 ~~~~q--li~~l----k~~-------p~lpi~~~---S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQ--LISEL----KRG-------PDLPIKGK---SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHH--HHHHH----hcC-------CCCCcCCC---CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 33211 11100 000 00100011 123455667899999999999999985
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.11 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.+|.+.+.||+|+||.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.+.|+||++++++|..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788899999999999999986 478899999887543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998642 47889999999999999999999 8999999999999999999999999999876543221
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....|++.|+|||++....++.++|||||||++|+|++|+.||....+... +..+.. .+. +.+.
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~----~~~------~~~~ 237 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT----NGT------PELQ 237 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhc----CCC------CCCC
Confidence 1 1234689999999999988899999999999999999999999976544221 111110 000 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........+..++.+||..+|.+||++.+++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 --NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011112335556678999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=304.45 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=209.5
Q ss_pred HhcCcccceeeeccCceEEEEEE-eCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----e
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-----L 488 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-----~ 488 (766)
..++|.+.+.||+|||+.||++. ..++..||+|.+.... +..+..++|++..++++|||++++++++..+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34679999999999999999998 4678899999987655 778899999999999999999999999865443 8
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||+++|...|+|.+.+...+..+..+++.++++|+.+|++||.+||... .++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999887766678999999999999999999999944 469999999999999999999999999987
Q ss_pred cccCCCCCce-------ecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004247 569 WASTSSSHIT-------CTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 569 ~~~~~~~~~~-------~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 638 (766)
...-...... ...-..|..|.|||.|. +...++++|||||||+||+|+.|..||+..-..+.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence 5543211100 01124688999999986 446789999999999999999999999754332221110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+++ +.-.......+.+.+++.+|++.||.+||++.+++..+..
T Consensus 254 -Av~n~q--------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 254 -AVQNAQ--------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -eeeccc--------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111111 1111111144567778889999999999999999998754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.34 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=189.7
Q ss_pred eeeccCceEEEEEEeCCC---CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCC
Q 004247 425 LIGKGGSSQVYKGCLPDG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 499 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 499 (766)
.||+|+||.||+|...++ ..+++|.++.. ....+.+.+|+.++..++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34667776643 2456789999999999999999999999999999999999999999
Q ss_pred HhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCcee
Q 004247 500 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579 (766)
Q Consensus 500 L~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~ 579 (766)
|.++++........+.+..+..++.||+.||.|||+ .+++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333456777888999999999999999 88999999999999999999999999998643222111112
Q ss_pred cccccccCCCCchhhcc-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 580 TDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 580 ~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||...........+ + .+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------I-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H-hhcccccCC
Confidence 23568899999998753 245789999999999999997 57788654332211111 1 112223344
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
+.+...+. ..+..++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44433322 23333445688 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=325.20 Aligned_cols=203 Identities=24% Similarity=0.303 Sum_probs=175.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 6788999998752 233456788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997543 358899999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCceecccccccCCCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
.... ......||+.|+|||++.. +.++.++|||||||+||||++|+.||.....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 3222 1223579999999999875 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.87 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=199.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 47888899999999999999864 68899999987543 34456888999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++.... .+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999986543 58899999999999999999999 8999999999999999999999999999876543221
Q ss_pred CceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 576 HITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
. .....||+.|+|||++. .+.++.++|||||||++|+|++|..||....+........ .. .. ..+
T Consensus 162 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~-----~~---~~~ 229 (267)
T cd06645 162 K--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KS-----NF---QPP 229 (267)
T ss_pred c--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--cc-----CC---CCC
Confidence 1 12357999999999984 4568899999999999999999999986554322111111 00 00 001
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....... ....+..++..||+.+|++||++.+|+++
T Consensus 230 ~~~~~~~--~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDKMK--WSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccCC--CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1111111 11234556678999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.87 Aligned_cols=253 Identities=23% Similarity=0.428 Sum_probs=201.5
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCC----EEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.+|.+.+.||+|+||.||+|..+ +|. .+|+|.+.... .....+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999864 333 58999887643 455788999999999999999999999987 78899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997643 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.............++..|+|||.+..+.++.++||||||+++|||++ |+.||...........+. .+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~--~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGER--L 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCCC--C
Confidence 54333222222234678999999988899999999999999999999 999997654332221111 1100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
-.+ ......+..++..||..+|..||++.++++.|..
T Consensus 231 ~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 231 PQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001 0111235556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.34 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=202.5
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||+||++... +|+.||+|++... ....+.+.+|++++..++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999864 6889999988643 34567899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++...+ .+++..+..++.+++.||.|||+ .++++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999987543 58999999999999999999996 1479999999999999999999999999987543322
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc-----hhhHHHhhccccccCccccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-----QESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-----~~~lv~~~~~~~~~g~~~~l 649 (766)
. ....|+..|+|||++..+.++.++|||||||++|+|++|+.||....... ...+..+....... .
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---- 229 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P---- 229 (284)
T ss_pred c----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c----
Confidence 1 23578999999999988899999999999999999999999998654321 11111111111110 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.+.+... +....+..++..||+.||.+||++.+++++.
T Consensus 230 -~~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCCch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111111 1223455667789999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.77 Aligned_cols=247 Identities=30% Similarity=0.498 Sum_probs=198.2
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||.||++.. +++.||+|+++... ....+.+|+.++..++||||+++++++..+ ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4588899999999999999875 77889999987543 346788999999999999999999998654 57999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999975432 357899999999999999999999 899999999999999999999999999997643321
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....+..|+|||++..+.++.++|+|||||++|||++ |+.||...........+. .+.. .++ ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---~~~--~~ 220 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYR---MEP--PE 220 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCC---CCC--CC
Confidence 11234678999999998899999999999999999998 999997654432211111 1100 000 01
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.....+..++..||+.+|.+||++.++++.|+.
T Consensus 221 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ----GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112345567778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=325.07 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=194.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++..+ +++.+|+|++... ......+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999875 5788999998642 223445788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997543 358899999999999999999999 8999999999999999999999999999976543
Q ss_pred CCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
.... ......||+.|+|||++. .+.++.++|||||||+||||++|+.||...........+. ......
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------~~~~~~ 227 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKERF 227 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh------CCCccc
Confidence 2221 222357999999999986 3468899999999999999999999997654332221111 000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ +..... ....+..++.. ++|...++..||++.+++++
T Consensus 228 ~~--p~~~~~-~s~~~~~li~~-ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QF--PAQVTD-VSEDAKDLIRR-LICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cC--CCcccc-CCHHHHHHHHH-HccChhhhcCCCCHHHHhCC
Confidence 00 000011 12333333332 23555566668999999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.85 Aligned_cols=238 Identities=24% Similarity=0.420 Sum_probs=186.7
Q ss_pred eeeccCceEEEEEEeC-------------------------CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEE
Q 004247 425 LIGKGGSSQVYKGCLP-------------------------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISL 478 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~-------------------------~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l 478 (766)
.||+|+||.||+|... ....|++|++.... .....|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999742 11358999987643 345678899999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-
Q 004247 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF- 557 (766)
Q Consensus 479 ~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~- 557 (766)
+++|......++||||+++|+|..++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986533 357899999999999999999999 8999999999999997643
Q ss_pred ------CeeEecccccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHH-hCCCCCCCCCccc
Q 004247 558 ------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKG 629 (766)
Q Consensus 558 ------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~ 629 (766)
.+||+|||++...... ....++..|+|||++.. ..++.++|||||||++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999998644321 12357889999998875 56899999999999999995 6999997654332
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
......... .+.. .....+..++..||+.+|.+||++.+|++.|.
T Consensus 230 ~~~~~~~~~--------------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKKH--------------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhcc--------------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 211111000 0000 01124566778899999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.39 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=204.2
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee--
Q 004247 409 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 484 (766)
Q Consensus 409 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~-- 484 (766)
++.++....+.|.+.+.||.|+||.||+|.. .+++.+|+|++.........+..|+.++.++ +|+||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4555556778899999999999999999987 4688999999977666667888999999999 69999999999853
Q ss_pred ----cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 485 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 485 ----~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
.+.++++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4578999999999999999875432 357888899999999999999999 8999999999999999999999
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 635 (766)
|+|||++......... .....|++.|+|||.+. ...++.++|||||||++|||++|+.||....+......+.
T Consensus 162 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 9999998765432211 12357899999999875 3468889999999999999999999997654322211111
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+. ..+.+... .....+..++..||+.||.+||++.+++++
T Consensus 240 ~~------------~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RN------------PPPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hC------------CCCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 10 00111100 111245566778999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.91 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=190.2
Q ss_pred eeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEe-ecCceEEEEeecC
Q 004247 424 NLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 496 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 496 (766)
+.||+|+||.||+|... ++..+|||.+... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998642 345678899999999999999999999876 4556899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++.... ..+.+..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997543 246778888999999999999999 89999999999999999999999999999755432111
Q ss_pred --ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 577 --ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 577 --~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.......+++.|+|||++....++.++|||||||++|||++| ..||....... +.... ..+.. +.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~----~~~~~-----~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL----LQGRR-----LL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----hcCCC-----CC
Confidence 111123567789999999988999999999999999999995 56665433221 11111 01100 00
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. .. .....+..++..||+.+|++||++.+|++.|+.
T Consensus 223 ~-~~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 Q-PE---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred C-CC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0 01 112345667788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.63 Aligned_cols=238 Identities=25% Similarity=0.463 Sum_probs=187.5
Q ss_pred eeeeccCceEEEEEEeCC-------------CCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 424 NLIGKGGSSQVYKGCLPD-------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~-------------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
+.||+|+||.||+|.... ...+++|++.... .....|..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999987643 44567888999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC-------eeEe
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-------PQLS 562 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-------vkL~ 562 (766)
+||||+++|+|..++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999886543 358999999999999999999999 89999999999999987654 8999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhc-cCCCCCchhhHHHHHHHHHHH-hCCCCCCCCCccchhhHHHhhccc
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
|||++...... ....|+..|+|||++. ...++.++|||||||++|||+ +|+.||........... +.
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~--- 223 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--YE--- 223 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--Hh---
Confidence 99998755322 1245889999999987 456899999999999999998 58888865432221111 11
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
+.. .... .....+..++..||+.||.+||++.+|++.|
T Consensus 224 ---~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 ---GQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---cCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0000 1123455677889999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.99 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=200.7
Q ss_pred CcccceeeeccCceEEEEEEeCC--CCEEEEEEccC-----------ChhHHHHHHHHHHHHHh-cCCCceeEEeeEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKP-----------SEDVIKEFVLEIEIITT-LHHKNIISLLGFCFE 484 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~-----------~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 484 (766)
+|.+.+.||+|+||.||+|.... ++.+|+|.+.. ......++.+|+.++.+ ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 68899998753 12345667889988875 799999999999999
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||+|+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886543334568999999999999999999995 157999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|++....... ......|+..|+|||++..+.++.++||||||+++|+|++|+.||...........+ ..+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~-------~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-------VEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH-------hhc
Confidence 9998665433 223357899999999999888999999999999999999999999654322111110 011
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
... +.....+ ...+..++.+||+.||.+||++.+|..+|.
T Consensus 229 ~~~----~~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 1111111 134555667899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.37 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=203.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC------
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~------ 486 (766)
..+++|.+.+.||.|+||.||+|... +++.+++|++.........+.+|+.+++++ .|+||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999974 678999999987666667899999999999 6999999999997654
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987644333568999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
+......... .....|++.|+|||++.. ..++.++|||||||+||+|++|+.||........ +... .
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~ 231 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI----P 231 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh----h
Confidence 8765443222 123568999999998853 3477899999999999999999999975432211 1110 0
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. +.+. ........+..++..||..||.+|||+.+++++
T Consensus 232 -~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -RNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -ccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0100 1111 011123355567778999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.74 Aligned_cols=256 Identities=25% Similarity=0.450 Sum_probs=200.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCC----EEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++|...+.||+|+||.||+|.+. +|. .+|+|.+.... .....+.+|+.++..++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999863 444 57999887543 3345788999999999999999999999754 568
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999987543 358899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||..........++. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~-- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGER-- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC--
Confidence 654333222223456788999999998899999999999999999998 999997643222211111 1110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
...+ . .....+..++..||..+|++||++.++++.|....
T Consensus 230 ~~~~---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 LPQP---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000 0 11234556677899999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.78 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|...+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||++++++|......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 68999999986432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|++++.|..++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888876543 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHh-hccc-------cccC
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKPI-------LSSG 644 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~-~~~~-------~~~g 644 (766)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.........+.. .... +...
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 123468899999999875 4588999999999999999999999986554322211110 0000 0000
Q ss_pred c-cccccCcccCCCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 K-VTQLLDPALGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~-~~~lld~~l~~~~~~-----~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ...+..+........ .....+..++..||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000011111000010 112345667788999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.20 Aligned_cols=199 Identities=26% Similarity=0.432 Sum_probs=162.7
Q ss_pred ceeeeccCceEEEEEEeC---CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEEeecCC
Q 004247 423 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 497 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~g 497 (766)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++||||++++++|.. +...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 467999999999999864 56789999987543 23457789999999999999999999864 4568999999964
Q ss_pred CCHhHhhhcCC-----CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee----CCCCCeeEecccccc
Q 004247 498 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 568 (766)
Q Consensus 498 gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla~ 568 (766)
+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8888775322 122358899999999999999999999 899999999999999 456789999999998
Q ss_pred cccCCCCC-ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 569 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 569 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 112346789999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.26 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=201.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||.|+||.||+|... +++.||+|++... ......+.+|+.+++.++|+||+++++++..+..+++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 6889999998754 34456788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++... .+++..++.++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998743 58899999999999999999999 889999999999999999999999999998776542
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...++......+ ..+ ..+.+
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------~~~-----~~~~~ 218 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------PKN-----NPPSL 218 (274)
T ss_pred cc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-------hhc-----CCCCC
Confidence 21 22357899999999999888999999999999999999999999765432211111 011 11111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... ....+..++..||..+|.+||++.+++++
T Consensus 219 ~~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1110 11234456677999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.45 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=196.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||.|+||.||+|... ++..||||+++.. ....+.+.+|+.++..++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999874 6899999998643 23346788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+. ++|.+++..... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 589888865432 2468999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH--Hhhccc---cc----cC
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV--MWAKPI---LS----SG 644 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv--~~~~~~---~~----~g 644 (766)
. ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||............ .+..+. +. ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 11224678999999988754 5789999999999999999999999765432211100 000000 00 00
Q ss_pred cccccc----CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLL----DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~ll----d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+ ...+... .......+..++..||+.||.+|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0000000 00012234566778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=366.85 Aligned_cols=260 Identities=29% Similarity=0.532 Sum_probs=214.8
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
..|...++||+|+||.||+|.. .+|..||||.++..... ...|++++++++|||||+++++|.+.+..++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 4577788999999999999986 57899999998754322 2346889999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.++++ .++|..+..|+.|++.||+|||..+..+|+||||||+||+++.++.+++. ||.+......
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 999999995 27899999999999999999996555899999999999999999888876 6665433221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
....||+.|+|||++..+.++.++|||||||++|||+||+.||..... ....++.|............++|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 123689999999999999999999999999999999999999954332 2345666766555555666777777754
Q ss_pred C--CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 657 N--YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 657 ~--~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
. ...+++..+..++..||+.+|.+||+|.+|++.|+...
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 3 34566777888999999999999999999999997543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.23 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=199.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E 493 (766)
+|.+.+.||+|++|.||++... +++.+|+|.+... ....+.+.+|++++++++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999864 5788999998643 2445678899999999999999999998764 446799999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|.+++..... ..+++.++..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999975432 358999999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... .....|++.|+|||++....++.++||||||+++|+|++|+.||............ ..+.+. .
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~-------~~~~~~-----~ 221 (257)
T cd08223 156 CDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-------IEGKLP-----P 221 (257)
T ss_pred CCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HhcCCC-----C
Confidence 221 22356899999999999889999999999999999999999999754432211111 011111 1
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+. ......+..++..|++.+|.+||++.+++++
T Consensus 222 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MP----KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred Cc----cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 1122345567778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.06 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=199.6
Q ss_pred cCcccceeeeccCceEEEEEEeCC----CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.+.||+|+||.||+|...+ ...|+||..... ....+.+.+|+.+++.++||||++++++|.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458889999999999999998643 346899988754 3456789999999999999999999999865 567899
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+|||++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997543 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
...... .....+++.|+|||++....++.++||||||+++|||++ |..||......... .+.. .+....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~----~~~~~~-- 228 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIE----NGERLP-- 228 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH----cCCcCC--
Confidence 442221 122345678999999988889999999999999999996 99999765432211 1111 111000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..... ...+..++..|+..+|.+||++.++++.|..
T Consensus 229 ---~~~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 229 ---MPPNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ---CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 1245556678999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.80 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=202.5
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~ 492 (766)
+|.+.+.||.|+||.||++.. .+++.+|+|++... ....+.+.+|+.+++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999986 47889999998643 3455678899999999999999999998864 45689999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC--CCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||+++++|.+++.........+++..++.++.+|+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444457899999999999999999999321 289999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
...... .....|++.|+|||++....++.++|+||||+++|+|++|+.||...... .+.... ..+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KEGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hcCCC----
Confidence 543321 22357899999999999888999999999999999999999999765421 111111 11111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+ .......+..++..|++.+|.+||++.+|+++
T Consensus 228 -~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 11222455666778999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.54 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=199.7
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 413 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 413 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777889999999999999854 67889999887543 456789999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEeccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKW 569 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~ 569 (766)
||||+++++|.+++..... ....++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975421 1122788888999999999999999 89999999999999976 67999999999976
Q ss_pred ccCCCCCceecccccccCCCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
....... .....|++.|+|||++..+. ++.++||||||+++|+|++|+.||....... ...+......
T Consensus 159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~----- 228 (268)
T cd06624 159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK----- 228 (268)
T ss_pred cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----
Confidence 5432221 12246899999999987654 7889999999999999999999996532211 1111111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.+ +......+..++..||+.+|.+||++.+++++
T Consensus 229 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 --IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111 11122345556678999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.02 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=200.5
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+++|.+.++||+|.|+.||++.. .+|+.+|+|+++.. ....+++.+|++|-..|+||||++|.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788889999999999999875 57999999988642 346788899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla~~ 569 (766)
|+|.|++|..-|-.. ..+++..+-.++.||+++|.|.|. ++|||||+||.|+||.. .--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766443 357888899999999999999999 99999999999999953 34589999999998
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
+.... ....++|||+|||||++....|+..+|||+.||+||-||.|+.||.+.+.......++. |.+.
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~-------g~yd-- 230 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA-------GAYD-- 230 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-------cccC--
Confidence 87332 23347899999999999999999999999999999999999999987543322222211 1100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+++.-- ....+..+. ++.+||..||.+|.|+.|.|++
T Consensus 231 ~~~~~w-~~is~~Ak~---LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 YPSPEW-DTVTPEAKS---LIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCCccc-CcCCHHHHH---HHHHHhccChhhhccHHHHhCC
Confidence 011000 011233343 4456999999999999999874
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.10 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=198.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.|.+.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3778899999999999999864 68899999886421 233568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.++||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997543 57889999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCc----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc
Q 004247 568 KWASTSSSHI----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 568 ~~~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
+......... ......|+..|+|||++..+.++.++|||||||++|+|++|+.||....... .. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~-~~~~----- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI-FKIG----- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH-HHHh-----
Confidence 8765321111 1112468899999999998889999999999999999999999997643211 11 1000
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+.+.. .....+..++..||+.+|.+||++.+|+++
T Consensus 226 ----~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 ----ENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----ccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011111111 122344556678999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.48 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=202.9
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|...++||.|+||.||.+.. .+++.+++|.+.. .....+++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999998875 4688999998764 235567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 2468999999999999999999999 889999999999999999999999999998665433
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+. .+......
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~---- 222 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPVV---- 222 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCCCCc----
Confidence 2 1223578999999999988889999999999999999999999997654322111111 11111110
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
......+..++..||+.+|.+||++.++++++
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -----SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123355566789999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.25 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+.|.+.+.||.|+||.||+|... +++.+++|++.... ...+.+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888999999999999999875 58899999987543 55678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|..++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998876443 358999999999999999999999 8999999999999999999999999999875433211
Q ss_pred CceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 576 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
......|++.|+|||++. ...++.++|||||||++|||++|+.||....+... ...+.. ...
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~-----~~~---- 232 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK-----SEP---- 232 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhc-----CCC----
Confidence 122356899999999985 34578899999999999999999999976543211 111111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.... .......+..++..||+.+|++||++.+++++
T Consensus 233 -~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 -PTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -ccCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 11112234556678999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.55 Aligned_cols=246 Identities=28% Similarity=0.434 Sum_probs=199.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.|...+.||+|+||.||+|.+. ++..||+|++... ....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666788999999999999864 6788999998743 345567899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++.. ..+.+..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998853 247899999999999999999999 8999999999999999999999999999986654321
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......|+..|+|||++....++.++|||||||++|||++|+.||....+.... .+ +..+. .+.+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~~~~-----~~~~~ 222 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IPKNS-----PPTLE 222 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hhcCC-----CCCCC
Confidence 112346899999999999888999999999999999999999999754332211 11 00010 11111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+..++..||+.+|.+||++.+|+++
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122345566678999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.08 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=203.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||.|+||.||+|... +++.+++|++.... ...+.+.+|+++++.++||||+++++++...+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999864 57889999987543 45678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999987542 358899999999999999999999 8999999999999999999999999999976554221
Q ss_pred CceecccccccCCCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
......|+..|+|||++... .++.++||||||+++|+|++|+.||....+....... ....+ ..+
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~~~~--------~~~ 224 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SKSNF--------PPP 224 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccC--------CCc
Confidence 11235689999999999876 8899999999999999999999999765433222111 11000 001
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+. ........+..++.+||..+|.+||++.+|+.+
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111 111223446677788999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=326.41 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=194.6
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec------
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 485 (766)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456899999999999999999986 468899999987532 3345678899999999999999999988543
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
...+++|+++ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCc
Confidence 4578999988 7799888753 248899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc----
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI---- 640 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~---- 640 (766)
+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.-....
T Consensus 164 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998654321 23578999999999876 46899999999999999999999999765432211111000000
Q ss_pred ----cccCccccccCcccCCCCCh-------HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 ----LSSGKVTQLLDPALGNNYDY-------DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ----~~~g~~~~lld~~l~~~~~~-------~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+........+. .+...... .....+..++..||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 00000000 001234566778999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.44 Aligned_cols=199 Identities=23% Similarity=0.332 Sum_probs=166.3
Q ss_pred cceeeecc--CceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 422 AENLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 422 ~~~~LG~G--~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+.++||+| +|++||++.. .+|+.||||++... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999986 47899999999753 244567778999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999965432 358899999999999999999999 8999999999999999999999999987543321111
Q ss_pred Cc-----eecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 004247 576 HI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 576 ~~-----~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 625 (766)
.. ......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 00 0112357788999999976 35899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.79 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=197.0
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
|.+.+.||+|+||.||+|... ++..+++|.+... ....+.+.+|+++++.++||||++++++|..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999875 5778899998753 35567889999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|..++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99999886532 368999999999999999999999 8999999999999999999999999999876543221
Q ss_pred eecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 578 TCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
......||+.|+|||++. ...++.++|||||||++|||++|+.||....+....... .. +....+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~-----~~~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK-----SEPPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--hh-----cCCCCCCCc
Confidence 122356899999999984 345788999999999999999999999765432211111 10 000011111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+ . ..+..++..||+.+|.+||++.+++++
T Consensus 232 ---~~~-~---~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ---SRW-S---SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---ccc-C---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 1 234556678999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.79 Aligned_cols=259 Identities=27% Similarity=0.384 Sum_probs=203.2
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~ 492 (766)
++|...+.||.|++|.||++... +++.+|+|++.... .....+.+|+++++.++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 68899999987543 4567899999999999999999999998653 4689999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.........+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876543334568899999999999999999999 8999999999999999999999999999875543
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc--cchhhHHHhhccccccCcccccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
... ....++..|+|||.+....++.++|||||||++|+|++|+.||..... .....+..+.... ....+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc
Confidence 221 124678899999999988999999999999999999999999976532 1111222221110 000110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+ ... ........+..++..||+.+|.+|||+.+++++
T Consensus 230 ~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 D-EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred c-CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 000 011223456677788999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.69 Aligned_cols=198 Identities=27% Similarity=0.433 Sum_probs=161.9
Q ss_pred ceeeeccCceEEEEEEeC---CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEEeecCC
Q 004247 423 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 497 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~g 497 (766)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+|+.+++.++||||++++++|.. +...++||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 367999999999999864 45789999987543 23467889999999999999999999854 4678999999865
Q ss_pred CCHhHhhhcCC-----CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee----CCCCCeeEecccccc
Q 004247 498 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 568 (766)
Q Consensus 498 gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla~ 568 (766)
+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7877764321 122458899999999999999999999 899999999999999 566789999999998
Q ss_pred cccCCCCC-ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 004247 569 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 569 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 625 (766)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 112235789999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.37 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=202.5
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
++|.+...||+|+||.||+|..+ +.+.+++|.+.... .....+.+|++++++++|+||++++++|.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999853 34679999987543 24678999999999999999999999999989999
Q ss_pred EEEeecCCCCHhHhhhcCCCC-----CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 490 LVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999755421 1258999999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
|+++....... .......++..|+|||.+..+.++.++||||||+++|+|++ |..||....... .+.... .
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~----~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ----A 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH----c
Confidence 99875433221 12223457788999999988889999999999999999999 888986543221 111111 1
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
+.+... . .......+..++..||+.+|.+||++.++++.|.
T Consensus 234 ~~~~~~----~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP----V----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000 0 0111235666778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.93 Aligned_cols=264 Identities=26% Similarity=0.354 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++..++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 58999999986432 245678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|..+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999998876543 248999999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHh-hccccccC-------
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKPILSSG------- 644 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~-~~~~~~~g------- 644 (766)
... .....|+..|+|||++.. ..++.++||||||+++|||++|+.||..........-+.. ........
T Consensus 154 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 321 223568999999999875 3578899999999999999999999976543221111111 00000000
Q ss_pred c-cccccCcccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 K-VTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~-~~~lld~~l~~~~-----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ......+...... .......+..++..||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000000 01112446667788999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=349.38 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=198.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 6899999998743 234568999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 493 DFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
||++||+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 12345678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----------------CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 566 LAKWASTSSS----------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 566 la~~~~~~~~----------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 011123579999999999999999999999999999999999999997643221
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHhh
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLR 692 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-~~eVL~~L~ 692 (766)
.. +.......... .+ ..+....+..++..|++.||.+||+ +.++++.|+
T Consensus 239 i~----~~~~i~~P~~~----~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 IS----YRDVILSPIEV----AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred hh----hhhhccChhhc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 11000000000 00 0011123445667899999999976 566666554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=305.38 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=204.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||.|+||+||+|... ++..+++|++.... .....+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999864 67899999986532 3567899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975432 1358899999999999999999998 899999999999999999999999999998765543
Q ss_pred CCc--eecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 575 SHI--TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 575 ~~~--~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||........ ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~----------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN----------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC----------CC
Confidence 221 11235689999999999877 789999999999999999999999976543221 1111110 00
Q ss_pred cccCCCCC-hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYD-YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~-~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+..... ......+..++..||+.+|.+||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111100 1122345566678999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.73 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=196.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||.|+||.||+|... +++.||||.+.... .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 68899999986532 2234577899999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+.+ +|.+++.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 9999887543 257899999999999999999999 899999999999999999999999999987543221
Q ss_pred CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc-hhhHHHhhccccccCcccc----
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSGKVTQ---- 648 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g~~~~---- 648 (766)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....... +...+...........+..
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1122357889999999875 458899999999999999999999997554211 1111100000000000000
Q ss_pred ----------ccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 ----------LLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 ----------lld~~l~~~~-~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+.... .......+..++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 01112445567788999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.11 Aligned_cols=250 Identities=31% Similarity=0.514 Sum_probs=199.7
Q ss_pred cccceeeeccCceEEEEEEeCC-----CCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 420 FLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
|.+.+.||.|+||.||++...+ +..||+|+++.... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 47899999986543 5778999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999976432 128999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
...... ....+++.|+|||.+....++.++||||||+++|+|++ |+.||...........+. .+....
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~--- 224 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-------KGYRLP--- 224 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCCCCC---
Confidence 422211 12347889999999988889999999999999999999 888887643222111111 111000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.... ....+..++..|+..+|.+|||+.++++.|
T Consensus 225 --~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPEN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011 123455566789999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.03 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=194.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 488 (766)
.+|...+.||+|+||.||+|... +++.|++|++... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999864 6889999988642 2345678899999999999999999999875 3568
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
+++|||+++++|.+++.... .+++.....++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997543 47889999999999999999998 889999999999999999999999999997
Q ss_pred cccCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........ .......|+..|+|||++....++.++|||||||++|||++|+.||........... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~------~~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK------IATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH------HhcCC---
Confidence 65432111 111224689999999999988899999999999999999999999975432211110 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.+.... .+. +..+ +.||..+|.+||++.+|+++
T Consensus 226 --~~~~~~~~~-~~~---~~~l-i~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 --TNPQLPSHI-SEH---ARDF-LGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --CCCCCchhc-CHH---HHHH-HHHhcCChhhCcCHHHHhcC
Confidence 011111111 112 2222 36888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.06 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=198.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-----------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 486 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-----------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 486 (766)
+|...+.||.|+||.||+|... +|+.+|||.++... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999864 68899999875311 12356788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 258899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
++...............|+..|+|||++.... ++.++|+||||+++|+|++|..||........ +.... . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~----~-~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG----N-K 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh----c-c
Confidence 98654432222223356899999999988654 88999999999999999999999964332211 11100 0 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+.+..... ....+..++..||+.+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSMN----LSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCcccccc----CCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111111111 12344455678999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.39 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=199.1
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
+|...+.||+|+||.||+|... +++.|++|.+... ....+.+.+|+.+++.++|+||+++++++..+..+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 7899999988643 23567899999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997542 47899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCCceecccccccCCCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
... ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||....... ....+.. .....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~----~~~~~--- 221 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIGR----SKELP--- 221 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHHh----cccCC---
Confidence 433 112356899999999998776 8999999999999999999999997654211 1111111 00000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. .....+..++..||+.+|.+||++.+++++
T Consensus 222 --~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 --PIPD----HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CcCC----CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111 112334456678999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=312.05 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||.||++... +|+.||+|.++.. ......+.+|++++.+++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 7899999988653 34457899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|..++.... ....+++..+..++.+++.||.|||+ ..+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999887532 12368999999999999999999996 1589999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCchhhccC------CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
. ....|++.|+|||++... .++.++|||||||++|+|++|+.||............. . ...+..
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~-~~~~~~-- 227 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---A-IVDGDP-- 227 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---H-HhhcCC--
Confidence 2 224688999999998544 35889999999999999999999997543322111100 0 001110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+ .......+..++..||+.+|.+||++.+++.+
T Consensus 228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 ---PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 11122344556678999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.42 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=201.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.|...+.||.|+||.||+|... ++..||||++... ......+.+|+.+++.+.||||++++++|.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999864 6889999998743 345678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998642 47888999999999999999999 8999999999999999999999999999976644322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....++..|+|||++.+..++.++|+|||||++|||++|..||....+......+ ..+. .
T Consensus 157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~~---------~ 218 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNN---------P 218 (277)
T ss_pred c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcCC---------C
Confidence 1 12246889999999999888999999999999999999999999765433211111 0000 0
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..........+..++..||+.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122233456667788999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=306.86 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=200.7
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
+|...+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 578999999986422 245788999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEeccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 569 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~ 569 (766)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997543 57899999999999999999999 8999999999999998775 599999999987
Q ss_pred ccCCCCC--ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 570 ASTSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 570 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
....... .......||..|+|||++....++.++||||||+++|+|++|+.||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----- 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----
Confidence 6543211 111235689999999999888899999999999999999999999975443322222111100000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ ..+......+..++..||+.+|.+||++.+++++
T Consensus 229 ---~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 ---AP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---CC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01 1111222345567778999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=314.16 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788999999999999999986 478999999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++... .+++..+..++.+++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998642 47889999999999999999999 8999999999999999999999999999876543322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....|++.|+|||++....++.++|||||||++|+|++|..||....+...... ....+ ...+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~~~~---- 237 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPELQN---- 237 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCCCCC----
Confidence 1 1234689999999999988899999999999999999999999976543221110 00000 000000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.+|.+||++.+++++
T Consensus 238 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 ---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111234456678999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.25 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=194.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHH-HHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||++... +|+.||||+++... .....+..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999875 69999999987542 334566667765 666789999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|++ |+|.+++.........+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 68988886543334578999999999999999999998 5 899999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCchhhcc----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
... .....|+..|+|||++.. ..++.++|+|||||++|+|++|+.||...... ...+..... +.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~-----~~--- 224 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVE-----EP--- 224 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHh-----cC---
Confidence 222 122468999999998864 45688999999999999999999999643221 111111000 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.+... .....+..++..||..+|.+||++.+++++
T Consensus 225 --~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 --SPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111100 011335556678999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.48 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=198.3
Q ss_pred cccceeeeccCceEEEEEEeC----CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 420 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
|.+.++||+|+||.||+|.+. +++.+|||++... ....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 4688999998753 345677899999999999999999999886532
Q ss_pred ceEEEEeecCCCCHhHhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
..+++++|+.+|+|.+++.... .....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875332 222357889999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |+.||....... +..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cC
Confidence 99986644332222223446678999999998889999999999999999999 889987554321 111111 00
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... . ........+..++..||+.+|.+||++.++++.|+.
T Consensus 232 ~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 0 011122456777788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.22 Aligned_cols=266 Identities=25% Similarity=0.439 Sum_probs=220.3
Q ss_pred ccCHHHHHHHhcCc---------ccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC
Q 004247 407 LFNYQDLLSATSNF---------LAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLH 471 (766)
Q Consensus 407 ~f~~~el~~~t~~f---------~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~ 471 (766)
.++|++-..+...| .++++||.|.||.||+|.++ ....||||.|+.. +....+|+.|..||.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 45555544444433 47799999999999999975 2356999999963 567789999999999999
Q ss_pred CCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCe
Q 004247 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 551 (766)
Q Consensus 472 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 551 (766)
||||++|.|+.......+||.|||++|+|+.+|+.+.. .|.+.+..-++.+|+.|+.||-+ +++|||||...||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence 99999999999999999999999999999999987653 59999999999999999999999 9999999999999
Q ss_pred eeCCCCCeeEecccccccccCCCCCceeccccc--ccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCcc
Q 004247 552 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 628 (766)
Q Consensus 552 LL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~ 628 (766)
|++.+...|++||||++.+.++... .++..-| ...|.|||.+.+.+++.++|||||||+|||.++ |.+||.+....
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred eeccceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 9999999999999999988765522 2222223 468999999999999999999999999999998 99999887655
Q ss_pred chhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 629 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 629 ~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
+....++..- + | ..+.+....+.++++.||++|-.+||.+.+|+..|.+..
T Consensus 842 dVIkaIe~gy------R--------L--PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 842 DVIKAIEQGY------R--------L--PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHhcc------C--------C--CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 4443333111 1 1 123445567888999999999999999999999987543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.04 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.+|...+.||.|+||.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++||||++++++|...+.+++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3688999999999999999985 578999999886533 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|..++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988642 47899999999999999999999 8999999999999999999999999999876544322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....|++.|+|||.+....++.++|||||||++|+|++|+.||....+......+. .. ....+..+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~~------~~~~~~~~--- 238 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TN------GTPELQNP--- 238 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hc------CCcccCCc---
Confidence 1 123468999999999998889999999999999999999999997755432221111 00 00000000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... ...+..++..||..+|.+||++.+++++
T Consensus 239 ~~~----~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKL----SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccC----CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011 1234455678999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.57 Aligned_cols=265 Identities=27% Similarity=0.382 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.++|+||++++++|..++.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 6889999998753 2345788999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|++++.|..++... ..+++..+..++.+|+.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 348899999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc-ccc--------cc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PIL--------SS 643 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-~~~--------~~ 643 (766)
... ......++..|+|||++... .++.++||||||+++|+|++|+.||................ ... ..
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 321 22335789999999999888 88999999999999999999999997654322111111100 000 00
Q ss_pred Ccc-----ccccCcc-cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKV-----TQLLDPA-LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~-----~~lld~~-l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.. ....++. +...+.......+..++..||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0000000 0000111113456677788999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.48 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=200.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||.|+||.||++... ++..+|+|++.... ...+.+.+|+++++.++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356889999999999999999874 68899999987543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999987543 358999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.. .....||+.|+|||++. ...++.++||||||+++|+|++|+.||........ +..+.. +....+
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~~~~~~ 228 (280)
T cd06611 158 QK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK-----SEPPTL 228 (280)
T ss_pred cc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc-----CCCCCc
Confidence 21 12356899999999985 33477899999999999999999999976543221 111111 110000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+ ..+ ...+..++..||+.+|.+||++.+++++
T Consensus 229 ~~~---~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQP---SKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc---ccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 011 1234455667999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.31 Aligned_cols=238 Identities=22% Similarity=0.382 Sum_probs=187.3
Q ss_pred eeeeccCceEEEEEEeCC--------CCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 424 NLIGKGGSSQVYKGCLPD--------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+.||+|+||.||+|.... ...+++|.+.... ...+.+..|+.+++.+.||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997532 2348888886543 4456788999999999999999999999998999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC--------eeEecccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------PQLSDFGL 566 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--------vkL~DFGl 566 (766)
+++|+|.++++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997654 258899999999999999999999 89999999999999987765 59999998
Q ss_pred cccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCC-CCCCCCCccchhhHHHhhccccccC
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
+...... ....+++.|+|||++... .++.++|||||||++|||++|. .||....+........ . ..
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~-----~~ 222 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-D-----RH 222 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-c-----cc
Confidence 8654321 224688999999999864 5899999999999999999984 6665433322111110 0 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
. .+......+..++..||+.+|++|||+.++++.|
T Consensus 223 ~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 Q------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred c------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 1111123456677789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=309.33 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=201.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||.|+||.||+|... +|+.||||++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 7899999998753 23456889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 368999999999999999999999 899999999999999999999999999998665433
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc---------C
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS---------G 644 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~---------g 644 (766)
. .......|+..|+|||++... .++.++||||||+++|||++|.+||...........+.-....... .
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 2 112235689999999998654 4689999999999999999998888665432211111000000000 0
Q ss_pred ccccccCcccC----CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~----~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+..+... .....+....+..++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00001122566677788999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.89 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=193.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 488 (766)
.+|.+.+.||+|+||.||+|... +|+.||||.+... ....+.+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999864 6899999987532 23456788999999999999999999998763 467
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 47888899999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||............ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI------ATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH------hcCC---
Confidence 65432111 1122356899999999998888999999999999999999999999754322111100 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.+ +......+..++..|+ .+|.+||++++|+++
T Consensus 226 --~~~~~----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --TNPVL----PPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred --CCCCC----chhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 01111 1122233444445677 489999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.98 Aligned_cols=253 Identities=26% Similarity=0.331 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|...+.||+|+||.||+|... +++.||+|.+.... ...+.+..|++++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 58999999997542 35567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875422 468999999999999999999999 8999999999999999999999999999875533
Q ss_pred CCCCc---------------------------eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 004247 573 SSSHI---------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 573 ~~~~~---------------------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 625 (766)
..... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21110 111246899999999999888999999999999999999999999765
Q ss_pred CccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC----HHHHHHH
Q 004247 626 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ----MSLVLKL 690 (766)
Q Consensus 626 ~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs----~~eVL~~ 690 (766)
........+. .. .............+..++..||..+|.+||+ +.+++.+
T Consensus 236 ~~~~~~~~~~-~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDETFSNIL-KK--------------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHHHHHHHh-cC--------------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 4322111100 00 0000001112345566677899999999999 6666663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.14 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|+||.||++... +|+.||+|.+... ....+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999864 6889999998642 34556889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+.+..... ..+++..++.++.|++.||.|||+ ++++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999875432 357899999999999999999999 899999999999999999999999999997654432
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....|++.|+|||++.++.++.++|+|||||++|+|++|+.||...........+. .+.... .
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~-----~ 221 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-------RGSYPP-----V 221 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-------cCCCCC-----C
Confidence 21 123468999999999998899999999999999999999999997644322111111 111100 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.+|.+||++.+|+++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11112345556678999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.57 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=199.5
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|...+.||+|+||.||++... +++.+|||.+... ....+.+.+|+++++.++||||+++++.+..++.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 6888999998643 34567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~~~~ 573 (766)
+++++|.+++..... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999976432 358899999999999999999999 899999999999999855 45899999999876543
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... ....|+..|+|||.+....++.++||||||+++|+|++|+.||........ ..... .+....+.
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~----~~~~~~~~--- 222 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIM----SGTFAPIS--- 222 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHH----hcCCCCCC---
Confidence 221 225689999999999988899999999999999999999999976543221 11110 01111111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .....+..++..||+.+|.+|||+.+++.+
T Consensus 223 --~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 --D----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --C----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 112234556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=333.86 Aligned_cols=203 Identities=21% Similarity=0.249 Sum_probs=161.9
Q ss_pred HhcCcccceeeeccCceEEEEEEeCC--CCEEE------------------EEEccCChhHHHHHHHHHHHHHhcCCCce
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPD--GKELA------------------VKILKPSEDVIKEFVLEIEIITTLHHKNI 475 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~--g~~vA------------------VK~l~~~~~~~~~~~~Ei~iL~~l~HpnI 475 (766)
..++|.+.+.||+|+||+||++.... +...+ .|.+.........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999986432 21122 22222233455678899999999999999
Q ss_pred eEEeeEEeecCceEEEEeecCCCCHhHhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 476 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
+++++++...+..|+|++++. ++|.+++..... .........+..|+.||+.||.|||+ ++||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999995 577777654321 11223456677899999999999999 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCC-CCC
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK-PIS 623 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~-Pf~ 623 (766)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||+||||++|.. |+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999998765432221 123579999999999999999999999999999999999875 444
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.69 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=198.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +++.|++|.+.... .....+.+|+++++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999875 57899999987542 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++|++|.+++.... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 58899999999999999999999 8999999999999999999999999999874221
Q ss_pred CCCC-------------ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 573 SSSH-------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 573 ~~~~-------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
.... .......|+..|+|||++....++.++|||||||++|||++|..||.+............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 1100 011124678899999999988999999999999999999999999976543221111100
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+. ...+.... .....+..++..||+.+|.+||++.++++.|..
T Consensus 231 ----~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 ----DD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----cc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00111111 111234556678999999999997666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=310.07 Aligned_cols=267 Identities=20% Similarity=0.241 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCc-----
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN----- 487 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~----- 487 (766)
++|.+.+.||+|+||.||+|... +|+.||||.++... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999864 68999999886532 23467888999999995 6999999999987665
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEeccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 565 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFG 565 (766)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888654332 3468999999999999999999999 89999999999999998 8899999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
++......... .....+++.|+|||++.. ..++.++||||||+++|+|++|..||...........+..........
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99865432221 122357889999998865 457899999999999999999999997654322111100000000000
Q ss_pred ccc---cccC----cccCC----CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVT---QLLD----PALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~---~lld----~~l~~----~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+. .+.+ +.... .........+..++..||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000 00000 0001122345567788999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.21 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=198.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
+|.+.+.||+|+||.||+|... +|+.||||.++... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999864 68999999997542 2345677899999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+ +|+|.+++.... ..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997543 258999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC------
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 644 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 644 (766)
...... ....+++.|+|||++.. ..++.++|||||||++|||++|..||...........+.-........
T Consensus 154 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 432221 22357889999999864 457899999999999999999988887654322111110000000000
Q ss_pred ccccccCcccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~-----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.............. .......+..++..||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11123456677788999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=309.82 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=194.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|+||.||+|... +|+.+|+|.++... .....+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999874 68999999986432 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+.+ +|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 8888776432 358999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccch-hhHHHhhccccccC---ccccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSG---KVTQL 649 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g---~~~~l 649 (766)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...+.......... .+..+
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 21 1234678999999998764 478999999999999999999988644332111 11000000000000 00000
Q ss_pred cCc----ccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDP----ALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~----~l~~~~-----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+. ...... .......+..++..||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000000 01112344566778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.90 Aligned_cols=243 Identities=27% Similarity=0.399 Sum_probs=198.1
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
|.-.+.||.|.||-||.|.+. +...||||.+..+ .....+++.|+..|.+++|||++.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 445577999999999999864 6778999999753 35678899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
|-| +-.++|.-.+ .++-+.++..|+.+.+.||.|||+ ++.||||||..||||++.|.+||+|||.|-......
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 955 7777775443 468889999999999999999999 889999999999999999999999999997665432
Q ss_pred CCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 575 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.++|||.|||||++. .|.|+-|+||||||+++.||.-.++|+...+......-+ + +--.
T Consensus 181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--A----------QNes 242 (948)
T KOG0577|consen 181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A----------QNES 242 (948)
T ss_pred ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--H----------hcCC
Confidence 378999999999985 678999999999999999999999998766543221111 1 1111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
|.|. ..+....+..++-.||++-|.+|||..+++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2232 22334445556667999999999999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.47 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=199.5
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|++++++++||||+++++++..++.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999865 68999999987532 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
. .....|++.|+|||.+....++.++||||||+++|+|++|+.||...........+ ..+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~------ 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-------LEGKV------ 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCc------
Confidence 3 12357899999999998888999999999999999999999999765421111110 01110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.+.... ...+..++..||..+|.+|| ++.+++++
T Consensus 216 ~~~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 23444566789999999999 77777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=307.57 Aligned_cols=207 Identities=29% Similarity=0.383 Sum_probs=182.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|...++||+|.||.|.++..+ +|+.||||++++. ++.+..-+.|-++|...+||.+..|.-.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56788899999999999999864 7999999999874 355566778999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+.||.|.-+|...+ .|++...+.+..+|+.||.|||+ ++||+||||.+|+|||.+|++||+||||++..-.
T Consensus 248 eyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999997654 58899999999999999999999 8999999999999999999999999999985433
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 633 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 633 (766)
.. .+..++||||.|+|||++....|+..+|+|.+||++|||++|+.||...+....-.+
T Consensus 321 ~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 321 YG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred cc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 22 234568999999999999999999999999999999999999999987654433333
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.40 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=204.2
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 492 (766)
...|.+++.||.||.+.||++...+.+.||+|.+.. +.....-|.+|+.+|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 346888999999999999999987888888887653 4567788999999999996 899999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||= ..+|..+|...... ...| .++.+..||+.|+.++|+ +||||-||||.|+|+-. |.+||+|||+|..+..
T Consensus 440 E~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 986 44999999876542 3345 677899999999999999 99999999999999965 5899999999999888
Q ss_pred CCCCceecccccccCCCCchhhccC-----------CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
+.+......-+||+.||+||.+... +.+.++|||||||+||+|+.|+.||.... . .|+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~a---- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIA---- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHH----
Confidence 8777776678999999999998643 35679999999999999999999996421 1 122
Q ss_pred ccCccccccCcccCCCCCh-HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~-~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
++..+.||.-.-+|+. ..-..++.++..||.+||.+||+..++|++
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2344555533222221 111116777788999999999999999984
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.40 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=204.6
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~ 492 (766)
+|...+.||+|++|.||+|... +++.+++|++.... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 78999999987654 4577899999999999999999999999988 8899999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997543 68999999999999999999999 8999999999999999999999999999987766
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
...........++..|+|||++....++.++||||||+++|+|++|+.||..... ... ..+.. ...+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~-~~~~~--~~~~~~~~---- 224 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMA-ALYKI--GSSGEPPE---- 224 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHH-HHHhc--cccCCCcC----
Confidence 5432112335789999999999988899999999999999999999999976541 111 11111 10011111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........+..++..|++.+|.+||++.+++++
T Consensus 225 -----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 -----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111113455666778999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.24 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=198.4
Q ss_pred cccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 420 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
|...+.||.|+||.||+|.. .+++.+|||++... ......+.+|+.++..++||||++++++|..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66788999999999999986 46889999998643 2445678899999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999998642 47899999999999999999999 8999999999999999999999999999876644221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......|+..|+|||++....++.++|+|||||++|+|++|..||...........+ ..+.. +.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-----~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------PKNNP-----PTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-------hcCCC-----CCCCc
Confidence 112346899999999999888999999999999999999999999754332111111 01110 11111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ....+..++..||+.+|.+||++.+++++
T Consensus 224 ~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 N----YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c----cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 12334556678999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.59 Aligned_cols=266 Identities=21% Similarity=0.325 Sum_probs=196.0
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999864 68899999986532 33346788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+. ++|.+.+.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 67777765432 347788899999999999999999 8999999999999999999999999999975433
Q ss_pred CCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc-cccC------
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-LSSG------ 644 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~-~~~g------ 644 (766)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.............|.... ....
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 2211 1234679999999998754 5788999999999999999999999765432211111111000 0000
Q ss_pred cc----ccccCcccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KV----TQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~----~~lld~~l~~~~-----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ ............ .......+..++..|+..||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 000000000000 00112334456678999999999999998853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.69 Aligned_cols=249 Identities=31% Similarity=0.468 Sum_probs=203.3
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+|...+.||+|++|.||++... +++.+++|++.... ...+.+.+|+++++.++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 68899999998654 366789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ..+++..+..++.+++.||.|||. .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987653 368999999999999999999999 8999999999999999999999999999987655432
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....|+..|+|||++....++.++||||||+++|+|++|+.||............. . .....+.++
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~~~~~---- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T-----NGPPGLRNP---- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h-----cCCCCcCcc----
Confidence 223578999999999998889999999999999999999999997653322111111 0 011111111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. ....+..++..||+.+|.+|||+.+++++
T Consensus 221 -~~--~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -EK--WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cc--cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 12345556678999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.11 Aligned_cols=205 Identities=27% Similarity=0.419 Sum_probs=171.5
Q ss_pred CcccceeeeccCceEEEEEEeC---CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 489 (766)
.|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.++..++||||++++++|... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778899999999999999974 4789999999863 23346778899999999999999999999988 7899
Q ss_pred EEEeecCCCCHhHhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC----CCCeeEecc
Q 004247 490 LVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 564 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~----~~~vkL~DF 564 (766)
+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776533322 2368899999999999999999999 89999999999999999 899999999
Q ss_pred cccccccCCCC-CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 565 GLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 565 Gla~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
|++........ ........+|+.|+|||++.+. .++.++|||||||+||+|++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987654322 1122335789999999988764 588999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.91 Aligned_cols=246 Identities=26% Similarity=0.441 Sum_probs=198.1
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.|...+.||.|+||.||+|.. .+++.||+|.++.. .....++.+|+.+++.++ |||+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 57899999998653 345667889999999997 999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++... .+++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998643 58899999999999999999999 8999999999999999999999999999987655
Q ss_pred CCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .....|+..|+|||++..+ .++.++|+|||||++|+|++|+.||......... .+. ... ..
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~----~~~-----~~ 219 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLI----PKS-----KP 219 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hcc----ccC-----CC
Confidence 4322 2235789999999998755 4688999999999999999999999765332111 110 000 11
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+.+.... ....+..++..||+.+|.+||++.++++
T Consensus 220 ~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111111 2234556667899999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.89 Aligned_cols=244 Identities=26% Similarity=0.400 Sum_probs=194.3
Q ss_pred ceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 423 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
...||+|+||.||++... ++..||||.+.... ...+.+.+|+.++..++|+||+++++.|..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456899999999999864 68899999986533 4556788999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++... .+++..+..++.+|+.||.|||+ ++|+||||||+||+++.++.++|+|||++......... ..
T Consensus 107 ~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~ 176 (292)
T cd06658 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RK 176 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cc
Confidence 9988532 47899999999999999999999 89999999999999999999999999998765433221 12
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...|++.|+|||++....++.++||||||+++|||++|+.||...........+. ..+.+.+.....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~- 243 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR------------DNLPPRVKDSHK- 243 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hcCCCccccccc-
Confidence 3568999999999988889999999999999999999999997654322111110 011111111111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 661 DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+..++..||..+|.+|||+.+++++
T Consensus 244 -~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 -VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233445567999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.33 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=199.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV 491 (766)
++|.+.+.||.|+||.||+|... +++.+++|.++... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 68899999997532 2334677899999999999999999999877 889999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 9999887543 268999999999999999999999 889999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH----------hhc--
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAK-- 638 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~----------~~~-- 638 (766)
.... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+. |..
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4322 12234678999999998754 46889999999999999999999997654322111110 100
Q ss_pred --cccccCccccccCcccCCCCChH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 --PILSSGKVTQLLDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 --~~~~~g~~~~lld~~l~~~~~~~-~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..............+...+... ....+..++..||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000011111111111111111 13345556678999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.57 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=201.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
+|.+.+.||.|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 68999999997532 456789999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+.+++|.+++... ..+++..+..++.++++||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999754 358899999999999999999999 88999999999999999999999999998866543
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. .....|+..|+|||++....++.++|+||||+++|+|++|+.||................. .. +.
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--------~~ 220 (258)
T cd05578 154 TL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--AD--------VL 220 (258)
T ss_pred cc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--cc--------cc
Confidence 21 1235689999999999988899999999999999999999999987654322222111100 00 00
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCH--HHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQM--SLVLK 689 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~--~eVL~ 689 (766)
.+......+..++..||+.+|.+||++ .++++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 221 ----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 111112455566678999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=314.47 Aligned_cols=246 Identities=20% Similarity=0.334 Sum_probs=204.7
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
+-|.+++.||+|.|+.|-+|.+ -+|..||||++.+.+ -....+.+|++.|+.++|||||+||++......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999875 489999999997653 345688999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccccccC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 572 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~ 572 (766)
+=++|+|+++|.+.. ..+.+..+.+++.||+.|+.|+|+ ..+|||||||+||.+.+ -|-+||+|||++..+..
T Consensus 98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999997654 468999999999999999999999 88999999999998854 57899999999976655
Q ss_pred CCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
+.. .++.||.+.|-|||++.+..|+ +++||||||||||.|++|+.||+..+..+....+| |
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm---------------D 233 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM---------------D 233 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------c
Confidence 433 2347999999999999998887 58999999999999999999998765543333322 2
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
-.. ..+......+-.++..||.+||.+|-+.++|..
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 111 112333455666777899999999999999875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=327.84 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEeCCCC-EEEEEEccC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~-~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+.|.++..||-|+||.||+|..++.. ..|-|++.. +....++|+-||+||..+.||+||+|++.|+..+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 35788899999999999999876543 446787753 5577889999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
.||-++..+-... ..+.+.++..++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+-.... .
T Consensus 112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 9999998887655 378999999999999999999999 8999999999999999999999999998743222 2
Q ss_pred CceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 576 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
......+.|||.|||||+++ ...|+.++||||||++|.||..+.+|...-++......+ ++ ..-.-++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi--aK-----SePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK-----SEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH--hh-----cCCCccc
Confidence 22334589999999999876 457999999999999999999999998765543222111 11 1111222
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.| ......+..+...||..||..||++++++++
T Consensus 257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 1223344455567999999999999999985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.62 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=196.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|+.++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999864 6899999988642 223445678999999999999999999987654
Q ss_pred --ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 487 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 487 --~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
..++||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999965 8888876442 358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC--ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 565 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 565 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|++......... .......++..|+|||++... .++.++||||||+++|||++|+.||...........+......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866443221 111234678899999988754 47889999999999999999999998765433322222111100
Q ss_pred ccCcccc-----ccCcc-cCCCC---------ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQ-----LLDPA-LGNNY---------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~-----lld~~-l~~~~---------~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....... ..+.. +.... ..-....+..++..||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 00000 00000 00011234567788999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.53 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=195.4
Q ss_pred ccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 421 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
.....||+|+||.||++... +++.||||++.... ...+.+.+|+.++..++||||++++++|..++..++||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999864 68999999986532 34567889999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|..++.. ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.........
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 173 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 173 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--
Confidence 99998754 247899999999999999999999 89999999999999999999999999998755433221
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
.....|++.|+|||++....++.++|||||||++|||++|+.||....+......+. . ... +....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~-----~~~-----~~~~~-- 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--D-----SPP-----PKLKN-- 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--c-----cCC-----CCccc--
Confidence 123568999999999998899999999999999999999999997654322211111 0 000 00000
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.+|.+||++.+++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00111234456678999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.75 Aligned_cols=265 Identities=21% Similarity=0.330 Sum_probs=198.8
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+|...+.||.|++|.||+|... +|+.||||+++... .....+.+|+.++++++||||++++++|...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 68899999987542 33467788999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++ +|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89888865432 2468999999999999999999998 8999999999999999999999999999976543222
Q ss_pred CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC-cc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-PA 653 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld-~~ 653 (766)
. .....+|+.|++||++... .++.++|||||||++|+|++|+.||...........+.-.........+..+.+ +.
T Consensus 156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 1224678999999998754 578899999999999999999999986654322111110000000000000000 00
Q ss_pred cCCC-----------CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNN-----------YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~-----------~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+... ........+..++..|++.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 001112345567778999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.14 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|...+.||.|+||.||++... +++.+|+|++... ......+.+|+++++.++||||++++++|...+.+++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999875 6889999998754 34567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... ..+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 368889999999999999999997 3679999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. ...|+..|+|||++....++.++||||||+++|+|++|+.||........ ............ . .+.+
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-~-----~~~~ 224 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE-P-----PPRL 224 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC-C-----CCCC
Confidence 21 15689999999999988999999999999999999999999975432111 111111111110 0 0111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... ....+..++..||..+|.+||++.+++.+
T Consensus 225 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGK---FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chhh---cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1110 22335566678999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.63 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=196.3
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|...+.||.|+||.||+|... +|+.||||+++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999864 68999999987432 3345788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+. ++|..++..... ..+++..+..++.+++.||+|||+ ++++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 589988865432 468899999999999999999999 899999999999999999999999999997654332
Q ss_pred CCceecccccccCCCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCccchh-hHHHhhccccc----------
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILS---------- 642 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~---------- 642 (766)
.. .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......... ....+......
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 21 12245789999999887544 688999999999999999999999765432111 11111100000
Q ss_pred --cCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 643 --SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 643 --~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...+.......+.. ........+..++..||+.||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 000011234456678999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=326.06 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=199.4
Q ss_pred eeeeccCceEEEEEEeCC-CCEEEEEEccC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 424 NLIGKGGSSQVYKGCLPD-GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
-+||+|.||+||.|++.+ ...+|||-+.. .....+-+..||.+.++|+|.|||+++|.|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999754 55689998864 3355677888999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-CCCCeeEecccccccccCCCCCceec
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+|+..-. +-.-.+...-.+..||++||.|||+ +.|||||||-+|||++ -.|.+||+|||-++.+....... .
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T--E 734 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT--E 734 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCccc--c
Confidence 99986542 2223788888999999999999999 8899999999999995 56899999999999887654432 3
Q ss_pred ccccccCCCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 581 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
++.||..|||||++..| .|+.++|||||||++.||.||++||-..... ...|+. -|-+ .....+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAAMFk-----VGmy------KvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAAMFK-----VGMY------KVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHhhhh-----hcce------ecCCCC
Confidence 47899999999999977 5889999999999999999999999643221 111111 1110 011234
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+.+.......++++|+..+|.+||++.++|+
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 5555666777888999999999999999986
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.26 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=199.8
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|+||.||+|... +++.|++|.++... ...+.+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 78899999987643 3678899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997542 47889999999999999999999 889999999999999999999999999998765433
Q ss_pred CCce--ecccccccCCCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 575 SHIT--CTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 575 ~~~~--~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.... .....+++.|+|||++.... ++.++||||||+++|+|++|+.||......... ..... .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~~~~~----~~~---- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHVG----AGH---- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH--HHHHh----cCC----
Confidence 2211 11256889999999998766 889999999999999999999999754322111 11000 010
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.+.+.... .....+..++..||+.+|.+||++.+++.
T Consensus 224 -~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 01223445667899999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.39 Aligned_cols=266 Identities=22% Similarity=0.336 Sum_probs=197.0
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 487 (766)
.+++|.+.+.||+|+||.||+|.. .+|+.||||++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999986 47899999998642 24556788999999999999999999987654 35
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.++||||+.+ +|.+.+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence 7999999965 888877532 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-eecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 568 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 568 ~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.........-.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 8654432211 1223578999999998754 4689999999999999999999999976443221111000000000000
Q ss_pred cccccCccc---------CCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLDPAL---------GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~l---------~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..+.+... ..... ......+..++..||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111110000 00000 0112345677788999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=297.37 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=205.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|++|.||+|... +++.|+||++.... .....+.+|+.++..++|+||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999876 58999999987654 4567899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++... ..+++..+..++.|++.||.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 3588999999999999999999962 679999999999999999999999999998765433
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
... ....++..|+|||.+....++.++|+||||+++|+|++|+.||..........+..+... .. .+.+
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~-----~~~~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GP-----PPSL 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CC-----CCCC
Confidence 321 235689999999999988999999999999999999999999976653222222222110 00 0111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... ....+..++..||..+|.+||++.+++++
T Consensus 224 ~~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEE---FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Cccc---CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1110 22455666678999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.09 Aligned_cols=205 Identities=27% Similarity=0.364 Sum_probs=182.4
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
..+.|+.-++||+||||.||-+.. .+|+.||.|.+.+. .......++|-.||.+++.++||.+--.|...+.++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 345788899999999999998875 47999999988643 2334567789999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
|+..|.||+|.-+|...+. ..|++..+..++.+|+.||++||+ .+||+|||||+|||||+.|+++|+|+|||..+
T Consensus 263 VLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999987654 569999999999999999999999 99999999999999999999999999999887
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCcc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 628 (766)
....... ..+||.||||||+++++.|+...|+|||||+||||+.|+.||.....+
T Consensus 338 ~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 338 PEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred CCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 7655443 258999999999999999999999999999999999999999765443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.13 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=205.1
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.+++|...+.||+|+||.||+|... ++..+++|++.........+.+|++++..++|+|+++++++|...+..++||||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4667888899999999999999976 688999999986655567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... ..+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999998653 368999999999999999999999 899999999999999999999999999987654432
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....++..|+|||++....++.++|+|||||++|+|++|+.||....+..... .... .....+.++
T Consensus 171 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~-----~~~~~~~~~-- 239 (286)
T cd06614 171 SK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITT-----KGIPPLKNP-- 239 (286)
T ss_pred hh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh-----cCCCCCcch--
Confidence 21 122458899999999988889999999999999999999999997654322111 1111 011111110
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+..++..||+.+|.+||++.+++++
T Consensus 240 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0011345556778999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=313.77 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=198.2
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 485 (766)
..++|...+.||+|+||.||+|... +|+.||||++... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 7899999998642 34456788899999999999999999998643
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 88887753 27888999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH----------
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM---------- 635 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~---------- 635 (766)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987654322 123468999999999998899999999999999999999999997654322111110
Q ss_pred ----------hhc--cccccCccccccCcccC----CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 636 ----------WAK--PILSSGKVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 636 ----------~~~--~~~~~g~~~~lld~~l~----~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.. +......+..++...+. ..........+..++..||+.||.+||++.++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000001111111110 00011123345667788999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.14 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=208.9
Q ss_pred CcccceeeeccCceEEEEEEeCC-CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+......||-|-||.||.|.++. ...||||.++.+....++|+.|..+|+.++|||+|+|+|+|.....+|||.|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 34567889999999999999864 56799999998888899999999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.++|++..+ ..++-...++++.||..|+.||.. +++|||||...|.|+.++..+|++||||++++..+...
T Consensus 348 GNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT- 421 (1157)
T KOG4278|consen 348 GNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT- 421 (1157)
T ss_pred ccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence 999999987654 345666788999999999999999 89999999999999999999999999999988664321
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......-.+-|.|||-+.+..++.|+|||+|||+|||+.| |..||.+-+...... ++......
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~----------------LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG----------------LLEKGYRM 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH----------------HHhccccc
Confidence 1111223567999999999999999999999999999999 999997643322222 22222222
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+.+......+..++..||+.+|.+||++.++-+.|+.
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2334445667778888999999999999988776653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.41 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=198.8
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|+||.||++... +|..+|+|.+... ....+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999875 5889999998653 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~ 573 (766)
+++++|.+++..... ..+++..+..++.+++.||.|||+ .+++|+||||+||++++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999975432 357899999999999999999999 8899999999999998875 4699999999866543
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... .....|++.|+|||++....++.++|+||||+++|+|++|+.||........ +. ... .+....+
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~-~~~~~~~---- 222 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VL---KIC-QGYFAPI---- 222 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH---HHh-cccCCCC----
Confidence 221 1224689999999999988899999999999999999999999975432211 11 001 1111111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... ....+..++.+||..+|.+||++.+++++
T Consensus 223 -~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -SPN----FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCC----CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111 11245556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.01 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEEEe
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYD 493 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~E 493 (766)
|.+.+.||.|+||.||+|... +|+.+|+|++... ......+.+|+++++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 5889999999865 34456788999999999999999999999887 88999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++ +|.+++.... ..+++..++.++.+|+.||.|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988886542 368999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc---
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 649 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l--- 649 (766)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...........+..+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 321 1223467889999998764 45789999999999999999999999766543222211111000000000000
Q ss_pred -----------cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 -----------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 -----------ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+...+.......++.++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000011113456777888999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.41 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=203.7
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|+||.||++... +++.+++|.+... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999754 7889999998753 34456788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.........+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987644334568999999999999999999999 899999999999999999999999999998776542
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
. ....|++.|+|||++....++.++|+||||+++|+|++|+.||...........+ ..+....+
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~----- 221 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-------QRGKYPPI----- 221 (256)
T ss_pred c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCCCCC-----
Confidence 1 1246899999999999888999999999999999999999999765432211111 11111111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.+|.+||++.+++++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223446667778999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.38 Aligned_cols=265 Identities=25% Similarity=0.326 Sum_probs=197.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l 490 (766)
.++|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+.++.+++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999874 68999999986432 2234567899999999999999999998754 46899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999965 8888886543 368999999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...++......+...........+..+
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543221 122346888999999865 45889999999999999999999999876544332222111100000000000
Q ss_pred c-----Cc-ccCCC-C-C-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 L-----DP-ALGNN-Y-D-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 l-----d~-~l~~~-~-~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
- .. .+... + . ......+..++..||+.||++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00 00000 0 0 0012334556778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=304.49 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=195.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999875 78899999986532 344678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccccccC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 572 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~ 572 (766)
|++ ++|.+++..... ..+++..+..++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 588888754332 346788888999999999999999 89999999999999985 56799999999976543
Q ss_pred CCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc------
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK------ 645 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~------ 645 (766)
.... .....|++.|+|||++.+. .++.++|||||||++|+|+||+.||......+................
T Consensus 156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 2211 1234678999999998754 578999999999999999999999976543222111110000000000
Q ss_pred cccccC--cccCC----CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLD--PALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld--~~l~~----~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..... +.... .........+..++..|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0001112335567778999999999999999973
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.05 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
|.+.+.||+|.||.||+|.++ .|..+|||.+... ...+++..||.|+.++..|++|++||.|.....+|+|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 566788999999999999875 7999999998754 45678899999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
++.+.++... .++++.++..|+...++||+|||. ..-||||||..||||+.+|++||+|||.|..+..... .
T Consensus 114 SiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K 185 (502)
T KOG0574|consen 114 SISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K 185 (502)
T ss_pred cHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence 9999997654 479999999999999999999998 7789999999999999999999999999987765433 2
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCC
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 658 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~ 658 (766)
..++.|||.|||||++..-.|+.++||||||++..||..|++||.+-++...... +.... -|.+ ..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~P-----PPTF--~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTKP-----PPTF--KK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCCC-----CCCC--CC
Confidence 3458999999999999999999999999999999999999999987665322111 11100 0111 11
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 659 DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 659 ~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+......+..++..||-++|++|-|+.+++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 33444556667788999999999999999885
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=301.23 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=193.2
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeec--CceEEEEe
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 493 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~lV~E 493 (766)
|.+.+.||+|+||.||+|... +++.||+|+++.. ........+|+.++.++. |+|++++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 6889999998753 222334567999999885 99999999999987 88999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+. |+|.+.+.... ..++|..++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 58888886543 368999999999999999999999 89999999999999999 99999999999866543
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhcc-------ccccC
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKP-------ILSSG 644 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~~~~-------~~~~g 644 (766)
... ....+++.|+|||++.. +.++.++|||||||++|||++|..||...+........ ..... .....
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 222 22468999999997754 45788999999999999999999999765432211100 00000 00000
Q ss_pred ccccccCcccCCC----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~----~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..... ........+..++..||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 001123556677788999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.62 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=193.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|...+.||+|+||.||++... +++.+|||.+... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999864 6899999998753 245567889999999996 99999999999998999999999
Q ss_pred cCCCCHhHhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
+.. +|.++.... ......+++..+..++.+++.||+|||+. .+|+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 655543211 11124689999999999999999999961 48999999999999999999999999999866443
Q ss_pred CCCceecccccccCCCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
... ....|++.|+|||++... .++.++|||||||++|+|++|+.||...... ...+ ..... +.
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----~~~~~-~~----- 227 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQL----TQVVK-GD----- 227 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHH----hhhcC-CC-----
Confidence 222 224689999999999866 6899999999999999999999999754311 0111 00000 11
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.+...........+..++..||+.+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111223345667778999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=306.11 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=194.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..|...+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+++++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34778899999999999999864 6899999988632 244567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 57777775432 358999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
. ....|++.|+|||++. .+.++.++||||||+++|||++|+.||...........+.+. ..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~--- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------DS--- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-------CC---
Confidence 2 1246889999999874 456889999999999999999999999765432211111100 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+. .......+..++..||..+|.+||++.+|+.+
T Consensus 232 --~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1110 11122345666778999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.35 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=196.9
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
|.+.+.||.|++|.||+|... +|+.||||++.... .....+.+|+++++.++|||++++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 79999999987532 33467889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+ ++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689999875542 358999999999999999999999 8999999999999999999999999999976543221
Q ss_pred CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhcccc--------cc-C
Q 004247 576 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPIL--------SS-G 644 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~~~~~~--------~~-g 644 (766)
. .....+++.|+|||++..+ .++.++||||||+++|+|++|+.||...........+ .+..... .. +
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 1223578999999988754 5789999999999999999999999765432211111 1000000 00 0
Q ss_pred ---ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 ---KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ---~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.....+... .........+..++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0011112355667788999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=304.95 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||.|+||.||++.. .++..||+|.+... ....+.+.+|+.+++.++||||++++++|...+..++||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999985 46889999998643 344567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 47889999999999999999999 8999999999999999999999999999876544322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....|++.|+|||++..+.++.++|||||||++|+|++|+.||....+......+ ...+. +.+.
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~~~ 236 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PELQ 236 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CCCC
Confidence 1 12346899999999998888999999999999999999999999765432211110 00000 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........+..++..||..+|.+||++.+++.+
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234456678999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=294.13 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=204.4
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||.|+||.||++... +++.+++|++.... .....+.+|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999875 68899999987542 4567788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.........+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998654333578999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
. ......|++.|+|||.+....++.++|+||||+++|+|++|+.||............ . .+.... +
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~~~~~~-----~ 223 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI------L-KGQYPP-----I 223 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH------h-cCCCCC-----C
Confidence 1 222357899999999999888999999999999999999999999765432111110 0 011111 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. .....+..++..||..+|.+||++.+++++
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112345556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.33 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=197.4
Q ss_pred cccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 420 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
|...+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999986 478899999886433 3456788999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.+++... .+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999998752 47899999999999999999999 89999999999999999999999999998765443221
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
.....|++.|+|||++....++.++|||||||++|+|++|+.||....+......+... . .+.+...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------~-----~~~~~~~ 238 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------L-----PPKLKNL 238 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-------C-----CCCCccc
Confidence 12256899999999998888999999999999999999999999765432221111110 0 0111100
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+..++..||+.+|.+||++.+++++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0011345666778999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.97 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=197.8
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccC---ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec--Cce
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED--NNL 488 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~--~~~ 488 (766)
..++|.+.+.||+|+||.||+|... +|+.+|||.+.. .......+.+|+.++.++ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999875 688999998853 223455678899999999 999999999998653 368
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||++ ++|..++... .+.|..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5999888643 57889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---ceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 569 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 569 ~~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
........ .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||...........+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66543321 12233578999999998764 457889999999999999999999997654332211111111100000
Q ss_pred c--------cccccCcccCC------CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 K--------VTQLLDPALGN------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~--------~~~lld~~l~~------~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ...+++..... .........+..++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00011100000 0000112345667788999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.30 Aligned_cols=267 Identities=25% Similarity=0.337 Sum_probs=197.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 486 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 486 (766)
...++|.+.+.||+|+||.||+|..+ +|+.||||+++.. ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 6889999999743 233456778999999999999999999987654
Q ss_pred ------ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 487 ------NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 487 ------~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
.+++||||+++ +|...+.... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999976 7777776432 368999999999999999999999 8999999999999999999999
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
|+|||++......... ......++..|+|||++... .++.++|||||||++|+|++|+.||...........+.....
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876543321 11223568889999988643 578999999999999999999999976543222111111000
Q ss_pred ccccCccccc--------cCc------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 ILSSGKVTQL--------LDP------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 ~~~~g~~~~l--------ld~------~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+..+ .++ .+..... .....+..++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000 000 0000000 012345667778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.35 Aligned_cols=241 Identities=26% Similarity=0.331 Sum_probs=193.4
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||.|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999986532 4457789999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cc
Confidence 99997643 47899999999999999999999 8999999999999999999999999999987654321 12
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...|++.|+|||++....++.++|+||||+++|+|++|..||............. ... +. ....++.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~-~~--------~~~~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND----ILK-GN--------GKLEFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH----Hhc-cC--------CCCCCCc
Confidence 2568999999999988889999999999999999999999997654211111111 000 00 0001111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 004247 661 DQMERMVLASILCIRRDPRARPQ-----MSLVLK 689 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~ 689 (766)
.....+..++..||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11234566677899999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.10 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=204.2
Q ss_pred cceeeeccCceEEEEEEeC--CCC--EEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 422 AENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~--~g~--~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..++||+|.||.|++|.+. +|+ .||||+++... ....+|.+|+.+|.+|+|+|+++|||+..+ ..+.||||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3467999999999999874 455 57999998754 467899999999999999999999999987 6789999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+.|+|.+.|+... ...|-......++.|||.||.||.. +++|||||...||||...-.+||+||||.+.+.....
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999998733 3568888999999999999999999 8999999999999999988999999999998877665
Q ss_pred Cceec-ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 576 HITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 576 ~~~~~-~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
++.+. ...-.+.|+|||.+...+++.++|||+|||+||||+| |..||-+......... +|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----------------iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----------------IDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------cccc
Confidence 55433 2344668999999999999999999999999999999 8999977544322222 2211
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
-.-.-.....+++..++..||..+|.+|||+..|.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 111123456678888889999999999999999864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.25 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=185.2
Q ss_pred eeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHH---hcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 425 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIIT---TLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+||+|+||.||++... +++.+|||.+.... .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68899999886432 22233444544433 3479999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999886543 58999999999999999999999 8899999999999999999999999999875543221
Q ss_pred ceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
....||+.|+|||.+.. ..++.++|||||||++|+|++|+.||..........+..... ..+..+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~ 219 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TVNVELP 219 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cCCcCCc
Confidence 22469999999999874 458999999999999999999999997654332222111100 0111111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
..+ ...+..++..||+.||.+|| ++.+++++
T Consensus 220 ~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSF----SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccc----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111 23445556789999999999 59999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.94 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=205.2
Q ss_pred cCcccceeeeccCceEEEEEEeC---CCC--EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP---DGK--ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~---~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
......++||.|-||.||+|... .|+ .||||..+.+ .+..+.|+.|.-+++.++||||++|+|+|.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34456788999999999999852 333 4899999864 3668899999999999999999999999976 56899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
|||+++-|.|..+|+.++. .++......++.||+.||.|||+ .++|||||..+|||+....-+||+||||++++
T Consensus 468 vmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999987653 68888889999999999999999 89999999999999999999999999999999
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
......... ...-..-|||||-+....++.++|||.|||++||++. |..||.+-...+.. ..++.|.-..
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeRlP- 612 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGERLP- 612 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCCCC-
Confidence 876554432 2334567999999999999999999999999999998 99999864433221 1223332111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+....-.+..++.+||..+|.+||.+.++...|..
T Consensus 613 --------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 613 --------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred --------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 122233456677889999999999999998877654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.04 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=199.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 488 (766)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||++++++|.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999864 68999999987532 345677889999999999999999998753 3568
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 58999886442 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC--ceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc----
Q 004247 569 WASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 641 (766)
Q Consensus 569 ~~~~~~~~--~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---- 641 (766)
........ .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...........+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 66443221 11123578999999999865 468999999999999999999999997655433222111100000
Q ss_pred ----ccCccccccCccc-CCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 ----SSGKVTQLLDPAL-GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ----~~g~~~~lld~~l-~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+...++..- ..... ......+..++..||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000111111000 00011 1123456677788999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.54 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=199.9
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
|.+.+.||.|++|.||++... +++.+++|.++... .....+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999874 78899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++ +|.+++.... ..+++..++.++.+++.||.|||+ ++|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888886543 368999999999999999999999 8999999999999999999999999999987755431
Q ss_pred CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC---
Q 004247 576 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD--- 651 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld--- 651 (766)
......++..|+|||.+... .++.++||||||+++|+|++|+.||...+.......+.-.........+..+.+
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 12234688899999999876 789999999999999999999999976554222111110000000000000000
Q ss_pred c---ccC-------CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 P---ALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~---~l~-------~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ... ..........+..++..||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000 00011223456677888999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.23 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=193.7
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
|...+.||+|+||.||++... ++..+|+|++... ......+.+|+++++.++|||+++++++|..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999864 6889999998642 24456788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+.+ +|.+.+.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 7877775432 358999999999999999999999 89999999999999999999999999998754332
Q ss_pred CCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 575 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||.......... .+... + .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~~----~-~----- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQN----E-S----- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhc----c-C-----
Confidence 2246899999999974 4578999999999999999999999987643222111 11110 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
+... .......+..++..||+.+|.+||++.+|++++
T Consensus 242 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 111223455667789999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.95 Aligned_cols=243 Identities=25% Similarity=0.331 Sum_probs=190.6
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||+|+||+||++... +|+.||+|++.... .....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999764 68999999986432 2345677899999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 999976543 358999999999999999999999 8999999999999999999999999999986644221 12
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...|+..|+|||++.++.++.++|||||||++|+|++|+.||...........+. ...... ...+...+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~-- 221 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEM-------AVEYPDKF-- 221 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccccc-------cccCCccC--
Confidence 2468889999999998889999999999999999999999997654321111110 000000 00011111
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 004247 661 DQMERMVLASILCIRRDPRARP-----QMSLVLK 689 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~ 689 (766)
...+..++..||+.+|.+|| ++.+++.
T Consensus 222 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 --SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22344566789999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.58 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=195.6
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhc---CCCceeEEeeEEeecCc-----
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNN----- 487 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~----- 487 (766)
|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|+.++.++ +|+|+++++++|...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999976 4899999999743 22345667788887766 59999999999988776
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.+++|||+.+ +|.+++..... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 89988865432 358999999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc-
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV- 646 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~- 646 (766)
......... ....++..|+|||++....++.++|||||||++|+|++|+.||...........+.-.........+
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 876443221 2245789999999999889999999999999999999999999765543221111100000000000
Q ss_pred ------ccccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 ------TQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ------~~lld~~l~~---~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...+...... ....+....+..++..||+.||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 0011223445567778999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.63 Aligned_cols=246 Identities=29% Similarity=0.472 Sum_probs=201.0
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.+.+.||+|++|.||++... +++.|++|.+.... .....+.+|++++.+++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 67899999997654 4667899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 358999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....|+..|+|||++....++.++||||||+++|+|++|+.||...... ...|.... ... +.+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~---~~~-----~~~ 219 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIVQ---DDH-----PPL 219 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhc---cCC-----CCC
Confidence 32 12356899999999998888899999999999999999999999754321 11111110 000 111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.. .....+..++..||..+|++||++.+++.
T Consensus 220 ~~----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PE----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 11234455667899999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.74 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=203.8
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+......||.|..|.|+++... +|..+|||.+... ....++++..++++...+ +|+||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4456678999999999999864 6889999999764 466788888999887776 89999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
|.. -++.++.... .++++..+-++...++.||.||.. .++|||||+||+|||||+.|++||||||++.++.+..
T Consensus 173 Ms~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 943 6667776554 368888889999999999999987 4789999999999999999999999999998887765
Q ss_pred CCceecccccccCCCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc-hhhHHHhhccccccCcccccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g~~~~ll 650 (766)
.+.. -+|-+.|||||.+.- .+|+.++||||||++|+||.||+.||.+.+..- ....+.. +..
T Consensus 247 Ahtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--------~eP--- 312 (391)
T KOG0983|consen 247 AHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--------EEP--- 312 (391)
T ss_pred cccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--------cCC---
Confidence 5543 479999999999863 479999999999999999999999998754322 1111111 111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh------hCCCCchhhhhhh
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL------RGDADVTKWARLQ 704 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L------~~~~~~~~~~~~~ 704 (766)
|.|..... ....+..+...||++|+.+||...++|++- ....+++.|-...
T Consensus 313 -P~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 313 -PLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred -CCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence 23322211 112233445579999999999999999852 1234556776543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=310.85 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=197.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 487 (766)
.++|.+.+.||+|+||+||+|... +++.||||.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 6899999998752 23456778899999999999999999988654 35
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999996 6898888644 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc-c------
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-P------ 639 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-~------ 639 (766)
........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.......+.-.. .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 86654321 1223468899999998875 468999999999999999999999997654322111111000 0
Q ss_pred -ccccCcccccc-------CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 -ILSSGKVTQLL-------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 -~~~~g~~~~ll-------d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+..+.....+ ++.+.. ........+..++..||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 000000 001123445677788999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.75 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=194.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 488 (766)
.+|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 6899999987531 24456888999999999999999999998764 458
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987543 47888999999999999999998 899999999999999999999999999998
Q ss_pred cccCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........ .......|+..|+|||++....++.++|+|||||++|+|++|+.||........ ..... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~----~~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKIA----TQP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHHH----cCC---
Confidence 65432111 111235689999999999988899999999999999999999999975432211 11100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.+ +......+..++..||+ +|..||++.+++.+
T Consensus 226 --~~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 --TKPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 01111 11122334555567888 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.47 Aligned_cols=249 Identities=27% Similarity=0.354 Sum_probs=201.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.+.||+|+||.||++... +|+.||+|++... ......+.+|++++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999875 7899999998752 234567889999999999 99999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCC------------------ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004247 572 TSSSH------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 633 (766)
Q Consensus 572 ~~~~~------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 633 (766)
..... .......|+..|+|||++....++.++||||||+++++|++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 43321 122235688999999999988899999999999999999999999976542111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH----HHHHHH
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM----SLVLKL 690 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~----~eVL~~ 690 (766)
...... . .. .+.......+..++..||+.+|.+||++ .+++++
T Consensus 231 ~~~~~~----~------~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 FQKILK----L------EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHh----c------CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 110000 0 00 0111113345667778999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.23 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=192.3
Q ss_pred eeeecc--CceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G--~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
..||+| +||+||++.+. +|+.||||++... ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999874 7999999998743 23457888999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 358899999999999999999998 899999999999999999999999998654332211110
Q ss_pred --e---ecccccccCCCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc-------c--
Q 004247 578 --T---CTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-------L-- 641 (766)
Q Consensus 578 --~---~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~-------~-- 641 (766)
. .....++..|+|||++.++ .++.++|||||||++|||++|+.||.............-..+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 0112356779999999764 4789999999999999999999999765432111100000000 0
Q ss_pred ---------------------ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 ---------------------SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ---------------------~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+......+..+...........+..++..||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000111111111122234456778888999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.42 Aligned_cols=254 Identities=17% Similarity=0.198 Sum_probs=182.8
Q ss_pred cCcccceeeeccCceEEEEEEeCC----CCEEEEEEccCChhH------------HHHHHHHHHHHHhcCCCceeEEeeE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIISLLGF 481 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~~~------------~~~~~~Ei~iL~~l~HpnIv~l~~~ 481 (766)
++|.+.++||+|+||.||+|...+ +..+|+|+....... ......+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999998654 456677765432211 0112234445667789999999998
Q ss_pred EeecC----ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 482 CFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 482 ~~~~~----~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
+.... ..+++++++.. ++.+.+.... .+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 76543 34677887743 6666665432 35678889999999999999999 8999999999999999999
Q ss_pred CeeEecccccccccCCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004247 558 EPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 632 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 632 (766)
.++|+|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999998664322111 1122469999999999998999999999999999999999999998653322111
Q ss_pred H---HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 633 L---VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 633 l---v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
. ..+...+ ..++ +..... ...+..++..|++.+|++||++.++++.|
T Consensus 244 ~~~~~~~~~~~-~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRL-HEGK--------IKIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHh-hhhh--------hccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 0111111 1111 100111 23455666779999999999999999876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.50 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=196.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
.++|.+.+.||.|+||.||+|... +++.+|||++.... .....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 68899999886422 22346778999999999999999999875433
Q ss_pred --ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 487 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 487 --~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
.+++||||+.+ +|...+.... ..+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 7777776432 368999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC---------ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004247 565 GLAKWASTSSSH---------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634 (766)
Q Consensus 565 Gla~~~~~~~~~---------~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 634 (766)
|++......... ...+...|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865433211 112235678999999988654 5889999999999999999999999765543322221
Q ss_pred Hhhcccccc------Ccccccc--------CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 635 MWAKPILSS------GKVTQLL--------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 635 ~~~~~~~~~------g~~~~ll--------d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......... ..+.... .+.+...+ ......+..++..||+.+|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111000000 0000000 00000000 1112456677788999999999999998863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.23 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=192.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.++..++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999864 6899999998642 234467889999999999999999999987543
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+++|+||+.. +|..++. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 7776552 247899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc--
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 643 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 643 (766)
++...... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+....+....
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 97653321 23467899999999876 46889999999999999999999999865432222211111100000
Q ss_pred ------CccccccC--cccC-CCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 ------GKVTQLLD--PALG-NNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 ------g~~~~lld--~~l~-~~~---~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+. +... ... .......+..++..||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 000 00112345567788999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.65 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=197.0
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCChh--HHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeec
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
|.+.+.||.|+||.||+|... +++.|+||.+..... ......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999975 578899999875422 2234567999999999 999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887654 2468999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH----------hhccccccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKPILSSG 644 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~----------~~~~~~~~g 644 (766)
. ....|+..|+|||++.. ..++.++|+||||++++||++|+.||............. |........
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 23468999999998854 458899999999999999999999997654332211110 100000000
Q ss_pred ccccccC----cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLD----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld----~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+...+. ..+..... .....+..++..||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000000 113456677888999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.47 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=194.5
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||.|+||.||++... +|+.+++|++.... ...+.+.+|++++..++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 48999999997543 3566788999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC-----
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 575 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~----- 575 (766)
.+++.... .+++..+..++.||+.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 58999999999999999999999 8999999999999999999999999999876543321
Q ss_pred -CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 -HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 -~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
........++..|+|||++....++.++||||||+++|+|++|..||...........+.. +... . +
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~-~--~-- 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-------GKIE-W--P-- 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CCcC-C--C--
Confidence 1122235688999999999988899999999999999999999999976543221111110 1100 0 0
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
. .......+..++..||+.+|.+||++..+.+.|.
T Consensus 222 -~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0001234456667899999999999966555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.40 Aligned_cols=261 Identities=25% Similarity=0.296 Sum_probs=192.9
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
+.+.+|.|+++.||++.. +++.||||+++.. ....+.+.+|+++++.++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556667766776655 7999999998753 355678999999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC---
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--- 575 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~--- 575 (766)
+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 357889999999999999999999 8999999999999999999999999999875532211
Q ss_pred --CceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc----cccccC---
Q 004247 576 --HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----PILSSG--- 644 (766)
Q Consensus 576 --~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~----~~~~~g--- 644 (766)
........++..|+|||++.. ..++.++|||||||++|||++|+.||........ +..... ..+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 111122457889999999875 3588999999999999999999999976433211 111000 000000
Q ss_pred ----cccc----ccCcccCC----CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 ----KVTQ----LLDPALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ----~~~~----lld~~l~~----~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... ..++.... .........+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 11111100 0111223455667788999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.13 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=193.4
Q ss_pred cCcccceeeeccCceEEEEEEeCC-CCEEEEEEccCCh--hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||+|..++ ++.||||+++... .....+..|+.++..+. ||||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999864 8999999997532 34556777888777775 9999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+. ++|..++.... ..+++..+..++.+++.||.|||+. ++|+||||+|+||+++.++.+||+|||++......
T Consensus 95 ~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 47777765432 3689999999999999999999961 48999999999999999999999999999766443
Q ss_pred CCCceecccccccCCCCchhhccCC----CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
... ....|++.|+|||++.... ++.++||||||+++|+|++|+.||...... ...+...... ....
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~-----~~~~- 238 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQE-----EPPS- 238 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcC-----CCCC-
Confidence 222 2245888999999987543 889999999999999999999999653221 1111111110 0000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.. .......+..++..||+.+|.+||++.+++++
T Consensus 239 ----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00112345667788999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.76 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=194.9
Q ss_pred cCcc-cceeeeccCceEEEEEEeC-CCCEEEEEEccCChhH---------------HHHHHHHHHHHHhcCCCceeEEee
Q 004247 418 SNFL-AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------------IKEFVLEIEIITTLHHKNIISLLG 480 (766)
Q Consensus 418 ~~f~-~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~---------------~~~~~~Ei~iL~~l~HpnIv~l~~ 480 (766)
++|. +.+.||.|+||.||+|... +++.||||+++..... ...+.+|++++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4578999999999999864 6899999998653211 125778999999999999999999
Q ss_pred EEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 481 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
+|...+..++||||+. |+|.+++... ..+++.....++.|++.||.|||+ .+|+||||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999997 5899988643 258899999999999999999999 8999999999999999999999
Q ss_pred EecccccccccCCC------------CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 561 LSDFGLAKWASTSS------------SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 561 L~DFGla~~~~~~~------------~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998665211 01111223578899999998754 478999999999999999999999987654
Q ss_pred cchhhHHHhhccccccCcccccc------------CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 628 KGQESLVMWAKPILSSGKVTQLL------------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 628 ~~~~~lv~~~~~~~~~g~~~~ll------------d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+...........+.... .+.+... .......+..++..||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 33221111100000000000000 0000000 01112345567778999999999999999964
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=314.28 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=201.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
...|.+.+.||+|.|+.|.+|.+. +|..||||++.++. .....+.+|+++|+.|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 567899999999999999999864 79999999998643 34456899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+.+|.++++|..... .....+..++.|+..|++|||+ ++|||||||++||||+.+.++||+|||++.++..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999987764 4457888999999999999999 8999999999999999999999999999998874
Q ss_pred CCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .+.+|++.|.|||++++.+|+ +.+|+||+|++||-|++|..||++...++-..
T Consensus 208 ~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------------- 265 (596)
T KOG0586|consen 208 GLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------------- 265 (596)
T ss_pred cccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-------------------
Confidence 4332 347999999999999987765 79999999999999999999998765443221
Q ss_pred cccCCCC--ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNY--DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~--~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+...+ +..-...+-.++..+|-.+|.+|+++.++.+.
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111 11111223334455788899999999988763
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.20 Aligned_cols=271 Identities=24% Similarity=0.293 Sum_probs=201.4
Q ss_pred cccCHHHHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004247 406 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGF 481 (766)
Q Consensus 406 ~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 481 (766)
+.....++...+++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++.+++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445567777889999999999999999999985 478899999987532 234678889999999999999999998
Q ss_pred Eeec------CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC
Q 004247 482 CFED------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555 (766)
Q Consensus 482 ~~~~------~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 555 (766)
+... ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence 8643 3468888887 77998887532 48899999999999999999999 89999999999999999
Q ss_pred CCCeeEecccccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004247 556 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634 (766)
Q Consensus 556 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 634 (766)
++.+||+|||++....... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999987653321 23468999999999875 46889999999999999999999999765432221111
Q ss_pred Hhhccc--------cccCc---cccccCcccCCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 635 MWAKPI--------LSSGK---VTQLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 635 ~~~~~~--------~~~g~---~~~lld~~l~~~~---~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...... +.... ....+.......+ .......+..++..|++.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100000 00000 0000000000000 00112345667778999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=296.85 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=194.0
Q ss_pred CcccceeeeccCceEEEEEEe----CCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 419 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
+|.+.+.||+|+||.||++.. .+|+.||+|+++... ...+.+.+|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 378999999987532 2346788899999999 599999999999998999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997543 57888999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
........ ......|+..|+|||++..+ .++.++||||||+++|+|++|+.||........... .........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSE-- 228 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH--HHHHhhccC--
Confidence 65443221 11235689999999998753 477899999999999999999999975432211111 111111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
+.. +......+..++..||+.+|.+|| ++.+++++
T Consensus 229 -----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001 111122345566789999999997 66776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=316.25 Aligned_cols=242 Identities=26% Similarity=0.429 Sum_probs=192.6
Q ss_pred ceeeeccCceEEEEEEeC-CCCEEEEEEcc-----CChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc--eEEEEee
Q 004247 423 ENLIGKGGSSQVYKGCLP-DGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDF 494 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~-----~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~lV~E~ 494 (766)
..+||+|+|-+||+|.+. +|.+||--.++ .+....++|..|+++|+.|+||||+++|.++.+... ..+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999974 57777633222 344566899999999999999999999999987655 7899999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~~ 573 (766)
+..|+|..|+.+.+. +....+..|+.||++||.|||+.. .+|||||||-+||+|+. .|.+||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988764 677889999999999999999976 79999999999999975 489999999999987664
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... .+.|||.|||||++. ..|++.+||||||++|+||+|+..||..-....+. ... ..+|.-..-+.
T Consensus 200 ~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YKK----V~SGiKP~sl~-- 266 (632)
T KOG0584|consen 200 HAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YKK----VTSGIKPAALS-- 266 (632)
T ss_pred ccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HHH----HHcCCCHHHhh--
Confidence 432 368999999999988 89999999999999999999999999754432221 111 12222222221
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.....+++. ++-.||.. ..+|||+.|+|+
T Consensus 267 ---kV~dPevr~---fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 ---KVKDPEVRE---FIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---ccCCHHHHH---HHHHHhcC-chhccCHHHHhh
Confidence 122233343 44579999 999999999997
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=291.16 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=186.5
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHH-HHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||.|+||.||+|... +|+.||||++.... .....+..|..+ ....+|+|++++++++..++.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68899999987532 222344555544 4455899999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997543 57889999999999999999999 8999999999999999999999999999875433
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||.............. +... ..+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~--~~~~~--- 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------RRIN--WPEEV--- 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------cccC--CCCcc---
Confidence 1234689999999999888899999999999999999999999976543221111110 0000 00000
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.......+..++..||+.+|.+||++..+.+.|
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 001123456667789999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.45 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=200.5
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 489 (766)
+|.+.+.||.|+||.||+|... +++.+|||++... ....+.+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999875 5899999998753 345578899999999999999999999998765 789
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++ +|.+++.... .+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999974 8988886543 68999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC---
Q 004247 570 ASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 644 (766)
Q Consensus 570 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 644 (766)
....... .......+|+.|+|||++... .++.++||||||+++|+|++|+.||...........+.-........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6554310 112235689999999999877 78999999999999999999999997765432222211111000000
Q ss_pred -----ccccccCcc-cCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 -----KVTQLLDPA-LGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 -----~~~~lld~~-l~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+... ...... ......+..++..||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000000 0112345567778999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=292.64 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=194.3
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccC------ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP------SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.|.+.+.||+|+||.||++... .+..+++|+++. .......+.+|+.++..++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999864 344566666553 123345677899999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.........+++..++.++.|++.||.|||+ ++++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999987644444578999999999999999999999 89999999999999975 569999999998664
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... .....|++.|+|||++....++.++|+||||+++|+|++|+.||....... ..... . .+. .
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~---~-~~~-----~ 222 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVLRI---V-EGP-----T 222 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHH---H-cCC-----C
Confidence 43221 223568999999999988889999999999999999999999996533211 11110 0 011 1
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+ +......+..++..||+.+|.+||++.+++++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111 11122345556678999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.10 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=197.1
Q ss_pred CcccceeeeccCceEEEEEEe----CCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 419 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
+|.+.+.||+|+||.||++.. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999874 367889999987432 3346788999999999 599999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998653 258899999999999999999998 899999999999999999999999999988
Q ss_pred cccCCCCCceecccccccCCCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
.......... ....|+..|+|||++.+.. .+.++||||||+++|||++|..||........... ........
T Consensus 154 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE--ISRRILKS--- 227 (288)
T ss_pred cccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH--HHHHHHcc---
Confidence 6544322211 2256899999999987665 78899999999999999999999965432211111 11111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.....++ ..+..++..||+.+|.+|||+.++.+.|..
T Consensus 228 ----~~~~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ----KPPFPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011111111 234456678999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=318.82 Aligned_cols=201 Identities=31% Similarity=0.445 Sum_probs=174.0
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------CceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~~ 489 (766)
.|...+.||+||||.||+|.. .+|+.||||.++.. ....+...+|+++|++|+|+|||++++.=.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355678899999999999994 58999999999863 35567888999999999999999999886543 3578
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC--CCC--CeeEeccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDF--EPQLSDFG 565 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~--~vkL~DFG 565 (766)
+|||||.||+|+..|.... ....+++.+.+.++..+..||.|||+ ++||||||||.||++- .+| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999997653 33579999999999999999999999 8999999999999994 323 47999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
.|+-++.+. .+..++||+.|++||++. .+.|+..+|.|||||++|+.+||..||-...
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 999887765 445689999999999999 4889999999999999999999999996543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.76 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=198.0
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cC
Q 004247 412 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DN 486 (766)
Q Consensus 412 el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~ 486 (766)
++..++++|.+.+.||.|+||.||++... +++.||||++... ....+.+.+|++++..++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44557889999999999999999999864 7899999987542 2345678899999999999999999999865 56
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
..++||||+ +++|..++... .+++..+..++.|++.||.|||+ ++|+||||+|+|||++.++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 56898888632 47788888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhH-HHh--------
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL-VMW-------- 636 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l-v~~-------- 636 (766)
+....... ....+++.|+|||++.. ..++.++|||||||++|+|++|+.||........... ..+
T Consensus 155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 87543221 22467889999998765 4689999999999999999999999976543221111 110
Q ss_pred hccccccCccccccCcc-cCCCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 637 AKPILSSGKVTQLLDPA-LGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~-l~~~~~~-----~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....... ....++... ....... .....+..++..||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000000 0001111 112455666778999999999999998864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=333.30 Aligned_cols=260 Identities=24% Similarity=0.291 Sum_probs=210.5
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEe
Q 004247 409 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 483 (766)
Q Consensus 409 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 483 (766)
...++....++|.+.++||+|+||.|..+..+ +++.||+|++++.+ ....-|..|-+||..-+.+-|++|+-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35667777889999999999999999999874 68889999998632 34557888999999999999999999999
Q ss_pred ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 484 ~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
+++++|||||||+||+|..++.... .+++..++.++.+|..||+-||+ .|+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999997664 58899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhc----c-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----Y-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~----~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 638 (766)
||.+..+..+ +...+...+|||.|++||+++ + +.|+..+|+||+||++||||.|..||..+.-.+-...++..+
T Consensus 219 FGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 219 FGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred chhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 9999877654 334455679999999999986 2 579999999999999999999999998877666666665443
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ---MSLVLKL 690 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs---~~eVL~~ 690 (766)
..+. +++.+ ...++.+.++.. +.| +|..|-. +.++-.+
T Consensus 298 ~~l~---FP~~~-------~VSeeakdLI~~-ll~---~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ESLS---FPDET-------DVSEEAKDLIEA-LLC---DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhcC---CCccc-------ccCHHHHHHHHH-Hhc---ChhhhcccccHHHHHhC
Confidence 2221 11111 123444554433 334 6666666 7776654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=294.49 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=185.2
Q ss_pred eeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHH---HHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 425 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE---IITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+||+|+||.||++... +++.||+|++.... .....+..|.. ++....||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68899999986432 11223444443 4444579999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
||+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988643 358999999999999999999999 8899999999999999999999999999875543221
Q ss_pred ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
....|+..|+|||++..+ .++.++|||||||++|+|++|+.||............ .... ...+.+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---------~~~~~~~ 219 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL---------TMAVELP 219 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh---------ccCCCCC
Confidence 234799999999999755 6899999999999999999999999765332222111 0000 0011111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
... ...+..++..|+..+|.+|| ++.+++++
T Consensus 220 ~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 23455556789999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=331.79 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=192.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-------
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------- 484 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------- 484 (766)
...++|...++||+||||.||+++.+ ||+.||||++... ......+.+|+.+|.+|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999876 9999999998764 5667789999999999999999998732100
Q ss_pred -----------------------------------------------------------------------c--------
Q 004247 485 -----------------------------------------------------------------------D-------- 485 (766)
Q Consensus 485 -----------------------------------------------------------------------~-------- 485 (766)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 004247 486 ---------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532 (766)
Q Consensus 486 ---------------------------------~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~y 532 (766)
-.+||-||||+...|.++++.+.... .-...++++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 12578899999988888887654211 356788999999999999
Q ss_pred HHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc----C------------CCCCceecccccccCCCCchhhcc
Q 004247 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----T------------SSSHITCTDVAGTFGYLAPEYFMY 596 (766)
Q Consensus 533 LH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~----~------------~~~~~~~~~~~GT~~Y~APE~l~~ 596 (766)
+|+ +|||||||||.||+|++++.+||+|||+|.... . .......+..+||.-|+|||++..
T Consensus 713 IH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999 899999999999999999999999999998721 0 111112345789999999999985
Q ss_pred C---CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhh
Q 004247 597 G---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILC 673 (766)
Q Consensus 597 ~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~C 673 (766)
. +|+.|+|+|||||||+||+. ||.... +....+. .++.|.+..- ..+..+.+..-..++.++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHH----hcccCCCCCC------cccccccchHHHHHHHHH
Confidence 5 49999999999999999984 575432 1122221 1233433332 122333444455566789
Q ss_pred cccCCCCCCCHHHHHH
Q 004247 674 IRRDPRARPQMSLVLK 689 (766)
Q Consensus 674 l~~dP~~RPs~~eVL~ 689 (766)
++.||.+|||+.++|+
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.91 Aligned_cols=243 Identities=27% Similarity=0.392 Sum_probs=193.1
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 424 NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
..||+|+||.||++.. .+|..||||.+.... .....+.+|+.+++.++|+||++++++|..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5789999999999986 478999999886433 45567889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecc
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 581 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~ 581 (766)
+++... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 987532 47899999999999999999999 89999999999999999999999999998765443221 123
Q ss_pred cccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChH
Q 004247 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661 (766)
Q Consensus 582 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~ 661 (766)
..|++.|+|||++....++.++|+||||+++|+|++|..||............... . .+.+... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~---~---------~~~~~~~--~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---L---------PPKLKNL--HK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---C---------CcccCCc--cc
Confidence 56899999999998888999999999999999999999999764332211111100 0 0111000 00
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 662 QMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 662 ~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+..++..||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11233445678999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.54 Aligned_cols=248 Identities=24% Similarity=0.280 Sum_probs=188.5
Q ss_pred HHHHHhcCcccceee--eccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004247 412 DLLSATSNFLAENLI--GKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 487 (766)
Q Consensus 412 el~~~t~~f~~~~~L--G~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 487 (766)
+.....++|.+.+.+ |.|+||.||++.. .++..+|+|++...... . .|+.+...+ +||||++++++|...+.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~--~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A--IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h--hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 333445667776666 9999999999986 46888999998753211 1 123233222 69999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGL 566 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGl 566 (766)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997543 68999999999999999999999 8899999999999999988 999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+....... ...|+..|+|||++....++.++||||||+++|+|++|+.||........ ....+..... ...
T Consensus 157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--~~~ 227 (267)
T PHA03390 157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQQ--KKL 227 (267)
T ss_pred ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhhc--ccC
Confidence 97664322 24689999999999988999999999999999999999999975433221 1111111110 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 689 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-~~eVL~ 689 (766)
.. . . .....+..++..||+.+|.+||+ +.++++
T Consensus 228 -~~----~-~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -PF----I-K----NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -Cc----c-c----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0 0 11233455567899999999996 688885
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=304.11 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=194.5
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 486 (766)
..++|.+.+.||+|+||.||++.. .+|..||||++... ......+.+|+.+++.++||||++++++|..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 47899999998642 234567889999999999999999999987654
Q ss_pred -ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 487 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 487 -~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7799888753 258899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc----
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI---- 640 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~---- 640 (766)
++....... ....+++.|+|||++.. ..++.++|+|||||++|+|++|+.||...........+.-....
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998654322 22467999999999875 45889999999999999999999999765432211111000000
Q ss_pred ----cccCccccccC--cccCC----CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 641 ----LSSGKVTQLLD--PALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 641 ----~~~g~~~~lld--~~l~~----~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+........+. +.... .........+..++..|++.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 00000 000011123556777899999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.02 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=191.2
Q ss_pred CcccceeeeccCceEEEEEEeC-C--CCEEEEEEccCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec----Cc
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-D--GKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED----NN 487 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~--g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~----~~ 487 (766)
+|.+.+.||+|+||.||++... . +..||||++... ....+.+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 778999998742 23456788999999999 599999999976432 45
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.+++++|+. ++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 6899988643 358899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--ceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 568 KWASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 568 ~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
+........ .......||+.|+|||++.. ..++.++|||||||++|+|++|..||...........+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 866532211 11123578999999998765 468999999999999999999999997654322111111000000000
Q ss_pred ccccccC---------------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 645 KVTQLLD---------------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 645 ~~~~lld---------------~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.+..+.+ ..+. .........+..++..||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000 000001234556777899999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.32 Aligned_cols=243 Identities=27% Similarity=0.439 Sum_probs=191.9
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
|...+.||+|+||.||+|... +|+.|++|++... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999864 6889999998642 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 57887776433 358899999999999999999999 8999999999999999999999999999864322
Q ss_pred CCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 575 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||.............. ........
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~ 242 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NDSPTLQS 242 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCCCCCc
Confidence 12357899999999984 45688999999999999999999999976543222211110 01111111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+. ..+..++..||+.+|.+||++.+++.+
T Consensus 243 ----~~~~----~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ----NEWT----DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----cccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 234556678999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=305.39 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=194.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeec---------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED--------- 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------- 485 (766)
..+|.+.+.||.|+||.||+|... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999864 68899999886543 4557788999999999999999999876543
Q ss_pred -----CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-CCCCe
Q 004247 486 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 559 (766)
Q Consensus 486 -----~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~v 559 (766)
...++||||+. ++|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 35799999997 5898887532 47899999999999999999999 8999999999999997 45678
Q ss_pred eEecccccccccCCCCCc-eecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004247 560 QLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 637 (766)
||+|||++.......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654322111 1122467889999998764 46888999999999999999999999766543322222111
Q ss_pred ccccccCccccccC---ccc-----CCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 638 KPILSSGKVTQLLD---PAL-----GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 638 ~~~~~~g~~~~lld---~~l-----~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.........+.+ ..+ ..... ......+..++..||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11111100000000 000 00000 0112345567788999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.92 Aligned_cols=245 Identities=29% Similarity=0.409 Sum_probs=192.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|...+.||+|+||.||+|... ++..+|+|.+.. ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999864 678899998863 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+. |+|.+.+.... ..+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 58887775433 357899999999999999999998 89999999999999999999999999998765432
Q ss_pred CCCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||.......... .+.. +..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~-----~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ-----NES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhh-----cCC----
Confidence 1246899999999985 3568889999999999999999999986543221111 1111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
+.... ......+..++..||+.+|.+||++.+++++.
T Consensus 232 -~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CCcCc---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 11101 11123345566789999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=298.61 Aligned_cols=206 Identities=25% Similarity=0.386 Sum_probs=178.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
..+|....+||+|+||.|.+|..+ +.+.||||+++++ .+..+--+.|-++|... +-|.+++|..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888999999999999999875 4567999999864 34445556788888877 46799999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+.||+|-..++..+ .|.+..+..++.+||-||-+||+ ++||+||||.+||||+.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999998775 47778889999999999999999 99999999999999999999999999999843
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 631 (766)
-- ...+..+++|||.|+|||++.+..|+..+|+|||||+||||+.|++||++++..+.-
T Consensus 501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 22 233445689999999999999999999999999999999999999999987655433
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.13 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=198.7
Q ss_pred cccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 420 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
|...+.||+|+||.||+|... +++.+|+|++... ....+.+..|+.+++.++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999875 5899999999864 344567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+ ++|.+++.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997643 358999999999999999999999 8999999999999999999999999999986644322
Q ss_pred CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH----------hhcc--cc-
Q 004247 576 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKP--IL- 641 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~----------~~~~--~~- 641 (766)
. .....++..|+|||++... .++.++|||||||++|||++|+.||...........+. |... ..
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 T--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1 1224567889999998866 78999999999999999999999997654322111110 0000 00
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
................ .......+..++..||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000000 00113456777788999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.83 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=197.5
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 487 (766)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 6889999998742 2345677889999999999999999998866554
Q ss_pred --eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 488 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 488 --~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6699998864 258999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccc--
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS-- 642 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~-- 642 (766)
++...... .....+|..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+.-......
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99865432 123468899999999865 3678999999999999999999999976544222111110000000
Q ss_pred ------cCccccccCccc---CCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 643 ------SGKVTQLLDPAL---GNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 643 ------~g~~~~lld~~l---~~~~---~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......++.... ...+ .......+..++..||+.+|.+|||+.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 0000 00113456777888999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.05 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=194.2
Q ss_pred HhcCccc-ceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee----cCce
Q 004247 416 ATSNFLA-ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNL 488 (766)
Q Consensus 416 ~t~~f~~-~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~~ 488 (766)
.|++|.+ -.+||-|-.|.|..+..+ +|+.+|+|++..+.. ..+|+++.-.. .|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4667766 368999999999988764 788999999986643 45677765544 59999999999854 3568
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 565 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFG 565 (766)
.+|||+|+||.|...++..+. ..|++.++-.|..||+.|+.|||+ .+|.||||||+|+|... |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987664 579999999999999999999999 99999999999999964 4569999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
+|+....... ..+.+-||.|.|||++...+|+..+|+||+||++|-||+|.+||...+..... - -.+..+..|.
T Consensus 210 FAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-p--gMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-P--GMKRRIRTGQ 283 (400)
T ss_pred cccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-h--hHHhHhhccC
Confidence 9996654322 23468899999999999999999999999999999999999999765431100 0 0111111111
Q ss_pred cccccCcccCCCCChHHH-HHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLDPALGNNYDYDQM-ERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~-~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+ ++ .+..++++ +....++...|+.+|.+|-|+.+++.+
T Consensus 284 y-~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 00 11122222 233445556799999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=323.33 Aligned_cols=144 Identities=31% Similarity=0.452 Sum_probs=131.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......+..|+.++..++||||+++++++...+.+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 6899999999753 234567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||+.+++|.+++.... .+++..++.|+.||+.||.|||. ++||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 47889999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=286.67 Aligned_cols=206 Identities=28% Similarity=0.467 Sum_probs=172.8
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEE-eCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 486 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 486 (766)
+++++..|+ ++||+|+|+.|--+. +.+|.+||||++.+.. ....+..+|++++.+.+ |+||++|++||.++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 556655554 579999999998876 5789999999997654 56788999999999996 999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC---eeEec
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 563 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~D 563 (766)
.+|||||.|.||+|..+|++.+ .|++.++.++...|+.||.|||. +||.||||||+|||...... +||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999998765 59999999999999999999999 99999999999999976554 79999
Q ss_pred ccccccccC--CCC---CceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 564 FGLAKWAST--SSS---HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 564 FGla~~~~~--~~~---~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
|.|+.-... +-+ .....+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+...
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 988643221 111 11122367899999999864 23689999999999999999999999987543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=303.30 Aligned_cols=213 Identities=27% Similarity=0.406 Sum_probs=180.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.-|..++.||-|+||.|++++.. +...||+|.|++.+ ........|-+||....++-||+||-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35777899999999999999854 45678999998643 33456778999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc---c
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---W 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~---~ 569 (766)
||++||++-.+|.+.+ .|.+..++.++.++..|+++.|+ .|+|||||||+|||||.+|++||+||||+. |
T Consensus 709 dYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999997664 58999999999999999999999 999999999999999999999999999984 2
Q ss_pred ccCC-----CCCc--------------------------------eecccccccCCCCchhhccCCCCCchhhHHHHHHH
Q 004247 570 ASTS-----SSHI--------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 612 (766)
Q Consensus 570 ~~~~-----~~~~--------------------------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL 612 (766)
..+. ..+. .....+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 2110 0000 01125799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccc-hhhHHHhh
Q 004247 613 LELLTGRKPISNDHPKG-QESLVMWA 637 (766)
Q Consensus 613 ~eLltG~~Pf~~~~~~~-~~~lv~~~ 637 (766)
|||+.|+.||..+.+.+ +..++.|.
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehh
Confidence 99999999999887755 34455554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=281.19 Aligned_cols=238 Identities=29% Similarity=0.352 Sum_probs=191.6
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 426 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
||.|+||.||++... +++.+|+|++.... .....+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 58999999987542 3556889999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 99997553 58899999999999999999999 8999999999999999999999999999986654321 122
Q ss_pred ccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 581 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
...|+..|+|||.+.....+.++|+||||+++|+|++|+.||...... ....... . +. ..+ +.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~---~-~~------~~~----~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKIL---K-DP------LRF----PE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHh---c-CC------CCC----CC
Confidence 356899999999999888899999999999999999999999654331 1111110 0 00 001 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCH---HHHHH
Q 004247 661 DQMERMVLASILCIRRDPRARPQM---SLVLK 689 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs~---~eVL~ 689 (766)
.....+..++..||..||++||++ .++++
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 112344556678999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.47 Aligned_cols=260 Identities=27% Similarity=0.365 Sum_probs=194.1
Q ss_pred ccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc--CCCceeEEeeEEeecC----ceEEEEee
Q 004247 421 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFEDN----NLLLVYDF 494 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~~----~~~lV~E~ 494 (766)
...++||+|.||.||+|.+ +++.||||++. ......|.+|-+|++.. .|+||++++++-.... .++||++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFP--EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecC--HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3456799999999999999 56999999997 44567888888887754 7999999999876554 79999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHc------CCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~------~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
.+.|+|.++|..+ .++|....+|+.-+++||+|||. +...+|+|||||++|||+.+|++..|+|||||.
T Consensus 290 h~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999865 48999999999999999999997 234679999999999999999999999999999
Q ss_pred cccCCCCCceecccccccCCCCchhhccCC-CC-----CchhhHHHHHHHHHHHhCCCCCCCCCccc-hh----------
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-----DKIDVYAFGVVLLELLTGRKPISNDHPKG-QE---------- 631 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s-----~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~---------- 631 (766)
.+...........-+||..|||||++.+.. +. .+.||||+|.|||||++...-+....... +.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 887655544444468999999999997432 22 26999999999999998654442111110 00
Q ss_pred -hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 632 -SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 632 -~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.-.+|.. ......-..+.|... ....+.-+...+-.||..||+.|-|+.=|-+++..
T Consensus 445 t~e~mq~~-VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 445 TLEEMQEL-VVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred CHHHHHHH-HHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 0001100 011111111112111 12345556666667999999999999888877653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=309.80 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=216.4
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee---
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE--- 484 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~--- 484 (766)
++.+..-++-|.+.++||.|.+|.||++.. ++|+..|+|++....+..+++..|.+||+.+ .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 444445567899999999999999999985 5789999999998888888899999999988 59999999999874
Q ss_pred --cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 485 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 485 --~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
++.+|||||||.+|+..+++.+.. ...+.|..+..|+.+++.||.+||+ +.+||||||-.||||+.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 467999999999999999998776 4679999999999999999999999 889999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 637 (766)
|||++..+...... ..+..|||.|||||++.-. .|+..+|+||||++..||.-|.+|+.+.++.-...++
T Consensus 166 DFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--- 240 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 240 (953)
T ss_pred eeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence 99999877654333 3457899999999998633 4778999999999999999999999887764322211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.++ --|.| .-+....+.+..++..||.+|-.+||++.++|++
T Consensus 241 ---pRN------PPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ---PRN------PPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---CCC------CCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 01112 2244566777788889999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=305.45 Aligned_cols=240 Identities=27% Similarity=0.352 Sum_probs=190.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+..|.+...+|.|+|+.|-++.. .+++..++|++.... .+..+|+.++... +||||+++.+.|.++.+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45677777899999999988875 478889999998652 2344577666655 699999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee-CCCCCeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL-~~~~~vkL~DFGla~~~~~~ 573 (766)
+.|+-|.+.+..... +. .++..|+.+|+.|+.|||. +|||||||||+|||+ +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999988865532 33 7788899999999999999 999999999999999 68899999999999877654
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
+...+-|..|.|||++....|++++||||||++||+||+|+.||...... ..+.. .+..+.+..
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~~~~s~----- 533 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQMPKFSE----- 533 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcCCcccc-----
Confidence 33356799999999999999999999999999999999999999764332 11111 112222221
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.-.+..+ .+...||+.||.+||+|.+++.+
T Consensus 534 ----~vS~~AK---dLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 534 ----CVSDEAK---DLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----ccCHHHH---HHHHHhccCChhhCcChhhhccC
Confidence 1223333 34467999999999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=307.69 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=207.0
Q ss_pred cccceeeeccCceEEEEEEe-CCC----CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 420 FLAENLIGKGGSSQVYKGCL-PDG----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~-~~g----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
...+++||.|+||+||+|.+ +.| -+||||++... .....+++.|+-+|.+|.|||+++|+++|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44568999999999999985 444 46899998754 355789999999999999999999999998754 89999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
+||+.|.|.++++..+ ..+.-...+.|..|||+||.|||. ++++||||-.+|||+..-.++||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998765 468889999999999999999998 9999999999999999999999999999999887
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
...........-.+-|||=|.+....|+.++|||||||++||++| |..|+.+....+...++. .|. .+-.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~ge--RLsq 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGE--RLSQ 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccc--cCCC
Confidence 766655444445677999999999999999999999999999999 999998766544333322 221 1111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
| ......+..+++.||..|+..||+++++...+..
T Consensus 922 P-------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 P-------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred C-------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2 2223455666778999999999999998876654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=328.71 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=197.4
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+-+|.-...||.|.||.||-|.. .+|...|+|.++.. ....+.+.+|..+|..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44677788999999999999985 57888999988643 244567888999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|||.+|+|.+.+...+ ..++.....+..|++.||.|||+ +|||||||||.||||+.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999997654 35666677889999999999999 9999999999999999999999999999987765
Q ss_pred CCCC--ceecccccccCCCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 573 SSSH--ITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 573 ~~~~--~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
.... .......||+.|||||++.+.+ ...+.||||||||.+||+||+.||...+. +..+|+.-. .|...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~---~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVA---AGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHh---ccCCC
Confidence 4211 1122368999999999997543 45689999999999999999999975433 333443221 12222
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
++. .... ..-..++-.||+.||++|=++.+++++=
T Consensus 1461 q~P-----~~ls----~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 QIP-----ERLS----SEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCc-----hhhh----HhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 221 1111 1112234569999999998888877753
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=278.21 Aligned_cols=206 Identities=28% Similarity=0.419 Sum_probs=173.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC---C--CCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP---D--GKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~---~--g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 487 (766)
...|...+.||+|.||.||+|... + .+.+|||.++.++ ..-....+|+.+++.++|||++.|..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888899999999999999643 2 3479999998653 234567899999999999999999999988 788
Q ss_pred eEEEEeecCCCCHhHhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC----CCeeEe
Q 004247 488 LLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLS 562 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~----~~vkL~ 562 (766)
++|++||.+. +|...|+-.+. ....++-.....|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999977 89998864432 22467888899999999999999999 779999999999999877 899999
Q ss_pred cccccccccCCCCCc-eecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 563 DFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 563 DFGla~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
|||+++.+...-... ....++-|+.|.|||.+.+. .|+.+.|||+.||++.||||-.+.|.+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999887654333 33347789999999998855 69999999999999999999988887543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=289.08 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=197.5
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--------hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-c
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-D 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~ 485 (766)
..++|.+..+||+|||+.||+|++ ...+.||||+-... +...+...+|.+|.+.|.||.||++|++|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345788999999999999999985 45778999986432 2346678899999999999999999999964 5
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEe
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 562 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~ 562 (766)
+.+|-|.|||+|.+|+-+|...+ .+++.+++.|+.||+.||.||.... .+|||-||||.||||.+ -|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 67899999999999999997664 5899999999999999999999865 78999999999999954 4789999
Q ss_pred cccccccccCCCCC-----ceecccccccCCCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004247 563 DFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 633 (766)
Q Consensus 563 DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 633 (766)
||||++.+...... .......||.+|++||.|.-+ +.+.|+||||.||++|..|.|++||..+... ..+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHH
Confidence 99999988765333 223347899999999998755 5788999999999999999999999765332 111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+. ...++....+.--..| ....+.+. ++.+||++..++|....++..
T Consensus 694 Lq-eNTIlkAtEVqFP~KP-----vVsseAka---FIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQ-ENTILKATEVQFPPKP-----VVSSEAKA---FIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hh-hhchhcceeccCCCCC-----ccCHHHHH---HHHHHHHhhhhhhhhHHHHcc
Confidence 11 1111111111110111 11223333 446799999999988776553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=296.79 Aligned_cols=208 Identities=27% Similarity=0.365 Sum_probs=183.6
Q ss_pred cCcccceeeeccCceEEEEEEeCCCC-EEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~-~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++..+..||-||||.|=+...++.. .+|+|++++. ....+.+..|-+||..++.|+||+||--|.+..+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 35566778999999999988875433 4899999863 244567888999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|-|-||.|...|+..+ .|.......++.++++|++|||. ++||+|||||+|.+|+.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997654 58888999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 635 (766)
+.... +++|||.|.|||++.+...+.++|.||||+++||||+|.+||.+.++.....++.
T Consensus 573 g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 573 GRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred CCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 54433 3799999999999999999999999999999999999999999988876665553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=282.61 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=193.8
Q ss_pred ccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecC
Q 004247 421 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+-...||.|+||+|++-.+ +.|+..|||.++.. +...+++..|.+...+- +.||||+++|.+..++..|+.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457799999999999775 47999999999864 35667888898875555 68999999999999999999999995
Q ss_pred CCCHhHhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 497 RGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 497 ggsL~~~L~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
- +|+.+.... ......+++...-.|......||.||-. ...||||||||+||||+..|.+||||||++..+..+..
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 4 776554211 1122468888889999999999999987 47899999999999999999999999999987765433
Q ss_pred CceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 576 HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
. +..+|-..|||||.+.. ..|+.++||||||++|||+.||+.|+...+. ..+.+.+ .-.|....++.+.
T Consensus 224 k---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~-----Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 224 K---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQ-----VVIGDPPILLFDK 294 (361)
T ss_pred h---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHH-----HHcCCCCeecCcc
Confidence 2 23578899999999863 3599999999999999999999999976443 1111111 1122222222211
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...+....++.++..||.+|-..||...+++++
T Consensus 295 ----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 123344456667778999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=274.51 Aligned_cols=219 Identities=21% Similarity=0.197 Sum_probs=174.1
Q ss_pred cCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcC
Q 004247 429 GGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 507 (766)
Q Consensus 429 G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~ 507 (766)
|.||.||++.+. +++.||+|.++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999874 78899999997653 2344555666677999999999999999999999999999999998654
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccC
Q 004247 508 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587 (766)
Q Consensus 508 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 587 (766)
. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ....++..
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 48899999999999999999999 899999999999999999999999999886554321 12356788
Q ss_pred CCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHH
Q 004247 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 667 (766)
Q Consensus 588 Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~ 667 (766)
|+|||++..+.++.++||||||+++|||++|+.||......... . .. ..+...+ ...+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-----------~---~~---~~~~~~~----~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----------H---TT---LNIPEWV----SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----------c---cc---cCCcccC----CHHHH
Confidence 99999998888999999999999999999999887542211000 0 00 0011111 12344
Q ss_pred HHHHhhcccCCCCCCCH
Q 004247 668 LASILCIRRDPRARPQM 684 (766)
Q Consensus 668 ~~~~~Cl~~dP~~RPs~ 684 (766)
.++..||+.||.+||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 56677999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=308.50 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=202.7
Q ss_pred CcccceeeeccCceEEEEEEeC----C----CCEEEEEEccCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP----D----GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 487 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~----~----g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 487 (766)
+..+.+.||+|.||.|++|... . ...||||.++... ...+.+..|+++|+.+ +|+||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3345568999999999999742 1 4568999998643 5678899999999999 49999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCC---CC-------C--CCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC
Q 004247 488 LLLVYDFLSRGSLEENLHGNK---KD-------P--AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~---~~-------~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 555 (766)
+++|+||+..|+|.++|+..+ .. . ..++....+.++.|||.|++||++ .++|||||-.+|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999998776 00 0 238889999999999999999999 88999999999999999
Q ss_pred CCCeeEecccccccccCCCCCceecccccc--cCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 556 DFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 556 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT--~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+..+||+|||+|+.......... ..-.|| ..|||||.+....|+.|+|||||||+||||+| |..||.+-.. ...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~ 530 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE 530 (609)
T ss_pred CCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence 99999999999996655443321 112232 34999999999999999999999999999999 9999976221 112
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+.. .+..|...+ .+......+..++..||+.+|++||++.++.+.|..
T Consensus 531 l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 LLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 222 223332111 122223455677788999999999999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=263.70 Aligned_cols=237 Identities=30% Similarity=0.405 Sum_probs=191.1
Q ss_pred CceEEEEEEeC-CCCEEEEEEccCChh-H-HHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHhHhhhc
Q 004247 430 GSSQVYKGCLP-DGKELAVKILKPSED-V-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 506 (766)
Q Consensus 430 ~fG~Vy~a~~~-~g~~vAVK~l~~~~~-~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~ 506 (766)
+||.||+|... +|+.+++|++..... . .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999976 589999999976432 2 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceeccccccc
Q 004247 507 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586 (766)
Q Consensus 507 ~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~ 586 (766)
.. .+++..++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......|+.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 43 27899999999999999999999 899999999999999999999999999998766542 122356899
Q ss_pred CCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHH
Q 004247 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 666 (766)
Q Consensus 587 ~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~ 666 (766)
.|++||.+....++.++||||||+++++|++|..||...... .....+... +..... .........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~----~~~~~~-------~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGK----PKPPFP-------PPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhc----cCCCCc-------cccccCCHHH
Confidence 999999999888999999999999999999999999763211 112211110 000000 0000022356
Q ss_pred HHHHHhhcccCCCCCCCHHHHHH
Q 004247 667 VLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 667 ~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
..++.+|+..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 66778899999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=275.83 Aligned_cols=267 Identities=28% Similarity=0.408 Sum_probs=203.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc--CCCceeEEeeEEeecC----ce
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFEDN----NL 488 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~~----~~ 488 (766)
....+..+.+.||+|-||.||+|.+ .|..||||++...++ ..+.+|.+|+... +|+||+.+++.=..++ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3445677889999999999999998 788999999985432 5677888888765 8999999998755443 58
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHc-----CCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-----GSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
|||.+|.+.|+|+++|... .++-...++++.-+|.||++||. .+...|.|||||+.|||+..++...|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999764 58889999999999999999995 3446799999999999999999999999
Q ss_pred ccccccccCCCCC--ceecccccccCCCCchhhccCC----C--CCchhhHHHHHHHHHHHhC----------CCCCCCC
Q 004247 564 FGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYGK----V--NDKIDVYAFGVVLLELLTG----------RKPISND 625 (766)
Q Consensus 564 FGla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~----~--s~ksDVwSlGvvL~eLltG----------~~Pf~~~ 625 (766)
+|||......... ......+||..|||||++.... + -..+||||||.||||+... +.||.+-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876654322 2334478999999999987432 1 1258999999999999752 4566554
Q ss_pred CccchhhHHHhhccccccCccccccCcccCC-CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 626 HPKGQESLVMWAKPILSSGKVTQLLDPALGN-NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 626 ~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~-~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
-+.+.....|. ...--.+ +.|.+.+ ....+.+..|..++..||..+|..|-|+-.+-+.|....
T Consensus 440 Vp~DPs~eeMr--kVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 440 VPSDPSFEEMR--KVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCHHHHh--cceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 43332222211 1111111 2222222 235678889999999999999999999988877775433
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=280.50 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=206.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCC--C----ceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH--K----NIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--p----nIv~l~~~~~~~~~~~ 489 (766)
++.|.+..++|+|.||.|..+.+. .+..||||+++.-....+..+-|+++|.++.+ | -+|++.+||.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 778999999999999999998764 47889999999888888888899999999942 2 3888999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC--------------
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------------- 555 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-------------- 555 (766)
+|+|.+ |-++.++|..+.- .+++...++.++.|+++++.|||+ .+++|.||||+|||+..
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 6699999987654 468889999999999999999999 89999999999999942
Q ss_pred ------CCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 556 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 556 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
+..++|+|||.|.+..... ..++.|..|.|||++.+-.++.++||||+||||+||.||...|+.....
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~- 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL- 315 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH-
Confidence 3458999999998665543 2367899999999999999999999999999999999999999876533
Q ss_pred hhhHHHhhc---c-------------ccccCc-----------cccccCcccC----CCCChHHHHHHHHHHHhhcccCC
Q 004247 630 QESLVMWAK---P-------------ILSSGK-----------VTQLLDPALG----NNYDYDQMERMVLASILCIRRDP 678 (766)
Q Consensus 630 ~~~lv~~~~---~-------------~~~~g~-----------~~~lld~~l~----~~~~~~~~~~~~~~~~~Cl~~dP 678 (766)
+.+.|... | .+..|. ....+++... ......+...++.++..+|..||
T Consensus 316 -EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 -EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred -HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 22322211 0 111111 0111111110 01123455567888888999999
Q ss_pred CCCCCHHHHHHH
Q 004247 679 RARPQMSLVLKL 690 (766)
Q Consensus 679 ~~RPs~~eVL~~ 690 (766)
.+|+|+.|+|.+
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=287.43 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=190.0
Q ss_pred ceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 423 ENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
+++||.|-||+||-|.+ ++|+.||||++.+- ......+.+|+.||.+++||.||.|.-.|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 68999999999999986 58999999998652 244477889999999999999999999999999999999999665
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---CCeeEecccccccccCCCC
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~~~~~~~ 575 (766)
-|+-.|...+ ..+++.....++.||+.||.|||. ++|+|+||||+||||... ..+||||||+|++++....
T Consensus 649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 5555554333 468888888999999999999999 999999999999999643 4689999999999887644
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. ..++|||.|+|||++....|+...|+||.||++|--|+|..||..+... ...+..+.-......+.++
T Consensus 723 R---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~PW~ei------ 791 (888)
T KOG4236|consen 723 R---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNPWSEI------ 791 (888)
T ss_pred h---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCchhhc------
Confidence 3 3479999999999999999999999999999999999999999754321 1112111111111111111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+.++...|+..=.+|-+...-|.+
T Consensus 792 -------s~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 792 -------SPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -------CHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1123334445566666788888776654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=270.26 Aligned_cols=198 Identities=23% Similarity=0.385 Sum_probs=174.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccC----ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.++||+|.|+.|..+.++ +.+.||+|++++ ..+...-...|-.+..+. +||++|-|..+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457899999999999999999874 678899999975 234455667788888777 69999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
|.||++||+|--+++..+ .++++.++.+..+|+.||.|||+ +|||+||||..|+|||..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999988887664 58999999999999999999999 99999999999999999999999999999854
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 623 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 623 (766)
-.. . .+..+++|||.|+|||++.+..|...+|+|+|||+++||+.|+.||+
T Consensus 402 l~~-g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 402 LGP-G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCC-C-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 332 2 22345899999999999999999999999999999999999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=298.94 Aligned_cols=262 Identities=18% Similarity=0.220 Sum_probs=169.2
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-C----CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeE------Eee
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-D----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF------CFE 484 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~------~~~ 484 (766)
..++|.+.+.||+|+||.||+|.+. + +..||||++...... +.+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4678999999999999999999875 4 689999988643221 111111 1222222222222221 245
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCC----------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccC
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKD----------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 548 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp 548 (766)
+..+++||||+.+++|.++++..... ........+..|+.||+.||.|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 66799999999999999998753210 0011233456799999999999999 8999999999
Q ss_pred CCeeeCC-CCCeeEecccccccccCCCCCceecccccccCCCCchhhccC----------------------CCCCchhh
Q 004247 549 SNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----------------------KVNDKIDV 605 (766)
Q Consensus 549 ~NILL~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----------------------~~s~ksDV 605 (766)
+|||++. ++.+||+|||+|+.+...... ......||+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 578999999999865443222 22346899999999965422 24556799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccc-------hhhHHHhhccccccCccccccCcccCCCCC--hHHHHHHHHHHHhhccc
Q 004247 606 YAFGVVLLELLTGRKPISNDHPKG-------QESLVMWAKPILSSGKVTQLLDPALGNNYD--YDQMERMVLASILCIRR 676 (766)
Q Consensus 606 wSlGvvL~eLltG~~Pf~~~~~~~-------~~~lv~~~~~~~~~g~~~~lld~~l~~~~~--~~~~~~~~~~~~~Cl~~ 676 (766)
|||||+||||+++..|+......- ...+..|....... ..+.+...+. .........++..||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999876654221000 00111221111000 0000000000 00011223566789999
Q ss_pred CCCCCCCHHHHHHH
Q 004247 677 DPRARPQMSLVLKL 690 (766)
Q Consensus 677 dP~~RPs~~eVL~~ 690 (766)
||.+|||+.++|++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=267.42 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=196.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--------C
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------N 486 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------~ 486 (766)
.|.-...||+|.||.||+|..+ .|+.||+|+.-- .+..-....+|+++|..|.|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555678999999999999864 678888876532 223445678999999999999999999988542 3
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+||||++++. +|..+|.... ..++..++.++..++..||.|+|. ..|+|||+|+.|+||+.+|.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 48999999977 8998886543 468999999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCC--CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc----
Q 004247 567 AKWASTSS--SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP---- 639 (766)
Q Consensus 567 a~~~~~~~--~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~---- 639 (766)
++.+.... ....+++.+-|..|++||.+.+ ..|+.+.|||..||++.||.||.+-|+++....+..++.....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98665432 2233556778999999998874 4799999999999999999999999988776655555432110
Q ss_pred -ccccC---cccccc--CcccCCCC--ChHHHH------HHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 640 -ILSSG---KVTQLL--DPALGNNY--DYDQME------RMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 640 -~~~~g---~~~~ll--d~~l~~~~--~~~~~~------~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
.+..- .+.+.+ .|.-.+.+ -.+.++ ..+.++-.++..||.+|+++.+++.+-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00000 000001 11000000 000011 223344458899999999999999753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=255.22 Aligned_cols=200 Identities=27% Similarity=0.389 Sum_probs=169.1
Q ss_pred ccceeeeccCceEEEEEEe-CCCCEEEEEEccC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecC
Q 004247 421 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.....||+|++|.|-+-.+ .+|+..|+|.++. ..+..++.++|+++..+. .+|++|.++|.+......++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3456789999999977664 5899999999875 346677888899886655 69999999999999999999999995
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
- +|..+..+.-.....+++..+-+|+..+.+||.|||+ ...+||||+||+||||+.+|++||||||++..+.++...
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 5 8888776555555678999999999999999999998 378999999999999999999999999999887665433
Q ss_pred ceecccccccCCCCchhhcc----CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
.. ..|-..|||||.+.. ..|+-|+||||||++++||.+++.||....
T Consensus 206 t~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 21 468889999998863 369999999999999999999999997643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=243.72 Aligned_cols=214 Identities=23% Similarity=0.346 Sum_probs=178.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+|.-.+.||+|.||+||+|... +++.||+|..+.++ .......+||-+|+.++|.|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3445578999999999999864 67889999987543 4556789999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+.. +|.++..... ..++.+..+.++.|+++||.+.|+ +++.||||||.|+||+.+|++||+|||+++..+-..
T Consensus 83 cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 8888886544 357888999999999999999999 899999999999999999999999999999776543
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
... ..-+-|..|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+-..+..-+.|.....
T Consensus 156 rcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p 222 (292)
T KOG0662|consen 156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_pred Eee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence 222 224579999999998765 48999999999999999998 777788776666655555544333
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=284.08 Aligned_cols=205 Identities=22% Similarity=0.313 Sum_probs=155.7
Q ss_pred HhcCcccceeeeccCceEEEEEEe-----------------CCCCEEEEEEccCChh-HHHH--------------HHHH
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-----------------PDGKELAVKILKPSED-VIKE--------------FVLE 463 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vAVK~l~~~~~-~~~~--------------~~~E 463 (766)
..++|.+.++||+|+||+||+|.+ ..++.||||.++.... ..++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 366899999999999999999964 2456899999875432 2223 3346
Q ss_pred HHHHHhcCCCce-----eEEeeEEee--------cCceEEEEeecCCCCHhHhhhcCCC--------------------C
Q 004247 464 IEIITTLHHKNI-----ISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 510 (766)
Q Consensus 464 i~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~L~~~~~--------------------~ 510 (766)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 677787753 3568999999999999999875321 0
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCC
Q 004247 511 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590 (766)
Q Consensus 511 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 590 (766)
...++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 1235678899999999999999999 889999999999999999999999999997654322211 111345899999
Q ss_pred chhhccCC----------------------CCCchhhHHHHHHHHHHHhCCC-CCCC
Q 004247 591 PEYFMYGK----------------------VNDKIDVYAFGVVLLELLTGRK-PISN 624 (766)
Q Consensus 591 PE~l~~~~----------------------~s~ksDVwSlGvvL~eLltG~~-Pf~~ 624 (766)
||.+.... ...+.||||+||+||+|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99876432 1235799999999999999875 7653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=289.17 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=186.4
Q ss_pred cccceeeeccCceE-EEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 420 FLAENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 420 f~~~~~LG~G~fG~-Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
|...+++|.|..|+ ||+|.. +|+.||||.+-.. ...-..+||..|+.- .|||||++++.-.+...+||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 34456789999987 699998 8889999988643 334567899999988 599999999998888999999999955
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---C--CCeeEecccccccccC
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---D--FEPQLSDFGLAKWAST 572 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~--~~vkL~DFGla~~~~~ 572 (766)
+|.+++......-....-...+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999998641111111214557789999999999999 88999999999999975 2 4689999999998776
Q ss_pred CCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccC-ccccc
Q 004247 573 SSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG-KVTQL 649 (766)
Q Consensus 573 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g-~~~~l 649 (766)
+.... ......||-||+|||++....-+.++|||||||++|+.++ |.+||...... +.+++ ... .+..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl-------~~~~~L~~- 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANIL-------TGNYTLVH- 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhhh-------cCccceee-
Confidence 54332 2345789999999999998888889999999999999999 59999764322 11111 111 1111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+....+. ....++..|+..+|..||++.+||.+
T Consensus 735 ----L~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 ----LEPLPDC----EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----eccCchH----HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111111 33445567999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=263.30 Aligned_cols=264 Identities=20% Similarity=0.325 Sum_probs=201.2
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-----C---CceeEEeeEEee---
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----H---KNIISLLGFCFE--- 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~l~~~~~~--- 484 (766)
..+|.+.+.||.|.|++||++.+ .+.+.||+|+.+......+..+.||.+|++++ | ..||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 46899999999999999999986 46788999999988888888999999999994 2 369999999964
Q ss_pred -cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-------
Q 004247 485 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------- 556 (766)
Q Consensus 485 -~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~------- 556 (766)
+.++|||+|++ |.+|..+|....- ..++...+.+|+.||+.||.|||..| +|||.||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 46899999999 7799999986654 45788999999999999999999854 79999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 004247 557 -------------------------------------------------------------------------------- 556 (766)
Q Consensus 557 -------------------------------------------------------------------------------- 556 (766)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 004247 557 -------------------------------------------------------------------------------F 557 (766)
Q Consensus 557 -------------------------------------------------------------------------------~ 557 (766)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc----hhhH
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG----QESL 633 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~----~~~l 633 (766)
.+||+|||-|.|.... ++.-..|..|.|||++.+..|+..+||||++|++|||+||...|+...... ...+
T Consensus 392 ~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 0355555555544322 223457889999999999999999999999999999999999997543222 1111
Q ss_pred H-------HhhccccccCc-cccccCc-----------------ccCC--CCChHHHHHHHHHHHhhcccCCCCCCCHHH
Q 004247 634 V-------MWAKPILSSGK-VTQLLDP-----------------ALGN--NYDYDQMERMVLASILCIRRDPRARPQMSL 686 (766)
Q Consensus 634 v-------~~~~~~~~~g~-~~~lld~-----------------~l~~--~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~e 686 (766)
. +....+...|+ ..++++. .|.. .+..++...+..+.+-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1 11112222222 1222221 1111 245677888888888899999999999999
Q ss_pred HHHH
Q 004247 687 VLKL 690 (766)
Q Consensus 687 VL~~ 690 (766)
.|++
T Consensus 547 cl~h 550 (590)
T KOG1290|consen 547 CLKH 550 (590)
T ss_pred HhcC
Confidence 9874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=272.65 Aligned_cols=236 Identities=26% Similarity=0.318 Sum_probs=194.8
Q ss_pred chhHHhhhhhccccccccCHHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHh
Q 004247 391 PKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITT 469 (766)
Q Consensus 391 ~~~l~~~~~~~~~~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~ 469 (766)
+.+...++..+...--.|.+.--+..-..|.+....|+|-|++|.+|.+. -|..||||++..++...+.=+.|++||++
T Consensus 405 ~~~~~~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkK 484 (752)
T KOG0670|consen 405 PRVNPGLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKK 484 (752)
T ss_pred cccCCccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHH
Confidence 44444555555554444555444556778999999999999999999864 57899999999998888888999999999
Q ss_pred cC------CCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEe
Q 004247 470 LH------HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543 (766)
Q Consensus 470 l~------HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 543 (766)
|+ .-++++|+-.|...+++|||||-+ ..+|.+.|...+.. ..|....+..++.|++.||..|-+ .+|+|
T Consensus 485 L~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~---c~vlH 559 (752)
T KOG0670|consen 485 LNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKK---CGVLH 559 (752)
T ss_pred hhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHh---cCeee
Confidence 96 348999999999999999999998 45999999887643 567888899999999999999998 78999
Q ss_pred ecccCCCeeeCCC-CCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCC
Q 004247 544 RDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622 (766)
Q Consensus 544 rDLKp~NILL~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf 622 (766)
.||||.|||+++. ..+||||||.|.......- +...-+..|.|||++.+-.|+...|+||.||+||||.||+..|
T Consensus 560 aDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 560 ADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 9999999999865 5689999999987765322 2234566799999999999999999999999999999999999
Q ss_pred CCCCccchhhHHH
Q 004247 623 SNDHPKGQESLVM 635 (766)
Q Consensus 623 ~~~~~~~~~~lv~ 635 (766)
.+........+.|
T Consensus 636 pG~TNN~MLrl~m 648 (752)
T KOG0670|consen 636 PGRTNNQMLRLFM 648 (752)
T ss_pred CCCCcHHHHHHHH
Confidence 8876555444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=238.18 Aligned_cols=210 Identities=35% Similarity=0.606 Sum_probs=182.8
Q ss_pred eeccCceEEEEEEeCC-CCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHhH
Q 004247 426 IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 502 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ 502 (766)
||+|++|.||++.... ++.+++|++..... ....+.+|+.++..+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999987654 36789999999999999999999999999889999999999999999
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccccccCCCCCceecc
Q 004247 503 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTD 581 (766)
Q Consensus 503 ~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 581 (766)
++.... ..+++..+..++.+++.+|.|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987542 357899999999999999999999 89999999999999999 89999999999986655331 1122
Q ss_pred cccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCCh
Q 004247 582 VAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660 (766)
Q Consensus 582 ~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~ 660 (766)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4688899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004247 661 DQMERMVLASILCIRRDPRARPQMSLVLKLL 691 (766)
Q Consensus 661 ~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L 691 (766)
..+..++..|++.+|.+||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3455566789999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=258.90 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=198.2
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----CceE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 489 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~ 489 (766)
+...++.||-|+||.||...++ +|+.||+|.+..-- ...+.+.+|+.+|..++|.|++..++...-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3456789999999999998874 89999999887532 4567899999999999999999998876432 3568
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+|.|+|.. +|.+.| ..++.++-..+.-+..||++||.|||+ .+|+||||||.|+|++.|..+||||||+|+.
T Consensus 134 V~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 88998855 777766 445678888889999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc--------cc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--------PI 640 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~--------~~ 640 (766)
........ .+.-+-|..|.|||++++. .|+.+.||||.||++.||+..+..|+..++..+..++.-.. ..
T Consensus 206 ee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 66544433 2345678999999999965 69999999999999999999999999888877665543211 00
Q ss_pred cccCccccccCcccCC-C----C---C-hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 641 LSSGKVTQLLDPALGN-N----Y---D-YDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~-~----~---~-~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
--+|.-..++...... . + . ...-..-+.+..+++..||++|.+..+.+.++-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0111111111111110 0 0 0 011122333445678999999999988887653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=257.28 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=209.4
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 481 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 481 (766)
.+++.....+++...++-+|.||.||+|.+. +.+.|.+|.++.. .-....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566667778888999999999999999653 3456778888753 3556788999999999999999999999
Q ss_pred Eeec-CceEEEEeecCCCCHhHhhhcCC----CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC
Q 004247 482 CFED-NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556 (766)
Q Consensus 482 ~~~~-~~~~lV~E~~~ggsL~~~L~~~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 556 (766)
+.++ ...+++|.++.-|+|..+|...+ .....++..+...++.|++.|++|||+ ++|||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 8764 57899999999999999998332 223456777888899999999999999 999999999999999999
Q ss_pred CCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHH
Q 004247 557 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 635 (766)
Q Consensus 557 ~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~ 635 (766)
..+||+|=.+++-+-....+.--.+--....||+||.+.+..|+.++|||||||+||||+| |+.|+..-+|.+.+..+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999886544443332222334567999999999999999999999999999999 999998877766554332
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
-.. ++.+ +.+....++.++..||...|++||++++++.-|.
T Consensus 513 dGy------RlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 513 DGY------RLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred ccc------eecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 111 1111 1222334566677899999999999999998775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=237.57 Aligned_cols=198 Identities=35% Similarity=0.503 Sum_probs=173.1
Q ss_pred cccceeeeccCceEEEEEEeCC-CCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 420 FLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
|.+.+.||.|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999864 88999999986542 57789999999999999999999999999899999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... .+++..+..++.+++.+|.|||+ .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976532 17889999999999999999999 79999999999999999999999999999877554311
Q ss_pred ceecccccccCCCCchhh-ccCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 004247 577 ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPISN 624 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 624 (766)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11235688899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=235.52 Aligned_cols=196 Identities=23% Similarity=0.436 Sum_probs=166.8
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeec--CceEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLV 491 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~lV 491 (766)
..++|.+.+.+|+|-|+.||.|.. .+.+.++||++++-+ .+.+.+|+.||..|+ ||||++|++...+. ..+.||
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 356899999999999999999974 578899999999654 467889999999998 99999999998654 467899
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEecccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 570 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~ 570 (766)
+||+.+.+...+.. .++...+..++.+++.||.|+|+ +||+|||+||.|++||.. -.++|+|+|||.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999987776653 46677888999999999999999 999999999999999865 46999999999988
Q ss_pred cCCCCCceecccccccCCCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
...... .-.+.+..|--||.+. ...|+...|+|||||+|..|+..+.||-...
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 765432 2246677888999876 5679999999999999999999999986544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=262.73 Aligned_cols=196 Identities=24% Similarity=0.360 Sum_probs=169.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHH---------HHHHHHHHHHhcC---CCceeEEeeEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIK---------EFVLEIEIITTLH---HKNIISLLGFCF 483 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~---------~~~~Ei~iL~~l~---HpnIv~l~~~~~ 483 (766)
..+|...+.+|.|+||.|++|.++ +...|+||.+.+++-... ....||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999976 466789999887543222 2445999999998 999999999999
Q ss_pred ecCceEEEEeecC-CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 484 EDNNLLLVYDFLS-RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 484 ~~~~~~lV~E~~~-ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
+++++||+||.-. |-+|.++|.... .+++.++..|+.|++.|+++||+ ++|||||||-+|+.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 9999999999764 558999997554 58999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCC
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPIS 623 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~ 623 (766)
|||.|-+...+.. ..++||.+|.|||++.+.+|- ..-|||+||++||.++....||.
T Consensus 713 dfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999977655433 347899999999999988775 46899999999999999888884
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=266.29 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=202.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.....||.|.||.|||+++. .++..|||+++... +...-+.+|+-+++..+|||||.++|.+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 357888899999999999999864 78899999998754 5667788899999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+.+|+|.+..+... ++++.++..++++.++||.|||+ ++-+|||||-.|||+++.|.+|+.|||.+-.+....
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999887654 68899999999999999999999 888999999999999999999999999987665543
Q ss_pred CCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 575 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.. ...+.||+.|||||+.. .+.|..++|||++|++..|+---+.|....++.. .+.+..+..+..
T Consensus 167 ~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~qp-------- 234 (829)
T KOG0576|consen 167 AK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQP-------- 234 (829)
T ss_pred hh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCCC--------
Confidence 32 34578999999999764 6789999999999999999998888876554422 121112211111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
|.+.+...+ -+.+-.++..|+..+|++||+++.+|.
T Consensus 235 p~lkDk~kw--s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 223222222 223344555699999999999987765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=238.24 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=166.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------Cc
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 487 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~ 487 (766)
.+|.....+|.|.- .|..+.+. .++.||+|.+... ....++..+|..++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666778888888 66666543 6889999987542 34567788999999999999999999998643 35
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.|+|||||.. +|...++. .++-..+..|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 7999999955 99988873 25567788999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 630 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 630 (766)
+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+...+
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 865544 234567899999999999988899999999999999999999999986554433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=228.40 Aligned_cols=198 Identities=25% Similarity=0.412 Sum_probs=164.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeE-EeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF-CFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~-~~~~~~~~lV~E 493 (766)
.+.|.+.+.||+|.||.+-++.++ +.+.+++|-+...-...++|.+|...--.| .|.||+.-|+. |+..+.++++||
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 346888999999999999999875 577899999988777889999999876666 48999988765 566678899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC--CCCCeeEeccccccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DFGla~~~~ 571 (766)
|++.|+|...+... .+.+....+++.|++.||.|+|+ .++||||||.+||||- +...+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988653 47788889999999999999999 8999999999999993 34579999999987554
Q ss_pred CCCCCceecccccccCCCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
.... ...-+..|.+||..... ...+.+|||.||+++|..|||..|++....
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 4322 23456789999987532 356789999999999999999999985443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-26 Score=275.17 Aligned_cols=197 Identities=21% Similarity=0.278 Sum_probs=139.9
Q ss_pred hcCC-CceeEEeeEE-------eecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc
Q 004247 469 TLHH-KNIISLLGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540 (766)
Q Consensus 469 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 540 (766)
.++| +||++++++| .....++++|||+ +++|.++|.... ..+++.+++.|+.||++||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 3455 5888888887 3335678889988 559999997432 358999999999999999999999 89
Q ss_pred eEeecccCCCeeeCC-------------------CCCeeEecccccccccCCCC--------------CceecccccccC
Q 004247 541 VIHRDVKSSNILLSD-------------------DFEPQLSDFGLAKWASTSSS--------------HITCTDVAGTFG 587 (766)
Q Consensus 541 IiHrDLKp~NILL~~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~GT~~ 587 (766)
||||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44567777777754321000 000112468999
Q ss_pred CCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHH
Q 004247 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 667 (766)
Q Consensus 588 Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~ 667 (766)
|+|||++.+..|+.++|||||||+||||++|..|+..... ........ .+.+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999888753211 11000000 011110 01112234
Q ss_pred HHHHhhcccCCCCCCCHHHHHHH
Q 004247 668 LASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 668 ~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.++..||+.+|.+||+|.+++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 55678999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=236.90 Aligned_cols=200 Identities=27% Similarity=0.398 Sum_probs=165.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 489 (766)
...+.|...+.||+|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34567889999999999999999853 46789999887543 2356889999999995 899999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 568 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 568 (766)
+|+||++.....+++.. ++..++..++..++.||.++|. +|||||||||+|+|.+. .+.-.|+|||||.
T Consensus 112 ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence 99999999998888853 5678899999999999999999 99999999999999975 4667899999997
Q ss_pred cccCCC---------------------------------CCc---------eecccccccCCCCchhhc-cCCCCCchhh
Q 004247 569 WASTSS---------------------------------SHI---------TCTDVAGTFGYLAPEYFM-YGKVNDKIDV 605 (766)
Q Consensus 569 ~~~~~~---------------------------------~~~---------~~~~~~GT~~Y~APE~l~-~~~~s~ksDV 605 (766)
...... +.. ..-..+||+||.|||++. .+..++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 000 011257999999999886 4467889999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 004247 606 YAFGVVLLELLTGRKPISND 625 (766)
Q Consensus 606 wSlGvvL~eLltG~~Pf~~~ 625 (766)
||.||+++-+++++.||-..
T Consensus 262 ws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeccceeehhhccccccccC
Confidence 99999999999999998643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=210.70 Aligned_cols=165 Identities=24% Similarity=0.232 Sum_probs=123.7
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++...+ ..++|..++.|+.|++.||.|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997543 369999999999999999999998 54 999999999999999 99998765422
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... +..+...... . ++.. ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~------~-~~~~-~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPA------D-DPRD-RS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhcc------C-Cccc-cc
Confidence 25899999999999999999999999999999999999999754332211 1111110000 0 0000 00
Q ss_pred CChHHH--HHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 658 YDYDQM--ERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 658 ~~~~~~--~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
...... ..+..++..||..+|.+||++.++++++.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 011111 24677888899999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-22 Score=206.87 Aligned_cols=258 Identities=30% Similarity=0.433 Sum_probs=195.1
Q ss_pred cccceeeeccCceEEEEEEeCCCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCC-ceeEEeeEEeecCceEEEEee
Q 004247 420 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~E~ 494 (766)
|.+...||.|+||.||++... ..+++|.+.... .....+.+|+.++..+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999886 789999997643 2477899999999999988 799999999777778999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~ 573 (766)
+.+++|.+++...... ..+.......++.+++.+|.|+|. .+++||||||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777544311 257888999999999999999999 8899999999999999988 7999999999865544
Q ss_pred CCCc----eecccccccCCCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCcc---chhhHHHhhcccccc
Q 004247 574 SSHI----TCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK---GQESLVMWAKPILSS 643 (766)
Q Consensus 574 ~~~~----~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---~~~~lv~~~~~~~~~ 643 (766)
.... ......||..|+|||.+.. ..++...|+||+|++++++++|..||...... .......+.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 3221 2345789999999999987 57889999999999999999999997665431 1111111111100
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.................+..+...|+..+|..|.++......
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001112344455567889999999999877654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=225.51 Aligned_cols=164 Identities=20% Similarity=0.184 Sum_probs=129.7
Q ss_pred HhcCcccceeeeccCceEEEEEEeC--CCCEEEEEEccCC------hhHHHHHHHHHHHHHhcCCCceeE-EeeEEeecC
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIIS-LLGFCFEDN 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~ 486 (766)
..++|.+.+.||+|+||+||+|.+. +++.+|||++... ......|.+|+++|.+++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3467999999999999999999864 5777899986532 234567899999999999999985 4432 4
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecc-cCCCeeeCCCCCeeEeccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL-Kp~NILL~~~~~vkL~DFG 565 (766)
..+|||||++|++|.. +... . ...++.++++||.|||+ ++|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~~-------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARPH-------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCcc-------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 6799999999999973 2110 0 14578899999999999 89999999 9999999999999999999
Q ss_pred ccccccCCCCCce------ecccccccCCCCchhhccC
Q 004247 566 LAKWASTSSSHIT------CTDVAGTFGYLAPEYFMYG 597 (766)
Q Consensus 566 la~~~~~~~~~~~------~~~~~GT~~Y~APE~l~~~ 597 (766)
+|+.+........ .++..+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997655432111 1356789999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=213.65 Aligned_cols=256 Identities=24% Similarity=0.282 Sum_probs=189.6
Q ss_pred CcccceeeeccCceEEEEEEeCCC--CEEEEEEccCChh-HHHHHHHHHHHHHhcCC----CceeEEeeEE-eecCceEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDG--KELAVKILKPSED-VIKEFVLEIEIITTLHH----KNIISLLGFC-FEDNNLLL 490 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g--~~vAVK~l~~~~~-~~~~~~~Ei~iL~~l~H----pnIv~l~~~~-~~~~~~~l 490 (766)
+|.+.+.||+|+||.||++..... ..+|+|+...... ....+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987553 4789998875432 22267889999999873 6899999988 47778899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-----CCeeEeccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFG 565 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-----~~vkL~DFG 565 (766)
||+.+ |.+|.++..... ...|+......|+.|++.+|.+||+ .|+|||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 779999886554 3579999999999999999999999 999999999999999765 358999999
Q ss_pred ccc--cccCCCCC----c-e-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH-Hh
Q 004247 566 LAK--WASTSSSH----I-T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MW 636 (766)
Q Consensus 566 la~--~~~~~~~~----~-~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~ 636 (766)
+++ ........ . . ...+.||..|.++....+...+.+.|+||++.++.||+.|..|+............ ..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 1 1 12356999999999999999999999999999999999999999665432221111 11
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.... .... .......+...+. ..+-..+...+|....+...|+.
T Consensus 253 ~~~~--------~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 253 PRKL--------LTDR--FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred hhhh--------cccc--ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHH
Confidence 1100 0000 1111222333322 23445788999999988887653
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=178.44 Aligned_cols=137 Identities=23% Similarity=0.369 Sum_probs=112.5
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCc------chhhhHHHHHHHHHHHhHhhhcCCc
Q 004247 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS------LLSLVKAFDSVLAVYEGFCNLKQVD 91 (766)
Q Consensus 18 ~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~~~~C~~k~V~ 91 (766)
+|+||+|+|+.|..||+||++.+...|+.|++|||.++........... .....+...++|+.+...|...++.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 4999999999999999999999888899999999987543221111100 0111233347889999999889999
Q ss_pred EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 92 ~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
++..++.|+++.++|+++|+..++++||||++++ .|.++| +||++||++++|++|||++|+||
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~g-ssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKK-SDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccC-CchhHHHHhcCCCCceEEEEeCc
Confidence 9999999889999999999999999999999998 345665 47999999999999999999997
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=192.25 Aligned_cols=201 Identities=22% Similarity=0.294 Sum_probs=170.1
Q ss_pred CcccceeeeccCceEEEEEE-eCCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecC
Q 004247 419 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+|.+.+.||+|.||.++.|. +-++++||||.-... ...-++..|.+..+.|. .++|...+-|..++-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 68999999999999999997 358999999976432 23356677888888885 689999998888888889999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-----CCeeEeccccccccc
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFGLAKWAS 571 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-----~~vkL~DFGla~~~~ 571 (766)
|.+|++++.-.. ..|+.....-||.|++.-++|+|. +.+|+|||||+|+||... ..+.|+|||+|+.+.
T Consensus 107 GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 789999987554 369999999999999999999999 889999999999999643 358899999999886
Q ss_pred CCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 572 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 572 ~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
+..+.. ......||..||+--...+...+.+-|+-|||-|+++.|.|..||++-..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 654332 12336799999999888888899999999999999999999999987543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-21 Score=196.18 Aligned_cols=170 Identities=14% Similarity=0.174 Sum_probs=134.4
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh----hHHHH------HHHHHHHHHhcCCCceeEEeeEEeec
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKE------FVLEIEIITTLHHKNIISLLGFCFED 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----~~~~~------~~~Ei~iL~~l~HpnIv~l~~~~~~~ 485 (766)
..++|...++||.|+||.||+... ++..+|||++.+.. ..... +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999766 67789999997532 22223 57899999999999999999886643
Q ss_pred --------CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 486 --------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 486 --------~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
+..+|||||++|.+|.++.. ++. ....+++.+|..||. .|++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 35899999999999988732 222 245689999999999 9999999999999999988
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHH
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLl 616 (766)
++|+|||........... ..++....|+.++|+|+||++|..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987644221111 11555566788999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.4e-21 Score=189.12 Aligned_cols=208 Identities=23% Similarity=0.308 Sum_probs=171.7
Q ss_pred HhcCcccceeeeccCceEEEEEE-eCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEe
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E 493 (766)
..+.|.+.+.||.|+||.+|.|. ..+|..||||+-.... ...++..|..+...|++ ..|..+..|..+..+-.||||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 35679999999999999999998 4689999999876432 23467789999999975 678888888888888899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---CCeeEecccccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWA 570 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~~ 570 (766)
++ |.+|++++.-.. ..|+..+.+-++.|++.-++|+|. +++|||||||+|+|+.-+ ..+.|+|||||+.+
T Consensus 92 LL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99 789999886543 368899999999999999999999 889999999999999643 46899999999976
Q ss_pred cCCCCC-----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh
Q 004247 571 STSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631 (766)
Q Consensus 571 ~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 631 (766)
-+..+. ....+..||..|.+--...+-..+..-|+-|+|.+|.++..|..||++.......
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 553222 1223467999999877766667788999999999999999999999987654433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=226.36 Aligned_cols=252 Identities=21% Similarity=0.248 Sum_probs=185.3
Q ss_pred cceeeeccCceEEEEEEeC-CCCEEEEEEcc----CCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 422 AENLIGKGGSSQVYKGCLP-DGKELAVKILK----PSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~----~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
..+++|.|++|.|+..... ..+..+.|..+ ... +....+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977776532 33333444332 221 223336678888888999999998888877766666799
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++ +|..++... ..+...++..++.|++.|+.|||. .||.|||||++|+++..+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999999765 247788999999999999999999 99999999999999999999999999999877665
Q ss_pred CCC--ceecccccccCCCCchhhccCCCCC-chhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 574 SSH--ITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 574 ~~~--~~~~~~~GT~~Y~APE~l~~~~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
... .....++|+..|+|||.+....|++ ..||||.|++++.|++|+.||.......+....+ . .....++..-.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--~-~~~~~~~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--N-YSDQRNIFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--c-cccccccccCh
Confidence 554 4455689999999999999999986 6999999999999999999997654433221000 0 00000000000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.........+...++..+|+.+|.+|-|+.+|++
T Consensus 551 -----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 -----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -----HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0011122234444556799999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=189.08 Aligned_cols=138 Identities=20% Similarity=0.222 Sum_probs=108.3
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChh---H------------------------HHHHHHHHHHHHhcCCCce
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---V------------------------IKEFVLEIEIITTLHHKNI 475 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~---~------------------------~~~~~~Ei~iL~~l~HpnI 475 (766)
.+.||+|+||.||+|...+|+.||||+++.... . ......|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999988999999999975421 0 1122349999999988776
Q ss_pred eEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH-HcCCCCceEeecccCCCeeeC
Q 004247 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 476 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDLKp~NILL~ 554 (766)
.....+.. ...+|||||+++++|...+... ..+++.....++.|++.+|.|| |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 44333322 2238999999998776543222 2578899999999999999999 67 7899999999999998
Q ss_pred CCCCeeEecccccccc
Q 004247 555 DDFEPQLSDFGLAKWA 570 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~ 570 (766)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-21 Score=192.50 Aligned_cols=245 Identities=21% Similarity=0.388 Sum_probs=184.3
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
..|.+...|..|+|.+ .|..+++|+++.. ....++|..|.-.|+.+.||||..+++.|....++.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4577888899999998 5566788888743 23456788999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceec
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 580 (766)
+..|++... ...+-.++.+++..+++|++|||+.. .-|.---|.+..++||++.+++|+= +-+++. ....
T Consensus 275 ynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs------fqe~ 344 (448)
T KOG0195|consen 275 YNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEV 344 (448)
T ss_pred HHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee------eecc
Confidence 999997653 45677889999999999999999843 2233346889999999998888751 111111 0111
Q ss_pred ccccccCCCCchhhccCCCC---CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 581 DVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 581 ~~~GT~~Y~APE~l~~~~~s---~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
...-.|.|++||.++...-+ .++|+|||.++||||.|...||..-.+.+.--.+. + ..|.-.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----l----------eglrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----L----------EGLRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----h----------cccccc
Confidence 23457889999999866543 47999999999999999999998766543211110 0 111222
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+++.....+..++..|...||.+||.+..|+-+|+..
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3333445666777789999999999999999888653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=182.64 Aligned_cols=187 Identities=16% Similarity=0.100 Sum_probs=144.1
Q ss_pred ccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHH-----HHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEee
Q 004247 421 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----EFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~-----~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.+...|++|+||+||.+.. .+.+++.+.+........ .|.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998766 778888888876554333 6889999999995 5889999886 356999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecc-cCCCeeeCCCCCeeEecccccccccCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL-Kp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
+.|.+|...+.. ....++.+++.+|.++|. +||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 013477899999999999 89999999 799999999999999999999855443
Q ss_pred CCC---ce--------ecccccccCCCCchhhccC-CCC-CchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 574 SSH---IT--------CTDVAGTFGYLAPEYFMYG-KVN-DKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 574 ~~~---~~--------~~~~~GT~~Y~APE~l~~~-~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
... .. ..-...++.|++|+...-- ..+ ...++++-|..+|.++|++.|+-.+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 00 0012368889999865422 233 56799999999999999999876554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=218.22 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=181.5
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
+|...+.||.+.|=.|.+|.++.|. |+||++-+.. ...++-..|+. ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777899999999999999998887 9999986432 22334444555 666689999999988877888899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc--cc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--AS 571 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~--~~ 571 (766)
|+.+ +|++.|... ..+...+...|+.|++.||.-.|+ .||+|||||.+||||+.-+-+.|+||---+. ++
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 999999654 357788888999999999999999 9999999999999999998999999976552 22
Q ss_pred CCCCC---ceecccccccCCCCchhhccC-----------CCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004247 572 TSSSH---ITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 636 (766)
Q Consensus 572 ~~~~~---~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 636 (766)
.+... ..+.+-..-.+|+|||.|... ..+++.||||+||++.||++ |++||.. ..+..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH
Confidence 22211 111222334579999988642 16778999999999999999 8888853 122221
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
. .|. .......| ..+... .+-.+++.|+++||.+|-++++.|+.-+|..
T Consensus 248 r-----~~~-~~~~e~~L-e~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 R-----SGN-ADDPEQLL-EKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred h-----ccC-ccCHHHHH-HhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1 111 00000011 111111 2333456799999999999999999766644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=179.85 Aligned_cols=141 Identities=23% Similarity=0.240 Sum_probs=110.8
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChh---------------------------HHHHHHHHHHHHHhcCCCce
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---------------------------VIKEFVLEIEIITTLHHKNI 475 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~---------------------------~~~~~~~Ei~iL~~l~HpnI 475 (766)
.+.||+|+||.||+|.+.+|+.||||+++.... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999987899999999875421 01234578999999999987
Q ss_pred eEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC
Q 004247 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555 (766)
Q Consensus 476 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 555 (766)
.....+... ..+|||||++|+++....... ..++......++.+++.+|.+||+ ..||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 544444333 248999999988654432221 246778889999999999999997 25899999999999998
Q ss_pred CCCeeEecccccccccC
Q 004247 556 DFEPQLSDFGLAKWAST 572 (766)
Q Consensus 556 ~~~vkL~DFGla~~~~~ 572 (766)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-20 Score=206.77 Aligned_cols=185 Identities=30% Similarity=0.373 Sum_probs=158.3
Q ss_pred eeeccCceEEEEEE----eCCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecC
Q 004247 425 LIGKGGSSQVYKGC----LPDGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~----~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
++|+|.||.|++.. ...|.-||+|++++.. ........|-.++...+ ||.+|++...++.+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999764 2357789999987532 11125566888899997 9999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
||.|...+.... .+.+.....+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999999886553 47777778888999999999999 9999999999999999999999999999986654322
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 624 (766)
.+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27999999999998 667789999999999999999999976
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=204.87 Aligned_cols=200 Identities=22% Similarity=0.255 Sum_probs=162.1
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCce
Q 004247 412 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNL 488 (766)
Q Consensus 412 el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~ 488 (766)
++......|.+.+.||+|+||.||+|...+|+.||+|+-++.... +|.--..++.+|+ -+.|..+..++.-.+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344455678999999999999999999888999999999875422 1222223444444 23455556666666778
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-------CCCCeeE
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-------DDFEPQL 561 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-------~~~~vkL 561 (766)
+||+||.+.|+|.+++... ..++|...+.++.|+++.++.||. .+|||+||||+|.||. +...++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999999844 368999999999999999999999 8999999999999994 2345899
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCC
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 620 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~ 620 (766)
+|||.+.-+.--....+....++|-++-.+|+..+..+++.+|.|.|.-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999976554444455666889999999999999999999999999999999999975
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-18 Score=178.30 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=133.9
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccC----ChhHHHHHHHHHHHHHhcCC----------CceeEEeeEE-
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHH----------KNIISLLGFC- 482 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~H----------pnIv~l~~~~- 482 (766)
++...+.||.|+++.||.+.+. +|+.+|||++.. .....+++.+|.-.+..+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556789999999999999985 589999999853 23456777777655544322 1122222211
Q ss_pred --------eecC--------ceEEEEeecCCCCHhHhhhc---CCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEe
Q 004247 483 --------FEDN--------NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543 (766)
Q Consensus 483 --------~~~~--------~~~lV~E~~~ggsL~~~L~~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 543 (766)
.... +.+++|+-+ .++|.+++.. .......+....++.+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 1111 347788888 4588887542 22222334556677888999999999999 99999
Q ss_pred ecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccC--------CCCCchhhHHHHHHHHHH
Q 004247 544 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--------KVNDKIDVYAFGVVLLEL 615 (766)
Q Consensus 544 rDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~s~ksDVwSlGvvL~eL 615 (766)
+||+|+|+|++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988765543211 1 2356789999977532 578899999999999999
Q ss_pred HhCCCCCCCCCc
Q 004247 616 LTGRKPISNDHP 627 (766)
Q Consensus 616 ltG~~Pf~~~~~ 627 (766)
.+|+.||....+
T Consensus 244 WC~~lPf~~~~~ 255 (288)
T PF14531_consen 244 WCGRLPFGLSSP 255 (288)
T ss_dssp HHSS-STCCCGG
T ss_pred HHccCCCCCCCc
Confidence 999999986543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=170.60 Aligned_cols=134 Identities=20% Similarity=0.246 Sum_probs=104.3
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCC-hhHHHHHHHHHHHHHhc-----CCCceeEEeeEEeecC---c-eEEE
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTL-----HHKNIISLLGFCFEDN---N-LLLV 491 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~-~~lV 491 (766)
-..+||+|+||.||. +++....+||+.... ....+.+.+|+.++..+ .||||++++|++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 443333479988754 23456789999999999 5799999999998863 3 3378
Q ss_pred Eee--cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHH-HHHHcCCCCceEeecccCCCeeeCC----CCCeeEecc
Q 004247 492 YDF--LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL-EYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 564 (766)
Q Consensus 492 ~E~--~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~IiHrDLKp~NILL~~----~~~vkL~DF 564 (766)
+|| +.+|+|.+++... .+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5579999999653 24444 35677888777 99999 89999999999999973 347999995
Q ss_pred ccc
Q 004247 565 GLA 567 (766)
Q Consensus 565 Gla 567 (766)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=171.93 Aligned_cols=142 Identities=20% Similarity=0.189 Sum_probs=111.4
Q ss_pred cCcccceeeeccCceEEEEEE--eCCCCEEEEEEccCChh-------------------------HHHHHHHHHHHHHhc
Q 004247 418 SNFLAENLIGKGGSSQVYKGC--LPDGKELAVKILKPSED-------------------------VIKEFVLEIEIITTL 470 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~--~~~g~~vAVK~l~~~~~-------------------------~~~~~~~Ei~iL~~l 470 (766)
..|.+.+.||+|+||.||+|. ..+|+.||||+++.... ....+.+|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 56899999999874320 112356899999999
Q ss_pred CCC--ceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc-eEeeccc
Q 004247 471 HHK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVK 547 (766)
Q Consensus 471 ~Hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-IiHrDLK 547 (766)
.+. .+.+++++ ...++||||++|++|...+... ..+.......++.+++.+|.+||+ ++ |+|||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCC
Confidence 763 34444443 2358999999998887654322 134555677899999999999999 88 9999999
Q ss_pred CCCeeeCCCCCeeEeccccccccc
Q 004247 548 SSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 548 p~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|+||+++ ++.++|+|||++....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-17 Score=185.72 Aligned_cols=214 Identities=21% Similarity=0.387 Sum_probs=160.0
Q ss_pred HHhcCCCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCce-Eeec
Q 004247 467 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV-IHRD 545 (766)
Q Consensus 467 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I-iHrD 545 (766)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.... ..++|.....++..|+.||.|||. -+| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 457889999999999999999999999999999999997633 578999999999999999999998 333 9999
Q ss_pred ccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCC-------CCCchhhHHHHHHHHHHHhC
Q 004247 546 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-------VNDKIDVYAFGVVLLELLTG 618 (766)
Q Consensus 546 LKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~s~ksDVwSlGvvL~eLltG 618 (766)
+++.|.+++..+.+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999988764311111111122345699999987531 46679999999999999999
Q ss_pred CCCCCCCCccch-hhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 619 RKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 619 ~~Pf~~~~~~~~-~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..||........ ..++.+.+. .....+.|.+.... +....+..++..||..+|.+||++..|-..++.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999986443322 233333222 11122223332111 222356777788999999999999998776654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=165.28 Aligned_cols=133 Identities=23% Similarity=0.392 Sum_probs=113.8
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+.||+|++|.||+|.. .|..++||+..... .....+.+|++++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77789999865421 1124678899999999999988877777777888999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
++|++|.+++.... + .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 2 788899999999999999 8999999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=164.07 Aligned_cols=145 Identities=20% Similarity=0.207 Sum_probs=113.3
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChh-----------------------HHHHHHHHHHHH
Q 004247 411 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------VIKEFVLEIEII 467 (766)
Q Consensus 411 ~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~-----------------------~~~~~~~Ei~iL 467 (766)
+++......|.+.+.||+|+||.||++...+|+.||||++..... ....+.+|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445888899999999999999988899999998764220 112367789999
Q ss_pred HhcCCCc--eeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeec
Q 004247 468 TTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545 (766)
Q Consensus 468 ~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrD 545 (766)
..+.|++ +...++. ...++||||++|++|...... .....++.+++.++.++|+ .+|+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 9998874 4444432 455999999999999765431 2345688999999999999 8999999
Q ss_pred ccCCCeeeCCCCCeeEecccccccccC
Q 004247 546 VKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 546 LKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999864433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.7e-17 Score=162.85 Aligned_cols=130 Identities=21% Similarity=0.350 Sum_probs=107.7
Q ss_pred eeeccCceEEEEEEeCCCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 425 LIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+||+|+||.||+|.. +|..+++|+..... ....++.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 12356788999999999887665555566667789999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
+|++|.+.+.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875421 0 789999999999999 8999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-17 Score=192.57 Aligned_cols=171 Identities=30% Similarity=0.444 Sum_probs=128.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|..+++|-.|+||.||...++ ..+.+|+|+-+. ....+. |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~lilRn------ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLILRN------ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-chhhhc------cccccCCccee-------------------
Confidence 357888999999999999999876 466788854332 211111 44444455554
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
|+-...+...+. ++. +++.+++|||+ .+|+|||+||+|.||+.-|++|++|||+.+.......
T Consensus 136 --gDc~tllk~~g~----lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP----LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccCCC----Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 455555544332 222 23778999999 9999999999999999999999999999875432111
Q ss_pred -------------CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch
Q 004247 576 -------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 630 (766)
Q Consensus 576 -------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 630 (766)
......++|||.|+|||++....|...+|+|++|+++||.+-|..||.++.+.+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 0112347899999999999999999999999999999999999999998876543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=185.82 Aligned_cols=139 Identities=19% Similarity=0.321 Sum_probs=113.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEcc-C---Ch-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-P---SE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFED 485 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~-~---~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 485 (766)
.....|...+.||+|+||.||+|.+... .+++|+.. . .. ...+.+.+|++++..++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3344567789999999999999987443 34444321 1 11 1235688999999999999999888888777
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
...++||||++|++|.+++. ....++.+++.+|.|||+ .+|+||||||+|||+ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999999885 346789999999999999 899999999999999 67799999999
Q ss_pred ccccc
Q 004247 566 LAKWA 570 (766)
Q Consensus 566 la~~~ 570 (766)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-17 Score=181.14 Aligned_cols=187 Identities=25% Similarity=0.328 Sum_probs=133.2
Q ss_pred eeeeccCceEEEEEEeCC----CCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEee-------EEe-----ecC
Q 004247 424 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLG-------FCF-----EDN 486 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~-------~~~-----~~~ 486 (766)
+..+..+++.++..+... ...+..+...... .......+++-.+....|-+..-+.+ .+. ...
T Consensus 250 k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~ 329 (516)
T KOG1033|consen 250 KSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKV 329 (516)
T ss_pred ccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccccc
Confidence 344555566555544322 2334444444333 33344444555544444333333222 111 123
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
++|+.|+++...+|.++|.+... ....+|.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 58999999999999999975543 3457889999999999999999 5789999999999999999999999999
Q ss_pred cccccCCC----CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh
Q 004247 567 AKWASTSS----SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617 (766)
Q Consensus 567 a~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt 617 (766)
........ .....+.-.||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665544 1122334679999999999999999999999999999999997
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.6e-15 Score=142.02 Aligned_cols=132 Identities=17% Similarity=0.178 Sum_probs=98.0
Q ss_pred cEEEEEEcCCcc--hHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCC--Ccc----hhhhHHHHHHHHHHHhHhhhc
Q 004247 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGK--SSL----LSLVKAFDSVLAVYEGFCNLK 88 (766)
Q Consensus 17 r~I~V~Vd~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~~~~~C~~k 88 (766)
++|+|++|+|+. +..||+||++.+.+.|..|++|||.++......... ... ....+...+.|+.+...+...
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 689999999998 579999999998889999999999975432111100 000 011112223444443333345
Q ss_pred CCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 89 QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 89 ~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~--~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
++.++..+.. |++.+.|+++|+..++|++|||+++. .+.++| |++.++++|+| |||++|+
T Consensus 83 ~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~~llG--S~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 83 TDRVHVHVEE-GSPKDRILELAKKIPADMIIIASHRPDITTYLLG--SNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred CCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCCCCCchheeec--chHHHHHHhCC--CCEEEeC
Confidence 6678888877 89999999999999999999999864 566778 99999999998 9999985
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.9e-15 Score=141.95 Aligned_cols=131 Identities=17% Similarity=0.169 Sum_probs=95.7
Q ss_pred cEEEEEEcCCc--chHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcc-hhh----hHHHHHHHHHHHhHhhhcC
Q 004247 17 RTVVVGVKLDT--HSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSL-LSL----VKAFDSVLAVYEGFCNLKQ 89 (766)
Q Consensus 17 r~I~V~Vd~s~--~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~-~~~----~~~~~~~l~~~~~~C~~k~ 89 (766)
++|+|++|+|+ .|..||+||+..+ +.+..|++|||.++............ ... .+...+.|+.+.......+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la-~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLA-QDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHH-hcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 68999999995 7999999999765 44679999999976432111000000 001 1112244444444333346
Q ss_pred CcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 90 V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~--~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
++++.++.. |++.+.|+++|+..++|++|||+||+ .+.++| |++.+++++++ |||++|+
T Consensus 82 ~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llG--S~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 82 SRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPSISTHLLG--SNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCCccceecC--ccHHHHHHcCC--CCEEEeC
Confidence 788888877 79999999999999999999999998 456678 99999999998 9999985
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-15 Score=141.22 Aligned_cols=135 Identities=23% Similarity=0.256 Sum_probs=114.8
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEEEeecCCCC
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 499 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggs 499 (766)
+.+.||.|.++.||++...+ ..++||+...... ...+.+|+.++..++| .++++++.++...+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35789999999999998844 7899999876544 5678899999999986 589999998887788999999999877
Q ss_pred HhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 500 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 500 L~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+..+ +......++.+++.+|.+||.....+++|+||+|.||+++..+.++++|||++..
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7644 4456677899999999999985445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7e-15 Score=156.18 Aligned_cols=145 Identities=27% Similarity=0.372 Sum_probs=110.4
Q ss_pred CCCceeEEeeEEee---------------------------cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHH
Q 004247 471 HHKNIISLLGFCFE---------------------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 523 (766)
Q Consensus 471 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~ 523 (766)
+|||||+++++|.+ ...+|+||.-.+. +|.+++-... .+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887743 2358999988855 8999986543 4556677799
Q ss_pred HHHHHHHHHHHcCCCCceEeecccCCCeee--CCCC--CeeEecccccccccCCCCCce----ecccccccCCCCchhhc
Q 004247 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDF--EPQLSDFGLAKWASTSSSHIT----CTDVAGTFGYLAPEYFM 595 (766)
Q Consensus 524 ~qia~aL~yLH~~~~~~IiHrDLKp~NILL--~~~~--~vkL~DFGla~~~~~~~~~~~----~~~~~GT~~Y~APE~l~ 595 (766)
.|+++|+.|||+ +||.|||+|++|||| ++|+ .+.|+|||++-......-... ....-|.-.-||||++.
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999998 4444 367899999854333111111 11245778899999986
Q ss_pred cCC------CCCchhhHHHHHHHHHHHhCCCCCCC
Q 004247 596 YGK------VNDKIDVYAFGVVLLELLTGRKPISN 624 (766)
Q Consensus 596 ~~~------~s~ksDVwSlGvvL~eLltG~~Pf~~ 624 (766)
... .-.|+|.|+.|-+.||+++...||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 432 23489999999999999999999976
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.3e-15 Score=141.91 Aligned_cols=135 Identities=13% Similarity=0.136 Sum_probs=98.1
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccc-cCCCCCcchhhh-HHHHHHHHHHHhHhhhcCCcEE
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DRDGKSSLLSLV-KAFDSVLAVYEGFCNLKQVDLK 93 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~~~~~~~~~~~-~~~~~~l~~~~~~C~~k~V~~~ 93 (766)
-++|+|++|+|+.|..||.||+..+...|..|++|||..+.... ............ ....+....++.++...++.+.
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 37899999999999999999999887789999999995322111 000000000001 1112333445556666678776
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 94 ~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
..+++.|++.++|+++|+..++|++|||+|+.....+| ||+.+++++++ |||++|+.
T Consensus 83 ~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~lg--Sva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 83 ETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQDFWSKLM--SSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred EEEEEecCHHHHHHHHHHHhCCCEEEEeCcccHHHHHH--HHHHHHHhhCC--CCEEEecC
Confidence 66666699999999999999999999999986222256 99999999998 99999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-15 Score=149.32 Aligned_cols=136 Identities=21% Similarity=0.265 Sum_probs=98.6
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhH---HHH----------------------HHHHHHHHHhcCCCc--e
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---IKE----------------------FVLEIEIITTLHHKN--I 475 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~---~~~----------------------~~~Ei~iL~~l~Hpn--I 475 (766)
.+.||+|+||.||+|...+|+.||||+++..... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753211 111 134666666665433 4
Q ss_pred eEEeeEEeecCceEEEEeecCCCCHhHh-hhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 476 ISLLGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 476 v~l~~~~~~~~~~~lV~E~~~ggsL~~~-L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .++|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444443 246999999999654322 21111 01 5677899999999999996 26799999999999999
Q ss_pred CCCCeeEeccccccccc
Q 004247 555 DDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~ 571 (766)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-14 Score=132.86 Aligned_cols=120 Identities=16% Similarity=0.146 Sum_probs=99.5
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEEEEE
Q 004247 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (766)
Q Consensus 18 ~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~ 97 (766)
+|+|+||.++.|++||+||...+.+.+..|++|||.++... ...+...+.++.+...++..+++ ..++
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~~--~~~~ 68 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN----------RLSEAERRRLAEALRLAEELGAE--VVTL 68 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc----------cCCHHHHHHHHHHHHHHHHcCCE--EEEE
Confidence 59999999999999999999988888999999999864321 01233346677777777766664 5566
Q ss_pred ECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004247 98 RGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (766)
Q Consensus 98 ~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV 152 (766)
.++++.++|+++|+.+++++||||++++ .+.++| |+++++++++ ..|+|+||
T Consensus 69 ~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~G--s~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 69 PGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRG--SLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred eCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcc--cHHHHHHHhC-CCCeEEEe
Confidence 7799999999999999999999999988 667788 9999999999 24999987
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-14 Score=135.85 Aligned_cols=133 Identities=16% Similarity=0.177 Sum_probs=98.1
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHH--HHHHHHHhHhhhcCCcEEE
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFD--SVLAVYEGFCNLKQVDLKL 94 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~C~~k~V~~~~ 94 (766)
++|+|++|.++.+..||+||+..+...++.|++|||.+..................... .........+...+.....
T Consensus 3 ~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T PF00582_consen 3 KRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVIE 82 (140)
T ss_dssp SEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhccceeE
Confidence 79999999999999999999999999999999999997653311110000000000000 1111111345555677777
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 95 KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 95 ~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
..+..+++.+.|+++++..++|+||||++++ .+.++| |++++|++++| |||++|+
T Consensus 83 ~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~g--s~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 83 VVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFG--SVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSH--HHHHHHHHHTS--SEEEEEE
T ss_pred EEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcC--CHHHHHHHcCC--CCEEEeC
Confidence 7777799999999999999999999999996 556667 99999999998 9999985
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=147.99 Aligned_cols=134 Identities=14% Similarity=0.162 Sum_probs=104.8
Q ss_pred ceeee-ccCceEEEEEEeCCCCEEEEEEccCCh--------------hHHHHHHHHHHHHHhcCCCce--eEEeeEEeec
Q 004247 423 ENLIG-KGGSSQVYKGCLPDGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNI--ISLLGFCFED 485 (766)
Q Consensus 423 ~~~LG-~G~fG~Vy~a~~~~g~~vAVK~l~~~~--------------~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~~ 485 (766)
..+|| .||.|+||+... .+..++||.+.... .....+.+|++++..|.|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 899999999887 47789999885311 223567889999999998774 6777765443
Q ss_pred Cc----eEEEEeecCC-CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 486 NN----LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 486 ~~----~~lV~E~~~g-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
.. .++||||++| .+|.+++... .++.. .+.+|+.+|.+||+ .||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 22 3599999997 6899888542 23433 35689999999999 9999999999999999988999
Q ss_pred Eeccccccc
Q 004247 561 LSDFGLAKW 569 (766)
Q Consensus 561 L~DFGla~~ 569 (766)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-13 Score=128.88 Aligned_cols=129 Identities=19% Similarity=0.192 Sum_probs=107.5
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEEEEE
Q 004247 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (766)
Q Consensus 18 ~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~ 97 (766)
+|+|+||+++.+..||+||...+-..+..|+++||...+..... .......+...+.+..+..++...+++++..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 77 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP---SQLEVNVQRARKLLRQAERIAASLGVPVHTIIR 77 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc---chhHHHHHHHHHHHHHHHHHhhhcCCceEEEEE
Confidence 59999999999999999999998888899999999975432111 011112334448888888888888999999988
Q ss_pred ECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 98 RGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 98 ~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
.+|++.+.|++.++.+++++||||++++ .+.++| |++++++++++ |||++|+
T Consensus 78 ~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lG--s~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 78 IDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFG--GVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred ecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecC--chHHHHHhcCC--CCEEEeC
Confidence 8889999999999999999999999998 356778 99999999998 9999985
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.4e-15 Score=174.45 Aligned_cols=203 Identities=27% Similarity=0.342 Sum_probs=165.0
Q ss_pred CcccceeeeccCceEEEEEEeCC--CCEEEEEEccCC---hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.|.+.+.||+|.|+.|-...... ...+|+|.+... ....+....|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35556679999999998876533 344566666533 344555666888888887 999999999999999999999
Q ss_pred eecCCCCHhHhh-hcCCCCCCCCChHHHHHHHHHHHHHHHHHH-cCCCCceEeecccCCCeeeCCCC-CeeEeccccccc
Q 004247 493 DFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L-~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~ 569 (766)
+|..|+++.+.+ +... ...+....-.++.|+..+|.|+| . .++.||||||+|.+++..+ .++++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 4332 13455667789999999999999 6 8899999999999999999 999999999998
Q ss_pred ccC-CCCCceeccccc-ccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 570 AST-SSSHITCTDVAG-TFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 570 ~~~-~~~~~~~~~~~G-T~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
+.. ..........+| ++.|.|||...+. ......|+||.|+++.-|++|..|+.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 877 555555556789 9999999998874 556789999999999999999999876544
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-13 Score=130.85 Aligned_cols=129 Identities=15% Similarity=0.093 Sum_probs=92.3
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCC-CCcc----hhhhHHHHHHHHHHHhHhhhcCCc
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG-KSSL----LSLVKAFDSVLAVYEGFCNLKQVD 91 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~-~~~~----~~~~~~~~~~l~~~~~~C~~k~V~ 91 (766)
++|+|+||+|+.|..||+||+..+-+.+..|++|||.++........ .... ....+...+.++.+...+. ...
T Consensus 4 k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~ 81 (142)
T PRK09982 4 KHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--WPK 81 (142)
T ss_pred eEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--CCc
Confidence 68999999999999999999999988999999999986532211100 0000 0111112234444443222 345
Q ss_pred EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 92 ~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~--~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
++..+.. |++++.|+++|+..+||++|||+++. .|.+ +|+.++++|++ |||++|+-
T Consensus 82 ~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~~~~~~~~~----~va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 82 TKLRIER-GEMPETLLEIMQKEQCDLLVCGHHHSFINRLM----PAYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred ceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCChhHHHHHH----HHHHHHHhcCC--CCEEEecC
Confidence 6667777 89999999999999999999998632 2222 49999999998 99999974
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.5e-13 Score=150.53 Aligned_cols=140 Identities=21% Similarity=0.301 Sum_probs=99.2
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChh-H------------------------------H----------HHHH
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-V------------------------------I----------KEFV 461 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~-~------------------------------~----------~~~~ 461 (766)
.+.||.|++|.||+|.+++|+.||||+.++.-. . . -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999876310 0 0 0234
Q ss_pred HHHHHHHhcC----CCceeEEeeEEe-ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHH-HHHHHHc
Q 004247 462 LEIEIITTLH----HKNIISLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-ALEYLHS 535 (766)
Q Consensus 462 ~Ei~iL~~l~----HpnIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~ 535 (766)
+|...+.++. |.+-+.+-..|. .....+|||||++|++|.+....... .+ .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 4555555542 333333333332 23456999999999999987653211 12 23456666665 4678888
Q ss_pred CCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 536 ~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
.|++|+|+||.||+++.++.++|+|||++..+.
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.4e-13 Score=126.12 Aligned_cols=135 Identities=12% Similarity=0.105 Sum_probs=97.5
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHH-HHHHHHHHhHhhhcCCcEEE
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF-DSVLAVYEGFCNLKQVDLKL 94 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~C~~k~V~~~~ 94 (766)
-++|+|++|.|+.+..||.+|+..+.+.|..|+++|+.+.................+.. .+....++.++...++..+.
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 37899999999999999999999988889999999998654322111110000111111 12233345555566776665
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCCccc-ccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHT-IRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 95 ~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~-~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
.+++.|++.+.|+++|++.++|++|||++++... ..+ |++.+++++++ |||++|+-
T Consensus 83 ~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~--s~a~~v~~~~~--~pVLvv~~ 139 (142)
T PRK10116 83 TFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS--CSAKRVIASSE--VDVLLVPL 139 (142)
T ss_pred EEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH--HHHHHHHhcCC--CCEEEEeC
Confidence 5666799999999999999999999999987211 123 79999999998 99999973
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.7e-13 Score=152.03 Aligned_cols=143 Identities=19% Similarity=0.242 Sum_probs=92.1
Q ss_pred CcccceeeeccCceEEEEEEeCC-CCEEEEEEccCCh-----------------------------------hHHHH---
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE-----------------------------------DVIKE--- 459 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~-----------------------------------~~~~~--- 459 (766)
.|.. +.||.|++|.||+|.+++ |+.||||++++.- +..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 789999999999999987 9999999998541 01111
Q ss_pred ---HHHHHHHHHhcC----CCceeEEeeEEee-cCceEEEEeecCCCCHhHh--hhcCCCCCCCCChHHHHHHHHHHHHH
Q 004247 460 ---FVLEIEIITTLH----HKNIISLLGFCFE-DNNLLLVYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAEA 529 (766)
Q Consensus 460 ---~~~Ei~iL~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~--L~~~~~~~~~l~~~~~~~i~~qia~a 529 (766)
|.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|++|.+. +...+.....+.......++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 233333333332 3333333233322 2456899999999999874 32221111122222222333333
Q ss_pred HHHHHcCCCCceEeecccCCCeeeCCCC----CeeEecccccccccC
Q 004247 530 LEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFGLAKWAST 572 (766)
Q Consensus 530 L~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DFGla~~~~~ 572 (766)
+. .|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 277 ----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 7899999999999999888 999999999987654
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=133.72 Aligned_cols=136 Identities=10% Similarity=0.084 Sum_probs=104.6
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCC--CCCcc----hhhhHHHHHHHHHHHhHhhhcC
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD--GKSSL----LSLVKAFDSVLAVYEGFCNLKQ 89 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~--~~~~~----~~~~~~~~~~l~~~~~~C~~k~ 89 (766)
-++|+|++|+|+.|..||+||+.-+...+..|++|||.+........ ..... ....+...+.|+.+...+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 36799999999999999999999888888999999997543211100 00000 0011112245666666666678
Q ss_pred CcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 90 V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
++++..+.++|++.++|+++|+..++|+||||+++. .+.++| |++.++++++| |||++|+.+
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~g--s~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFT--PTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccC--hhHHHHHhcCC--CCEEEeccc
Confidence 999998888799999999999999999999999987 566777 99999999998 999999864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.5e-12 Score=123.61 Aligned_cols=130 Identities=22% Similarity=0.197 Sum_probs=97.4
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeecCCCCHh
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
.+.|+.|.++.||++.. .+..|++|+..........+.+|+.++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 35689999999999887 477899999876543334567899999998765554 444443 23458999999998876
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC--CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
... . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 430 0 11235678999999999832 23369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-12 Score=133.39 Aligned_cols=204 Identities=21% Similarity=0.296 Sum_probs=140.6
Q ss_pred HHHHhcCCCceeEEeeEEeec-----CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC
Q 004247 465 EIITTLHHKNIISLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539 (766)
Q Consensus 465 ~iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 539 (766)
+-|-++-|.|||+++.|+.+. ....++.|||..|+|..+|++.+.....+......+|+.||+.||.|||++. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445667799999999987543 4578999999999999999987766667777888899999999999999855 8
Q ss_pred ceEeecccCCCeeeCCCCCeeEecccccccccCCCCC-ce--ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHH
Q 004247 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH-IT--CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 616 (766)
Q Consensus 540 ~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~-~~--~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLl 616 (766)
+|+|+++.-.-|++..+|-+||.-- -.......... .. ...-.|-++|.+||+=.....+..+|||+||...+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999988887521 11100000000 00 00123678999999877777888999999999999998
Q ss_pred hCCCCC-CCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 617 TGRKPI-SNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 617 tG~~Pf-~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
-|..-- ........+..+......+.+| + +.+ .+..|++-.|..||+|.+++.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~len~---------l----qr~-------~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLENG---------L----QRG-------SITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeeccCc---------c----ccC-------cCcccccCCCCCCcchhhhhcC
Confidence 876532 2211111111111111111111 1 101 1235999999999999988764
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.3e-11 Score=110.60 Aligned_cols=127 Identities=17% Similarity=0.240 Sum_probs=102.8
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEEEEE
Q 004247 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (766)
Q Consensus 18 ~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~ 97 (766)
+|+|++|.++.++.+|+||+..+-..+..|.+|||.+....... ...........+.|..+...|...++.+...+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 77 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAA---ELAELLEEEARALLEALREALAEAGVKVETVVL 77 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch---hHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 48999999999999999999999999999999999865422111 001112234457888888888888999998888
Q ss_pred ECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004247 98 RGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (766)
Q Consensus 98 ~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV 152 (766)
. |++.+.|+++++..++++||||++++ .+.+.| +++++.+++++ |||++|
T Consensus 78 ~-~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~--~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 78 E-GDPAEAILEAAEELGADLIVMGSRGRSGLRRLLLG--SVAERVLRHAP--CPVLVV 130 (130)
T ss_pred c-CCCHHHHHHHHHHcCCCEEEEcCCCCCccceeeec--cHHHHHHhCCC--CCEEeC
Confidence 7 67799999999999999999999987 234566 99999999987 999975
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=9e-11 Score=126.82 Aligned_cols=135 Identities=16% Similarity=0.141 Sum_probs=96.1
Q ss_pred CcEEEEEEcCCcch-------HHHHHHHHhhccCC-CCEEEEEEeecCCccccCC--CCCcchhhhHHH-HHHHHHHHhH
Q 004247 16 GRTVVVGVKLDTHS-------RELLTWALVKVAQP-GDTVIALHVLANNAIVDRD--GKSSLLSLVKAF-DSVLAVYEGF 84 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S-------~~AL~WAl~~~~~~-gd~vvlvHV~~~~~~~~~~--~~~~~~~~~~~~-~~~l~~~~~~ 84 (766)
.++|+||+|+++++ ..||++|+.-+..- +..|++|||.+........ .........+.. .+....++.+
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 231 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKAL 231 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHHH
Confidence 57999999999763 67999999877765 8899999998643221100 000000111111 1233344555
Q ss_pred hhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 85 CNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 85 C~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
.+..++..+...+..|++.+.|+++|+..++|+||||++++ .+.|+| |++++++++++ |||++|+.
T Consensus 232 ~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llG--S~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 232 RQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLG--NTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred HHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeec--chHHHHHhcCC--CCEEEEcC
Confidence 55556665434445589999999999999999999999988 667788 99999999998 99999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-11 Score=136.58 Aligned_cols=247 Identities=22% Similarity=0.247 Sum_probs=175.5
Q ss_pred Ccccceeeec--cCceEEEEEEe---CCCCEEEEEEccC--C-hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004247 419 NFLAENLIGK--GGSSQVYKGCL---PDGKELAVKILKP--S-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 419 ~f~~~~~LG~--G~fG~Vy~a~~---~~g~~vAVK~l~~--~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 489 (766)
.|-+...+|. |.+|.||.+.. .++..+|+|.-+. . ......-.+|+.-..+++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556778899 99999999875 3678899987432 1 233344456777777774 999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHH----HHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEecc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE----ALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDF 564 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DF 564 (766)
+-.|++. .+|..+.+.... .++....+.++..... ||.++|. .+++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 9999884 688888876543 3455556666666666 9999999 889999999999999999 88999999
Q ss_pred cccccccCCCCCcee---cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 565 GLAKWASTSSSHITC---TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 565 Gla~~~~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|+...+....-.... ....|..-|++||... +-++.+.|||+||.++++-.+|..+....... .|.. +
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~--~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ--L 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc--c
Confidence 999877665422111 1235777899999877 78899999999999999999987765432110 1211 1
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+.+. +..++...-...+-....++++.+|..|++.+.+..
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111 111111111111222556799999999999887765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=115.17 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=99.2
Q ss_pred ceeeeccCceEEEEEEeCC-------CCEEEEEEccCC-------------h----------hHHHHHH----HHHHHHH
Q 004247 423 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPS-------------E----------DVIKEFV----LEIEIIT 468 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~-------g~~vAVK~l~~~-------------~----------~~~~~~~----~Ei~iL~ 468 (766)
...||.|--+.||.|...+ +..+|||+.+.+ + ...+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 479999998631 0 1122233 7999999
Q ss_pred hcCC--CceeEEeeEEeecCceEEEEeecCCCCHhH-hhhcCCCCCCCCChHHHHHHHHHHHHHHHHH-HcCCCCceEee
Q 004247 469 TLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHR 544 (766)
Q Consensus 469 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~L~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHr 544 (766)
++.. -++.+++++ ..-+|||||+.++.+.. .+.. ..++......+..+++.+|..| |+ .+|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 9963 466667764 34599999997754422 2221 1244455677889999999999 78 789999
Q ss_pred cccCCCeeeCCCCCeeEeccccccccc
Q 004247 545 DVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 545 DLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
||++.|||++ ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.8e-10 Score=116.08 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=111.1
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCChh--HHHHHHHHHHHHHhcCC--CceeEEeeEEeec---CceEEEEeecC
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHH--KNIISLLGFCFED---NNLLLVYDFLS 496 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~~ 496 (766)
+.|+.|.++.||++...+|+.+++|+...... ....+.+|++++..+.+ .++.+++.++... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999876433 45678899999999976 3456777776653 26689999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 537 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 537 (766)
|.+|.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876532 13667777888888888888888521
Q ss_pred --------------CCceEeecccCCCeeeCC--CCCeeEeccccccc
Q 004247 538 --------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKW 569 (766)
Q Consensus 538 --------------~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~ 569 (766)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-09 Score=104.78 Aligned_cols=135 Identities=17% Similarity=0.180 Sum_probs=103.7
Q ss_pred CCcEEEEEEc-CCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCc-c-------hhhhHHHHHHHHHHHhHh
Q 004247 15 AGRTVVVGVK-LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS-L-------LSLVKAFDSVLAVYEGFC 85 (766)
Q Consensus 15 ~~r~I~V~Vd-~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~-~-------~~~~~~~~~~l~~~~~~C 85 (766)
..++|++++| .++.+..|+.+|+......+..+.++||.............. . ........+.++.++..-
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALA 83 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHH
Confidence 3578999999 999999999999999999999999999986543211111000 0 111222236677777776
Q ss_pred hhcCCcE-EEEEEECCCh-hHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 86 NLKQVDL-KLKICRGTSI-RKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 86 ~~k~V~~-~~~v~~~~d~-~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
...++.. +..+.. |++ ...|++.|...++|++|||++++ .+.++| ||+.+++++++ |||++|+-
T Consensus 84 ~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llG--svs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 84 EAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLG--SVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCccccceeee--hhHHHHHhcCC--CCEEEEcc
Confidence 7778884 777777 676 79999999999999999999987 445778 99999999998 99999974
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.8e-10 Score=109.03 Aligned_cols=130 Identities=23% Similarity=0.330 Sum_probs=100.0
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCC---------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
..|++|+-+.+|.+.+ -|.++++|.-.+. .-...+..+|.++|.+++--.|.-.+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999976 4445777765431 12244677899999999765555555555567777999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
++|..|.+.+... ...++..+-.-+.-||. .+|||+||.++||++..+. +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999988888644 23466777777889999 8999999999999998764 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=105.40 Aligned_cols=141 Identities=22% Similarity=0.292 Sum_probs=106.5
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCC---------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
...+|-+|+-+.|+++.+ .|+.+.||.-... .-..++..+|+++|.+++--.|.-..-+|.+.+.-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999988 7788888754321 123567888999999997656655555666767779999
Q ss_pred eecCC-CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---CeeEecccccc
Q 004247 493 DFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAK 568 (766)
Q Consensus 493 E~~~g-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~ 568 (766)
||++| -++.+++...... .........++..|-+.+.-||. ..|||+||.++||+|..++ .+.|+|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 4778887654432 11222226788888889999999 8899999999999996554 35899999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.9e-10 Score=127.27 Aligned_cols=196 Identities=22% Similarity=0.173 Sum_probs=146.9
Q ss_pred HHHhcCcccceeeeccCceEEEEEEe--CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004247 414 LSATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 487 (766)
Q Consensus 414 ~~~t~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 487 (766)
.-.+.+|.....||.|.|+.|+.... .++..|++|.+...- .....-..|+-+...+ .|.+++.++..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788899999999999998764 368889999886532 1111223455555555 48888888887777788
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEecccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGL 566 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGl 566 (766)
.|+--||++++++...+... ..+....++.+..+++.++.++|+ +.++|+|+||+||++..+ +..++.|||+
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence 88999999999988776322 346777889999999999999998 889999999999999886 7889999999
Q ss_pred cccccCCCCCceecccccccCCC--CchhhccCCCCCchhhHHHHHHHHHHHhCCCC
Q 004247 567 AKWASTSSSHITCTDVAGTFGYL--APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~--APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P 621 (766)
+..+.-.. ....++-++. +|+......+..+.|+||||..+.+.++|..-
T Consensus 414 ~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 414 WTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 86422111 1122333444 45555556788899999999999999998653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.3e-09 Score=118.65 Aligned_cols=165 Identities=24% Similarity=0.292 Sum_probs=126.2
Q ss_pred eCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChH
Q 004247 439 LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 517 (766)
Q Consensus 439 ~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~ 517 (766)
..++.+|.|..++.+. .......+-++-|+.++||||++++..+...+.+|||+|-+. .|..++.+. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3478888888887543 344567778899999999999999999999999999999884 577777543 245
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccC
Q 004247 518 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597 (766)
Q Consensus 518 ~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 597 (766)
.....+.||+.||.|||+. .+++|++|.-+.|+++..|+.||++|.++.......... ....---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCcc
Confidence 5666789999999999863 579999999999999999999999998875444322210 011122347777765432
Q ss_pred CCCCchhhHHHHHHHHHHHhC
Q 004247 598 KVNDKIDVYAFGVVLLELLTG 618 (766)
Q Consensus 598 ~~s~ksDVwSlGvvL~eLltG 618 (766)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.8e-10 Score=133.17 Aligned_cols=206 Identities=23% Similarity=0.300 Sum_probs=149.4
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChh----HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
..+.|.+.+-+-.|.++.++.+.-. .|...++|+...... ..+....+-.++-..++|.++...--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456677777888999988876532 344445555543222 12233334344444556777766655666778899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
+++|+.+++|...|+... ..+.+-.+..+..+..+++|||. ..++|||++|.|+|+..+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998765 34444556677778899999998 66899999999999999999999999843322
Q ss_pred cCC-----C-------------------CC-----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC
Q 004247 571 STS-----S-------------------SH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621 (766)
Q Consensus 571 ~~~-----~-------------------~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P 621 (766)
... . .. .......||+.|++||...+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 0 00 001225689999999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 004247 622 ISNDHPK 628 (766)
Q Consensus 622 f~~~~~~ 628 (766)
|....+.
T Consensus 1035 ~na~tpq 1041 (1205)
T KOG0606|consen 1035 FNAETPQ 1041 (1205)
T ss_pred CCCcchh
Confidence 9876653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.5e-08 Score=100.25 Aligned_cols=125 Identities=23% Similarity=0.298 Sum_probs=83.7
Q ss_pred EEEEEEeCCCCEEEEEEccCC---------------------------hhHHHHHHHHHHHHHhcCCC--ceeEEeeEEe
Q 004247 433 QVYKGCLPDGKELAVKILKPS---------------------------EDVIKEFVLEIEIITTLHHK--NIISLLGFCF 483 (766)
Q Consensus 433 ~Vy~a~~~~g~~vAVK~l~~~---------------------------~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~ 483 (766)
.||.|...+|..+|||+.+.. ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999989999999998631 01234566799999999865 466666542
Q ss_pred ecCceEEEEeecC--CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHH-HHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 484 EDNNLLLVYDFLS--RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY-LHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 484 ~~~~~~lV~E~~~--ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|. .||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 3389999998 65554433321 1134456677777775555 567 899999999999999888 999
Q ss_pred Eeccccccccc
Q 004247 561 LSDFGLAKWAS 571 (766)
Q Consensus 561 L~DFGla~~~~ 571 (766)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.8e-08 Score=103.09 Aligned_cols=139 Identities=18% Similarity=0.172 Sum_probs=101.5
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCCh--hHHH----------HHHHHHHHHHhcCCC--ceeEEeeEEee-----
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIK----------EFVLEIEIITTLHHK--NIISLLGFCFE----- 484 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~----------~~~~Ei~iL~~l~Hp--nIv~l~~~~~~----- 484 (766)
+++-.-....|++... +|+.|.||...... ...+ .+.+|...+..|... .++.+++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444555777666 77889999875432 1122 378899999888543 34445555543
Q ss_pred cCceEEEEeecCCC-CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-------C
Q 004247 485 DNNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------D 556 (766)
Q Consensus 485 ~~~~~lV~E~~~gg-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-------~ 556 (766)
....+||||++++. +|.+++..... .......+..++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 89988853221 234566778899999999999999 99999999999999975 4
Q ss_pred CCeeEecccccc
Q 004247 557 FEPQLSDFGLAK 568 (766)
Q Consensus 557 ~~vkL~DFGla~ 568 (766)
+.+.|+||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 679999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.3e-08 Score=106.16 Aligned_cols=169 Identities=21% Similarity=0.287 Sum_probs=128.7
Q ss_pred ceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEEeecCC-CCHhHh
Q 004247 431 SSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDFLSR-GSLEEN 503 (766)
Q Consensus 431 fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-gsL~~~ 503 (766)
..+.|++..+ ||..|++|++.... ........-++.++++.|+|+|++.++|.. +..++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3567998754 89999999995432 223344556789999999999999998863 4568999999985 477776
Q ss_pred hhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 504 LHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 504 L~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
...... .+...++..+|.++.|+..||.++|+ .|+.-+-|.+.+||++.+-+++|+-.|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543221 22456788999999999999999999 8888999999999999998999998888766554
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P 621 (766)
+.. |-+.. -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 1256888899999999999543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.4e-06 Score=94.80 Aligned_cols=194 Identities=17% Similarity=0.224 Sum_probs=126.1
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeE------EeecCc-eEEEEe
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF------CFEDNN-LLLVYD 493 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~------~~~~~~-~~lV~E 493 (766)
..+.||+|+.+.+|-.- .-...+-|++.......+.- -+..|... .||-+-.=+.+ .-.... .-+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45779999999999532 22234567776433211111 11122222 34432221111 112222 567888
Q ss_pred ecCCCC-HhHhhh--cCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 494 FLSRGS-LEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 494 ~~~ggs-L~~~L~--~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
.+.+.. +..++. ..++.-..+.|...++++..++.+.+-||. .|.+-+|+.++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 887652 222221 112233467899999999999999999999 88899999999999999999999985443333
Q ss_pred cCCCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhC-CCCCCCC
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTG-RKPISND 625 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~ 625 (766)
.++. .....+|...|++||... +..-+...|-|.|||++++||.| ++||.+-
T Consensus 168 ~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2221 122357999999999765 33456789999999999999995 9999764
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.6e-07 Score=99.52 Aligned_cols=105 Identities=13% Similarity=0.162 Sum_probs=81.6
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCC--CCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhh-----
Q 004247 15 AGRTVVVGVKLDTHSRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL----- 87 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~--gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~----- 87 (766)
.-++|+|+||+|+.|+.||..|++.+-.. +..|++|||.+....... . ....+..+++++.++..+..
T Consensus 4 ~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~--~---~~~~~~~eelle~~~~~~~~~l~~~ 78 (357)
T PRK12652 4 AANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE--G---QDELAAAEELLERVEVWATEDLGDD 78 (357)
T ss_pred ccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc--h---hHHHHHHHHHHHHHHHHHHHhhhcc
Confidence 34789999999999999999999988774 589999999875322111 1 11123334667777766665
Q ss_pred -cCCcEEEEEEEC-------CChhHHHHHHHHhcCCcEEEEccCC
Q 004247 88 -KQVDLKLKICRG-------TSIRKILVREAQSYSATKFIVGTAK 124 (766)
Q Consensus 88 -k~V~~~~~v~~~-------~d~~~~lv~~a~~~~a~~LVlG~~~ 124 (766)
.+|+++.+++.+ |++.++|+++|++.++|++|||-.-
T Consensus 79 ~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~ 123 (357)
T PRK12652 79 ASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEY 123 (357)
T ss_pred cCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCC
Confidence 489999999874 8999999999999999999999763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.5e-07 Score=95.13 Aligned_cols=133 Identities=20% Similarity=0.214 Sum_probs=95.3
Q ss_pred cccceeeeccCceEEEEEEeCCCCEEEEEEccCC-----------------------hhHHHHHHHHHHHHHhcCCC--c
Q 004247 420 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-----------------------EDVIKEFVLEIEIITTLHHK--N 474 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-----------------------~~~~~~~~~Ei~iL~~l~Hp--n 474 (766)
..+.+.||-|--+.||.|..+.|.++|||.-+.. .-......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4466889999999999999999999999985421 01234466799999999755 6
Q ss_pred eeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 475 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
+.+.+++ +...+||||++|-.|...-- .....-.|+..|++-+.-+-. .||||+|+.+-|||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 7777765 55699999999966664331 111122233333333333334 7899999999999999
Q ss_pred CCCCeeEecccccc
Q 004247 555 DDFEPQLSDFGLAK 568 (766)
Q Consensus 555 ~~~~vkL~DFGla~ 568 (766)
++|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5e-07 Score=103.75 Aligned_cols=140 Identities=21% Similarity=0.274 Sum_probs=89.8
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCCh-------------------------------hHHHH----------HHH
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------------------DVIKE----------FVL 462 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-------------------------------~~~~~----------~~~ 462 (766)
+-|+.++-|.||+|.+++|+.||||+.++.- ...++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999987520 01111 222
Q ss_pred HHHHHHhcC-----CCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHH-HHHHHcC
Q 004247 463 EIEIITTLH-----HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA-LEYLHSG 536 (766)
Q Consensus 463 Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~ 536 (766)
|..-+.+++ .+++.-..=|..-.+...|+|||++|-.+.+...... ..++-.. |+..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHHh-
Confidence 333333332 2333222222222355699999999999998843222 1233222 22222222 122222
Q ss_pred CCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 537 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
.|++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6799999999999999999999999999876654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.8e-06 Score=88.32 Aligned_cols=123 Identities=19% Similarity=0.169 Sum_probs=91.0
Q ss_pred CCCEEEEEEccCC--h------hHHHHHHHHHHHHHhcCC--CceeEEeeEEeecC----ceEEEEeecCCC-CHhHhhh
Q 004247 441 DGKELAVKILKPS--E------DVIKEFVLEIEIITTLHH--KNIISLLGFCFEDN----NLLLVYDFLSRG-SLEENLH 505 (766)
Q Consensus 441 ~g~~vAVK~l~~~--~------~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~----~~~lV~E~~~gg-sL~~~L~ 505 (766)
.++.+.+|.+... . -....+.+|...+..|.. -.+.+.+++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4556666654321 1 123467788888888853 34556666665532 358999999984 7999987
Q ss_pred cCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---CeeEecccccccc
Q 004247 506 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWA 570 (766)
Q Consensus 506 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~~~ 570 (766)
.... ++......++.+++..+.-||. .||+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 111 ~~~~----~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ----LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc----cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5332 4556678899999999999999 9999999999999998887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.9e-06 Score=85.35 Aligned_cols=137 Identities=19% Similarity=0.131 Sum_probs=102.1
Q ss_pred eeeccCceEEEEEEeCCCCEEEEEEccCC-------hhHHHHHHHHHHHHHhcCC--CceeEEeeEEeec-----CceEE
Q 004247 425 LIGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHH--KNIISLLGFCFED-----NNLLL 490 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~-----~~~~l 490 (766)
--|+||-+.|++-.. +|+.+-+|.-... .-....|.+|+..|..|.. -.+.++. ++... ...+|
T Consensus 25 N~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 347899999999776 5557888886521 2245679999999999963 2344555 33211 23589
Q ss_pred EEeecCC-CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC--eeEeccccc
Q 004247 491 VYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 567 (766)
Q Consensus 491 V~E~~~g-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--vkL~DFGla 567 (766)
|+|-++| -+|.+++..... ...+...+..++.+++.++.-||+ .|+.|+|+.+.|||++.++. ++++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997763 488888865432 245667778999999999999999 99999999999999986666 999999766
Q ss_pred c
Q 004247 568 K 568 (766)
Q Consensus 568 ~ 568 (766)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.2e-07 Score=106.68 Aligned_cols=152 Identities=22% Similarity=0.357 Sum_probs=97.8
Q ss_pred HHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce--ec-----ccccccCCCCchhhc
Q 004247 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT--CT-----DVAGTFGYLAPEYFM 595 (766)
Q Consensus 523 ~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~--~~-----~~~GT~~Y~APE~l~ 595 (766)
+.+++.||.|||.. .++||+.|.|++|.++.++..||+.|+++........... ++ -..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44556999999983 6799999999999999999999999999865544221110 00 012355799999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHhCCCC-CCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhc
Q 004247 596 YGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCI 674 (766)
Q Consensus 596 ~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl 674 (766)
....+.++|+|||||++|.+..|..+ |............... ...+ .. ....+.+.+..+. +.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---~~~~---~~---~~s~~~p~el~~~----l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---LNAG---AF---GYSNNLPSELRES----LKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---cccc---cc---cccccCcHHHHHH----HHHHh
Confidence 98899999999999999999965554 4332211111111100 0000 00 0012223333333 34578
Q ss_pred ccCCCCCCCHHHHHH
Q 004247 675 RRDPRARPQMSLVLK 689 (766)
Q Consensus 675 ~~dP~~RPs~~eVL~ 689 (766)
..++.-||++.+++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 899999998877654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.4e-06 Score=95.13 Aligned_cols=173 Identities=21% Similarity=0.270 Sum_probs=103.2
Q ss_pred CchhHHhhhhhccccccccCHHHHHHHhc---------Ccc--cceeeeccCceEEEEEEeCCCCEEEEEEccCCh----
Q 004247 390 LPKELEGLHEKYSATCRLFNYQDLLSATS---------NFL--AENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---- 454 (766)
Q Consensus 390 ~~~~l~~~~~~~~~~~~~f~~~el~~~t~---------~f~--~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---- 454 (766)
+|++.-.........+..|+++|+...-+ =|. ..+.||.-..|.||+|.+++|+.||||+-++.-
T Consensus 122 lP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~ 201 (538)
T KOG1235|consen 122 LPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLI 201 (538)
T ss_pred CcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHH
Confidence 44444333344444555666655543321 111 236789999999999999999999999987520
Q ss_pred ----------------------------hHHHH------HHHHHH----HHHhcCCCc------eeEEeeEEeecCceEE
Q 004247 455 ----------------------------DVIKE------FVLEIE----IITTLHHKN------IISLLGFCFEDNNLLL 490 (766)
Q Consensus 455 ----------------------------~~~~~------~~~Ei~----iL~~l~Hpn------Iv~l~~~~~~~~~~~l 490 (766)
+..+. |.+|.+ +.+.+.|-+ |.+++-.+ .....|
T Consensus 202 ~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVL 279 (538)
T KOG1235|consen 202 MLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVL 279 (538)
T ss_pred HHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEE
Confidence 11111 222332 222333444 33343333 245699
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC----CCCCeeEecccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS----DDFEPQLSDFGL 566 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~----~~~~vkL~DFGl 566 (766)
+||||+|..+.+.-.-... .++-.. |+..+.++ |+++-...|++|.|-.|.||++. .++.+.+-|||+
T Consensus 280 tME~~~G~~i~Dl~~i~~~---gi~~~~---i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl 351 (538)
T KOG1235|consen 280 TMEYVDGIKINDLDAIDKR---GISPHD---ILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL 351 (538)
T ss_pred EEEecCCccCCCHHHHHHc---CCCHHH---HHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence 9999999988775432211 233333 33333332 22222226799999999999998 367899999999
Q ss_pred cccccC
Q 004247 567 AKWAST 572 (766)
Q Consensus 567 a~~~~~ 572 (766)
...+..
T Consensus 352 ~~~is~ 357 (538)
T KOG1235|consen 352 YAVISH 357 (538)
T ss_pred cccccH
Confidence 876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=83.96 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=86.1
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc--eeEEeeEEeecCceEEEEeecCCCC-H
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGS-L 500 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggs-L 500 (766)
..||+|..+.||+. .|..+++|+..... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 35568899987533 2345688999999986443 4677777777777889999999963 1
Q ss_pred hHh---------------------hhcCCCCCCCCChHHHH-HHHH----------HHHH-HHHHHHc-CCCCceEeecc
Q 004247 501 EEN---------------------LHGNKKDPAAFGWSERY-KVAM----------GVAE-ALEYLHS-GSAQRVIHRDV 546 (766)
Q Consensus 501 ~~~---------------------L~~~~~~~~~l~~~~~~-~i~~----------qia~-aL~yLH~-~~~~~IiHrDL 546 (766)
... ||..... ........ .+.. .+.. ...+|.. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 1211101 11111100 0000 0011 1222221 12346799999
Q ss_pred cCCCeeeCCCCCeeEecccccc
Q 004247 547 KSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 547 Kp~NILL~~~~~vkL~DFGla~ 568 (766)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.4e-06 Score=83.32 Aligned_cols=136 Identities=15% Similarity=0.160 Sum_probs=90.9
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHH----------HHHHHHHHHhcCC---CceeEEeeEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE----------FVLEIEIITTLHH---KNIISLLGFC 482 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~----------~~~Ei~iL~~l~H---pnIv~l~~~~ 482 (766)
..++|...+++-......|.+-.. +|+.+++|..+......++ ..+++..+..++. -.+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888888888888766 7789999998753321111 1223333333322 2222222222
Q ss_pred -----eecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 483 -----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 483 -----~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
......+|+|||++|..|.+... +.. .++..+..++.-||+ .|+.|+|..|+|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 12234579999999988876542 111 255667788999999 899999999999999865
Q ss_pred CeeEecccccc
Q 004247 558 EPQLSDFGLAK 568 (766)
Q Consensus 558 ~vkL~DFGla~ 568 (766)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-05 Score=82.10 Aligned_cols=144 Identities=21% Similarity=0.263 Sum_probs=87.1
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC--ceeEEeeEEee---cCceEEEEeecCC
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFE---DNNLLLVYDFLSR 497 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~~---~~~~~lV~E~~~g 497 (766)
.+.|+.|..+.||+....+ ..+++|+.... .....+.+|..++..+... .+.+++.++.. ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 3678999999999998866 69999998765 5667788899998888533 35566664432 2346899999999
Q ss_pred CCHhH----------------hh---hcCCCCCCCCChHH---------HHHH------------HHHHHH-HHHHHHc-
Q 004247 498 GSLEE----------------NL---HGNKKDPAAFGWSE---------RYKV------------AMGVAE-ALEYLHS- 535 (766)
Q Consensus 498 gsL~~----------------~L---~~~~~~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~- 535 (766)
..+.. .+ +........+.+.. .... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 11110111111111 0000 111222 2333332
Q ss_pred ---CCCCceEeecccCCCeeeC-CCCCeeEecccccc
Q 004247 536 ---GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAK 568 (766)
Q Consensus 536 ---~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~ 568 (766)
.....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2346799999999999999 55666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=97.42 Aligned_cols=127 Identities=17% Similarity=0.096 Sum_probs=99.3
Q ss_pred CCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004247 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (766)
Q Consensus 14 ~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (766)
..+.+|+|+|+.++++..++++|.+-+.+-+..+++|||..+.... . .+....-+..+..+|++-+.+
T Consensus 248 ~~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~-------~---~~~~~~~l~~~~~lA~~lGa~-- 315 (895)
T PRK10490 248 HTRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLHR-------L---PEKKRRAILSALRLAQELGAE-- 315 (895)
T ss_pred CcCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcCc-------C---CHHHHHHHHHHHHHHHHcCCE--
Confidence 3467899999999999999999999999999999999998642110 0 111112233333577776666
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 94 ~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
..++.|+|+.++|++.|+..+++.+|||.+++.+-|+ .+||++.+++.++ .-.|.+|..
T Consensus 316 ~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~~~-~~s~~~~l~r~~~-~idi~iv~~ 374 (895)
T PRK10490 316 TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRWWR-RESFADRLARLGP-DLDLVIVAL 374 (895)
T ss_pred EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCCcc-CCCHHHHHHHhCC-CCCEEEEeC
Confidence 5577889999999999999999999999998865432 2599999999998 899999964
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.3e-05 Score=80.97 Aligned_cols=152 Identities=24% Similarity=0.258 Sum_probs=98.7
Q ss_pred cCHHHHHHHhcCccccee---eeccCceEEEEEEeCCCCEEEEEEccCChhH-------------------------HHH
Q 004247 408 FNYQDLLSATSNFLAENL---IGKGGSSQVYKGCLPDGKELAVKILKPSEDV-------------------------IKE 459 (766)
Q Consensus 408 f~~~el~~~t~~f~~~~~---LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~-------------------------~~~ 459 (766)
.++..+....+...+..+ |..|-.+.||+|...++..+|||+++..... ..-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345555556666665554 5567778899999888999999999743111 111
Q ss_pred HHHHHHHHHhcC--CCceeEEeeEEeecCceEEEEeecCCCCH-hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcC
Q 004247 460 FVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSL-EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536 (766)
Q Consensus 460 ~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~ggsL-~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~ 536 (766)
...|+.-|.++. +-.+.+.+++. .-.|||||+...-+ .-.|.. ..+...+...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH-
Confidence 234666677664 34455556554 23899999965311 111211 122222455666667766666654
Q ss_pred CCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 537 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
..++||+||..-|||+. ++.+.|+|||-|....
T Consensus 185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 25799999999999999 7899999999886544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.1e-05 Score=80.86 Aligned_cols=140 Identities=19% Similarity=0.157 Sum_probs=85.8
Q ss_pred eeccCc-eEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecCCCCHhHh
Q 004247 426 IGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 503 (766)
Q Consensus 426 LG~G~f-G~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~ 503 (766)
|-.|.+ ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 344445 789998764 4788999887543 345678999988884 34466777777666678999999999877643
Q ss_pred h-------------------hcCCCCCCCCCh--HHHHHHHH--------------------HHHHHHHHHHc----CCC
Q 004247 504 L-------------------HGNKKDPAAFGW--SERYKVAM--------------------GVAEALEYLHS----GSA 538 (766)
Q Consensus 504 L-------------------~~~~~~~~~l~~--~~~~~i~~--------------------qia~aL~yLH~----~~~ 538 (766)
. |........+.. ........ .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 111110111110 00000000 01111222211 112
Q ss_pred CceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 539 ~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.9e-07 Score=101.51 Aligned_cols=185 Identities=22% Similarity=0.187 Sum_probs=134.7
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEEeecCCC-C
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRG-S 499 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~gg-s 499 (766)
.-+-+++|+++.+||.+---.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 33456899999999876433344445655433 34455889999999999 777777777788899999999887 2
Q ss_pred HhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCcee
Q 004247 500 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579 (766)
Q Consensus 500 L~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~ 579 (766)
-..... .....+...+...+...-+++|+|||+ -.=+||| ||+..+ +..+..||+.+..+.... ..
T Consensus 322 ~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 322 SALEMT---VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred ccccCC---hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 211111 111234444555677777889999998 3348888 887766 589999999987666543 23
Q ss_pred cccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 004247 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624 (766)
Q Consensus 580 ~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 624 (766)
....+|+.++|||+.+.+.+..+.|.|++|+=-.+|--|-+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 347899999999999999999999999999877777777777543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.8e-05 Score=78.41 Aligned_cols=105 Identities=25% Similarity=0.253 Sum_probs=83.0
Q ss_pred HHHHHHHHhcCC-CceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC
Q 004247 461 VLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539 (766)
Q Consensus 461 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 539 (766)
..|.-++..+.+ +++.+++|+|-. ++|.||+..+++....... ..-...+|..|.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888976 699999999933 7899999887665321000 0112368999999999999999999987656
Q ss_pred ceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 540 ~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
.+.-.|++++|+-+++++.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6778999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.8e-05 Score=74.79 Aligned_cols=130 Identities=22% Similarity=0.271 Sum_probs=90.0
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
..+.||+|++|.||+|.+ .|..+|+|+-+.+ .....+..|.++|..+.--++.+=+-++.+ -++.|||+.|-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 456799999999999988 5568999988754 345678889999999987776654433322 25569999998887
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccC-CCeeeCCCCCeeEecccccccc
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS-SNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp-~NILL~~~~~vkL~DFGla~~~ 570 (766)
++-.... .+-...+++.-.-|.. .||-|+.|.- ..++|.++..+.|+||.-|...
T Consensus 101 ~~~~~~~-----------rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGGD-----------RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhccc-----------HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 7654321 1223334444334444 7888988864 4444545559999999988743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.4e-05 Score=77.46 Aligned_cols=142 Identities=20% Similarity=0.276 Sum_probs=83.8
Q ss_pred ceeeeccCceEEEEEEeCC--CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeecCCCC
Q 004247 423 ENLIGKGGSSQVYKGCLPD--GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGS 499 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggs 499 (766)
.+.|..|-...+|+....+ ++.|++|+........-...+|+.++..+...++ .++++.+. + .+||||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 3567788888999987654 6789999887543322233578889888854333 44444332 2 48999999876
Q ss_pred HhHh-----------------hhcCCCCC--------CCCChHHHHHHHH----------------------HHHHHHHH
Q 004247 500 LEEN-----------------LHGNKKDP--------AAFGWSERYKVAM----------------------GVAEALEY 532 (766)
Q Consensus 500 L~~~-----------------L~~~~~~~--------~~l~~~~~~~i~~----------------------qia~aL~y 532 (766)
+... +|...... ....|..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 12111110 1111222222211 11111111
Q ss_pred ----HHc-CCCCceEeecccCCCeeeCC-CCCeeEecccccc
Q 004247 533 ----LHS-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 568 (766)
Q Consensus 533 ----LH~-~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 568 (766)
+-. .....++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111 12357999999999999997 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=73.20 Aligned_cols=127 Identities=24% Similarity=0.396 Sum_probs=94.3
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCCh-----------------hHHHHHHHHHHHHHhcC------CCceeEEe
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------DVIKEFVLEIEIITTLH------HKNIISLL 479 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-----------------~~~~~~~~Ei~iL~~l~------HpnIv~l~ 479 (766)
...||+|+.=.||. +++.....||+..... ...+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999994 6777778999988654 33567778888777776 78899999
Q ss_pred eEEeecCceEEEEeecCCC------CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 480 GFCFEDNNLLLVYDFLSRG------SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 480 ~~~~~~~~~~lV~E~~~gg------sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
|+..++-.+.+|+|.+.+. +|.+++... .++. ...+.+.++ ..||-. ..|+.+||+|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHHH---cCCeecCCCcccEEE
Confidence 9999999999999987532 677888543 2444 334444444 456666 779999999999999
Q ss_pred CCC---C-CeeEec
Q 004247 554 SDD---F-EPQLSD 563 (766)
Q Consensus 554 ~~~---~-~vkL~D 563 (766)
... . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00013 Score=75.90 Aligned_cols=73 Identities=15% Similarity=0.224 Sum_probs=47.5
Q ss_pred eeeeccCce-EEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC---ceeEEeeEEeec---CceEEEEeecC
Q 004247 424 NLIGKGGSS-QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCFED---NNLLLVYDFLS 496 (766)
Q Consensus 424 ~~LG~G~fG-~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~lV~E~~~ 496 (766)
+.|+.||.. .||+. +..+++|+.+.. .....+.+|.+++..+... -+.++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467777776 48874 235788876642 2345788899999888632 344444443322 23588999999
Q ss_pred CCCHh
Q 004247 497 RGSLE 501 (766)
Q Consensus 497 ggsL~ 501 (766)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00026 Score=87.07 Aligned_cols=148 Identities=14% Similarity=0.298 Sum_probs=92.4
Q ss_pred ceeeeccCceEEEEEEeCCC---CEEEEEEccCCh--hHHHHHHHHHHHHHhcC-CCce--eEEeeEEeec---CceEEE
Q 004247 423 ENLIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNI--ISLLGFCFED---NNLLLV 491 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g---~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~~~lV 491 (766)
...|+.|.++.+|+....++ ..+++|+..... .....+.+|+++|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876554 467888765432 23356889999999996 6654 7788887654 467999
Q ss_pred EeecCCCCHhH-----------------------hhhcCCCCC-------CCCChH--HHHHH---------------HH
Q 004247 492 YDFLSRGSLEE-----------------------NLHGNKKDP-------AAFGWS--ERYKV---------------AM 524 (766)
Q Consensus 492 ~E~~~ggsL~~-----------------------~L~~~~~~~-------~~l~~~--~~~~i---------------~~ 524 (766)
|||++|..+.+ .||...... .+..+. ++..+ .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998865321 122211100 011110 11111 01
Q ss_pred HHHHHHHHHHcCCC--------CceEeecccCCCeeeCCC-CC-eeEecccccccc
Q 004247 525 GVAEALEYLHSGSA--------QRVIHRDVKSSNILLSDD-FE-PQLSDFGLAKWA 570 (766)
Q Consensus 525 qia~aL~yLH~~~~--------~~IiHrDLKp~NILL~~~-~~-vkL~DFGla~~~ 570 (766)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. .-|.||+++.+.
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667754221 359999999999999853 33 468999987644
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00015 Score=85.10 Aligned_cols=133 Identities=17% Similarity=0.104 Sum_probs=103.9
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcE
Q 004247 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDL 92 (766)
Q Consensus 13 ~~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~ 92 (766)
.....+|+|+|+.++.|-..++||-+-+-+-+....+|||-.+..... .+.-...|+....+|++ ..-
T Consensus 245 ~~~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~~~----------~~~~~~~l~~~~~Lae~--lGa 312 (890)
T COG2205 245 WAARERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPELHRL----------SEKEARRLHENLRLAEE--LGA 312 (890)
T ss_pred ccccceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEeccccccc----------cHHHHHHHHHHHHHHHH--hCC
Confidence 345679999999999999999999999999999999999986542110 11222344555556554 344
Q ss_pred EEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCCeeeec
Q 004247 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQ 160 (766)
Q Consensus 93 ~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~gk~~~~ 160 (766)
+.+.+.|+|+.++|+++|+.+++..+|||.+.+ .+.|.+ |+.++.+++++ ...|.+|..+.....
T Consensus 313 e~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~--~l~~~L~~~~~-~idv~ii~~~~~~~~ 380 (890)
T COG2205 313 EIVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKG--SLADRLAREAP-GIDVHIVALDAPPDK 380 (890)
T ss_pred eEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcc--cHHHHHHhcCC-CceEEEeeCCCCccc
Confidence 677888999999999999999999999999887 344456 99999999998 889999987654433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00029 Score=71.36 Aligned_cols=124 Identities=22% Similarity=0.341 Sum_probs=91.0
Q ss_pred cCcccceeeeccCc-eEEEEEEeCCCCEEEEEEccC---C------------h-------hHHHHHHHHHHHHHhcC---
Q 004247 418 SNFLAENLIGKGGS-SQVYKGCLPDGKELAVKILKP---S------------E-------DVIKEFVLEIEIITTLH--- 471 (766)
Q Consensus 418 ~~f~~~~~LG~G~f-G~Vy~a~~~~g~~vAVK~l~~---~------------~-------~~~~~~~~Ei~iL~~l~--- 471 (766)
.++...+.||.|.- |.||++.. +|+.||+|+++. . . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 99999998 778999999431 0 0 12345778888877775
Q ss_pred CCce--eEEeeEEeec------------------CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 004247 472 HKNI--ISLLGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531 (766)
Q Consensus 472 HpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~ 531 (766)
+.++ |+.+||..-. ..+.||.||++... .+.. .-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 4456 8999987422 12468888886643 1122 23456677778
Q ss_pred HHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 532 yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 8999 89999999999986 3489999854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00022 Score=77.08 Aligned_cols=141 Identities=25% Similarity=0.355 Sum_probs=86.4
Q ss_pred eeeeccCceEEEEEEeCC-------CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeec
Q 004247 424 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~-------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E~~ 495 (766)
+.|..|-...+|+....+ ++.+++|+.........+..+|.+++..+....+. ++++++. + .+||||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 456677777899987655 57899999876544445667898888888643333 4555543 2 4689999
Q ss_pred CCCCHhHh-----------------hhcCCCC--C-----CCCChHHHHH--------------------------HHHH
Q 004247 496 SRGSLEEN-----------------LHGNKKD--P-----AAFGWSERYK--------------------------VAMG 525 (766)
Q Consensus 496 ~ggsL~~~-----------------L~~~~~~--~-----~~l~~~~~~~--------------------------i~~q 525 (766)
+|..+... +|..... . ...-|..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98776431 1211111 0 0011111111 1122
Q ss_pred HHHHHHHHHc------CCCCceEeecccCCCeeeCCC----CCeeEecccccc
Q 004247 526 VAEALEYLHS------GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 568 (766)
Q Consensus 526 ia~aL~yLH~------~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~ 568 (766)
+...+.+|-. .....++|+|+.+.|||++++ +.+.|+||..|.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2223334432 244679999999999999874 789999998773
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00075 Score=73.08 Aligned_cols=76 Identities=11% Similarity=0.016 Sum_probs=57.2
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC---CceeEEeeEEee---cCceEEEEeecC
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGFCFE---DNNLLLVYDFLS 496 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~~~~~lV~E~~~ 496 (766)
.+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.|.. -.+.+++++|.. .+..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 46799999999999876556 477787543 1123578889999998853 367888888754 356899999999
Q ss_pred CCCH
Q 004247 497 RGSL 500 (766)
Q Consensus 497 ggsL 500 (766)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00073 Score=71.24 Aligned_cols=137 Identities=14% Similarity=0.169 Sum_probs=80.2
Q ss_pred eeccCceEEEEEEeCCCCEEEEEEccCChhHH-HHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeecCCCCHhHh
Q 004247 426 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEEN 503 (766)
Q Consensus 426 LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~-~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggsL~~~ 503 (766)
+..|-.+.+|+... ++..+++|+........ -...+|.++++.+....+ .+++..+ . -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677788998774 67789999876443221 245779999998865433 3334333 2 3799999998765421
Q ss_pred -----------------hhcCCCCCCCCChHHH-HHHHHHH---------HHHHHHHHc-----CCCCceEeecccCCCe
Q 004247 504 -----------------LHGNKKDPAAFGWSER-YKVAMGV---------AEALEYLHS-----GSAQRVIHRDVKSSNI 551 (766)
Q Consensus 504 -----------------L~~~~~~~~~l~~~~~-~~i~~qi---------a~aL~yLH~-----~~~~~IiHrDLKp~NI 551 (766)
||........++.... ..+..++ ...+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 2222111112222211 1111111 111222211 1124689999999999
Q ss_pred eeCCCCCeeEecccccc
Q 004247 552 LLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 552 LL~~~~~vkL~DFGla~ 568 (766)
++++++ +.|+||+.+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0017 Score=72.81 Aligned_cols=75 Identities=19% Similarity=0.207 Sum_probs=55.0
Q ss_pred ceeeeccCceEEEEEEeCCC-CEEEEEEccCC--------hhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCceEE
Q 004247 423 ENLIGKGGSSQVYKGCLPDG-KELAVKILKPS--------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g-~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l 490 (766)
.+.||.|.+..||+....+| +.++||.-.+. ....+++..|.+.|..+. ..++.+++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35789999999999998777 48999985421 124566778888888863 24567777663 355799
Q ss_pred EEeecCCCC
Q 004247 491 VYDFLSRGS 499 (766)
Q Consensus 491 V~E~~~ggs 499 (766)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0014 Score=70.43 Aligned_cols=143 Identities=16% Similarity=0.180 Sum_probs=86.9
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC--ceeEEeeE------EeecCceEEEEee
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 494 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~~~~~~lV~E~ 494 (766)
.+.|..|....+|+....+ ..+++|+... ........|++++..+.+. .+.+++.. ....+..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4567788888999987644 4689998875 2335566788888888533 24444432 1234567899999
Q ss_pred cCCCCHhH--------------hhhcCCC---C----CCCCChHHHH----------HHHHHHHHHHHHHHc----CCCC
Q 004247 495 LSRGSLEE--------------NLHGNKK---D----PAAFGWSERY----------KVAMGVAEALEYLHS----GSAQ 539 (766)
Q Consensus 495 ~~ggsL~~--------------~L~~~~~---~----~~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 539 (766)
++|..+.. .+|.... . .....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876532 1111100 0 0112232211 011223344455443 2236
Q ss_pred ceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 540 ~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0029 Score=68.85 Aligned_cols=142 Identities=18% Similarity=0.239 Sum_probs=77.6
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC--ceeEEee------EEeecCceEEEEeec
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLG------FCFEDNNLLLVYDFL 495 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~------~~~~~~~~~lV~E~~ 495 (766)
+.|+.|....+|+....+| .+++|++.. ...+....|+.++..|... .+.+.+. +....+..+++|+|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567777789999877555 688898762 1223344455666555321 1233332 122345679999999
Q ss_pred CCCCHh-----------Hh---hhcCCCC-------CCCCCh-HHHHH------------HH-HHHHHHHHHHHc----C
Q 004247 496 SRGSLE-----------EN---LHGNKKD-------PAAFGW-SERYK------------VA-MGVAEALEYLHS----G 536 (766)
Q Consensus 496 ~ggsL~-----------~~---L~~~~~~-------~~~l~~-~~~~~------------i~-~qia~aL~yLH~----~ 536 (766)
+|..+. +. +|..... ...+.| ..... .+ ..+...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 987532 11 1211110 001112 11111 11 111122233321 1
Q ss_pred CCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 537 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
-+.++||+|+.|.|||++++...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24689999999999999876555799998774
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0031 Score=68.43 Aligned_cols=144 Identities=17% Similarity=0.186 Sum_probs=83.6
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC--ceeEEeeEE------eecCceEEEEee
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFC------FEDNNLLLVYDF 494 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~------~~~~~~~lV~E~ 494 (766)
.+.|+.|....+|+....+| .+++|+..... .......|++++..|... .+.+++... ...+..+++|+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677787789999876555 57889876532 123445677777777422 233443321 124567899999
Q ss_pred cCCCCHhH--------------hhhcCCC---CCC-----CCChHHHHH------------HHHHHHHHHHHHHc----C
Q 004247 495 LSRGSLEE--------------NLHGNKK---DPA-----AFGWSERYK------------VAMGVAEALEYLHS----G 536 (766)
Q Consensus 495 ~~ggsL~~--------------~L~~~~~---~~~-----~l~~~~~~~------------i~~qia~aL~yLH~----~ 536 (766)
++|..+.. .+|.... .+. .-.|..... ....+...+++|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99865321 1221111 000 012221110 11123344555542 2
Q ss_pred CCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 537 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
.+.++||+|+.+.||++++++...|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34789999999999999988767899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0015 Score=79.77 Aligned_cols=196 Identities=18% Similarity=0.167 Sum_probs=131.3
Q ss_pred HHHHHHHHHhcCCCceeEEeeEEeecCceE----EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHc
Q 004247 460 FVLEIEIITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535 (766)
Q Consensus 460 ~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~----lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 535 (766)
...|++.+..+.|+|++.++.|-.+....- +..+++..-++...++... ..+....+.+..++.+||.|+|.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence 344667788889999999999987654332 3457788888888886554 46778888899999999999998
Q ss_pred CCCCceEeecccCC---CeeeCCCCCeeEe--cccccccccCCCCCceecccccccCCCCchhhccCCCCC--chhhHHH
Q 004247 536 GSAQRVIHRDVKSS---NILLSDDFEPQLS--DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND--KIDVYAF 608 (766)
Q Consensus 536 ~~~~~IiHrDLKp~---NILL~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~--ksDVwSl 608 (766)
....|.-+..+ +-..+..+...++ ||+..+.+........ ..-+..|.+||......++. ..|+|.+
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 44455444444 4444556667777 9988876665433222 23455688888877665554 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 004247 609 GVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688 (766)
Q Consensus 609 GvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL 688 (766)
|..+..+..|..+-.... ....+++.. ... .+......|+..++++|+.+.+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~~----~~~----~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDVL----STS----ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhccc----cch----hhhhhhhhhcchhhhhccchhhhh
Confidence 999999998865432110 000111110 010 122333569999999999999999
Q ss_pred HHh
Q 004247 689 KLL 691 (766)
Q Consensus 689 ~~L 691 (766)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00043 Score=74.01 Aligned_cols=134 Identities=22% Similarity=0.234 Sum_probs=94.6
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh----------h-------------HHHHHHHHHHHHHhcCC--C
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----------D-------------VIKEFVLEIEIITTLHH--K 473 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----------~-------------~~~~~~~Ei~iL~~l~H--p 473 (766)
-+.+.+.||-|--+.||.+-..+|++.++|+-+... + ..-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 356789999999999999999999999999754211 0 11234567888888853 3
Q ss_pred ceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 474 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
-+.+.+++ +..++|||++.|-.|...-+-. ....++.-+.++ +.-|-. +|+||+|..-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~---Iv~la~---~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGL---IVRLAN---HGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHH---HHHHHH---cCceecccchheeEE
Confidence 35555555 4559999999998887654321 223333333333 344555 899999999999999
Q ss_pred CCCCCeeEeccccccc
Q 004247 554 SDDFEPQLSDFGLAKW 569 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~ 569 (766)
++++.++++||--...
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999966543
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0016 Score=56.52 Aligned_cols=83 Identities=24% Similarity=0.212 Sum_probs=66.4
Q ss_pred EEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEEEEEE
Q 004247 19 VVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICR 98 (766)
Q Consensus 19 I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~~ 98 (766)
|+|+++++..|..+|.||.... +.+..++++|+-
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH---------------------------------------------
Confidence 6899999999999999999977 556677777774
Q ss_pred CCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEE
Q 004247 99 GTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLA 151 (766)
Q Consensus 99 ~~d~~~~lv~~a~~~~a~~LVlG~~~~--~r~~~g~~sVs~yc~~~ap~~C~V~v 151 (766)
...+.+.+.|++.+++++++|.++. .....+..+++.++++.++ |||+.
T Consensus 35 --~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 --AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred --HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--CceeC
Confidence 5577888889999999999999987 2222331278999999997 88873
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0038 Score=69.04 Aligned_cols=142 Identities=15% Similarity=0.225 Sum_probs=84.3
Q ss_pred ceeeeccCceEEEEEEeCC-----CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeecC
Q 004247 423 ENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~ 496 (766)
...|-.|-...+|+....+ ++.|++|+........-+-.+|..++..+..-++. ++++++.. . .|++|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 3455568888999987532 36899999876433222336799999888654444 45555532 2 6899998
Q ss_pred CCCHhHh-----------------hhcCCCC--CCCCChHHHHHHHHHH-----------------HHHHHHH----Hc-
Q 004247 497 RGSLEEN-----------------LHGNKKD--PAAFGWSERYKVAMGV-----------------AEALEYL----HS- 535 (766)
Q Consensus 497 ggsL~~~-----------------L~~~~~~--~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~- 535 (766)
+.+|... +|..... .....|.....+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 2221111 1112233333332221 1112222 21
Q ss_pred CCCCceEeecccCCCeeeCC-CCCeeEecccccc
Q 004247 536 GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 568 (766)
Q Consensus 536 ~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 568 (766)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22357899999999999986 4679999998774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0086 Score=64.14 Aligned_cols=69 Identities=17% Similarity=0.115 Sum_probs=42.0
Q ss_pred eccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC--Cc-eeEEeeEEeecCceEEEEeecCCCCH
Q 004247 427 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 427 G~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pn-Iv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
+.|-...||.....+|..+++|.-+. ......+.+|.++|..+.. |- +.+++.. . .-+++|+++.|..+
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~--~~~~~y~~i~G~p~ 91 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRVH--T--PELIAYPKLPGVPA 91 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceeee--c--CceEEEeccCCCcc
Confidence 44445566665555788999998863 3445678899999999863 21 1222211 1 22567777776544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00027 Score=87.42 Aligned_cols=164 Identities=10% Similarity=-0.044 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH
Q 004247 457 IKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534 (766)
Q Consensus 457 ~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH 534 (766)
.+-...|.+.++...|+++.....-... ....+.+++|+.+|.+...|-+.......+...-....-.+......-.|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3344456666777789988876654432 34568999999999999998765544344444433333333344555545
Q ss_pred c--CCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHH
Q 004247 535 S--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 612 (766)
Q Consensus 535 ~--~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL 612 (766)
. +...-.+|+++|+-|.+|..+..+|+.++|+.+....... ..+...+++.|+.|++...-+++.++|+|..|+-+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 4 2234579999999999999999999999999984333221 22345788899999999988999999999999999
Q ss_pred HHHHhCCCCC
Q 004247 613 LELLTGRKPI 622 (766)
Q Consensus 613 ~eLltG~~Pf 622 (766)
|++-.|..+|
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9998888876
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0071 Score=65.96 Aligned_cols=139 Identities=24% Similarity=0.283 Sum_probs=96.8
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEccCC---------------------------hhHHHHHHHHHHHHHhcCCCc
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------------------------EDVIKEFVLEIEIITTLHHKN 474 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---------------------------~~~~~~~~~Ei~iL~~l~Hpn 474 (766)
+...|..|--+.||.+...+|..+|||+++.+ +...--...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 35678899999999999999999999998731 011223446888888887655
Q ss_pred eeEEeeEEeecCceEEEEeecCCCCHhH-hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 475 IISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 475 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
|.-.--+... ...|||+|+....-.. .|. ...++...+..+-.+++.-+.-|.+.| ++||.||.--|+|+
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 4333222222 2389999995321111 111 134667778888888888888887744 69999999999998
Q ss_pred CCCCCeeEecccccccc
Q 004247 554 SDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~ 570 (766)
. +|.+.|+|-+-+...
T Consensus 299 h-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVEH 314 (520)
T ss_pred E-CCEEEEEEccccccC
Confidence 5 458999998876533
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0099 Score=65.37 Aligned_cols=141 Identities=19% Similarity=0.305 Sum_probs=82.0
Q ss_pred eeeeccCceEEEEEEeCC----CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeecCCC
Q 004247 424 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~gg 498 (766)
+.|..|-...+|+....+ +..|++|+........-.-.+|..+++.+..-++. ++++++ .++ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcCC
Confidence 445557778889886533 34799999875443333446789999998765554 455555 222 589999877
Q ss_pred CHhH-----------------hhhcCCCC--CCCCChHHHHHHHHHH----------------------HHHHHHH---H
Q 004247 499 SLEE-----------------NLHGNKKD--PAAFGWSERYKVAMGV----------------------AEALEYL---H 534 (766)
Q Consensus 499 sL~~-----------------~L~~~~~~--~~~l~~~~~~~i~~qi----------------------a~aL~yL---H 534 (766)
+|.. .+|..... ...-.|..+.++..++ ..-+..+ .
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6532 12221110 0111244333332222 1111111 1
Q ss_pred -c-CCCCceEeecccCCCeeeCC-CCCeeEecccccc
Q 004247 535 -S-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 568 (766)
Q Consensus 535 -~-~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 568 (766)
. ..+.-++|.|+.+.|||+++ ++.++++||..|.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 12234799999999999974 5789999998873
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 766 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-138
Identities = 115/314 (36%), Positives = 181/314 (57%), Gaps = 5/314 (1%)
Query: 395 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 454
E E + + F+ ++L A+ NF +N++G+GG +VYKG L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 455 D--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 512
+F E+E+I+ H+N++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 513 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572
W +R ++A+G A L YLH ++IHRDVK++NILL ++FE + DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 632
+H+T T V GT G++APEY GK ++K DV+ +GV+LLEL+TG++ +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 633 --LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690
L+ W K +L K+ L+D L NY +++E+++ ++LC + P RP+MS V+++
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 691 LRGDADVTKWARLQ 704
L GD +W Q
Sbjct: 306 LEGDGLAERWEEWQ 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-128
Identities = 109/315 (34%), Positives = 174/315 (55%), Gaps = 6/315 (1%)
Query: 382 STDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD 441
S +T + DL AT+NF + LIG G +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 442 GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 500
G ++A+K P S I+EF EIE ++ H +++SL+GFC E N ++L+Y ++ G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560
+ +L+G+ + W +R ++ +G A L YLH+ + +IHRDVKS NILL ++F P+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 561 LSDFGLAKWA-STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
++DFG++K +H++ T V GT GY+ PEYF+ G++ +K DVY+FGVVL E+L R
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 620 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 679
I P+ +L WA ++G++ Q++DP L + + + + ++ C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 680 ARPQMSLVLKLLRGD 694
RP M VL L
Sbjct: 299 DRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-116
Identities = 95/311 (30%), Positives = 159/311 (51%), Gaps = 23/311 (7%)
Query: 399 EKYSATCRLFNYQDLLSATSNF------LAENLIGKGGSSQVYKGCLPDGKELAVKILKP 452
E F++ +L + T+NF + N +G+GG VYKG + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 453 SEDV-----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 507
D+ ++F EI+++ H+N++ LLGF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 508 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567
P W R K+A G A + +LH IHRD+KS+NILL + F ++SDFGLA
Sbjct: 125 DGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 568 KWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626
+ + + + +T + + GT Y+APE + G++ K D+Y+FGVVLLE++TG + D
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 627 PKGQESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 685
+ + L+ + I + +D + + D +E M + C+ RP +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 686 LVLKLLRGDAD 696
V +LL+
Sbjct: 296 KVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-77
Identities = 73/318 (22%), Positives = 121/318 (38%), Gaps = 28/318 (8%)
Query: 396 GLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED 455
G H + ++ ++L + + +G V+K + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 456 VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDP 511
+ E+ + + H+NI+ +G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 512 AAFGWSERYKVAMGVAEALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDF 564
W+E +A +A L YLH G + HRD+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGR 619
GLA S GT Y+APE +ID+YA G+VL EL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 620 KPISNDHPKGQESL--VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-C 673
+ + P L + V + P L + + M+ +I C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 674 IRRDPRARPQMSLVLKLL 691
D AR V + +
Sbjct: 296 WDHDAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-62
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
E ++G+G V K K++A+K ++ SE K F++E+ ++ ++H NI+ L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
N + LV ++ GSL LHG + P + + + ++ + YLHS + +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 543 HRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
HRD+K N+LL ++ DFG A T T+ G+ ++APE F ++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 602 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661
K DV+++G++L E++T RKP + V P L N
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDE----------IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 662 QMERMVLASIL--CIRRDPRARPQMSLVLKLLR 692
+ S++ C +DP RP M ++K++
Sbjct: 233 ------IESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 8e-61
Identities = 65/319 (20%), Positives = 110/319 (34%), Gaps = 43/319 (13%)
Query: 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 467
+ N LIG+G VYKG L D + +AVK+ + + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 468 TT--LHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 520
+ H NI + LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 521 KVAMGVAEALEYLHSGSAQR------VIHRDVKSSNILLSDDFEPQLSDFGLAK------ 568
++A V L YLH+ + + HRD+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 569 WASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKP 621
GT Y+APE ++D+YA G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 622 ISNDHPKGQESL----VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-- 672
+ + + + P + + P + + + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 673 CIRRDPRARPQMSLVLKLL 691
C +D AR + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-60
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 37/280 (13%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 479
+ IG G V++ G ++AVKIL + + EF+ E+ I+ L H NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
G + NL +V ++LSRGSL LH R +A VA+ + YLH+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
++HR++KS N+L+ + ++ DFGL++ AST S AGT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPEVLRDEP 215
Query: 599 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDP 652
N+K DVY+FGV+L EL T ++P N +P Q V+ A + + L+P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQ---VVAAVGFKCKRLEIPRN-----LNP 266
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ +E C +P RP + ++ LLR
Sbjct: 267 QV-----AAIIEG-------CWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-57
Identities = 82/290 (28%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----VIKEFVLEIEIITTLHHKNIIS 477
E +IG GG +VY+ G E+AVK + D I+ E ++ L H NII+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L G C ++ NL LV +F G L L G + A+ +A + YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 538 AQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+IHRD+KSSNIL+ E ++DFGLA+ ++ AG + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWM 181
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------PILS 642
APE + DV+++GV+L ELLTG P V + PI S
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-LA---VAYGVAMNKLALPIPS 237
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ ME C DP +RP + +L L
Sbjct: 238 T------CPEPF-----AKLMED-------CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-56
Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHK 473
E IGKGG V+KG + D +A+K L + +EF E+ I++ L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
NI+ L G N +V +F+ G L L WS + ++ + +A +EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYM 138
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTFGY 588
+ ++HRD++S NI L E ++DFGL++ + S + + G F +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQW 192
Query: 589 LAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK- 645
+APE +K D Y+F ++L +LTG P + + I G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLR 248
Query: 646 --VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ + P L + +E C DP+ RP S ++K L
Sbjct: 249 PTIPEDCPPRL-----RNVIEL-------CWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-54
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IG G VYKG ++AVK+L + ++ F E+ ++ H NI+ +G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
L +V + SL +LH ++ F + +A A ++YLH+ + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE---YFMYGKV 599
HRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDPA 653
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ P LS KV
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLS--KVRSNCPKR 257
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ M C+++ RP +L +
Sbjct: 258 M-----KRLMAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 46/284 (16%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 479
+ + S +++KG G ++ VK+LK S ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 480 GFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
G C + L+ ++ GSL LH S+ K A+ +A + +LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 595
+ + S ++++ +D ++S + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKK 183
Query: 596 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP------KGQESLVMWAKPILSSGKVTQ 648
D+++F V+L EL+T P ++ E L +P + G
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPG---- 235
Query: 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ P + M+ C+ DP RP+ +++ +L
Sbjct: 236 -ISPHV-----SKLMKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 49/290 (16%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 479
LIGKG QVY G E+A++++ +ED +K F E+ H+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
G C +L ++ +L + K ++ ++A + + + YLH+ +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMY 596
++H+D+KS N+ D+ + ++DFGL G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 597 GKV---------NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-----KPILS 642
+ DV+A G + EL P ++W KP LS
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGMKPNLS 264
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ + D + C + RP + ++ +L
Sbjct: 265 QIGM----GKEI-----SDILLF-------CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 480
IGKG +V+ G G+++AVK+ +E+ + E EI T + H+NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 481 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
+ L L+ D+ GSL + L D K+A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTE 153
Query: 537 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 589
+ HRD+KS NIL+ + ++D GLA + T+ I GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 590 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISN----DHPKGQESLVMWAKP 639
PE + + D+Y+FG++L E+ P +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 692
+ + L P+ N + D+ R + ++ C +P +R V K L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLR-QMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-50
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNIISLLG 480
++GKG Q K G+ + +K L + E+ + F+ E++++ L H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
++D L + +++ G+L + + WS+R A +A + YLHS
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAK------------WASTSSSHITCTDVAGTFGY 588
+IHRD+ S N L+ ++ ++DFGLA+ + V G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---PILSSGK 645
+APE ++K+DV++FG+VL E++ + P+ + +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247
Query: 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
P+ + R C DP RP + L
Sbjct: 248 ----CPPSF-----FPITVR-------CCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 34/294 (11%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 480
+GKG +V++G G+ +AVKI ++ K + E E+ T L H+NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIA 69
Query: 481 FC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIE 124
Query: 537 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 589
+ HRD+KS NIL+ + + ++D GLA ST+ + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 590 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH----PKGQESLVMWAKP 639
APE ++D++AFG+VL E+ P +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLL 691
+ P + N + D LA ++ C ++P AR + K L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLT-SLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-48
Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 34/295 (11%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 480
+ IGKG +V++G G+E+AVKI E+ + + E EI T L H+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 103
Query: 481 FCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 537 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYL 589
+ HRD+KS NIL+ + ++D GLA +++ I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 590 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKP 639
APE + + + D+YA G+V E+ P +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 692
+ Q L P + N + + R V+A I+ C + AR + K L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALR-VMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHH 472
+NF E IG+G S+VY+ CL DG +A+K ++ + + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 530
N+I EDN L +V + G L + KK ER K + + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
E++HS +RV+HRD+K +N+ ++ +L D GL ++ S+ ++ + GT Y++
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS 204
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ-L 649
PE N K D+++ G +L E+ + P D SL K+ Q
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQCD 254
Query: 650 LDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 690
P ++Y + L ++ CI DP RP ++ V +
Sbjct: 255 YPPLPSDHYSEE------LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 73/300 (24%), Positives = 133/300 (44%), Gaps = 35/300 (11%)
Query: 398 HEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPS 453
H +S+ L + ++ IG+G + DG++ +K + + S
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 454 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 513
+E E+ ++ + H NI+ E+ +L +V D+ G L + ++ K
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-- 121
Query: 514 FGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571
+ E + + AL+++H ++++HRD+KS NI L+ D QL DFG+A+ +
Sbjct: 122 --FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631
++ GT YL+PE N+K D++A G VL EL T + K
Sbjct: 177 STVEL-ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--- 231
Query: 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 689
+LV+ K+ P + +Y YD L S++ +R+PR RP ++ +L+
Sbjct: 232 NLVL---------KIISGSFPPVSLHYSYD------LRSLVSQLFKRNPRDRPSVNSILE 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 41/291 (14%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNII 476
++L +G+GG S V L DG A+K IL + +E E ++ +H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 477 SLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
L+ +C + L+ F RG+L + K + + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSHITCTDVA---GT 585
+H+ + HRD+K +NILL D+ +P L D G A S +T D A T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 586 FGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 642
Y APE F + ++++ DV++ G VL ++ G P KG +S+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL------- 258
Query: 643 SGKVTQLLDPALGNNYDYDQMERM--VLASIL--CIRRDPRARPQMSLVLK 689
A+ N Q R L +L + DP RP + L+L
Sbjct: 259 ----------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 476
+F LIG GG QV+K DGK +K +K + + + E++ + L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIV 67
Query: 477 SLLGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 519
G C++ L + +F +G+LE+ + + + +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----LDKV 122
Query: 520 Y--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
++ + + ++Y+HS +++I+RD+K SNI L D + ++ DFGL
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637
GT Y++PE ++D+YA G++L ELL +
Sbjct: 180 R---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLR 232
Query: 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
I+S +D+ E+ +L + + P RP S +L+
Sbjct: 233 DGIISDI---------------FDKKEKTLLQK--LLSKKPEDRPNTSEILR 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 47/297 (15%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKN 474
++F +G+GG V++ D A+K L E ++ + E++ + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 475 IISLLGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
I+ E N L + + +L++ ++G S +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK----------WAST 572
+ +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 632
++ T GT Y++PE + K+D+++ G++L ELL +P +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------YPFSTQM 231
Query: 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ + + K L E +++ + P RP+ +++
Sbjct: 232 ERVRTLTDVRNLKFPPLFT-------QKYPCEYVMVQD--MLSPSPMERPEAINIIE 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLG 480
IG+G VYKG E+A L K ++ + F E E++ L H NI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 481 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
++LV + ++ G+L+ L K + + L++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 537 SAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ +IHRD+K NI ++ ++ D GLA S V GT ++APE +
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655
K ++ +DVYAFG+ +LE+ T P S Q ++SG D
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------RVTSGVKPASFDKVA- 255
Query: 656 NNYDYDQMERMVLASILCIRRDPRARP 682
+ ++ CIR++ R
Sbjct: 256 -----IPEVKEIIE--GCIRQNKDERY 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 540
+D L ++ ++L GS + L E + + + L+YLHS ++
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
IHRD+K++N+LLS+ E +L+DFG+ + T T GT ++APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPILSSGKVTQLLDPALGNNY 658
+ K D+++ G+ +EL G P S HP M I + P L NY
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP------PTLEGNY 243
Query: 659 DYDQMERMVLASILCIRRDPRARP 682
++ V C+ ++P RP
Sbjct: 244 S-KPLKEFV---EACLNKEPSFRP 263
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 426 IGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IG+G +V+ G L D +AVK + D+ +F+ E I+ H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
+ + +V + + G L ++ A +EYL S + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 600
HRD+ + N L+++ ++SDFG+++ + + APE YG+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 601 DKIDVYAFGVVLLELLT-GRKP 621
+ DV++FG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-35
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 25/251 (9%)
Query: 392 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS--QVYKG-CLPDGKELAVK 448
H + + ++ + +IGKG V P G+ + V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 449 IL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 505
+ S +++ E+ + +H NI+ DN L +V F++ GS ++ +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 506 GNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563
+ D G +E + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 119 THFMD----GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 564 FGLAKWASTS-----SSHITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELL 616
+ H +L+PE + K D+Y+ G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 617 TGRKPISNDHP 627
G P +
Sbjct: 232 NGHVPFKDMPA 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 64/286 (22%), Positives = 107/286 (37%), Gaps = 30/286 (10%)
Query: 415 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTL 470
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 471 HHKNIISLLG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
H NI+ N L +V ++ G L + K+ +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 529 ALEYLHS--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
AL+ H V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTP 180
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646
Y++PE N+K D+++ G +L EL P + Q+ L K+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---------KI 228
Query: 647 TQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 690
+ + Y + L I+ + RP + +L+
Sbjct: 229 REGKFRRIPYRYSDE------LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 478
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 479 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
+ D + +V +L + S++ W + EA
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 139
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 590 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 621
PE K++ K DV++ G +L + G+ P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 72/271 (26%), Positives = 114/271 (42%), Gaps = 27/271 (9%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IG G ++ V C P +++A+K L+ + + E + EI+ ++ HH NI+S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW--SERY--KVAMGVAEALEYLHSGSA 538
+ L LV LS GS+ + + E + V E LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC---TDVAGTFGYLAPEYFM 595
IHRDVK+ NILL +D Q++DFG++ + +T GT ++APE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 596 YGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
+ + K D+++FG+ +EL TG P P M + L
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQNDPPSLETGVQ 252
Query: 655 GNNYDYD---QMERMVLASILCIRRDPRARP 682
+M+ LC+++DP RP
Sbjct: 253 DKEMLKKYGKSFRKMI---SLCLQKDPEKRP 280
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 15/205 (7%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 477
L+G+GG VY+ + +A+K++ + E L +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
+ F D L + ++ L L + + + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA-GTFGYLAPEYFMY 596
A HRDVK NIL+S D L DFG+A +T+ +T GT Y+APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKP 621
+ D+YA VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 39/271 (14%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 479
+G GG S VY ++A+K + E+ +K F E+ + L H+NI+S++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
ED+ LV +++ +L E + + + + +++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMYGK 598
R++HRD+K NIL+ + ++ DFG+AK + S + +T T+ V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 599 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG------QESLVMWAKPILSSGKVTQLLDP 652
++ D+Y+ G+VL E+L G P + + Q+S+ P +++ V + +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-----PNVTT-DVRKDIPQ 242
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 683
+L ++L +D R +
Sbjct: 243 SL---------SNVILR---ATEKDKANRYK 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 50/301 (16%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 475
S+F ++G+G QV K D + A+K ++ +E+ + + E+ ++ +L+H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 476 ISLLGFCFEDNN-------------LLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYK 521
+ E N L + ++ G+L + +H N W +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----R 120
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-- 579
+ + EAL Y+HS Q +IHRD+K NI + + ++ DFGLAK S +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 580 ----------TDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628
T GT Y+A E G N+KID+Y+ G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST------- 230
Query: 629 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
G E + + K L S + P +N + + ++ ++ DP RP +L
Sbjct: 231 GMERVNILKK--LRSVSIE--FPPDFDDNKMKVE--KKIIRLLID--HDPNKRPGARTLL 282
Query: 689 K 689
Sbjct: 283 N 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 38/272 (13%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE---FVLEIEIITTL-HH 472
+F + +G G +V+K DG+ AVK K+ + E+ + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
+ L E L L + SL+++ + A+ ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LHS Q ++H DVK +NI L +L DFGL T+ + G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
G DV++ G+ +LE+ + P G E W + L G L P
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNMEL-----PHGGEG---WQQ--LRQGY----LPP 271
Query: 653 ALGNNYDYDQMERMVLASIL--CIRRDPRARP 682
+ L S+L + DP+ R
Sbjct: 272 EFTAGLSSE------LRSVLVMMLEPDPKLRA 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 478
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 479 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
+ D + +V +L + S++ W + EA
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 120
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 590 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 621
PE K++ K DV++ G +L + G+ P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 478
+GKG VY LA+K+L ++ V + E+EI + L H NI+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 535
G+ + + L+ ++ G++ L K A +E +A AL Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LANALSYCHS 127
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628
++K+D+++ GV+ E L G+ P + +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 57/293 (19%), Positives = 101/293 (34%), Gaps = 57/293 (19%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTL-H 471
T+ F IG G V+K DG A+K K + + E+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
H +++ ED+++L+ ++ + GSL + + N + + F +E + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-------------------LSDFGLAKWAST 572
Y+HS ++H D+K SNI +S P + D G S+
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 573 SSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQE 631
G +LA E + K D++A + ++ N
Sbjct: 187 PQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235
Query: 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARP 682
W + + G++ P + + +L I DP RP
Sbjct: 236 ---QWHE--IRQGRL-----PRIPQVLSQE------FTELLKVMIHPDPERRP 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 477
+F ++++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
+ + + L +L+E + ++ A E + L +LHS
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 538 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKW-ASTSSSHITCTDVAGTFGYLAP 591
++HRD+K NIL+S +SDFGL K A S + V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 592 EYF---MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647
E +D+++ G V +++ G P +++ ++ L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQANILLGACSLDCLHPE 253
Query: 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ D + +E+M I DP+ RP VLK
Sbjct: 254 KHEDVIA-----RELIEKM-------IAMDPQKRPSAKHVLK 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 417 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 475
F +G+G VYK G+ +A+K + D ++E + EI I+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHV 86
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 533
+ G F++ +L +V ++ GS+ + + K +E + + LEYL
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYL 141
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPE 592
H R IHRD+K+ NILL+ + +L+DFG+ + T + T V GT ++APE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
N D+++ G+ +E+ G+ P ++ HP
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 412 DLLSATSNFLAE---------NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDV 456
+L+ A + + +IG+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 457 IKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 515
+ +F+ E I+ H N++SLLG C + + L+V ++ G L + +P
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-- 127
Query: 516 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575
+ + VA+ ++YL ++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 128 -KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 576 HITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ ++A E K K DV++FGV+L EL+T G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 65/321 (20%), Positives = 123/321 (38%), Gaps = 50/321 (15%)
Query: 420 FLAENLIGKGGSSQVYKGCL-PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 476
F + +G G V+K P G +A K+ L+ + + + E++++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 534
G + D + + + + GSL++ L + P E+ KV++ V + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLR 148
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
+++HRDVK SNIL++ E +L DFG++ S GT Y++PE
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 202
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
+ + D+++ G+ L+E+ GR PI K E + ++ + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 655 GNNYDYDQMERM-----VLASIL----------------------CIRRDPRARP----- 682
N +L I+ C+ ++P R
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 683 -QMSLVLKLLRGDADVTKWAR 702
+ + + + D W
Sbjct: 323 MVHAFIKRSDAEEVDFAGWLC 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 478
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 479 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
+ D + +V +L + S++ W + EA
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 167
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+ +H ++H D+K +N L+ D +L DFG+A ++ + G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 590 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 621
PE K++ K DV++ G +L + G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 479
++G GG S+V+ L D +++AVK+L+ F E + L+H I+++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 480 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+ +V +++ +L + +H +V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 133
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYF 594
+IHRDVK +NI++S ++ DFG+A+ + S + +T T V GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
V+ + DVY+ G VL E+LTG P + D P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 26/243 (10%)
Query: 423 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 476
+ +GKG V L D AVK L+ D ++F EI+I+ LH I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 477 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
G + +L LV ++L G L + L ++ S + + + +EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG 144
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 589
S +R +HRD+ + NIL+ + +++DFGLAK + G
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSPIFWY 197
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648
APE + + DV++FGVVL EL T K S ++ + + + ++ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLE 255
Query: 649 LLD 651
LL+
Sbjct: 256 LLE 258
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
+IG+G VY G L DGK++ AVK L + +F+ E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 477 SLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
SLLG C + + L+V ++ G L + +P + + VA+ +++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFL-- 208
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 590
++++ +HRD+ + N +L + F +++DFGLA+ T L A
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMA 264
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
E K K DV++FGV+L EL+T G P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
IHR++ + N L+ ++ +++DFGL++ T ++ + APE Y K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 602 KIDVYAFGVVLLELLT-GRKP 621
K DV+AFGV+L E+ T G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 483 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 599
+HRD+ + N+L+S+D ++SDFGL K + T G APE K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 600 NDKIDVYAFGVVLLELLT-GRKP 621
+ K DV++FG++L E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-32
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 28/254 (11%)
Query: 379 SPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC 438
P + D++ L ++L+ + +Y +Q +G+G +V++
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMK 78
Query: 439 -LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497
G + AVK + E E E+ L I+ L G E + + + L
Sbjct: 79 DKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD- 556
GSL + + K E LEYLH+ +R++H DVK+ N+LLS D
Sbjct: 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187
Query: 557 FEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 613
L DFG A S +T + GT ++APE M + K+D+++ ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 614 ELLTGRKPISNDHP 627
+L G P +
Sbjct: 248 HMLNGCHPWTQYFR 261
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 423 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 475
++G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
LLG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 596 YGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ + DV+++GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 481
+G+G V K +P G+ +AVK + K +++++I T+ ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
F + ++ + + + SL++ E K+A+ + +ALE+LHS
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHS--KL 129
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
VIHRDVK SN+L++ + ++ DFG++ + + AG Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELN 186
Query: 600 ND----KIDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
K D+++ G+ ++EL R P + P Q V+ P L
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS------------PQL 234
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 702
+ + C++++ + RP Q DV + +
Sbjct: 235 PADKFSAEFVDFTSQ---CLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVK 285
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 57/297 (19%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKN 474
F L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 475 IISLLG------FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 526
I + G D+ L LV +F GS+ + + K + E + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGT 585
L +LH +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGT 192
Query: 586 FGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA--- 637
++APE + D K D+++ G+ +E+ G P+ + HP M A
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL 245
Query: 638 -----KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
P L S K ++ + + C+ ++ RP ++K
Sbjct: 246 IPRNPAPRLKSKKWSKKF--------------QSFIE--SCLVKNHSQRPATEQLMK 286
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 483 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 599
+HRD+ + N+L+S+D ++SDFGL K AS++ G APE K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKF 191
Query: 600 NDKIDVYAFGVVLLELLT-GRKP---ISN 624
+ K DV++FG++L E+ + GR P I
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 47/285 (16%)
Query: 423 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 476
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 477 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 589
+ +R IHRD+ + NIL+ ++ ++ DFGL K G
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWY 184
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 650 LD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 682
L + Y M C + RP
Sbjct: 245 LKNNGRLPRPDGCPDEI-----YMIMTE-------CWNNNVNQRP 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 21/212 (9%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
+G G +VYK G A K+++ SE+ ++++++EIEI+ T H I+ LLG +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 541
D L ++ +F G+++ + + G +E V + EAL +LHS +R+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
IHRD+K+ N+L++ + + +L+DFG+ AK T + GT ++APE M +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMK 195
Query: 601 D-----KIDVYAFGVVLLELLTGRKPISNDHP 627
D K D+++ G+ L+E+ P +P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G G V G ++AVK++K EF E + + L H ++ G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
++ + +V +++S G L L + K S+ ++ V E + +L + + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 596
HRD+ + N L+ D ++SDFG+ ++ + + G APE F Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 597 GKVNDKIDVYAFGVVLLELLT-GRKP 621
K + K DV+AFG+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 479
L+GKG + VY+ + G E+A+K++ +++ E++I L H +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 535
FED N + LV + G + L K + A R+ + + + YLHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ-IITGMLYLHS 130
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEY 593
++HRD+ SN+LL+ + +++DFGLA + C GT Y++PE
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEI 183
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ DV++ G + LL GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 47/285 (16%)
Query: 423 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 476
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 477 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 589
+ +R IHRD+ + NIL+ ++ ++ DFGL K + G
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWY 215
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 650 LD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 682
L + Y M C + RP
Sbjct: 276 LKNNGRLPRPDGCPDEI-----YMIMTE-------CWNNNVNQRP 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 70/318 (22%), Positives = 137/318 (43%), Gaps = 55/318 (17%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
+G+G VY+G + D E A+K + S EF+ E ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALE 531
LLG + L++ + ++RG L+ L + A ++A +A+ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAGTFGYL 589
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-------IYETDYYRKGGKGLL 202
Query: 590 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPI 640
+PE G DV++FGVVL E+ T +P +SN ++ L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRF----- 252
Query: 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 700
+ G + L P + ++ M C + +P+ RP ++ ++ + + +
Sbjct: 253 VMEGGL--LDKPDNCPDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEME-PGF 302
Query: 701 ARLQVNASEESEMLDDES 718
+ SEE+++ + E
Sbjct: 303 REVSFYYSEENKLPEPEE 320
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 421 LAENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 475
+A+ +G G V +G K++ A+K+LK + +E + E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+ L+G C + L+LV + G L + L G +++ S ++ V+ ++YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 593
+ +HRD+ + N+LL + ++SDFGL+K S+ T AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPEC 184
Query: 594 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ K + + DV+++GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 481
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 482 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 536
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 593 YFMYGKVND--------KIDVYAFGVVLLELLTGRKP 621
+ + +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 53/284 (18%)
Query: 426 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +V C DG AVK LK + EI+I+ TL+H++II
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 479 LGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
G C + +L LV +++ GSL + L + G ++ A + E + YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA- 152
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 591
Q IHRD+ + N+LL +D ++ DFGLAK + G AP
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650
E K DV++FGV L ELLT S P L+ A+ ++ ++T+LL
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRLTELL 264
Query: 651 D------------PALGNNYDYDQMERMVLASILCIRRDPRARP 682
+ + Y M+ C + RP
Sbjct: 265 ERGERLPRPDKCPAEV-----YHLMKN-------CWETEASFRP 296
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 481
+G G QV+K G +AVK +++ K +++++++ + I+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
+ ++ + + + + + P ER K+ + + +AL YL
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLKE--KH 144
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
VIHRDVK SNILL + + +L DFG++ AG Y+APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDP 201
Query: 600 ND-----KIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPA 653
+ DV++ G+ L+EL TG+ P N + V+ +P P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP------------PL 249
Query: 654 LGNNYDY-DQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 702
L + + + V C+ +D R RP + S + + + DV W +
Sbjct: 250 LPGHMGFSGDFQSFVKD---CLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 541
+ L +V ++L+ GSL + + E V +ALE+LHS +V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
IHRD+KS NILL D +L+DFG A + + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 602 KIDVYAFGVVLLELLTGRKPISNDHP 627
K+D+++ G++ +E++ G P N++P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNI 475
++G+G V +G L DG L AVK +K S+ I+EF+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 476 ISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAE 528
I LLG C E + +++ F+ G L L ++ + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTF 586
+EYL S + +HRD+ + N +L DD ++DFGL+K I D G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-------IYSGDYYRQGRI 208
Query: 587 GYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ A E K DV+AFGV + E+ T G P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 479
+GKG VY + +A+K+L S+ V + EIEI + L H NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSG 536
+ + + L+ +F RG L + L + + +A E +A+AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE- 132
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
++VIHRD+K N+L+ E +++DFG + A + C GT YL PE
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEG 186
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKP 621
++K+D++ GV+ E L G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 53/284 (18%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 365 DSGAIVPVGNEIVSSPLSTDHDST---ELPKELEGLHEKYSATCRLFNYQ---DLLSATS 418
S V N IV +P L K + + C+L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 419 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVL---EIEIITT 469
+L+G+G +QVY+ + ++ +K+ KP+ EF + +E +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 470 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAE 528
+ N +LV + S G+L ++ K P AM +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEP-----------QLSDFGLAKWASTSSSHI 577
+E +H +IH D+K N +L + F L D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
T T G+ E N +ID + + +L G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
+ +IGKG VY G D + A+K L ++ F+ E ++ L+H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 477 SLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+L+G + ++ ++ G L + + +++P + + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL-- 140
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 593
+ Q+ +HRD+ + N +L + F +++DFGLA+ + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 594 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ K DV++FGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 426 IGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 478
+GKG V + L DG + AVK+LK + I+EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 479 LGFCFED------NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL 530
+G +++ F+ G L L ++P + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTFGY 588
EYL S++ IHRD+ + N +L++D ++DFGL++ I D G
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-------IYSGDYYRQGCASK 200
Query: 589 L-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
L A E DV+AFGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 51/287 (17%)
Query: 423 ENLIGKGGSSQVYKGCLP-----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 475
+G+G +V G+++AVK LKP + I + EIEI+ L+H+NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 476 ISLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ G C ED + L+ +FL GSL+E L NK ++ K A+ + + ++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL---- 589
S ++ +HRD+ + N+L+ + + ++ DFGL K T + T
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFW 195
Query: 590 -APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647
APE M K DV++FGV L ELLT S ++ ++ ++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFLKMIGPTHGQMTVTRLV 253
Query: 648 QLLD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 682
L + Y M + C P R
Sbjct: 254 NTLKEGKRLPCPPNCPDEV-----YQLMRK-------CWEFQPSNRT 288
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 33/293 (11%), Positives = 71/293 (24%), Gaps = 51/293 (17%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLL 479
+ G S V+ + ++ A+K+ + S ++ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 480 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDP 511
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 512 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571
G + + + L S + ++H N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 572 TSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
T + Y E+ ++ + G+ + + P P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682
+ S + + + A G+ + ++ L D R R
Sbjct: 301 KGSWKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIGRFL--NFDRRRRL 345
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP----SEDVIKEFVLEIEIITTLHHKN 474
+G G V +G P GK + AVK LKP + + +F+ E+ + +L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+I L G + +V + GSL + L ++ F + A+ VAE + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL- 137
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPE 592
++R IHRD+ + N+LL+ ++ DFGL + + H + + APE
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKVPFAWCAPE 194
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
IG G V+ G + ++A+K ++ ++F+ E E++ L H ++ L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
E + LV +F+ G L + L + F + + V E + YL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 600
HRD+ + N L+ ++ ++SDFG+ ++ + F +PE F + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 601 DKIDVYAFGVVLLELLT-GRKP 621
K DV++FGV++ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 603 IDVYAFGVVLLELLT-GRKP 621
DV++FG++L EL T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
E +IG G S +V G L P +++ A+K LK +E ++F+ E I+ H NII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L G ++V +++ GSL+ L + F + + GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--- 167
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 591
S +HRD+ + N+L+ + ++SDFGL++ T G + AP
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTTTGGKIPIRWTAP 223
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
E + + DV++FGVV+ E+L G +P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G G V G ++A+K++K EF+ E +++ L H+ ++ L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
+ + ++ ++++ G L L + F + ++ V EA+EYL +++ +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 596
HRD+ + N L++D ++SDFGL+++ + + + G PE MY
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 597 GKVNDKIDVYAFGVVLLELLT-GRKP 621
K + K D++AFGV++ E+ + G+ P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 49/268 (18%)
Query: 425 LIGKGGSSQVYKG--CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 480
I GG +Y +G+ + +K L S D + E + + + H +I+ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 481 FCFEDNNLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
F + +V +++ SL+ + +E + + AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH- 199
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ +++ D+K NI+L+++ + +L D G S + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEIVR 250
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655
D+Y G L L + + G DP L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPEDDPVLK 292
Query: 656 NNYDYDQMERMVLASILCIRRDPRARPQ 683
YD R++ I DPR R
Sbjct: 293 ---TYDSYGRLLRR---AIDPDPRQRFT 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 421 LAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP---SEDVIKEFVLEIEIITTLHHKN 474
L + +G G V KG K + AVKILK + E + E ++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPE 592
+HRD+ + N+LL ++SDFGL+K ++ G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPE 190
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
Y K + K DV++FGV++ E + G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 481
IG+G V K P G+ +AVK E K+ +++++++ + I+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
F + + + + +S S ++ E K+ + +AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
++IHRD+K SNILL +L DFG++ S I T AG Y+APE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSAS 202
Query: 600 ND----KIDVYAFGVVLLELLTGRKPISNDHP 627
+ DV++ G+ L EL TGR P +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
++ + ++ +F+++GSL + L ++ + + +AE + ++ + I
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSH----ITCTDVAGTFGYLAPEYF 594
HRD++++NIL+S +++DFGLA+ T+ I T APE
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---------APEAI 357
Query: 595 MYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
+G K DV++FG++L+E++T GR P +SN
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 423 ENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----APEYFMY 596
IHRD+ + N L+ ++ +++DFGL++ + T A APE Y
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAY 186
Query: 597 GKVNDKIDVYAFGVVLLELLT-GRKP 621
K + K DV+AFGV+L E+ T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +V+ P ++ AVK LK + K+F E E++T L H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAMGV 526
G C + + L++V++++ G L + L + D + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAG 584
A + YL ++Q +HRD+ + N L+ + ++ DFG+++ + TD G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------DVYSTDYYRVG 192
Query: 585 TFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
L PE MY K + DV++FGV+L E+ T G++P +SN
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 30/261 (11%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 483
IG+G + V G+++AVK++ + +E + E+ I+ H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 541
L ++ +FL G+L + + + +E V V +AL YLH+ Q V
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QGV 162
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
IHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 602 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661
++D+++ G++++E++ G P +D P +++ + S P L N++
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR----LRDSPP------PKLKNSHKVS 268
Query: 662 QMERMVLASILCIRRDPRARP 682
+ R L + RDP+ R
Sbjct: 269 PVLRDFLE--RMLVRDPQERA 287
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 478
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 479 LGFCFEDNNLLLVYDFLSRGSL-----------EENLHGNKKDPAAFGWSERYKVAMGVA 527
G C E LL+V++++ G L + G P G + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGT 585
+ YL + +HRD+ + N L+ ++ DFG+++ I TD G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 218
Query: 586 FGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
L PE +Y K + DV++FGVVL E+ T G++P +SN
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 423 ENLIGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKN 474
+G+ +VYKG P + A+K LK + +EF E + L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKV 522
++ LLG +D L +++ + S G L E L ++ +A + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 581
+A +EYL S+ V+H+D+ + N+L+ D ++SD GL + + D
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-------EVYAADY 183
Query: 582 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
L APE MYGK + D++++GVVL E+ + G +P SN
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 603 IDVYAFGVVLLELLT-GRKP 621
DV++FG++L EL T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 426 IGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 478
+G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
LG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED--- 135
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 598
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 599 VNDKIDVYAFGVVLLELLT-GRKP 621
+ DV+++GV + EL+T G KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 479
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK--DPAAFGWSERYKVAMGVAEALEYLHSG 536
G FED + + +V + R SL E K +P A RY + + +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 133
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 594
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 187
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ ++DV++ G ++ LL G+ P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 16/245 (6%)
Query: 385 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGK 443
+P + +S L + + L + +A+ +G G V +G K
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 444 EL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 499
++ A+K+LK + +E + E +I+ L + I+ L+G C + L+LV + G
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 500 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559
L + L G +++ S ++ V+ ++YL + +HR++ + N+LL +
Sbjct: 422 LHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 560 QLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVNDKIDVYAFGVVLLELLT 617
++SDFGL+K S+ T AG + APE + K + + DV+++GV + E L+
Sbjct: 476 KISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 618 -GRKP 621
G+KP
Sbjct: 535 YGQKP 539
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 482 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 536
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 593 YFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 621
+ YG +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGA---TVDLWSIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 479
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 480 GFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
G FED + + +V + R SL E +P A RY + + +YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 159
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 594
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 213
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ ++DV++ G ++ LL G+ P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G G +V+ G ++AVK LK F+ E ++ L H+ ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
++ + ++ +++ GSL + L ++ +A +AE + ++ + I
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 543 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 596
HRD++++NIL+SD +++DFGLA+ I + G APE Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 597 GKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
G K DV++FG++L E++T GR P ++N
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL---AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 475
+ +IG G +VYKG L GK+ A+K LK +E +F+ E I+ H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
I L G + ++++ +++ G+L++ L + F + + G+A ++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL-- 163
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 590
+ +HRD+ + NIL++ + ++SDFGL++ + G + A
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTA 218
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE Y K DV++FG+V+ E++T G +P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
+ ++G G +V G L P KE+ A+K LK +E ++F+ E I+ H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L G + +++V +++ GSL+ L + F + + G+A ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--- 163
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 591
S +HRD+ + NIL++ + ++SDFGL + G + +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSP 219
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
E Y K DV+++G+VL E+++ G +P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
++GKG VY G L + +A+K I + + EI + L HKNI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 540
E+ + + + + GSL L + +E+ + E L+YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 541 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
++HRD+K N+L+ + ++SDFG +K + + GT Y+APE G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPR 200
Query: 600 --NDKIDVYAFGVVLLELLTGRKPISN-DHP 627
D+++ G ++E+ TG+ P P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVKILK------------------PSEDVIKEFVLEIEII 467
+ +G +++ C D K A+K + + +F E++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 468 TTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKV 522
T + ++ ++ G + + + ++Y+++ S+ E +K +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582
V + Y+H+ + + HRDVK SNIL+ + +LSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 583 AGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDH 626
GT+ ++ PE+F K+D+++ G+ L + P S
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLH 471
F IG G VY + + + +A+K + K S + ++ + E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 529
H N I G ++ LV ++ GS + L +KK E V G +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQG 166
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
L YLHS +IHRDVK+ NILLS+ +L DFG AS + + GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANS---FVGTPYWM 217
Query: 590 APEYFMYGKV---NDKIDVYAFGVVLLELLTGRKPISNDHP 627
APE + + K+DV++ G+ +EL + P+ N +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
IG+G V++G P+ L A+K K S+ V ++F+ E + H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--- 132
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------A 590
++R +HRD+ + N+L+S + +L DFGL+++ + + A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 185
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE + + DV+ FGV + E+L G KP
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLH 534
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 589
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAML 207
Query: 590 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE FM G K D ++FGV+L E+ + G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 423 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNI 475
++G G V+KG P+G+ + +K+++ + + I +L H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+ LLG C + L LV +L GSL +++ ++ G + +A+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL-- 131
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
++HR++ + N+LL + Q++DFG+A + ++ ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 596 YGKVNDKIDVYAFGVVLLELLT-GRKP 621
+GK + DV+++GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 22/230 (9%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 478
+G G +V E A+KI+ S + + E+ ++ L H NI+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 536
F + N LV + G L + + K ++E + V + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK- 154
Query: 537 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
++HRD+K N+LL D ++ DFGL+ + GT Y+APE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643
K ++K DV++ GV+L LL G P + V K S
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLLG 480
+GKG +V G+E AVK++ + + + E++++ L H NI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 538
F + LV + + G L + + K+ +SE ++ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK--- 144
Query: 539 QRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+++HRD+K N+LL S D ++ DFGL+ S D GT Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH 201
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKP 621
G ++K DV++ GV+L LL+G P
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKEL--------AVKILKP-SEDVIKEFVLEIEIITTLHHK 473
+G+G ++++KG + + +K+L + + F +++ L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+++ G C + +LV +F+ GSL+ L NK + +VA +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGT 585
+IH +V + NILL + + + LSD G++ V
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------TVLPK 174
Query: 586 FGY------LAPEYFMYGKV-NDKIDVYAFGVVLLELLT-GRKP 621
+ PE K N D ++FG L E+ + G KP
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLH 534
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 589
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKGGCAML 248
Query: 590 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE FM G K D ++FGV+L E+ + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 61/307 (19%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNII 476
+ ++E ++G G S V G+ +AVK + D ++EI++ + H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQ-------------LSDFGLAK--WASTSSSHIT 578
HS ++IHRD+K NIL+S +SDFGL K + SS
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 579 CTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631
+ +GT G+ APE ++ ID+++ G V +L+ K HP G +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDK 243
Query: 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL---------CIRRDPRARP 682
I+ + D+M+ + S++ I DP RP
Sbjct: 244 YSRESN--IIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 683 QMSLVLK 689
VL+
Sbjct: 289 TAMKVLR 295
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 423 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 476
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAM 524
+LLG C L L ++ G+L + L ++ ++ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--V 582
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ + V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 196
Query: 583 AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
T G L A E Y DV+++GV+L E+++ G P ++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIISLL 479
++ +GG + VY+ + G+E A+K +L E+ + + E+ + L H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 480 GFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
L+ L +G L E L + K+ A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------- 583
+H +IHRD+K N+LLS+ +L DFG A S +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 584 -GTFGYLAPEYF-MYGK--VNDKIDVYAFGVVLLELLTGRKP 621
T Y PE +Y + +K D++A G +L L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
++G+G +VY+G G+++ AVK K + D ++F+ E I+ L H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L+G E+ ++ + G L L NK ++ + +A+ YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMAYL--- 129
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYL-----A 590
+ +HRD+ NIL++ +L DFGL+++ I D + L +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYYKASVTRLPIKWMS 182
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE + + DV+ F V + E+L+ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKI-----LKPSEDVIKEFVL-EIEIITTLHHKNIISL 478
IGKG S V + G++ AVKI S + E + E I L H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 536
L D L +V++F+ L + K+ A F +SE + EAL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE- 592
+IHRDVK +LL+ L FG+A S GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEV 204
Query: 593 --YFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
YGK +DV+ GV+L LL+G P
Sbjct: 205 VKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
IG+G +V++ LP AVK+LK S D+ +F E ++ + NI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------------- 520
LLG C + L++++++ G L E L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 521 ---KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ +I
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NI 224
Query: 578 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
D A + PE Y + + DV+A+GVVL E+ + G +P +++
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-28
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 423 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
IG+G V++G P+ + A+K K S+ V ++F+ E + H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--- 507
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYL-----A 590
++R +HRD+ + N+L+S + +L DFGL+++ + + + G L A
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 560
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
PE + + DV+ FGV + E+L G KP
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 478
++GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 536
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK- 139
Query: 537 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKP 621
G ++K DV++ GV+L LL+G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 44/313 (14%), Positives = 97/313 (30%), Gaps = 48/313 (15%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKEFVLEIEIITTL----HHKNI 475
++G+ + G+ V + +P + IK+ E+ + L + K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 476 ISLLGFCFEDN-----------------------NLLLVYDFL--SRGSLEENLHGNKKD 510
L F F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 511 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 571 STSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISND 625
S+ A + + D + G+ + + P ++D
Sbjct: 262 GASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 626 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 685
G + + + V LL+ L Y + +R++ + + R ++S
Sbjct: 321 AALGGSEWIFRSCKNIPQP-VRALLEGFL----RYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 686 LVLKLLRGDADVT 698
L L + D + T
Sbjct: 376 AALPLYQTDGEPT 388
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 426 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 477
+G+G +V K K AVK+LK S +++ + E ++ ++H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG------------ 525
L G C +D LLL+ ++ GSL L ++K + S + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 526 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
+++ ++YL + +++HRD+ + NIL+++ + ++SDFGL++ +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-------V 200
Query: 578 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 624
D V + G + A E + DV++FGV+L E++T G P I
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 46/253 (18%)
Query: 404 TCRLFNYQDLLSATSNFLAENL---------IGKGGSSQVYKGC-LPDGKELAVKILKPS 453
++F + DL + + L +G G +V K++A++I+
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 454 EDVIKEFVL---------EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 504
+ I EIEI+ L+H II + F F+ + +V + + G L + +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 505 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ-- 560
GNK+ E + A++YLH +IHRD+K N+LLS E
Sbjct: 231 VGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 561 -LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------YFMYGKVNDKIDVYAFGVVLL 613
++DFG +K +S + GT YLAPE Y + +D ++ GV+L
Sbjct: 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNR---AVDCWSLGVILF 335
Query: 614 ELLTGRKPISNDH 626
L+G P S
Sbjct: 336 ICLSGYPPFSEHR 348
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILK--------------PSEDVIKEFVLEIEII 467
+G G +V E A+K++K E +E EI ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 468 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMG 525
+L H NII L + LV +F G L E + K + E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQ 154
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDV 582
+ + YLH ++HRD+K NILL + ++ DFGL+ + S D
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 583 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
GT Y+APE K N+K DV++ GV++ LL G P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHK 473
+G G +V + + AVK+LK D + + E++I++ L H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------KVA 523
NI++LLG C +L++ ++ G L L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-- 581
VA+ + +L +++ IHRDV + N+LL++ ++ DFGLA+ I
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-------DIMNDSNY 220
Query: 582 VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
+ L APE + DV+++G++L E+ + G P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 40/317 (12%), Positives = 93/317 (29%), Gaps = 71/317 (22%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKE-------------------- 459
++G+ + G+ V + +P + IK+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 460 -----FVLEIEIITTLHHKNIISLLGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 510
F+ +++ K +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 511 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 571 STSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGR 619
+ + G+ PE + D +A G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 620 KPISNDHPKGQESLVMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASILCIRR 676
PI+ D G + + + + L + +R++ +
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--------PKEDRLLPLQAM---E 359
Query: 677 DP---RARPQMSLVLKL 690
P + R ++S L L
Sbjct: 360 TPEYEQLRTELSAALPL 376
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 426 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 474
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 522
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 581
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-------DINNIDY 212
Query: 582 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 625
T G L APE + DV++FGV++ E+ T G P I +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 426 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 474
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 522
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 581
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-------INNIDY 258
Query: 582 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 625
T G L APE + DV++FGV++ E+ T G P I +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 483
IG G S + E AVKI+ S+ E EIEI+ H NII+L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYD 86
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 541
+ + +V + + G L + + K +SER V + + +EYLH+ Q V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QGV 137
Query: 542 IHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 595
+HRD+K SNIL D+ + DFG AK + T ++APE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ 195
Query: 596 -YGKVNDKIDVYAFGVVLLELLTGRKP 621
Y D+++ GV+L +LTG P
Sbjct: 196 GYDA---ACDIWSLGVLLYTMLTGYTP 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 419 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 475
+ + +G GG V + G+++A+K + S + + LEI+I+ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 476 ISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVA 527
+S ++ LL ++ G L + L+ + G E + ++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAG 584
AL YLH R+IHRD+K NI+L + + D G AK CT+ G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 585 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627
T YLAPE K +D ++FG + E +TG +P +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 58/248 (23%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILK------PSEDVIKEFVLEIEIITTLHHKNIISL 478
IG+G V A+KI+ + ++ E+ ++ LHH NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 479 LGFCFEDNNLLLVYDFLSRGSL----------------------------------EENL 504
++ + LV + G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 505 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 560
++ F E+ + + AL YLH+ Q + HRD+K N L S FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 561 LSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPE-----YFMYGKVNDKIDVYAFGVVLL 613
L DFGL+K + + T AGT ++APE YG K D ++ GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP---KCDAWSAGVLLH 267
Query: 614 ELLTGRKP 621
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 423 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 480
++G G S+V+ GK A+K +K S + EI ++ + H+NI++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 481 FCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
+E + LV +S RG E KD + V V A
Sbjct: 74 I-YESTTHYYLVMQLVSGGELFDRILERGVYTE------KDAS--------LVIQQVLSA 118
Query: 530 LEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
++YLH ++HRD+K N+L ++ + ++DFGL+K + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 587 GYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
GY+APE Y K +D ++ GV+ LL G P
Sbjct: 172 GYVAPEVLAQKPYSK---AVDCWSIGVITYILLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G G V+ G E +K + S+ +++ EIE++ +L H NII +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 540
+ +N+ +V + G L E + + A SE Y ++ + AL Y HS Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS---QH 144
Query: 541 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
V+H+D+K NIL S ++ DFGLA+ + T+ AGT Y+APE F
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-R 200
Query: 598 KVNDKIDVYAFGVVLLELLTGRKP 621
V K D+++ GVV+ LLTG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 53/227 (23%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 421 LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISL 478
L++ ++G G + +V + G++ A+K+L S +E ++ +I+ +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCI 87
Query: 479 LGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 531
L +E+ LL++ + + G L + ++ AF +ER ++ + A++
Sbjct: 88 LDV-YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAF--TEREAAEIMRDIGTAIQ 142
Query: 532 YLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
+LHS + HRDVK N+L D +L+DFG AK + ++ C T Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYY 195
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635
+APE K + D+++ GV++ LL G P ++ + +
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 44/234 (18%)
Query: 426 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 474
+G+G QV + AVK+LK +E + + + E+E++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK----------VAM 524
II+LLG C +D L ++ ++ S+G+L E L + + ++ + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 525 G--VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 581
VA +EYL ++++ IHRD+ + N+L+++D +++DFGLA+ I D
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHIDY 246
Query: 582 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 625
T G L APE + DV++FGV+L E+ T G P + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 482
+G G V++ C+ G+ K + + K V EI I+ LHH +I+L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 483 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
FED ++L+ +FLS G L + + +D + SE E L+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--AAED---YKMSEAEVINYMRQACEGLKHMHE---H 168
Query: 540 RVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
++H D+K NI+ + DFGLA + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE 225
Query: 598 KVNDKIDVYAFGVVLLELLTGRKP 621
V D++A GV+ LL+G P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 426 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 476
+G+G QV + + AVK+LK + + + E++I+ + HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 477 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVA 523
+LLG C + L+++ +F G+L L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV- 582
VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ I
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-------IYKDPDY 204
Query: 583 -AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
L APE + DV++FGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---H 140
Query: 540 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 595
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG 197
Query: 596 -YGKVNDKIDVYAFGVVLLELLTGRKP 621
Y + K DV++ GV+L LL+G P
Sbjct: 198 TYDE---KCDVWSAGVILYILLSGTPP 221
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 415 SATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEII 467
S + F L E+++G+G ++V L +E AVKI++ I+ V E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 468 TTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVA 523
H+N++ L+ F FE+ + LV++ + GS+ ++H + ++E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAK-----WASTSSS 575
VA AL++LH+ + + HRD+K NIL + ++ DF L + S
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 576 HITCTDVAGTFGYLAPE--------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
G+ Y+APE +Y K + D+++ GV+L LL+G P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVILYILLSGYPP 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 421 LAENLIGKGGSSQVYKGC-LPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIIS 477
L + +G+G S K + AVK I K E ++ EI + H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 535
L + + LV + L+ G L E + K +SE + + A+ ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD 124
Query: 536 GSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
V+HRD+K N+L +D+ E ++ DFG A+ + + T Y APE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPE 179
Query: 593 YFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
Y + D+++ GV+L +L+G+ P
Sbjct: 180 LLNQNGYDE---SCDLWSLGVILYTMLSGQVP 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPS----------EDVIKEFVLEIEIITTL-HHK 473
+G+G SS V + P KE AVKI+ + +++ + + E++I+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 531
NII L + LV+D + +G L + L SE+ K+ + E +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVIC 138
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
LH ++HRD+K NILL DD +L+DFG + +V GT YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 192
Query: 592 EYFM---------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
E YGK ++D+++ GV++ LL G P +
Sbjct: 193 EIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
IG+G +V A K I K + + F EIEI+ +L H NII L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 484 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 540
ED ++ LV + + G L E + + + E ++ V A+ Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LN 126
Query: 541 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 595
V HRD+K N L S D +L DFGLA GT Y++P+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKP 621
YG + D ++ GV++ LL G P
Sbjct: 184 YGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---------EIEIITTLHHKNI 475
+G G +V K++A+KI+ + I EIEI+ L+H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 533
I + F F+ + +V + + G L + + GNK+ E + A++YL
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYL 130
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
H +IHRD+K N+LLS E ++DFG +K +S + GT YLA
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLA 184
Query: 591 PE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626
PE Y + +D ++ GV+L L+G P S
Sbjct: 185 PEVLVSVGTAGYNR---AVDCWSLGVILFICLSGYPPFSEHR 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 24/205 (11%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
+G+G V++ C+ K K +K EI I+ H+NI+ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 484 EDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
L+++++F+S + N+++ ++ V EAL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVCEALQFLHS--- 120
Query: 539 QRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
+ H D++ NI+ + +FG A+ + + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKP 621
V+ D+++ G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 420 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 477
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 478 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 530
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 174
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAKWASTSSSHITCTDVAGTFG 587
+YLHS + HRDVK N+L + +L+DFG AK ++ + + T T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635
Y+APE K + D+++ GV++ LL G P ++H +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 426 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 476
+G G +V + + + AVK+LKP + + E+++++ L +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 525
+LLG C L++ ++ G L L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 526 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582
VA+ + +L +++ IHRD+ + NILL+ ++ DFGLA+ I
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-------DIKNDSN 200
Query: 583 --AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
L APE + DV+++G+ L EL + G P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 426 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 476
+G G +V + AVK+LK + + E++++T L H+NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 525
+LLG C + L++++ G L L ++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 526 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577
VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+ I
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-------DI 222
Query: 578 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
V L APE G K DV+++G++L E+ + G P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 124
Query: 540 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 595
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 181
Query: 596 --YGKVNDKIDVYAFGVVLLELLTGRKP 621
Y K +D++A GV+L LL G P
Sbjct: 182 DPYSK---PVDIWACGVILYILLVGYPP 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 419 NFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNI 475
++G G QV+K C G +LA KI+K KE V EI ++ L H N+
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 476 ISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 532
I L FE N+++LV +++ G L + + + + +E + E + +
Sbjct: 149 IQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDES---YNLTELDTILFMKQICEGIRH 202
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLA 590
+H ++H D+K NIL + Q+ DFGLA+ GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
PE Y V+ D+++ GV+ LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 482
+G G V++ G A K + + KE V EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 483 FEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
+DN ++++Y+F+S G L +E+ ++ + + V + L ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--------MRQVCKGLCHMHE-- 273
Query: 538 AQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+H D+K NI+ + +L DFGL S GT + APE
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 329
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKP 621
V D+++ GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 398 HEKYSATCRLFNYQDLLSATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKIL- 450
H +S+ L + NF L +G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 451 --KPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHG 506
+ +D E + EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 507 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---L 561
+ SE ++ + E + YLH ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
DFG+++ + ++ GT YLAPE Y + D++ G++ LLT P
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILK---------PSEDVIKEFVLEIEIITTLH-HKN 474
IG+G SS V + G E AVKI++ E+V + E I+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 532
II+L+ + + LV+D + +G L + L SE+ + + EA+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSF 215
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LH+ ++HRD+K NILL D+ + +LSDFG + ++ GT GYLAPE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
Query: 593 ---------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ YGK ++D++A GV+L LL G P
Sbjct: 270 ILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPP 304
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 147
Query: 540 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 595
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 204
Query: 596 --YGKVNDKIDVYAFGVVLLELLTGRKP 621
Y K +D++A GV+L LL G P
Sbjct: 205 DPYSK---PVDIWACGVILYILLVGYPP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+GKG S V + + G+E A I+ K S ++ E I L H NI+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 539
E+ + L++D ++ G L E++ + +SE + EA+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---M 129
Query: 540 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 595
V+HR++K N+LL +L+DFGLA AGT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRK 187
Query: 596 --YGKVNDKIDVYAFGVVLLELLTGRKP 621
YGK +D++A GV+L LL G P
Sbjct: 188 DPYGK---PVDLWACGVILYILLVGYPP 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 32/247 (12%)
Query: 453 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 512
S + ++I + KN + L L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 513 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572
+ + +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 573 SSSHITC----------TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
T T GT Y++PE + K+D+++ G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST- 275
Query: 623 SNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682
E + + + + K L E M++ +L P RP
Sbjct: 276 ------QMERVRIITD--VRNLKFPLLFT-------QKYPQEHMMVQDMLS--PSPTERP 318
Query: 683 QMSLVLK 689
+ + +++
Sbjct: 319 EATDIIE 325
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 425 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNI 475
++G+G S V +E A+KIL+ +IK +V E ++++ L H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 476 ISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALE 531
+ L F F+D+ L + G L + + F +E + ALE
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALE 144
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
YLH + +IHRD+K NILL++D Q++DFG AK S S GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 592 EYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
E K D++A G ++ +L+ G P
Sbjct: 202 ELLTEKSACKS---SDLWALGCIIYQLVAGLPP 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 476
+G G + V K C G E A K +K V +E + E+ I+ + H N+I
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 534
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
+G+G +S VY+ K A+K+LK + D K EI ++ L H NII L F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEI-F 117
Query: 484 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 540
E + LV + ++ G L + + +SER + EA+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHE---NG 168
Query: 541 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 595
++HRD+K N+L + D +++DFGL+K V GT GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC 225
Query: 596 -YGKVNDKIDVYAFGVVLLELLTGRKP 621
YG ++D+++ G++ LL G +P
Sbjct: 226 AYGP---EVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHKNIIS 477
+G G + V K GKE A K +K +E E+ I+ + H NII+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 535
L +++L+ + +S G L + L + +E + + + + YLHS
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLHS 126
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
+R+ H D+K NI+L D P L DFG+A + ++ GT ++AP
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAP 180
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
E Y + + D+++ GV+ LL+G P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 476
+G G + V K C G E A K +K V +E + E+ I+ + H NII
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 534
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 591 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 426 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 476
+G G + V K C G + A K +K V +E + E+ I+ + H N+I
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 477 SLLGFCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMG 525
+L +E+ +++L+ + ++ + SL E ++ F
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE------EEATEF--------LKQ 122
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTD 581
+ + YLHS ++ H D+K NI+L D P+ + DFGLA + +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ GT ++APE Y + + D+++ GV+ LL+G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLL 479
IGKG +V D K++ A+K + + V + V E++I+ L H +++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 480 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAE---ALEY 532
+ F+D ++ +V D L G L +L N + + + E AL+Y
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F-----ICELVMALDY 130
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
L + QR+IHRD+K NILL + ++DF +A + T +AGT Y+APE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYMAPE 184
Query: 593 YFM------YGKVNDKIDVYAFGVVLLELLTGRKP 621
F Y +D ++ GV ELL GR+P
Sbjct: 185 MFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 40/279 (14%), Positives = 84/279 (30%), Gaps = 57/279 (20%)
Query: 425 LIGKGGSSQVYKGCLPD---GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 477
G Q ++ D +++A+ + P +DV++E + ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
+L L+V +++ GSL+E + A + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAH--- 146
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
V S + +S D G +
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD------ 178
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
N + D+ G L LL R P+ + + Q ++PA +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADIDR 230
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696
Q+ + ++ D R +L+ + + A
Sbjct: 231 DIPFQISAVAAR---SVQGDGGIRSASTLLNLMQQATAV 266
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 56/267 (20%), Positives = 102/267 (38%), Gaps = 44/267 (16%)
Query: 378 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 437
SS H S +P+ +L ++ S + L+G GG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 438 C-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNN 487
+ D +A+K ++ +E+ ++ + +I LL + ++
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 488 LLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
+L+ +DF+ RG+L+E V EA+ + H+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LARSFFWQVLEAVRHCHN- 167
Query: 537 SAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
V+HRD+K NIL+ + E +L DFG + GT Y PE+
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221
Query: 596 YGKVN-DKIDVYAFGVVLLELLTGRKP 621
Y + + V++ G++L +++ G P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNII 476
++F +IG+GG +VY D ++ A+K L + IK + L+ + ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKM---KQGETLALNERIML 243
Query: 477 SL-----------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYK 521
SL + + F L + D ++ G L +L + F +E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 581
+ LE++H+ + V++RD+K +NILL + ++SD GLA S H +
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 582 VAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESL 633
GT GY+APE G D D ++ G +L +LL G P K + +
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFV-LEIEIITTLH----H 472
L+GKGG V+ G L D ++A+K++ S LE+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 473 KNIISLLGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYK 521
+I LL + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 580
V A+++ HS + V+HRD+K NIL+ +L DFG
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 581 DVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKP 621
GT Y PE+ + + V++ G++L +++ G P
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 477
++G+GG +V+ + +L A K L + +K+ ++E +I+ +H + I+S
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 478 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 533
L + FE +L LV ++ G + +++ +D F E + A + LE+L
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQ-IVSGLEHL 305
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H + +I+RD+K N+LL DD ++SD GLA + T AGT G++APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG-YAGTPGFMAPEL 360
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKP 621
+ + + +D +A GV L E++ R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 44/226 (19%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---------PSEDVIKEFVLEIEIIT 468
+ + +G G V+ KE+ VK +K + + + LEI I++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 469 TLHHKNIISLLGFCFEDNNLLLV----------YDFLSRGSLEENLHGNKKDPAAFGWSE 518
+ H NII +L LV + F+ R H +P A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLA----- 132
Query: 519 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HI 577
Y + A+ YL + +IHRD+K NI++++DF +L DFG A + +
Sbjct: 133 SYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 578 TCTDVAGTFGYLAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 621
C GT Y APE M G ++++++ GV L L+ P
Sbjct: 189 FC----GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIK----EFVL-EIEIITTLH 471
F +G G +V + A+KIL + V+K E L E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 472 HKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVA 527
++ L F F+DN NL +V ++++ G + +L + A F Y A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----Y--AAQIV 151
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
EYLHS +I+RD+K N+L+ Q++DFG AK T T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPE 203
Query: 588 YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
LAPE + Y K +D +A GV++ E+ G P D P
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 56/229 (24%)
Query: 419 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKN 474
L ++G+G +V+ K D ++L A+K+LK K + + + T ++
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATLKVRDRVRTKMERD 78
Query: 475 IISL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKV 522
I+ L + F+ + L L+ DFL G L L + F Y
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y-- 131
Query: 523 AMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
+AE AL++LHS +I+RD+K NILL ++ +L+DFGL+K I
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDH 179
Query: 580 TDVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
A +F G Y+APE + + D ++FGV++ E+LTG P
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLP 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISL 478
L+G+G +V + AVKILK + EI+++ L HKN+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 479 LGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA--------E 528
+ + E + +V ++ G E + + A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
LEYLHS Q ++H+D+K N+LL+ ++S G+A+ ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 589 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 621
PE K+D+++ GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 381 LSTDHDSTELPKE--LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY--- 435
L D D L K ++ +Y T +DL ++ +IG+G +V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89
Query: 436 -KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDN-NL 488
K K A+K+L E +IK F E +I+ + ++ L + F+D+ L
Sbjct: 90 HKS---TRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYL 144
Query: 489 LLVYDF---------LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+V ++ +S + E A F +E V AL+ +HS
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPE-------KWARFYTAE-------VVLALDAIHS---M 187
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------- 592
IHRDVK N+LL +L+DFG + T V GT Y++PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
YG+ D ++ GV L E+L G P D G
Sbjct: 247 DGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
IGKG ++V + G+E+A+KI+ + + +++ E+ I+ L+H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 482 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+ L L+ ++ S G + + L HG K+ A R + A++Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----R-SKFRQIVSAVQYCHQ---K 133
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYGK 598
R++HRD+K+ N+LL D +++DFG + + C G Y APE F GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQ-GK 188
Query: 599 VND--KIDVYAFGVVLLELLTGRKP 621
D ++DV++ GV+L L++G P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
+L L+GKG +V A+KILK KE ++ E+ TL ++
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVL 202
Query: 477 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 524
L + F+ + L V ++ + G L +L + D A F +E
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
+ AL+YLHS + V++RD+K N++L D +++DFGL K I
Sbjct: 257 -IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 585 TF----GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVM 635
TF YLAPE +D + GVV+ E++ GR P + DH K E ++M
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 425 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 477
++GKGG +V + ++ A K L+ + IK+ + E +I+ ++ + ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 478 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP-----AAFGWSERYKVAMGVAEALE 531
L + +E + L LV ++ G L+ +++ + A F +E + LE
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
LH +R+++RD+K NILL D ++SD GLA V GT GY+AP
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV-GTVGYMAP 354
Query: 592 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
E + D +A G +L E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 414 LSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK-PSEDVIKEFVL-EIEIITTL 470
+S++S F +G G + VYKG G +A+K +K SE+ + EI ++ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 471 HHKNIISLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVA 527
H+NI+ L +N L LV++F+ + ++ P + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLL 118
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
+ L + H +++HRD+K N+L++ + +L DFGLA+ + + V T
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 588 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 619
Y AP+ M Y ID+++ G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTYST---SIDIWSCGCILAEMITGK 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
++L L+GKG +V A+KIL+ KE ++ E+ T+ ++
Sbjct: 8 DYLK--LLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVL 59
Query: 477 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 524
L + F+ + L V ++ + G L +L + + A F +E
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
+ ALEYLHS + V++RD+K N++L D +++DFGL K I+
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 163
Query: 585 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 625
TF G YLAPE YG+ +D + GVV+ E++ GR P N
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 5e-19
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 426 IGKGGSSQVYKGC---LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+G+G VYK D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 483 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEALEYLHSG 536
D + L++D+ ++ + + + + + YLH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWAST---SSSHITCTDVAGTFGYL 589
V+HRD+K +NIL+ + + ++D G A+ ++ + + V TF Y
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 202
Query: 590 APEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
APE + Y K ID++A G + ELLT +PI
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLT-SEPI 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 418 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIIT 468
+F +G G +V+ + +G+ A+K+LK E V++ E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLS 61
Query: 469 TLHHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 524
+ H II + F+D + ++ D++ G L L +++ A F +E
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
V ALEYLHS + +I+RD+K NILL + +++DFG AK DV
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTY 161
Query: 585 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
T G Y+APE Y K ID ++FG+++ E+L G P + +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKIL---------------------------KPSEDV 456
IGKG V D A+K+L
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 457 IKEFVLEIEIITTLHHKNIISLLGFCFE------DNNLLLVYDFLSRGSL-EENLHGNKK 509
I++ EI I+ L H N++ L E +++L +V++ +++G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 510 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569
+ A + + +EYLH Q++IHRD+K SN+L+ +D +++DFG++
Sbjct: 136 EDQAR------FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKP 621
S + ++ T GT ++APE + +DV+A GV L + G+ P
Sbjct: 187 FKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 52/228 (22%)
Query: 419 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIE-------II 467
L ++GKGG +V+ K + ++ A+K+LK + +I + I+
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNIL 75
Query: 468 TTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
+ H I+ L+ + F+ L L+ ++LS G L L D A F Y
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--- 126
Query: 524 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 580
+AE AL +LH + +I+RD+K NI+L+ +L+DFGL K I
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDG 175
Query: 581 DVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
V TF G Y+APE M + + +D ++ G ++ ++LTG P
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPP 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHH 472
+ IG+G V+K + +A+K ++ +D E V EI ++ L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
KNI+ L D L LV++F + L++ + + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
HS + V+HRD+K N+L++ + E +L++FGLA+ + V T Y P+
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPD 171
Query: 593 YFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
Y ID+++ G + EL +P+
Sbjct: 172 VLFGAKLYST---SIDMWSAGCIFAELANAGRPL 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 425 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNII 476
+IG+G S+V K G+ A+KI+ + + + F E +++ + I
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 477 SLLGFCFEDN-NLLLVYDFLSRGSLEENL--HGNK--KDPAAFGWSERYKVAMGVAEALE 531
L F F+D L LV ++ G L L G + + A F +E + A++
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------IVMAID 176
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
+H +HRD+K NILL +L+DFG + + V GT YL+P
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 592 E----------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
E YG D +A GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYGQTP 269
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
F+ ++GKG +V + + +L AVK+LK K+ +L+ ++ T+ K I+
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRIL 77
Query: 477 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
SL L CF+ + L V +F++ G L ++ +++ A F +E
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
+ AL +LH + +I+RD+K N+LL + +L+DFG+ K I
Sbjct: 133 --IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTT 181
Query: 584 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
TF G Y+APE YG +D +A GV+L E+L G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAP 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLGF 481
IG+G V+K G+ +A+K SED VIK+ L EI ++ L H N+++LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
L LV+++ ++ L + + +A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YG 597
IHRDVK NIL++ +L DFG A+ + D T Y +PE + YG
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 598 KVNDKIDVYAFGVVLLELLTGR 619
+DV+A G V ELL+G
Sbjct: 182 P---PVDVWAIGCVFAELLSGV 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
+FL +IGKG +V + AVK+L+ K+ +L+ E + +N++
Sbjct: 41 HFLK--VIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVL 92
Query: 477 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
L F F+ + L V D+++ G L +L + A F +E
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
+A AL YLHS +++RD+K NILL L+DFGL K +I
Sbjct: 148 --IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTT 196
Query: 584 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
TF G YLAPE Y + +D + G VL E+L G P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPP 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 418 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITT 469
+F +IG+G +V K K A+KIL E + + F E +++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 470 LHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAM 524
K I +L + F+D NNL LV D+ G L L + + A F +E
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
+ A++ +H +HRD+K NIL+ + +L+DFG + + V G
Sbjct: 184 -MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 585 TFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKP 621
T Y++PE YG D ++ GV + E+L G P
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYGETP 280
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 48/228 (21%)
Query: 420 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 477
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 478 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 530
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 130
Query: 531 EYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
+YLHS + HRDVK N+L + +L+DFG AK + G
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-- 173
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635
Y K D+++ GV++ LL G P ++H +
Sbjct: 174 -------KYDK---SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
+ L +IG+G ++V L + A+K++K KE V + +I K++
Sbjct: 12 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMKVVK------KELVNDDEDIDWVQTEKHVF 63
Query: 477 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 119 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 167
Query: 584 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
++GKG +V+ + A+K LK K+ VL ++ T+ K ++
Sbjct: 20 ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVL 71
Query: 477 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
SL + F+ NL V ++L+ G L ++ K A F +E
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
+ L++LHS + +++RD+K NILL D +++DFG+ K ++
Sbjct: 127 --IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKT 175
Query: 584 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 625
TF G Y+APE + K N +D ++FGV+L E+L G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 479
IG G V + +A+K + +P ++ K E+ ++ ++HKNII LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 480 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 532
F+D + +V + + + NL + ER + + +++
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 196
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGR 619
+ + +D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 3e-18
Identities = 86/435 (19%), Positives = 154/435 (35%), Gaps = 56/435 (12%)
Query: 220 MNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPV 279
MN+ + V G+ ++ ++ + L+ V
Sbjct: 138 MNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYV 197
Query: 280 QNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTR-- 337
+ + P + D+ + + W L
Sbjct: 198 KLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFM 257
Query: 338 -QPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEG 396
S+ + K S VP + L + ++ + +
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 397 LHEKYSATCRLFNYQDLLSATS----NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILK 451
EK + T F+ NFL ++GKG +V EL AVKILK
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLM--VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 452 PSEDVIKEFVLEI-EIITTLHHKNIISL---------LGFCFE-DNNLLLVYDFLSRGSL 500
K+ V++ ++ T+ K +++L L CF+ + L V ++++ G L
Sbjct: 376 ------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 501 EENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557
++ + A F +E +A L +L S + +I+RD+K N++L +
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 558 EPQLSDFGLAKWASTSSSHITCTDVAGTF-G---YLAPE---YFMYGKVNDKIDVYAFGV 610
+++DFG+ K +I TF G Y+APE Y YGK +D +AFGV
Sbjct: 480 HIKIADFGMCK------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGV 530
Query: 611 VLLELLTGRKPISND 625
+L E+L G+ P +
Sbjct: 531 LLYEMLAGQAPFEGE 545
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 479
L+G+G V K G+ +A+K S+D ++K+ + EI+++ L H+N+++LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
C + LV++F+ + + + + P + K + + + HS
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 595
+IHRD+K NIL+S +L DFG A+ + ++ D T Y APE +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 596 -YGKVNDKIDVYAFGVVLLELLTGR 619
YGK +DV+A G ++ E+ G
Sbjct: 201 KYGK---AVDVWAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 412 DLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFV----L-EI 464
D+ S + + +G+G + VYK + +A+K I K+ + L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 465 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 524
+++ L H NII LL +N+ LV+DF+ LE + K + S +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYML 119
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
+ LEYLH ++HRD+K +N+LL ++ +L+DFGLAK + + T V
Sbjct: 120 MTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-- 174
Query: 585 TFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
T Y APE YG +D++A G +L ELL R P
Sbjct: 175 TRWYRAPELLFGARMYGV---GVDMWAVGCILAELLL-RVPF 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
+ L +IG+G ++V L + A++++K KE V + +I K++
Sbjct: 55 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVF 106
Query: 477 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 162 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 210
Query: 584 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 621
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 476
NFL ++GKG +V EL AVKILK K+ V++ ++ T+ K ++
Sbjct: 23 NFLM--VLGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVL 74
Query: 477 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 523
+L L CF+ + L V ++++ G L ++ + A F +E
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
+A L +L S + +I+RD+K N++L + +++DFG+ K +I
Sbjct: 130 --IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTT 178
Query: 584 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 621
TF G Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 52/230 (22%)
Query: 419 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEI--EIITTLHH 472
L ++G G +V+ K D +L A+K+LK K +++ T
Sbjct: 57 ELLK--VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK------KATIVQKAKTTEHTRTE 108
Query: 473 KNIISL---------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSER 519
+ ++ L + F+ L L+ D+++ G L +L ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 163
Query: 520 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576
Y V E ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 164 Y-----VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 577 ITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 621
GT Y+AP+ + K +D ++ GV++ ELLTG P
Sbjct: 216 RAYD-FCGTIEYMAPDIVRGGDSGHDKA---VDWWSLGVLMYELLTGASP 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 479
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 480 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 533
++ + +V +++S G L + + HG ++ A R ++ + A++Y
Sbjct: 77 ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYC 127
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPE 592
H V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPE 180
Query: 593 YFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDH 626
G++ ++D+++ GV+L LL G P ++H
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 415 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITT 469
+ +G+G VYK G+ +A+K ++ + E + EI ++
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKE 75
Query: 470 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
LHH NI+SL+ + L LV++F+ + L++ L ++ S+ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRG 131
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 589
+ + H R++HRD+K N+L++ D +L+DFGLA+ T V T Y
Sbjct: 132 VAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR 186
Query: 590 APEYFM----YGKVNDKIDVYAFGVVLLELLTGR 619
AP+ M Y +D+++ G + E++TG+
Sbjct: 187 APDVLMGSKKYST---SVDIWSIGCIFAEMITGK 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 479
IG G V + +A+K + +P ++ K E+ ++ ++HKNIISLL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 480 ----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLH 534
E ++ LV + + + NL + ER + + +++LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH 181
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 235
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGR 619
+ + +D+++ G ++ E++ +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 482
IG G + +AVK + I E V EI +L H NI+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 483 FEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
+L ++ ++ S G L E + G + A R+ ++ + Y HS +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-GVSYCHS---MQ 136
Query: 541 VIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG 597
+ HRD+K N LL P+L DFG +K + S T GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLL-R 191
Query: 598 KVND--KIDVYAFGVVLLELLTGRKP 621
+ D DV++ GV L +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 481
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 482 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 595
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 596 YGKVND--KIDVYAFGVVLLELLTGRKP 621
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNI 475
++ + +G+G + VYKG L A+K L+ E + E+ ++ L H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-VAEALEYLH 534
++L + +L LV+++L +++L D K+ + + L Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
Q+V+HRD+K N+L+++ E +L+DFGLA+ S + V T Y P+
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 595 M----YGKVNDKIDVYAFGVVLLELLTGR 619
+ Y +ID++ G + E+ TGR
Sbjct: 173 LGSTDYST---QIDMWGVGCIFYEMATGR 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 472
+++ +G G V G+++A+K + +P + I K E+ ++ + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 473 KNIISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-G 525
+N+I LL + LV F+ + +L + E+ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS---EEKIQYLVYQ 134
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 585
+ + L+Y+HS V+HRD+K N+ +++D E ++ DFGLA+ A T T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVT 186
Query: 586 FGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 619
Y APE + + N +D+++ G ++ E+LTG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKN 474
F E + G+G V G G +A+K +++ +E + ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 475 IISLLGF-------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSER 519
I+ L + D L +V ++ + + LH P
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 520 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT 578
+++ + LH S V HRD+K N+L+ D +L DFG AK S S ++
Sbjct: 136 FQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 579 --CTDVAGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
C+ Y APE Y +D+++ G + E++ G +PI
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLG-EPI 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHHK 473
+ IG+G VYK G+ A+K ++ ++ E + EI I+ L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
NI+ L L+LV++ L + L++ L + + + Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H +RV+HRD+K N+L++ + E +++DFGLA+ T V T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDV 171
Query: 594 FM----YGKVNDKIDVYAFGVVLLELLTGR 619
M Y ID+++ G + E++ G
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLH 471
+ +G+G +VYK + +A+K ++ + +E V E+ ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
H+NII L ++ L L++++ E +L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTF 586
+ HS +R +HRD+K N+LLS + + DFGLA+ T + T
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 587 GYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 619
Y PE + Y +D+++ + E+L
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 474
++ +IG G VY+ G+ +A+K K +D K F E++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD--KRFKNRELQIMRKLDHCN 108
Query: 475 IISLLGF------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERY 520
I+ L F ++ L LV D+ + E ++ + P + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 521 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT- 578
++ +A Y+HS + HRD+K N+LL D +L DFG AK +++
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 579 -CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
C+ Y APE Y IDV++ G VL ELL G+ PI
Sbjct: 217 ICSRY-----YRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ-PI 256
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 481
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 482 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 595
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 596 YGKVND--KIDVYAFGVVLLELLTGRKP 621
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 82.6 bits (203), Expect = 3e-16
Identities = 105/661 (15%), Positives = 183/661 (27%), Gaps = 194/661 (29%)
Query: 125 NHHTIRSTTSLAKYCAKKL--------SKDCSVLAVNNG-KVVFQKEGCPS--TAGTEDH 173
+HH + T +Y K + + V + K + KE +
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 174 RRNSLLDVIHRSIS------------------MSKITGQKNSK------------VVTDD 203
L + MS I ++ + +D
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 204 GSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEES 263
V L + L QAL++ R +N I G
Sbjct: 123 NQVFAKYNVSRL-QPYLKLRQALLELRPA-------KNVLIDG----------------- 157
Query: 264 PSDGGAGDESLAIVPVQNVEAASTS------ITMLVRQLPES--RPGWPLLRRAIFPDRR 315
G+G +A+ + + + + PE+ LL +
Sbjct: 158 --VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 316 APDRSS---LRKISVVQWALRLPTRQP---SYLANSDVKQITYDPGDNESINLN------ 363
D SS LR S+ RL +P L +V + + NL+
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV----QNAKAWNAFNLSCKILLT 271
Query: 364 -GDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL--LSATSNF 420
+ + H T P E++ L KY CR QDL T+N
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY-LDCRP---QDLPREVLTTNP 327
Query: 421 LAENLIG---KGGSS--QVYKGCLPDGK----ELAVKILKPSE-------------DV-I 457
++I + G + +K D E ++ +L+P+E I
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 458 KEFVLEI-----------EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 506
+L + ++ LH SL+ + + +
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKY---SLV---EKQPKESTIS-----------IPS 430
Query: 507 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD-VKSSNILL---SDDFEPQLS 562
Y LE + +HR V NI SDD P
Sbjct: 431 ------------IY---------LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL 469
Query: 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEY----FMYGKV-NDKIDVYAFGVV---LLE 614
D + S H+ + + F+ K+ +D A G + L +
Sbjct: 470 D---QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
Query: 615 LLTGRKPISNDHPKGQESL------VMWAKPILSSGKVTQLLDPALGNNYD--YDQMERM 666
L + I ++ PK + + + + L K T LL AL + +++ +
Sbjct: 527 LKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586
Query: 667 V 667
V
Sbjct: 587 V 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 2e-12
Identities = 57/498 (11%), Positives = 130/498 (26%), Gaps = 152/498 (30%)
Query: 340 SYLANSDVKQITYDPGDNESINL-------NGDSGAIVPVGNEIVSSPLSTDHD------ 386
S L+ ++ I + + V L ++
Sbjct: 44 SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV-----QKFVEEVLRINYKFLMSPI 98
Query: 387 STELPKELEGLHEKYSATC-RLFN---------------YQDLLSATSNFLAENLI---G 427
TE ++ + Y RL+N Y L A + G
Sbjct: 99 KTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 428 KGGSSQVYKGCLPDGKE-LAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 486
GS GK +A+ + S V + +I + L C
Sbjct: 158 VLGS----------GKTWVALDVCL-SYKVQCKMDFKIFWLN----------LKNCNSPE 196
Query: 487 NLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR- 540
+L L+Y + + + L S +
Sbjct: 197 TVLEMLQKLLYQI--DPNWTSRSDHSSNIKLRIHSIQAEL--------RRLLKSKPYENC 246
Query: 541 -VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
++ +V+++ + F + C + T + +V
Sbjct: 247 LLVLLNVQNAKAW--NAF-----NLS-------------CKILLTT---------RFKQV 277
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHPKG---QESLVMWAK-----------------P 639
D + + L+ H E + K P
Sbjct: 278 TDFLSAATTTHISLD----------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 640 ILSSGKVTQLLD-PALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695
S + D A +N+ + D++ ++ +S+ + +P +M L + A
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--EPAEYRKMFDRLSVFPPSA 385
Query: 696 DVTK------WARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMS-SIEQS 748
+ W + + ++ ++ S ++ + + + + +E
Sbjct: 386 HIPTILLSLIWFDVI---KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 749 VSLEDYLLGRWSRSSSFD 766
+L ++ ++ +FD
Sbjct: 443 YALHRSIVDHYNIPKTFD 460
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 479
+G+G +V +++A+K + D+ EI + L H +II L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 480 GFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 530
++++V +D++ + + E+ E + + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAI 121
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYL 589
EY H +++HRD+K N+LL D+ +++DFGL+ + + +C G+ Y
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYA 174
Query: 590 APEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 621
APE GK+ ++DV++ G+VL +L GR P
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 483
+G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 484 ED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
+D LV++ ++ ++ F E K AL+Y HS
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHS---MG 150
Query: 541 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 595
++HRDVK N+++ + + +L D+GLA++ + + + PE Y M
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQM 207
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPI 622
Y +D+++ G +L ++ ++P
Sbjct: 208 YDY---SLDMWSLGCMLASMIFRKEPF 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNI 475
+ +IG G V++ L + E+A+K +L+ +E ++I+ + H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 476 ISLLGFCF------EDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERYK 521
+ L F + ++ L LV ++ + E ++ + P Y+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 522 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 580
+ +A Y+HS + HRD+K N+LL +L DFG AK +
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNV 199
Query: 581 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPI 622
+ Y APE ++G ID+++ G V+ EL+ G +P+
Sbjct: 200 SYICSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHK 473
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 474 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM 524
NII + + ++ +V D + E +L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSN------DHICYFL 134
Query: 525 -GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDV 582
+ L+Y+HS + V+HRD+K SN+LL+ + ++ DFGLA+ A H T+
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 583 AGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 619
T Y APE Y K ID+++ G +L E+L+ R
Sbjct: 192 VATRWYRAPEIMLNSKGYTK---SIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-F----VLEIEIITTLHHKNIISLL 479
IG+G +V+K G+++A+K + + KE F + EI+I+ L H+N+++L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 480 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
C ++ LV+DF L N+ F SE +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGT 585
L Y+H +++HRD+K++N+L++ D +L+DFGLA+ ++ + T V T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--T 191
Query: 586 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 622
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWT-RSPI 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 479
+G G V G ++A+K + +P + + K E+ ++ + H+N+I LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 480 ------GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAM-GVAEALE 531
F D LV F+ +L K + +R + + + + L
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLR 142
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 591
Y+H+ +IHRD+K N+ +++D E ++ DFGLA+ A + T T Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP 194
Query: 592 E----YFMYGKVNDKIDVYAFGVVLLELLTGR 619
E + Y + +D+++ G ++ E++TG+
Sbjct: 195 EVILNWMRYTQ---TVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 479
+G G V G +AVK + +P + +I K E+ ++ + H+N+I LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 480 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEAL 530
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD------DHVQFLIYQILRGL 145
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ + T T Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 591 PEYFM-YGKVNDKIDVYAFGVVLLELLTGR 619
PE + + N +D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 479
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
+++ +V +++S G L + + +G + + R ++ ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILS-GVDYCHR-- 134
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMY 596
V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS- 188
Query: 597 GKVND--KIDVYAFGVVLLELLTGRKP 621
G++ ++D+++ GV+L LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NII 476
+IGKG QV K + +A+K+++ + ++ EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 477 SLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+L F F N++ + ++ LS +L E + NK F K A + + L+ LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHK 218
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
R+IH D+K NILL + DFG + T + F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEV 270
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGR 619
+ + ID+++ G +L ELLTG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 36/216 (16%)
Query: 426 IGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVL-----------EIEIITTLHHK 473
I G V G +G +A+K + D +L EI ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 474 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVA 527
NI+ L + L LV + + +L D + + M +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
L LH V+HRD+ NILL+D+ + + DF LA+ + ++ T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRW 198
Query: 588 YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 619
Y APE + + K +D+++ G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTK---LVDMWSAGCVMAEMFNRK 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 41/218 (18%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH----------- 471
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 472 HKNIISLLG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 527
+I+ LL F + N +++V++ L +L + + +++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQISKQLL 141
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ------LSDFGLAKWASTSSSHITCTD 581
L+Y+H +IH D+K N+L+ P+ ++D G A W T+
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEHYTN 194
Query: 582 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 619
T Y +PE + D+++ ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 31/226 (13%)
Query: 415 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVL-----EIEII 467
ATS + IG G VYK G +A+K + P+ + E+ ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 468 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 517
L H N++ L+ + + LV++ + + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA------ 119
Query: 518 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576
E K M L++LH+ ++HRD+K NIL++ +L+DFGLA+ S
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL--- 479
+G+G V P G+ +A+K ++P + + + EI+I+ H+NII++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 480 --GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEY 532
N + ++ + + + +LH + + + A++
Sbjct: 79 RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSD------DHIQYFIYQTLRAVKV 127
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----- 587
LH + VIHRD+K SN+L++ + + ++ DFGLA+ S++ + +
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 588 ---YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 619
Y APE Y + +DV++ G +L EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSR---AMDVWSCGCILAELFLRR 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 415 SATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPSEDVIKEFV----L-EIEII 467
A + IG+G +V+K G+ +A+K ++ +E + + E+ ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVL 65
Query: 468 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 517
L H N++ L + L LV++ + + + + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT------ 119
Query: 518 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576
E K M + L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S
Sbjct: 120 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 58/250 (23%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 474
+ + +G G V + + GK A+K K +D + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--------------- 519
II L+ + + + + N +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 520 ---YKVAMGVAE-------------------ALEYLHSGSAQRVIHRDVKSSNILL-SDD 556
+KV A+ ++HS + HRD+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 557 FEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVN--DKIDVYAFGVVL 612
+L DFG AK S + C+ Y APE M G ID+++ G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSIDLWSIGCVF 232
Query: 613 LELLTGRKPI 622
EL+ G KP+
Sbjct: 233 GELILG-KPL 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 424 NLIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNI 475
+LIGKG QV K + + +A+KI+K + + + +E+ ++ + I
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 476 ISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+ L F F N+L LV++ LS +L + L + K A + AL +L
Sbjct: 119 VHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLA 174
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
+ +IH D+K NILL + + DFG +S + F Y +PE
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQSRF-YRSPE 228
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGR 619
+ + ID+++ G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 58/289 (20%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 472
N++ ++LIG+G VY K +A+K + + ED+I K + EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 473 KNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-V 526
II L + + L +V + + +L K P E K + +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYNL 138
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
++H +IHRD+K +N LL+ D ++ DFGLA+ ++ D+
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 587 G--------------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
Y APE Y K ID+++ G + ELL +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK---SIDIWSTGCIFAELLNMLQSH 252
Query: 623 SNDHPKGQESLVMWAKPI---LSSGKVTQLLDPALGNNYDY-DQMERMV 667
ND P+ S ++ + + DQ+ +
Sbjct: 253 INDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLL---- 479
+G GG+ V+ K +A+K + ++ + L EI+II L H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 480 ----------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM- 524
G E N++ +V +++ E +L E ++ M
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLE------EHARLFMY 127
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITC-TDV 582
+ L+Y+HS + V+HRD+K +N+ + ++D ++ DFGLA+ SH ++
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 583 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 619
T Y +P + Y K ID++A G + E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 64/315 (20%)
Query: 355 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 414
+ +SG V H S++ + H + R Y+
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR---YEIR- 58
Query: 415 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTL 470
+LIG G V + + + +A+K IL+ ED+I K + EI I+ L
Sbjct: 59 ---------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 471 HHKNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM- 524
+H +++ +L + + L +V + + + + P K +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLY 163
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 584
+ ++Y+HS ++HRD+K +N L++ D ++ DFGLA+ + + ++
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 585 TFG-------------------------YLAPEYFM----YGKVNDKIDVYAFGVVLLEL 615
Y APE + Y + IDV++ G + EL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDVWSIGCIFAEL 277
Query: 616 LTGRKPISNDHPKGQ 630
L K H
Sbjct: 278 LNMIKENVAYHADRG 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582
+ VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ ++ D
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 583 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 621
++APE + DV++FGV+L E+ + G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 426 IGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 476
+G+G QV + + +AVK+LK + + + E++I+ + HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 477 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAF 514
+LLG C + L+++ +F G+L L + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 53/232 (22%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLH-HKNIISLLG 480
+GKG V+K G+ +AVK I ++ + EI I+T L H+NI++LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 481 FCFEDNN--LLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEYL 533
DN+ + LV+D++ E +LH N +P + + + + ++YL
Sbjct: 77 VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEP------VHKQYVVYQLIKVIKYL 125
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 587
HSG ++HRD+K SNILL+ + +++DFGL++ ++
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 588 -------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622
Y APE Y K ID+++ G +L E+L KPI
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTK---GIDMWSLGCILGEIL-CGKPI 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 425 LIGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NI 475
+G+G +V + C+ G+ +AVKI+K + + EI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 476 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+ +L FE ++ +V++ L S + + N P F K+A + +++ +LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 535 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 587
S ++ H D+K NIL D+ + + + I D FG
Sbjct: 136 S---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD----FGSATYDD 188
Query: 588 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 618
Y APE + + DV++ G +L+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 40/222 (18%)
Query: 425 LIGKGGSSQVYKGC--LPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHK------NI 475
+G+G +V + C GK A+KI++ + LEI ++ + K
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 476 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+ + F ++ + ++ L + + E L N P + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 535 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 587
++ H D+K NIL + +FE ++ + S ++ I D FG
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD----FGSATFDH 193
Query: 588 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 618
Y PE + DV++ G +L E G
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 36/222 (16%)
Query: 425 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-----HHKNIIS 477
+G G +V C + + K AVK+++ + + +E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 478 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
G F +++ L+++ L SL E + N + F + + + +AL YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRK- 155
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------GTFG- 587
+ H D+K NILL D + + TF
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 588 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 618
Y APE + + D+++FG VL EL TG
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNII 476
+G G S V+ + K +A+K++K +E + + EI ++ ++ + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 477 SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
LL F+ ++ +V++ L L + + + K+ V + L+
Sbjct: 105 QLLD-DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160
Query: 532 YLHSGSAQRVIHRDVKSSNILL-------------------------------------- 553
YLH+ R+IH D+K NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 554 -----------SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 602
++ + +++D G A W + T Y + E + N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 603 IDVYAFGVVLLELLTGR 619
D+++ + EL TG
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 21/180 (11%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNII 476
NF IG G ++ G L + +A+K+ + LE L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIP 68
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+ F +V + L SLE+ +L F +A+ + +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 587
S + +I+RDVK N L+ + DF LAK + HI + G
Sbjct: 123 S---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 483
IG+G +++G L + +++A+K +P + E L I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 484 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
E + +LV D L SLE+ +L G K F A + ++ +H + +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 542 IHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 587
++RD+K N L+ + DFG+ K + HI + G
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 8e-09
Identities = 42/273 (15%), Positives = 76/273 (27%), Gaps = 71/273 (26%)
Query: 414 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------IKEFVLEI 464
T IG+G +V++ D +A+KI+ +E + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 465 EIITTLH---------HKNIISLLGFC------------------------------FED 485
I L + I L F+D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 545
+ L +V +F G E + + + + +L ++ R HRD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 546 VKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTD-----------VAGTFGYLAPE 592
+ N+LL +L K ++ + ++ D V + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 593 YFMYGKVNDKIDVY-AFGVVLLELLTGRKPISN 624
F G + + D+Y P SN
Sbjct: 248 LFT-GDGDYQFDIYRLMKKENNNRWGEYHPYSN 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 33/184 (17%)
Query: 419 NFLAENLIGKGGSSQVYKGC---------LPDGKELAVKILKPSEDVIKEF--------V 461
+ ++ + +Y+ P ++ ++K+ + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 462 LEIEIITTLH---HKNIISLLGF-CFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFG 515
L++ L+ I + +GF +D LV L R SL+ ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LS 157
Query: 516 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTS 573
+VA + +ALE+LH +H +V + NI + + + Q L+ +G A S
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 574 SSHI 577
H+
Sbjct: 215 GKHV 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 425 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEI-----------ITTLHH 472
IG GG +Y ++ A ++K + + L E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 473 KNIISLLGF----------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
+ + LG + +V + L L++ N F S ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT----FKKSTVLQL 156
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHI 577
+ + + LEY+H +H D+K++N+LL Q L+D+GL+ + +H
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 19/171 (11%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 483
IG G +Y G + G+E+A+K+ + + + +E +I + I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 484 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
E + ++V + L SLE+ N K F +A + +EY+HS +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 542 IHRDVKSSNILL---SDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFG 587
IHRDVK N L+ + DFGLAK + + HI + G
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 425 LIGKGGSSQVYKGCLPDGKELAVKI-----LKPSED-------------VIKEFVLEIEI 466
IG+GG +Y + + + ++PS++ E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 467 ITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEE--NLHGNKKDPAAFGWSERY 520
L + + G D N ++ D L++ + + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-----FSRKTVL 155
Query: 521 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAK 568
++++ + + LEY+H +H D+K+SN+LL+ Q L D+GLA
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 42/218 (19%)
Query: 426 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 483
IG G ++Y G + +E+A+K+ + + E +I L I ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 484 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
E + +LV D L SLE+ N K +A + +E++HS +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 542 IHRDVKSSNILLSDDFEPQ---LSDFGLAK--WASTSSSHI---TCTDVAGTFGYLAPEY 593
+HRD+K N L+ + DFGLAK +++ HI ++ GT Y +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--- 181
Query: 594 FMYGKVN----------DKIDVYAFGVVLLELLTGRKP 621
VN D D+ + G VL+ L G P
Sbjct: 182 -----VNTHLGIEQSRRD--DLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 766 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.66 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.64 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.64 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.62 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.62 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.61 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.61 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.61 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.61 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.6 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.58 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.48 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.46 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.39 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.37 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.34 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.34 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.34 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.33 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.32 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.49 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 87.84 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 86.59 | |
| 1ni5_A | 433 | Putative cell cycle protein MESJ; structural genom | 80.1 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=451.18 Aligned_cols=257 Identities=26% Similarity=0.466 Sum_probs=210.9
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999863 4778999999864 4567889999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCC---------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 491 VYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
|||||++|+|.++|+... ..+..++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 234579999999999999999999999 89999999999999999999999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...........+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~----- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT----- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999987655444333344679999999999999999999999999999999999 999998765433222221
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.... .... ....+..++..||+.||.+||||.+|++.|+.
T Consensus 245 --~~~~~~-----~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 245 --QGRVLQ-----RPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp --HTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cCCCCC-----CCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111 1111 12345567788999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=452.35 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=203.8
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999863 4788999999864 4567889999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 491 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
|||||++|+|.++|+.... ...+++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999976532 22469999999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 638 (766)
||+|||+|+...........+...||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-- 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-- 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--
Confidence 9999999997765444444445789999999999999999999999999999999999 9999987654332222211
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+.. +...... ...+..++..||+.||.+||||.+|+++|+..
T Consensus 276 -----g~~-----~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 276 -----GRE-----LERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -----TCC-----CCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCC-----CCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 110 0111111 23455677789999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=449.27 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=210.9
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667889999999999999862 5678999999753 345678999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 490 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
||||||++|+|.++|+.... ....++|..++.|+.|||.||.|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 99999999999999975431 12468999999999999999999999 8999999999999999999
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 636 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 636 (766)
.+||+|||+|+...........+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.........+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i-- 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-- 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence 999999999987755443333445789999999999999999999999999999999999 89999876543222221
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+..... +.+....+..++..||+.||.+||||.+|+++|+..
T Consensus 261 -----~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 -----RNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -----HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----HcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11211111 111223456677889999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=445.19 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||+||+|.+++ .||||+++. .....+.|.+|+.+|++++|||||+++++|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567888999999999999998743 599999874 34567889999999999999999999999865 578999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
|+||+|.++|+... ..++|..+..|+.||+.||.|||+ ++||||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999997553 369999999999999999999999 899999999999999999999999999998776544
Q ss_pred CCceecccccccCCCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
........+||+.|||||++.. +.|+.++|||||||+||||+||+.||............. . .+. ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~--~----~~~----~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV--G----RGY----AS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--H----TTC----CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH--h----cCC----CC
Confidence 4334445789999999999963 468999999999999999999999998655432221111 1 110 11
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
|.+. ....+....+..++..||+.||.+||||.+|++.|+.
T Consensus 257 p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 257 PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 1111122345566778999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=445.35 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=201.7
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999986 47999999999753 3556789999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|++||+|.++|...+. ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975432 357899999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
. ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.......+.. +... .
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------~~~~-----~ 244 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-------GSFP-----P 244 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCC-----C
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------CCCC-----C
Confidence 1 122346899999999999999999999999999999999999999987654332222111 1111 1
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+...++ ..+..++..||+.||.+|||+.++|++
T Consensus 245 ~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 VSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122 234456678999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=438.65 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=207.7
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+. ....+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999986 47999999999753 234578999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++||+|.++|...+ .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997653 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
..........+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.......+.. +.+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------LEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCC------
Confidence 5444444568999999999999999999999999999999999999999987654332222211 110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL 688 (766)
.+...+. ..+..++..||+.||.+|||+.|++
T Consensus 252 ~~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111122 2344566789999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=440.96 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=206.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..|.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999874 79999999996533 33456889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+||+|.+++... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 48999999999999999999999 8999999999999999999999999999997765433
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. ....+||+.|||||++....|+.++|||||||+||||++|+.||.+.+.......+.... .+.+.
T Consensus 226 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------~~~~~ 291 (346)
T 4fih_A 226 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLK 291 (346)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS------------CCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------CCCCC
Confidence 2 234789999999999999999999999999999999999999998765433322221110 01111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .......+..++..||+.||.+|||+.|++++
T Consensus 292 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp C--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 01111234456678999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=437.16 Aligned_cols=250 Identities=23% Similarity=0.259 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+.|.+.+.||+|+||.||+|.+. +|+.||||+++.... +.+|+.+++.++|||||+++++|.+++.+||||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 45788899999999999999874 699999999976432 2469999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccccccccCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~~~ 575 (766)
||+|.++|+..+ .+++..+..|+.||+.||.|||+ ++||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 134 gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999997653 58999999999999999999999 8999999999999999887 699999999997754322
Q ss_pred C---ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 576 H---ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 576 ~---~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
. .....++||+.|||||++.+..|+.++|||||||+||||+||+.||...........+....+. +.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----~~----- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-----IR----- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----GG-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----ch-----
Confidence 1 1223468999999999999999999999999999999999999999876654433322211110 00
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.+....+ ..+..++..||+.||.+|||+.|++++|.
T Consensus 277 ~~~~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 277 EIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp GSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcCccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 1111111 23445567899999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=433.02 Aligned_cols=265 Identities=27% Similarity=0.330 Sum_probs=201.5
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----ceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~lV~E 493 (766)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+..+.+++|||||+++++|.+.+ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4678899999999999999998 6899999999865543334445666677899999999999998764 5799999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC-----CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
|+++|+|.++|+.. .++|..+.+|+.|++.||+|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999754 4899999999999999999999831 2489999999999999999999999999998
Q ss_pred cccCCCCCc--eecccccccCCCCchhhccC------CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh---------
Q 004247 569 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--------- 631 (766)
Q Consensus 569 ~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--------- 631 (766)
......... .....+||+.|||||++.+. .|+.++|||||||+||||+||..||.........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 776543321 22236899999999999754 4778999999999999999998887543321100
Q ss_pred hHHHhhccccccCccccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 632 SLVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 632 ~lv~~~~~~~~~g~~~~lld~~l~~~~-~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
........ . ....++|.+.... ..+....+..++..||+.||.+||||.+|++.|+.
T Consensus 237 ~~~~~~~~-~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SVEEMRKV-V----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHH-H----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHH-H----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 00000000 0 1112223322221 23455677888899999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=425.47 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=195.3
Q ss_pred ccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEE
Q 004247 421 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 492 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~ 492 (766)
.+.+.||+|+||+||+|.+. +++.||||++... ....+.|.+|+++|++++|||||+++++|.. .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56788999999999999864 6899999998643 3556789999999999999999999999875 34689999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeCC-CCCeeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSD-DFEPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~-~~~vkL~DFGla~~ 569 (766)
|||+||+|.++|.... .+++..+..|+.||+.||.|||+ ++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999997653 58999999999999999999998 55 999999999999974 78999999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
..... ....+||+.|||||++. ++|+.++|||||||+||||+||+.||........ +... +..+.....
T Consensus 182 ~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~----i~~~~~~~~ 250 (290)
T 3fpq_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR----VTSGVKPAS 250 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH----HTTTCCCGG
T ss_pred CCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHH----HHcCCCCCC
Confidence 54322 23468999999999886 5799999999999999999999999975433221 1111 111111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+++ . ... .+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~----~-~~~---~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 FDK----V-AIP---EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG----C-CCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCc----c-CCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1 112 24456678999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=437.71 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=211.0
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCC-CceeEEeeEEeec-
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLGFCFED- 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~- 485 (766)
..++|.+.+.||+|+||.||+|.+. .++.||||+++.. ....+.|.+|+.+|.+++| ||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 3568999999999999999999853 2467999999764 3456789999999999965 8999999999764
Q ss_pred CceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
+.++||||||++|+|.++|+.... ....++|..+..|+.|||.||.|||+ ++||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 568999999999999999975432 12458999999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998766555555556789999999999999999999999999999999998 999998754332211
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. +..|.. +...... ...+..++..||+.||.+|||+.+|+++|..
T Consensus 299 ~~------i~~g~~-----~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 299 RR------LKEGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HH------HHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH------HHcCCC-----CCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 11 111110 1111111 2345566778999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=443.00 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=206.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+.|.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999874 79999999997543 34467889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+||+|.+++... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999753 48999999999999999999999 8999999999999999999999999999987755433
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. ....+||+.|||||++....|+.++|||||||+||||++|+.||.+.........+... ..+.+.
T Consensus 303 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------~~~~~~ 368 (423)
T 4fie_A 303 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------LPPRLK 368 (423)
T ss_dssp C--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------CCCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------CCCCCc
Confidence 2 23478999999999999999999999999999999999999999876543332222111 011111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... .....+..++..||+.||.+|||+.|+|++
T Consensus 369 ~~~--~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLH--KVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTT--SSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 100 111234456678999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=418.35 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=189.5
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+++|+.++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 47999999999653 234567999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+ +|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999997653 58999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... ....+||+.|+|||++.+..| +.++|||||||+||||+||+.||.+.+.......+.. +..
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~-------~~~----- 229 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------GVY----- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCC-----
T ss_pred CCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CCC-----
Confidence 332 234689999999999998776 5799999999999999999999986543222111111 110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+|||+.+++++
T Consensus 230 -~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 -TLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0111112 234456678999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=426.32 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=195.7
Q ss_pred cCcccceeeeccCceEEEEEEe----CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+++|++++|||||+++++|.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999975 257899999997532 233468889999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||++||+|.++|.... .+++.++..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997653 58999999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
...... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.......+.....
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------- 243 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL----------- 243 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred cCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence 443322 2347899999999999999999999999999999999999999987654433222221110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+||| +++++++
T Consensus 244 --~~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 --GMPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CCCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0111112 23445667899999999999 4677653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=412.75 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=187.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--------
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-------- 486 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-------- 486 (766)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999864 7999999998643 345678999999999999999999999997654
Q ss_pred ----ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 487 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 487 ----~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
.+||||||+++|+|.+++...... ....+..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 379999999999999999765422 235677789999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCC----------ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004247 563 DFGLAKWASTSSSH----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 632 (766)
Q Consensus 563 DFGla~~~~~~~~~----------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 632 (766)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence 99999876543221 11234689999999999999999999999999999999996 7754211 111
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.... .........+ .........++..||+.||.+|||+.+++++
T Consensus 236 ~~~~----~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTD----VRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH----HHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH----HhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 1111111110 1111223456678999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=402.86 Aligned_cols=284 Identities=37% Similarity=0.675 Sum_probs=247.6
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004247 407 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED 485 (766)
Q Consensus 407 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 485 (766)
.+++.++...+++|.+.+.||+|+||.||+|.+.+|+.||||++.... ...+.+.+|+.+++.++||||++++++|...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 344555666789999999999999999999998889999999987643 5567899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
+..++||||+++|+|.+++.........++|..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999998765544579999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
+++...............||+.|+|||++..+.++.++|||||||++|||++|+.||....+........|.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99875543333233345799999999999999999999999999999999999999988777666666667666666677
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+..++++.+......+....+..++..||+.||.+|||+.+|+++|+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 788888888777788888889999999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=402.95 Aligned_cols=296 Identities=38% Similarity=0.715 Sum_probs=255.2
Q ss_pred cccccCHHHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004247 404 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGF 481 (766)
Q Consensus 404 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 481 (766)
..+.|++.++...+++|.+.+.||+|+||.||+|...+|+.||||++.... .....+.+|+.++..++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456789999999999999999999999999999998889999999997643 223368899999999999999999999
Q ss_pred EeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 482 ~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
|...+..++||||+++|+|.+++.........++|..+..|+.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999877655567999999999999999999999932239999999999999999999999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--ccchhhHHHhhcc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH--PKGQESLVMWAKP 639 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--~~~~~~lv~~~~~ 639 (766)
+|||+++......... .....||+.|+|||++..+.++.++|||||||++|+|++|+.||.... .........|...
T Consensus 176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999998775543332 334679999999999998999999999999999999999999996321 1223345567777
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCCchhh
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 700 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~~~~~ 700 (766)
......+..+++..+...+..+....+..++..||+.||.+|||+.+|+++|++..-.++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 7777788888888888888888899999999999999999999999999999987655555
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=411.96 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=203.3
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee------cC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 486 (766)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999986 47999999999753 3456788999999999999999999998754 36
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+|||||||+ |+|.+++.... .+++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 68999997543 69999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCC--CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc
Q 004247 567 AKWASTSS--SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 567 a~~~~~~~--~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
|+.+.... ........+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+...+...+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98764432 12223457899999999998865 5699999999999999999999999887655444433221111100
Q ss_pred Cccc--------cccCcccC-CCCChH-----HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKVT--------QLLDPALG-NNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~~--------~lld~~l~-~~~~~~-----~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+. ..+..... ...... ....+..++..||+.||.+|||+.++|++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000000 000110 11234556778999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=401.49 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=171.8
Q ss_pred HhcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
..+.|.+.+.||+|+||+||+|..+ .++.||||++..... ..++.+|+++|..+ +||||++++++|.+.+++||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4578999999999999999999753 467899999876543 35678999999998 69999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEeccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 569 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~ 569 (766)
||||+++|+|.+++. .+++.++..++.||+.||.|||+ ++||||||||+||||+.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999983 37899999999999999999999 999999999999999876 7999999999986
Q ss_pred ccCCCCC--------------------------ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCC
Q 004247 570 ASTSSSH--------------------------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPI 622 (766)
Q Consensus 570 ~~~~~~~--------------------------~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf 622 (766)
....... ......+||+.|+|||++.+. .|+.++||||+||+||||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 112335799999999999865 5899999999999999999999999
Q ss_pred CCCC
Q 004247 623 SNDH 626 (766)
Q Consensus 623 ~~~~ 626 (766)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=420.82 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=207.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999874 79999999987543 4567788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC--CCeeEecccccccccC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWAST 572 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--~~vkL~DFGla~~~~~ 572 (766)
|+||+|.++|.... ..+++.++..|+.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999996443 368999999999999999999999 899999999999999854 8999999999998755
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+......+ .+
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~---------~~ 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM---------DD 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC---------CS
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC---------Cc
Confidence 332 234689999999999999999999999999999999999999998765443322222111100 01
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+. ..+..++..||+.||.+|||+.++|++
T Consensus 378 ~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112 234456678999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=419.32 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=198.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.++||+|+||.||+|... +|+.||||++++.. ........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999874 79999999996421 1222333446677778999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||||||++||+|.++|.... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998653 58999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
....... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||.+........+...... ..
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~~-- 410 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MA-- 410 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----CC--
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----CC--
Confidence 7765432 23689999999999975 4799999999999999999999999976544333222111100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
..+...+. ..+..++..||+.||.+|++ +.+|+++
T Consensus 411 ----~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ----VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----CCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----CCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 01111122 23445667899999999998 6888764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=366.87 Aligned_cols=281 Identities=32% Similarity=0.585 Sum_probs=230.8
Q ss_pred cccccCHHHHHHHhcCcccc------eeeeccCceEEEEEEeCCCCEEEEEEccCC-----hhHHHHHHHHHHHHHhcCC
Q 004247 404 TCRLFNYQDLLSATSNFLAE------NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH 472 (766)
Q Consensus 404 ~~~~f~~~el~~~t~~f~~~------~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~l~H 472 (766)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45789999999999999887 8999999999999987 7889999998642 3456789999999999999
Q ss_pred CceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCee
Q 004247 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 552 (766)
Q Consensus 473 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NIL 552 (766)
|||+++++++...+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999999975432 2468999999999999999999999 89999999999999
Q ss_pred eCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004247 553 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 632 (766)
Q Consensus 553 L~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 632 (766)
++.++.+||+|||++................||+.|+|||.+. +.++.++||||||+++|+|++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 9999999999999998766544333334467999999999886 568999999999999999999999998654432211
Q ss_pred HHHhhccc-cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 633 LVMWAKPI-LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 633 lv~~~~~~-~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+ .... .....+...+++.+. .........+..++..||+.+|.+||++.+|+++|+.
T Consensus 245 ~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 245 DI--KEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp HH--HHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HH--HHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11 1111 111234444554442 3445566778888899999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=379.94 Aligned_cols=269 Identities=25% Similarity=0.315 Sum_probs=209.9
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----eEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|.. .++.||||++.........+.+|+.++.+++||||++++++|..... +++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46799999999999999999987 47899999998766666677789999999999999999999987543 69999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC----------ceEeecccCCCeeeCCCCCeeEe
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ----------RVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~----------~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
||+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 102 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999753 48999999999999999999998 6 99999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 637 (766)
|||+++...............||+.|+|||++... .++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999877654443333446899999999999863 5667899999999999999999999865433221111100
Q ss_pred ccccccCcc-----ccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 638 KPILSSGKV-----TQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 638 ~~~~~~g~~-----~~lld~~l~~~~-~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
........+ .....+.+.... .......+..++..||+.||.+|||+.+|++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000000 000111111111 123445677788899999999999999999998743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=378.52 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=210.5
Q ss_pred hcCcccceeeeccCceEEEEEEe--------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 485 (766)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.+++.+ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36789999999999999999985 24567999999764 34567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
+.+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999986542 12358999999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987665433333334568899999999999999999999999999999999 999998754432222
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+. .+.. +.. +......+..++..||+.+|.+||++.++++.|+..
T Consensus 317 ~~~-------~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 317 LLK-------EGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHH-------TTCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh-------cCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1110 001 111123455666789999999999999999998743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=358.68 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=212.2
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...++..||||+++......+++.+|+.++..++||||++++++|...+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 46799999999999999999999888899999998766566789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 87 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999997643 358999999999999999999999 89999999999999999999999999999876553322
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+..... ...+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~--- 227 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------LYRP--- 227 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------CCCC---
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC---------CCCC---
Confidence 2233457788999999998899999999999999999999 9999976544322221111110 0011
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
.... ..+..++..||+.+|.+|||+.++++.|+...+
T Consensus 228 -~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 -HLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -TTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1111 235556678999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.14 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=206.0
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++||||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999986 578999999986533 3456788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 48899999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....||+.|+|||++....++.++|||||||++|||++|+.||....+......+..... ..+..
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~--- 238 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------PELQN--- 238 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-------CCCSC---
T ss_pred cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CCCCC---
Confidence 32 2346899999999999999999999999999999999999999977654332222111100 00000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.||.+|||+.+++++
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11112334556678999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=366.68 Aligned_cols=258 Identities=25% Similarity=0.457 Sum_probs=207.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.. .....+.+.+|++++..++||||++++++|.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357899999999999999999874 689999998865 446678899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999998643 368999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCc------------eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccc
Q 004247 575 SHI------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 642 (766)
Q Consensus 575 ~~~------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~ 642 (766)
... ......||+.|+|||++.+..++.++||||||+++|||++|..||....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------- 234 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------- 234 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence 221 011357999999999999999999999999999999999999998765433221100
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 643 ~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.....++.......+ ..+..++..||+.||.+|||+.++++.|+..
T Consensus 235 --~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 235 --NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp --CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000111111111111 2344566789999999999999999988753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=371.57 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=205.4
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 58999999998653 355678899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997653 48999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.. +..
T Consensus 167 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~~----- 231 (328)
T 3fe3_A 167 GGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR-------GKY----- 231 (328)
T ss_dssp SCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC-----
T ss_pred CCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC-----
Confidence 322 2346899999999999988775 799999999999999999999987654332222211 110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ +......+..++..||+.||.+|||+.+++++
T Consensus 232 -~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 00111234456678999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.96 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=205.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.+.+|+.++..++||||++++++|.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357899999999999999999874 3456999999863 4556789999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 571 STSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
...... .......||+.|+|||++....++.++|||||||++|||++ |+.||...........+....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---------- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---------- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------
Confidence 554322 22223456889999999999999999999999999999999 999997654432222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.... .......+..++..||+.||.+||++.+|++.|+..
T Consensus 272 --~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 272 --RLPA----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCC----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001 111123455667789999999999999999998743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=359.60 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=209.9
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...+++.||||++.......+.+.+|++++++++||||++++++|.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35789999999999999999999889999999998766566789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999997543 368999999999999999999999 8999999999999999999999999999986644221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+.. + ..+...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-------~-----~~~~~~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------G-----FRLYKP 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------T-----CCCCCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-------C-----ccCCCC
Confidence 11223467888999999999999999999999999999999 9999976544322111110 0 000011
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. . ...+..++..||+.+|.+||++.+++++|+..
T Consensus 230 ~~-~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 RL-A---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TT-S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-C---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11 1 12355566789999999999999999998743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.11 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=200.0
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346799999999999999999987 7889999998753 345678999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999975431 1248999999999999999999999 77 999999999999999999999999999865
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..... ......||+.|+|||++....++.++|||||||++|+|++|+.||...........+......
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------- 257 (309)
T 3p86_A 190 ASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR---------- 257 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred ccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 44322 123367999999999999999999999999999999999999999876543322222111100
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+....+ ..+..++..||+.+|.+|||+.++++.|+.
T Consensus 258 -~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 258 -LEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01111112 234556678999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=374.55 Aligned_cols=268 Identities=24% Similarity=0.388 Sum_probs=213.2
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEE
Q 004247 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISL 478 (766)
Q Consensus 408 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l 478 (766)
+.........++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34444555678899999999999999999973 35678999999764 34567899999999999 79999999
Q ss_pred eeEEeecCc-eEEEEeecCCCCHhHhhhcCCCC-----------------------------------------------
Q 004247 479 LGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 510 (766)
Q Consensus 479 ~~~~~~~~~-~~lV~E~~~ggsL~~~L~~~~~~----------------------------------------------- 510 (766)
+++|.+.+. +++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 89999999999999999865421
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 511 ---------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 511 ---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1228999999999999999999999 8999999999999999999999999999987755544
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
........||+.|+|||++....++.++|||||||++|||++ |+.||............... +.. ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------~~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE------GTR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH------TCC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc------CCC-----CCC
Confidence 444445678999999999999999999999999999999998 99999775543322111111 000 001
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..... ..+..++..||+.||.+|||+.+|+++|+.
T Consensus 318 ~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 318 PDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11111 234556678999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.71 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=207.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||.||+|... +++.||+|++.........+.+|+.++..++||||++++++|.+.+.+++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999875 6889999999877666778899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC--CCCeeEecccccccccCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~~~~~ 573 (766)
++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999997543 358999999999999999999999 89999999999999987 789999999999876543
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+......+ ++.
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------DEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------CHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---------Chh
Confidence 22 233679999999999998889999999999999999999999998755432222221111000 000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..... ...+..++..||..||.+|||+.+++++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111 1234566678999999999999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=364.20 Aligned_cols=261 Identities=24% Similarity=0.343 Sum_probs=211.5
Q ss_pred cccCHHHHHHHhcC----------cccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCC
Q 004247 406 RLFNYQDLLSATSN----------FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK 473 (766)
Q Consensus 406 ~~f~~~el~~~t~~----------f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~Hp 473 (766)
..|+++++..+++. |...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777787777764 777889999999999999976 79999999987543 4457789999999999999
Q ss_pred ceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 474 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
||++++++|...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999998642 48999999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 633 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 633 (766)
+.++.+||+|||++......... .....||+.|+|||++....++.++|||||||++|||++|+.||...........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999876553322 2346799999999999999999999999999999999999999976543222111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.. . ..+.+.. .......+..++..||+.||.+|||+.+++++
T Consensus 253 ~~~-------~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LRD-------S-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH-------S-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Hhc-------C-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0 0011100 01111234556678999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.55 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=210.9
Q ss_pred hcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999985 24578999999753 35567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccC
Q 004247 489 LLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 548 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp 548 (766)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999986543 12348999999999999999999999 8999999999
Q ss_pred CCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCc
Q 004247 549 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 627 (766)
Q Consensus 549 ~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~ 627 (766)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755444333334568899999999999999999999999999999999 9999987654
Q ss_pred cchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 628 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 628 ~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
......+.. +.. +..... ....+..++..||+.||.+||++.++++.|+.
T Consensus 259 ~~~~~~~~~-------~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ERLFNLLKT-------GHR-----MERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGHHHHHHT-------TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhhc-------CCc-----CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 332222211 100 001111 12345566678999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.32 Aligned_cols=254 Identities=22% Similarity=0.401 Sum_probs=206.6
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...++..||||+++......+++.+|++++..++||||++++++|.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 45789999999999999999999888899999998766556789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 103 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999997643 358999999999999999999999 8999999999999999999999999999986644211
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+.... .....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------------RLYRP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC------------CCCCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc------------CCCCC
Confidence 11122457888999999999999999999999999999998 999997655432222111110 00000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. . ...+..++..||+.+|.+|||+.+++++|..
T Consensus 244 ~~-~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 HL-A---SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TT-C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc-C---CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11 1 1345556678999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=367.53 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=210.8
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.+++.++||||++++++|...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999874 3478999999753 3456789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeeccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD--------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 547 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLK 547 (766)
.++||||+++|+|.+++...... ...+++..++.|+.||+.||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 99999999999999999764321 2468999999999999999999999 899999999
Q ss_pred CCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 004247 548 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 626 (766)
Q Consensus 548 p~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~ 626 (766)
|+|||++.++.+||+|||+++...............||+.|+|||++..+.++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654332223334578999999999999999999999999999999999 999997654
Q ss_pred ccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 627 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 627 ~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.......+ ..+.... .....+ ..+..++..||+.||.+||++.+|+++|+...
T Consensus 282 ~~~~~~~~-------~~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HEEVIYYV-------RDGNILA-----CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHHHH-------HTTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHH-------hCCCcCC-----CCCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 32221111 1111111 111111 34555667899999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.51 Aligned_cols=213 Identities=25% Similarity=0.354 Sum_probs=188.5
Q ss_pred ccccCHHHHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-----CCceeEE
Q 004247 405 CRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISL 478 (766)
Q Consensus 405 ~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l 478 (766)
...|++++.....++|.+.+.||+|+||.||+|.. .+++.||||+++........+..|+.++..+. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34556666666788999999999999999999987 47899999999877777788899999999997 9999999
Q ss_pred eeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---
Q 004247 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--- 555 (766)
Q Consensus 479 ~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~--- 555 (766)
+++|...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 99999999999999999 8999999986543 358999999999999999999999 89999999999999975
Q ss_pred ----------------------CCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHH
Q 004247 556 ----------------------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 613 (766)
Q Consensus 556 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ 613 (766)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7899999999998655432 2357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcc
Q 004247 614 ELLTGRKPISNDHPK 628 (766)
Q Consensus 614 eLltG~~Pf~~~~~~ 628 (766)
+|++|+.||......
T Consensus 251 ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 251 ELYTGSLLFRTHEHM 265 (360)
T ss_dssp HHHHSSCSCCCSSHH
T ss_pred HHHHCCCCCCCCcHH
Confidence 999999999875543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=360.94 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||+||+|...+|+.||||+++... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36799999999999999999999889999999997532 345778899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++ +|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 8888887543 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc--
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL-- 650 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll-- 650 (766)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+....
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 222 233578999999999876 568999999999999999999999998765544332221111000000000000
Q ss_pred ----CcccC--CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 ----DPALG--NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 ----d~~l~--~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.... .... ......+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 0000 0112345567778999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.36 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=203.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 78999999986543 334678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999654 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
..........||+.|+|||++....+ +.++|||||||++|+|++|+.||......... ...|...... +.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~-------~~~ 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-------LNP 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTT-------STT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhccccc-------CCc
Confidence 33333334689999999999987775 77899999999999999999999765443222 1122111100 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.||.+|||+.+++++
T Consensus 231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00111234456678999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.23 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=207.2
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.++..++||||++++++|......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57889999999999999999842 4678999999753 455668999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---CeeEec
Q 004247 490 LVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSD 563 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~D 563 (766)
+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999976542 22468999999999999999999999 8999999999999999554 599999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 642 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 642 (766)
||+++...............||+.|+|||++..+.++.++|||||||+||||++ |+.||...........+..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~------ 301 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS------ 301 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT------
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence 999986543322222334578999999999999999999999999999999998 9999977544322221111
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 643 ~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+.. ....... ...+..++..||+.+|.+||++.+|+++|+..
T Consensus 302 -~~~-----~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 302 -GGR-----MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -TCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC-----CCCCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 110 0001111 22355667789999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=376.96 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=206.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|+.+++.++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457889999999999999999985 7899999999754 3455678999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999997543 358999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
..........+|+.|+|||++..+.++.++|||||||+||||++ |..||...........+. .+.. +
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--~--- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGR--L--- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTCC--C---
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC--C---
Confidence 11111112346788999999999999999999999999999998 999997754332222111 1110 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..... . ...+..++..||+.||.+|||+.+|++.|+.
T Consensus 335 ~~~~~-~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 335 PCPEL-C---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp CCCTT-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC-C---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 00011 1 1245556678999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=365.33 Aligned_cols=256 Identities=22% Similarity=0.380 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCC----EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++|.+.+.||+|+||.||+|.+. +++ .||+|.++.. ....+.+.+|+.++++++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 357999999999999999999863 444 3588888643 24567899999999999999999999999875 578
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999998654 368999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
..............||+.|+|||++.++.++.++|||||||++|||++ |+.||...........+......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--------
Confidence 766544444444567889999999999999999999999999999999 99999876544333222211100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.........+..++..||+.+|.+||++.+++++|+...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 001112234556777899999999999999999987544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=369.39 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=204.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.+.|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|..++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 68999999997532 1357889999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC----CeeEecc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 564 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 564 (766)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999654 358999999999999999999999 8999999999999998877 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|+++....... .....||+.|+|||++....++.++|||||||++|+|++|..||.+.........+.. +
T Consensus 164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------~ 233 (361)
T 2yab_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA-------V 233 (361)
T ss_dssp SSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT-------T
T ss_pred CCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------c
Confidence 99987655332 2346799999999999988999999999999999999999999987543322211111 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. -+++...... ...+..++..||..||.+|||+.+++++
T Consensus 234 ~~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SY--DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0011110111 1234456678999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=366.97 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=204.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..++||||++++++|...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999875 6899999999753 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997643 58999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... .
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------~------ 221 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------E------ 221 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------C------
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C------
Confidence 3222 223468999999999999999999999999999999999999999765433222211110 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
..+....+ ..+..++..||+.||.+|| ++.+++++
T Consensus 222 ~~~p~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00111111 2344566789999999999 89999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=357.90 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=203.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +++.||||++.. .....+.+.+|+.++..++||||+++++++...+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357999999999999999999864 789999999853 335567899999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............ .. . ..... .
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~----~-~~~~~-~ 233 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--IQ----D-SVPNV-T 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH--HS----S-CCCCH-H
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hh----c-cCCCc-c
Confidence 43222 223367999999999999999999999999999999999999999765432211110 00 0 00000 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHhhCCC
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDA 695 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-s~~eVL~~L~~~~ 695 (766)
....... ...+..++..||+.||.+|| ++.++.+.|....
T Consensus 234 ~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111111 23455566789999999999 7999988887543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=355.34 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=202.3
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHh--cCCCceeEEeeEEeec----CceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~----~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+.+|.+++.. ++||||+++++++... ..+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46899999999999999999988 78999999997543 3556667777776 7999999999997653 45899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH--------cCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
||||+++|+|.++++.. .+++..++.++.||+.||.||| + ++|+||||||+|||++.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999532 5899999999999999999999 6 899999999999999999999999
Q ss_pred cccccccccCCCCCce--ecccccccCCCCchhhccC------CCCCchhhHHHHHHHHHHHhC----------CCCCCC
Q 004247 563 DFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKPISN 624 (766)
Q Consensus 563 DFGla~~~~~~~~~~~--~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG----------~~Pf~~ 624 (766)
|||+++.......... .....||+.|+|||++... .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999987655433221 2235799999999999876 455799999999999999999 888865
Q ss_pred CCccchhhHHHhhccccccCccccccCcccC-CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 625 DHPKGQESLVMWAKPILSSGKVTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 625 ~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~-~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+.......... .....+. .+.+. ..........+..++..||+.||.+|||+.+|++.|+.
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDMRK-VVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCHHHHHH-HHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcchhhhhH-HHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 4433221111110 0011111 11111 11123355667788889999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=370.75 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=210.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC--------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 485 (766)
.++|.+.+.||+|+||.||+|... .+..||||+++.. ......+.+|++++..+ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467899999999999999999852 3457999999764 35567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 999999999999999999986542 12458999999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987765443333344578899999999999999999999999999999999 999997654332221
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.+. .+.. ....... ...+..++..||+.||.+||++.+|++.|+...
T Consensus 305 ~~~-------~~~~-----~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 305 LLK-------EGHR-----MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHH-------TTCC-----CCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-------cCCC-----CCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1100 0001111 234555667899999999999999999986543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=373.06 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=196.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+.++.+++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999864 5778999999753 4556789999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 571 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
....... ......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-------~~~--- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-------EGY--- 267 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-------TTE---
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---
Confidence 5432211 1122346789999999999999999999999999999998 999997654332221111 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
...........+..++..||+.||.+||++.+|++.|+..
T Consensus 268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0001111223456677889999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.53 Aligned_cols=272 Identities=21% Similarity=0.299 Sum_probs=210.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999875 58999999997533 34577889999999999999999999998755 78999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee----CCCCCeeEeccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 567 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla 567 (766)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999976532 2348999999999999999999999 899999999999999 78888999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhc--------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHh---
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW--- 636 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~--- 636 (766)
+........ ....||+.|+|||++. ...++.++|||||||++|||++|+.||...........++.
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 877554332 2357999999999986 57899999999999999999999999975443222111111
Q ss_pred -hccccccCccccccC------cc--cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 637 -AKPILSSGKVTQLLD------PA--LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 637 -~~~~~~~g~~~~lld------~~--l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
..+......+....+ +. ............+..++..||+.||.+|||+.+++++...+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111000000000000 01 111234455556677788899999999999999999886433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=363.67 Aligned_cols=261 Identities=23% Similarity=0.391 Sum_probs=209.2
Q ss_pred hcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.++.++ +||||++++++|...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46799999999999999999985 24568999999753 24457899999999999 89999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC-------------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccC
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD-------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 548 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp 548 (766)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 99999999999999999765321 1247999999999999999999999 8999999999
Q ss_pred CCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCc
Q 004247 549 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 627 (766)
Q Consensus 549 ~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~ 627 (766)
+|||++.++.+||+|||++................||+.|+|||++..+.++.++|||||||+||+|+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987766554444445678999999999999999999999999999999998 9999977654
Q ss_pred cchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 628 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 628 ~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
....... .. .+. .+.. +......+..++..||+.||.+||++.+++++|+...
T Consensus 281 ~~~~~~~--~~----~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 281 DANFYKL--IQ----NGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp SHHHHHH--HH----TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHH--Hh----cCC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 3221111 11 110 0001 1111234555667899999999999999999997543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=362.83 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=200.6
Q ss_pred hcCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 488 (766)
.++|.+.+.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+.++..++||||++++++|.. ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35789999999999999999973 36889999999764 3556789999999999999999999999865 3568
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997653 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch---------hhHHHhhc
Q 004247 569 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ---------ESLVMWAK 638 (766)
Q Consensus 569 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~---------~~lv~~~~ 638 (766)
......... ......||+.|+|||++....++.++||||||+++|||++|..||........ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 765433221 12234578889999999999999999999999999999999999864321100 00000000
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+..+. ...........+..++..||+.||.+|||+.++++.|+.
T Consensus 243 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 243 ELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0001000 001111122345566778999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.90 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=203.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 567999999999999999999874 6899999999753 345678899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---CCeeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~ 569 (766)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998654 358999999999999999999999 899999999999999865 4599999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+......+.
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 250 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------- 250 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 654332 2236799999999999988999999999999999999999999976543222111111100000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. ......+..++..||+.||.+||++.+++++
T Consensus 251 -~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 -SPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -TTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0111234556678999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=358.99 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=211.0
Q ss_pred hcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++.++ +||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45789999999999999999974 356789999998643 4567899999999999 99999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCC--------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKD--------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999765421 2358999999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+.++.+||+|||++................||+.|+|||++....++.++||||||+++|+|++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987766554444444678899999999999999999999999999999999 999997655432211
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... ... ..+..... ....+..++..||+.||.+|||+.+++++|+.
T Consensus 259 ~~~--~~~---------~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 259 KMI--KEG---------FRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHH--HHT---------CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh--ccC---------CCCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 111 000 00001111 12345556678999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.79 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=203.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.+.|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+++.++||||++++++|...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999875 68999999986532 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC----CeeEecc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 564 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 564 (766)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999654 358999999999999999999999 8999999999999999887 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|+++....... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+......
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 235 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---- 235 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC----
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC----
Confidence 99987654322 22357999999999999899999999999999999999999999765433222111111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+...... ...+..++..||+.||.+|||+.+++++
T Consensus 236 -----~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -----FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000111 1234456678999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=360.75 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=194.1
Q ss_pred HHhcCcccceeeeccCceEEEEEEeCCC----CEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLPDG----KELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~g----~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
...++|.+.+.||+|+||.||+|.+... ..||||+++.. ....+.+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456899999999999999999986533 27999999753 3556789999999999999999999999987665
Q ss_pred e------EEEEeecCCCCHhHhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 488 L------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 488 ~------~lV~E~~~ggsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
. ++||||+++|+|.+++.... .....+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 4 99999999999999986432 223368999999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 638 (766)
||+|||+++...............+|+.|+|||.+....++.++|||||||++|+|++ |+.||...........+....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999987655433333333567889999999999999999999999999999999 999998765433222211110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.. .. .......+..++..||+.||.+|||+.++++.|+...
T Consensus 257 ~~------------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 257 RL------------KQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CC------------CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC------------CC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 1111234556777899999999999999999887543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=354.49 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||.||+|...+|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999889999999987543 2346788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 976 9999887543 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc-----c
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT-----Q 648 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~-----~ 648 (766)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...........+. .
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 21 2235789999999999754 58999999999999999999999998754332221111100000000000 0
Q ss_pred ccCcccCC-------CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~-------~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+++.+.. .+.......+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01111100 0001112344566778999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=370.62 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=199.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.++||+|+||.||+|... +|+.||||+++.. ......+.+|..++..+ +||||++++++|.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999875 6899999999753 23456788999999988 69999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999997653 58999999999999999999999 89999999999999999999999999999854
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..... .....+||+.|+|||++....|+.++|||||||++|||++|+.||...+.......+.....
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------- 241 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 33222 22346899999999999988999999999999999999999999987654332222211100
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~------~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+||++ .+++++
T Consensus 242 --~~p~~~----~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 --VYPTWL----HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --CCCCCC----CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 001111 1234456678999999999998 777764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=384.38 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=212.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..+|.+.+.||+|+||.||+|.+. ++..||||+++......+.|.+|+.+|++++||||++++++|...+.++|||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 457889999999999999999976 4889999999877666788999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 299 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999986433 458999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+.. +. ..
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~-----~~-- 438 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------DY-----RM-- 438 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-------TC-----CC--
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CC-----CC--
Confidence 12223456789999999999999999999999999999999 9999987654332222110 10 00
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
..+......+..++..||+.||.+|||+.+|++.|+...
T Consensus 439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011111234556667899999999999999999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=355.16 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=213.9
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
..++|.+.+.||+|+||.||+|.+. ++..||||++.......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4578999999999999999999975 488899999988777788999999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999976433 468999999999999999999999 899999999999999999999999999998765443
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
. .......||+.|+|||++....++.++||||||+++|+|++ |..||...........+.... ...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~------------~~~ 232 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------RME 232 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------CCC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC------------CCC
Confidence 2 22334567889999999999999999999999999999999 999997765433222211110 000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..... ...+..++..||+.||.+||++.++++.|+..
T Consensus 233 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 233 RPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111 23455666789999999999999999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=381.49 Aligned_cols=257 Identities=22% Similarity=0.409 Sum_probs=209.4
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..++|.+.+.||+|+||.||+|.++++..||||+++......+.|.+|+.+|+.++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 34678899999999999999999988899999999876666789999999999999999999999986 56789999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.++++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999975421 247889999999999999999999 8999999999999999999999999999987643211
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+.. +. .+ ..
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-------~~--~~---~~ 406 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-------GY--RM---PR 406 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-------TC--CC---CC
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CC--CC---CC
Confidence 11122456789999999999999999999999999999999 9999986543322221111 10 00 00
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
+......+..++..||+.||.+|||+.+|++.|+...
T Consensus 407 ----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 407 ----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1111234556677899999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=361.99 Aligned_cols=255 Identities=22% Similarity=0.410 Sum_probs=203.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCE----EEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~----vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
++|.+.+.||+|+||.||+|.+. +++. ||+|++.... .....+.+|+.++..++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999864 4443 7888875432 33456788999999999999999999986 567899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999997643 368999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.............||+.|+|||++..+.++.++|||||||++|+|++ |+.||...........+......... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 241 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP----QI 241 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC----TT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC----Cc
Confidence 66554444445678999999999999999999999999999999999 99999876544433332221111100 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
. . ..+..++..||+.||.+||++.+++++|+...
T Consensus 242 ~--------~----~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 C--------T----IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp B--------C----TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred C--------c----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 1 12344567899999999999999999997644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=364.94 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=195.6
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.+|..++| |||+++++++...+.+++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4579999999999999999999988999999998643 3456789999999999986 9999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|| +.+++|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999998653 58899999999999999999999 8999999999999997 5789999999998776
Q ss_pred CCCCCceecccccccCCCCchhhcc-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
............||+.|+|||++.. +.++.++|||||||+||||++|+.||........ .+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~----- 232 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHA----- 232 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHH-----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-HHHH-----
Confidence 5443333344689999999999975 6789999999999999999999999975432111 1111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
++++.....++......+..++..||+.||.+|||+.+++++
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111111111112345566678999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.93 Aligned_cols=249 Identities=31% Similarity=0.481 Sum_probs=193.0
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.+ .|+.||||+++... ...+.+.+|+++++.++||||++++++|...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46799999999999999999997 58899999987532 2357789999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc---eEeecccCCCeeeCC--------CCCee
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR---VIHRDVKSSNILLSD--------DFEPQ 560 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~---IiHrDLKp~NILL~~--------~~~vk 560 (766)
|||+++++|.+++... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998532 58999999999999999999999 66 999999999999986 67899
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
|+|||++......... ...||+.|+|||++....++.++||||||+++|+|++|+.||...........+...
T Consensus 157 l~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--- 229 (271)
T 3dtc_A 157 ITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN--- 229 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS---
T ss_pred EccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC---
Confidence 9999999866543222 357999999999999999999999999999999999999999765432221111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... ... .......+..++..||+.||.+|||+.+++++|+.
T Consensus 230 ----~~~----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 ----KLA----LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----CCC----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CCC----CCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 000 001 11112345566778999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=366.84 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
+.|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||++++++|.+.+.+++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46899999999999999999864 78999999986422 235788999999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC---eeEeccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLA 567 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFGla 567 (766)
||||+++|+|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543333468999999999999999999999 89999999999999986654 999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
+....... ......||+.|+|||++....++.++|||||||++|+|++|+.||..........+. .+...
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~--------~~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII--------KGKYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH--------HTCCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH--------cCCCC
Confidence 87655322 123467999999999999889999999999999999999999999764211111110 01000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+...... ...+..++..||+.||.+|||+.+++++
T Consensus 251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000111 1344556678999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=349.12 Aligned_cols=255 Identities=24% Similarity=0.424 Sum_probs=209.1
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...+++.||||++.......+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35789999999999999999998888899999998766556789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999997653 358999999999999999999999 8999999999999999999999999999986643211
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+. .+. .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-------~~~-----~~~~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TGF-----RLYKP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTC-----CCCCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-------cCC-----cCCCC
Confidence 11122467889999999998999999999999999999999 899997654322211111 010 00000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. . ...+..++..||+.+|.+||++.++++.|+..
T Consensus 228 ~~-~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 RL-A---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TT-S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-C---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1 23445566789999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=349.76 Aligned_cols=260 Identities=18% Similarity=0.208 Sum_probs=207.3
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..+ +|+|++++++++......++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 45799999999999999999986 578999999986543 234678899999999 799999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC-----eeEeccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 569 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-----vkL~DFGla~~ 569 (766)
+ +++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 999999998653 358999999999999999999999 89999999999999987776 99999999987
Q ss_pred ccCCCCC-----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 570 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 570 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654322 11234679999999999999999999999999999999999999998765433322221111000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... .+....+ ..+..++..||+.||.+||++.+|++.|+.
T Consensus 241 ~~~-----~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 241 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cHH-----HHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 000 1111111 345556678999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=374.10 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=203.8
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999986 478999999987543 4556789999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC---CCCCeeEecccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAK 568 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~ 568 (766)
|||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999997653 58999999999999999999999 8999999999999998 56789999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
........ .....||+.|+|||++....|+.++|||||||++|+|++|+.||...........+......+
T Consensus 162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------- 232 (444)
T 3soa_A 162 EVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF------- 232 (444)
T ss_dssp CCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------
T ss_pred EecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-------
Confidence 76543322 234689999999999998899999999999999999999999997654332222221111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.. ... ...+..++..||+.||.+|||+.++|++
T Consensus 233 -~~~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -PSPEW-DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -Ccccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 011 1234456678999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=377.94 Aligned_cols=264 Identities=22% Similarity=0.237 Sum_probs=209.2
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEE
Q 004247 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 482 (766)
Q Consensus 408 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 482 (766)
+.+.++...+++|.+.++||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445667777899999999999999999999975 57889999997532 1223488899999999999999999999
Q ss_pred eecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 483 ~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
.+.+.+||||||++||+|.+++.... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999997643 368999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 637 (766)
|||+++........ .....+||+.|+|||++. .+.|+.++|||||||+||||++|+.||...+.......+...
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 99999876543332 223468999999999997 567999999999999999999999999876544333222211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 690 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~--RPs~~eVL~~ 690 (766)
...+ .+ |...... .+ .+..++..||..+|++ ||++.+++++
T Consensus 297 ~~~~---~~-----p~~~~~~-s~---~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERF---QF-----PTQVTDV-SE---NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHC---CC-----CSSCCCS-CH---HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc---cC-----CcccccC-CH---HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 00 1000111 12 2334455677777777 9999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.22 Aligned_cols=258 Identities=21% Similarity=0.224 Sum_probs=206.2
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46799999999999999999986 578999999987543 234688999999999 999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC-----eeEeccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 569 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-----vkL~DFGla~~ 569 (766)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 999999998643 368999999999999999999999 89999999999999998887 99999999987
Q ss_pred ccCCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 570 ASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 570 ~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---- 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT---- 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH----
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh----
Confidence 65433221 123468999999999999999999999999999999999999999876544332222111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.... ....+....+ .+..++..||+.+|.+||++.+|++.|+
T Consensus 236 ~~~~-~~~~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 236 KRAT-PIEVLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHS-CHHHHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred hccC-CHHHHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 0000 0001111111 4556667899999999999999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.05 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=199.5
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||+||+|... +|+.||||++... ......+.+|+.++++++||||++++++|.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 6899999999743 3456788999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++ +|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 6666665432 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCcc-chhhHHHhhccccccCccc---c
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVT---Q 648 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~~~---~ 648 (766)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+...........+. .
T Consensus 155 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 222 23357899999999998765 899999999999999999988885433222 1111111110000000000 0
Q ss_pred ccCc---------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDP---------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~---------~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+. .............+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00000111122344566678999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.22 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=203.1
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+|..++||||++++++|.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 68899999987532 34567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+.||+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997643 58999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
... ....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+........
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 236 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-------- 236 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------
Confidence 322 234689999999999974 458999999999999999999999998655443333322211100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 689 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-~~eVL~ 689 (766)
. .++......+..++..||+.||.+||+ +.+|++
T Consensus 237 --~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 011111234556667899999999999 777765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=362.01 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=192.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ......+..|+..+..+ +||||++++++|.+++.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 7999999998653 23444566666666655 8999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+ +++|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 679999887653 368999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
... .....||++|+|||++.+ .++.++|||||||++|||++|..|+..... ... +..+.. .+
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-----~~~~~~----~~ 271 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQ-----LRQGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHH-----HTTTCC----CH
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHH-----HhccCC----Cc
Confidence 332 223579999999998874 799999999999999999999777643211 111 011111 11
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+|||+.+++++
T Consensus 272 ~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111 2345566678999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.72 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=193.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||.||++... +++.||||++.......+.+.+|+.+++.++||||++++++|...+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 457999999999999999999975 7899999999876655577889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC--eeEecccccccccCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWASTS 573 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--vkL~DFGla~~~~~~ 573 (766)
++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999997543 58999999999999999999999 89999999999999987765 999999999754332
Q ss_pred CCCceecccccccCCCCchhhccCCCCCc-hhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~k-sDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.. .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............. .... ...
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--~~~~-~~~------ 239 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ--RILS-VKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH--HHHT-TCC------
T ss_pred CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH--HHhc-CCC------
Confidence 22 223579999999999998888766 8999999999999999999986544322211110 0000 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. .......+..++..||+.||.+|||+.+++++
T Consensus 240 ~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000 00011334556678999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.97 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=200.6
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh------hHHHHHHHHHHHHHhcC---CCceeEEeeEEeec
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLH---HKNIISLLGFCFED 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~ 485 (766)
.+++|.+.+.||+|+||+||+|.+ .+|+.||||++.... .....+.+|+.+++.++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 578999999986321 22345667777777665 99999999999876
Q ss_pred C-----ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 486 N-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 486 ~-----~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
. ..++||||+. |+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 4899999997 599999976543 348999999999999999999999 8899999999999999999999
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
|+|||+++........ ....||+.|+|||++....++.++|||||||++|+|++|+.||...........+......
T Consensus 161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876543322 3468999999999999999999999999999999999999999876544333222211111
Q ss_pred cccCcccccc---CcccCCC-------CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 LSSGKVTQLL---DPALGNN-------YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ~~~g~~~~ll---d~~l~~~-------~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+.... ...+... ...+....+..++..||+.||.+|||+.++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111110000 0000000 001112345566778999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=356.48 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=208.5
Q ss_pred hcCcccceeeeccCceEEEEEEe--------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 485 (766)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.++..+ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46799999999999999999986 35678999999764 35567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999865421 1348999999999999999999999 899999999999999
Q ss_pred CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004247 554 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 632 (766)
Q Consensus 554 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 632 (766)
+.++.+||+|||+++...............||+.|+|||++....++.++||||||+++|+|++ |+.||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987665433333333567899999999998899999999999999999999 999997654322211
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.+.. +.. ....... ...+..++..||+.+|.+||++.++++.|+...
T Consensus 271 ~~~~-------~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 271 LLKE-------GHR-----MDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHH-------TCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc-------CCC-----CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 100 0011111 234555667899999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.65 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=194.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---------------------------hHHHHHHHHHHHHH
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------------------------DVIKEFVLEIEIIT 468 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---------------------------~~~~~~~~Ei~iL~ 468 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999864 68899999986532 12356889999999
Q ss_pred hcCCCceeEEeeEEee--cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecc
Q 004247 469 TLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 546 (766)
Q Consensus 469 ~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL 546 (766)
.++||||+++++++.. .+.+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5678999999999999886542 358999999999999999999999 89999999
Q ss_pred cCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCC
Q 004247 547 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPIS 623 (766)
Q Consensus 547 Kp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~ 623 (766)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654332 223467999999999998655 4778999999999999999999997
Q ss_pred CCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 624 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 624 ~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..........+.. +... . + ..... ...+..++..||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~-------~~~~-~--~-~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 242 DERIMCLHSKIKS-------QALE-F--P-DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSHHHHHHHHHH-------CCCC-C--C-SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CccHHHHHHHHhc-------ccCC-C--C-Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 6543221111110 0000 0 0 00111 1235556678999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.21 Aligned_cols=267 Identities=24% Similarity=0.377 Sum_probs=212.5
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEee
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLG 480 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 480 (766)
........++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567899999999999999999974 35688999999764 34567899999999999 7999999999
Q ss_pred EEeecC-ceEEEEeecCCCCHhHhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeeccc
Q 004247 481 FCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 547 (766)
Q Consensus 481 ~~~~~~-~~~lV~E~~~ggsL~~~L~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLK 547 (766)
+|...+ .+++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 998754 489999999999999999865431 1238899999999999999999999 899999999
Q ss_pred CCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 004247 548 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 626 (766)
Q Consensus 548 p~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~ 626 (766)
|+|||++.++.+||+|||+++...............||+.|+|||++....++.++||||||+++|+|++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987765544444445678999999999999999999999999999999998 999997654
Q ss_pred ccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 627 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 627 ~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
......... . .+.. ....... ...+..++..||+.||.+||++.+++++|+..
T Consensus 256 ~~~~~~~~~-~-----~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDEEFCRRL-K-----EGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSHHHHHHH-H-----HTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHh-c-----cCcc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 332211111 0 0100 0011111 12355566789999999999999999998743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.46 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=203.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.++..++||||++++++|.+.+.+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999875 78999999997532 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.. ....+||+.|+|||++....++.++|||||||++|||++|+.||...+.......+... .+
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~~----- 220 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------EL----- 220 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------CC-----
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC-----
Confidence 42 12367999999999999999999999999999999999999999765433222111110 00
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.+...+. ..+..++..||+.||.+|| ++.+++++
T Consensus 221 -~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -RFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0111111 2344566789999999999 88988864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=374.85 Aligned_cols=263 Identities=22% Similarity=0.247 Sum_probs=208.8
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEE
Q 004247 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 482 (766)
Q Consensus 408 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 482 (766)
+.+++.....++|.+.++||+|+||.||++... +|+.||||+++... .....+.+|+.++..++||||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666667889999999999999999999974 79999999997532 2234578899999999999999999999
Q ss_pred eecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 483 ~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
.+.+.+||||||++||+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997643 258999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhc-------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 635 (766)
|||+++....... ......+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...+.......+.
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999987654332 1223468999999999997 3578999999999999999999999998765443322221
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCC---CCHHHHHHH
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR---PQMSLVLKL 690 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~R---Ps~~eVL~~ 690 (766)
.....+. -|.+...++ ..+..++..||. +|.+| |++.+++++
T Consensus 284 ~~~~~~~--------~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEHLS--------LPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHCC--------CC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccCcC--------CCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1110000 011111122 234445567998 99988 689999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=348.21 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=194.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|... .+..||||+++.. ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 467899999999999999999864 2457999998753 355678999999999999999999999984 567899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997653 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... ......+|+.|+|||++....++.++||||||+++|||++ |..||...........+.. +...
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-------~~~~-- 236 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERL-- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCCC--
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-------CCCC--
Confidence 543322 1223457889999999999999999999999999999997 9999987654332222111 1100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+.... ...+..++..||+.||.+||++.++++.|+..
T Consensus 237 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ---PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111 23445566789999999999999999998743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=368.38 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=195.6
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcC--CCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.+|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.+|..++ ||||+++++++...+.++|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999888999999998643 355678999999999996 599999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
| +.+++|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999997653 58899999999999999999999 8999999999999996 57999999999987755
Q ss_pred CCCCceecccccccCCCCchhhcc-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
..........+||+.|+|||++.. ..++.++|||||||+||||++|+.||....... ..+..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~------ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHA------ 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHH------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHH------
Confidence 433333344689999999999875 468999999999999999999999997543211 11111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
++++.....++......+..++..||+.||.+||++.+++++
T Consensus 280 -------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 -------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111111112345566678999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=373.94 Aligned_cols=259 Identities=24% Similarity=0.293 Sum_probs=207.4
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEee
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 484 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 484 (766)
+.++....++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556667789999999999999999999875 68899999997532 123357889999999999999999999999
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
.+.+||||||++||+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999753 48899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCC----CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
|+++....... ......+||+.|+|||++.... |+.++|||||||+||||++|+.||...+.......+......
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 99987654322 2233478999999999998655 889999999999999999999999876544332222211100
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 690 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~--RPs~~eVL~~ 690 (766)
+. + |. ...+ . ..+..++..||+.+|.+ ||++.+|+++
T Consensus 292 ~~------~--p~-~~~~-s---~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LT------F--PD-DNDI-S---KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CC------C--CT-TCCC-C---HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc------C--CC-cccc-c---HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0 00 0011 1 23444556799989988 9999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=347.87 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=206.7
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|...++..||||+++......+.+.+|+++++.++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4678999999999999999999888889999999876656678999999999999999999999986 456899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 91 ~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999999964321 258899999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
.......||+.|+|||++..+.++.++||||||+++|||++ |+.||...........+. .+. .....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~~ 232 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGY-----RMVRP 232 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC-----CCCCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-------ccc-----CCCCc
Confidence 12223467889999999998999999999999999999999 999997654322111111 010 00111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 233 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 233 DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111 1345556678999999999999999998864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.40 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=197.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------- 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------- 486 (766)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|+.++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999975 7999999998743 346678999999999999999999999986644
Q ss_pred --------------------------------------------------ceEEEEeecCCCCHhHhhhcCCCCCCCCCh
Q 004247 487 --------------------------------------------------NLLLVYDFLSRGSLEENLHGNKKDPAAFGW 516 (766)
Q Consensus 487 --------------------------------------------------~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~ 516 (766)
..++||||+++|+|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27999999999999999986543 234577
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC----------ceeccccccc
Q 004247 517 SERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH----------ITCTDVAGTF 586 (766)
Q Consensus 517 ~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~GT~ 586 (766)
..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7899999999999999999 89999999999999999999999999999877654221 1123357999
Q ss_pred CCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHH
Q 004247 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 666 (766)
Q Consensus 587 ~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~ 666 (766)
.|+|||++.+..++.++|||||||++|||++|..|+.. ........ ..+..... .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~----~~~~~~~~---------~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDV----RNLKFPLL---------FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHH----HTTCCCHH---------HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHh----hccCCCcc---------cccCChhH
Confidence 99999999999999999999999999999998776521 11111100 00111000 01112334
Q ss_pred HHHHHhhcccCCCCCCCHHHHHHH
Q 004247 667 VLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 667 ~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..++..||+.||.+|||+.+++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 556778999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=366.10 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=202.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
...++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+..|..++..+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999975 6889999999753 23456788899999987 899999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999997643 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+....
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 167 ENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------- 234 (345)
T ss_dssp CCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred hcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 64332222 234689999999999999999999999999999999999999998755432222221111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 689 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~-eVL~ 689 (766)
+.+....+ ..+..++..||+.||.+||++. ++++
T Consensus 235 ---~~~p~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ---PFYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCcccC----HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11111111 2344566789999999999997 6654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=363.78 Aligned_cols=207 Identities=23% Similarity=0.306 Sum_probs=179.7
Q ss_pred hcCcccceeeecc--CceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G--~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+| +||.||+|... +|+.||||+++.. ....+.+.+|+.+++.++||||++++++|.+.+.+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999975 7999999999753 3556788899999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999976532 358999999999999999999999 89999999999999999999999999998654
Q ss_pred cCCCC-----CceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCcc
Q 004247 571 STSSS-----HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628 (766)
Q Consensus 571 ~~~~~-----~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 628 (766)
..... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 32211 111122479999999999987 57999999999999999999999999765443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=367.41 Aligned_cols=265 Identities=18% Similarity=0.222 Sum_probs=202.9
Q ss_pred HhcCcccceeeeccCceEEEEEEeCC------CCEEEEEEccCChhH------------HHHHHHHHHHHHhcCCCceeE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIIS 477 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAVK~l~~~~~~------------~~~~~~Ei~iL~~l~HpnIv~ 477 (766)
..++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998754311 112344666777888999999
Q ss_pred EeeEEeec----CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee
Q 004247 478 LLGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 553 (766)
Q Consensus 478 l~~~~~~~----~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 553 (766)
+++++... ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999875 4589999999 999999997643 368999999999999999999999 899999999999999
Q ss_pred C--CCCCeeEecccccccccCCCCCce-----ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 554 S--DDFEPQLSDFGLAKWASTSSSHIT-----CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 554 ~--~~~~vkL~DFGla~~~~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
+ .++.+||+|||+++.+........ .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 889999999999987654322111 123569999999999998899999999999999999999999998543
Q ss_pred ccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 627 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 627 ~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..... +.+.... ....+..++++.+......+. +..++..||+.+|.+||++.+|++.|+.
T Consensus 266 ~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KDPKY--VRDSKIR-YRENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCHHH--HHHHHHH-HHHCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCHHH--HHHHHHH-hhhhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 32211 1111110 112334445544432223333 4445567999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.45 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=192.9
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||+|.... .+|||+++.. ....+.+.+|+.+++.++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4579999999999999999998643 5999999753 35567899999999999999999999976 5567899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996543 468999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..........||+.|+|||++. ...++.++||||||+++|+|++|+.||............ .. .+.....+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~----~~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--VG----RGSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH--HH----HTSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH--hc----ccccCcch
Confidence 3333334467999999999986 567889999999999999999999999765433221111 11 11111111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. + .......+..++..||+.+|.+||++.++++.|+..
T Consensus 248 ~~-~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 SK-V----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp TS-S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hh-c----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00 1 111123455666789999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=372.23 Aligned_cols=250 Identities=29% Similarity=0.430 Sum_probs=203.9
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-ceEEEEee
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDF 494 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~lV~E~ 494 (766)
..++|.+.+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.++++++||||++++++|.+.. .+++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 346789999999999999999988 47899999998654 4578999999999999999999999987765 78999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999986532 347899999999999999999999 899999999999999999999999999998543321
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
....+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.. ..
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-----~~ 406 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYK-----MD 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCC-----CC
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-----CC
Confidence 12357899999999999999999999999999999999 999998765433222211 1110 00
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. +......+..++..||+.||.+|||+.++++.|+.
T Consensus 407 ~----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 A----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 11112345556678999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=365.02 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=204.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.++..++||||++++++|.+.+.+++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999875 68999999997643 4456789999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC--CCCeeEecccccccccC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 572 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~~~~ 572 (766)
+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997543 368999999999999999999999 89999999999999974 47799999999987654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.... ....||+.|+|||++....++.++|||||||++|||++|+.||...........+... .. .+++
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------~~--~~~~ 271 (387)
T 1kob_A 204 DEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------DW--EFDE 271 (387)
T ss_dssp TSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------CC--CCCS
T ss_pred Ccce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC--CCCc
Confidence 3322 2357999999999999999999999999999999999999999875432221111100 00 0011
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...... ...+..++..||+.||.+|||+.+++++
T Consensus 272 ~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111 2345566778999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.88 Aligned_cols=267 Identities=21% Similarity=0.382 Sum_probs=212.4
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEE
Q 004247 411 QDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFC 482 (766)
Q Consensus 411 ~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 482 (766)
++.....++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344445678999999999999999999754 36789999997543 4556789999999999999999999999
Q ss_pred eecCceEEEEeecCCCCHhHhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC
Q 004247 483 FEDNNLLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556 (766)
Q Consensus 483 ~~~~~~~lV~E~~~ggsL~~~L~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 556 (766)
.+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence 99999999999999999999987532 111357899999999999999999999 899999999999999999
Q ss_pred CCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHH
Q 004247 557 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 635 (766)
Q Consensus 557 ~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~ 635 (766)
+.+||+|||+++...............||+.|+|||++.++.++.++||||||+++|+|++ |+.||...........+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999999986654433222233567899999999999999999999999999999999 899997654322211111
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
.+.... ..... ...+..++..||+.||.+||++.+++++|+....
T Consensus 255 -------~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 -------EGGLLD-----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -------TTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------cCCcCC-----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111 01111 2335556678999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.31 Aligned_cols=263 Identities=25% Similarity=0.274 Sum_probs=202.2
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEee
Q 004247 412 DLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 484 (766)
Q Consensus 412 el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 484 (766)
++....++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4455677899999999999999999987 46889999998643 3456789999999999999999999999999
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCC------------------------------------CCCCChHHHHHHHHHHHH
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKD------------------------------------PAAFGWSERYKVAMGVAE 528 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~------------------------------------~~~l~~~~~~~i~~qia~ 528 (766)
.+..++||||+++|+|.+++...... ...+++..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521110 112456778899999999
Q ss_pred HHHHHHcCCCCceEeecccCCCeeeCCCC--CeeEecccccccccCCCCC--ceecccccccCCCCchhhcc--CCCCCc
Q 004247 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDF--EPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMY--GKVNDK 602 (766)
Q Consensus 529 aL~yLH~~~~~~IiHrDLKp~NILL~~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~--~~~s~k 602 (766)
||.|||+ ++|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.. ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 8999999999866442221 12234679999999999975 678999
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004247 603 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 682 (766)
Q Consensus 603 sDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP 682 (766)
+|||||||++|||++|+.||...........+......+. .+.. ......+..++..||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE--------NPNY-----NVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT--------SGGG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC--------Cccc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999976554332222111111000 0100 00112345566789999999999
Q ss_pred CHHHHHHH
Q 004247 683 QMSLVLKL 690 (766)
Q Consensus 683 s~~eVL~~ 690 (766)
++.+++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=376.82 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=203.6
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45788999999999999999999888889999998765556789999999999999999999999976 67899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999974321 358899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.. ...
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-----~~~- 402 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYR-----MPC- 402 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC-----CCC-
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-----CCC-
Confidence 1223457889999999999999999999999999999999 999997654432221111 1100 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
+......+..++..||+.||.+|||+.+|++.|+...
T Consensus 403 ---~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111234556677899999999999999999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.34 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=191.0
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3467999999999999999999864 68999999987532 34467889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 493 DFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||++ |+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999886432 223458999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC-----
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG----- 644 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g----- 644 (766)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..........
T Consensus 159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 543222 223579999999999976 468999999999999999999999998765433322221110000000
Q ss_pred ----------------ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 ----------------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ----------------~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.+.+.+...... ...+..++..||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00011111111111 2345567778999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=357.18 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=193.9
Q ss_pred hcCcccceeeeccCceEEEEEEe----CCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... .....+.+|+.+++.++||||++++++|...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999986 478999999997542 344567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997643 58899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
+....... ......||+.|+|||++....++.++|||||||++|+|++|+.||...........+.....
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------- 238 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 75443222 12346799999999999988999999999999999999999999986543322211111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+|| ++.+++++
T Consensus 239 -----~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -----NLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----CCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011111 13345566789999999999 78888875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.41 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.+ +++.||||+++.. ....+.+.+|+.++++++||||++++++|... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999998 5889999999753 35567899999999999999999999999876 788999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 358999999999999999999998 77 99999999999999999999999988754
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCC---chhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVND---KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~---ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
... ....||+.|+|||++....++. ++||||||+++|||++|+.||...........+.. .+
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------~~-- 227 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------EG-- 227 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH------SC--
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh------cC--
Confidence 322 2246899999999998765554 89999999999999999999976543322111110 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+.+....+ ..+..++..||+.||.+|||+.++++.|+..
T Consensus 228 ---~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 ---LRPTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---CCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0111111122 2355566789999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=359.11 Aligned_cols=251 Identities=18% Similarity=0.230 Sum_probs=200.9
Q ss_pred HhcCcccceeeeccCceEEEEEE------eCCCCEEEEEEccCChhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecC
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDN 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~------~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~ 486 (766)
..++|.+.+.||+|+||.||+|. ..+++.||||+++... ..++.+|+.++..++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 34679999999999999999994 4578899999998643 356778888888887 999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC----------
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------- 555 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---------- 555 (766)
..+|||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999975322 23469999999999999999999999 89999999999999998
Q ss_pred -CCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004247 556 -DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634 (766)
Q Consensus 556 -~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 634 (766)
++.+||+|||+++..............+||++|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999987654444444556789999999999999999999999999999999999999995432210
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCC-CCHHHHHHHhh
Q 004247 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR-PQMSLVLKLLR 692 (766)
Q Consensus 635 ~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~R-Ps~~eVL~~L~ 692 (766)
| . +...+......+... .+...|++.+|.+| |++.++.+.|+
T Consensus 293 -~--------~----~~~~~~~~~~~~~~~---~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 293 -C--------K----PEGLFRRLPHLDMWN---EFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp -E--------E----ECSCCTTCSSHHHHH---HHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred -e--------e----echhccccCcHHHHH---HHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 0 0 111111112233333 34456999999988 56777777665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=361.58 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=204.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||++... +|+.||||++.... ...+.+.+|+.++..++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 78999999997532 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997653 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... ...+||+.|+|||++....++.++|||||||++|||++|+.||...........+.. +.+
T Consensus 193 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------~~~----- 255 (350)
T 1rdq_E 193 GRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------GKV----- 255 (350)
T ss_dssp SCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC-----
T ss_pred CCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc-------CCC-----
Confidence 421 235799999999999999999999999999999999999999986544322211111 110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
.+...++ ..+..++..||+.||.+||+ +.+|+++
T Consensus 256 -~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0111112 23455667899999999998 8888874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.38 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999864 6899999998653 345678889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC---eeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFGla~~ 569 (766)
||+++++|.+.+.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887653 58999999999999999999999 89999999999999986655 99999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
....... ....||+.|+|||++....++.++||||||+++|+|++|+.||...........+...... .
T Consensus 158 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~ 226 (284)
T 3kk8_A 158 VNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--------Y 226 (284)
T ss_dssp CCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------C
T ss_pred cccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--------C
Confidence 6543322 2357999999999999999999999999999999999999999765433222221111000 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.. ... ...+..++..||+.||.+|||+.+++++
T Consensus 227 ~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSPEW-DTV----TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cchhh-ccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 011 1234556678999999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.20 Aligned_cols=251 Identities=30% Similarity=0.513 Sum_probs=200.2
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-----hH---HHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-----DV---IKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-----~~---~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.... .. .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36799999999999999999987 478999999986432 11 167899999999999999999999986654
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeCCCCC-----ee
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFE-----PQ 560 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~-----vk 560 (766)
++||||+++|+|.+.+.... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887543 368999999999999999999999 77 999999999999988776 99
Q ss_pred EecccccccccCCCCCceecccccccCCCCchhhc--cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 638 (766)
|+|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||................
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 9999999754332 23367999999999984 4568899999999999999999999998655433222211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. ..+.+.... ...+..++..||+.||.+||++.++++.|+.
T Consensus 245 ~~---------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG---------LRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC---------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC---------CCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 10 011111111 2345566678999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=365.61 Aligned_cols=255 Identities=20% Similarity=0.307 Sum_probs=198.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.++||+|+||.||+|... +++.||||+++... .....+.+|..++.++ +||||++++++|.+.+.++|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999875 67889999997532 3345678899999887 89999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997653 58999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhh--HHHhhccccccCcccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES--LVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~--lv~~~~~~~~~g~~~~ 648 (766)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...+....+..+.
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 33222 2234789999999999999999999999999999999999999996432211000 0000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~------~eVL~~ 690 (766)
..+.... ...+..++..||+.||.+||++ .+|+++
T Consensus 279 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ---cCCCCcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0111111 2234556678999999999995 566664
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=356.29 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=209.2
Q ss_pred hcCcccceeeeccCceEEEEEEeCC------CCEEEEEEccCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||+|.... ++.||||+++... ...+.+.+|+.++..+ +||||++++++|...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4679999999999999999998632 3479999997643 4567899999999999 89999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCC----------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC
Q 004247 488 LLLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 557 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 557 (766)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999875321 12357999999999999999999999 8999999999999999999
Q ss_pred CeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004247 558 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 636 (766)
Q Consensus 558 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 636 (766)
.+||+|||++................||+.|+|||++....++.++|||||||++|||++ |..||..............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999987665544444444678899999999999999999999999999999999 9999976544322211110
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 637 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 637 ~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. . ...... .. ...+..++..||+.||.+||++.+|+++|+..
T Consensus 282 ~~--~---------~~~~~~-~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 282 DG--Y---------QMAQPA-FA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HT--C---------CCCCCT-TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC--C---------CCCCCC-CC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 00 0 000001 11 13455566789999999999999999998743
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=358.57 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=188.2
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
..++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++..++||||++++++|...+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567999999999999999999975 58899999998643 346788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAS 571 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla~~~~ 571 (766)
+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999754 358999999999999999999999 89999999999999975 8899999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.... . .+.. ....
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i---~-~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRI---L-NCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHH---H-TTCC-CCCT
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHH---H-hCCC-ccCC
Confidence 4322 2236799999999999988999999999999999999999999976543221 11100 0 0000 0001
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+. .. .....+..++..||+.||.+|||+.+++++
T Consensus 273 ~~-~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PW-WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch-hh----hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 01 112345566678999999999999999984
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=350.76 Aligned_cols=264 Identities=24% Similarity=0.293 Sum_probs=199.3
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++||||++++++|...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999875 58999999986532 346778899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886543 58999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc--------cccC
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI--------LSSG 644 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~--------~~~g 644 (766)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+...... ....
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 223579999999999975 57899999999999999999999999876544332222111000 0000
Q ss_pred -ccc--cccCcccCCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 -KVT--QLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 -~~~--~lld~~l~~~~---~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... .+.++...... .......+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000000000 00112235567778999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=363.56 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=196.0
Q ss_pred ccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004247 421 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 498 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 498 (766)
...+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+.++.+++||||++++++|...+.++|||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3467899999999999986 478999999998643 55678999999999999999999999999999999999999999
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee--CCCCCeeEecccccccccCCCCC
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL--~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999887543 358999999999999999999999 899999999999999 66789999999999876543322
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
....||+.|+|||++..+.++.++|||||||+||||++|+.||...........+...... + .+....
T Consensus 246 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------~-~~~~~~ 313 (373)
T 2x4f_A 246 ---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--------L-EDEEFQ 313 (373)
T ss_dssp ---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------S-CSGGGT
T ss_pred ---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------C-Chhhhc
Confidence 2357999999999999889999999999999999999999999876543222111111000 0 000001
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ ...+..++..||+.||.+||++.+++++
T Consensus 314 ~~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DI----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11 1345556678999999999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.76 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=199.7
Q ss_pred HHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc--CCCceeEEeeEEeec----Cc
Q 004247 414 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFED----NN 487 (766)
Q Consensus 414 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~----~~ 487 (766)
....++|.+.+.||+|+||.||+|.. .|+.||||++..... ..+.+|.+++..+ +||||+++++++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34457899999999999999999988 489999999975443 3445566666554 899999999999887 68
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC-----CCceEeecccCCCeeeCCCCCeeEe
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
+++||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 99999999999999999653 4899999999999999999999820 1299999999999999999999999
Q ss_pred cccccccccCCCCCce--ecccccccCCCCchhhccCCCCCc------hhhHHHHHHHHHHHhC----------CCCCCC
Q 004247 563 DFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVNDK------IDVYAFGVVLLELLTG----------RKPISN 624 (766)
Q Consensus 563 DFGla~~~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~k------sDVwSlGvvL~eLltG----------~~Pf~~ 624 (766)
|||+++.......... .....||+.|+|||++....++.+ +|||||||++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999986654332211 123579999999999987766665 9999999999999999 666654
Q ss_pred CCccchhhHHHhhccccccCccccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 625 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 625 ~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~-~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+.......... ...... +.+.+.... ..+....+..++..||+.||.+|||+.+|+++|+..
T Consensus 265 ~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 265 LVPSDPSYEDMRE--IVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TSCSSCCHHHHHH--HHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCchhhhHH--HHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 3322211110000 000000 111111111 124456677888899999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.47 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=205.2
Q ss_pred hcCcccce-eeeccCceEEEEEEeC---CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+ .||+|+||.||+|... ++..||||+++.. ....+.+.+|+.++..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666665 9999999999999853 6778999999863 45677899999999999999999999999 5667999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997443 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 571 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
........ .....||+.|+|||++....++.++||||||+++|+|++ |+.||...........+. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~~-- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKR-- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCCc--
Confidence 54332211 122457899999999998899999999999999999998 999997654432221111 1110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+.+... ....+..++..||+.+|.+||++.+++++|+..
T Consensus 232 ---~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ---MECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---CCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111 123455566789999999999999999998743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.65 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=198.2
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||.||++... ++..+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56899999999999999999864 68999999987543 3467889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEeccccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 571 (766)
+++|+|.+++.........+++..+..|+.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986543223468999999999999999999999 899999999999999 456789999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||.............+..+... .
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~--- 246 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----V--- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----C---
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----c---
Confidence 4322 22357999999999986 6789999999999999999999999987543332222221111100 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..... . ..+..++..||+.||.+|||+.+++++
T Consensus 247 --~~~~~-~---~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 --ECRPL-T---PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----CCC-C---HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --ccCcC-C---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 1 234456678999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=351.01 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=196.2
Q ss_pred HhcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-- 486 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 486 (766)
..++|.+.+.||+|+||.||+|... ++..||||+++.. ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4578999999999999999999753 3458999999753 355678999999999999999999999998754
Q ss_pred ---ceEEEEeecCCCCHhHhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 487 ---NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 487 ---~~~lV~E~~~ggsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 4599999999999999985432 233568999999999999999999999 89999999999999999999999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+++...............+++.|+|||.+....++.++||||||+++|+|++ |..||...........+..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 264 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH---- 264 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc----
Confidence 99999987654433222233567889999999999999999999999999999999 8999977654332221111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+.. +..... ....+..++..||+.||.+||++.+++++|+.
T Consensus 265 ---~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 265 ---GHR-----LKQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp ---TCC-----CCCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC-----CCCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 100 001111 12345566678999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.47 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=200.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++.++ +||||++++++|.+.+.+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 6889999999753 34566788999999988 89999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997643 58999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh--hHHHhhccccccCcccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--SLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--~lv~~~~~~~~~g~~~~ 648 (766)
..... .....+||+.|+|||++....++.++|||||||++|||++|+.||......... .........+..+.
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence 33222 223468999999999999999999999999999999999999999653211100 00000000000010
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~------~eVL~~ 690 (766)
..+.... ...+..++..||+.||.+||++ .+++++
T Consensus 236 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0111111 2234556678999999999995 566653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.19 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=193.8
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 487 (766)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ......+.+|+.++..++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45799999999999999999986 57899999999753 3456788999999999999999999999877554
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999997643 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 568 KWASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 568 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...................
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 238 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 238 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----
Confidence 876543222 12223579999999999999999999999999999999999999997755432211111000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
. ....... ...+..++..||+.||.+||++.+++.
T Consensus 239 ~----~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 P----SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp H----HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c----ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 0000111 123455667899999999998777665
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=354.77 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=198.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCE----EEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~----vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.+... ....+.+.+|+.++..++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 367999999999999999999864 4543 577777542 34567899999999999999999999999865 488
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||+|+.+|+|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999998654 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 755444333334567889999999999999999999999999999999 99999876544333222211100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.. .......+..++..||+.||.+||++.++++.|....
T Consensus 239 ----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 ----PQ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00 1111223555667899999999999999999987644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.69 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=200.2
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+|+.+++.++||||++++++|...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999996 578999999987432 2345788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999887653 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .+..+.
T Consensus 160 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~~----- 224 (336)
T 3h4j_B 160 DGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSCV----- 224 (336)
T ss_dssp TSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSSC-----
T ss_pred CCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcCC-----
Confidence 43322 23579999999999987776 689999999999999999999997643321110 001100
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.... ...+..++..||+.||.+|||+.+++++
T Consensus 225 -~~~p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -YVMPDFL----SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCcccC----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011111 1234456678999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=360.96 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=202.4
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 489 (766)
..++|.+.++||+|+||.||+|... +|+.||||+++... ...+.+..|..++..+ +||||++++++|.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999975 57899999997532 3456788999999988 7999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999997643 58999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... .....+||+.|+|||++....++.++|||||||++|||++|+.||...+.......+... .+
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------~~--- 238 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------NV--- 238 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC---
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-------CC---
Confidence 433222 223468999999999999999999999999999999999999999875443222221111 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+||+ +.+++++
T Consensus 239 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ---AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011111 133455667899999999995 5777764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.96 Aligned_cols=253 Identities=29% Similarity=0.499 Sum_probs=197.1
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||.||+|.. .++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 5788999999999999999987 5788999999754 45578999999999999999999999987 457999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC-eeEecccccccccCCCCC
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-vkL~DFGla~~~~~~~~~ 576 (766)
|+|.+++..... ...+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999976532 124788999999999999999999865578999999999999988876 7999999997654321
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .+.|... .+.. +.+..
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~---~~~~-----~~~~~ 227 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH---NGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH---TTCC-----CCCBT
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh---cCCC-----CCccc
Confidence 224699999999999988999999999999999999999999975433221 1222111 1111 11111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+ ..+..++..||+.||.+|||+.++++.|+..
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 112 2345566789999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.16 Aligned_cols=266 Identities=27% Similarity=0.362 Sum_probs=203.6
Q ss_pred cccceeeeccCceEEEEEEe-----CCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEE
Q 004247 420 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 490 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l 490 (766)
|.+.+.||+|+||.||++.. .+++.||||+++... ...+.+.+|+++++.++||||+++++++.+. ..+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999864 268899999998643 5567899999999999999999999999874 57899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 38999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
....... ......||+.|+|||++....++.++||||||+++|+|++|+.||....... .....+.........+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence 6543221 1223568889999999999999999999999999999999999986432110 0000000000000001111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+...............+..++..||+.||.+|||+.++++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111122224566677789999999999999999998743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.94 Aligned_cols=269 Identities=26% Similarity=0.334 Sum_probs=207.1
Q ss_pred cCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEe--ecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~ 489 (766)
++|.+.+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|++++++++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999983 468899999997653 55677999999999999999999999987 456689
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++++|.+++.... ..+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999997643 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh--ccccccCcc
Q 004247 570 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA--KPILSSGKV 646 (766)
Q Consensus 570 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~--~~~~~~g~~ 646 (766)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...+. ........+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSRL 253 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHHHH
Confidence 75443322 1223568889999999999999999999999999999999999986432110 00000 000000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
...+...............+..++..||+.||.+|||+.+++++|+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111111111112222344556677899999999999999999997654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=344.74 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=200.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999864 67899999986432 2356788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999997653 48999999999999999999999 899999999999999999999999999986544
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 224 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------ 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC------------
Confidence 322 1235799999999999988999999999999999999999999986543322222111100
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+... . ...+..++..||+.||.+||++.+++++
T Consensus 225 -~~~~~-~---~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -TFPDF-V---TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCTT-S---CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCc-C---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111 1 1234456678999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=366.23 Aligned_cols=206 Identities=29% Similarity=0.435 Sum_probs=167.9
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC--ce
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN--NL 488 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~--~~ 488 (766)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++.. .......+.+|+.++..+. ||||++++++|...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999986 4789999999864 2455678889999999997 999999999997544 68
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
|+||||++ |+|..++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5999998753 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCC-------------------CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCcc
Q 004247 569 WASTSS-------------------SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628 (766)
Q Consensus 569 ~~~~~~-------------------~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 628 (766)
...... .....+..+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 654311 1112234689999999999986 67999999999999999999999999876654
Q ss_pred ch
Q 004247 629 GQ 630 (766)
Q Consensus 629 ~~ 630 (766)
.+
T Consensus 238 ~~ 239 (388)
T 3oz6_A 238 NQ 239 (388)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.38 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=202.6
Q ss_pred cCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 488 (766)
+.|.+.+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.++..++||||++++++|... +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588899999999999999983 478899999997543 3457889999999999999999999999876 678
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC---
Q 004247 569 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 644 (766)
Q Consensus 569 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 644 (766)
........ .......||..|+|||++....++.++||||||+++|+|++|..|+..... .......+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence 77654332 122335688999999999999999999999999999999999998643210 0000000000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+...+...............+..++..||+.||.+|||+.++++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0000000000001111222345567778999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.36 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=204.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 7899999998643 3456788999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998653 358999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
..........||+.|+|||++....+ +.++||||||+++|+|++|+.||......... ...|...... +.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-------~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-------LNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTCTT-------STT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcccc-------cCc
Confidence 32222334679999999999987665 77999999999999999999999765443221 1122211100 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.||.+|||+.+++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00111234556678999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.70 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=202.1
Q ss_pred hcCcccceeeeccCceEEEEEEeCC----CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|...+ +..||||++... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4679999999999999999998532 346999999864 3556789999999999999999999999865 56799
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999997643 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... ......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+......
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--------- 233 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--------- 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---------
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---------
Confidence 543322 1223567889999999998999999999999999999998 99999765443332222111100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
...... ...+..++..||+.||.+||++.++++.|+..
T Consensus 234 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ---PKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 000111 12355566789999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.24 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=199.9
Q ss_pred hcCcccceeeeccCceEEEEEEeCC-C-------CEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD-G-------KELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~-g-------~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
.++|.+.+.||+|+||.||+|.... + ..||+|++.... ...+.+.+|+.+++.++||||++++++|...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4579999999999999999998642 3 579999997543 556789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC--------e
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------P 559 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--------v 559 (766)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999997653 348999999999999999999999 89999999999999998887 9
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCC-CCCCCCccchhhHHHhh
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRK-PISNDHPKGQESLVMWA 637 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~-Pf~~~~~~~~~~lv~~~ 637 (766)
||+|||++...... ....||+.|+|||++.. ..++.++|||||||++|||++|.. ||............ .
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--~ 232 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--E 232 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--H
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--h
Confidence 99999998654321 22568999999999987 679999999999999999999554 44433222111111 1
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 638 ~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
.. ..+.. .. . ..+..++..||+.||.+|||+.++++.|+....
T Consensus 233 ~~----~~~~~--------~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DR----HQLPA--------PK-A---AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TT----CCCCC--------CS-S---CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cc----CCCCC--------CC-C---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 10 00001 01 1 124456678999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.30 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=196.6
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++. .......+.+|+.+++.++||||++++++|...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 4789999999874 235567899999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.........+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999997533333568999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||......... +.... ..+....+.
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~----~~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKI----EQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHHH----HTTCSCCCC-
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHHh----hcccCCCCc-
Confidence 43222 12357999999999999999999999999999999999999999764332211 11111 111111111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
...+ ...+..++..||+.||.+||++.+|++.|+...
T Consensus 260 ---~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 260 ---SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111 123455667899999999999999999986443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=368.90 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=196.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------C
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 486 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.+|+.++||||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 568999999999999999999864 688999999975 345567889999999999999999999999654 3
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+||||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 57666642 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc------
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI------ 640 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~------ 640 (766)
++....... .+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+...+...+......
T Consensus 211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987654322 23468999999999999999999999999999999999999999876543332222110000
Q ss_pred ----------------cccCccccccCcccCCCCC---hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 ----------------LSSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ----------------~~~g~~~~lld~~l~~~~~---~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...-.+..++...+..... ......+..++..||+.||.+|||+.++|++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011111111100000 0113456677788999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.63 Aligned_cols=250 Identities=25% Similarity=0.298 Sum_probs=201.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|... ++..+|+|++... ....+.+.+|+++++.++||||++++++|...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457999999999999999999875 5778999998753 24467899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEeccccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 571 (766)
+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999987643 58999999999999999999999 899999999999999 788999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... ....||+.|+|||++. +.++.++||||||+++|+|++|+.||...........+........
T Consensus 161 ~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 227 (277)
T 3f3z_A 161 PGKMM---RTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--------- 227 (277)
T ss_dssp TTSCB---CCCCSCTTTCCHHHHT-TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred Cccch---hccCCCCCccChHHhc-ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence 43322 2357999999999987 4599999999999999999999999976543322211111100000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....... ...+..++..||+.||.+||++.+++++
T Consensus 228 ~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 228 EKDWLNV----SPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred chhhhcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001 1344556678999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.99 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=204.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++..++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456999999999999999999875 68999999987532 1367899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC----CeeEecc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 564 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 564 (766)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999754 358999999999999999999999 8999999999999999887 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|++......... ....||+.|+|||++....++.++||||||+++|+|++|+.||...........+....
T Consensus 164 g~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------ 234 (321)
T 2a2a_A 164 GLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS------ 234 (321)
T ss_dssp TTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC------
T ss_pred ccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------
Confidence 999876553322 23579999999999998999999999999999999999999997654322211111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+++.+....+ ..+..++..||+.||.+|||+.+++++
T Consensus 235 ---~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 ---YDFDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CCCCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---cccChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111111111 234556678999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=361.24 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=189.8
Q ss_pred cCcccc-eeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHH-hcCCCceeEEeeEEee----cCceEE
Q 004247 418 SNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFE----DNNLLL 490 (766)
Q Consensus 418 ~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~----~~~~~l 490 (766)
++|.+. ++||+|+||+||+|.+. +|+.||||+++.. ..+.+|++++. ..+||||++++++|.. ...+||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 466665 78999999999999875 6899999999754 34667888874 4589999999999875 567899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 567 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla 567 (766)
||||++||+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999976432 358999999999999999999999 89999999999999987 789999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh-hHHHhhccccccCcc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKV 646 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~~ 646 (766)
+....... ....+||+.|+|||++....|+.++|||||||+||||++|+.||......... ..... +..+.+
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~ 284 (400)
T 1nxk_A 212 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC
T ss_pred cccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc
Confidence 86654322 23467999999999999999999999999999999999999999765543211 00000 000110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. +..+.. . .....+..++..||+.||.+|||+.+++++
T Consensus 285 ~-~~~~~~-~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E-FPNPEW-S----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-CCTTTT-T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-CCCccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 0 112335556678999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.92 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=196.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||.||+|... +++.||||+++.... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 789999999975432 222456799999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
++ |+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 59999887653 368999999999999999999999 899999999999999999999999999998654432
Q ss_pred CCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc-
Q 004247 575 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP- 652 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~- 652 (766)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+...+..
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 KT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 22 223578999999999876 56899999999999999999999999876554433322211111111111111110
Q ss_pred --------ccCCCC----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 --------ALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 --------~l~~~~----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...... .......+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 00111334566778999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.56 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=202.5
Q ss_pred hcCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++..++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45789999999999999999984 35778999999643 45567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEe
Q 004247 489 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 562 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~ 562 (766)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986542 22458999999999999999999999 89999999999999984 4569999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhcccc
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|||++................||+.|+|||++..+.++.++||||||+++|+|++ |+.||...........+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh------
Confidence 9999986654433333334578999999999999999999999999999999998 999997654322211111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.. +...... ...+..++..||+.||.+||++.+++++|..
T Consensus 260 -~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 -SGGR-----MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp -TTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCCC-----CCCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1100 0011111 1345556678999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.65 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=199.1
Q ss_pred cCcccceeeeccCceEEEEEEeCC----CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEe-ecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~l 490 (766)
.+|.+.+.||+|+||.||+|...+ +..+|+|.++.. ....+.+.+|+.++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999998642 235899998753 345678999999999999999999999865 4567899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997543 357899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCC--ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 571 STSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 571 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
...... .......||+.|+|||.+....++.++||||||+++|+|++ |.+||...........+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-------
Confidence 443211 11223568889999999999999999999999999999999 56666654433322211111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+ .. .. ..+..++..||+.+|.+||++.++++.|+.
T Consensus 252 --~~~---~~-~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 252 --LQP---EY-CP---DPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp --CCC---TT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCC---cc-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 11 11 235556678999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=346.63 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=205.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~l 490 (766)
.++|.+.+.||+|+||.||++... +|+.||+|++... ....+.+.+|+.++++++||||++++++|.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 7899999999753 3556789999999999999999999998854 567899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc-----eEeecccCCCeeeCCCCCeeEeccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-----VIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-----IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997654334568999999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
++........ ......||+.|+|||++....++.++||||||+++|+|++|+.||...........+ ..+.
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-------~~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGK 232 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH-------hhcc
Confidence 9987654322 112357999999999999889999999999999999999999999865432211111 1111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
... +...+ ...+..++..||+.||.+||++.+|++++....
T Consensus 233 ~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 FRR-----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCC-----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ccc-----CCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 111 11111 234555667899999999999999998775443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=370.47 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=194.4
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|+.++..++||||++++++|...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999986 47899999999742 34456788899999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ .++|+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997653 58999999999999999999995 1679999999999999999999999999998644
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...........+..... .
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~------ 367 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----R------ 367 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----C------
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----C------
Confidence 3322 22346899999999999999999999999999999999999999976544332222211110 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
+....+ ..+..++..||+.||.+|| ++.+++++
T Consensus 368 --~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 --FPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111111 2345566789999999999 99999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=347.33 Aligned_cols=264 Identities=28% Similarity=0.375 Sum_probs=207.3
Q ss_pred HHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHh--cCCCceeEEeeEEeecC----c
Q 004247 414 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----N 487 (766)
Q Consensus 414 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~ 487 (766)
....++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34567899999999999999999988 6899999999754 34567889999988 78999999999998876 7
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH--------cCCCCceEeecccCCCeeeCCCCCe
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
.++||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCE
Confidence 89999999999999999753 4899999999999999999999 6 899999999999999999999
Q ss_pred eEecccccccccCCCCCc--eecccccccCCCCchhhccC------CCCCchhhHHHHHHHHHHHhC----------CCC
Q 004247 560 QLSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKP 621 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG----------~~P 621 (766)
||+|||++.......... ......||+.|+|||++... .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998766543321 12335799999999999865 234689999999999999999 778
Q ss_pred CCCCCccchhhHHHhhccccccCccccccCcccCCC-CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 622 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 622 f~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~-~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
|........... .+...... ..+.+.+... ...+....+..++..||+.||.+|||+.+|+++|+..
T Consensus 267 ~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVE-EMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHH-HHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHH-HHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 865443221111 01111111 1111111111 1234556777888899999999999999999998743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.81 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=199.3
Q ss_pred hcCcccceeeeccCceEEEEEEeCC-----CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++|.+.+.||+|+||.||+|.... +..||||+++.. ......+.+|+.++..++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3568889999999999999998642 246999999753 345667999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997643 368999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 570 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 570 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........ ......+|+.|+|||++....++.++|||||||++|||++ |+.||...........+. .+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-------~~~~- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFR- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------CCCc-
Confidence 65432211 1122456889999999999999999999999999999999 999997654322211111 1100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
... .......+..++..||+.+|.+||++.++++.|+...
T Consensus 269 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 ----LPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ----CCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 1111234556667899999999999999999986533
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=354.47 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=194.4
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHH--HHhcCCCceeEEeeEEee-----cCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI--ITTLHHKNIISLLGFCFE-----DNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~i--L~~l~HpnIv~l~~~~~~-----~~~~~ 489 (766)
.++|.+.+.||+|+||.||+|.. +++.||||++..... ..+..|.++ +..++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46799999999999999999977 789999999975443 344444444 556899999999986643 23578
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC---------ceEeecccCCCeeeCCCCCee
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ---------RVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~---------~IiHrDLKp~NILL~~~~~vk 560 (766)
+||||+++|+|.+++.... +++..+..|+.||+.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 9999999999999997543 5899999999999999999998 6 999999999999999999999
Q ss_pred EecccccccccCCCC------CceecccccccCCCCchhhcc-------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 561 LSDFGLAKWASTSSS------HITCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 561 L~DFGla~~~~~~~~------~~~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 111223579999999999986 3567799999999999999999777643322
Q ss_pred cchh-hHHH---hhcc-------ccccCccccccCcccCCCC--ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 628 KGQE-SLVM---WAKP-------ILSSGKVTQLLDPALGNNY--DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 628 ~~~~-~lv~---~~~~-------~~~~g~~~~lld~~l~~~~--~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.... .... ...+ ...... ..+.+.... .......+..++..||+.||.+|||+.++++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1110 0000 0000 000000 011111111 223445677788899999999999999999998754
Q ss_pred C
Q 004247 695 A 695 (766)
Q Consensus 695 ~ 695 (766)
.
T Consensus 317 l 317 (336)
T 3g2f_A 317 M 317 (336)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.53 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=199.0
Q ss_pred CcccceeeeccCceEEEEEEeC-C---CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce-EEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL-LLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~-~lV 491 (766)
.|...+.||+|+||.||+|... + +..+|+|++... ....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999853 2 237999998753 34567899999999999999999999999876655 999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 368999999999999999999999 899999999999999999999999999998654
Q ss_pred CCC--CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC-CCCCCccchhhHHHhhccccccCcccc
Q 004247 572 TSS--SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 572 ~~~--~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
... .........||+.|+|||.+....++.++||||||+++|+|++|..| |...........+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--------
Confidence 322 11122235789999999999999999999999999999999995555 5443332222221111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 248 ----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 248 ----PQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp ----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000111 1345566678999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.28 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=182.4
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999986 578999999997532 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997543 368999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||........... ... . +
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-~------~ 228 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVL-A------D 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-S------C
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------Hhh-c------c
Confidence 33221 1235799999999999988999999999999999999999999976543221110 000 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.... ...+..++..||+.||.+||++.+++++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0111111 1234556678999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.38 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=176.9
Q ss_pred ceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 423 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++..+. ||||++++++|.+....++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999875 6899999999743 3467788999999997 99999999999999999999999999999
Q ss_pred hHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---CeeEecccccccccCCCCCc
Q 004247 501 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 501 ~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~~~~~~~~~~ 577 (766)
.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 99997653 58999999999999999999999 8999999999999997665 7999999999866543322
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~ 657 (766)
.....||+.|+|||++....++.++|||||||++|+|++|+.||..................+..+.... ....
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~--- 239 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEA--- 239 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHH---
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cccc---
Confidence 2335789999999999999999999999999999999999999976543211000000000111111100 0000
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 658 ~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.||.+|||+.+++++
T Consensus 240 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 -WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00112345566678999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.41 Aligned_cols=252 Identities=29% Similarity=0.404 Sum_probs=198.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++..... .+.+|++++.++ +||||++++++|.+.+..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 457999999999999999999875 688999999976542 345688888888 799999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC----CCeeEecccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 570 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~~~ 570 (766)
+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999997543 58999999999999999999999 899999999999998543 34999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
...... ....+||+.|+|||++....|+.++|||||||++|||++|+.||..........+.... ..+.+.
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~--- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS--- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC---
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc---
Confidence 554322 23468999999999999888999999999999999999999999764333222222111 111110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+...........+..++..||+.||.+||++.+++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001112234456678999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=368.87 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999875 79999999997532 3456789999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999754 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+. .+..
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~---- 233 (476)
T 2y94_A 168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC-------DGIF---- 233 (476)
T ss_dssp TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH-------TTCC----
T ss_pred cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCc----
Confidence 4332 223579999999999987765 689999999999999999999998654432211111 1110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+ ..+..++..||+.||.+|||+.+++++
T Consensus 234 --~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 --YTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --CCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0001111 234556678999999999999999973
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=380.81 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=208.4
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+.+|++++||||++++++|.+ +..+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 356788999999999999999999888889999998765556789999999999999999999999976 6789999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
.+|+|.++|..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999974321 358899999999999999999999 8999999999999999999999999999986643211
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.......+|..|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.. ...
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-----~~~ 485 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYR-----MPC 485 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-------TTCC-----CCC
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-----CCC
Confidence 11122457889999999999999999999999999999999 999997654332221111 1100 000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.......+..++..||+.||.+|||+.+|+++|+...
T Consensus 486 ----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111234556677899999999999999999997654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.65 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=199.7
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEE-eecCceEEEEe
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 493 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~lV~E 493 (766)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999986 578999999876432 224578899999999988877776666 56677899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEecccccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~ 570 (766)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 999999997543 358999999999999999999999 899999999999999 78899999999999876
Q ss_pred cCCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 571 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 571 ~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----c
Confidence 6543311 122467999999999999999999999999999999999999999875443322221110000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.... .+.+...++ ..+..++..||+.||.+||++.+|++.|+.
T Consensus 235 ~~~~-~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 235 MSTP-IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHSC-HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ccch-hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0000 000111111 345566678999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.10 Aligned_cols=264 Identities=19% Similarity=0.275 Sum_probs=193.6
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46799999999999999999986 478899999997543 33567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee-----CCCCCeeEeccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-----SDDFEPQLSDFGLA 567 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL-----~~~~~vkL~DFGla 567 (766)
||+++ +|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99975 9999997653 48999999999999999999999 899999999999999 45556999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...........+
T Consensus 185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 876543222 2335789999999999864 4899999999999999999999999876543322222111111100000
Q ss_pred c------cccC--cccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 T------QLLD--PALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~------~lld--~~l~~~~-----~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .+.. +...... .......+..++..||+.||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 0000 0000000 00012345567778999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.15 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=202.4
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~l 490 (766)
.++|.+.+.||+|+||.||++.. .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999987 5789999998864 34566789999999999999999999999973 347899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997643334578999999999999999999999 89999999999999999999999999998755
Q ss_pred cCCCCCc-------eecccccccCCCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 571 STSSSHI-------TCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 571 ~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
....... ......||+.|+|||++.... ++.++||||||+++|+|++|+.||.................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~- 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ- 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-
Confidence 3211110 011245799999999987543 78999999999999999999999953211111111110000
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
. . + + ..... ...+..++..||+.||.+||++.+++++|+....
T Consensus 264 ~---~---~--~-~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 264 L---S---I--P-QSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --------C--C-CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred C---C---C--C-ccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0 0 0 00111 2345566678999999999999999999976553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.79 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=202.3
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee--------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 484 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999987 578999999986432 334578899999999999999999999987
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
.+.+++||||+++ +|.+.+.... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 8888776543 358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCC--CceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 565 GLAKWASTSSS--HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 565 Gla~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653221 122234679999999999875 458999999999999999999999998765443333322111111
Q ss_pred ccCccccc-----cCcc---cCCCCC-hHH------HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQL-----LDPA---LGNNYD-YDQ------MERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~l-----ld~~---l~~~~~-~~~------~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....+... .+.. ...... .+. ...+..++..||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111000 0000 000001 111 1235567788999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.80 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=200.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999975 68999999986432 2367899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC----CeeEecc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 564 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 564 (766)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997543 58999999999999999999999 8999999999999998877 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|++........ .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.....
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 228 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY----- 228 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-----
Confidence 99987654322 2235799999999999989999999999999999999999999976543221111110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.+...... ...+..++..||+.||.+||++.+++++
T Consensus 229 ----~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 ----DFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ----CCCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ----CCcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0001110111 1235556678999999999999999973
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.72 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=202.6
Q ss_pred hcCcccce-eeeccCceEEEEEEe---CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAEN-LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~-~LG~G~fG~Vy~a~~---~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45688877 999999999999954 34688999999754 23467899999999999999999999999 667889
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999997643 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 570 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 570 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
......... .....||+.|+|||++....++.++||||||+++|+|++ |+.||...........+. .+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC-
Confidence 655433221 122456789999999998899999999999999999999 999998754432222111 1110
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
+.... .....+..++..||+.||.+||++.+|++.|+..
T Consensus 239 ----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 ----MGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ----CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 1123455666789999999999999999998743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=353.45 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=204.0
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---------hHHHHHHHHHHHHHhc-CCCceeEEeeE
Q 004247 413 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTL-HHKNIISLLGF 481 (766)
Q Consensus 413 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 481 (766)
.....++|.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999975 79999999986532 2356788999999999 79999999999
Q ss_pred EeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 482 ~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
|...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999997542 58999999999999999999999 89999999999999999999999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhcc------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 635 (766)
+|||++........ .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+.
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999987654332 233689999999999863 358899999999999999999999997654322111111
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 636 ~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. +... ...+.. ... ...+..++..||+.||.+||++.+++++
T Consensus 319 ~-------~~~~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 E-------GQYQ-FSSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H-------TCCC-CCHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred h-------CCCC-CCCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 1000 000000 011 1235556678999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=340.37 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=202.5
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEE-eecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++..++|++++..+.++ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 56899999999999999999986 5789999999875432 24688999999999998877666665 556778999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEeccccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 571 (766)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9 899999997543 358999999999999999999999 899999999999999 488899999999998766
Q ss_pred CCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 572 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 572 ~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----cc
Confidence 543321 123467999999999999999999999999999999999999999865433222111110000 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.. ..+.+...++ ..+..++..||+.||.+||++.+|++.|+.
T Consensus 236 ~~-~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 236 ST-PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HS-CHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CC-chHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 00 0001111112 335566678999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.65 Aligned_cols=263 Identities=19% Similarity=0.271 Sum_probs=204.7
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC--------CCceeEEeeEEe----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNIISLLGFCF---- 483 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~~~~~---- 483 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++......+.+.+|+.+++.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46899999999999999999986 46889999999987777788999999999996 788999999997
Q ss_pred ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCC-----
Q 004247 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDF----- 557 (766)
Q Consensus 484 ~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~----- 557 (766)
....+++||||+ +++|.+.+..... ..+++..++.|+.||+.||.|||+ + +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 456799999999 5677776654432 358999999999999999999999 7 899999999999999775
Q ss_pred --------------------------------------------CeeEecccccccccCCCCCceecccccccCCCCchh
Q 004247 558 --------------------------------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593 (766)
Q Consensus 558 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~ 593 (766)
.+||+|||++....... ....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence 79999999998765432 23579999999999
Q ss_pred hccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh----hH---HHhhcc--------------cc-ccCccccccC
Q 004247 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE----SL---VMWAKP--------------IL-SSGKVTQLLD 651 (766)
Q Consensus 594 l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~----~l---v~~~~~--------------~~-~~g~~~~lld 651 (766)
+.+..++.++|||||||+||||++|+.||......... .+ ...... .+ ..+.+..+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999865533211 00 000000 00 0011111100
Q ss_pred ccc---------CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PAL---------GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l---------~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... ...........+..++..||+.||.+|||+.++|++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 011234555667788889999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=351.58 Aligned_cols=267 Identities=25% Similarity=0.303 Sum_probs=198.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
...++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++..++||||++++++|...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 68999999997532 123468899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.++||||+++ +|..++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 8998886543 368899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||...........+...........+
T Consensus 160 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 876543322 2335799999999999754 5899999999999999999999999876543322221111111101011
Q ss_pred cc---ccCccc---CCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQ---LLDPAL---GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~---lld~~l---~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. +.+... ..... ......+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000000 00001 1112445667778999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=373.02 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=205.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.++||+|+||.||+|... +|+.||||++.... .....+.+|+.++..++||||++++++|...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999975 69999999997532 3346788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||++||+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999998665444579999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch-hhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~~~~ll 650 (766)
..... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ ..+... +.. +.
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~~-~~----- 409 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VLE-QA----- 409 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HHH-CC-----
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hhh-cc-----
Confidence 44322 2235899999999999999999999999999999999999999987543221 111110 000 00
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~-----~eVL~~ 690 (766)
..+...+ ...+..++..||+.||.+||++ .+|+++
T Consensus 410 -~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 -VTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -CCCCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -cCCCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0011111 1234455678999999999975 666653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=353.81 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=200.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999875 5899999998643 344567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988875443 58999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh-cccc--------c
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPIL--------S 642 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~-~~~~--------~ 642 (766)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .... .
T Consensus 177 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Cccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3222 2235799999999999865 7899999999999999999999999876543322211100 0000 0
Q ss_pred cCccccccCcccCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 643 SGKVTQLLDPALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 643 ~g~~~~lld~~l~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.........+.+..... ......+..++..||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000111111111111 1123446667788999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=345.70 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=207.1
Q ss_pred hcCcccceeeeccCceEEEEEEe--CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc------eeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++......+.+.+|+.++..++|++ +++++++|...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 45799999999999999999986 36889999999887777788999999999997654 99999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-------------
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD------------- 555 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~------------- 555 (766)
++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8899999976543 358899999999999999999999 89999999999999987
Q ss_pred ------CCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 556 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 556 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999998654432 23579999999999998899999999999999999999999998765433
Q ss_pred hhhHHHhhcccccc--------Ccc------------------ccccCcccC-CCCChHHHHHHHHHHHhhcccCCCCCC
Q 004247 630 QESLVMWAKPILSS--------GKV------------------TQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARP 682 (766)
Q Consensus 630 ~~~lv~~~~~~~~~--------g~~------------------~~lld~~l~-~~~~~~~~~~~~~~~~~Cl~~dP~~RP 682 (766)
....+......+.. ... .....+... ..........+..++..||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 22222111000000 000 000000000 011223445677788899999999999
Q ss_pred CHHHHHHH
Q 004247 683 QMSLVLKL 690 (766)
Q Consensus 683 s~~eVL~~ 690 (766)
|+.+++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=376.05 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=205.8
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
..++|.+.++||+|+||.||+|... +|+.||||++.... .....+.+|+.+|..++||||++++++|.+.+.+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999875 79999999997532 334668899999999999999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||++||+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976542 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.... ...
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---~~~------ 404 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---KEV------ 404 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---HHC------
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---hcc------
Confidence 54332 223589999999999998899999999999999999999999998754332211111000 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
...+...++ ..+..++..||+.||.+|| ++.+|+++
T Consensus 405 ~~~~p~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 PEEYSERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCCTTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccCCccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 000111111 2345566789999999999 78888875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=359.58 Aligned_cols=270 Identities=21% Similarity=0.311 Sum_probs=208.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999875 58999999997533 34577889999999999999999999998755 78999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee----CCCCCeeEeccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 567 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla 567 (766)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999976432 2348999999999999999999999 899999999999999 77888999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhcc--------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHh---
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW--- 636 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~--- 636 (766)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...........++.
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87654322 223579999999999875 5678899999999999999999999975432221111111
Q ss_pred -hcccc--------ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 637 -AKPIL--------SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 637 -~~~~~--------~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+.. ..+.+.-.-+..............+..++..||+.||.+||++.++++.+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11100 0000000000011122334555666778888999999999999999988754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.75 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=192.2
Q ss_pred CcccceeeeccCceEEEEEEeC--CC--CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~--~g--~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV 491 (766)
.|.+.+.||+|+||.||+|... ++ ..||||.++.. ....+.|.+|+.++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5778899999999999999863 22 36899998753 3567889999999999999999999998764 4678999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 357899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCCc--eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 572 TSSSHI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 572 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
...... ......||+.|+|||++....++.++|||||||++|||++ |..||...........+.. +. .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-------~~--~ 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------GR--R 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-------TC--C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-------CC--C
Confidence 432211 1223467889999999999999999999999999999999 7788876554332222111 11 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+ .. .. ..+..++..||+.||.+||++.++++.|+.
T Consensus 315 ~~~p---~~-~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 315 LLQP---EY-CP---DPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CCCC---TT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC---CC-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0011 11 11 235556678999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.99 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=200.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEE--EEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKEL--AVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~v--AVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.+.||+|+||.||+|... +|..+ |||.++.. ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999864 56544 99988753 34556789999999999 899999999999999999999
Q ss_pred EeecCCCCHhHhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 492 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 223468999999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 638 (766)
||+|||+++....... .....+|+.|+|||++....++.++||||||+++|||++ |+.||...........+
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 254 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh----
Confidence 9999999974432211 122457889999999998899999999999999999998 99999765432211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
..+. .... .......+..++..||+.+|.+||++.++++.|..
T Consensus 255 ---~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 255 ---PQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ---GGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---hcCC-----CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1110 0001 11112345566778999999999999999998864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.68 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=191.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHH-HHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.++||+|+||.||+|... +++.||||+++... .....+.+|..+ ++.++||||++++++|.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999875 68899999997532 334566777776 577899999999999999999999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997643 58899999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... +.
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~---------- 256 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PL---------- 256 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CC----------
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cc----------
Confidence 43222 223468999999999999999999999999999999999999999765433222211110 00
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.+..... ..+..++..||+.||.+||++.+.++
T Consensus 257 --~~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 257 --QLKPNIT----NSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp --CCCSSSC----HHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred --CCCCCCC----HHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 0111111 23445667899999999999854333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.34 Aligned_cols=264 Identities=17% Similarity=0.212 Sum_probs=196.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCChh------------HHHHHHHHHHHHHhcCCCceeEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSED------------VIKEFVLEIEIITTLHHKNIISLLG 480 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~~~------------~~~~~~~Ei~iL~~l~HpnIv~l~~ 480 (766)
.++|.+.+.||+|+||.||+|... ++..+|||++..... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999975 578899999875421 1224667889999999999999999
Q ss_pred EEee----cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC
Q 004247 481 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 556 (766)
Q Consensus 481 ~~~~----~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 556 (766)
++.. ....++||||+ +++|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999997653 68999999999999999999999 899999999999999887
Q ss_pred C--CeeEecccccccccCCCCC-----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 557 F--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 557 ~--~vkL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 11133579999999999998899999999999999999999999996533222
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
....... .... ..+...+......... ...+..++..||+.||.+||++.+|++.|+..
T Consensus 268 ~~~~~~~-~~~~--~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAK-TNLL--DELPQSVLKWAPSGSS---CCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHH-HHHH--HTTTHHHHHHSCTTSC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHH-Hhhc--ccccHHHHhhcccccc---HHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111110 0000 0111111111111011 12455566789999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.02 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=198.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 567999999999999999999875 7999999998753 34567888999999999 999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---------------
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--------------- 556 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--------------- 556 (766)
|||+++++|.+++.........+++..++.|+.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997653323468999999999999999999999 899999999999999844
Q ss_pred ----CCeeEecccccccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh
Q 004247 557 ----FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 631 (766)
Q Consensus 557 ----~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 631 (766)
..+||+|||++....... ...||+.|+|||++... .++.++|||||||++|+|++|..|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 23599999999999866 566899999999999999999987643211
Q ss_pred hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 632 ~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... +..+... .+....+ ..+..++..||+.||.+|||+.+++++
T Consensus 237 -~~~-----~~~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHE-----IRQGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHH-----HHTTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHH-----HHcCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 0111111 1111122 234556678999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.77 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=200.8
Q ss_pred HHhcCcccc-eeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCce
Q 004247 415 SATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 488 (766)
Q Consensus 415 ~~t~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 488 (766)
...+.|.+. +.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+. ||||++++++|...+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 345567776 89999999999999875 6899999998753 234678899999999995 69999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 565 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFG 565 (766)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999865422 468999999999999999999999 89999999999999987 7899999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
+++....... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+........
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 253 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS--- 253 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred cccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC---
Confidence 9987654322 2235799999999999999999999999999999999999999977544322221111110000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .........+..++..||+.||.+|||+.+++++
T Consensus 254 ------~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 ------E----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------T----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------c----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0001112334556678999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.53 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=199.5
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 486 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.+++.++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999985 478899999997542 13346778999999999999999999999999
Q ss_pred ceEEEEeecCCC-CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 487 NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 487 ~~~lV~E~~~gg-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
.+++||||+.+| +|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999997653 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
+++........ ....||+.|+|||++....+ +.++|||||||++|+|++|+.||...... ..
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~-- 238 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE-- 238 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT--
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh--
Confidence 99877654332 23579999999999988776 78999999999999999999999642110 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.+ .... ...+..++..||+.||.+|||+.+++++
T Consensus 239 ---~~~~~---~~~~---~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ---AAIHP---PYLV---SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TCCCC---SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hccCC---Cccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0001 1234556678999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.57 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=178.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++..++||||++++++|...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999875 7899999999754 4556789999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
|+++++|.+++.... .+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999997653 58899999999999999999998 5 799999999999999999999999999976543
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22 1235799999999999999999999999999999999999999976543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.40 Aligned_cols=245 Identities=28% Similarity=0.416 Sum_probs=198.6
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
+.|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++||||++++++|...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999986 57899999998643 244578899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888886433 368999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...........+. . +.
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~--~-----~~---- 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--Q-----NE---- 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-----SC----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--h-----cC----
Confidence 2 2357999999999985 5679999999999999999999999997654322211111 0 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.+...... ..+..++..||+.||.+|||+.+++++
T Consensus 270 -~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 -SPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCC---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111111112 234456678999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=340.85 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=204.0
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
+.|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..++||||++++++|...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4588999999999999999986 47899999998754 34567899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999864 258999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
.. .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.. +. .+.+
T Consensus 174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~-----~~~~ 239 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-------NN-----PPTL 239 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SC-----CCCC
T ss_pred cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------CC-----CCCC
Confidence 22 2335799999999999999999999999999999999999999976543222111110 11 0111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...++ ..+..++..||+.||.+|||+.+++++
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11222 235556678999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=350.61 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=194.7
Q ss_pred cCccc-ceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLA-ENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~-~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
+.|.+ .++||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.++ +||||+++++++.+.+.+++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 46777 47899999999999986 478999999997543 4467889999999985 79999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC---eeEecccccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKWA 570 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFGla~~~ 570 (766)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999997653 58999999999999999999999 89999999999999998776 999999999765
Q ss_pred cCCCC-----CceecccccccCCCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhH-------
Q 004247 571 STSSS-----HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL------- 633 (766)
Q Consensus 571 ~~~~~-----~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l------- 633 (766)
..... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 43211 111123569999999999975 5689999999999999999999999987543321000
Q ss_pred --HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 634 --VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 634 --v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..... .+..+.. .+..+ .... ....+..++..||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~-~i~~~~~-~~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFE-SIQEGKY-EFPDK-DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHH-HHHHCCC-CCCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHH-HHhccCc-ccCch-hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000 0000100 00000 0000 11345566778999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=361.16 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=190.7
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFED 485 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 485 (766)
..++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+|++++||||++++++|. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999864 68999999986432 22335789999999999999999999985 4
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---CeeEe
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 562 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~ 562 (766)
+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 56899999999999999987543 58999999999999999999999 8999999999999997544 59999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
|||+++....... .....||+.|+|||++. ...++.++|||||||+||+|++|+.||.............
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---- 357 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----
Confidence 9999987654322 23467999999999985 3678889999999999999999999997644322111110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+.... .+..... ....+..++..||+.||.+||++.+++++
T Consensus 358 --~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 --TSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HTTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --hcCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0111000 0000011 12345566778999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=363.09 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=178.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhc------CCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~~~~~~~ 489 (766)
..+|.+.+.||+|+||.||+|... +++.||||+++........+.+|+.++..+ +|+||++++++|...+.++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 346899999999999999999864 688999999998777778889999999888 5679999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC--eeEeccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 567 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--vkL~DFGla 567 (766)
+||||+. ++|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999996 699999976543 358999999999999999999999 89999999999999999887 999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCcc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 628 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 628 (766)
....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 7654322 2357999999999999999999999999999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.23 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=200.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-----------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----------- 484 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ..+.+|++++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457999999999999999999975 79999999997654 356789999999999999999999854
Q ss_pred -----cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 485 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 485 -----~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4458999999999999999975432 358999999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
||+|||++......... ....||+.|+|||++....++.++||||||+++|+|++|..|+... .....
T Consensus 162 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~---- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT---- 229 (284)
T ss_dssp EECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH----
T ss_pred EECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH----
Confidence 99999999876554322 2357999999999999889999999999999999999999887421 11100
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+..+. +...++ ..+..++..||+.||.+||++.+++++|..
T Consensus 230 ~~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 230 DLRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hhhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 011111 111122 234456678999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.68 Aligned_cols=267 Identities=19% Similarity=0.247 Sum_probs=197.2
Q ss_pred HHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-------
Q 004247 414 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------- 485 (766)
Q Consensus 414 ~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------- 485 (766)
....++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34567899999999999999999986 57999999998755322 34799999999999999999998543
Q ss_pred -------------------------------CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH
Q 004247 486 -------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534 (766)
Q Consensus 486 -------------------------------~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH 534 (766)
..+++||||++ |+|.+.+.........+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999998 4888877643233356899999999999999999999
Q ss_pred cCCCCceEeecccCCCeeeC-CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHH
Q 004247 535 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVL 612 (766)
Q Consensus 535 ~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL 612 (766)
+ ++|+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9 8999999999999997 6889999999999876544332 235789999999998765 589999999999999
Q ss_pred HHHHhCCCCCCCCCccchhhHHHhhccc------------cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC
Q 004247 613 LELLTGRKPISNDHPKGQESLVMWAKPI------------LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 680 (766)
Q Consensus 613 ~eLltG~~Pf~~~~~~~~~~lv~~~~~~------------~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~ 680 (766)
|||++|+.||.+.........+...... ...-.+..+........+.......+..++..||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999876544332222110000 0000000000000000011111233556677899999999
Q ss_pred CCCHHHHHHH
Q 004247 681 RPQMSLVLKL 690 (766)
Q Consensus 681 RPs~~eVL~~ 690 (766)
|||+.+++++
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=362.12 Aligned_cols=193 Identities=23% Similarity=0.372 Sum_probs=154.9
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 487 (766)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+|+.++||||++++++|... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999864 7899999998652 34567899999999999999999999999543 56
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
+|+||||+ +|+|.+++... ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 56999999754 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-------------------------ceecccccccCCCCchhh-ccCCCCCchhhHHHHHHHHHHHh
Q 004247 568 KWASTSSSH-------------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLT 617 (766)
Q Consensus 568 ~~~~~~~~~-------------------------~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSlGvvL~eLlt 617 (766)
+........ ...+..+||+.|+|||++ ....|+.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 876532211 122346799999999986 45679999999999999999999
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.84 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=195.9
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-CceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|+.++..++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46799999999999999999987 58899999998643 457889999999999999999999997654 4789999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999975421 237899999999999999999999 899999999999999999999999999998654422
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
....+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+ ..+. .+..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTC-----CCCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC-----CCCC
Confidence 12367899999999999999999999999999999998 99999765433221111 1110 0111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.... ...+..++..||+.||.+||++.++++.|+..
T Consensus 236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1111 23455566789999999999999999988643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=378.23 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=199.3
Q ss_pred cCcccce-eeeccCceEEEEEEeC---CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+.+|++++||||++++++|.. +.+++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 8999999999999763 5667999999863 3456889999999999999999999999976 679999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997543 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 572 TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 572 ~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
....... .....+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+....
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~~- 559 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRME- 559 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------TTCCCC-
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCCC-
Confidence 4332211 122346789999999999999999999999999999998 999998765433222211 111000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 560 --------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 560 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp --------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111112345566778999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.71 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=185.0
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ...+.+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999986 478999999997542 22334445555688889999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
||+++ +|.+++.........+++..++.|+.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 8888876532233568999999999999999999998 7 89999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhh----ccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
..... ....||+.|+|||++ ....++.++||||||+++|+|++|+.||......... +...... . .
T Consensus 162 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~----~-~- 231 (290)
T 3fme_A 162 DDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVEE----P-S- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHHS----C-C-
T ss_pred ccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhcc----C-C-
Confidence 53322 224799999999996 4567899999999999999999999999754322211 1111110 0 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+..... .....+..++..||+.||.+|||+.++++
T Consensus 232 ----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ----PQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCcccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001111 11223555667899999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.75 Aligned_cols=271 Identities=20% Similarity=0.241 Sum_probs=193.4
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004247 413 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 487 (766)
Q Consensus 413 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 487 (766)
.....++|.+.+.||+|+||.||+|... +|+.||||++.........+.+|+..+..++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3455678999999999999999999874 68999999987665555677888999999999999999999976543
Q ss_pred ---eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH--cCCCCceEeecccCCCeeeCC-CCCeeE
Q 004247 488 ---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--SGSAQRVIHRDVKSSNILLSD-DFEPQL 561 (766)
Q Consensus 488 ---~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~IiHrDLKp~NILL~~-~~~vkL 561 (766)
+++||||+++ +|...+.........+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 8899999986 565554432223346889999999999999999999 6 89999999999999996 899999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus 174 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999876554332 235799999999998755 4899999999999999999999999876543332222111000
Q ss_pred cc---------cCccccccC------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 LS---------SGKVTQLLD------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ~~---------~g~~~~lld------~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. ........+ ..+...........+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000000 000011111234556677788999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.86 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=201.1
Q ss_pred hcCcccceeeeccCceEEEEEEe----CCCCEEEEEEccCCh-----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 486 (766)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... ...+.+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999987 478999999987532 3345677899999999 6999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997643 58899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
++........ ......||+.|+|||++.++ .++.++|||||||+||||++|+.||...........+. ......
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS- 281 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC-
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhcc-
Confidence 9865433222 12346799999999999853 47899999999999999999999997654332221111 000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHHh
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKLL 691 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~L 691 (766)
.+.+.. .....+..++..||+.||.+|| ++.+++++.
T Consensus 282 ------~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011111 1123345566789999999999 999999865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=367.84 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=200.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--------------hHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNIISLLGF 481 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--------------~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 481 (766)
.++|.+.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 568999999999999999999875 68899999987532 335678999999999999999999999
Q ss_pred EeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC---C
Q 004247 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---E 558 (766)
Q Consensus 482 ~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~ 558 (766)
|.+...+++||||+++|+|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999987643 58999999999999999999999 8999999999999998775 6
Q ss_pred eeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004247 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 559 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 638 (766)
+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+....
T Consensus 188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999987755432 23357999999999987 579999999999999999999999998765433222221111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+. ....... ...+..++..||+.||.+|||+.++|++
T Consensus 264 ~~~~---------~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 264 YYFD---------FNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC---------HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC---------ccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 0000011 1234556678999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.30 Aligned_cols=261 Identities=16% Similarity=0.247 Sum_probs=201.7
Q ss_pred hcCcccceeeeccCceEEEEEEeCC---------CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeE----------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS---------- 477 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~---------- 477 (766)
.++|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3679999999999999999998753 789999999755 46788999999999999987
Q ss_pred -----EeeEEee-cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCe
Q 004247 478 -----LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 551 (766)
Q Consensus 478 -----l~~~~~~-~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 551 (766)
+++++.. ++..++||||+ +++|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 6777766 67889999999 9999999986521 368999999999999999999999 8999999999999
Q ss_pred eeCCCC--CeeEecccccccccCCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 004247 552 LLSDDF--EPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 624 (766)
Q Consensus 552 LL~~~~--~vkL~DFGla~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 624 (766)
|++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998765432211 11235799999999999988999999999999999999999999986
Q ss_pred CCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 625 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 625 ~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
....... +....... ......+.+......... ..+..++..||+.||.+||++.+|++.|+.
T Consensus 271 ~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 271 CLPNTED-IMKQKQKF--VDKPGPFVGPCGHWIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GTTCHHH-HHHHHHHH--HHSCCCEECTTSCEECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCcCHHH-HHHHHHhc--cCChhhhhhhccccCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 5432221 11111100 011111222111101112 345556678999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.44 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=203.8
Q ss_pred cCcccceeeeccCceEEEEEEe-----CCCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~ 489 (766)
++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+++.++||||+++++++...+ .++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5688999999999999999983 46889999999764 355678999999999999999999999987643 789
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998653 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc---------hhhHHHhhcc
Q 004247 570 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG---------QESLVMWAKP 639 (766)
Q Consensus 570 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~---------~~~lv~~~~~ 639 (766)
......... .....+|..|+|||++....++.++||||||+++|||++|..||....... ..........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 765433211 122457888999999998899999999999999999999999985321000 0000000000
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+..+. ...........+..++..||+.||.+||++.+|++.|+..
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011100 0001111123455667789999999999999999998743
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=363.75 Aligned_cols=243 Identities=13% Similarity=0.187 Sum_probs=188.6
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC----ChhHHHHHHHHH---HHHHhcCCCceeEEe-------eE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEI---EIITTLHHKNIISLL-------GF 481 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei---~iL~~l~HpnIv~l~-------~~ 481 (766)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.. .....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999996 4799999999863 335668899999 455566899999998 66
Q ss_pred EeecC-----------------ceEEEEeecCCCCHhHhhhcCCCC---CCCCChHHHHHHHHHHHHHHHHHHcCCCCce
Q 004247 482 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541 (766)
Q Consensus 482 ~~~~~-----------------~~~lV~E~~~ggsL~~~L~~~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 541 (766)
+...+ ..+|||||+ +|+|.+++...... ...+++..++.|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 389999999 67999999754221 1234568889999999999999999 899
Q ss_pred EeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccC-----------CCCCchhhHHHHH
Q 004247 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGV 610 (766)
Q Consensus 542 iHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSlGv 610 (766)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 2234578 999999999987 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 611 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 611 vL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+||||++|+.||........... +... ....+ ..+..++..||+.||.+||++.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~---------------~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW---------------IFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------GGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchhh---------------hhhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999976543221111 0000 01112 234556678999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.91 Aligned_cols=258 Identities=21% Similarity=0.281 Sum_probs=197.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999875 7889999999753 23457889999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999997643 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... ......||+.|+|||++....++.++||||||+++|+|++|+.||...........+ .... ....
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~---~~~~--- 255 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI---NQAI---PRPS--- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH---HSCC---CCGG---
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh---ccCC---CCcc---
Confidence 43221 122357999999999999889999999999999999999999999765432111111 1000 0000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHhhCCCC
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDAD 696 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-s~~eVL~~L~~~~~ 696 (766)
.....++ ..+..++..||+.||.+|| ++.++++.|+....
T Consensus 256 -~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 -TVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -GTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -ccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0111111 2344566789999999999 89999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=340.42 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=203.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357899999999999999999975 5889999998643 34567889999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.. +..
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~----- 232 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-------NEY----- 232 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCC-----
T ss_pred cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-------ccC-----
Confidence 43222 2235799999999999988899999999999999999999999976543222111111 000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+||++.+++++
T Consensus 233 -~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -SIPKHIN----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCccccC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111111 234556678999999999999998863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.58 Aligned_cols=272 Identities=21% Similarity=0.284 Sum_probs=200.1
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC------------hhHHHHHHHHHHHHHhcCCCcee
Q 004247 409 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS------------EDVIKEFVLEIEIITTLHHKNII 476 (766)
Q Consensus 409 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~------------~~~~~~~~~Ei~iL~~l~HpnIv 476 (766)
...++....++|.+.+.||+|+||.||+|...+|+.||||++... ....+.+.+|+.++..++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778889999999999999999999999888999999998532 22347899999999999999999
Q ss_pred EEeeEEeec-----CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCe
Q 004247 477 SLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 551 (766)
Q Consensus 477 ~l~~~~~~~-----~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 551 (766)
+++++|... ..+++||||+. |+|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 999999543 35899999997 58888887543 368999999999999999999999 8999999999999
Q ss_pred eeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch
Q 004247 552 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 630 (766)
Q Consensus 552 LL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 630 (766)
|++.++.+||+|||+++........ ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999855443222 23579999999999886 6799999999999999999999999987553322
Q ss_pred hhHHHh-hc-cc------cccCccccccCcccCCCC-------ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 631 ESLVMW-AK-PI------LSSGKVTQLLDPALGNNY-------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 631 ~~lv~~-~~-~~------~~~g~~~~lld~~l~~~~-------~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...+.. .. +. .........+...+.... .......+..++..||+.||.+|||+.+++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 211110 00 00 000000001111110000 00112335567778999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=339.53 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=196.6
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 490 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~l 490 (766)
.|.+.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4788899999999999999864 6889999998643 4556789999999999999999999999875 355899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeC-CCCCeeEeccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLA 567 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~-~~~~vkL~DFGla 567 (766)
||||+++|+|.+++.... .+++..++.|+.||+.||.|||+ ++ |+||||||+|||++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999997643 58899999999999999999999 66 99999999999997 7899999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........ ....||+.|+|||++. +.++.++||||||+++|+|++|+.||.......... .... .+...
T Consensus 180 ~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~----~~~~~ 248 (290)
T 1t4h_A 180 TLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RRVT----SGVKP 248 (290)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HHHT----TTCCC
T ss_pred cccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH--HHHh----ccCCc
Confidence 75544321 2357999999999887 569999999999999999999999997644322211 1111 11101
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..++ .. . ...+..++..||+.||.+|||+.+++++
T Consensus 249 ~~~~----~~-~---~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ASFD----KV-A---IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGG----GC-C---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccC----CC-C---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 11 1 1235566678999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.20 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=202.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 67889999986432 23467889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999997653 58999999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. .. .
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~------~ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------VD------L 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TC------C
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------cc------c
Confidence 22 1235799999999999998999999999999999999999999976543222111110 00 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+||++.+++++
T Consensus 230 ~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 KFPPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCcCC----HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1111111 234556678999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.22 Aligned_cols=252 Identities=13% Similarity=0.077 Sum_probs=180.6
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc--CCCceeEEe-------eEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL--HHKNIISLL-------GFCF 483 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l--~HpnIv~l~-------~~~~ 483 (766)
.+|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999964 7899999999863 24556777886555555 699988855 4443
Q ss_pred ec-----------------CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHH------HHHHHHHHHHHHHHHcCCCCc
Q 004247 484 ED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQR 540 (766)
Q Consensus 484 ~~-----------------~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~ 540 (766)
.. ..++|||||++ |+|.+++..... .+.+..+ +.++.||+.||.|||+ ++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 32 23799999998 899999986432 3456666 7888999999999999 89
Q ss_pred eEeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhC
Q 004247 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTG 618 (766)
Q Consensus 541 IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG 618 (766)
|+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.. ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999866432 113467899999999987 6799999999999999999999
Q ss_pred CCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 619 RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 619 ~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
+.||....+..... |............+..+. .......+..++..||+.||.+|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS---WKRPSLRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC---CCBCCTTSCCCCSCCCTT-----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc---hhhhhhhhccccccchhh-----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998764432111 111000000000000010 0111234555667899999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.30 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=200.5
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee-
Q 004247 408 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE- 484 (766)
Q Consensus 408 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~- 484 (766)
+++.++....++|.+.+.||+|+||.||+|.. .+|+.||||++.........+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34444455678899999999999999999987 4789999999987655667889999999999 79999999999987
Q ss_pred -----cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 485 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 485 -----~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
.+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 4678999999999999999976432 358899999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 634 (766)
||+|||++......... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 99999999866543221 22357999999999997 567899999999999999999999999765432221111
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 635 ~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. . +....+.. ..+ . ..+..++..||..||.+||++.+++++
T Consensus 247 ~--~-----~~~~~~~~----~~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 P--R-----NPAPRLKS----KKW-S---KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H--H-----SCCCCCSC----SCS-C---HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred h--c-----CccccCCc----ccc-C---HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 0 00011111 111 1 234556678999999999999999983
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=353.38 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=195.5
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999987 4799999999864 2345678899999999999999999999997653
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999999752 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccc---
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS--- 642 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~--- 642 (766)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+........
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9876542 223579999999999886 6799999999999999999999999987654333222211100000
Q ss_pred -----cCc-------cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 643 -----SGK-------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 643 -----~g~-------~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... +.......+.. ........+..++..||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 00000000000 001112345556678999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=341.89 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=200.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||++... +|+.||||+++... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457999999999999999999875 78999999997653 3445788999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEeccccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 571 (766)
+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999987543 58899999999999999999999 899999999999999 788999999999997544
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
... .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.. +.. .+ .
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~~-~~-~ 227 (304)
T 2jam_A 161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE-------GYY-EF-E 227 (304)
T ss_dssp CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------CCC-CC-C
T ss_pred CCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CCC-CC-C
Confidence 321 1235799999999999988999999999999999999999999976543222111110 100 00 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
....... ...+..++..||+.||.+||++.+++++
T Consensus 228 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 SPFWDDI----SESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111111 2345556678999999999999999973
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=367.40 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=203.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.++++++||||++++++|.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999875 7899999998643 34567899999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEecccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 568 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~ 568 (766)
|||+.+|+|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999997543 58999999999999999999999 899999999999999 567899999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.........
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 248 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----- 248 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 7655432 223579999999999874 7999999999999999999999999876543322222111100000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.. ......+..++..||+.+|.+|||+.+++++
T Consensus 249 ---~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 ---PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ---GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000 0112334556678999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=366.33 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=198.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.+.|.+.+.||+|+||.||+|... ++..||||++.... .....+.+|+.+++.++||||++++++|.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346899999999999999999975 78899999987532 33567899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---CCeeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~ 569 (766)
||+++|+|.+.+.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887553 58999999999999999999999 899999999999999764 4599999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... .....||+.|+|||++. +.|+.++|||||||++|+|++|+.||...........+......+.
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 257 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD------- 257 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 665332 23367999999999986 6799999999999999999999999987654332222221111100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. .... ..+..++..||+.||.+|||+.++|++
T Consensus 258 -~~~~-~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 -SPEW-KNVS----EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -SGGG-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -chhc-ccCC----HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0100 1111 234456678999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=347.86 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=204.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357899999999999999999875 5789999998643 34567889999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.....
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 258 (335)
T 2owb_A 193 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY------------ 258 (335)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------
T ss_pred cCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC------------
Confidence 43222 2235799999999999988999999999999999999999999976543222111111000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+||++.+++++
T Consensus 259 -~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -SIPKHIN----PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111 234456678999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.94 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=199.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEe--ecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~ 488 (766)
.++|.+.+.||+|+||.||++... +++.||||+++... .....+.+|+.+++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 68899999997532 34578999999999999999999999984 45688
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||++++ |.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 468999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
...............||+.|+|||++.... ++.++||||||+++|+|++|+.||...........+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-------~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK-------GSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------CCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc-------CCC
Confidence 775544444444567999999999997644 47799999999999999999999986543222111111 100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+||++.+++++
T Consensus 231 ------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111 1234456678999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.57 Aligned_cols=207 Identities=25% Similarity=0.333 Sum_probs=179.1
Q ss_pred HHHhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CC-----ceeEEeeEEeecC
Q 004247 414 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HK-----NIISLLGFCFEDN 486 (766)
Q Consensus 414 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~~~~~~~ 486 (766)
....++|.+.+.||+|+||.||+|... +++.||||+++........+..|+.++..++ |+ +|++++++|...+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 344678999999999999999999865 6889999999987777788889999999885 54 4999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC--CCCCeeEecc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDF 564 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DF 564 (766)
..++||||+. |+|.+++..... ..+++..+..++.|++.||.|||.+. .+|+||||||+||||+ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 599999976542 35899999999999999999999522 7899999999999995 4788999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
|+++...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 206 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 206 GSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9998765422 23579999999999999999999999999999999999999998765433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.29 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=198.0
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcC--CCceeEEeeE
Q 004247 407 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGF 481 (766)
Q Consensus 407 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~ 481 (766)
.|.++.+....++|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.++..++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34444444566789999999999999999999888999999998643 456678999999999997 5999999999
Q ss_pred EeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeE
Q 004247 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 561 (766)
Q Consensus 482 ~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 561 (766)
+...+..++||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||+++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 999999999999 56889999997653 58899999999999999999999 89999999999999964 79999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhcc-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 630 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 630 (766)
+|||+++...............||+.|+|||++.. ..++.++||||||+++|+|++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 99999987655433333334579999999999875 4788899999999999999999999975432211
Q ss_pred hhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 631 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 631 ~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.... ++.....+.......+..++..||+.||.+||++.+++++
T Consensus 248 -~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 -KLHAII-------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHH-------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHH-------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 1111111111112345556678999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=365.21 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=200.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||+||+|... +++.||||++... ......+.+|++++++++||||+++++++...+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999875 7899999998642 234578899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC---CCCCeeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~ 569 (766)
||+.+|+|.+.+.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999987653 58999999999999999999999 8999999999999995 456799999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... .....||+.|+|||++. +.|+.++|||||||++|+|++|+.||...........+.........
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 243 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------ 243 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGG-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------
Confidence 654322 23357999999999987 46999999999999999999999999876543322222111100000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.. ......+..++..||+.||.+|||+.++|++
T Consensus 244 --~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 --PQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --ccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0111234556678999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.24 Aligned_cols=263 Identities=23% Similarity=0.270 Sum_probs=194.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------CceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~~l 490 (766)
.+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+++|+.++||||++++++|... ..+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35888999999999999999975 689999999875432 234799999999999999999998642 23679
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-CCeeEeccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 569 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~ 569 (766)
||||+++ +|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999976 6776665322223468999999999999999999999 899999999999999955 5689999999987
Q ss_pred ccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccc------
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS------ 642 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~------ 642 (766)
....... ....||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.....+...+........
T Consensus 207 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543322 235799999999998764 799999999999999999999999987654332222211100000
Q ss_pred -cCccccccCcccCCC-----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 643 -SGKVTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 643 -~g~~~~lld~~l~~~-----~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......+.-+.+... +.......+..++..||+.||.+||++.+++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001111111111000 011112345667778999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.80 Aligned_cols=265 Identities=27% Similarity=0.429 Sum_probs=186.7
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3568999999999999999999864 7899999998754 244567889999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcC----CCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 493 DFLSRGSLEENLHGN----KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 493 E~~~ggsL~~~L~~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||+++++|.+++... ......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641 1122468999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---ceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 569 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 569 ~~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
........ .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||................+ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---PS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC---CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC---Cc
Confidence 66543211 11223579999999999875 5689999999999999999999999987654332211110000 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......++.....+. ..+..++..||+.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000111111111222 234556678999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.67 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=202.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----------hHHHHHHHHHHHHHhcC-CCceeEEeeEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFE 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 484 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999875 68899999986431 33567889999999996 9999999999999
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999997642 58999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhc------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 638 (766)
|++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+..
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 243 (298)
T 1phk_A 169 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS-- 243 (298)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--
T ss_pred cchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc--
Confidence 99987654332 22357999999999985 45688999999999999999999999976543221111111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+... ...+. .......+..++..||+.||.+||++.+++++
T Consensus 244 -----~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 244 -----GNYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp -----TCCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -----CCcc-cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1000 00000 01112345566778999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.65 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=199.1
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEee--cCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|+.++..++ ||||+++++++.. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36799999999999999999986 578999999998543 467889999999997 9999999999987 66789999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEeccccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAS 571 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~ 571 (766)
||+.+++|.+++. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999984 37889999999999999999999 8999999999999999776 89999999998765
Q ss_pred CCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc-----------
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP----------- 639 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~----------- 639 (766)
..... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||........ .+......
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHH
T ss_pred CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHH
Confidence 44332 23579999999999986 6799999999999999999999999965433211 11100000
Q ss_pred ---c------------cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 ---I------------LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 ---~------------~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .....+..++.. .........+..++..||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHS----ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCT----TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Hhccccccchhhhhhhccccchhhhccc----cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000011111111 1111123445667788999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.44 Aligned_cols=261 Identities=21% Similarity=0.249 Sum_probs=193.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||++++++|...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 6889999998652 355678899999999999999999999997654
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 68999999975 78888852 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc--------
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 638 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-------- 638 (766)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 174 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 986654321 223579999999999999899999999999999999999999998765432221111000
Q ss_pred --------------cccccCccccccCcccCCCCC---hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 --------------PILSSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 --------------~~~~~g~~~~lld~~l~~~~~---~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+......+..++...+..... ......+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000011111111100000 1113456677788999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=335.71 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=194.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999975 79999999987532 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
.... .....||+.|+|||++....+ +.++||||||+++|+|++|+.||...........+. .+.
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~----- 227 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-------GGV----- 227 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC-----
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-------cCc-----
Confidence 4322 123579999999999987665 589999999999999999999997653322111111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+....+ ..+..++..||+.||.+||++.+++++
T Consensus 228 -~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -FYIPEYLN----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -ccCchhcC----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00111111 234556678999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.60 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=182.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcC-CCceeEEeeEEee--------c
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--------D 485 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--------~ 485 (766)
..+|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357899999999999999999864 7899999988644 355678899999999996 9999999999943 3
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeCCCCCeeEec
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~vkL~D 563 (766)
..+++||||+. |+|.+++..... ...+++..++.|+.||+.||.|||+ ++ |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 45899999995 699998865321 2368999999999999999999999 77 99999999999999999999999
Q ss_pred ccccccccCCCCCc----------eecccccccCCCCchhh---ccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch
Q 004247 564 FGLAKWASTSSSHI----------TCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 630 (766)
Q Consensus 564 FGla~~~~~~~~~~----------~~~~~~GT~~Y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 630 (766)
||+++......... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 11134699999999998 56678999999999999999999999997543211
Q ss_pred hhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 631 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 631 ~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
... +.... ..... ... .+..++..||+.||.+||++.+++++|+..
T Consensus 261 --~~~--------~~~~~----~~~~~-~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 --IVN--------GKYSI----PPHDT-QYT---VFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---------------CCC----CTTCC-SSG---GGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhc--------CcccC----Ccccc-cch---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 00000 00001 111 234556789999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.90 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=202.3
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 487 (766)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999864 6888999999753 34557899999999999999999999999754 36
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.++||||+. |+|.+++... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 5999998653 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-eecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 568 KWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 568 ~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
+......... ......||+.|+|||++..+ .++.++|||||||++|+|++|+.||...........+...........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8765432221 12335899999999987644 589999999999999999999999987665443322211100000000
Q ss_pred cccccC--------cc-cCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLD--------PA-LGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld--------~~-l~~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..+.+ .. ...... ......+..++..||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 000000 0112345567778999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=339.78 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=196.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC--CCC--EEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~--~g~--~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|.+. +++ .||||+++.. ....+.+.+|+.++..++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999853 333 6899998753 345678999999999999999999999997754 8
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 569 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 569 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
.......... .....||+.|+|||++....++.++||||||+++|+|++ |+.||...........+. ..+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH------ccCCC
Confidence 7755433221 223567889999999998899999999999999999999 999997654322211111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
..... .....+..++..||+.||.+||++.+++++|+...
T Consensus 244 -----~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 -----LPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00011 11234556667899999999999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=376.44 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=196.0
Q ss_pred ceeeeccCceEEEEEEe---CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 423 ENLIGKGGSSQVYKGCL---PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~---~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.+.||+|+||.||+|.+ ..++.||||+++... ...+++.+|+.+|.+++|||||+++++|. .+.+++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 35899999999999965 356789999998532 44678999999999999999999999996 456899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++........
T Consensus 453 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999997543 58999999999999999999999 89999999999999999999999999999877554322
Q ss_pred c-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCccc
Q 004247 577 I-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654 (766)
Q Consensus 577 ~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l 654 (766)
. ......||+.|+|||++....++.++|||||||+||||++ |+.||...........+. .+.... .
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~~-----~ 593 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMG-----C 593 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC-----C
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC-----C
Confidence 1 2223457889999999999999999999999999999998 999998765433222221 111000 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+......+..++..||+.||.+||++.+|++.|+.
T Consensus 594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11112345566778999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.44 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=194.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-----------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----------- 484 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.......+.+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 567999999999999999999864 78999999998777777889999999999999999999999865
Q ss_pred --cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 485 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 485 --~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 356899999999999999997543 357889999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCC------------CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 563 DFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 563 DFGla~~~~~~~~------------~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
|||++........ ........||+.|+|||++... .++.++|||||||++|+|++ ||.... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence 9999986643210 1112235799999999999854 78999999999999999998 554211 1
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
......... .. ...+...+.......+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLR----SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHH----ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcc----cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111110 00 0011111222223345566778999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=354.26 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=167.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 487 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999864 6889999999753 34567899999999999999999999999776 57
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 5999999754 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--------------------ceecccccccCCCCchhh-ccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 004247 568 KWASTSSSH--------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPIS 623 (766)
Q Consensus 568 ~~~~~~~~~--------------------~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 623 (766)
+........ ...+..+||+.|+|||++ ....|+.++|||||||+||||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543221 112457899999999986 45579999999999999999998655543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=379.30 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=203.7
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 489 (766)
..++|.+.++||+|+||.||+|... +++.||||+++.. ....+.+..|..+|..+ +||||++++++|.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999875 6889999999753 23456788899999988 7999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
|||||+++|+|.++++... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999998653 58999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... .....+||+.|+|||++....|+.++|||||||+||||++|+.||...+.......+.....
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 433222 23347899999999999999999999999999999999999999987654332222211100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~-----~eVL~~ 690 (766)
.+...+ ...+..++..||+.||.+||++ .+|+++
T Consensus 560 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 ---AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---CCCTTS----CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---CCCccC----CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 011111 2334556678999999999997 677653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=358.09 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=194.2
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc------eEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------LLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~------~~lV 491 (766)
.+|.+.++||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||++++++|...+. +++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 468999999999999999999877777999988654322 2369999999999999999999976543 8899
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-CCCCeeEecccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWA 570 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~ 570 (766)
|||++++ |...+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999874 444433221222468999999999999999999999 8999999999999998 7899999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc-----------
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----------- 638 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~----------- 638 (766)
...... ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.....+...+....
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 544332 235789999999998754 59999999999999999999999998765433222211100
Q ss_pred -cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 -PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 -~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+......+.......+...+.......+..++..||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000001111000000000111112345667778999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.92 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=195.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 486 (766)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 467999999999999999999874 68899999987532 2234588999999999999999999998665
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC---eeEec
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 563 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~D 563 (766)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 489999999999999998654 358999999999999999999999 89999999999999987654 99999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchh-hHHHhhcc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKP 639 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~ 639 (766)
||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ..+.
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---- 233 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---- 233 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----
Confidence 99998764321 122357999999999974 467899999999999999999999999765432211 1111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+... ..+...... ...+..++..||+.||.+||++.+++++
T Consensus 234 ---~~~~~--~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 ---SGKYN--FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ---HTCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---hCccc--cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 01100 001111111 2345566778999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.46 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=199.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 467999999999999999999875 58999999997643 3467889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++++|.+++.... ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999997432 368999999999999999999999 8999999999999999999999999999987654322
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.. +....+..
T Consensus 181 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~---- 247 (314)
T 3com_A 181 K--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-------NPPPTFRK---- 247 (314)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCCCCCSS----
T ss_pred c--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------CCCcccCC----
Confidence 2 2235799999999999988999999999999999999999999976543221111110 00000000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.||.+||++.+++++
T Consensus 248 ---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 ---PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112345566678999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.04 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=196.3
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+|....+||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++||||++++++|...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345566999999999999986 478899999987643 456789999999999999999999999999999999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecccccccccCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~~~~ 575 (766)
+++|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997653 22456788999999999999999999 89999999999999987 89999999999987654322
Q ss_pred CceecccccccCCCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
. .....||+.|+|||++..+. ++.++||||||+++|+|++|+.||......... . +..... ...+.
T Consensus 179 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~--~~~~~~-------~~~~~ 246 (295)
T 2clq_A 179 C--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M--FKVGMF-------KVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H--HHHHHH-------CCCCC
T ss_pred c--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H--Hhhccc-------ccccc
Confidence 1 22357999999999997654 889999999999999999999999653322111 1 110000 00111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.... ...+..++..||+.||.+||++.+++++
T Consensus 247 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 IPESM----SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 2344556678999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.36 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=199.7
Q ss_pred HhcCcccceeeeccCceEEEEEEe--CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhc---CCCceeEEeeEEe----
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCF---- 483 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~---- 483 (766)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 468899999986422 2223566788777766 8999999999997
Q ss_pred -ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEe
Q 004247 484 -EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 562 (766)
Q Consensus 484 -~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 562 (766)
.....++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 599999976543 358999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccc
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 642 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~ 642 (766)
|||++....... ......||+.|+|||++....++.++|||||||++|+|++|+.||...........+........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999998654322 22336799999999999999999999999999999999999999987654332221111100000
Q ss_pred cCccccc-------cC----cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 643 SGKVTQL-------LD----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 643 ~g~~~~l-------ld----~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...+... +. ..+ ..+.......+..++..||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00 000 00011112344556678999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.47 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=203.2
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CC-CEEEEEEccCChhHHHHHHHHHHHHHhcCCCc------eeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DG-KELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g-~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~~~~~~ 488 (766)
.++|.+.+.||+|+||.||+|... ++ +.||||+++......+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 467999999999999999999864 44 68999999887777788999999999998766 99999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---------------
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--------------- 553 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL--------------- 553 (766)
++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6677777765432 358999999999999999999999 899999999999999
Q ss_pred ----CCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccc
Q 004247 554 ----SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629 (766)
Q Consensus 554 ----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 629 (766)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998654432 23579999999999999999999999999999999999999998755432
Q ss_pred hhhHHHhhccccccC------ccccccC--------------------cccC-CCCChHHHHHHHHHHHhhcccCCCCCC
Q 004247 630 QESLVMWAKPILSSG------KVTQLLD--------------------PALG-NNYDYDQMERMVLASILCIRRDPRARP 682 (766)
Q Consensus 630 ~~~lv~~~~~~~~~g------~~~~lld--------------------~~l~-~~~~~~~~~~~~~~~~~Cl~~dP~~RP 682 (766)
....+......+... ....... +... ..........+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 222111110000000 0000000 0000 011122334566778889999999999
Q ss_pred CHHHHHHH
Q 004247 683 QMSLVLKL 690 (766)
Q Consensus 683 s~~eVL~~ 690 (766)
|+.+++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=359.50 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=204.1
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|++++..++| ++|..+..++...+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46899999999999999999986 5799999998865332 2457889999999987 5566666677778889999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee---CCCCCeeEeccccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 571 (766)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+|||| +.++.+||+|||+++...
T Consensus 85 ~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 999999997543 368999999999999999999999 899999999999999 588999999999998776
Q ss_pred CCCCCc-----eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 572 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 572 ~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence 543321 122468999999999999999999999999999999999999999876554333322211110 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+. .+...++ ..+..++..||+.+|.+||++.+|+++|+.
T Consensus 234 ~~~~~-~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 234 ATSIE-ALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HSCHH-HHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccHH-HHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111 0111111 345566778999999999999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.34 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=197.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999975 58999999987543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+++++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999987543 358999999999999999999999 899999999999999999999999999976432211
Q ss_pred CCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
. ......||+.|+|||++. ...++.++||||||+++|+|++|+.||.......... ..... .....
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-----~~~~~ 242 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKS-----DPPTL 242 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHS-----CCCCC
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHhcc-----CCccc
Confidence 1 112357999999999984 5678999999999999999999999997654322111 11110 00011
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+ ......+..++..||+.||.+|||+.+++++
T Consensus 243 ~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 LTP-------SKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SSG-------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CCc-------cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 100 1112345556678999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.57 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=203.1
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChh------------------HHHHHHHHHHHHHhcCCCceeEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED------------------VIKEFVLEIEIITTLHHKNIISL 478 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~------------------~~~~~~~Ei~iL~~l~HpnIv~l 478 (766)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... ..+.+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 999999999874321 12789999999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCCHhHh------hhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCee
Q 004247 479 LGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 552 (766)
Q Consensus 479 ~~~~~~~~~~~lV~E~~~ggsL~~~------L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NIL 552 (766)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.||+.||.|||+ .++|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999998 54321 3578999999999999999999996 267999999999999
Q ss_pred eCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccC-CCCC-chhhHHHHHHHHHHHhCCCCCCCCCccch
Q 004247 553 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQ 630 (766)
Q Consensus 553 L~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 630 (766)
++.++.+||+|||++...... ......||+.|+|||++... .++. ++||||||+++|+|++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876543 23346799999999999877 6666 99999999999999999999986554211
Q ss_pred -hhHHHhhccccccCccccccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 631 -ESLVMWAKPILSSGKVTQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 631 -~~lv~~~~~~~~~g~~~~lld~~l~~---~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...+......+.. .......+.... .........+..++..||+.||.+||++.+++++
T Consensus 261 ~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPL-DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCC-SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCcc-chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111100000000 000001110000 0001112345566678999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.96 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=183.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------C
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 486 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+++.++||||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999985 47899999999653 34567889999999999999999999998654 5
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 7899998864 258999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc----
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 641 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---- 641 (766)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+.......
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 223579999999999986 679999999999999999999999998765443332221111000
Q ss_pred ----ccCccccccCcccC-CCCChH-----HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 ----SSGKVTQLLDPALG-NNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ----~~g~~~~lld~~l~-~~~~~~-----~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......++..... ...... ....+..++..||+.||.+|||+.++|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000000000 000111 11335566678999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.47 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~ 488 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 568999999999999999999875 6899999999753 34567788999999999999999999998754 678
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
++||||+. |+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 5999998753 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc--------eecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 569 WASTSSSHI--------TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 569 ~~~~~~~~~--------~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 765432111 1223578999999998765 6789999999999999999999999987654322221111000
Q ss_pred ccc-cCc--------cccccCcccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 ILS-SGK--------VTQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 ~~~-~g~--------~~~lld~~l~-~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... ... ..+.+..... .... ......+..++..||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000 0000000000 0000 0112344566778999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=343.57 Aligned_cols=263 Identities=18% Similarity=0.303 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-----------CCceeEEeeEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~~~~ 484 (766)
.++|.+.+.||+|+||.||+|.. .+++.||||++.........+.+|+.++.+++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35799999999999999999986 47899999999987777788899999999887 8999999999986
Q ss_pred cC----ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeC-----
Q 004247 485 DN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLS----- 554 (766)
Q Consensus 485 ~~----~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~----- 554 (766)
.+ .+++||||+ +++|.+++..... ..+++..+..|+.||+.||.|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8899999976543 358999999999999999999999 7 899999999999994
Q ss_pred -CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch---
Q 004247 555 -DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--- 630 (766)
Q Consensus 555 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~--- 630 (766)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44589999999998765432 235799999999999999999999999999999999999999986542211
Q ss_pred -hhH---HHhhcc--------------cccc-CccccccC-------ccc--CCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004247 631 -ESL---VMWAKP--------------ILSS-GKVTQLLD-------PAL--GNNYDYDQMERMVLASILCIRRDPRARP 682 (766)
Q Consensus 631 -~~l---v~~~~~--------------~~~~-g~~~~lld-------~~l--~~~~~~~~~~~~~~~~~~Cl~~dP~~RP 682 (766)
..+ ...... .+.. +.+..+.. ..+ ...+.......+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111 000000 0000 00000000 000 0123345566777888899999999999
Q ss_pred CHHHHHHH
Q 004247 683 QMSLVLKL 690 (766)
Q Consensus 683 s~~eVL~~ 690 (766)
|+.+++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=337.33 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=193.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEe-----------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCF----------- 483 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----------- 483 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999975 5899999998754 356678999999999999999999999873
Q ss_pred ---ecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-CCCCe
Q 004247 484 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 559 (766)
Q Consensus 484 ---~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~v 559 (766)
+.+..++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999864 258899999999999999999999 8999999999999997 56799
Q ss_pred eEecccccccccCCCCC-ceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004247 560 QLSDFGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 637 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 637 (766)
||+|||+++........ .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876532211 11223568999999998875 67899999999999999999999999876543322222211
Q ss_pred ccccccCccccccC-------cccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 638 KPILSSGKVTQLLD-------PALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 638 ~~~~~~g~~~~lld-------~~l~-~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+........++.. .... .... ......+..++..||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11111100000000 0000 0000 0112345567778999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.30 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred HhcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
..++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999875 7899999998643 23567889999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC---CCeeEecccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAK 568 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~ 568 (766)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999887543 58999999999999999999999 899999999999999754 469999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
........ ....||+.|+|||++. +.++.++||||||+++|+|++|+.||...........+. .+....
T Consensus 173 ~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTKM---KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-------TGKYAF 241 (287)
T ss_dssp TBCCCSSC---SCHHHHHTTCCHHHHT-TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCCC
T ss_pred eecCCCcc---ccccCcccccChHHhc-CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCCC
Confidence 76543222 2346899999999987 459999999999999999999999997654322111111 111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. +.. ..+ ...+..++..||+.||.+|||+.+++++
T Consensus 242 ~~-~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DL-PQW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CS-GGG-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc-hhh-hhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 000 111 1234556678999999999999999973
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=347.57 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=195.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL---- 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~---- 488 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999864 6899999999753 34567889999999999999999999999877654
Q ss_pred --EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 489 --LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 489 --~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588888732 38999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
++..... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+...........
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9865432 223578999999999986 6799999999999999999999999987553322211110000000000
Q ss_pred c--------ccccCcccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 V--------TQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~--------~~lld~~l~-~~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ...+..... .... ......+..++..||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000 0000 0112345567778999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=341.05 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=171.9
Q ss_pred hcCcccc-eeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEE
Q 004247 417 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 490 (766)
Q Consensus 417 t~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~l 490 (766)
.++|.+. ++||+|+||.||+|... +|+.||||++........++ ...+..+.||||+++++++.. ...+++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 5678884 57999999999999875 78999999998654433332 234667799999999999976 455899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 567 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla 567 (766)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999986532 468999999999999999999999 89999999999999976 455999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
+....... ....||+.|+|||++....++.++|||||||++|+|++|+.||............ ...+..+..
T Consensus 179 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~- 250 (336)
T 3fhr_A 179 KETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQY- 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcccc-
Confidence 86654322 2357899999999998889999999999999999999999999765432211000 000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+..+ ........+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 GFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 001112334556678999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.51 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=195.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 487 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999874 6899999999753 3456788999999999999999999999987654
Q ss_pred -eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 488 -LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 488 -~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
+++||||+. ++|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 588887742 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc----
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 641 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---- 641 (766)
++..... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 123578999999999886 678999999999999999999999998765432221111000000
Q ss_pred ----ccC-------ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 ----SSG-------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ----~~g-------~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... .+.....+.+. .........+..++..||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000000000 0111122345566678999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=348.58 Aligned_cols=203 Identities=26% Similarity=0.423 Sum_probs=156.1
Q ss_pred Cccc-ceeeeccCceEEEEEEeC---CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEE
Q 004247 419 NFLA-ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 492 (766)
Q Consensus 419 ~f~~-~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~ 492 (766)
.|.+ .++||+|+||.||+|... +++.||||++.... ....+.+|+.+|+.++||||++++++|.. ...+++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 4665 458999999999999864 57899999997543 23468899999999999999999999964 67899999
Q ss_pred eecCCCCHhHhhhcCC-----CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeee----CCCCCeeEec
Q 004247 493 DFLSRGSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSD 563 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~D 563 (766)
||+.+ +|.+++.... .....+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99965 8888775321 122358999999999999999999999 899999999999999 6778999999
Q ss_pred ccccccccCCCCC-ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 004247 564 FGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 626 (766)
Q Consensus 564 FGla~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 626 (766)
||+++........ .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999876543221 222346899999999999864 58999999999999999999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.18 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=187.9
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+.+++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 45667899999999998776678999999998753 345678999999987 89999999999999999999999995
Q ss_pred CCHhHhhhcCCCCCCC---CChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC-------------CCeeE
Q 004247 498 GSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-------------FEPQL 561 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~---l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-------------~~vkL 561 (766)
|+|.+++......... ..+..++.|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999865432221 1344567899999999999999 899999999999999654 48999
Q ss_pred ecccccccccCCCCCc--eecccccccCCCCchhhcc-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchh
Q 004247 562 SDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQE 631 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~ 631 (766)
+|||+++......... ......||++|+|||++.. ..++.++|||||||++|||++ |+.||....... .
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~ 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-S 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-H
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-H
Confidence 9999998776543221 1234679999999999975 578999999999999999999 999997543322 1
Q ss_pred hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 632 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 632 ~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. ....... +...........+..++..||+.||.+|||+.+|+++
T Consensus 249 ~i~~---~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 249 NIIR---GIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHH---TCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhc---CCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111 1111000 1111123344566777888999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.68 Aligned_cols=257 Identities=21% Similarity=0.353 Sum_probs=197.1
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..++|.+.+.||+|+||.||+|.... .+|+|+++.. ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35679999999999999999998744 4999998753 233456788999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999997543 368999999999999999999999 8999999999999998 67999999999876532
Q ss_pred CCC---CceecccccccCCCCchhhcc---------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 573 SSS---HITCTDVAGTFGYLAPEYFMY---------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 573 ~~~---~~~~~~~~GT~~Y~APE~l~~---------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...........+.
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----- 256 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG----- 256 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH-----
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc-----
Confidence 211 111223569999999999874 357889999999999999999999997654322111111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
.+........ ..+ ..+..++..||..||.+|||+.++++.|+....
T Consensus 257 --~~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 257 --TGMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp --TTCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred --cCCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111100 111 124456678999999999999999999986553
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=338.20 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=177.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC--hhHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367899999999999999999974 7899999999754 344456666766 777889999999999999999999999
Q ss_pred eecCCCCHhHhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 493 DFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||+++ +|.+++.... .....+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 8887775311 112468999999999999999999999 7 8999999999999999999999999999866
Q ss_pred cCCCCCceecccccccCCCCchhh----ccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
...... ....||+.|+|||++ ....++.++|||||||++|+|++|+.||........ . .... ..+..
T Consensus 177 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~-~~~~~ 247 (327)
T 3aln_A 177 VDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-Q----LTQV-VKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCC-CCSCC
T ss_pred cccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-H----HHHH-hcCCC
Confidence 543222 224799999999998 456789999999999999999999999975432110 0 1111 11111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. +...........+..++..||+.||.+||++.+++++
T Consensus 248 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11 1111111112345566678999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=365.44 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=201.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC----CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 467999999999999999999864 2457999998753 355678999999999999999999999985 467899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
...... ......||+.|+|||++....++.++|||||||++|||++ |..||.+.........+.. +..
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-------~~~--- 610 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GER--- 610 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-------TCC---
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-------CCC---
Confidence 543322 2223467889999999999999999999999999999997 9999986544322211111 100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
..+.... ...+..++..||+.||.+||++.++++.|+..
T Consensus 611 --~~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 --LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011111 23455667789999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.84 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=189.7
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-------hHHHHHHHHHHHHHhc----CCCceeEEeeEEe
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTL----HHKNIISLLGFCF 483 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l----~HpnIv~l~~~~~ 483 (766)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 456899999999999999999986 478899999997543 1234566799999999 8999999999999
Q ss_pred ecCceEEEEee-cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-CCCCeeE
Q 004247 484 EDNNLLLVYDF-LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 561 (766)
Q Consensus 484 ~~~~~~lV~E~-~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL 561 (766)
..+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 78999999997643 58999999999999999999999 8999999999999998 8899999
Q ss_pred ecccccccccCCCCCceecccccccCCCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004247 562 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640 (766)
Q Consensus 562 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 640 (766)
+|||++....... .....||+.|+|||++....+. .++||||||+++|+|++|+.||.... .... ...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~-~~~- 250 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE-AEL- 250 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-TCC-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh-hcc-
Confidence 9999998765432 2235799999999999877765 48999999999999999999996421 1111 000
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 641 ~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.... ...+..++..||+.||.+||++.+++++
T Consensus 251 ------------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ------------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 1234556678999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=327.07 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=177.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hH-HHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .. .+.+..+..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999875 78999999997542 22 334444556788889999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCC-ceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
||+ ++.+..++.... ..+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 556665554322 358999999999999999999998 5 89999999999999999999999999997665
Q ss_pred CCCCCceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
..... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||........ .+..... +..
T Consensus 177 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~-----~~~ 247 (318)
T 2dyl_A 177 DDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVLQ-----EEP 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHH-----SCC
T ss_pred CCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHhc-----cCC
Confidence 43222 2357999999999994 55789999999999999999999999976432211 1111000 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+.... .....+..++..||+.||.+||++.+++++
T Consensus 248 -----~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 -----PLLPGHM--GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -----CCCCSSS--CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----CCCCccC--CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111000 011234556678999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=338.40 Aligned_cols=242 Identities=22% Similarity=0.372 Sum_probs=197.5
Q ss_pred HHhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcC--CCceeEEeeEEee
Q 004247 415 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFE 484 (766)
Q Consensus 415 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~ 484 (766)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999986 478899999987532 12345778999999996 5999999999999
Q ss_pred cCceEEEEeecCC-CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC-CCCCeeEe
Q 004247 485 DNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLS 562 (766)
Q Consensus 485 ~~~~~lV~E~~~g-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL~ 562 (766)
.+..++||||+.+ ++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999986 89999997643 58999999999999999999999 8999999999999998 78899999
Q ss_pred cccccccccCCCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 563 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 563 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|||+++...... .....||+.|+|||++....+ +.++||||||+++|||++|+.||.... .... . ..
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~-~-~~- 260 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR-G-QV- 260 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-C-CC-
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc-c-cc-
Confidence 999998765432 223579999999999987766 678999999999999999999996431 1110 0 00
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. +....+ ..+..++..||+.||.+||++.+++++
T Consensus 261 -------~----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 -------F----FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------C----CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------c----ccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011111 234556678999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=343.60 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=186.6
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
..+|.+.++||+|+||+||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 346889999999999997655556899999999975431 2356899999999 7999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-----CCCeeEecccccccc
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWA 570 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-----~~~vkL~DFGla~~~ 570 (766)
. |+|.+++..... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999976542 34555677899999999999999 89999999999999953 335789999999876
Q ss_pred cCCCCC-ceecccccccCCCCchhhc---cCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCc
Q 004247 571 STSSSH-ITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 571 ~~~~~~-~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
...... .......||++|+|||++. ...++.++|||||||++|||++ |..||........ ... .....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~------~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL------LGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH------TTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH------hccCC
Confidence 543211 2223467999999999997 4567889999999999999999 9999965432211 111 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. .... ........+..++..||+.||.+|||+.+|+++
T Consensus 247 ~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 0000 111223335567778999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=356.01 Aligned_cols=236 Identities=21% Similarity=0.291 Sum_probs=189.8
Q ss_pred hcCcccceeeeccCceEEEEEEeC--CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 487 (766)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.++.+++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999875 6899999998653 3556788999999999999999999999988766
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||+ ++||||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987743 48999999999999999999999 899999999999999886 8999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
+..... ....||++|+|||++..+ ++.++|||||||+||+|++|..||....... ..
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~------ 285 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP------ 285 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC------
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------cc------
Confidence 876543 235799999999999865 4899999999999999999998886421110 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHhh
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLR 692 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-~~eVL~~L~ 692 (766)
...........+..++..||+.||.+||+ +.++...|.
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00000111234556777899999999996 555555454
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=354.02 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=198.3
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee------cCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~~ 488 (766)
++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|++++..++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999986 46899999998753 4556789999999999999999999998765 6778
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC---eeEeccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFG 565 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFG 565 (766)
++||||+++|+|.+++..... ...+++..++.|+.+++.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999986532 2358899999999999999999999 89999999999999987665 8999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
++......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..|.......+.
T Consensus 170 ~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred ccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 99876554322 3367999999999999999999999999999999999999999754221 122211111110
Q ss_pred cccccC----------c--ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 004247 646 VTQLLD----------P--ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688 (766)
Q Consensus 646 ~~~lld----------~--~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL 688 (766)
...... . .............+..++..||..||.+|||+.+++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000 0 011122334456677777889999999999997643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=334.17 Aligned_cols=242 Identities=14% Similarity=0.186 Sum_probs=179.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCC-Cce---------------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH-KNI--------------- 475 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~H-pnI--------------- 475 (766)
+.+|...++||+|+||.||+|.+ .+|+.||||+++.. ....+.+.+|+.++..++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44678889999999999999995 57999999999842 2335778999999999987 221
Q ss_pred eE------EeeEEee-----cCceEEEEeecCCCCHhHhhhcC---CCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCce
Q 004247 476 IS------LLGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541 (766)
Q Consensus 476 v~------l~~~~~~-----~~~~~lV~E~~~ggsL~~~L~~~---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 541 (766)
+. ++.++.. ....+++|+++ +++|.+++... ......+++..++.|+.||+.||.|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 11 1111111 22457777766 67999988421 1222468889999999999999999999 899
Q ss_pred EeecccCCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhh----------ccCCCCCchhhHHHHHH
Q 004247 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF----------MYGKVNDKIDVYAFGVV 611 (766)
Q Consensus 542 iHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~s~ksDVwSlGvv 611 (766)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865442 234578 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 612 LLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 612 L~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
||||++|+.||.......... .++... ..++ ..+..++..||+.||.+||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999997654322111 011100 0112 34556667899999999999998876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.01 Aligned_cols=228 Identities=16% Similarity=0.186 Sum_probs=179.8
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++..++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999975 5899999999754 345678999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++|++|.+++... ....++..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999532 2455788899999999999999 899999999999999999999998543
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
|++| ++.++|||||||+||||++|+.||........... ..... .+..... .
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~-~~~~~~~--~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDT-AGQPIEP--A 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCT-TSCBCCH--H
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHh-ccCCCCh--h
Confidence 3333 68899999999999999999999987654321100 00000 0000000 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.+....+ ..+..++..||+.||.+| |+.++++.|+..
T Consensus 227 ~~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 227 DIDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hcccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0111111 235556678999999999 999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=310.72 Aligned_cols=231 Identities=23% Similarity=0.365 Sum_probs=176.0
Q ss_pred cCcccc-eeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHH-HhcCCCceeEEeeEEee----cCceEE
Q 004247 418 SNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLLL 490 (766)
Q Consensus 418 ~~f~~~-~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~~~~~l 490 (766)
++|.+. ++||+|+||.||+|.. .+++.||||+++.. ..+.+|+.++ +.++||||++++++|.. ...+++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 467766 7899999999999987 47899999999754 3566788887 56689999999999987 677999
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEeccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 567 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla 567 (766)
||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999986532 368999999999999999999999 89999999999999998 788999999998
Q ss_pred ccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
.... ...++.++|||||||++|||++|+.||........... ....+..+..
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~- 219 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY- 219 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCC-
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccc-
Confidence 6432 14567899999999999999999999976433211000 0000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+..+ .... ....+..++..||+.||.+|||+.+++++
T Consensus 220 ~~~~~-~~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNP-EWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHH-HHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCch-hccc----CCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 0001 12345556678999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.32 Aligned_cols=190 Identities=21% Similarity=0.234 Sum_probs=160.4
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcC---------CCceeEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLH---------HKNIISL 478 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~---------HpnIv~l 478 (766)
.++|.+.+.||+|+||.||+|.. +|+.||||+++... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688999999999999999988 78999999997532 23478899999999886 6666666
Q ss_pred eeEE-----------------ee-------------cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHH
Q 004247 479 LGFC-----------------FE-------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528 (766)
Q Consensus 479 ~~~~-----------------~~-------------~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~ 528 (766)
.+.+ .+ .+.++|||||+++|++.+.+.. ..+++..+..|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 6553 32 6789999999999987777743 25799999999999999
Q ss_pred HHHHHH-cCCCCceEeecccCCCeeeCCCC--------------------CeeEecccccccccCCCCCceecccccccC
Q 004247 529 ALEYLH-SGSAQRVIHRDVKSSNILLSDDF--------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFG 587 (766)
Q Consensus 529 aL~yLH-~~~~~~IiHrDLKp~NILL~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 587 (766)
||.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 8 8999999999999999887 8999999999876542 2479999
Q ss_pred CCCchhhccCCCCCchhhHHHHHH-HHHHHhCCCCCC
Q 004247 588 YLAPEYFMYGKVNDKIDVYAFGVV-LLELLTGRKPIS 623 (766)
Q Consensus 588 Y~APE~l~~~~~s~ksDVwSlGvv-L~eLltG~~Pf~ 623 (766)
|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999998555 899999998777 788888999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-30 Score=298.15 Aligned_cols=185 Identities=17% Similarity=0.100 Sum_probs=131.1
Q ss_pred eeeccCceEEEEEEe-CCCCEEEEEEccCC-----------hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004247 425 LIGKGGSSQVYKGCL-PDGKELAVKILKPS-----------EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 425 ~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~-----------~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++.|++|.+..+.. -.|+.||||++... +...++|.+|+++|+++ .|+||+++++++.+++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356677766655432 35888999999642 23456799999999999 699999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||++|++|.++|.... +++.. +|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999997653 35443 589999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 622 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf 622 (766)
..... ....+||++|+|||++. +.+..++|+||+|+++++|.+|..|+
T Consensus 391 ~~~~~--~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSW--PTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCcc--ccCceechhhccHHHhC-CCCCCcccccccccchhhhccccchh
Confidence 54332 23478999999999987 56788999999999988887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-27 Score=270.95 Aligned_cols=185 Identities=17% Similarity=0.217 Sum_probs=148.1
Q ss_pred ccceeeeccCceEEEEEEeCCCCEEEEEEccCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 421 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
...++||+|+||.||+|.. .++.+++|+..... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 67889999864321 1245689999999999999999777777788888999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++++|.+++.. +..|+.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999964 45799999999999999 89999999999999998 99999999999775
Q ss_pred CCCCCc-----eecccccccCCCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCC
Q 004247 572 TSSSHI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPIS 623 (766)
Q Consensus 572 ~~~~~~-----~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~ 623 (766)
...... ....+.||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 1124689999999999986 568889999999999999998887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=221.10 Aligned_cols=152 Identities=16% Similarity=0.126 Sum_probs=125.1
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-------------------hHHHHHHHHHHHHHhc
Q 004247 410 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTL 470 (766)
Q Consensus 410 ~~el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~iL~~l 470 (766)
+..+......|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+.+++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 444555566778889999999999999999779999999997432 1356789999999999
Q ss_pred CCCceeEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCC
Q 004247 471 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 550 (766)
Q Consensus 471 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 550 (766)
+ | +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||.|||+ ++|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 9 5 677776544 56799999999999998 521 1234699999999999999 899999999999
Q ss_pred eeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhc
Q 004247 551 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595 (766)
Q Consensus 551 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 595 (766)
||++ ++.+||+|||+++ .+..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 9999 9999999999985 344588999886
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=186.50 Aligned_cols=136 Identities=20% Similarity=0.199 Sum_probs=107.7
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCE--EEEEEccCChh-------------------------HHHHHHHHHHHHHhc
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKE--LAVKILKPSED-------------------------VIKEFVLEIEIITTL 470 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~--vAVK~l~~~~~-------------------------~~~~~~~Ei~iL~~l 470 (766)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++.... ....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 68989 99999764321 123678899999999
Q ss_pred CCCce--eEEeeEEeecCceEEEEeecCC-C----CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH-cCCCCceE
Q 004247 471 HHKNI--ISLLGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVI 542 (766)
Q Consensus 471 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~Ii 542 (766)
+|+++ ..++++ +..+|||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 88764 333332 356999999942 4 66665432 234567889999999999999 8 8999
Q ss_pred eecccCCCeeeCCCCCeeEecccccccc
Q 004247 543 HRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 543 HrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=148.32 Aligned_cols=133 Identities=15% Similarity=0.175 Sum_probs=108.0
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcc----hhhhHHHHHHHHHHHhHhhhcCC-
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSL----LSLVKAFDSVLAVYEGFCNLKQV- 90 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~C~~k~V- 90 (766)
-++|+|++|.|+.|..||+||+..+.+.|..|++|||.+............. ....+...+.|+.+...+...++
T Consensus 5 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 84 (146)
T 3s3t_A 5 YTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSAP 84 (146)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSCC
T ss_pred cceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCCc
Confidence 4799999999999999999999999888999999999876532211100000 11122333778888888888899
Q ss_pred cEEEEEEECCChhHHHHH-HHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 91 DLKLKICRGTSIRKILVR-EAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 91 ~~~~~v~~~~d~~~~lv~-~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
.++..+.. |++.+.|++ +|+..++|+||||++++ .+.++| |++.+++++++ |||++|+
T Consensus 85 ~~~~~~~~-g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 85 NLKTEISY-GIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVG--STTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCEEEEEE-ECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSC--HHHHHHHHHCS--SEEEEEC
T ss_pred ceEEEEec-CChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEc--chHHHHhccCC--CCEEEeC
Confidence 99999888 799999999 99999999999999987 556778 99999999998 9999985
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=7.5e-16 Score=148.61 Aligned_cols=135 Identities=16% Similarity=0.121 Sum_probs=107.1
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCC-----ccccCC-CC----Cc--------chhhhHHHHHH
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN-----AIVDRD-GK----SS--------LLSLVKAFDSV 77 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~-----~~~~~~-~~----~~--------~~~~~~~~~~~ 77 (766)
-++|+|++|+|+.|..||+||+..+.+.|..|++|||.++. ...... .. .. .....+...+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 84 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHH
Confidence 47999999999999999999999988889999999998753 100000 00 11 00111223377
Q ss_pred HHHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 78 l~~~~~~C~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
|+.+...+...+++++..+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 85 l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~G--Sv~~~vl~~~~--~pVlvv~~ 159 (162)
T 1mjh_A 85 MENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLG--SVTENVIKKSN--KPVLVVKR 159 (162)
T ss_dssp HHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSC--HHHHHHHHHCC--SCEEEECC
T ss_pred HHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEec--chHHHHHHhCC--CCEEEEeC
Confidence 888888888889999998887 79999999999999999999999987 566788 99999999997 99999975
Q ss_pred C
Q 004247 155 G 155 (766)
Q Consensus 155 g 155 (766)
+
T Consensus 160 ~ 160 (162)
T 1mjh_A 160 K 160 (162)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=174.96 Aligned_cols=136 Identities=15% Similarity=0.151 Sum_probs=100.9
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh---------------h--------HHHHHHHHHHHHHhcCCCce
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------------D--------VIKEFVLEIEIITTLHHKNI 475 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------------~--------~~~~~~~Ei~iL~~l~HpnI 475 (766)
-|.+.+.||.|+||.||+|...+|+.||||+++... . ......+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 488999999999999999999999999999976320 0 00112356777777755443
Q ss_pred eEEeeEEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC
Q 004247 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 555 (766)
Q Consensus 476 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 555 (766)
.-..-+.. ...+|||||++|++|.++... .....++.||+.+|.|||+ .|||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 22221211 233899999999888765421 1235688999999999999 89999999999999987
Q ss_pred CC----------CeeEeccccccc
Q 004247 556 DF----------EPQLSDFGLAKW 569 (766)
Q Consensus 556 ~~----------~vkL~DFGla~~ 569 (766)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997753
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=5.9e-16 Score=146.43 Aligned_cols=131 Identities=15% Similarity=0.117 Sum_probs=106.8
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCc-cccCC--CCC-----cchhhhHHHHHHHHHHHhHhhhc
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA-IVDRD--GKS-----SLLSLVKAFDSVLAVYEGFCNLK 88 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~-~~~~~--~~~-----~~~~~~~~~~~~l~~~~~~C~~k 88 (766)
++|+|++|+|+.|..||+||+..+.+.|..|++|||.+... ..... ... ......+...+.++.+...+...
T Consensus 3 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (147)
T 3hgm_A 3 NRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATEL 82 (147)
T ss_dssp SEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 68999999999999999999999888899999999987542 10000 000 01122344458888999999988
Q ss_pred CCcE---EEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004247 89 QVDL---KLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (766)
Q Consensus 89 ~V~~---~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV 152 (766)
++.+ +..+.. |++.+.|+++|+..++|++|||++++ .+.++| |++.+++++++ |||++|
T Consensus 83 g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 83 GVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLG--SVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCC--HHHHHHHHHCS--SCEEEC
T ss_pred CCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccceeec--cHHHHHHhhCC--CCEEEC
Confidence 9888 888887 79999999999999999999999987 556778 99999999998 999987
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.64 E-value=9e-16 Score=149.16 Aligned_cols=137 Identities=16% Similarity=0.091 Sum_probs=104.6
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEE--EeecCCccccCCC--CCcc-hhhhHHHHHHHHHHHhHhhh
Q 004247 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIAL--HVLANNAIVDRDG--KSSL-LSLVKAFDSVLAVYEGFCNL 87 (766)
Q Consensus 13 ~~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlv--HV~~~~~~~~~~~--~~~~-~~~~~~~~~~l~~~~~~C~~ 87 (766)
...-++|+|+||.|+.|..||+||+..+. .|..|++| ||.++........ .... ....+...+.|+.+...+..
T Consensus 14 ~~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 92 (163)
T 1tq8_A 14 LSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHN 92 (163)
T ss_dssp CCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHT
T ss_pred cccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 44568999999999999999999999998 99999999 8875432100000 0000 01112234678888888888
Q ss_pred cCCc-EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 88 KQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 88 k~V~-~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
.+++ ++..+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+..
T Consensus 93 ~gv~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lG--Sva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 93 AGAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLG--SVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp TTCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTB--BHHHHHHHHTT--CEEEEECCC
T ss_pred cCCCeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccceeec--cHHHHHHHhCC--CCEEEEeCC
Confidence 8898 8888877 79999999999999999999999987 456778 99999999998 999999753
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.62 E-value=4e-15 Score=144.81 Aligned_cols=135 Identities=14% Similarity=0.043 Sum_probs=106.8
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCC-CC---------C--c-chhhhHHHHHHHHHHH
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD-GK---------S--S-LLSLVKAFDSVLAVYE 82 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~-~~---------~--~-~~~~~~~~~~~l~~~~ 82 (766)
-++|+|++|.|+.|..||+||+..+.+.|..|++|||.++....... +. . . .....+...+.|+.+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 84 (170)
T 2dum_A 5 FRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEKA 84 (170)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHHH
T ss_pred cceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999999999899999999998754221000 00 0 1 1111233347788888
Q ss_pred hHhhhcCCcEEE--EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 83 GFCNLKQVDLKL--KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 83 ~~C~~k~V~~~~--~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
..+...+++++. .+.. |++.+.|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.+
T Consensus 85 ~~~~~~g~~~~~~~~~~~-g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~G--sv~~~vl~~~~--~PVlvv~~~ 157 (170)
T 2dum_A 85 EEVKRAFRAKNVRTIIRF-GIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLG--STVMRVLRKTK--KPVLIIKEV 157 (170)
T ss_dssp HHHHHHTTCSEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCC--HHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHcCCceeeeeEEec-CChHHHHHHHHHHcCCCEEEECCCCCCccccceec--hHHHHHHHhCC--CCEEEEccC
Confidence 888778888887 7777 79999999999999999999999987 456778 99999999998 999999853
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.62 E-value=9.8e-16 Score=143.60 Aligned_cols=129 Identities=13% Similarity=0.151 Sum_probs=104.4
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhc-cCCCCEEEEEEeecCCccccCCCCC---cchhhh-HHHHHHHHHHHhHhhhcCCc
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKV-AQPGDTVIALHVLANNAIVDRDGKS---SLLSLV-KAFDSVLAVYEGFCNLKQVD 91 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~-~~~gd~vvlvHV~~~~~~~~~~~~~---~~~~~~-~~~~~~l~~~~~~C~~k~V~ 91 (766)
++|+|++|+|+.|..||+||+..+ .+.|..|++|||.++.......... ...... +...+.|+.+...+...+++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 589999999999999999999999 8889999999999765321100000 011111 33347788888888888999
Q ss_pred EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 92 ~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
++..+.. |++.++|+++|+ ++|+||||++++ .+.+ | |++.+++++++ |||++|+
T Consensus 82 ~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~-G--s~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 82 PFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFLNKIF-A--SHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp CEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTTSSCC-C--CTTCHHHHHCS--SCEEEEC
T ss_pred eEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchHHHHh-C--cHHHHHHhcCC--CCEEEeC
Confidence 9999988 799999999999 899999999987 4556 7 99999999998 9999985
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.4e-15 Score=143.18 Aligned_cols=136 Identities=17% Similarity=0.242 Sum_probs=107.4
Q ss_pred CCCcEEEEEEc--CCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCc--chhhhHHHHHHHHHHHhHhhhcC
Q 004247 14 GAGRTVVVGVK--LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS--LLSLVKAFDSVLAVYEGFCNLKQ 89 (766)
Q Consensus 14 ~~~r~I~V~Vd--~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~C~~k~ 89 (766)
..-++|+|++| +|+.|..||+||+..+.+.|..|++|||.+............ .....+...+.|+.+...+...+
T Consensus 13 ~~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 92 (156)
T 3fg9_A 13 LVYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRG 92 (156)
T ss_dssp CCCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 34689999999 999999999999998888899999999997653211111010 01112233378888888888889
Q ss_pred C-cEEEEEEECCChhHHHHHH-HHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 90 V-DLKLKICRGTSIRKILVRE-AQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 90 V-~~~~~v~~~~d~~~~lv~~-a~~~~a~~LVlG~~~~--~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
+ .++..+..+|++.++|+++ |+..++|+||||++++ .+.++| |++.+++++++ |||++|+
T Consensus 93 ~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~G--s~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 93 VNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAG--AIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp CSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCS--CHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeec--chHHHHHHhCC--CCEEEeC
Confidence 9 5888888878999999999 9999999999999987 223677 99999999998 9999985
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.2e-15 Score=140.79 Aligned_cols=132 Identities=14% Similarity=0.172 Sum_probs=102.4
Q ss_pred cEEEEEEcCCcc--hHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCc---chhhhHHHHHHHHHHHhHhhhcC--
Q 004247 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS---LLSLVKAFDSVLAVYEGFCNLKQ-- 89 (766)
Q Consensus 17 r~I~V~Vd~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~C~~k~-- 89 (766)
++|+|++|+|+. |..||+||+..+.+.|..|++|||.+............ .....+...+.++.++.++...+
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 789999999999 99999999998888899999999997643221111100 11123334477778888888764
Q ss_pred -CcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 90 -VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 90 -V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~--~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
+.++..+.. |++.++|+++|+..++|+||||+++. .+.++| |++.+++++++ |||++|+
T Consensus 82 ~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~G--s~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 82 EDRMHFHVAE-GSPKDKILALAKSLPADLVIIASHRPDITTYLLG--SNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp GGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSC--HHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCCCCCCeeeeec--cHHHHHHHhCC--CCEEEeC
Confidence 457888888 69999999999999999999999965 556778 99999999998 9999985
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=145.41 Aligned_cols=128 Identities=17% Similarity=0.161 Sum_probs=106.9
Q ss_pred CCcEEEEEEcC-CcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004247 15 AGRTVVVGVKL-DTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (766)
Q Consensus 15 ~~r~I~V~Vd~-s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (766)
.-++|+|++|. |+.|..||+||+..+...|..|++|||.+.... ......+...+.|+.+...+...++.++
T Consensus 23 m~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~-------~~~~~~~~~~~~l~~~~~~~~~~g~~~~ 95 (155)
T 3dlo_A 23 IYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR-------TKDEDIIEAKETLSWAVSIIRKEGAEGE 95 (155)
T ss_dssp CCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT-------SCHHHHHHHHHHHHHHHHHHHHTTCCEE
T ss_pred ccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc-------ccHHHHHHHHHHHHHHHHHHHhcCCCce
Confidence 45789999999 999999999999999888999999999875421 1112234445788888888888888888
Q ss_pred EEE-EECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 94 LKI-CRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 94 ~~v-~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
..+ +..|++.++|+++|+..++|+||||++++ .+.++| |++.+++++++ |||++|+
T Consensus 96 ~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lG--Sv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 96 EHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFG--SVARDVILKAN--KPVICIK 155 (155)
T ss_dssp EEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECC--HHHHHHHHHCS--SCEEEEC
T ss_pred EEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEec--cHHHHHHHhCC--CCEEEeC
Confidence 754 55689999999999999999999999987 456778 99999999998 9999985
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.8e-15 Score=141.59 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=97.9
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccc----cCCCCCcch-hhhHHHHHHHHHHHhHhhh
Q 004247 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV----DRDGKSSLL-SLVKAFDSVLAVYEGFCNL 87 (766)
Q Consensus 13 ~~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~----~~~~~~~~~-~~~~~~~~~l~~~~~~C~~ 87 (766)
|..-++|+|++|.|+.|..||+||+..+.+.+..|++|||.++.... ......... ...+...+..+.++.++..
T Consensus 3 m~~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 82 (150)
T 3tnj_A 3 MSVYHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNT 82 (150)
T ss_dssp -CCCSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCccceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHH
Confidence 34568999999999999999999999988889999999998754321 111000000 1122223444555556666
Q ss_pred cCCc-EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCc--ccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 88 KQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH--HTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 88 k~V~-~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~--r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
.++. ++..+.. |++.++|+++|+..++|+||||++++. ..++| |++.+++++++ |||++|+..
T Consensus 83 ~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 83 LGIDPAHRWLVW-GEPREEIIRIAEQENVDLIVVGSHGRHGLALLLG--STANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp HTCCGGGEEEEE-SCHHHHHHHHHHHTTCSEEEEEEC--------CC--CHHHHHHHHCS--SEEEEEECC
T ss_pred cCCCcceEEEec-CCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEec--chHHHHHHhCC--CCEEEEeCC
Confidence 6776 4666666 899999999999999999999999872 25677 99999999998 999999853
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=6.2e-15 Score=144.27 Aligned_cols=136 Identities=18% Similarity=0.297 Sum_probs=100.4
Q ss_pred CCcEEEEEEcCCc---------chHHHHHHHHhhccCC---CCEEEEEEeecCCcc-ccCC-C--CCc-ch-----hhhH
Q 004247 15 AGRTVVVGVKLDT---------HSRELLTWALVKVAQP---GDTVIALHVLANNAI-VDRD-G--KSS-LL-----SLVK 72 (766)
Q Consensus 15 ~~r~I~V~Vd~s~---------~S~~AL~WAl~~~~~~---gd~vvlvHV~~~~~~-~~~~-~--~~~-~~-----~~~~ 72 (766)
.-++|+|+||.|+ .|..||.||+..+++. +..|++|||.+.... .... . ... .. ...+
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 3579999999999 9999999999998764 789999999854321 1000 0 000 00 0111
Q ss_pred HHHHHHHHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEE
Q 004247 73 AFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSV 149 (766)
Q Consensus 73 ~~~~~l~~~~~~C~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V 149 (766)
...+.|+.+...+...++.++..+.. |++.+.|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~G--sva~~vl~~a~--~pV 158 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVG--TVSAFCVKHAE--CPV 158 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC----------CHHHHHHHHCS--SCE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcC--chHHHHHhCCC--CCE
Confidence 23367788888888889999988888 79999999999999999999999987 466778 99999999998 999
Q ss_pred EEEeCC
Q 004247 150 LAVNNG 155 (766)
Q Consensus 150 ~vV~~g 155 (766)
++|+.+
T Consensus 159 lvv~~~ 164 (175)
T 2gm3_A 159 MTIKRN 164 (175)
T ss_dssp EEEECC
T ss_pred EEEcCC
Confidence 999864
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.7e-15 Score=139.00 Aligned_cols=129 Identities=16% Similarity=0.176 Sum_probs=96.1
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCcc-ccCC-CCCcchhhhHHHHHHHHHHHhHhhhcCC-cEE
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAI-VDRD-GKSSLLSLVKAFDSVLAVYEGFCNLKQV-DLK 93 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~-~~~~-~~~~~~~~~~~~~~~l~~~~~~C~~k~V-~~~ 93 (766)
++|+|++|+|+.|..||+||+..+...|..|++|||.++... .... .........+...+.|+. ++...++ +++
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~g~~~~~ 79 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEE---ARALTGVPKED 79 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHH---HHHHHCCCGGG
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHH---HHHHcCCCccE
Confidence 689999999999999999999988888999999999874321 0000 000000111222234444 4444678 777
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 94 ~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
..+.. |++.+.|+++|+..++|++|||++++ .+.++| |++.+++++++ |||++|+
T Consensus 80 ~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 80 ALLLE-GVPAEAILQAARAEKADLIVMGTRGLGALGSLFLG--SQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp EEEEE-SSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSC--HHHHHHHHHCS--SCEEEEC
T ss_pred EEEEe-cCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhc--cHHHHHHhcCC--CCEEEeC
Confidence 77777 79999999999999999999999987 456778 99999999997 9999985
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=3.2e-14 Score=133.68 Aligned_cols=132 Identities=13% Similarity=0.128 Sum_probs=93.9
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecC-CccccCCCCCcchhhhH-HHHHHHHHHHhHhhhcCCcE-E
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN-NAIVDRDGKSSLLSLVK-AFDSVLAVYEGFCNLKQVDL-K 93 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~-~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~C~~k~V~~-~ 93 (766)
++|+|++|+|+.|..||+||+..+...|..|++|||.+. +...............+ ...+....++.++...++.+ +
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (141)
T 1jmv_A 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (141)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred ceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHHHHHHcCCCceE
Confidence 689999999999999999999988888999999999854 21111100000000000 00122333444555567776 3
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCCc--ccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNH--HTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 94 ~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~--r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
..+.. |++.+.|+++|+..++|+||||++ +. +. +| |++.+++++++ |||++|+.+
T Consensus 83 ~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-lg--s~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 83 KLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-LM--SSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp EEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-HH--HHHHHHHTTCC--SEEEEEECC
T ss_pred EEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-hc--chHHHHHhcCC--CCEEEeeCC
Confidence 44544 899999999999999999999999 61 11 36 99999999998 999999864
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-13 Score=127.97 Aligned_cols=125 Identities=10% Similarity=-0.028 Sum_probs=93.9
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEee-cC-C--cccc--CCC-CCcc-hhhhHHHHHHHHHHHhHh--
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVL-AN-N--AIVD--RDG-KSSL-LSLVKAFDSVLAVYEGFC-- 85 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~-~~-~--~~~~--~~~-~~~~-~~~~~~~~~~l~~~~~~C-- 85 (766)
-++|+|++|+|+.|..||.||+..+.+.|..|++|||. +. + .... ... .... ....+...+.|+.+ ..|
T Consensus 4 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~ 82 (138)
T 1q77_A 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKLT 82 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHHH
T ss_pred ccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHhh
Confidence 47899999999999999999999998889999999998 53 1 1000 000 0111 11122233666666 553
Q ss_pred hhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 86 NLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 86 ~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
...+ .++..+.. |++.+.|+++|+..++|+||||++++ ||+.+++++++ |||++|+
T Consensus 83 ~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~--------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 83 GSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp SCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHSS--SEEEECC
T ss_pred ccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC--------chHHHHHHhCC--CceEeeC
Confidence 3345 66666666 89999999999999999999999964 99999999998 9999984
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-12 Score=138.09 Aligned_cols=132 Identities=14% Similarity=0.162 Sum_probs=99.1
Q ss_pred CCcEEEEEEcCCcc-------hHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhH-HHHHHHHHHHhHhh
Q 004247 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVK-AFDSVLAVYEGFCN 86 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~-------S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~C~ 86 (766)
..++|+|++|+|+. |..||+||+..+...|..|++|||.++...... .+.....+ ...+..+.++.+++
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~~ 209 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA---DPTFQLSETIEARYREACRTFQA 209 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC------------CHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc---CchhHHHHHHHHHHHHHHHHHHH
Confidence 46899999999999 999999999999888999999999975432111 11101111 11233444455566
Q ss_pred hcCCc-EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 87 LKQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 87 ~k~V~-~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
..++. +...+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 210 ~~g~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~G--sv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 210 EYGFSDEQLHIEE-GPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIG--NTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHTCCTTTEEEEE-SCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSC--HHHHHHHTTCS--SEEEEECC
T ss_pred HcCCCcceEEEec-cCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecc--hHHHHHHhcCC--CCEEEECC
Confidence 65674 4566666 79999999999999999999999988 566778 99999999998 99999974
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-12 Score=137.77 Aligned_cols=139 Identities=11% Similarity=0.061 Sum_probs=109.2
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCc--chh----hhHHHHHHHHHHHhHhh
Q 004247 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS--LLS----LVKAFDSVLAVYEGFCN 86 (766)
Q Consensus 13 ~~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~--~~~----~~~~~~~~l~~~~~~C~ 86 (766)
|..-++|+|++|+|+.|..||.||+.-+.+.|..|++|||.+............ ... ..+...+.|+.+...|.
T Consensus 4 M~~~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 83 (319)
T 3olq_A 4 MEKYQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYL 83 (319)
T ss_dssp -CCSCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 445689999999999999999999999888899999999976432211111100 100 11122367777777777
Q ss_pred hcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 87 LKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 87 ~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
..++.++..+.+.|++...|+++|+..++|++|||+++. .+.++| |++.+++++++ |||++|+.+
T Consensus 84 ~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~G--s~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 84 EAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFT--PLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp HTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCC--HHHHHHHHHCS--SCEEEEESS
T ss_pred hcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhccccc--ccHHHHHhcCC--CCEEEecCc
Confidence 889999999996699999999999999999999999987 556678 99999999998 999999864
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.5e-12 Score=136.27 Aligned_cols=134 Identities=10% Similarity=0.117 Sum_probs=104.6
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccc-cCCCCCc-c-hhhhHHHHHHHHHHHhHhhhc---
Q 004247 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DRDGKSS-L-LSLVKAFDSVLAVYEGFCNLK--- 88 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~~~~~~-~-~~~~~~~~~~l~~~~~~C~~k--- 88 (766)
.-++|+|++|.|+.|..||+||+..+.+.|..|++|||.++.... ....... . ....+...+.|+.+...|...
T Consensus 18 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 97 (309)
T 3cis_A 18 SSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASLR 97 (309)
T ss_dssp CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred CCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhccc
Confidence 468999999999999999999999998889999999998632210 0000010 0 011223346778877777765
Q ss_pred --CCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 89 --QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 89 --~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
+++++..+.. |++.+.|+++|+ ++|++|||++++ .+.++| |++.+++++++ |||++|+.+
T Consensus 98 ~~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~G--s~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 98 AGPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLG--SVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp SCCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSC--HHHHHHHHHCS--SCEEEECTT
T ss_pred CCCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCccccccccC--cHHHHHHHhCC--CCEEEEcCC
Confidence 8999988877 899999999998 699999999987 456778 99999999997 999999854
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=137.95 Aligned_cols=137 Identities=9% Similarity=0.031 Sum_probs=107.9
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcc----hhhhHHHHHHHHHHHhHhhhc
Q 004247 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSL----LSLVKAFDSVLAVYEGFCNLK 88 (766)
Q Consensus 13 ~~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~C~~k 88 (766)
+..-++|+|++|.|+.|..||+||+.-+.+.|..|++|||.+............. ....+...+.|+.+...|...
T Consensus 19 m~m~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 98 (294)
T 3loq_A 19 YFQSNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAA 98 (294)
T ss_dssp SSTTCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhhccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 3446899999999999999999999998888999999999876532111111111 112233347888888899888
Q ss_pred CCcEEE-EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 89 QVDLKL-KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 89 ~V~~~~-~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
++.++. .+.+.|++.++| +++..++|+||||++++ .+.++| |++.+++++++ |||++|+.+
T Consensus 99 g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~G--s~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 99 GIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLG--SVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp TCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHC--CHHHHHHHHCS--SCEEEECCC
T ss_pred CCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeec--cHHHHHHhcCC--CCEEEecCc
Confidence 999998 777348999999 88999999999999987 456678 99999999998 999999754
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-12 Score=134.27 Aligned_cols=132 Identities=11% Similarity=0.031 Sum_probs=103.1
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccc-cC-CCCC----c--------chhhhHHHHHHHHHHH
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DR-DGKS----S--------LLSLVKAFDSVLAVYE 82 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~-~~~~----~--------~~~~~~~~~~~l~~~~ 82 (766)
++|+|++|.|+.|..||+||+..+.+.|..|++|||.+..... .. .+.. . .....+...+.|+.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999999999988889999999998643210 00 0000 0 0011223347888888
Q ss_pred hHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCc----ccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 83 GFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH----HTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 83 ~~C~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~----r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
..+...++.++..+.. |++.+.|+++ ..++|++|||++++. +.++| |++.+++++++ |||++|+.+
T Consensus 81 ~~~~~~g~~~~~~~~~-g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~G--s~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEE-GVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLG--STADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHTTCCEEEEEEE-ECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCC--HHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHhCCCCeEEEEec-CCHHHHHHhh--ccCCCEEEEeccCCCccccccccc--hhHHHHHHhCC--CCEEEECCC
Confidence 8888889999998887 8999999999 778999999999753 45677 99999999998 999999854
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5.4e-12 Score=134.84 Aligned_cols=131 Identities=17% Similarity=0.149 Sum_probs=98.3
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhh--cCCcEE
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL--KQVDLK 93 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~--k~V~~~ 93 (766)
.++|+|++|+++.|..||+||+..+...|..|++|||..+.... ...........+...+.++.+...+.. .++.++
T Consensus 171 ~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 249 (309)
T 3cis_A 171 QAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVS-EWPGIDWPATQSMAEQVLAERLAGWQERYPNVAIT 249 (309)
T ss_dssp CCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCT-TCSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCEE
T ss_pred CCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeeccccc-CCCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcEE
Confidence 46899999999999999999999888889999999998654321 001111111122222344443333322 478888
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 94 ~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
..+.. |++.++|+++|+ ++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 250 ~~~~~-g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~G--sv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 250 RVVVR-DQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVG--SVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp EEEES-SCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSC--HHHHHHHHHCS--SCEEEECC
T ss_pred EEEEc-CCHHHHHHHhhC--CCCEEEECCCCCCCccccccC--cHHHHHHhcCC--CCEEEeCC
Confidence 88776 799999999998 799999999987 566778 99999999998 99999974
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-12 Score=135.57 Aligned_cols=121 Identities=13% Similarity=0.061 Sum_probs=102.4
Q ss_pred CCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004247 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (766)
Q Consensus 14 ~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (766)
..-++|+|++|.|+.|..||.||+.-+.+.|..|++|||..+ . ... +.|+.+...+...++.++
T Consensus 5 ~~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~---------~---~~~----~~l~~~~~~~~~~~~~~~ 68 (290)
T 3mt0_A 5 QAIRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR---------R---DHS----AALNDLAQELREEGYSVS 68 (290)
T ss_dssp TTCCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS---------S---CCH----HHHHHHHHHHHHTTCCEE
T ss_pred hhhceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc---------H---HHH----HHHHHHHHHHhhCCCeEE
Confidence 345899999999999999999999999888999999999862 0 011 334444455556789999
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 94 ~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
..+.++|++.+.|+++|+..++|++|||++++ .+.++| |++.+++++++ |||++|+.
T Consensus 69 ~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~g--s~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 69 TNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILT--PDDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp EEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCC--HHHHHHHHHCS--SCEEEECC
T ss_pred EEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccC--HHHHHHHhcCC--CCEEEecC
Confidence 99998899999999999999999999999987 456677 99999999998 99999984
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-12 Score=135.55 Aligned_cols=120 Identities=17% Similarity=0.242 Sum_probs=102.3
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004247 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (766)
..++|+|++|+++.|..||+||+.-+...+..|.+|||.++.. ..+.++.+...+...+++++.
T Consensus 169 ~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~----------------~~~~l~~~~~~l~~~~~~~~~ 232 (294)
T 3loq_A 169 LFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD----------------KTADLRVMEEVIGAEGIEVHV 232 (294)
T ss_dssp TTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC----------------CHHHHHHHHHHHHHTTCCEEE
T ss_pred cCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch----------------HHHHHHHHHHHHHHcCCcEEE
Confidence 4589999999999999999999998878899999999986532 123455566666667899888
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 95 KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 95 ~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
.+.. |++.++|+++|+..++|+||||++++ .+.++| |++.+++++++ |||++|+.+
T Consensus 233 ~~~~-g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 233 HIES-GTPHKAILAKREEINATTIFMGSRGAGSVMTMILG--STSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp EEEC-SCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHH--CHHHHHHHHCS--SCEEEECSC
T ss_pred EEec-CCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeC--cHHHHHHhcCC--CCEEEECCC
Confidence 7776 79999999999999999999999987 455678 99999999998 999999864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.6e-11 Score=127.52 Aligned_cols=143 Identities=17% Similarity=0.123 Sum_probs=112.6
Q ss_pred HhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEe
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 493 (766)
....|.+...++.|+++.||+... .+..+++|+..... .....+.+|+.+++.+. +..+.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345688888899999999999876 46899999987421 22346888999999985 6778899999988889999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS------------------------------------ 537 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------ 537 (766)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876421 1223468889999999999811
Q ss_pred --------------------CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 538 --------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 538 --------------------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876556799998764
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=131.30 Aligned_cols=135 Identities=12% Similarity=0.072 Sum_probs=99.2
Q ss_pred CCcEEEEEEcCCcc-------hHHHHHHHHhhccCC--CCEEEEEEeecCCccccCCCCC--cchhh-hHHHHHHHHHHH
Q 004247 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDGKS--SLLSL-VKAFDSVLAVYE 82 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~-------S~~AL~WAl~~~~~~--gd~vvlvHV~~~~~~~~~~~~~--~~~~~-~~~~~~~l~~~~ 82 (766)
..++|+|++|+|++ |..||+||+..+... |..|.+|||............. ..... .+...+..+.++
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAMK 234 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHHH
Confidence 36899999999994 699999999877765 9999999999765332111100 00011 112223444455
Q ss_pred hHhhhcCC-cEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 83 GFCNLKQV-DLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 83 ~~C~~k~V-~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
.++...++ .++..+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 235 ~~~~~~~~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~G--sv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 235 ELRQKFSIPEEKTHVKE-GLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLG--NTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HHHHHTTCCGGGEEEEE-SCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHH--HHHHHHHTTCC--SEEEEECC
T ss_pred HHHHHhCCCcccEEEec-CCcHHHHHHHHHHhCCCEEEEeccCccCCcccccc--HHHHHHHhhCC--CCEEEECC
Confidence 55556555 34556666 79999999999999999999999987 456778 99999999998 99999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=124.72 Aligned_cols=136 Identities=16% Similarity=0.088 Sum_probs=100.7
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc--eeEEeeEEeecCceEEEEeecC
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ 496 (766)
+|.+..+.+.|..+.||+....+|..+++|+.... ....+.+|+.+++.+.+.+ +.++++++..++..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34443343456669999998777888999998754 2245778999999986544 4568888887778999999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 537 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 537 (766)
|.+|. ... .. ...++.+++..|..||+..
T Consensus 99 G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98884 211 11 2356777888888888632
Q ss_pred ----------------CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 538 ----------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 538 ----------------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
...++|+|++|.|||++++..+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877666799999875
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.6e-11 Score=124.61 Aligned_cols=116 Identities=12% Similarity=0.039 Sum_probs=97.5
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004247 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (766)
..++|+|++|+++.|..||.||.......|..|.+|||.++. +...+.++.+...+...+++++.
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~---------------~~~~~~l~~~~~~l~~~~~~~~~ 217 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP---------------ARAEAWALEAEAYLRDHGVEASA 217 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH---------------HHHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH---------------HHHHHHHHHHHHHHHHcCCceEE
Confidence 357999999999999999999998777778899999998642 12234556666666667899888
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 95 ~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
.+.. |++.++|+++|+.. |+||||+ +..+.++| |++.+++++++ |||++|+
T Consensus 218 ~~~~-g~~~~~i~~~a~~~--dliV~G~-~~~~~~~G--s~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 218 LVLG-GDAADHLLRLQGPG--DLLALGA-PVRRLVFG--STAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp EEEC-SCHHHHHHHHCCTT--EEEEEEC-CCSCCSSC--CHHHHHHHHCS--SCEEEEC
T ss_pred EEeC-CChHHHHHHHHHhC--CEEEECC-cccccEec--cHHHHHHhcCC--CCEEEeC
Confidence 8776 89999999999998 9999999 66777888 99999999998 9999985
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.1e-09 Score=119.39 Aligned_cols=141 Identities=14% Similarity=0.261 Sum_probs=107.3
Q ss_pred cceeeeccCceEEEEEEeCCCCEEEEEEcc--CCh--hHHHHHHHHHHHHHhcC--CCceeEEeeEEeec---CceEEEE
Q 004247 422 AENLIGKGGSSQVYKGCLPDGKELAVKILK--PSE--DVIKEFVLEIEIITTLH--HKNIISLLGFCFED---NNLLLVY 492 (766)
Q Consensus 422 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~--~~~--~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~~~~lV~ 492 (766)
..+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998874 4688999886 432 23457788999999997 45688889888766 4489999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----------------------------------- 537 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----------------------------------- 537 (766)
||++|..+.+... ..++...+..++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987754221 23677888899999999999999721
Q ss_pred --------------------CCceEeecccCCCeeeCCCCC--eeEeccccccc
Q 004247 538 --------------------AQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKW 569 (766)
Q Consensus 538 --------------------~~~IiHrDLKp~NILL~~~~~--vkL~DFGla~~ 569 (766)
...++|+|+++.|||++.++. +.|+||+.+.+
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=6e-10 Score=118.56 Aligned_cols=183 Identities=19% Similarity=0.199 Sum_probs=123.5
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCc--eeEEeeEEeecC---ceEEEEeecC
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKN--IISLLGFCFEDN---NLLLVYDFLS 496 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~~ 496 (766)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|..+. +.. +.+++.+....+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999852 46899987643 45577889999999884 322 344444443332 3488999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 537 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 537 (766)
|.+|...... .++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9888754321 3566777788888888888888511
Q ss_pred ----------------CCceEeecccCCCeeeCC--CCCeeEecccccccccCCCCCceecccccccCC---CCchhhc-
Q 004247 538 ----------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---LAPEYFM- 595 (766)
Q Consensus 538 ----------------~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y---~APE~l~- 595 (766)
...++|+|++|.||++++ +..+.|+||+.+...... . ++.....+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~-----Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-N-----DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-H-----HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-H-----HHHHHHhhccccCHHHHHH
Confidence 135899999999999988 456789999998754321 0 01111111 2333221
Q ss_pred ----cCCC---------CCchhhHHHHHHHHHHHhCCCCC
Q 004247 596 ----YGKV---------NDKIDVYAFGVVLLELLTGRKPI 622 (766)
Q Consensus 596 ----~~~~---------s~ksDVwSlGvvL~eLltG~~Pf 622 (766)
++.. ....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 22368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.6e-06 Score=92.38 Aligned_cols=137 Identities=20% Similarity=0.196 Sum_probs=95.8
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC---ceeEEeeEEe-ecCceEEEEeecCCC
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCF-EDNNLLLVYDFLSRG 498 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~gg 498 (766)
.+.++.|....||+. |..+++|+.. .......+.+|.++|..+.+. .+.+++.++. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456889999999987 5678999854 334567889999999999752 3556666664 345678999999998
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------------ 536 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------ 536 (766)
+|...... .++...+..++.+++..|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88763211 123444445555555555555541
Q ss_pred ---------------CCCceEeecccCCCeeeCC---CCCe-eEecccccccc
Q 004247 537 ---------------SAQRVIHRDVKSSNILLSD---DFEP-QLSDFGLAKWA 570 (766)
Q Consensus 537 ---------------~~~~IiHrDLKp~NILL~~---~~~v-kL~DFGla~~~ 570 (766)
....++|+|+++.|||++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2245799999999999987 4554 79999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=9.1e-06 Score=84.12 Aligned_cols=134 Identities=19% Similarity=0.123 Sum_probs=95.6
Q ss_pred eeeccCce-EEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 425 LIGKGGSS-QVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 425 ~LG~G~fG-~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
.+..|..| .||+.... ++..+++|+.... ....+.+|..+|+.+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34455554 68987754 5678999987643 3456788999998885 334677888998888999999999998887
Q ss_pred HhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 004247 502 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------------------- 537 (766)
Q Consensus 502 ~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------------- 537 (766)
+..... ......+..+++..|.-||...
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 655321 1223345556666666666411
Q ss_pred -----------CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 538 -----------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 538 -----------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987767799998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=3.4e-06 Score=91.31 Aligned_cols=80 Identities=13% Similarity=0.104 Sum_probs=57.2
Q ss_pred ceee-eccCceEEEEEEeC-------CCCEEEEEEccCChh----HHHHHHHHHHHHHhcCC---CceeEEeeEEeec--
Q 004247 423 ENLI-GKGGSSQVYKGCLP-------DGKELAVKILKPSED----VIKEFVLEIEIITTLHH---KNIISLLGFCFED-- 485 (766)
Q Consensus 423 ~~~L-G~G~fG~Vy~a~~~-------~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~-- 485 (766)
.+.| +.|....+|+.... ++..+++|+...... ....+.+|+.++..+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88888999988764 267899998765331 12457788888888852 3567788877654
Q ss_pred -CceEEEEeecCCCCHhH
Q 004247 486 -NNLLLVYDFLSRGSLEE 502 (766)
Q Consensus 486 -~~~~lV~E~~~ggsL~~ 502 (766)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-05 Score=85.50 Aligned_cols=141 Identities=19% Similarity=0.291 Sum_probs=81.5
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC--CceeEEee------EEeecCceEEEEeec
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLG------FCFEDNNLLLVYDFL 495 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~------~~~~~~~~~lV~E~~ 495 (766)
+.|+.|..+.||+....+| .+++|+..... ..+..|..++..|.. -.+.+++. +....+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677899999887555 59999998643 233345555555531 12333332 123456789999999
Q ss_pred CCCCHh--------------HhhhcCCC-C--C-------CCCChHHHH-------------------------------
Q 004247 496 SRGSLE--------------ENLHGNKK-D--P-------AAFGWSERY------------------------------- 520 (766)
Q Consensus 496 ~ggsL~--------------~~L~~~~~-~--~-------~~l~~~~~~------------------------------- 520 (766)
+|.++. ..+|.... . + ....|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11221110 0 1 012332211
Q ss_pred HHHHHHHHHHHHHHc----------CCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 521 KVAMGVAEALEYLHS----------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 521 ~i~~qia~aL~yLH~----------~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 123789999999999999888889999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.7e-05 Score=87.34 Aligned_cols=74 Identities=16% Similarity=0.139 Sum_probs=50.1
Q ss_pred ceeeeccCceEEEEEEeC-CCCEEEEEEccCChh--------HHHHHHHHHHHHHhcCC--Cc-eeEEeeEEeecCceEE
Q 004247 423 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLL 490 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~--------~~~~~~~Ei~iL~~l~H--pn-Iv~l~~~~~~~~~~~l 490 (766)
.+.||.|.++.||++... +++.++||....... ....+..|.++|..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567899999999999754 568899998654211 23456779999988743 33 3455543 3455689
Q ss_pred EEeecCCC
Q 004247 491 VYDFLSRG 498 (766)
Q Consensus 491 V~E~~~gg 498 (766)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00025 Score=78.73 Aligned_cols=76 Identities=16% Similarity=0.192 Sum_probs=47.0
Q ss_pred CceEeecccCCCeeeCCCCCeeEecccccccccCCCCCceeccccc--ccCCCCchhhccCC---CCCchhhHHHHHHHH
Q 004247 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGK---VNDKIDVYAFGVVLL 613 (766)
Q Consensus 539 ~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ 613 (766)
..++|+|++|.|||++.++ +.|+||+.+.+..... ... ...+ ...|++|++..... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIG--AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHH--HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHH--HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 7899999999999998876 9999999887543210 000 0011 12356665553111 112345567777788
Q ss_pred HHHhC
Q 004247 614 ELLTG 618 (766)
Q Consensus 614 eLltG 618 (766)
+++++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00022 Score=76.21 Aligned_cols=139 Identities=14% Similarity=0.187 Sum_probs=93.5
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCceEEEEeecCCCC
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRGS 499 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~ggs 499 (766)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++.++...+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46789999999999876 5778999987643 3567888999988884 3568888888877788999999999986
Q ss_pred Hh-----------HhhhcCCCCC------------------CCCChHHHH---HHH----------------HHHHHH-H
Q 004247 500 LE-----------ENLHGNKKDP------------------AAFGWSERY---KVA----------------MGVAEA-L 530 (766)
Q Consensus 500 L~-----------~~L~~~~~~~------------------~~l~~~~~~---~i~----------------~qia~a-L 530 (766)
+. -.||.....+ -.-+|...+ ++. ..++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 52 1233322100 011454332 111 111111 2
Q ss_pred HHHHc-CCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 531 EYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 531 ~yLH~-~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
..|.. .....+||+|+.+.|++++.++ +.|+||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 1236799999999999999887 8899974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00029 Score=74.35 Aligned_cols=139 Identities=14% Similarity=0.111 Sum_probs=77.4
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeec-CCCCH
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL-SRGSL 500 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~ggsL 500 (766)
.+.|+.|....+|+. ..+++|+............+|+.++..+...++ .++++++ .+.-++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 678899999999998 568999887542222223568888877753233 3555443 33347899999 66554
Q ss_pred hH------------------hhhcCCC-CCCCCC-hHHHHHHHH--------------HHHHHH----HHHHc-CCCCce
Q 004247 501 EE------------------NLHGNKK-DPAAFG-WSERYKVAM--------------GVAEAL----EYLHS-GSAQRV 541 (766)
Q Consensus 501 ~~------------------~L~~~~~-~~~~l~-~~~~~~i~~--------------qia~aL----~yLH~-~~~~~I 541 (766)
.. .+|.... .+..+. +.....+.. .+...+ ..|.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 32 1222111 000011 111111111 011111 12211 223568
Q ss_pred EeecccCCCeeeCCCCCeeEeccccccc
Q 004247 542 IHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 542 iHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566889999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0016 Score=69.01 Aligned_cols=143 Identities=17% Similarity=0.248 Sum_probs=83.8
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC--ceeEEeeE-----EeecCceEEEEeecC
Q 004247 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF-----CFEDNNLLLVYDFLS 496 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~-----~~~~~~~~lV~E~~~ 496 (766)
..|+ |....||+....+|+.+++|+..........+..|..++..+... .+++++.. ....+..++||+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 888899998777787899999975433345667788888877522 23444442 122455688999998
Q ss_pred CCCHhH--------------hhhcCCC-----CCCCCChHHH----HHH---------------HHHHHHHHHHHHc---
Q 004247 497 RGSLEE--------------NLHGNKK-----DPAAFGWSER----YKV---------------AMGVAEALEYLHS--- 535 (766)
Q Consensus 497 ggsL~~--------------~L~~~~~-----~~~~l~~~~~----~~i---------------~~qia~aL~yLH~--- 535 (766)
|..+.. .+|.... ....+++... ..+ ...+...+..|..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 864321 1221100 0011222211 001 0111122233321
Q ss_pred -CCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 536 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 536 -~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999999 4 899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0005 Score=72.85 Aligned_cols=144 Identities=17% Similarity=0.170 Sum_probs=81.1
Q ss_pred ceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc--eeEEeeE------EeecCceEEEEee
Q 004247 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 494 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E~ 494 (766)
.+.|+.|....+|+....+| .+++|+.... .....+..|+.++..|...+ +.+++.. ....+..+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 35577788899999887666 6889998752 11234556777777774222 2333321 1223567899999
Q ss_pred cCCCCHhH--------------hhhcCCC---CCC--C---CChHHHHH------------HHHHHHHHHHHHHc----C
Q 004247 495 LSRGSLEE--------------NLHGNKK---DPA--A---FGWSERYK------------VAMGVAEALEYLHS----G 536 (766)
Q Consensus 495 ~~ggsL~~--------------~L~~~~~---~~~--~---l~~~~~~~------------i~~qia~aL~yLH~----~ 536 (766)
++|..+.. .+|.... .+. . ..|...+. +...+...+.+|+. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 1222110 000 0 12332111 01123445555553 1
Q ss_pred CCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 537 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
....+||+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23579999999999999887556899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00028 Score=78.72 Aligned_cols=73 Identities=18% Similarity=0.228 Sum_probs=50.8
Q ss_pred ceeeeccCceEEEEEEeCC--------CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEe
Q 004247 423 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E 493 (766)
.+.|+.|....+|+....+ +..+++|+..... ....+.+|..++..|...++ .++++.+.. .+|||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4678888899999998653 5789999985421 11455579999888853333 566665532 38999
Q ss_pred ecCCCCH
Q 004247 494 FLSRGSL 500 (766)
Q Consensus 494 ~~~ggsL 500 (766)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0022 Score=67.00 Aligned_cols=78 Identities=19% Similarity=0.183 Sum_probs=56.8
Q ss_pred CcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCC---ceeEEeeEEeecCceEEEEee
Q 004247 419 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK---NIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~~~~~lV~E~ 494 (766)
.......+|.|..+.||+....+|+.|++|+..... .....|..|...|+.|..- -+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455567899999999999999999999999876432 2234577899999988532 244444432 34899999
Q ss_pred cCCCCH
Q 004247 495 LSRGSL 500 (766)
Q Consensus 495 ~~ggsL 500 (766)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00097 Score=73.13 Aligned_cols=142 Identities=19% Similarity=0.254 Sum_probs=84.3
Q ss_pred ceeeeccCceEEEEEEeC--------CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEEe
Q 004247 423 ENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E 493 (766)
.+.|..|-...+|+.... +++.+++|+..........+.+|..+++.|..-+ ..++++++.. .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356777888899998864 3578999997543233456678999998885322 3556666543 39999
Q ss_pred ecCCCCHhHh-----------------hhcCCC-CCCCC--ChHHHHHHHHHHHH-------------------HHHHHH
Q 004247 494 FLSRGSLEEN-----------------LHGNKK-DPAAF--GWSERYKVAMGVAE-------------------ALEYLH 534 (766)
Q Consensus 494 ~~~ggsL~~~-----------------L~~~~~-~~~~l--~~~~~~~i~~qia~-------------------aL~yLH 534 (766)
|++|.+|... ||.... ..... -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 222111 01112 24455555443321 223332
Q ss_pred ----c-CCCCceEeecccCCCeeeCCC----CCeeEecccccc
Q 004247 535 ----S-GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 568 (766)
Q Consensus 535 ----~-~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~ 568 (766)
. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 233579999999999999876 689999998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0015 Score=69.65 Aligned_cols=143 Identities=15% Similarity=0.140 Sum_probs=74.8
Q ss_pred eeeeccCceE-EEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEEEeecCCCCH
Q 004247 424 NLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 424 ~~LG~G~fG~-Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
+.|+.|+... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+....+ +++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 4465555554 6676654477888887654321 234456677666642 23455666543333 789999987776
Q ss_pred hHhhhcC---------------------CCCC-CCCChHHHH-------H-H------------HHHHHHHHHHHH---c
Q 004247 501 EENLHGN---------------------KKDP-AAFGWSERY-------K-V------------AMGVAEALEYLH---S 535 (766)
Q Consensus 501 ~~~L~~~---------------------~~~~-~~l~~~~~~-------~-i------------~~qia~aL~yLH---~ 535 (766)
.+.+... .... ..+...... . + ...+...+..|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 5443221 0000 011111000 0 0 011112222221 1
Q ss_pred CCCCceEeecccCCCeeeCCC----CCeeEecccccccc
Q 004247 536 GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 570 (766)
Q Consensus 536 ~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~~~ 570 (766)
.....++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 224689999999999999874 67899999988643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00044 Score=75.11 Aligned_cols=74 Identities=18% Similarity=0.183 Sum_probs=46.4
Q ss_pred ceeeeccCceEEEEEEeCC---------CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEE
Q 004247 423 ENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 492 (766)
...|+.|....+|+....+ +..+++|+.............|..++..+...+ ..++++.+ . -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567888889999987654 268999998754332223457888888885333 34566543 2 27899
Q ss_pred eecCCCCH
Q 004247 493 DFLSRGSL 500 (766)
Q Consensus 493 E~~~ggsL 500 (766)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00097 Score=75.02 Aligned_cols=74 Identities=22% Similarity=0.181 Sum_probs=49.0
Q ss_pred ceeeeccCceEEEEEEeCC-CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeecCCCCH
Q 004247 423 ENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSL 500 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggsL 500 (766)
.+.|+.|-...+|+....+ +..+++|+........-...+|..++..|...++ .++++++. + .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4678888899999988755 4789999885432111112578999999875555 45666662 2 359999988554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0029 Score=68.09 Aligned_cols=66 Identities=18% Similarity=0.202 Sum_probs=43.9
Q ss_pred cCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC---CceeEEeeE------EeecCceEEEEeecCCCC
Q 004247 429 GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGF------CFEDNNLLLVYDFLSRGS 499 (766)
Q Consensus 429 G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~------~~~~~~~~lV~E~~~ggs 499 (766)
|....||+....+| .+++|+...... ..|+.++..|.. |++.+++.. ....+..++||+|++|..
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 33678999987777 899998876441 356666666632 224444432 233467799999999876
Q ss_pred H
Q 004247 500 L 500 (766)
Q Consensus 500 L 500 (766)
+
T Consensus 108 ~ 108 (339)
T 3i1a_A 108 G 108 (339)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.018 Score=64.00 Aligned_cols=141 Identities=14% Similarity=0.194 Sum_probs=84.9
Q ss_pred ceeeeccCceEEEEEEeCC--------CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEEe
Q 004247 423 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E 493 (766)
.+.|..|-...+|+....+ +..+++|+........-+..+|..+++.+..-+ ..++++.+ .+ ++|||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 4567778888999988753 688999997653322223357888888885323 34555433 22 78999
Q ss_pred ecCCCCHhH-----------------hhhcCCC---------CCCCCChHHHHHHHHHH-------------------HH
Q 004247 494 FLSRGSLEE-----------------NLHGNKK---------DPAAFGWSERYKVAMGV-------------------AE 528 (766)
Q Consensus 494 ~~~ggsL~~-----------------~L~~~~~---------~~~~l~~~~~~~i~~qi-------------------a~ 528 (766)
|++|.+|.. .||.... ...+..|..+.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999876421 0111100 11122344444443222 22
Q ss_pred HHHHHHc---------------------CCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 529 ALEYLHS---------------------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 529 aL~yLH~---------------------~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
.+.+|.+ .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 2333321 12356899999999999 778889999998874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.38 E-value=0.21 Score=50.13 Aligned_cols=98 Identities=18% Similarity=0.149 Sum_probs=65.2
Q ss_pred CHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCce
Q 004247 499 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 578 (766)
Q Consensus 499 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 578 (766)
+|.+.|.... .+++++++|.++.|.+.+|.-+-... .+ ..+=+-|..|+|..+|.+-+.+ +.+.
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 7999998665 48999999999999999887762100 11 1333457899999999887764 1110
Q ss_pred ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh
Q 004247 579 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 617 (766)
Q Consensus 579 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt 617 (766)
.....+.|||.+. ...+.+.=|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888764 355678899999999999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.49 E-value=0.19 Score=55.06 Aligned_cols=29 Identities=34% Similarity=0.471 Sum_probs=24.4
Q ss_pred ceEeecccCCCeee------CCCCCeeEecccccc
Q 004247 540 RVIHRDVKSSNILL------SDDFEPQLSDFGLAK 568 (766)
Q Consensus 540 ~IiHrDLKp~NILL------~~~~~vkL~DFGla~ 568 (766)
.++|+|+.+.|||+ +++..+.++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456679999998774
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=87.84 E-value=1.3 Score=49.45 Aligned_cols=97 Identities=21% Similarity=0.158 Sum_probs=65.7
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEEE
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLK 95 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~ 95 (766)
+.+|+||+.+..+|.-+|.++....-+.|-.|+++||-+... + ..-+.-.+..+.+|+.-+|.+...
T Consensus 18 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr--------g-----~~s~~~~~~v~~~~~~lgi~~~v~ 84 (464)
T 3a2k_A 18 GAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR--------G-----RESEEEMEFVKRFCVERRILCETA 84 (464)
T ss_dssp SSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC--------T-----HHHHHHHHHHHHHHHHTTCEEEEE
T ss_pred CCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC--------c-----cccHHHHHHHHHHHHHcCCcEEEE
Confidence 568999999999999888777664444578999999975421 0 111123455677898888887665
Q ss_pred EEECC----Ch------------hHHHHHHHHhcCCcEEEEccCCC
Q 004247 96 ICRGT----SI------------RKILVREAQSYSATKFIVGTAKN 125 (766)
Q Consensus 96 v~~~~----d~------------~~~lv~~a~~~~a~~LVlG~~~~ 125 (766)
-+... +. ...+.+.|+.++++.|++|.+..
T Consensus 85 ~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~d 130 (464)
T 3a2k_A 85 QIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGD 130 (464)
T ss_dssp ECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHH
T ss_pred EechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChH
Confidence 44310 00 14556677788899999998753
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=86.59 E-value=3.1 Score=43.80 Aligned_cols=96 Identities=15% Similarity=0.014 Sum_probs=63.4
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCE-EEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDT-VIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~-vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (766)
+.+|+||+.+..+|.-+|.++....-..|-. |+++||-.... ...+.-.+..+.+|+.-+|.+..
T Consensus 24 ~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r--------------~~s~~~~~~v~~~a~~lgi~~~v 89 (317)
T 1wy5_A 24 ERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR--------------ESAERDEEFCKEFAKERNMKIFV 89 (317)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS--------------THHHHHHHHHHHHHHHHTCCEEE
T ss_pred CCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC--------------cccHHHHHHHHHHHHHcCCcEEE
Confidence 5689999999999998877765543344666 99999964321 01112345566788888888665
Q ss_pred EEEE--------CCCh-------h-HHHHHHHHhcCCcEEEEccCCC
Q 004247 95 KICR--------GTSI-------R-KILVREAQSYSATKFIVGTAKN 125 (766)
Q Consensus 95 ~v~~--------~~d~-------~-~~lv~~a~~~~a~~LVlG~~~~ 125 (766)
.-+. +.++ + ..+.+.|+.++++.|++|.+..
T Consensus 90 ~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 90 GKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp EECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred EEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 4432 1111 1 2566677888999999998854
|
| >1ni5_A Putative cell cycle protein MESJ; structural genomics, ATPase, PP-type, putative cell cycle PR PSI, protein structure initiative; 2.65A {Escherichia coli} SCOP: b.153.1.2 c.26.2.5 d.229.1.1 | Back alignment and structure |
|---|
Probab=80.10 E-value=2 Score=47.60 Aligned_cols=68 Identities=24% Similarity=0.268 Sum_probs=46.7
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccC-CCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQ-PGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~-~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (766)
+.+|+||+.+..+|.-+|.++....-+ .|-.|+++||-+.... . . ++-.+..+.+|+.-+|.+..
T Consensus 13 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~g~~v~avhvdhglr~------~-----s---~~~~~~v~~~~~~lgi~~~v 78 (433)
T 1ni5_A 13 SRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLSA------N-----A---DAWVTHCENVCQQWQVPLVV 78 (433)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCCS------S-----H---HHHHHHHHHHHHHTTCCEEE
T ss_pred CCEEEEEEcchHHHHHHHHHHHHHHHhcCCCeEEEEEEECCCCc------c-----c---HHHHHHHHHHHHHcCCcEEE
Confidence 468999999999999777766654434 6889999999754210 0 0 11234556788888888766
Q ss_pred EEE
Q 004247 95 KIC 97 (766)
Q Consensus 95 ~v~ 97 (766)
.-+
T Consensus 79 ~~~ 81 (433)
T 1ni5_A 79 ERV 81 (433)
T ss_dssp ECC
T ss_pred EEe
Confidence 544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 766 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-64
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 26/281 (9%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 474
IG G VYKG ++AVK+L P+ ++ F E+ ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I+ +G+ L +V + SL +LH + F + +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
+ + +IHRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 595 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-------L 231
Query: 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ +N M+R++ C+++ RP +L +
Sbjct: 232 SKVRSNCP-KAMKRLMAE---CLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-61
Identities = 56/274 (20%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
+G G +V+ G ++AVK LK F+ E ++ L H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L + ++ +++ GSL + L ++ +A +AE + ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ IHRD++++NIL+SD +++DFGLA+ + + APE YG
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 185
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
K DV++FG++L E++T + + V+ + + +N
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ--------NLERGYRMVRPDN 234
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
+++ +++ LC + P RP + +L
Sbjct: 235 CP-EELYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-61
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
S IG G V+ G + ++A+K ++ ++F+ E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
VIHRD+ + N L+ ++ ++SDFG+ ++ + + +PE F +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFS 177
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
+ + K DV++FGV++ E+ + K P S + I + + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFR---LYKPRLAST 229
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696
+ Y M C + P RP S +L+ L A+
Sbjct: 230 HVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 59/304 (19%), Positives = 119/304 (39%), Gaps = 40/304 (13%)
Query: 416 ATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH 472
+F + +G G V+K P G +A K++ + + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
I+ G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
L +++HRDVK SNIL++ E +L DFG++ S + GT Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI-SNDHPKGQESLVMWAKPILSSGKVTQLLD 651
+ + D+++ G+ L+E+ GR PI D + + + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 652 PALGNNYDYDQMERMVLASIL--------------------------CIRRDPRARPQMS 685
++Y D M + +L C+ ++P R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 686 LVLK 689
++
Sbjct: 294 QLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-59
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 482
+ IGKG +V++G G+E+AVKI E+ EI L H+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 483 FEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS--- 535
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIV 121
Query: 536 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAP 591
+ HRD+KS NIL+ + ++D GLA ++T + I GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 592 EYF------MYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKPIL 641
E + + + D+YA G+V E+ P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 642 SSGKVTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLKLLR 692
Q L P + N + + R++ + C + AR + K L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 9e-58
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 33/277 (11%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 472
+F +GKG VY LA+K+L + V + E+EI + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
NI+ L G+ + + L+ ++ G++ L K F +A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
HS +RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 174
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
++K+D+++ GV+ E L G+ P + + + + +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-----FVTE 229
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
D + R ++ +P RP + VL+
Sbjct: 230 GA-----RDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 24/276 (8%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
+ +G G V G ++A+K++K EF+ E +++ L H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L G C + + ++ ++++ G L L + F + ++ V EA+EYL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
++ +HRD+ + N L++D ++SDFGL+++ + + PE MY
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 598 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
K + K D++AFGV++ E+ + G+ P + L P L +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------LYRPHLAS 227
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
Y M C RP ++L +
Sbjct: 228 EKVYTIMYS-------CWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 58/274 (21%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
+ E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L + + +V +++S+GSL + L G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER-- 131
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+HRD++++NIL+ ++ +++DFGLA+ + + APE +YG
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG 189
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
+ K DV++FG++L EL T + + + +V ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVERGYRMP 234
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
+ E + C R++P RP + L
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-57
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 26/283 (9%)
Query: 415 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTL 470
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 471 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
H NI+ + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 529 ALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
AL+ H S V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178
Query: 587 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646
Y++PE N+K D+++ G +L EL P + K + K
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------- 231
Query: 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ Y D++ ++ + RP + +L+
Sbjct: 232 -----RRIPYRYS-DELNEIITR---MLNLKDYHRPSVEEILE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 6e-57
Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 41/304 (13%)
Query: 408 FNYQDLLSATSNFLAE---------NLIGKGGSSQVYKGCLPDGKEL----AVKILKP-- 452
F ++D A F E +IG G +V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 453 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 512
+E ++F+ E I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 513 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572
F + + G+A ++YL +HRD+ + NIL++ + ++SDFGL+++
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 573 SSSHITCTDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 628
+S T T + APE Y K DV+++G+V+ E+++ G +P + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 629 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 688
V ++ D + + C ++D RP+ ++
Sbjct: 241 ----------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 689 KLLR 692
L
Sbjct: 285 NTLD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 411 QDLLSATSNFLAENL-IGKGGSSQVYKGCL---PDGKELAVKILKP--SEDVIKEFVLEI 464
+ L N L ++ +G G V +G ++A+K+LK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 465 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 524
+I+ L + I+ L+G C + L+LV + G L + L G +++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 525 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VA 583
V+ ++YL + +HRD+ + N+LL + ++SDFGL+K S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 584 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 642
+ APE + K + + DV+++GV + E L+ G+KP + + K +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ L Y M C RP V + +R
Sbjct: 234 PPECPPEL---------YALMSD-------CWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 478 LLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
LLG E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
+HRD+ + N+L+S+D ++SDFGL K AS+ T + APE
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE 174
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
K + K DV++FG++L E+ + + P + L +V + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYKMDAPD 223
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ ++ C D RP + + L
Sbjct: 224 GCP-PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 3e-56
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISL 478
IG G VY + + + +A+K + S + ++ + E+ + L H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 479 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 538
G ++ LV ++ + + K E V G + L YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 539 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 595
+IHRDVK+ NILLS+ +L DFG A + ++S + GT ++APE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 187
Query: 596 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655
G+ + K+DV++ G+ +EL + P+ N + + + PAL
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------PALQ 235
Query: 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ + + V + C+++ P+ RP ++LK
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-55
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 25/275 (9%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 475
++ +G+G +V + +AVKI+ + D + EI I L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 476 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 535
+ G E N L ++ S G L + + + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG 121
Query: 536 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 595
+ HRD+K N+LL + ++SDFGLA ++ + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 596 YGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
+ + +DV++ G+VL +L G P QE K + + +D A
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 236
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ + + +P AR + + K
Sbjct: 237 -----LALLHK-------ILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-55
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 421 LAENLIGKGGSSQVYKGCLPD---GKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 474
L + +G G V KG K +AVKILK + E + E ++ L +
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE 124
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEY 593
+HRD+ + N+LL ++SDFGL+K ++ + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 594 FMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
Y K + K DV++FGV++ E + G+KP +++ + + + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM-- 239
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
YD M C D RP + V LR
Sbjct: 240 -------YDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-55
Identities = 66/273 (24%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+G G +VYK A K++ SE+ ++++++EI+I+ + H NI+ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+ +NNL ++ +F + G+++ + ++ S+ V +AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
IHRD+K+ NIL + D + +L+DFG++ + + GT ++APE M D
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKD 189
Query: 602 -----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
K DV++ G+ L+E+ P +P + ++P P L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------------PTLAQ 237
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ + L C+ ++ AR S +L+
Sbjct: 238 PSRWSSNFKDFLKK--CLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 8e-55
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 22/285 (7%)
Query: 409 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEII 467
NY ++ ++ +G G +VY+G +AVK LK ++EF+ E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 468 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 527
+ H N++ LLG C + ++ +F++ G+L + L + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125
Query: 528 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 587
A+EYL + IHRD+ + N L+ ++ +++DFGL++ + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647
+ APE Y K + K DV+AFGV+L E+ T Q V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VY 226
Query: 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+LL+ E++ C + +P RP + + +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-54
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDV--IKEFVLEIEIITT 469
+ +G G +V + +AVK+LKPS + + + E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 470 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DPAAF 514
L +H NI++LLG C L++ ++ G L L + D A
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 515 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574
+ + VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634
+++ + ++APE + DV+++G+ L EL + P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
+++ M C DP RP +++L+
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 33/276 (11%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 478
+ IG+G VYKG E+A L+ ++ + F E E++ L H NI+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 479 LGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
++LV + ++ G+L+ L K + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 535 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
+ + +IHRD+K NI ++ ++ D GLA S + V GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
+ K ++ +DVYAFG+ +LE+ T P S Q ++ +VT + PA
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYR-------RVTSGVKPA 232
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ +++ ++ CIR++ R + +L
Sbjct: 233 SFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-54
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 419 NFLAENLIGKGGSSQVYKGCLPDGK----ELAVKILKPSEDV--IKEFVLEIEIITTLHH 472
+F +IG+G VY G L D AVK L D+ + +F+ E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 473 KNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
N++SLLG C + + L+V ++ G L + +P + + VA+ ++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIGFGLQVAKGMK 144
Query: 532 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS--SHITCTDVAGTFGYL 589
+L S ++ +HRD+ + N +L + F +++DFGLA+ S T ++
Sbjct: 145 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649
A E K K DV++FGV+L EL+T P P + +L + L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---L 253
Query: 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 691
L P Y D + ++L C RP S ++ +
Sbjct: 254 LQP----EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-54
Identities = 60/302 (19%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSED--VIKEFVLEIEIITT 469
N ++G G +V ++AVK+LK D + + E++++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 470 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK------------------- 509
L H+NI++LLG C + L++++ G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 510 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569
D + + A VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
+ S+++ + ++APE G K DV+++G++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+L+ + + E + + C D R RP +
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 690 LL 691
L
Sbjct: 320 FL 321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-53
Identities = 59/284 (20%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKE-----LAVKILKP--SEDVIKEFVLEIEIITTL 470
S + +IG G +VYKG L +A+K LK +E +F+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 471 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 530
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYL 589
+YL + +HRD+ + NIL++ + ++SDFGL++ T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 590 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649
APE Y K DV++FG+V+ E++T + + + V +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKA 225
Query: 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693
++ D + + C +++ RP+ + ++ +L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 481
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
+ L +V ++L+ GSL + + D + V +ALE+LHS +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS---NQV 137
Query: 542 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
IHRD+KS NILL D +L+DFG + S + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 602 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661
K+D+++ G++ +E++ G P N++P L+ P L N
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------------PELQNPEKLS 243
Query: 662 QMERMVLASILCIRRDPRARPQMSLVLK 689
+ R L C+ D R +L+
Sbjct: 244 AIFRDFLNR--CLDMDVEKRGSAKELLQ 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 8e-53
Identities = 62/303 (20%), Positives = 126/303 (41%), Gaps = 46/303 (15%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITT 469
+N IG+G +V++ P +AVK+LK S D+ +F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 470 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------------------- 510
+ NI+ LLG C + L++++++ G L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 511 -PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569
P +E+ +A VA + YL ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 629
++ + + A ++ PE Y + + DV+A+GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247
Query: 630 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
E ++ + + G + + ++ ++ LC + P RP + +
Sbjct: 248 HEEVIYYVR----DGNILACPENCP------LELYNLMR---LCWSKLPADRPSFCSIHR 294
Query: 690 LLR 692
+L+
Sbjct: 295 ILQ 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-52
Identities = 61/269 (22%), Positives = 103/269 (38%), Gaps = 29/269 (10%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 473
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ L +D L + G L + + F + + ALEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
H + +IHRD+K NILL++D Q++DFG AK S S GT Y++PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
D++A G ++ +L+ G P + ++ + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-----FFPK 236
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARP 682
D +E+ + D R
Sbjct: 237 A-----RDLVEK-------LLVLDATKRL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 64/293 (21%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP--SEDVIKEFVLEIEIITTL-H 471
++ +++IG+G QV K + A+K +K S+D ++F E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 472 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDPAAFGWSER 519
H NII+LLG C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 520 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 579
A VA ++YL ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 580 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639
++A E Y DV+++GV+L E+++ P + +
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ ++ + L+ D++ ++ C R P RP + +L L
Sbjct: 239 LPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-51
Identities = 65/341 (19%), Positives = 140/341 (41%), Gaps = 46/341 (13%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
LLG C + + L+ + G L + + +K + G + +A+ + YL
Sbjct: 75 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 129
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
+ DV+++GV + EL+T + P + ++ +L+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERL 232
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK-LLRGDADVTKWARLQVNASEESEMLD 715
+ + + C D +RP+ ++ + D ++ +Q +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 716 DESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLL 756
D + R+ L+D ED ++ V ++YL+
Sbjct: 293 DSNFYRA---------LMDEED-------MDDVVDADEYLI 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 3e-50
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 26/275 (9%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNII 476
++ +G G V++ G A K + P E + EI+ ++ L H ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
+L +DN ++++Y+F+S G L E + E + V + L ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
+H D+K NI+ + + L DFGL S T GT + APE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
V D+++ GV+ LL+G P ++ V + + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG- 256
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
D + + + DP R + L+
Sbjct: 257 -----KDFIRK-------LLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-49
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 39/297 (13%)
Query: 418 SNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPS--EDVIKEFVLEIEIIT- 468
+G+G QV + + +AVK+LK + + E++I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 469 TLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPA------------AFG 515
HH N+++LLG C + L+++ +F G+L L + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 516 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575
+ VA+ +E+L S ++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 635
++ D ++APE + DV++FGV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 636 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
L G + D Y +M + +L C +P RP S +++ L
Sbjct: 245 EFCRRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (431), Expect = 2e-48
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 477
++G GG S+V+ L +++AVK+L+ F E + L+H I++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 478 LLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ + +V +++ +L + +H +V +AL +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPE 592
H +IHRDVK +NI++S ++ DFG+A+ + S + +T V GT YL+PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
V+ + DVY+ G VL E+LTG P + D P + PI S + L
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 683
+ + + ++P R Q
Sbjct: 245 L------DAVVLK-------ALAKNPENRYQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 426 IGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIIS 477
+G G V +G +AVK LKP + + +F+ E+ + +L H+N+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
L G + +V + GSL + L ++ F + A+ VAE + YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMY 596
+R IHRD+ + N+LL+ ++ DFGL + + H + F + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
+ D + FGV L E+ T + P + I G+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE-----RLPRPE 238
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+ + +++ C P RP + L
Sbjct: 239 DCP-QDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 7e-48
Identities = 53/293 (18%), Positives = 118/293 (40%), Gaps = 32/293 (10%)
Query: 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITT 469
+G+G VY+G +A+K + S EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 470 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFG------WSERYKVA 523
+ +++ LLG + L++ + ++RG L+ L + A S+ ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 524 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 583
+A+ + YL++ + +HRD+ + N ++++DF ++ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 584 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643
+++PE G DV++FGVVL E+ T + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVME 250
Query: 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696
G + D D + ++ +C + +P+ RP ++ ++ + +
Sbjct: 251 GGLLDKPDNCP------DMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 7e-48
Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 26/269 (9%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 482
+G G V++ G+ K + + K V EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 483 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 542
+ ++L+ +FLS G L + + +E E L+++H ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 543 HRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
H D+K NI+ + DFGLA + T T + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 601 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660
D++A GV+ LL+G P + + V + + A
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA------K 260
Query: 661 DQMERMVLASILCIRRDPRARPQMSLVLK 689
D ++ ++++PR R + L+
Sbjct: 261 DFIKN-------LLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 168 bits (427), Expect = 8e-48
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 41/289 (14%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----------EDVIKEFVLEIEII 467
N+ + ++G+G SS V + P KE AVKI+ + +++ + + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 468 TTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 526
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 527 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 586
E + LH ++HRD+K NILL DD +L+DFG + +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 587 GYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 640
YLAPE + ++D+++ GV++ LL G P + ++M
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 641 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
S + D D + R + P+ R L
Sbjct: 234 FGSPEWDDYSDTV------KDLVSR-------FLVVQPQKRYTAEEALA 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 423 ENLIGKGGSSQVYKGCLPDGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 476
IG+G V++G + +A+K K S+ V ++F+ E + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
L+G +N + ++ + + G L + + + A ++ AL YL S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
+R +HRD+ + N+L+S + +L DFGL+++ S+ + + ++APE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183
Query: 597 GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655
+ DV+ FGV + E+L G KP + + + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL----- 238
Query: 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
Y M + C DP RP+ + + L
Sbjct: 239 ----YSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 32/277 (11%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHH 472
+F+ ++GKG +V+ + A+K LK +D ++ ++E +++ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
+ + NL V ++L+ G L ++ K F S A + L++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LHS + +++RD+K NILL D +++DFG+ K GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE 173
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
+ K N +D ++FGV+L E+L G+ P + + P L+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEK 228
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
D + + R+P R + ++
Sbjct: 229 EA-----KDLLVK-------LFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 51/268 (19%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 483
+G+G V++ K K +K EI I+ H+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 484 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 543
L+++++F+S + E ++ + + E V EAL++LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 544 RDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 601
D++ NI+ + +FG A+ + Y APE + V+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 602 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 661
D+++ G ++ LL+G P + + +M A+ ++ A+ D
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM------D 236
Query: 662 QMERMVLASILCIRRDPRARPQMSLVLK 689
++R + ++ ++R S L+
Sbjct: 237 FVDR-------LLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 8e-47
Identities = 67/315 (21%), Positives = 123/315 (39%), Gaps = 37/315 (11%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLL 479
+++G G S+V K +A+K + E EI ++ + H NI++L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+L L+ +S G L + + + + ++ V +A++YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHD---L 126
Query: 540 RVIHRDVKSSNILLS---DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
++HRD+K N+L +D + +SDFGL+K S + GT GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 597 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656
+ +D ++ GV+ LL G P +++ ++ A+ S + D A
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA--- 240
Query: 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK--LLRGDADVTKWARLQVNASEESEML 714
D + + +DP R L+ + GD + K V+ +
Sbjct: 241 ---KDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF- 289
Query: 715 DDESCPRSNLQSHLN 729
+S + N
Sbjct: 290 -----AKSKWKQAFN 299
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 2e-46
Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 34/273 (12%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTL 470
+F +IG+GG +VY GK A+K L E + + + +++T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 471 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 530
I+ + + L + D ++ G L +L + ++ A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGL 120
Query: 531 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
E++H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 591 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649
PE G D D ++ G +L +LL G P K + + + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDS 231
Query: 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARP 682
P L +E ++RD R
Sbjct: 232 FSPEL-----RSLLEG-------LLQRDVNRRL 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-46
Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 41/304 (13%)
Query: 418 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKP--SEDVIKEFVLEIEII 467
+ +G+G QV ++AVK+LK +E + + + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 468 TTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA------------F 514
+ HKNII+LLG C +D L ++ ++ S+G+L E L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 515 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574
+ A VA +EYL S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 575 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 634
+ T+ ++APE + DV++FGV+L E+ T P V
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 243
Query: 635 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694
+L G +++ M+ C P RP +++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCT------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 294
Query: 695 ADVT 698
+T
Sbjct: 295 VALT 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 4e-45
Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 25/279 (8%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
IG G +Y G + G+E+A+K+ + +E +I + I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 482 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 541
C + + ++ L SLE+ + + F +A + +EY+HS +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 542 IHRDVKSSNILLSD---DFEPQLSDFGLAKWASTSSSHITC-----TDVAGTFGYLAPEY 593
IHRDVK N L+ + DFGLAK + +H ++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
+ + + + D+ + G VL+ G P + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEV 239
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
L Y + + C +P S + +L R
Sbjct: 240 LCKGYP-SEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (409), Expect = 6e-45
Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 472
+F +G G +V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
II + G + + ++ D++ G L L +++ P A V ALEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEY 119
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
LHS + +I+RD+K NILL + +++DFG AK+ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
N ID ++FG+++ E+L G P + + ++ A+ +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-----FNE 226
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 683
+ D + R I RD R
Sbjct: 227 DV-----KDLLSR-------LITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 28/285 (9%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNII 476
+ +G+G + VYK + +A+K +K + + + + EI+++ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
LL +N+ LV+DF+ + S + + LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 596
++HRD+K +N+LL ++ +L+DFGLAK S S + T T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 597 GKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKPILSSGK 645
++ +D++A G +L ELL + D Q + + W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 646 VTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLK 689
VT P + ++ + +L I +P AR + LK
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-44
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 31/296 (10%)
Query: 417 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHK 473
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 474 NIISLLGFC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 529
NII + E + + L L + L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 530 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 588
L+Y+HS V+HRD+K SN+LL+ + ++ DFGLA+ T+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 589 LAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647
APE + K ID+++ G +L E+L+ R H Q + ++ S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 648 QLLD-PALGNNYDYDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 689
+++ A ++ + + +P R ++ L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 4e-43
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 25/282 (8%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 480
IG+G VYK G+ A+K ++ E + + EI I+ L H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
L+LV++ L + + + + + Y H +R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
V+HRD+K N+L++ + E +++DFGLA+ ++ + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYS 179
Query: 601 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660
ID+++ G + E++ G Q + +S + + + ++
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 661 DQMERMVLASIL-------------CIRRDPRARPQMSLVLK 689
E + S L ++ DP R L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (388), Expect = 2e-42
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
++ IG+G +++G L + +++A+K D + E L I
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIP 64
Query: 478 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
+ + ++ ++ L SLE+ L + F A + ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE-- 119
Query: 538 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSH-----ITCTDVAGTFG 587
+ +++RD+K N L+ + DFG+ K+ + +++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 588 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647
Y++ + + + + D+ A G V + L G P + S +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692
+L + + + A P + L
Sbjct: 239 ELCA-------GFPEEFYKYMHY--ARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-42
Identities = 59/333 (17%), Positives = 134/333 (40%), Gaps = 28/333 (8%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
++G G + +V + ++ A+K+L+ +E L +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 482 C----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 537
LL+V + L G L + F E ++ + EA++YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS-- 129
Query: 538 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 597
+ HRDVK N+L + + +A ++SH + T T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 598 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 657
K + D+++ GV++ LL G P ++H + + + + ++ Q P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 658 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDE 717
++++ ++ ++ +P R ++ + + + ++ S +L ++
Sbjct: 243 EVSEEVKMLIRN---LLKTEPTQRMTITEFMN----HPWIMQSTKVPQTPLHTSRVLKED 295
Query: 718 SCPRSNLQSHLNLAL--LDVEDDSFSMSSIEQS 748
+++ + AL + V+ + + IE +
Sbjct: 296 KERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNII 476
+G G + V K G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 477 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 536
+L +++L+ + ++ G L + L + E + + + YLHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 537 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 592
++ H D+K NI+L D P+ + DFGLA + ++ GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 593 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
Y + + D+++ GV+ LL+G P D + + V +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
A D + R + +DP+ R + L+
Sbjct: 247 A------KDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-42
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 474
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
I+ LL +N L LV++FL + + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE-Y 593
S RV+HRD+K N+L++ + +L+DFGLA+ T T Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 174
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
+ +D+++ G + E++T R D Q + + G +++ P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-----LFRIFRTLGTPDEVVWPG 229
Query: 654 LGNNYDYD----QMERMVLASIL-------------CIRRDPRARPQMSLVLK 689
+ + DY + R + ++ + DP R L
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 63/302 (20%), Positives = 123/302 (40%), Gaps = 37/302 (12%)
Query: 418 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHK 473
S + IG+G +V+K G+++A+K + E + EI+I+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 474 NIISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 525
N+++L+ C ++ LV+DF + K F SE +V
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 526 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVA 583
+ L Y+H +++HRD+K++N+L++ D +L+DFGLA+ S + S T+
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 584 GTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 642
T Y PE + + ID++ G ++ E+ T + + + Q +L+ ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASIL---------------CIRRDPRARPQMSLV 687
+ + L + + ++ + L + DP R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 688 LK 689
L
Sbjct: 303 LN 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 54/297 (18%), Positives = 107/297 (36%), Gaps = 32/297 (10%)
Query: 416 ATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTL 470
A + IG+G +V+K G+ +A+K ++ E + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 471 ---HHKNIISLLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 522
H N++ L C + L LV++ + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121
Query: 523 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 582
+ L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175
Query: 583 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 642
T Y APE + +D+++ G + E+ + Q ++ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 643 SGKVTQLLDPALGNNYDYDQMERMVLASIL----------CIRRDPRARPQMSLVLK 689
+ + + + + C+ +P R L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 76/352 (21%), Positives = 129/352 (36%), Gaps = 32/352 (9%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 477
++ +IG G VY+ G+ +A+K + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 478 LLGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 531
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLA 136
Query: 532 YLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 590
Y+HS + HRD+K N+LL D +L DFG AK +++ + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 591 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649
PE IDV++ G VL ELL G+ D Q LV K + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248
Query: 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASE 709
+ + Q++ + R P A +L +LL ARL +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI---ALCSRLLEYTPT----ARLTPLEAC 301
Query: 710 ESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSR 761
D+ P L + + L +F+ + + L L+ +R
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPAL----FNFTTQELSSNPPLATILIPPHAR 349
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 51/277 (18%), Positives = 99/277 (35%), Gaps = 45/277 (16%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKN 474
L+G GG VY G + D +A+K ++ +E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 475 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+I LL + ++ +L+ + + + A V EA+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 535 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
+ V+HRD+K NIL+ + E +L DFG + TD GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 594 FMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
Y + + + V++ G++L +++ G P +D ++ + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR-----VSS 229
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689
+ C+ P RP +
Sbjct: 230 EC-----QHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 480
+G G V G ++A+K L SE K E+ ++ + H+N+I LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
D L DF G G + + + L Y+H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
+IHRD+K N+ +++D E ++ DFGLA+ A + + V + + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----GYVVTRWYRAPEVILNWMRYT 197
Query: 601 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL-LDPALGNNYD 659
+D+++ G ++ E++TG+ Q +M + V +L D A
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 660 YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 689
++E+ ASIL + D R L
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-39
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 31/271 (11%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 473
+F L+GKG +V G+ A+KIL+ ++D + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 474 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 533
+ +L + L V ++ + G L +L + F + ALEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYL 121
Query: 534 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
HS + V++RD+K N++L D +++DFGL K + + + GT YLAPE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 594 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653
+D + GVV+ E++ GR P N + L++ + L P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPE 231
Query: 654 LGNNYDYDQMERMVLASILCIRRDPRARPQM 684
+ +++DP+ R
Sbjct: 232 A-----KSLLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 33/287 (11%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 479
IG+G V+K + +A+K ++ E V + EI ++ L HKNI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
D L LV++F + + N + + L + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
V+HRD+K N+L++ + E +L++FGLA+ + V + F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLY 179
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 659
+ ID+++ G + EL +P+ G + + G T+ P++ D
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLF----PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 660 YDQMERMVLASIL-----------------CIRRDPRARPQMSLVLK 689
Y + L ++ +P R L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 5e-38
Identities = 58/263 (22%), Positives = 99/263 (37%), Gaps = 34/263 (12%)
Query: 426 IGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 480
+G G +V G A+KIL I+ + E I+ ++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 540
+++NL +V ++++ G + +L + F A + EYLHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 541 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 600
+I+RD+K N+L+ Q++DFG AK + GT LAPE + N
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 601 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 660
+D +A GV++ E+ G P D P ++ K S L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDL-----K 266
Query: 661 DQMERMVLASILCIRRDPRARPQ 683
D + ++ D R
Sbjct: 267 DLLRN-------LLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 419 NFLAENLIGKGGSSQVYKG----CLPDGKELAVKILKPS-----EDVIKEFVLEIEIITT 469
NF ++G G +V+ GK A+K+LK + + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 470 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 528
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 529 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
ALE+LH +I+RD+K NILL + L+DFGL+K + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 196
Query: 589 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646
+AP+ G +D ++ GV++ ELLTG P + D K ++ + + + S
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 255
Query: 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 685
Q + D ++R + +DP+ R
Sbjct: 256 PQEMSALA-----KDLIQR-------LLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 4e-33
Identities = 55/287 (19%), Positives = 120/287 (41%), Gaps = 27/287 (9%)
Query: 419 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNII 476
++ +G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 477 SLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
+L + LV++ ++ ++ + + +AL+Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 535 SGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 593
S ++HRDVK N+++ + + +L D+GLA++ + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 594 FM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652
+ Y + +D+++ G +L ++ ++P + H + LV AK + + +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 259
Query: 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMS-----LVLKLLRGD 694
+ + ++ + + +S + KLLR D
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 9e-33
Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 25/284 (8%)
Query: 424 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 479
+ +G G V G +AVK L S K E+ ++ + H+N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 480 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 539
+L D L N + + L+Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 540 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 599
+IHRD+K SN+ +++D E ++ DFGLA+ + T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHY 196
Query: 600 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 659
N +D+++ G ++ ELLTGR Q L++ + + ++ + N
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 660 -YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 689
QM +M A++ + D R + L
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (308), Expect = 5e-31
Identities = 54/312 (17%), Positives = 106/312 (33%), Gaps = 47/312 (15%)
Query: 423 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 481
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 482 C----------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 529
F V+ + L ENL K G Y +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 530 LEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 588
L+Y+H +IH D+K N+L+ D L +A + T+ T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 589 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-----------QESLVMWA 637
+PE + D+++ ++ EL+TG D E L
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 638 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--------------------CIRRD 677
+L +GK T+ + G + +++ L +L ++ D
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 678 PRARPQMSLVLK 689
PR R ++
Sbjct: 316 PRKRADAGGLVN 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 425 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 480
IG G V + +A+K L ++ K E+ ++ ++HKNIISLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 481 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 534
E ++ LV + + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 535 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 594
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 595 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 654
+ + +D+++ G ++ E++ + Q + V+ + +L
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 655 GNNYDYDQMERMVLASILCIRRDPRARPQ--------MSLVLKLLRGD 694
+ + + + P L+ K+L D
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 2e-20
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 22/156 (14%)
Query: 424 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----------EFVLEIEIITTLHH 472
L+G+G S V+ E VK K K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 473 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 532
+ + L G Y + L E + + + + E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 533 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568
+ + ++H D+ N+L+ + + DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 766 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.83 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.75 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.71 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.67 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.65 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.36 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 91.06 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 87.17 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 82.9 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=420.17 Aligned_cols=254 Identities=24% Similarity=0.435 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||.||+|.+.+++.||||+++......++|.+|+.++++++|||||+++|+|...+.+++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57899999999999999999998889999999987766678899999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 85 g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999987553 368999999999999999999999 899999999999999999999999999998775543322
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
.....||+.|+|||++..+.|+.++|||||||+||||+|+ ++||...........+.... ....|.
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------~~~~p~--- 225 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------RLYKPR--- 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC---------CCCCCT---
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC---------CCCCcc---
Confidence 2235799999999999999999999999999999999995 55555433222111111110 011111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.. ...+..++..||+.||.+||||++|+++|+..
T Consensus 226 -~~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 -LA---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cc---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 23455677889999999999999999998743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=423.03 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=203.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... +..+.+.+|+++|++++|||||++++++.+.+.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999874 79999999986543 345678999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.++|... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999654 368999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.........+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.................... .+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~--------~~ 228 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------NP 228 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS--------TT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------Cc
Confidence 43333445789999999999988776 5789999999999999999999976544332221111111000 00
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ...+ ..+..++..||+.||.+|||+.+++++
T Consensus 229 ~--~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 W--KKID----SAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp G--GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--ccCC----HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0111 233455678999999999999999763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=422.26 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=200.5
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.++|.+.+.||+|+||+||+|.++. .||||+++. .....+.|.+|+.+|.+++|||||++++++.+ +.++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678899999999999999998643 599999974 34567889999999999999999999999854 57899999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+++|+|.++++... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999997554 368999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCceecccccccCCCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
..........||+.|+|||++.. +.|+.++|||||||+||||+||+.||.+.............. .....+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~--- 232 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG--YLSPDLS--- 232 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT--SCCCCGG---
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--CCCCcch---
Confidence 44444455789999999999964 358999999999999999999999998765433322211111 0000110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+.... ...+..++..||+.||.+||||.+|++.|+.
T Consensus 233 --~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 233 --KVRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp --GSCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --hccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111111 2345566778999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=418.08 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=205.4
Q ss_pred hcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 496 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 496 (766)
.++|.+.+.||+|+||.||+|.+++++.||||+++......+.|.+|+.++.+++|||||+++++|.+ +.+++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35788999999999999999999888999999998766667889999999999999999999998854 56799999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.+++..... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||++++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998865432 358999999999999999999999 89999999999999999999999999999977653322
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC-CCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
......||+.|+|||++..+.++.++|||||||+||||+||..| |....... +..... .+ ..+...
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~----~~-----~~~~~p 232 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLE----RG-----YRMVRP 232 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TT-----CCCCCC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----hc-----CCCCCc
Confidence 22346799999999999999999999999999999999996555 44332221 111111 11 011111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
...+ ..+..++..||+.||++||||.+|++.|+
T Consensus 233 ~~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 233 DNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 1112 24556677899999999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=422.14 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=195.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CC---CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.++||+|+||+||+|.+. +| ..||||.+... ....+.|.+|+.+|++++|||||+++|+|...+.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777899999999999999874 33 25899998653 45667899999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... ..++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999887543 368999999999999999999999 899999999999999999999999999999776
Q ss_pred CCCCCce---ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 572 TSSSHIT---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 572 ~~~~~~~---~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
....... .....||+.|+|||++..+.|+.++|||||||+||||+| |+.||...........+. .+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-------~~~~- 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-------QDYR- 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-
Confidence 5433222 122468999999999999999999999999999999998 899998765432222211 1100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+ ..+.+....+..++..||+.||.+||||.+|++.|+.
T Consensus 252 ----~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 ----L----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ----C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----C----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 0111122345567788999999999999999998863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=415.17 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=204.9
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ....+.+.+|+.+++.++|||||+++++|.+.+.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999998643 234567899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997653 58999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
... ....||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+.....
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------- 221 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------- 221 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------
T ss_pred Ccc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 322 236899999999999999999999999999999999999999987554332222111110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+....+ ..+..++..||+.||.+|||+.+++++
T Consensus 222 ~~p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 TFPDFVT----EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1111111 234456678999999999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=417.87 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=194.8
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~l 490 (766)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... +...+.+.+|++++++++|||||+++++|.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999986 47899999998653 3456779999999999999999999999864 456899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC--CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||||+++|+|.+++.........+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998754333457999999999999999999999822 2359999999999999999999999999999
Q ss_pred cccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
........ .....||+.|+|||++.+..|+.++|||||||+||||+||+.||...+.......+. .+....
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-------~~~~~~ 233 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCCCC
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCCC
Confidence 87653322 234689999999999999999999999999999999999999998654432221111 111111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+...++ ..+..++..||+.||.+|||+.+++++
T Consensus 234 -----~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 -----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111122 234556678999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-49 Score=422.06 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=210.6
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+.+|++++|||||+++++|.+++.+++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 357888999999999999999875 6889999999877666788999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999976433 468999999999999999999999 8999999999999999999999999999997765433
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. ......||+.|+|||++.++.|+.++|||||||+||||++|..||........ +.... ..+. .+...
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----~~~~-----~~~~~ 238 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----EKDY-----RMERP 238 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----HTTC-----CCCCC
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----hcCC-----CCCCC
Confidence 2 33345789999999999999999999999999999999997776644332221 11111 1110 01111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
... ...+..++..||+.||.+||||.+|++.|+..
T Consensus 239 ~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 239 EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 23455677889999999999999999988643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=408.91 Aligned_cols=253 Identities=23% Similarity=0.440 Sum_probs=213.0
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|.+.+.||+|+||+||+|.+++++.||||+++......++|.+|+.++.+++||||++++|+|.+.+.+++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68899999999999999999998888999999987766678899999999999999999999999999999999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++.... ..+++..+++|+.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 84 GCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp EEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999976544 358899999999999999999999 89999999999999999999999999999876554333
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......||+.|+|||++..+.++.++|||||||++|||+| |+.||...........+. .+. .+..|.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~--~~~~p~--- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGL--RLYRPH--- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTC--CCCCCT---
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hCC--CCCCcc---
Confidence 2234679999999999999999999999999999999998 899998765433222221 111 111111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. . ...+..++..||+.||.+|||+.+|+++|..
T Consensus 225 ~-~---~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 L-A---SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp T-C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred c-c---cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1 1 1345567778999999999999999999853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=415.41 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=205.2
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.++++++|||||+++++|.+.+.+||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999986 479999999987543 34577999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
+||+|.+++... .+++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 48999999999999999999999 8999999999999999999999999999987755433
Q ss_pred CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. ....+||+.|+|||++.++.|+.++|||||||+||+|++|+.||.+.+.......+... +. ..+-.
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------~~-~~~~~---- 238 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN------GT-PELQN---- 238 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH------CS-CCCSS----
T ss_pred c--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CC-CCCCC----
Confidence 2 23468999999999999999999999999999999999999999765543222211110 00 00000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.......+..++..||+.||.+|||+.+++++
T Consensus 239 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 ---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111234456678999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=421.79 Aligned_cols=257 Identities=23% Similarity=0.410 Sum_probs=207.6
Q ss_pred cCcccceeeeccCceEEEEEEeCC-C-----CEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPD-G-----KELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~-g-----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
++|.+.+.||+|+||+||+|.... + ..||||++... ......+.+|+.+|.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999998642 2 36899998653 34456789999999998 899999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCC
Q 004247 489 LLVYDFLSRGSLEENLHGNKK-------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 549 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~ 549 (766)
+|||||+++|+|.++|+.... ....++|..++.|+.||+.||.|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999976532 12358999999999999999999999 89999999999
Q ss_pred CeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCcc
Q 004247 550 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 628 (766)
Q Consensus 550 NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~ 628 (766)
|||++.++.+||+|||+|+...............||+.|+|||++..+.|+.++|||||||+||||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998776665555556789999999999999999999999999999999998 89999875543
Q ss_pred chhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 629 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 629 ~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
.....+. ..+. .+.. +......+..++..||+.||.+|||+.+|+++|.
T Consensus 274 ~~~~~~~------~~~~-----~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLI------QNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHH------HTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH------hcCC-----CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221111 1110 0011 1111234556677899999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=417.30 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=202.6
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++||||++++++|.+.+.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999987 47999999998743 234567999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++||+|.+++...+ .+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987654 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+. .+.+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-------~~~~------ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------KLEY------ 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------TTCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-------cCCC------
Confidence 544444445789999999999999999999999999999999999999998754432222111 1110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 689 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~ 689 (766)
.+...+. ..+..++..||+.||.+|||+.|++.
T Consensus 228 ~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0111122 23455667899999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=410.24 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=205.5
Q ss_pred hcCccccee-eeccCceEEEEEEeC---CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENL-IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~-LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.++ ||+|+||.||+|.+. ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.. +.++|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777775 999999999999753 4557999999753 4557889999999999999999999999864 57899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++...+ ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986543 368999999999999999999999 89999999999999999999999999999977
Q ss_pred cCCCCCc-eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 571 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 571 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
....... ......||+.|+|||++..+.++.++|||||||+||||+| |+.||...........+. .|....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~~~~ 232 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRME 232 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC
Confidence 6543322 2223578999999999999999999999999999999998 999998765432222221 121111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
+....+ ..+..++..||+.||++||||.+|++.|+
T Consensus 233 -----~p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 233 -----CPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp -----CCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----CCCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 111112 34456677899999999999999999886
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=412.50 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=203.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+.|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+.++|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45899999999999999999864 7899999999653 355678999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.+++.... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 9999999986543 358999999999999999999999 8999999999999999999999999999976543211
Q ss_pred CceecccccccCCCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 576 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
......||+.|+|||++. ...|+.++|||||||+||||+||+.||...++......+... ....+.
T Consensus 166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-------~~~~~~ 236 (288)
T d2jfla1 166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------EPPTLA 236 (288)
T ss_dssp --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-------CCCCCS
T ss_pred --cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------CCCCCC
Confidence 123468999999999984 456899999999999999999999999876544322221111 111110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ ......+..++..||+.||.+|||+.+++++
T Consensus 237 ~~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 QP-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cc-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1112334556678999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=420.40 Aligned_cols=202 Identities=25% Similarity=0.442 Sum_probs=179.8
Q ss_pred HhcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
..++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ......+.+|+.+|++++|||||+++++|.+.+.++|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999996 47899999998753 355678999999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++||+|.+++.... .+++..+..++.||+.||.|||+. ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 589999999999999999999961 3799999999999999999999999999997654
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 627 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 627 (766)
... ...+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 158 ~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 SMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred Ccc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 322 236899999999999999999999999999999999999999977553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=409.32 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=197.7
Q ss_pred hcCcccceeeeccCceEEEEEEeCCC-----CEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPDG-----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~g-----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
.+.|...++||+|+||.||+|.++.+ ..||||+++.. .....+|.+|+.++++++|||||+++|+|.+.+.++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999986532 36999998753 345668999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+.+|+|.+.+.... ..++|..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999887554 368999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccc
Q 004247 570 ASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 648 (766)
Q Consensus 570 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ 648 (766)
....... .......||+.|+|||++..+.++.++|||||||+||||++|..|+....... .+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~~i----~~~~--- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAI----NDGF--- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH----HTTC---
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHHHH----hccC---
Confidence 6553322 22233578999999999999999999999999999999999666654432221 111111 1110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 649 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 649 lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+ ..+.+....+..++..||+.||.+||||.+|+++|+.
T Consensus 231 --~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 --RL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp --CC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 01 1111122446667788999999999999999998864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=405.63 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=197.3
Q ss_pred eeeeccCceEEEEEEeC---CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 424 NLIGKGGSSQVYKGCLP---DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 424 ~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
+.||+|+||+||+|.+. .++.||||+++.. ....++|.+|+++|++++|||||+++++|.. +.++|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 3568999999753 2456789999999999999999999999954 568999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|.++++... .++|..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997653 58999999999999999999999 899999999999999999999999999998775543332
Q ss_pred e-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 578 T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 578 ~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
. .....||+.|+|||.+..+.++.++|||||||++|||+| |+.||.+.........+. .+.... +.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~~~~-----~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMG-----CP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC-----CC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------cCCCCC-----CC
Confidence 2 233579999999999999999999999999999999998 899998765432222221 111111 11
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
...+ ..+..++..||+.||.+|||+.+|++.|+
T Consensus 233 ~~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 233 AGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 1112 34556677899999999999999998885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-48 Score=412.90 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=189.5
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.+.|.+.+.||+|+||+||+|... +|+.||||++.... .....+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999874 68999999987542 334678899999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC---CCCCeeEecccccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 570 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~~ 570 (766)
|++||+|.++|.... .+++.++..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997543 58999999999999999999999 8999999999999994 5789999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
...... ...+||+.|+|||++.++.|+.++|||||||+||||++|+.||.+.........+...... +
T Consensus 161 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------~ 228 (307)
T d1a06a_ 161 DPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE---------F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC---------C
T ss_pred cCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC---------C
Confidence 543322 2367999999999999999999999999999999999999999875443222221111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........+ ..+..++..||+.||.+|||+.|++++
T Consensus 229 ~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011111111 234556678999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=403.77 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=194.4
Q ss_pred ccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEE
Q 004247 421 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 492 (766)
Q Consensus 421 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~ 492 (766)
.+.+.||+|+||+||+|.+. +++.||+|++... ....+.|.+|+++|++++|||||+++++|.. ...++|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999874 6889999998643 3456789999999999999999999999875 34589999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCc--eEeecccCCCeeeC-CCCCeeEeccccccc
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAKW 569 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~-~~~~vkL~DFGla~~ 569 (766)
||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++ |+||||||+||||+ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997653 58999999999999999999998 66 99999999999996 578999999999986
Q ss_pred ccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 570 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 570 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
..... ....+||+.|+|||++. ++|+.++|||||||+||||++|+.||........ +... +..+.....
T Consensus 165 ~~~~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~----i~~~~~~~~ 233 (270)
T d1t4ha_ 165 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR----VTSGVKPAS 233 (270)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH----HTTTCCCGG
T ss_pred ccCCc----cCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHH----HHcCCCCcc
Confidence 54432 22468999999999987 5699999999999999999999999975433221 1111 111111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
++ .. ..+ .+..++..||+.||++|||+.|++++
T Consensus 234 ~~----~~-~~~---~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FD----KV-AIP---EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG----GC-CCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cC----cc-CCH---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 11 112 24456678999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-47 Score=414.09 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=206.5
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+|++++|||||+++++|.+.+.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999986 478999999997643 4567889999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC--CCCCeeEecccccccccC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DFGla~~~~~ 572 (766)
++||+|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999996443 369999999999999999999999 8999999999999996 457899999999987765
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.... ....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+...... +. .
T Consensus 179 ~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~----~ 246 (350)
T d1koaa2 179 KQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-----MD----D 246 (350)
T ss_dssp TSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----SC----C
T ss_pred cccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CC----c
Confidence 4332 3368999999999999999999999999999999999999999876543322222111110 00 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
...... ...+..++..||+.||.+|||+.++|++
T Consensus 247 ~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111 1234556678999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=406.46 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=200.5
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 497 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 497 (766)
++|++.+.||+|+||.||+|.+++++.||||+++......+.|.+|+.++.+++|||||+++++|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 5689999999999999999999888899999998776667889999999999999999999999954 568999999999
Q ss_pred CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCCc
Q 004247 498 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 577 (766)
Q Consensus 498 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 577 (766)
|+|..++..... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 96 g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 96 GSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp CBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999999875432 358999999999999999999999 89999999999999999999999999999876543322
Q ss_pred eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-ccchhhHHHhhccccccCccccccCcccCC
Q 004247 578 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH-PKGQESLVMWAKPILSSGKVTQLLDPALGN 656 (766)
Q Consensus 578 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~lv~~~~~~~~~g~~~~lld~~l~~ 656 (766)
......||+.|+|||++..+.++.++|||||||+||||++|..|+.... .......+.+ +. .+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-------~~-----~~~~~~ 237 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GY-----RMPCPP 237 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------TC-----CCCCCT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------cC-----CCCCCc
Confidence 2234679999999999999999999999999999999999666554432 2211111111 10 011111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 657 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 657 ~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+.+..++..||+.||++||+|.+|+++|+.
T Consensus 238 ----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 238 ----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 112345667788999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=406.36 Aligned_cols=261 Identities=24% Similarity=0.421 Sum_probs=211.6
Q ss_pred HhcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004247 416 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 487 (766)
Q Consensus 416 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 487 (766)
..++|.+.+.||+|+||+||+|... +++.||||+++.. ....++|.+|+.+|++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999853 4578999999753 3456789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeeccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 547 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLK 547 (766)
.++||||+++|+|.++++.... ....+++..++.|+.|++.||+|||+ ++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 9999999999999999975321 12358999999999999999999999 899999999
Q ss_pred CCCeeeCCCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCC-CCCCCCC
Q 004247 548 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDH 626 (766)
Q Consensus 548 p~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~ 626 (766)
|+||||+.++.+||+|||+++...........+...||+.|+|||++....|+.++|||||||+||||++|. .||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765544444444578999999999999999999999999999999999985 6787654
Q ss_pred ccchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004247 627 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 695 (766)
Q Consensus 627 ~~~~~~lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~ 695 (766)
.......+. .+..... .... ...+..++..||+.+|.+||||.+|+++|+...
T Consensus 248 ~~e~~~~v~-------~~~~~~~-----p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVR-------DGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHH-------TTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHH-------cCCCCCC-----Cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 433222221 1221111 1111 234566778899999999999999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.4e-47 Score=411.89 Aligned_cols=251 Identities=21% Similarity=0.248 Sum_probs=206.1
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999986 479999999987643 44567889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC--CCCCeeEecccccccccCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DFGla~~~~~~ 573 (766)
+||+|.+.+.... ..+++.+++.|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998876543 369999999999999999999999 8999999999999997 6789999999999987654
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
... ....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.........+...... +...
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---------~~~~ 250 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------FDED 250 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---------CCSS
T ss_pred Cce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CCcc
Confidence 332 2367999999999999999999999999999999999999999875543322221111100 0011
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.....+ ..+..++..||+.||.+|||+.++|++
T Consensus 251 ~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVS----PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 234456678999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-47 Score=406.54 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=199.5
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
.|...+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488999999999999999986 47889999998643 2455779999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+.+|+|..++... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998776544 258999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCceecccccccCCCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 650 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~ll 650 (766)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.+.........+.. +..
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-------~~~---- 231 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NES---- 231 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCC----
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CCC----
Confidence 23579999999999863 4689999999999999999999999976543322111110 111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 d~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+.+...... ..+..++..||+.||.+|||+.++|++
T Consensus 232 -~~~~~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 -PALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCCSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCC---HHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111111112 234556678999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=400.81 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC-------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.+.|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|++++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999997 47999999998642 12467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC----CeeEecc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 564 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 564 (766)
||||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997653 58999999999999999999999 8999999999999998776 4999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
|+|+........ ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.......+.....
T Consensus 162 G~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 162 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 233 (293)
T ss_dssp TTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred hhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 999877544322 235799999999999999999999999999999999999999987554332221111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
... +...... ...+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~----~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFE----DEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCC----HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC----chhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000111 1234456678999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=403.67 Aligned_cols=253 Identities=22% Similarity=0.388 Sum_probs=202.0
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCC----EEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.+|++.++||+|+||+||+|.+. +|+ .||||.++.. ....++|.+|+.++++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999864 444 5899988653 3456789999999999999999999999976 46788
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
+|||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887654 468999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
.............||+.|+|||++.++.|+.++|||||||+||||+| |..||...........+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 66555444445679999999999999999999999999999999999 89999876544333332211110
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. .+......+..++..||+.||.+|||+.+|+++|..
T Consensus 233 ---~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ---P----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---C----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---C----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0 011112345567778999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=406.47 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=206.1
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999986 47999999999753 23457789999999999999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||++||+|.+++.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998654 58899999999999999999999 999999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+.. +.+
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------~~~----- 222 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EEI----- 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC-----
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------CCC-----
Confidence 4332 22347899999999999999999999999999999999999999987654332222111 110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
.+...+. ..+..++..||+.||.+||+ +.+++++
T Consensus 223 -~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1111122 23445667899999999995 8888874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=393.19 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=195.4
Q ss_pred hcCcccceeeeccCceEEEEEEeCC----CCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 490 (766)
.++|.+.+.||+|+||.||+|.+.. +..||||.++.. ....+.|.+|+.++++++|||||+++++|. .+.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3579999999999999999998642 356899998753 455678999999999999999999999995 467899
Q ss_pred EEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccc
Q 004247 491 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 570 (766)
Q Consensus 491 V~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 570 (766)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999887544 368999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccc
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 649 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~l 649 (766)
....... .....||+.|+|||++..+.|+.++|||||||+||||+| |..||...........+. .+....
T Consensus 159 ~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~~~~~- 229 (273)
T d1mp8a_ 159 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLP- 229 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCCC-
T ss_pred cCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC-
Confidence 5433322 234678999999999999999999999999999999998 899998765543322221 111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 650 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 650 ld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+....+ ..+..++..||..||.+|||+.+|++.|+.
T Consensus 230 ----~~~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 230 ----MPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111122 345566778999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-46 Score=401.41 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=204.3
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999997 47999999999743 234578899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||++||+|..++.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999997654 47889999999999999999999 8999999999999999999999999999987754
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.. ...+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+..... .
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~------- 219 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----R------- 219 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----C-------
T ss_pred cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----C-------
Confidence 32 236899999999999988999999999999999999999999987654332222221110 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
+....+ ..+..++..||+.||.+|| |+++++++
T Consensus 220 -~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111112 2344566789999999996 89999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=398.99 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=198.4
Q ss_pred hcCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec-C
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~ 486 (766)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|..++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367999999999999999999853 3568999999753 34567788898888887 689999999998764 4
Q ss_pred ceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
.+++||||+++|+|.++|+.... ....+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999975432 12458999999999999999999999 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCccchhhH
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESL 633 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~l 633 (766)
.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+|| ..||...........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999977665555455557899999999999999999999999999999999996 567865543322111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
. +..+.. +...... ...+..++..||+.||.+|||+.+|+++|+.
T Consensus 249 ~------~~~~~~-----~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 249 R------LKEGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp H------HHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H------HhcCCC-----CCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 111111 1111111 2245566778999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=393.65 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=195.7
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 496 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ 496 (766)
++|.+.+.||+|+||.||+|.+ .|+.||||+++.+ ...+.|.+|++++++++||||++++|+|.+ .+.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 5688899999999999999998 5789999999764 345789999999999999999999999965 456899999999
Q ss_pred CCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCCC
Q 004247 497 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 576 (766)
Q Consensus 497 ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 576 (766)
+|+|.++|..... ..++|..++.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999975432 358999999999999999999999 899999999999999999999999999998654432
Q ss_pred ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccccccCcccC
Q 004247 577 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 655 (766)
Q Consensus 577 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~l~ 655 (766)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...........+ ..+.. +.+.
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-------~~~~~-----~~~~ 222 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYK-----MDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTCC-----CCCC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCCC-----CCCC
Confidence 22468999999999999999999999999999999998 78888765443222211 11111 1111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 656 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
...+ ..+..++..||+.||.+||||.+|+++|+.
T Consensus 223 ~~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1112 345566778999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=400.74 Aligned_cols=252 Identities=19% Similarity=0.241 Sum_probs=207.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++........+.+|+++|+.++|||||+++++|.+.+.+||||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 367999999999999999999875 6889999999877666677899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCC--CCeeEecccccccccCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWASTS 573 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--~~vkL~DFGla~~~~~~ 573 (766)
+||+|.++|.... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997543 358999999999999999999999 899999999999999854 57999999999876543
Q ss_pred CCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. .....||+.|+|||.+.+..|+.++|||||||+||+|++|+.||...+.......+......+ +..
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------~~~ 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------DEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------CHH
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------Chh
Confidence 22 233679999999999999999999999999999999999999998765433222221111000 000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..... ...+..++..||+.||.+|||+.+++++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011 1234556678999999999999999984
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-45 Score=389.45 Aligned_cols=250 Identities=27% Similarity=0.398 Sum_probs=203.9
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----------hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----------EDVIKEFVLEIEIITTLH-HKNIISLLGFCFED 485 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----------~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 485 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.++++++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999986 47899999998643 123457889999999997 99999999999999
Q ss_pred CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccc
Q 004247 486 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 565 (766)
Q Consensus 486 ~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 565 (766)
+.+||||||+++|+|.++|.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997643 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCchhhcc------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004247 566 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 639 (766)
Q Consensus 566 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 639 (766)
+++........ ....||+.|+|||++.. ..++.++|||||||+||||++|+.||...........+.....
T Consensus 156 ~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 156 FSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 99987654322 34689999999999863 3578899999999999999999999987654332222221111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 ~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+.. + ........+..++..||+.||.+|||+.+|+++
T Consensus 233 ~~~~--------~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 QFGS--------P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCT--------T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC--------c-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 0 001111345556678999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.4e-46 Score=390.10 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=197.9
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 487 (766)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ......|.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 57999999999753 3456789999999999999999999999987543
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
+||||||++||+|.+++...+ .+++.+++.|+.||+.||.|||+ ++||||||||+||||+.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 799999999999999987654 58999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCC-CceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 568 KWASTSSS-HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 568 ~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
+....... .......+||+.|+|||++.+..|+.++|||||||+||||+||+.||....+...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----- 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-----
Confidence 76544322 222334689999999999999899999999999999999999999998765432221111111110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHhh
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLR 692 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-s~~eVL~~L~ 692 (766)
..... ...+ ..+..++..||+.||.+|| |++++++.|.
T Consensus 234 ~~~~~----~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 PSARH----EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGTS----SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Cchhc----cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 00111 1111 2344566789999999999 7999887664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=398.97 Aligned_cols=270 Identities=26% Similarity=0.324 Sum_probs=200.8
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----ceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~lV~E 493 (766)
.+|.+.+.||+|+||.||+|.+ +|+.||||+++........+..|+..+.+++|||||+++++|.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4688899999999999999987 7889999999765443333334555566789999999999998754 5799999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcC-----CCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
|+++|+|.++|+.. .++|..++.++.+++.||.|||.. ..++||||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999764 489999999999999999999973 13699999999999999999999999999999
Q ss_pred cccCCCCCc--eecccccccCCCCchhhccC------CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHh-hcc
Q 004247 569 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKP 639 (766)
Q Consensus 569 ~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~-~~~ 639 (766)
......... ......||+.|+|||++... .++.++|||||||+||||+||..||.............. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 776543221 22346899999999998754 367799999999999999999988754332111000000 000
Q ss_pred ---ccccCccccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 640 ---ILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 640 ---~~~~g~~~~lld~~l~~~~-~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+........++|.+.... ..+....+..++..||+.||.+|||+.+|++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0000001111222222221 23445667788899999999999999999998863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=398.60 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=210.7
Q ss_pred cCcccceeeeccCceEEEEEEe------CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 488 (766)
++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ......|.+|+.++..+ +|||||+++++|.+.+.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788899999999999999975 35678999999754 34566899999999999 699999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCC--------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 489 LLVYDFLSRGSLEENLHGNKK--------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
++||||+++|+|.++++.... ....+++..+..|+.||+.||.|||+ ++||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 999999999999999976542 22368999999999999999999999 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchh-h
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQE-S 632 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~-~ 632 (766)
.++.+||+|||+++...............||+.|+|||++..+.++.++|||||||+||||+| |.+||......... .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999998877666555566789999999999999999999999999999999999 55556554433221 1
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 633 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 633 lv~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
++....+ +.. +......+..++..||+.||.+||||.+|+++|+.
T Consensus 260 ~i~~~~~------------~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 260 MIKEGFR------------MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHTCC------------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCC------------CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111110 111 11112345667788999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-45 Score=403.01 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=199.3
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCCh----hHHHHHH---HHHHHHHhcCCCceeEEeeEEeecCce
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNL 488 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~---~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 488 (766)
.++|.+.++||+|+||.||+|... +|+.||||++.... .....+. .|+.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999874 79999999986422 1222333 446777778899999999999999999
Q ss_pred EEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 489 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 489 ~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||||||++||+|.++|.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999997653 57899999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 569 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 569 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
....... ....||+.|+|||++..+ .|+.++|||||||+||||+||+.||..........+.......
T Consensus 156 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------- 224 (364)
T d1omwa3 156 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224 (364)
T ss_dssp ECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------
T ss_pred ecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------
Confidence 7665432 235799999999999754 6899999999999999999999999876554433332211100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 690 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs-----~~eVL~~ 690 (766)
...+...++ ..+..++..||+.||.+||| +.+++++
T Consensus 225 ---~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 ---AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 001111122 23445667899999999999 6888874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=393.26 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=206.0
Q ss_pred cCcccceeeeccCceEEEEEEeC--------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 486 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 486 (766)
++|.+.+.||+|+||.||+|... ++..||||+++.. .....++.+|..++.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 57889999999999999999853 2347999999754 35567899999999888 7999999999999999
Q ss_pred ceEEEEeecCCCCHhHhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 554 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 554 (766)
..++||||+++|+|.++|..... ....+++..++.++.||+.||+|||+ ++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 99999999999999999976532 12468999999999999999999999 8999999999999999
Q ss_pred CCCCeeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004247 555 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 633 (766)
Q Consensus 555 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 633 (766)
.++.+||+|||+++...............||+.|+|||++..+.|+.++|||||||+||||++ |+.||...........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999998776655554555789999999999999999999999999999999998 7888876554322111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 634 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 634 v~~~~~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+ ..+.. +...... ...+..++.+||+.||.+|||+.+|++.|+.
T Consensus 250 i-------~~~~~-----~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 250 L-------KEGHR-----MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp H-------HTTCC-----CCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-------HcCCC-----CCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 11110 1111111 2345667788999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=391.29 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEeC--CC--CEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~--~g--~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
++|.+.+.||+|+||.||+|.+. ++ ..||||+++.. ....++|.+|+.+|++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999853 23 36899998753 3556789999999999999999999999965 5779
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887543 358999999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCce-ecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 570 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 570 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
......... .....||+.|+|||++....++.++|||||||++|||+| |+.||.+.+.......+. ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~------~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH------hCCCC-
Confidence 765443322 223568889999999999999999999999999999998 899998654433222111 11110
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 648 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 648 ~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
+......+ ..+..++..||+.||.+||||.+|++.|+.
T Consensus 234 ----~~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ----LPRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 00111112 235566778999999999999999998863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-45 Score=400.24 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=204.1
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 492 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 492 (766)
++|.+.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|+.+|+.++|||||+++++|...+.+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999987 47999999998643 234567899999999999999999999999999999999
Q ss_pred eecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccC
Q 004247 493 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 493 E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 572 (766)
||+.+|+|..++.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 58999999999999999999999 8999999999999999999999999999997754
Q ss_pred CCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCc
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 652 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~ 652 (766)
.. ....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+.....
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------- 255 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------- 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred cc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------
Confidence 32 236799999999999999999999999999999999999999987654332222211110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 653 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 653 ~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
......+ ..+..++..||+.||.+|+ |+.+++++
T Consensus 256 ~~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 RFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0111112 2344566789999999994 89999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=393.66 Aligned_cols=260 Identities=21% Similarity=0.382 Sum_probs=210.8
Q ss_pred cCcccceeeeccCceEEEEEEeC------CCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 489 (766)
++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......|.+|+.++++++||||++++++|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56888999999999999999863 3578999999753 345567999999999999999999999999999999
Q ss_pred EEEeecCCCCHhHhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 490 LVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
+||||+++|+|.+++.... .....+++..+..|+.|++.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 122357899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCccchhhHHHhhccccc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILS 642 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~lv~~~~~~~~ 642 (766)
||+++...............||+.|+|||.+.++.++.++|||||||+||||+|| +.||...........+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence 9999877665444444446799999999999999999999999999999999998 47776544332222211
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004247 643 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 696 (766)
Q Consensus 643 ~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~~~ 696 (766)
.+..... .... ...+..++..||+.+|.+||||.+|+++|+...+
T Consensus 250 ~~~~~~~-----p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCC-----cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 1111 1346667788999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=390.00 Aligned_cols=259 Identities=25% Similarity=0.288 Sum_probs=195.6
Q ss_pred ceeeeccCceEEEEEEeC-CCCEEEEEEccCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004247 423 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 495 (766)
+++||+|+||+||+|.+. +|+.||||+++... ...+.+.+|+.+|++++|||||+++++|..++.++|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999974 69999999997532 12356889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
.++++..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 988777666433 358899999999999999999999 8999999999999999999999999999987655432
Q ss_pred CceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc---cccC
Q 004247 576 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT---QLLD 651 (766)
Q Consensus 576 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~---~lld 651 (766)
. ....+||+.|+|||++..+ .|+.++|||||||++|||++|+.||...........+...........+. ....
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2 2235799999999998755 57999999999999999999999998765443322221110000000000 0000
Q ss_pred cc-cC--CCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 652 PA-LG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 652 ~~-l~--~~~~~-----~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.. .. ..... .....+..++..||+.||++|||+.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00 00010 112345667788999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=394.36 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCC--EEEEEEccC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.+.||+|+||.||+|.+. +|. .||||.++. .....+.|.+|+++|.++ +|||||+++++|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999875 444 477888754 234567899999999999 799999999999999999999
Q ss_pred EeecCCCCHhHhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCe
Q 004247 492 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 559 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 559 (766)
|||+++|+|.++|+... .....++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997642 223579999999999999999999999 899999999999999999999
Q ss_pred eEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCC-CCCCCCCccchhhHHHhhc
Q 004247 560 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAK 638 (766)
Q Consensus 560 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~lv~~~~ 638 (766)
||+|||+++........ ....||..|+|||.+..+.|+.++|||||||++|||++|. .||...+... +.....
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 99999999865543322 2256999999999999999999999999999999999975 5676544322 211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004247 639 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 693 (766)
Q Consensus 639 ~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~ 693 (766)
.+. .+.. +......+..++..||+.||++||||.+|++.|+.
T Consensus 241 ----~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 241 ----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp ----GTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----hcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 0111 11112345566778999999999999999998864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=397.13 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=197.1
Q ss_pred hcCcccc-eeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee----cCceE
Q 004247 417 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNLL 489 (766)
Q Consensus 417 t~~f~~~-~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~~~ 489 (766)
.++|.+. ++||+|+||+||+|.+ .+|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4578876 5799999999999986 57899999999754 3466799987655 89999999999875 46789
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC---CCCeeEecccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 566 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGl 566 (766)
|||||++||+|.++|..... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999975432 469999999999999999999999 89999999999999985 56799999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCcc
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 646 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~ 646 (766)
|+........ ....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.........+ ...+..+..
T Consensus 161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY 234 (335)
T ss_dssp CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC
Confidence 9876654332 3368999999999999889999999999999999999999999765433221111 001111110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. +...........+..++..||+.||.+|||+.+++++
T Consensus 235 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp S------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 0000001112345667788999999999999999984
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=397.05 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=202.7
Q ss_pred cCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC----hhHHHHHHHHHHHHH-hcCCCceeEEeeEEeecCceEEE
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLV 491 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~~lV 491 (766)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999874 7899999999743 234556778888765 68999999999999999999999
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 571 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 571 (766)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997654 58899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccC
Q 004247 572 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 651 (766)
Q Consensus 572 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld 651 (766)
..... .+...||+.|+|||++.++.|+.++|||||||++|||++|+.||.+.+.......+....+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------ 220 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------ 220 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred ccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 43332 2346899999999999999999999999999999999999999987654433222221111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004247 652 PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 689 (766)
Q Consensus 652 ~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~-eVL~ 689 (766)
.+....+ ..+..++..||+.||.+||++. ++++
T Consensus 221 -~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111112 2345566789999999999985 6765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=388.93 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=198.6
Q ss_pred ceeeeccCceEEEEEEeCCC----CEEEEEEccC--ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-CceEEEEeec
Q 004247 423 ENLIGKGGSSQVYKGCLPDG----KELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 495 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~g----~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~~~~lV~E~~ 495 (766)
.++||+|+||+||+|.+.++ ..||||+++. .....++|.+|+++|++++||||++++|+|.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987432 2589999974 445678899999999999999999999998764 5789999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCCC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 575 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 575 (766)
++|+|.+++.... ..+.+..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987654 357888999999999999999999 8999999999999999999999999999987655432
Q ss_pred Cc--eecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccccccCcc
Q 004247 576 HI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 653 (766)
Q Consensus 576 ~~--~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~~lld~~ 653 (766)
.. ......||+.|+|||++..+.++.++||||||++||||+||+.||........ +..+. ..|. ....|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i----~~g~--~~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGR--RLLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC--CCCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCC--CCCCc-
Confidence 21 22235799999999999999999999999999999999998888765432211 11111 1111 11111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004247 654 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 694 (766)
Q Consensus 654 l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~~~ 694 (766)
.... ..+..++..||+.||++||+|.+|+++|+..
T Consensus 257 ---~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 ---EYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---ccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112 2455667789999999999999999998644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=386.28 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+++|++++|||||+++++|.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 579999999997533 235688999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
|+.+ .+..++..... ..+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976 44444433322 368999999999999999999999 89999999999999999999999999999877543
Q ss_pred CCCceecccccccCCCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC---ccccc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQL 649 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~~~~l 649 (766)
.. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+.......+.......... .....
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32 223457999999999987665 5789999999999999999999998765433222111100000000 00000
Q ss_pred cC--cccCC--CCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 650 LD--PALGN--NYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 650 ld--~~l~~--~~~-----~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
.+ +.... ... ......+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 000 0111344556778999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-44 Score=381.26 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004247 418 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 494 (766)
++|.+.+.||+|+||+||+|.+++|+.||||+++... ...+.+.+|+.+|++++||||++++++|...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999997532 3357899999999999999999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCCC
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 574 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 574 (766)
+.++.+..+.... ..+++..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887766666443 369999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC---cccccc
Q 004247 575 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQLL 650 (766)
Q Consensus 575 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~~~~ll 650 (766)
.. .....||+.|+|||.+... .++.++|||||||++|||++|+.||.+.+.......+.......... ......
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 2235799999999998754 57899999999999999999999998765433222211111000000 000000
Q ss_pred --CcccC-------CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 651 --DPALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 651 --d~~l~-------~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..+. ..........+..++..||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00011112345566778999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=384.72 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=196.5
Q ss_pred hcCcccceeeeccCceEEEEEEe-CC-CCEEEEEEccCC---hhHHHHHHHHHHHHHhc---CCCceeEEeeEEee----
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PD-GKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE---- 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~-g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~---- 484 (766)
.++|.+.+.||+|+||+||+|.+ .+ ++.||||+++.. ......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 567999998642 22234566788777666 79999999999863
Q ss_pred -cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEec
Q 004247 485 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 563 (766)
Q Consensus 485 -~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 563 (766)
...++++|||+.++.+........ ..+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 346899999999877765554332 468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc
Q 004247 564 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 564 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
||+++...... ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+.........
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99998654332 223468999999999999999999999999999999999999999876544333322211100000
Q ss_pred Cccc-----------cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKVT-----------QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~~-----------~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+. ......+ ..+.......+..++..||+.||.+|||+.|+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000000 00111112234456678999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=381.14 Aligned_cols=240 Identities=22% Similarity=0.362 Sum_probs=194.6
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCCh-------hHHHHHHHHHHHHHhcC--CCceeEEeeEEeecC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFEDN 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~ 486 (766)
.++|.+.++||+|+||+||+|.. .+|+.||||+++... ....++.+|+.+|++++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999986 478999999986421 12345678999999997 899999999999999
Q ss_pred ceEEEEeecCC-CCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-CCCeeEecc
Q 004247 487 NLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDF 564 (766)
Q Consensus 487 ~~~lV~E~~~g-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DF 564 (766)
..++||||+.+ +++.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 57888876543 58999999999999999999999 89999999999999985 479999999
Q ss_pred cccccccCCCCCceecccccccCCCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc
Q 004247 565 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 643 (766)
Q Consensus 565 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 643 (766)
|+|+...... .+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... .+ ......
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-~~~~~~--- 222 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-IRGQVF--- 222 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-HHCCCC---
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-hhcccC---
Confidence 9998654432 234689999999999987766 567899999999999999999996531 11 111110
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+...++ ..+..++..||+.||.+|||+.+++++
T Consensus 223 ----------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 ----------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111122 234556678999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=374.11 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=197.2
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 484 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 484 (766)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++... ....+.+.+|+.+|++++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 47999999998643 2345678899999999999999999999855
Q ss_pred cCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecc
Q 004247 485 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 564 (766)
Q Consensus 485 ~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 564 (766)
.+.+++||||+.++.+....... ..++...+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999887666554333 358889999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC--ceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004247 565 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 641 (766)
Q Consensus 565 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 641 (766)
|+++........ ......+||+.|+|||++... .|+.++|||||||++|||++|+.||.+.........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999866543211 122235799999999998755 68999999999999999999999998765443333322211111
Q ss_pred ccCccccccCc--------ccCCCCCh-HH------HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 642 SSGKVTQLLDP--------ALGNNYDY-DQ------MERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 642 ~~g~~~~lld~--------~l~~~~~~-~~------~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
........... ........ +. ...+..++..||+.||++|||+.|+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11000010000 00000011 11 1123456778999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-43 Score=380.07 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=192.3
Q ss_pred CcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------CceEEE
Q 004247 419 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLLV 491 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~~lV 491 (766)
+|...++||+|+||+||+|.+. +|+.||||+++.... .+.+|+++|++++||||++++++|... .+++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4778899999999999999974 799999999976543 234799999999999999999998643 347899
Q ss_pred EeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccccccc
Q 004247 492 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 570 (766)
Q Consensus 492 ~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~ 570 (766)
|||++++.+..+.+ .......+++..++.|+.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998764443332 11223468999999999999999999999 8999999999999999775 8999999999877
Q ss_pred cCCCCCceecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc-----------
Q 004247 571 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----------- 638 (766)
Q Consensus 571 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~----------- 638 (766)
...... ....||+.|+|||.+.. ..|+.++|||||||++|||++|+.||...........+....
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 554332 23579999999998775 478999999999999999999999998765433222221100
Q ss_pred -cccccCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 -PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 -~~~~~g~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+......+...................+..++.+||+.||.+|||+.|+|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001111100000000011112234556678999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=374.54 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=197.3
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----ceE
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLL 489 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~ 489 (766)
+++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 58999999999753 355678999999999999999999999997643 235
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccccc
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 569 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 569 (766)
++++|+.+|+|.+++... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667799999999753 48999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-eecccccccCCCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCccc
Q 004247 570 ASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 647 (766)
Q Consensus 570 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~~~ 647 (766)
........ .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 65432221 1234679999999999854 467899999999999999999999998765433322221111110000000
Q ss_pred --------c-ccCcccCCCCChH-----HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 648 --------Q-LLDPALGNNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 648 --------~-lld~~l~~~~~~~-----~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
. ............. ....+..++..||+.||.+|||+.++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000000110 01235567788999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=373.73 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=192.8
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 486 (766)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999986 46999999999753 355678999999999999999999999997654
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+|+||||+ +++|..+++.. .+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 66788777543 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc--
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 643 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 643 (766)
|+...... +...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.................
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98765432 235799999999998764 5689999999999999999999999876543322111110000000
Q ss_pred -------------CccccccCc---ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 -------------GKVTQLLDP---ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 -------------g~~~~lld~---~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+...... .+....+ ..+..++..||+.||.+|||+.++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0001112 234456678999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=362.76 Aligned_cols=257 Identities=22% Similarity=0.283 Sum_probs=193.7
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCceeE-EeeEEeecCceEEEEeec
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS-LLGFCFEDNNLLLVYDFL 495 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~~~lV~E~~ 495 (766)
++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ..++.+|+++++.++|+|++. +.+++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 5699999999999999999986 4689999999875432 246788999999998776555 455566778889999999
Q ss_pred CCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeC---CCCCeeEecccccccccC
Q 004247 496 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWAST 572 (766)
Q Consensus 496 ~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~~~~ 572 (766)
+++|...+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+....
T Consensus 86 -~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 -GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp -CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred -CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 557777665443 368999999999999999999999 8999999999999985 455799999999998765
Q ss_pred CCCC-----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHH-hhccccccCcc
Q 004247 573 SSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM-WAKPILSSGKV 646 (766)
Q Consensus 573 ~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~-~~~~~~~~g~~ 646 (766)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+. +...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh
Confidence 4322 12234689999999999998899999999999999999999999998755433222211 1110000 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 647 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 647 ~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
+.+....+ ..+..++..||+.+|.+||++.++.+.|+
T Consensus 238 -----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 238 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp -----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred -----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11111122 23445567899999999999999888775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=360.14 Aligned_cols=264 Identities=21% Similarity=0.241 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 493 (766)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.. ......+.+|+.+|+.++||||++++++|......++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 47899999998643 3567889999999999999999999999999999999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccccccccCC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 573 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 573 (766)
++.+++|..++...+ .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876543 57899999999999999999999 89999999999999999999999999999977654
Q ss_pred CCCceecccccccCCCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCccch-hhHHHhhccccccCcc---cc
Q 004247 574 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKV---TQ 648 (766)
Q Consensus 574 ~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~~---~~ 648 (766)
.... ....+++.|+|||.+.... ++.++|||||||++|||++|+.||........ ...+............ ..
T Consensus 155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 3322 2346788999999988665 68999999999999999999999754332221 1111111000000000 00
Q ss_pred ccC---------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 649 LLD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 649 lld---------~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
..+ ..-...........+..++..||+.||.+|||++|+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000111112334556678999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-41 Score=360.45 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=203.1
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEee
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 494 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~ 494 (766)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+|++++..+.| +|++.+++++..+...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 368999999999999999999964 68999999986533 22456789999999975 8999999999999999999999
Q ss_pred cCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCC-----CCCeeEeccccccc
Q 004247 495 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKW 569 (766)
Q Consensus 495 ~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-----~~~vkL~DFGla~~ 569 (766)
+ +++|.++++... ..+++..+..++.|++.||+|||+ ++||||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 789999987654 368999999999999999999999 99999999999999974 57899999999997
Q ss_pred ccCCCCC-----ceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccC
Q 004247 570 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 644 (766)
Q Consensus 570 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 644 (766)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543222 12234689999999999999999999999999999999999999998765544332221111000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004247 645 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 692 (766)
Q Consensus 645 ~~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~L~ 692 (766)
...+ +....+ + .+..++..|+..+|.+||+++.+.+.|+
T Consensus 236 ~~~~-----l~~~~p-~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 236 PLRE-----LCAGFP-E---EFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp CHHH-----HTTTSC-H---HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ChHH-----hcCCCC-H---HHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1111 112222 2 3444556799999999999998888775
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=365.65 Aligned_cols=258 Identities=19% Similarity=0.303 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEee--cCceEEEEe
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVYD 493 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~~lV~E 493 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... .+++.+|+.+|..++ ||||++++++|.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5899999999999999999987 478999999997643 467889999999995 9999999999974 456999999
Q ss_pred ecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCC-CeeEecccccccccC
Q 004247 494 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAST 572 (766)
Q Consensus 494 ~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~ 572 (766)
|+.+++|..+.+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987642 48899999999999999999999 9999999999999998655 699999999987655
Q ss_pred CCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhh-HH----------Hhhcc-
Q 004247 573 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LV----------MWAKP- 639 (766)
Q Consensus 573 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv----------~~~~~- 639 (766)
.... ....||+.|+|||.+... .++.++|||||||++|||++|+.||.......... .+ .|...
T Consensus 183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 336799999999998765 47999999999999999999999997654322111 10 00000
Q ss_pred -ccccCccccccC--------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 640 -ILSSGKVTQLLD--------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 640 -~~~~g~~~~lld--------~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
............ ..............+..++..||+.||.+|||++|+|++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 000000111112334556778999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-42 Score=367.29 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEe----CCCCEEEEEEccCC-----hhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCc
Q 004247 418 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNN 487 (766)
Q Consensus 418 ~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~ 487 (766)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999975 25889999998642 2345678899999999976 899999999999999
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
+++||||+.+|+|.+++.... .+....+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998664 46788899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhccccccCc
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 645 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 645 (766)
+......... .....||+.|+|||.+... .++.++|||||||+||||++|+.||...........+...... +
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---~- 251 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S- 251 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---C-
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---C-
Confidence 8765433322 2346799999999999754 4788999999999999999999999876654433222111100 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004247 646 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 690 (766)
Q Consensus 646 ~~~lld~~l~~~~~~~~~~~~~~~~~~Cl~~dP~~RP-----s~~eVL~~ 690 (766)
.+.+.. .....+..++..||+.||.+|| |++|++++
T Consensus 252 -----~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -----EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 001111 1123445566789999999999 47888863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=364.88 Aligned_cols=261 Identities=22% Similarity=0.250 Sum_probs=191.0
Q ss_pred hcCcccceeeeccCceEEEEEEeC-CCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee------cC
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 486 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 486 (766)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. .....++.+|+.+|++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999875 6999999999753 3556678999999999999999999999964 36
Q ss_pred ceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEecccc
Q 004247 487 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 566 (766)
Q Consensus 487 ~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 566 (766)
.+|+||||+.++ |.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 789999999765 444443 247899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhc--------
Q 004247 567 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 638 (766)
Q Consensus 567 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-------- 638 (766)
++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 886655332 234679999999999999999999999999999999999999998765332221111000
Q ss_pred --------------cccccCccccccCcccCCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 639 --------------PILSSGKVTQLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 639 --------------~~~~~g~~~~lld~~l~~~~---~~~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
+..........+........ .......+..++..||+.||++|||++|+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000011111111111111 11223456667788999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=366.04 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=194.1
Q ss_pred hcCcccceeeeccCceEEEEEEe-CCCCEEEEEEccCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004247 417 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 487 (766)
Q Consensus 417 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 487 (766)
+++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999986 57999999999753 34556789999999999999999999998643 34
Q ss_pred eEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCeeEeccccc
Q 004247 488 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 567 (766)
Q Consensus 488 ~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 567 (766)
.+++|+|+.+|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 46777888899999998643 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCccchhhHHHhhcccccc---
Q 004247 568 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS--- 643 (766)
Q Consensus 568 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~--- 643 (766)
...... .....||+.|+|||.+... .++.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus 169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 755432 2336799999999987765 4688999999999999999999999876543332222111100000
Q ss_pred -----CccccccCcccC-CCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004247 644 -----GKVTQLLDPALG-NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 690 (766)
Q Consensus 644 -----g~~~~lld~~l~-~~~~~-----~~~~~~~~~~~~Cl~~dP~~RPs~~eVL~~ 690 (766)
............ ..... .....+..++..||+.||.+|||+.|+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000 00000 011234556678999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-36 Score=330.15 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=191.8
Q ss_pred CcccceeeeccCceEEEEEEe-CCCCEEEEEEccCChhHHHHHHHHHHHHHhcC-----------CCceeEEeeEEeec-
Q 004247 419 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFED- 485 (766)
Q Consensus 419 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~~~~~- 485 (766)
+|.+.+.||+|+||+||+|.. .+|+.||||+++......+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 499999999999999999986 57999999999987766778899999998885 47899999988653
Q ss_pred -CceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCC------
Q 004247 486 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE------ 558 (766)
Q Consensus 486 -~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~------ 558 (766)
...+++|+++..+......... .....+.+..+..++.||+.||.|||+ ..+|+||||||+||||+.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 4567777776665443333222 122468889999999999999999996 268999999999999976543
Q ss_pred eeEecccccccccCCCCCceecccccccCCCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCccch----hhHH
Q 004247 559 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLV 634 (766)
Q Consensus 559 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~----~~lv 634 (766)
++|+|||.+....... ...+||+.|+|||++....++.++|||||||++++|++|+.||........ ..+.
T Consensus 171 ~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 8999999998655432 235799999999999999999999999999999999999999976543211 1111
Q ss_pred H--hhc---------------cccccCccccccCcc----------cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 004247 635 M--WAK---------------PILSSGKVTQLLDPA----------LGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 687 (766)
Q Consensus 635 ~--~~~---------------~~~~~g~~~~lld~~----------l~~~~~~~~~~~~~~~~~~Cl~~dP~~RPs~~eV 687 (766)
. +.. ...........+... ............+..++..||..||.+|||+.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 000 000000000000000 0112234456677778889999999999999999
Q ss_pred HHH
Q 004247 688 LKL 690 (766)
Q Consensus 688 L~~ 690 (766)
|++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.3e-23 Score=207.62 Aligned_cols=164 Identities=16% Similarity=0.168 Sum_probs=123.2
Q ss_pred cccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-------------------hHHHHHHHHHHHHHhcCCCceeEEee
Q 004247 420 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHHKNIISLLG 480 (766)
Q Consensus 420 f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~iL~~l~HpnIv~l~~ 480 (766)
+.+.+.||+|+||+||+|.+.+|+.||||+++... .....+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34678999999999999998899999999876321 11234557889999999999998876
Q ss_pred EEeecCceEEEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCCCCceEeecccCCCeeeCCCCCee
Q 004247 481 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 560 (766)
Q Consensus 481 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 560 (766)
+. ..+++|||++++.+.+ +.......++.|++.+|.|||+ ++|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 53 2389999998865533 2334456799999999999999 899999999999999865 599
Q ss_pred EecccccccccCCCCCceecccccccCCCC------chhhccCCCCCchhhHHHHHHHH
Q 004247 561 LSDFGLAKWASTSSSHITCTDVAGTFGYLA------PEYFMYGKVNDKIDVYAFGVVLL 613 (766)
Q Consensus 561 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~A------PE~l~~~~~s~ksDVwSlGvvL~ 613 (766)
|+|||+|......... .|+. .+++ ...|+.++|+||+.--++
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 9999999765432211 1111 1233 257889999999765443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.83 E-value=9.1e-21 Score=183.66 Aligned_cols=134 Identities=19% Similarity=0.298 Sum_probs=102.8
Q ss_pred cEEEEEEcCCc---------chHHHHHHHHhhccCCCC---EEEEEEeecCCccccCCCCC---c-------chhhhHHH
Q 004247 17 RTVVVGVKLDT---------HSRELLTWALVKVAQPGD---TVIALHVLANNAIVDRDGKS---S-------LLSLVKAF 74 (766)
Q Consensus 17 r~I~V~Vd~s~---------~S~~AL~WAl~~~~~~gd---~vvlvHV~~~~~~~~~~~~~---~-------~~~~~~~~ 74 (766)
++|+||||.|. +|++||+||++++++.|| .|+++||............. . .....+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 68999999986 799999999999999999 48899998654322111111 1 01112233
Q ss_pred HHHHHHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEE
Q 004247 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLA 151 (766)
Q Consensus 75 ~~~l~~~~~~C~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~v 151 (766)
.++|+.+...|..+++.++..+.. |++.++|+++|++.++++||||++++ .+.++| ||++||++|++ |||++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lG--Sv~~~vi~~~~--cpVlv 156 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVG--TVSAFCVKHAE--CPVMT 156 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC----------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEe-CChHHHHHHHHhhcCCcEEEeccCCccccccCccC--cHHHHHHhCCC--CCEEE
Confidence 488999999999999999999888 89999999999999999999999988 667788 99999999998 99999
Q ss_pred EeCC
Q 004247 152 VNNG 155 (766)
Q Consensus 152 V~~g 155 (766)
|+.+
T Consensus 157 V~~~ 160 (171)
T d2gm3a1 157 IKRN 160 (171)
T ss_dssp EECC
T ss_pred EeCC
Confidence 9864
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.75 E-value=4.9e-18 Score=161.80 Aligned_cols=134 Identities=17% Similarity=0.156 Sum_probs=108.6
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCC----------CCcchh--------hhHHHHHHH
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG----------KSSLLS--------LVKAFDSVL 78 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~----------~~~~~~--------~~~~~~~~l 78 (766)
|+|+||||+|+.|.+||+||++.+-+.++.|++|||.++........ ...... ..+...+.|
T Consensus 4 ~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 83 (160)
T d1mjha_ 4 KKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNKM 83 (160)
T ss_dssp CEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999888899999999986543211100 000000 112223778
Q ss_pred HHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004247 79 AVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (766)
Q Consensus 79 ~~~~~~C~~k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~g 155 (766)
+.+...|...+|.++.++.. |++.+.|+++|+..++|++|||++++ .+.|+| |+++|+++|++ |||++|++.
T Consensus 84 ~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--S~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 84 ENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLG--SVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSC--HHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCcccccccC--cHHHHHHhcCC--CCEEEEcCC
Confidence 88888899999999999998 79999999999999999999999987 677788 99999999998 999999864
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.71 E-value=8.1e-18 Score=155.59 Aligned_cols=131 Identities=16% Similarity=0.138 Sum_probs=102.8
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEEEEE
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKI 96 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v 96 (766)
++|+|+||+|+.|..||+||+..+.+.|+.|+++||.++........ .......+..++..+.++.+++..++.....+
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 80 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEP-FFEEALRRRLERAEGVLEEARALTGVPKEDAL 80 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCTT-HHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCccccccc-hhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEE
Confidence 68999999999999999999999999999999999997543321111 01111222333555556666666666666666
Q ss_pred EECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004247 97 CRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (766)
Q Consensus 97 ~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV 152 (766)
+.+|++.++|+++|+..++|+||||++++ .|.+.| |+++||+++++ |||++|
T Consensus 81 ~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 81 LLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLG--SQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCB--HHHHHHHHHCS--SCEEEE
T ss_pred EEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccC--cHHHHHHHhCC--CCEEeC
Confidence 66799999999999999999999999987 566777 99999999998 999997
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.67 E-value=5.5e-17 Score=150.58 Aligned_cols=132 Identities=13% Similarity=0.127 Sum_probs=104.6
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccCCCCCcchhhhHHH----HHHHHHHHhHhhhcCCcE
Q 004247 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF----DSVLAVYEGFCNLKQVDL 92 (766)
Q Consensus 17 r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~----~~~l~~~~~~C~~k~V~~ 92 (766)
++|+||||+++.|..||+||+..+.+.|+.|+++||.+.+........... ..+.. .+....+...+...+...
T Consensus 3 k~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (140)
T d1jmva_ 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVN--MSSMQDRISTETQKALLDLAESVDYPI 80 (140)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHH--HHHHTTCCCCHHHHHHHHHHHHSSSCC
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccc--hHHHHHHHHHHHHHHHHHHHHhcCCce
Confidence 789999999999999999999999899999999999876643222221111 11111 155566666777777666
Q ss_pred EEEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 93 ~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
...++++|++.++|+++|+++++|+||||++++....+| |+++|+++|++ |||++|+-
T Consensus 81 ~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lg--s~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 81 SEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLM--SSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp CCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHH--HHHHHHHTTCC--SEEEEEEC
T ss_pred EEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcc--cHHHHHHhccC--CCEEEEec
Confidence 677777799999999999999999999999988555577 99999999998 99999973
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.65 E-value=2.6e-16 Score=147.16 Aligned_cols=137 Identities=16% Similarity=0.056 Sum_probs=97.9
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEe-ecCCccccCCCC----CcchhhhHHHHHHHHHHHhHhhh
Q 004247 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHV-LANNAIVDRDGK----SSLLSLVKAFDSVLAVYEGFCNL 87 (766)
Q Consensus 13 ~~~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV-~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~C~~ 87 (766)
|..=++|+|+||+|+.|++||+||+..+. .++.++++|+ .+.......... .......+...+.++.++..|..
T Consensus 2 M~~yk~ILv~vD~s~~s~~al~~A~~la~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 80 (147)
T d1tq8a_ 2 LSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHN 80 (147)
T ss_dssp CCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHT
T ss_pred CcCCCEEEEEECCCHHHHHHHHHHHHHHh-cCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 33458999999999999999999998665 5555555554 432221111110 00111122233788999999998
Q ss_pred cCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004247 88 KQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (766)
Q Consensus 88 k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~---~r~~~g~~sVs~yc~~~ap~~C~V~vV~~ 154 (766)
.++......+..|++.+.|+++|+.+++++||||++++ .+.++| |++.||+++++ |||++|+.
T Consensus 81 ~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~G--s~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 81 AGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLG--SVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp TTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTB--BHHHHHHHHTT--CEEEEECC
T ss_pred cCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccc--cHHHHHHHhCC--CCEEEEec
Confidence 88875444555599999999999999999999999987 566788 99999999998 99999973
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.38 E-value=3.2e-13 Score=124.11 Aligned_cols=127 Identities=11% Similarity=-0.013 Sum_probs=89.5
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCccccC----CCCCcchh----hhHHHHHHHHHHHhHhhh
Q 004247 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR----DGKSSLLS----LVKAFDSVLAVYEGFCNL 87 (766)
Q Consensus 16 ~r~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~----~~~~~~~~----~~~~~~~~l~~~~~~C~~ 87 (766)
=|+|+|++|+|+.|..||.||++.+-+.|+.|+++||..+...... .+...... ..+...+.++.+..-+..
T Consensus 4 mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~ 83 (138)
T d1q77a_ 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTG 83 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred CCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhcccccc
Confidence 3899999999999999999999999999999999999853211000 01111111 112222444444444444
Q ss_pred cCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEe
Q 004247 88 KQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (766)
Q Consensus 88 k~V~~~~~v~~~~d~~~~lv~~a~~~~a~~LVlG~~~~~r~~~g~~sVs~yc~~~ap~~C~V~vV~ 153 (766)
.++.++.++.. |++.+.|++.|+..++|++|||++++ +....++... .||+++|+
T Consensus 84 ~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~--------~~l~r~l~g~--~~~~livk 138 (138)
T d1q77a_ 84 STEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGL--NLASLIVK 138 (138)
T ss_dssp CCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHS--SSEEEECC
T ss_pred cceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCCC--------cHHHHHhcCC--CCCEEEeC
Confidence 57788888877 89999999999999999999999985 2223344444 39999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=8.1e-07 Score=89.16 Aligned_cols=147 Identities=18% Similarity=0.145 Sum_probs=98.8
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEeCCCCEEEEEEccCCh-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004247 412 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 489 (766)
Q Consensus 412 el~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 489 (766)
++......|++.+..+.+..+.||+... +++.+++|+..... .....+.+|...+..+. +--+.+++.++..++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444445666666555555578998765 66678888876432 23345677888888775 333667788888888899
Q ss_pred EEEeecCCCCHhHhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 004247 490 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------- 537 (766)
Q Consensus 490 lV~E~~~ggsL~~~L~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------- 537 (766)
+||++++|.++.+...... ....++.+++..|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999988865542111 12234455555555565411
Q ss_pred ------------------------CCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 538 ------------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 538 ------------------------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=7.8e-06 Score=81.30 Aligned_cols=75 Identities=16% Similarity=0.040 Sum_probs=54.6
Q ss_pred eeeccC-ceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEEEeecCCCCHh
Q 004247 425 LIGKGG-SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLE 501 (766)
Q Consensus 425 ~LG~G~-fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 501 (766)
.+..|. .+.||+....++..+++|....... ..+..|...++.+.. -.+.+++.++.+.+..++||+|++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344444 3679999887888899998775432 346678888877743 33567788888888899999999887654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00015 Score=77.37 Aligned_cols=76 Identities=17% Similarity=0.138 Sum_probs=49.6
Q ss_pred ceeeeccCceEEEEEEeC-CCCEEEEEEccCC--------hhHHHHHHHHHHHHHhcC-C--CceeEEeeEEeecCceEE
Q 004247 423 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--------EDVIKEFVLEIEIITTLH-H--KNIISLLGFCFEDNNLLL 490 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~l 490 (766)
.+.||.|....||+.... +++.++||.-.+. .....+...|.+.|..+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999865 4678999975431 112334556888887763 2 345555544 4456689
Q ss_pred EEeecCCCCH
Q 004247 491 VYDFLSRGSL 500 (766)
Q Consensus 491 V~E~~~ggsL 500 (766)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.19 E-value=0.00054 Score=70.72 Aligned_cols=136 Identities=16% Similarity=0.231 Sum_probs=81.1
Q ss_pred ceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCCce--eEEe-----eEEeecCceEEEEeecCCCCHhH-
Q 004247 431 SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--ISLL-----GFCFEDNNLLLVYDFLSRGSLEE- 502 (766)
Q Consensus 431 fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~-----~~~~~~~~~~lV~E~~~ggsL~~- 502 (766)
--.||+....+|..|++|+.++.....+++..|...+..|...++ +..+ ..+..++..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 468999999999999999998765556778889988888853222 1111 12334566789999998753321
Q ss_pred -------------hhhc----CC-CCCCCCChH-------------------HHHHHHHHHHHHHHHHH----cCCCCce
Q 004247 503 -------------NLHG----NK-KDPAAFGWS-------------------ERYKVAMGVAEALEYLH----SGSAQRV 541 (766)
Q Consensus 503 -------------~L~~----~~-~~~~~l~~~-------------------~~~~i~~qia~aL~yLH----~~~~~~I 541 (766)
.+|. .. .....+++. .+..+...+...+..+. ...+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0111 00 001111111 11112222222333332 2234679
Q ss_pred EeecccCCCeeeCCCCCeeEecccccc
Q 004247 542 IHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 542 iHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
||+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 5689998775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.79 E-value=0.001 Score=70.42 Aligned_cols=74 Identities=18% Similarity=0.229 Sum_probs=51.5
Q ss_pred ceeeeccCceEEEEEEeCC--------CCEEEEEEccCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEe
Q 004247 423 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYD 493 (766)
Q Consensus 423 ~~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E 493 (766)
.+.|+.|-.-.+|+...++ .+.|++++.-..... ....+|..+++.+.-.++ .+++++|.. .+|||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678889999999988653 356788887643333 345679999988863344 467777642 78999
Q ss_pred ecCCCCHh
Q 004247 494 FLSRGSLE 501 (766)
Q Consensus 494 ~~~ggsL~ 501 (766)
|++|..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.36 E-value=0.0042 Score=63.05 Aligned_cols=158 Identities=15% Similarity=0.094 Sum_probs=82.2
Q ss_pred CHHHHHHHhcCccccee-----eeccCceEEEEEEeCCCCEEEEEEccCChhHHHHHHHHHHHHHhcCCC-----ceeEE
Q 004247 409 NYQDLLSATSNFLAENL-----IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK-----NIISL 478 (766)
Q Consensus 409 ~~~el~~~t~~f~~~~~-----LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp-----nIv~l 478 (766)
+.+++.....+|.+.++ |..|---+.|+....+|+ +++|+..... ..+++..|++++..|... ..+..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhcccccccccee
Confidence 34555556666655333 445666788998886665 8999986532 223455567777776432 21111
Q ss_pred e-e--EEeecCceEEEEeecCCCCHhH--------------hhhcCC---CCCCC--C------------------ChHH
Q 004247 479 L-G--FCFEDNNLLLVYDFLSRGSLEE--------------NLHGNK---KDPAA--F------------------GWSE 518 (766)
Q Consensus 479 ~-~--~~~~~~~~~lV~E~~~ggsL~~--------------~L~~~~---~~~~~--l------------------~~~~ 518 (766)
. | +.........++.++.+..... .++... ..+.. . ....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1 0 1122345667777776643321 011000 00000 0 0011
Q ss_pred HHHHHHHHHHHHHHHHc-CCCCceEeecccCCCeeeCCCCCeeEecccccc
Q 004247 519 RYKVAMGVAEALEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 568 (766)
Q Consensus 519 ~~~i~~qia~aL~yLH~-~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 568 (766)
....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 12222223333333332 235789999999999999988767899999773
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=91.06 E-value=0.37 Score=45.70 Aligned_cols=97 Identities=13% Similarity=-0.026 Sum_probs=63.3
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCC-CEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004247 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPG-DTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~S~~AL~WAl~~~~~~g-d~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (766)
++.+|+|||.+..+|..+|.++..-.-.-+ ..|.++||-+.... . -+.-....+.+|+..+|++.
T Consensus 23 ~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r~------~--------s~~~~~~~~~~~~~l~i~~~ 88 (216)
T d1wy5a1 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLRE------S--------AERDEEFCKEFAKERNMKIF 88 (216)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSST------H--------HHHHHHHHHHHHHHHTCCEE
T ss_pred CCCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeeccccc------c--------hhhhhhHHHHHHHhhhhhhh
Confidence 467999999999999966665544322223 37899999643210 0 01122445778888888876
Q ss_pred EEEEEC--------C-------Ch-hHHHHHHHHhcCCcEEEEccCCC
Q 004247 94 LKICRG--------T-------SI-RKILVREAQSYSATKFIVGTAKN 125 (766)
Q Consensus 94 ~~v~~~--------~-------d~-~~~lv~~a~~~~a~~LVlG~~~~ 125 (766)
..-... . .. ...+.+.|++.+++.|++|.+..
T Consensus 89 i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 89 VGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp EEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred hhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 543320 0 11 24678889999999999999865
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=87.17 E-value=0.35 Score=46.12 Aligned_cols=96 Identities=17% Similarity=0.157 Sum_probs=61.0
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhcc-CCCCEEEEEEeecCCccccCCCCCcchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004247 15 AGRTVVVGVKLDTHSRELLTWALVKVA-QPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (766)
Q Consensus 15 ~~r~I~V~Vd~s~~S~~AL~WAl~~~~-~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (766)
..++|+|||.+..+|..+|..+....- .+|-.|+++||-+.... . . +.-....+.+|...+|.+.
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r~------~-----s---~~~~~~~~~~~~~~~i~~~ 77 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLSA------N-----A---DAWVTHCENVCQQWQVPLV 77 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCCS------S-----H---HHHHHHHHHHHHHTTCCEE
T ss_pred CCCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCCCc------c-----h---hhhHHHHHHHHhhccCcce
Confidence 357999999999999977776655433 35789999999754311 0 1 1223456778998888877
Q ss_pred EEEEECCChh----------HHHHHHHHhcCCcEEEEccCC
Q 004247 94 LKICRGTSIR----------KILVREAQSYSATKFIVGTAK 124 (766)
Q Consensus 94 ~~v~~~~d~~----------~~lv~~a~~~~a~~LVlG~~~ 124 (766)
..-....... +.+...+...+++.+++|.+.
T Consensus 78 i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 78 VERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp EECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred eeeccccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 6544321111 222333455667787777664
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=82.90 E-value=3.6 Score=37.79 Aligned_cols=33 Identities=21% Similarity=0.161 Sum_probs=28.6
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeec
Q 004247 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLA 54 (766)
Q Consensus 18 ~I~V~Vd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~ 54 (766)
+|+||+.+..+|.-|+.|+... |..|++||+-.
T Consensus 6 Kvvv~~SGG~DS~vla~ll~k~----g~~v~av~~~~ 38 (218)
T d2c5sa1 6 KVMVLLSGGIDSPVAAYLTMKR----GVSVEAVHFHS 38 (218)
T ss_dssp EEEEECCSSSHHHHHHHHHHHB----TEEEEEEEEEC
T ss_pred EEEEEecCcHHHHHHHHHHHHc----CCeEEEEEEeC
Confidence 7999999999999888887653 78999999964
|